Drug Name,Current Indication,Possible Repurposed Use,Repurposing Score (%),Molecular Formula,Mechanism of Action,Side Effects,Approval Year,Generic Name,Brand Name,Side Effect Prediction (AI/ML),Pharmacokinetics (ADME),Clinical Trial Data,Preclinical Studies,Pathway Analysis,Dosage Forms,Recommended Dosage,Marketed By,Half-Life (tÂ½) (hours),AI Predicted Repurposing Potential,AI-Based Drug-Drug Interaction Risk,Bioavailability,Absorption Rate,Metabolism Type,AI-Powered Personalized Medicine Suitability
Aspirin,Cholesterol Control,Antiviral,47.3,C9H8O4,Proton Pump Inhibitor,"Headache, Rash",1965,Omeprazole,Lipitor,Low Risk,Liver Metabolism,Completed,Toxicology Report,Immune Response Pathway,Capsule,10mg once daily,Roche,6,Moderate,Low Risk,Low (<50%),Moderate,Gut,Not Suitable
Metformin,Diabetes,Liver Disease,84.66,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1996,Atorvastatin Calcium,Advil,Moderate Risk,Liver Metabolism,Phase 2,No Preclinical Data,PI3K-AKT Pathway,Syrup,50mg daily,Novartis,12,High,Low Risk,Moderate (50-80%),Moderate,Liver,Partially Suitable
Ibuprofen,Diabetes,Alzheimer's,86.66,C9H8O4,AMPK Activator,"Nausea, Dizziness",1994,Metformin Hydrochloride,Lipitor,High Risk,Renal Excretion,Completed,Toxicology Report,Dopaminergic Pathway,Injection,250mg every 8 hours,Pfizer,12,Moderate,Low Risk,Low (<50%),Slow,Enzyme-Specific,Not Suitable
Atorvastatin,Diabetes,Cardiovascular Disease,71.7,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Muscle Pain,1965,Omeprazole,Lipitor,High Risk,Liver Metabolism,Phase 3,Animal Testing,MAPK Pathway,Tablet,250mg every 8 hours,Novartis,6,Moderate,Moderate Risk,Low (<50%),Fast,Gut,Not Suitable
Omeprazole,Gastric Ulcer,Migraine Treatment,36.33,C13H18O2,Proton Pump Inhibitor,Muscle Pain,1996,Ibuprofen,Aspirin,Moderate Risk,High Bioavailability,Phase 1,In Vitro Studies,Serotonin Pathway,Topical Gel,250mg every 8 hours,Merck,24,High,Low Risk,Low (<50%),Fast,Gut,Partially Suitable
Losartan,Diabetes,Antiviral,44.99,C4H11N5,Proton Pump Inhibitor,Acid Reflux,1996,Acetylsalicylic Acid,Glucophage,Moderate Risk,Renal Excretion,Phase 3,In Vitro Studies,MAPK Pathway,Tablet,50mg daily,AstraZeneca,6,High,Low Risk,Moderate (50-80%),Fast,Liver,Partially Suitable
Paracetamol,Inflammation,Liver Disease,93.59,C4H11N5,COX Inhibitor,"Nausea, Dizziness",1996,Atorvastatin Calcium,Prilosec,Moderate Risk,Rapid Absorption,Completed,Animal Testing,Dopaminergic Pathway,Capsule,50mg daily,Novartis,2,Low,High Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Ranitidine,Hypertension,Antiviral,37.49,C9H8O4,NSAID,Muscle Pain,1994,Metformin Hydrochloride,Advil,Low Risk,Rapid Absorption,Completed,Animal Testing,PI3K-AKT Pathway,Topical Gel,500mg twice a day,Novartis,6,High,High Risk,Moderate (50-80%),Fast,Liver,Suitable
Simvastatin,Diabetes,Migraine Treatment,75.16,C4H11N5,Proton Pump Inhibitor,Muscle Pain,1987,Ibuprofen,Advil,Low Risk,Liver Metabolism,Phase 1,Animal Testing,Immune Response Pathway,Topical Gel,10mg once daily,Roche,12,Moderate,High Risk,Moderate (50-80%),Slow,Gut,Suitable
Levothyroxine,Thyroid Hormone Replacement,Autoimmune Disorders,76.55,C17H19N3O3S,AMPK Activator,"Nausea, Dizziness",1996,Metformin Hydrochloride,Advil,Low Risk,Liver Metabolism,Phase 1,No Preclinical Data,Dopaminergic Pathway,Topical Gel,As prescribed,Pfizer,6,Low,Moderate Risk,Low (<50%),Moderate,Enzyme-Specific,Partially Suitable
Aspirin,Blood Thinner,Anti-Aging,31.17,C17H19N3O3S,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1987,Ibuprofen,Advil,Low Risk,Rapid Absorption,Phase 4,Animal Testing,MAPK Pathway,Syrup,As prescribed,Novartis,24,High,Low Risk,High (>80%),Moderate,Enzyme-Specific,Suitable
Metformin,Inflammation,Weight Loss,94.47,C17H19N3O3S,NSAID,"Nausea, Dizziness",1996,Metformin Hydrochloride,Prilosec,High Risk,Liver Metabolism,Phase 3,Animal Testing,Dopaminergic Pathway,Tablet,500mg twice a day,Novartis,6,Moderate,Low Risk,Low (<50%),Moderate,Gut,Suitable
Ibuprofen,Diabetes,Weight Loss,88.1,C4H11N5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1987,Omeprazole,Glucophage,High Risk,Renal Excretion,Ongoing,Animal Testing,PI3K-AKT Pathway,Capsule,As prescribed,Novartis,6,Moderate,High Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Partially Suitable
Atorvastatin,Gastric Ulcer,Liver Disease,77.84,C17H19N3O3S,Proton Pump Inhibitor,"Nausea, Dizziness",1965,Omeprazole,Prilosec,Low Risk,Slow Metabolism,Phase 2,Animal Testing,Dopaminergic Pathway,Topical Gel,500mg twice a day,Pfizer,24,Moderate,High Risk,High (>80%),Fast,Enzyme-Specific,Suitable
Omeprazole,Inflammation,Parkinson's,69.48,C13H18O2,Proton Pump Inhibitor,Acid Reflux,1971,Atorvastatin Calcium,Advil,Moderate Risk,Slow Metabolism,Phase 4,No Preclinical Data,Immune Response Pathway,Injection,500mg twice a day,Roche,24,High,Low Risk,Moderate (50-80%),Slow,Enzyme-Specific,Not Suitable
Losartan,Thyroid Hormone Replacement,Anti-Aging,69.38,C17H19N3O3S,COX Inhibitor,Acid Reflux,1987,Atorvastatin Calcium,Prilosec,Low Risk,Rapid Absorption,Phase 2,Toxicology Report,Dopaminergic Pathway,Topical Gel,10mg once daily,Pfizer,24,Moderate,Moderate Risk,Low (<50%),Fast,Enzyme-Specific,Suitable
Paracetamol,Diabetes,Weight Loss,82.41,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Acid Reflux,1996,Ibuprofen,Prilosec,High Risk,Renal Excretion,Phase 3,No Preclinical Data,MAPK Pathway,Capsule,250mg every 8 hours,Novartis,12,Moderate,Moderate Risk,Moderate (50-80%),Fast,Enzyme-Specific,Suitable
Ranitidine,Inflammation,Anti-Aging,41.28,C33H35FN2O5,Proton Pump Inhibitor,Gastrointestinal Issues,1994,Metformin Hydrochloride,Lipitor,Low Risk,Liver Metabolism,Phase 1,In Vitro Studies,MAPK Pathway,Injection,10mg once daily,Novartis,2,High,Moderate Risk,Low (<50%),Slow,Liver,Partially Suitable
Simvastatin,Thyroid Hormone Replacement,Migraine Treatment,87.84,C17H19N3O3S,NSAID,"Headache, Rash",1994,Atorvastatin Calcium,Aspirin,Low Risk,Liver Metabolism,Phase 4,Animal Testing,Serotonin Pathway,Topical Gel,10mg once daily,AstraZeneca,24,Moderate,Moderate Risk,Low (<50%),Slow,Enzyme-Specific,Partially Suitable
Levothyroxine,Fever,Antiviral,50.88,C13H18O2,COX Inhibitor,Gastrointestinal Issues,1987,Metformin Hydrochloride,Aspirin,Moderate Risk,Renal Excretion,Completed,Animal Testing,PI3K-AKT Pathway,Topical Gel,10mg once daily,Roche,2,High,Moderate Risk,Low (<50%),Fast,Enzyme-Specific,Not Suitable
Aspirin,Fever,Parkinson's,69.39,C9H8O4,Proton Pump Inhibitor,Acid Reflux,1994,Omeprazole,Prilosec,High Risk,Renal Excretion,Phase 2,No Preclinical Data,MAPK Pathway,Injection,As prescribed,Roche,48,Moderate,High Risk,Moderate (50-80%),Slow,Enzyme-Specific,Not Suitable
Metformin,Acid Reflux,Parkinson's,72.08,C9H8O4,AMPK Activator,Gastrointestinal Issues,1994,Atorvastatin Calcium,Prilosec,Moderate Risk,Rapid Absorption,Ongoing,In Vitro Studies,MAPK Pathway,Topical Gel,10mg once daily,Pfizer,12,Moderate,Moderate Risk,High (>80%),Slow,Liver,Partially Suitable
Ibuprofen,Hypertension,Cardiovascular Disease,82.79,C9H8O4,HMG-CoA Reductase Inhibitor,Acid Reflux,1971,Omeprazole,Prilosec,Low Risk,Renal Excretion,Phase 3,In Vitro Studies,Serotonin Pathway,Topical Gel,As prescribed,Pfizer,12,Low,Low Risk,Moderate (50-80%),Slow,Renal,Suitable
Atorvastatin,Cholesterol Control,Cancer Therapy,88.19,C9H8O4,AMPK Activator,"Nausea, Dizziness",1965,Ibuprofen,Lipitor,Moderate Risk,Renal Excretion,Phase 4,Toxicology Report,Dopaminergic Pathway,Topical Gel,500mg twice a day,Pfizer,2,Moderate,Low Risk,Moderate (50-80%),Slow,Renal,Suitable
Omeprazole,Gastric Ulcer,Anti-Aging,43.42,C33H35FN2O5,Proton Pump Inhibitor,Gastrointestinal Issues,1996,Atorvastatin Calcium,Glucophage,Low Risk,Rapid Absorption,Ongoing,No Preclinical Data,Serotonin Pathway,Injection,250mg every 8 hours,Novartis,48,High,Moderate Risk,Moderate (50-80%),Fast,Gut,Partially Suitable
Losartan,Inflammation,Alzheimer's,92.75,C33H35FN2O5,NSAID,"Nausea, Dizziness",1994,Metformin Hydrochloride,Glucophage,Moderate Risk,Rapid Absorption,Phase 1,Animal Testing,PI3K-AKT Pathway,Syrup,50mg daily,AstraZeneca,12,Moderate,Low Risk,Moderate (50-80%),Moderate,Liver,Partially Suitable
Paracetamol,Gastric Ulcer,Migraine Treatment,88.91,C9H8O4,Proton Pump Inhibitor,Acid Reflux,1994,Metformin Hydrochloride,Glucophage,Moderate Risk,Slow Metabolism,Phase 3,No Preclinical Data,Immune Response Pathway,Topical Gel,10mg once daily,AstraZeneca,24,Low,Moderate Risk,High (>80%),Slow,Enzyme-Specific,Not Suitable
Ranitidine,Blood Thinner,Parkinson's,62.7,C9H8O4,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1994,Ibuprofen,Aspirin,High Risk,High Bioavailability,Phase 4,Animal Testing,PI3K-AKT Pathway,Syrup,500mg twice a day,Roche,6,High,High Risk,Low (<50%),Moderate,Liver,Partially Suitable
Simvastatin,Fever,Migraine Treatment,67.54,C4H11N5,AMPK Activator,Gastrointestinal Issues,1971,Metformin Hydrochloride,Glucophage,Low Risk,High Bioavailability,Phase 2,In Vitro Studies,Serotonin Pathway,Syrup,10mg once daily,Pfizer,2,High,Low Risk,Low (<50%),Moderate,Gut,Not Suitable
Levothyroxine,Diabetes,Cancer Therapy,56.01,C17H19N3O3S,COX Inhibitor,"Headache, Rash",1971,Omeprazole,Aspirin,Moderate Risk,High Bioavailability,Phase 3,No Preclinical Data,PI3K-AKT Pathway,Injection,As prescribed,Merck,2,Low,High Risk,Moderate (50-80%),Fast,Renal,Not Suitable
Aspirin,Fever,Anti-Aging,47.27,C33H35FN2O5,COX Inhibitor,Muscle Pain,1971,Metformin Hydrochloride,Glucophage,Moderate Risk,Renal Excretion,Phase 2,Toxicology Report,PI3K-AKT Pathway,Capsule,250mg every 8 hours,Merck,2,High,Low Risk,High (>80%),Moderate,Enzyme-Specific,Partially Suitable
Metformin,Fever,Parkinson's,91.93,C9H8O4,Proton Pump Inhibitor,Gastrointestinal Issues,1987,Metformin Hydrochloride,Glucophage,High Risk,Liver Metabolism,Phase 3,In Vitro Studies,PI3K-AKT Pathway,Syrup,500mg twice a day,Merck,2,Low,High Risk,Moderate (50-80%),Fast,Renal,Not Suitable
Ibuprofen,Acid Reflux,Cancer Therapy,40.24,C4H11N5,Proton Pump Inhibitor,"Headache, Rash",1965,Atorvastatin Calcium,Advil,High Risk,High Bioavailability,Ongoing,Animal Testing,Serotonin Pathway,Injection,50mg daily,Merck,12,High,Moderate Risk,Low (<50%),Slow,Renal,Partially Suitable
Atorvastatin,Pain Relief,Alzheimer's,42.76,C17H19N3O3S,COX Inhibitor,"Nausea, Dizziness",1996,Metformin Hydrochloride,Aspirin,Low Risk,Slow Metabolism,Phase 2,Toxicology Report,MAPK Pathway,Injection,50mg daily,Roche,6,High,Moderate Risk,Moderate (50-80%),Moderate,Renal,Not Suitable
Omeprazole,Diabetes,Antiviral,79.48,C13H18O2,Proton Pump Inhibitor,"Headache, Rash",1994,Acetylsalicylic Acid,Prilosec,Low Risk,Renal Excretion,Ongoing,No Preclinical Data,Immune Response Pathway,Capsule,500mg twice a day,Pfizer,12,Low,High Risk,Moderate (50-80%),Fast,Renal,Suitable
Losartan,Blood Thinner,Weight Loss,77.16,C9H8O4,AMPK Activator,Muscle Pain,1994,Atorvastatin Calcium,Aspirin,Moderate Risk,High Bioavailability,Phase 2,No Preclinical Data,Immune Response Pathway,Topical Gel,50mg daily,Roche,48,High,Low Risk,Low (<50%),Fast,Liver,Partially Suitable
Paracetamol,Thyroid Hormone Replacement,Antiviral,76.58,C13H18O2,COX Inhibitor,Muscle Pain,1987,Acetylsalicylic Acid,Prilosec,Low Risk,High Bioavailability,Completed,In Vitro Studies,MAPK Pathway,Topical Gel,50mg daily,AstraZeneca,12,Moderate,High Risk,Moderate (50-80%),Slow,Gut,Not Suitable
Ranitidine,Diabetes,Antiviral,56.38,C4H11N5,Proton Pump Inhibitor,"Headache, Rash",1971,Metformin Hydrochloride,Advil,Low Risk,High Bioavailability,Phase 3,In Vitro Studies,Immune Response Pathway,Topical Gel,500mg twice a day,Pfizer,12,High,Low Risk,Low (<50%),Slow,Gut,Suitable
Simvastatin,Hypertension,Migraine Treatment,59.76,C4H11N5,COX Inhibitor,Gastrointestinal Issues,1971,Ibuprofen,Glucophage,High Risk,High Bioavailability,Completed,No Preclinical Data,Dopaminergic Pathway,Tablet,As prescribed,Novartis,48,High,Moderate Risk,High (>80%),Moderate,Gut,Partially Suitable
Levothyroxine,Cholesterol Control,Parkinson's,93.56,C17H19N3O3S,Proton Pump Inhibitor,"Headache, Rash",1996,Omeprazole,Aspirin,High Risk,Slow Metabolism,Phase 1,Toxicology Report,Immune Response Pathway,Topical Gel,250mg every 8 hours,AstraZeneca,12,Moderate,Moderate Risk,High (>80%),Slow,Renal,Partially Suitable
Aspirin,Pain Relief,Alzheimer's,59.72,C4H11N5,NSAID,Acid Reflux,1987,Acetylsalicylic Acid,Advil,Moderate Risk,Slow Metabolism,Phase 1,In Vitro Studies,Immune Response Pathway,Tablet,500mg twice a day,Pfizer,48,Moderate,High Risk,Moderate (50-80%),Fast,Gut,Suitable
Metformin,Fever,Cardiovascular Disease,77.94,C9H8O4,COX Inhibitor,"Headache, Rash",1987,Ibuprofen,Prilosec,Moderate Risk,Renal Excretion,Phase 3,Toxicology Report,PI3K-AKT Pathway,Tablet,500mg twice a day,Pfizer,24,Moderate,Low Risk,Low (<50%),Moderate,Enzyme-Specific,Partially Suitable
Ibuprofen,Cholesterol Control,Antiviral,37.16,C4H11N5,AMPK Activator,Gastrointestinal Issues,1987,Metformin Hydrochloride,Lipitor,High Risk,Slow Metabolism,Phase 1,Toxicology Report,MAPK Pathway,Topical Gel,500mg twice a day,Novartis,2,Moderate,High Risk,Low (<50%),Moderate,Enzyme-Specific,Partially Suitable
Atorvastatin,Cholesterol Control,Liver Disease,59.86,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1994,Metformin Hydrochloride,Glucophage,High Risk,High Bioavailability,Completed,Animal Testing,Dopaminergic Pathway,Syrup,As prescribed,Roche,24,Moderate,Low Risk,High (>80%),Slow,Liver,Suitable
Omeprazole,Inflammation,Alzheimer's,44.89,C33H35FN2O5,Proton Pump Inhibitor,"Headache, Rash",1987,Atorvastatin Calcium,Aspirin,Low Risk,Slow Metabolism,Ongoing,Animal Testing,PI3K-AKT Pathway,Syrup,50mg daily,AstraZeneca,48,High,High Risk,Moderate (50-80%),Moderate,Gut,Not Suitable
Losartan,Cholesterol Control,Anti-Aging,36.02,C17H19N3O3S,COX Inhibitor,"Headache, Rash",1996,Metformin Hydrochloride,Lipitor,Low Risk,High Bioavailability,Phase 2,Animal Testing,MAPK Pathway,Injection,50mg daily,AstraZeneca,2,Moderate,Low Risk,Moderate (50-80%),Moderate,Gut,Suitable
Paracetamol,Blood Thinner,Parkinson's,38,C4H11N5,COX Inhibitor,Acid Reflux,1965,Acetylsalicylic Acid,Aspirin,Moderate Risk,Slow Metabolism,Phase 2,No Preclinical Data,MAPK Pathway,Tablet,As prescribed,AstraZeneca,2,High,Moderate Risk,Low (<50%),Fast,Gut,Partially Suitable
Ranitidine,Blood Thinner,Migraine Treatment,93.58,C13H18O2,NSAID,Muscle Pain,1994,Atorvastatin Calcium,Glucophage,Low Risk,Renal Excretion,Phase 2,Toxicology Report,Immune Response Pathway,Topical Gel,As prescribed,Merck,6,Low,High Risk,Low (<50%),Moderate,Renal,Partially Suitable
Simvastatin,Inflammation,Antiviral,84.51,C13H18O2,Proton Pump Inhibitor,"Nausea, Dizziness",1996,Ibuprofen,Aspirin,Moderate Risk,Rapid Absorption,Phase 2,Animal Testing,MAPK Pathway,Syrup,500mg twice a day,Novartis,2,Low,Moderate Risk,Low (<50%),Fast,Enzyme-Specific,Suitable
Levothyroxine,Inflammation,Antiviral,40.16,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Acid Reflux,1987,Ibuprofen,Advil,Low Risk,High Bioavailability,Phase 4,In Vitro Studies,Dopaminergic Pathway,Injection,50mg daily,Novartis,2,Moderate,Moderate Risk,Low (<50%),Moderate,Enzyme-Specific,Suitable
Aspirin,Gastric Ulcer,Parkinson's,80.46,C17H19N3O3S,AMPK Activator,"Nausea, Dizziness",1965,Atorvastatin Calcium,Aspirin,High Risk,High Bioavailability,Phase 2,Toxicology Report,Immune Response Pathway,Capsule,As prescribed,Novartis,2,Low,High Risk,High (>80%),Slow,Liver,Suitable
Metformin,Acid Reflux,Cardiovascular Disease,31.35,C9H8O4,AMPK Activator,"Nausea, Dizziness",1965,Acetylsalicylic Acid,Aspirin,High Risk,High Bioavailability,Phase 3,Animal Testing,MAPK Pathway,Syrup,250mg every 8 hours,Merck,24,Moderate,Moderate Risk,High (>80%),Moderate,Enzyme-Specific,Not Suitable
Ibuprofen,Thyroid Hormone Replacement,Migraine Treatment,69.34,C17H19N3O3S,Proton Pump Inhibitor,"Nausea, Dizziness",1965,Atorvastatin Calcium,Prilosec,High Risk,High Bioavailability,Completed,Animal Testing,MAPK Pathway,Topical Gel,250mg every 8 hours,AstraZeneca,2,Moderate,Low Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Atorvastatin,Hypertension,Autoimmune Disorders,40.32,C9H8O4,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1987,Omeprazole,Advil,Low Risk,Slow Metabolism,Phase 3,Animal Testing,PI3K-AKT Pathway,Tablet,500mg twice a day,Novartis,24,Low,Low Risk,Low (<50%),Moderate,Gut,Not Suitable
Omeprazole,Diabetes,Cardiovascular Disease,70.93,C13H18O2,HMG-CoA Reductase Inhibitor,"Headache, Rash",1965,Acetylsalicylic Acid,Glucophage,Low Risk,Liver Metabolism,Ongoing,Animal Testing,Immune Response Pathway,Capsule,10mg once daily,Novartis,12,Low,Moderate Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Losartan,Cholesterol Control,Migraine Treatment,91.01,C13H18O2,Proton Pump Inhibitor,Acid Reflux,1996,Atorvastatin Calcium,Prilosec,High Risk,Renal Excretion,Phase 1,Animal Testing,PI3K-AKT Pathway,Capsule,50mg daily,Novartis,24,Moderate,Moderate Risk,Low (<50%),Slow,Renal,Suitable
Paracetamol,Hypertension,Parkinson's,77.02,C33H35FN2O5,AMPK Activator,"Nausea, Dizziness",1996,Omeprazole,Advil,Low Risk,High Bioavailability,Ongoing,Animal Testing,MAPK Pathway,Topical Gel,500mg twice a day,Roche,6,Moderate,Moderate Risk,Moderate (50-80%),Slow,Gut,Not Suitable
Ranitidine,Acid Reflux,Liver Disease,67.01,C9H8O4,Proton Pump Inhibitor,"Nausea, Dizziness",1994,Omeprazole,Advil,Low Risk,Slow Metabolism,Ongoing,Toxicology Report,PI3K-AKT Pathway,Capsule,250mg every 8 hours,Pfizer,48,Low,Moderate Risk,High (>80%),Slow,Liver,Suitable
Simvastatin,Cholesterol Control,Liver Disease,65.37,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1994,Acetylsalicylic Acid,Prilosec,High Risk,Rapid Absorption,Phase 4,In Vitro Studies,Serotonin Pathway,Syrup,500mg twice a day,Pfizer,48,Low,Moderate Risk,Moderate (50-80%),Slow,Enzyme-Specific,Suitable
Levothyroxine,Hypertension,Liver Disease,59.85,C33H35FN2O5,NSAID,"Nausea, Dizziness",1994,Acetylsalicylic Acid,Prilosec,Low Risk,Rapid Absorption,Phase 4,Toxicology Report,PI3K-AKT Pathway,Syrup,250mg every 8 hours,Merck,48,High,Moderate Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Aspirin,Hypertension,Cancer Therapy,85.37,C9H8O4,HMG-CoA Reductase Inhibitor,"Headache, Rash",1987,Metformin Hydrochloride,Aspirin,High Risk,Liver Metabolism,Phase 1,Animal Testing,Dopaminergic Pathway,Tablet,500mg twice a day,Roche,6,High,High Risk,High (>80%),Slow,Gut,Partially Suitable
Metformin,Fever,Cancer Therapy,79.75,C17H19N3O3S,Proton Pump Inhibitor,"Headache, Rash",1996,Atorvastatin Calcium,Advil,High Risk,Slow Metabolism,Phase 3,No Preclinical Data,Dopaminergic Pathway,Injection,50mg daily,Roche,48,Low,Low Risk,Low (<50%),Fast,Liver,Suitable
Ibuprofen,Inflammation,Parkinson's,71.94,C4H11N5,AMPK Activator,"Nausea, Dizziness",1996,Acetylsalicylic Acid,Prilosec,Moderate Risk,Slow Metabolism,Phase 1,No Preclinical Data,MAPK Pathway,Topical Gel,As prescribed,Roche,24,Moderate,Moderate Risk,Low (<50%),Fast,Enzyme-Specific,Not Suitable
Atorvastatin,Hypertension,Anti-Aging,64.58,C13H18O2,Proton Pump Inhibitor,Acid Reflux,1994,Atorvastatin Calcium,Glucophage,Moderate Risk,Renal Excretion,Phase 4,In Vitro Studies,MAPK Pathway,Tablet,As prescribed,Novartis,12,Low,Low Risk,Low (<50%),Moderate,Enzyme-Specific,Partially Suitable
Omeprazole,Blood Thinner,Antiviral,90.7,C17H19N3O3S,COX Inhibitor,"Headache, Rash",1971,Metformin Hydrochloride,Aspirin,High Risk,Rapid Absorption,Phase 1,In Vitro Studies,MAPK Pathway,Topical Gel,50mg daily,Merck,24,High,Low Risk,Moderate (50-80%),Moderate,Liver,Partially Suitable
Losartan,Blood Thinner,Cancer Therapy,37.98,C4H11N5,AMPK Activator,Muscle Pain,1987,Metformin Hydrochloride,Aspirin,High Risk,Renal Excretion,Phase 3,Toxicology Report,PI3K-AKT Pathway,Topical Gel,10mg once daily,Roche,6,Moderate,Low Risk,Moderate (50-80%),Fast,Enzyme-Specific,Partially Suitable
Paracetamol,Acid Reflux,Alzheimer's,46.96,C17H19N3O3S,Proton Pump Inhibitor,Muscle Pain,1987,Omeprazole,Advil,Moderate Risk,Slow Metabolism,Ongoing,In Vitro Studies,MAPK Pathway,Injection,10mg once daily,Pfizer,2,High,Moderate Risk,High (>80%),Slow,Gut,Partially Suitable
Ranitidine,Diabetes,Cardiovascular Disease,52.36,C13H18O2,AMPK Activator,Gastrointestinal Issues,1994,Acetylsalicylic Acid,Lipitor,High Risk,Slow Metabolism,Phase 3,Toxicology Report,Immune Response Pathway,Injection,250mg every 8 hours,Pfizer,12,Low,High Risk,Low (<50%),Slow,Renal,Not Suitable
Simvastatin,Hypertension,Anti-Aging,93.99,C4H11N5,COX Inhibitor,Gastrointestinal Issues,1965,Metformin Hydrochloride,Glucophage,Low Risk,Slow Metabolism,Completed,No Preclinical Data,PI3K-AKT Pathway,Injection,250mg every 8 hours,Pfizer,2,High,High Risk,Low (<50%),Slow,Enzyme-Specific,Partially Suitable
Levothyroxine,Thyroid Hormone Replacement,Liver Disease,90.43,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1965,Ibuprofen,Lipitor,Low Risk,High Bioavailability,Phase 4,No Preclinical Data,Immune Response Pathway,Tablet,As prescribed,AstraZeneca,48,Moderate,Moderate Risk,Moderate (50-80%),Fast,Renal,Not Suitable
Aspirin,Gastric Ulcer,Anti-Aging,64.65,C13H18O2,Proton Pump Inhibitor,Gastrointestinal Issues,1971,Omeprazole,Aspirin,High Risk,Slow Metabolism,Completed,Toxicology Report,Serotonin Pathway,Capsule,500mg twice a day,Roche,24,Moderate,High Risk,High (>80%),Slow,Liver,Partially Suitable
Metformin,Thyroid Hormone Replacement,Autoimmune Disorders,77.41,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Acid Reflux,1994,Metformin Hydrochloride,Lipitor,Low Risk,Rapid Absorption,Phase 4,In Vitro Studies,Dopaminergic Pathway,Injection,As prescribed,Novartis,48,High,High Risk,Moderate (50-80%),Slow,Gut,Suitable
Ibuprofen,Gastric Ulcer,Liver Disease,90.22,C9H8O4,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1994,Atorvastatin Calcium,Lipitor,High Risk,Rapid Absorption,Phase 1,Toxicology Report,Dopaminergic Pathway,Topical Gel,As prescribed,Merck,2,High,Moderate Risk,High (>80%),Moderate,Renal,Partially Suitable
Atorvastatin,Fever,Autoimmune Disorders,43.77,C13H18O2,NSAID,Muscle Pain,1996,Omeprazole,Advil,High Risk,Slow Metabolism,Phase 3,No Preclinical Data,Serotonin Pathway,Capsule,500mg twice a day,Roche,6,Moderate,Moderate Risk,Moderate (50-80%),Slow,Liver,Partially Suitable
Omeprazole,Blood Thinner,Liver Disease,38.04,C9H8O4,AMPK Activator,Acid Reflux,1996,Atorvastatin Calcium,Prilosec,Moderate Risk,High Bioavailability,Ongoing,Toxicology Report,Immune Response Pathway,Topical Gel,500mg twice a day,Roche,6,Low,Moderate Risk,Moderate (50-80%),Slow,Gut,Suitable
Losartan,Inflammation,Weight Loss,80.55,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Acid Reflux,1971,Metformin Hydrochloride,Prilosec,Low Risk,Slow Metabolism,Phase 3,Animal Testing,Immune Response Pathway,Injection,500mg twice a day,Pfizer,2,Low,Moderate Risk,Moderate (50-80%),Slow,Gut,Partially Suitable
Paracetamol,Pain Relief,Migraine Treatment,47.74,C33H35FN2O5,NSAID,Acid Reflux,1994,Ibuprofen,Glucophage,High Risk,Renal Excretion,Phase 2,Animal Testing,Dopaminergic Pathway,Tablet,10mg once daily,Roche,48,High,Low Risk,High (>80%),Fast,Enzyme-Specific,Not Suitable
Ranitidine,Diabetes,Anti-Aging,83.74,C17H19N3O3S,NSAID,Acid Reflux,1994,Acetylsalicylic Acid,Aspirin,Moderate Risk,Rapid Absorption,Phase 3,Toxicology Report,Dopaminergic Pathway,Syrup,As prescribed,Roche,24,Low,Low Risk,Low (<50%),Slow,Liver,Suitable
Simvastatin,Blood Thinner,Parkinson's,93.39,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1987,Omeprazole,Prilosec,Moderate Risk,Rapid Absorption,Phase 3,Toxicology Report,Serotonin Pathway,Syrup,10mg once daily,Novartis,12,High,Moderate Risk,Low (<50%),Slow,Liver,Partially Suitable
Levothyroxine,Hypertension,Anti-Aging,75.45,C33H35FN2O5,Proton Pump Inhibitor,Acid Reflux,1994,Metformin Hydrochloride,Prilosec,Moderate Risk,Renal Excretion,Phase 1,Toxicology Report,MAPK Pathway,Capsule,10mg once daily,Merck,6,High,Low Risk,Moderate (50-80%),Slow,Renal,Partially Suitable
Aspirin,Cholesterol Control,Parkinson's,46.12,C4H11N5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1994,Atorvastatin Calcium,Aspirin,High Risk,Liver Metabolism,Phase 2,In Vitro Studies,PI3K-AKT Pathway,Topical Gel,500mg twice a day,Merck,6,Low,High Risk,Low (<50%),Moderate,Renal,Not Suitable
Metformin,Acid Reflux,Migraine Treatment,86.52,C4H11N5,Proton Pump Inhibitor,"Nausea, Dizziness",1996,Acetylsalicylic Acid,Prilosec,High Risk,Slow Metabolism,Phase 3,No Preclinical Data,Dopaminergic Pathway,Syrup,As prescribed,Pfizer,6,Low,Moderate Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Partially Suitable
Ibuprofen,Cholesterol Control,Autoimmune Disorders,85.83,C17H19N3O3S,COX Inhibitor,Gastrointestinal Issues,1965,Acetylsalicylic Acid,Lipitor,Moderate Risk,Slow Metabolism,Phase 2,In Vitro Studies,PI3K-AKT Pathway,Tablet,250mg every 8 hours,Novartis,24,Low,Low Risk,Low (<50%),Moderate,Gut,Suitable
Atorvastatin,Pain Relief,Cancer Therapy,70.6,C4H11N5,NSAID,Muscle Pain,1987,Metformin Hydrochloride,Prilosec,Low Risk,Rapid Absorption,Ongoing,Toxicology Report,Immune Response Pathway,Topical Gel,50mg daily,Pfizer,48,Moderate,Moderate Risk,High (>80%),Fast,Liver,Not Suitable
Omeprazole,Fever,Weight Loss,82.21,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1996,Ibuprofen,Aspirin,Low Risk,High Bioavailability,Phase 4,In Vitro Studies,Dopaminergic Pathway,Injection,As prescribed,Pfizer,24,Low,Low Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Suitable
Losartan,Fever,Migraine Treatment,82.06,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Muscle Pain,1965,Ibuprofen,Lipitor,Low Risk,Rapid Absorption,Phase 3,In Vitro Studies,Serotonin Pathway,Injection,250mg every 8 hours,Pfizer,24,High,Moderate Risk,Low (<50%),Slow,Renal,Suitable
Paracetamol,Acid Reflux,Weight Loss,31.76,C9H8O4,COX Inhibitor,"Nausea, Dizziness",1996,Atorvastatin Calcium,Lipitor,High Risk,Rapid Absorption,Phase 1,Toxicology Report,Immune Response Pathway,Topical Gel,10mg once daily,Pfizer,24,Moderate,Low Risk,Moderate (50-80%),Slow,Liver,Partially Suitable
Ranitidine,Hypertension,Cancer Therapy,60.61,C4H11N5,AMPK Activator,"Headache, Rash",1994,Ibuprofen,Lipitor,Low Risk,Liver Metabolism,Completed,Toxicology Report,Dopaminergic Pathway,Syrup,As prescribed,Merck,48,Low,Low Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Simvastatin,Thyroid Hormone Replacement,Alzheimer's,75.83,C17H19N3O3S,COX Inhibitor,"Headache, Rash",1996,Atorvastatin Calcium,Advil,High Risk,Rapid Absorption,Phase 2,No Preclinical Data,MAPK Pathway,Capsule,As prescribed,Merck,6,High,Low Risk,High (>80%),Fast,Enzyme-Specific,Partially Suitable
Levothyroxine,Blood Thinner,Autoimmune Disorders,63.99,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1994,Metformin Hydrochloride,Glucophage,High Risk,Liver Metabolism,Phase 4,Animal Testing,PI3K-AKT Pathway,Injection,250mg every 8 hours,Novartis,12,Low,Low Risk,High (>80%),Fast,Renal,Suitable
Aspirin,Cholesterol Control,Weight Loss,76.84,C9H8O4,AMPK Activator,Gastrointestinal Issues,1996,Acetylsalicylic Acid,Aspirin,Low Risk,High Bioavailability,Phase 4,Animal Testing,Dopaminergic Pathway,Syrup,250mg every 8 hours,Pfizer,12,High,High Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Suitable
Metformin,Gastric Ulcer,Antiviral,46.05,C9H8O4,AMPK Activator,"Nausea, Dizziness",1994,Metformin Hydrochloride,Aspirin,High Risk,Renal Excretion,Phase 1,Animal Testing,PI3K-AKT Pathway,Capsule,10mg once daily,Novartis,12,Low,Low Risk,Low (<50%),Slow,Gut,Suitable
Ibuprofen,Fever,Alzheimer's,79.89,C4H11N5,NSAID,"Nausea, Dizziness",1971,Acetylsalicylic Acid,Prilosec,Low Risk,High Bioavailability,Phase 3,In Vitro Studies,PI3K-AKT Pathway,Capsule,10mg once daily,AstraZeneca,48,Low,Moderate Risk,High (>80%),Moderate,Liver,Partially Suitable
Atorvastatin,Blood Thinner,Autoimmune Disorders,31.41,C9H8O4,NSAID,Acid Reflux,1996,Acetylsalicylic Acid,Aspirin,High Risk,High Bioavailability,Phase 2,Animal Testing,Dopaminergic Pathway,Syrup,10mg once daily,Novartis,12,Low,High Risk,Moderate (50-80%),Slow,Liver,Suitable
Omeprazole,Fever,Cancer Therapy,53.79,C4H11N5,AMPK Activator,Acid Reflux,1996,Atorvastatin Calcium,Lipitor,Low Risk,Slow Metabolism,Phase 2,No Preclinical Data,Dopaminergic Pathway,Topical Gel,10mg once daily,Roche,6,Low,Moderate Risk,High (>80%),Moderate,Gut,Not Suitable
Losartan,Hypertension,Liver Disease,44.15,C33H35FN2O5,COX Inhibitor,"Nausea, Dizziness",1965,Ibuprofen,Aspirin,Moderate Risk,Rapid Absorption,Ongoing,In Vitro Studies,Immune Response Pathway,Syrup,50mg daily,Merck,6,Low,High Risk,Moderate (50-80%),Slow,Enzyme-Specific,Suitable
Paracetamol,Thyroid Hormone Replacement,Migraine Treatment,58.65,C4H11N5,COX Inhibitor,"Nausea, Dizziness",1987,Omeprazole,Glucophage,Low Risk,High Bioavailability,Phase 3,Animal Testing,MAPK Pathway,Tablet,500mg twice a day,Roche,6,Low,High Risk,Moderate (50-80%),Moderate,Gut,Suitable
Ranitidine,Acid Reflux,Liver Disease,72.38,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Muscle Pain,1987,Acetylsalicylic Acid,Aspirin,Moderate Risk,Renal Excretion,Ongoing,In Vitro Studies,Dopaminergic Pathway,Syrup,500mg twice a day,Roche,48,High,High Risk,High (>80%),Fast,Enzyme-Specific,Not Suitable
Simvastatin,Thyroid Hormone Replacement,Cancer Therapy,57.62,C33H35FN2O5,Proton Pump Inhibitor,Acid Reflux,1971,Omeprazole,Glucophage,High Risk,Slow Metabolism,Phase 3,No Preclinical Data,PI3K-AKT Pathway,Capsule,As prescribed,Roche,12,Moderate,Low Risk,Low (<50%),Fast,Renal,Suitable
Levothyroxine,Hypertension,Cardiovascular Disease,94.58,C4H11N5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1996,Ibuprofen,Aspirin,Low Risk,Rapid Absorption,Phase 1,In Vitro Studies,MAPK Pathway,Capsule,250mg every 8 hours,Novartis,12,Moderate,High Risk,High (>80%),Moderate,Renal,Suitable
Aspirin,Pain Relief,Anti-Aging,85.22,C9H8O4,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1996,Metformin Hydrochloride,Lipitor,Moderate Risk,Slow Metabolism,Phase 4,No Preclinical Data,Serotonin Pathway,Capsule,As prescribed,AstraZeneca,24,Low,Moderate Risk,High (>80%),Moderate,Enzyme-Specific,Partially Suitable
Metformin,Inflammation,Weight Loss,90.83,C33H35FN2O5,COX Inhibitor,"Headache, Rash",1987,Metformin Hydrochloride,Aspirin,High Risk,Liver Metabolism,Phase 2,In Vitro Studies,Serotonin Pathway,Injection,50mg daily,Pfizer,12,Low,Moderate Risk,High (>80%),Fast,Enzyme-Specific,Suitable
Ibuprofen,Hypertension,Alzheimer's,35.17,C17H19N3O3S,AMPK Activator,Acid Reflux,1965,Acetylsalicylic Acid,Prilosec,Low Risk,High Bioavailability,Ongoing,No Preclinical Data,MAPK Pathway,Topical Gel,500mg twice a day,Novartis,48,Low,High Risk,Low (<50%),Fast,Liver,Partially Suitable
Atorvastatin,Fever,Migraine Treatment,35.29,C9H8O4,AMPK Activator,Muscle Pain,1994,Ibuprofen,Lipitor,Moderate Risk,Renal Excretion,Ongoing,Animal Testing,Immune Response Pathway,Injection,250mg every 8 hours,Pfizer,2,High,Low Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Not Suitable
Omeprazole,Fever,Cardiovascular Disease,80.48,C13H18O2,COX Inhibitor,Acid Reflux,1996,Atorvastatin Calcium,Glucophage,Low Risk,Rapid Absorption,Phase 3,In Vitro Studies,MAPK Pathway,Capsule,250mg every 8 hours,Novartis,6,Low,Low Risk,High (>80%),Moderate,Renal,Not Suitable
Losartan,Cholesterol Control,Migraine Treatment,61.31,C17H19N3O3S,HMG-CoA Reductase Inhibitor,"Headache, Rash",1994,Acetylsalicylic Acid,Glucophage,Low Risk,Rapid Absorption,Phase 3,In Vitro Studies,Serotonin Pathway,Topical Gel,500mg twice a day,Merck,24,Moderate,High Risk,High (>80%),Moderate,Gut,Partially Suitable
Paracetamol,Gastric Ulcer,Anti-Aging,40.28,C4H11N5,COX Inhibitor,Muscle Pain,1994,Ibuprofen,Advil,Low Risk,Slow Metabolism,Phase 3,In Vitro Studies,PI3K-AKT Pathway,Syrup,500mg twice a day,Merck,2,Low,Low Risk,High (>80%),Slow,Enzyme-Specific,Not Suitable
Ranitidine,Cholesterol Control,Cardiovascular Disease,68.35,C4H11N5,Proton Pump Inhibitor,"Headache, Rash",1996,Atorvastatin Calcium,Glucophage,Moderate Risk,Liver Metabolism,Phase 1,Animal Testing,MAPK Pathway,Syrup,As prescribed,Pfizer,24,Low,Low Risk,High (>80%),Fast,Renal,Partially Suitable
Simvastatin,Gastric Ulcer,Autoimmune Disorders,41.73,C13H18O2,AMPK Activator,Gastrointestinal Issues,1996,Metformin Hydrochloride,Glucophage,Moderate Risk,Rapid Absorption,Phase 2,In Vitro Studies,Immune Response Pathway,Injection,250mg every 8 hours,Pfizer,2,Low,Moderate Risk,Moderate (50-80%),Moderate,Liver,Suitable
Levothyroxine,Acid Reflux,Migraine Treatment,76.6,C17H19N3O3S,Proton Pump Inhibitor,Gastrointestinal Issues,1965,Metformin Hydrochloride,Prilosec,Moderate Risk,High Bioavailability,Phase 3,In Vitro Studies,PI3K-AKT Pathway,Topical Gel,10mg once daily,Pfizer,48,High,High Risk,Low (<50%),Moderate,Renal,Not Suitable
Aspirin,Thyroid Hormone Replacement,Cardiovascular Disease,69.73,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1971,Atorvastatin Calcium,Glucophage,High Risk,High Bioavailability,Phase 4,Toxicology Report,Immune Response Pathway,Capsule,250mg every 8 hours,Novartis,24,Moderate,Low Risk,Low (<50%),Moderate,Renal,Suitable
Metformin,Hypertension,Weight Loss,46.8,C4H11N5,AMPK Activator,"Nausea, Dizziness",1965,Omeprazole,Lipitor,Low Risk,Renal Excretion,Completed,Toxicology Report,Serotonin Pathway,Tablet,As prescribed,Roche,48,Moderate,Low Risk,High (>80%),Moderate,Enzyme-Specific,Not Suitable
Ibuprofen,Cholesterol Control,Weight Loss,36.11,C4H11N5,AMPK Activator,"Headache, Rash",1994,Acetylsalicylic Acid,Prilosec,Low Risk,Rapid Absorption,Phase 4,Toxicology Report,Immune Response Pathway,Injection,As prescribed,Roche,48,Moderate,High Risk,Low (<50%),Moderate,Gut,Suitable
Atorvastatin,Gastric Ulcer,Anti-Aging,65.81,C13H18O2,HMG-CoA Reductase Inhibitor,Acid Reflux,1994,Metformin Hydrochloride,Aspirin,Moderate Risk,Liver Metabolism,Ongoing,Animal Testing,PI3K-AKT Pathway,Syrup,500mg twice a day,Roche,12,High,High Risk,High (>80%),Moderate,Liver,Partially Suitable
Omeprazole,Blood Thinner,Cancer Therapy,65.49,C9H8O4,Proton Pump Inhibitor,"Headache, Rash",1965,Metformin Hydrochloride,Advil,Moderate Risk,High Bioavailability,Phase 4,No Preclinical Data,Dopaminergic Pathway,Capsule,10mg once daily,Merck,12,Moderate,High Risk,Low (<50%),Fast,Renal,Suitable
Losartan,Gastric Ulcer,Migraine Treatment,59.69,C4H11N5,NSAID,"Nausea, Dizziness",1965,Atorvastatin Calcium,Glucophage,Low Risk,Slow Metabolism,Ongoing,Animal Testing,Serotonin Pathway,Injection,500mg twice a day,Pfizer,48,Moderate,Moderate Risk,Moderate (50-80%),Moderate,Gut,Not Suitable
Paracetamol,Hypertension,Migraine Treatment,80.05,C33H35FN2O5,Proton Pump Inhibitor,Acid Reflux,1996,Acetylsalicylic Acid,Lipitor,High Risk,Liver Metabolism,Phase 4,Animal Testing,MAPK Pathway,Injection,250mg every 8 hours,Merck,24,Moderate,High Risk,Moderate (50-80%),Slow,Liver,Suitable
Ranitidine,Diabetes,Cancer Therapy,39.38,C9H8O4,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1971,Omeprazole,Advil,Low Risk,Rapid Absorption,Phase 4,Animal Testing,PI3K-AKT Pathway,Tablet,As prescribed,Pfizer,2,Low,High Risk,Low (<50%),Fast,Renal,Partially Suitable
Simvastatin,Thyroid Hormone Replacement,Alzheimer's,87.28,C4H11N5,NSAID,Muscle Pain,1996,Acetylsalicylic Acid,Prilosec,Low Risk,Slow Metabolism,Phase 4,No Preclinical Data,Immune Response Pathway,Capsule,10mg once daily,Pfizer,12,High,Low Risk,Moderate (50-80%),Moderate,Renal,Partially Suitable
Levothyroxine,Inflammation,Liver Disease,66.04,C33H35FN2O5,AMPK Activator,"Headache, Rash",1971,Atorvastatin Calcium,Advil,Low Risk,Slow Metabolism,Phase 3,No Preclinical Data,Serotonin Pathway,Topical Gel,As prescribed,Novartis,48,Low,High Risk,High (>80%),Fast,Enzyme-Specific,Partially Suitable
Aspirin,Hypertension,Weight Loss,87.65,C9H8O4,Proton Pump Inhibitor,"Headache, Rash",1965,Acetylsalicylic Acid,Prilosec,High Risk,Slow Metabolism,Phase 4,Animal Testing,MAPK Pathway,Injection,10mg once daily,Pfizer,2,High,Moderate Risk,Moderate (50-80%),Slow,Enzyme-Specific,Partially Suitable
Metformin,Gastric Ulcer,Liver Disease,55.24,C4H11N5,HMG-CoA Reductase Inhibitor,Acid Reflux,1994,Metformin Hydrochloride,Advil,High Risk,High Bioavailability,Ongoing,No Preclinical Data,Dopaminergic Pathway,Capsule,250mg every 8 hours,Novartis,2,High,High Risk,Moderate (50-80%),Slow,Enzyme-Specific,Suitable
Ibuprofen,Diabetes,Liver Disease,79.81,C33H35FN2O5,AMPK Activator,"Nausea, Dizziness",1996,Omeprazole,Prilosec,High Risk,High Bioavailability,Completed,In Vitro Studies,Serotonin Pathway,Injection,As prescribed,Pfizer,48,Low,Low Risk,High (>80%),Fast,Renal,Partially Suitable
Atorvastatin,Blood Thinner,Autoimmune Disorders,68.12,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1971,Metformin Hydrochloride,Prilosec,Moderate Risk,Slow Metabolism,Ongoing,Animal Testing,MAPK Pathway,Topical Gel,As prescribed,AstraZeneca,48,Moderate,Low Risk,High (>80%),Fast,Liver,Partially Suitable
Omeprazole,Pain Relief,Weight Loss,50.16,C4H11N5,HMG-CoA Reductase Inhibitor,Acid Reflux,1987,Omeprazole,Glucophage,High Risk,Rapid Absorption,Phase 3,No Preclinical Data,Serotonin Pathway,Topical Gel,10mg once daily,Roche,48,Low,Low Risk,Low (<50%),Fast,Renal,Suitable
Losartan,Fever,Anti-Aging,67.08,C9H8O4,Proton Pump Inhibitor,Acid Reflux,1965,Atorvastatin Calcium,Glucophage,Moderate Risk,Renal Excretion,Completed,Toxicology Report,PI3K-AKT Pathway,Capsule,250mg every 8 hours,Roche,48,Moderate,Low Risk,Moderate (50-80%),Fast,Liver,Suitable
Paracetamol,Fever,Liver Disease,35.59,C17H19N3O3S,Proton Pump Inhibitor,Gastrointestinal Issues,1965,Acetylsalicylic Acid,Glucophage,High Risk,Renal Excretion,Phase 2,No Preclinical Data,PI3K-AKT Pathway,Topical Gel,As prescribed,Roche,24,Moderate,Moderate Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Suitable
Ranitidine,Pain Relief,Liver Disease,30.49,C13H18O2,COX Inhibitor,Acid Reflux,1965,Omeprazole,Aspirin,Moderate Risk,Slow Metabolism,Phase 4,Toxicology Report,MAPK Pathway,Tablet,50mg daily,Roche,24,High,Moderate Risk,Low (<50%),Fast,Renal,Partially Suitable
Simvastatin,Inflammation,Autoimmune Disorders,50.09,C4H11N5,NSAID,"Nausea, Dizziness",1965,Acetylsalicylic Acid,Advil,Low Risk,Rapid Absorption,Phase 3,In Vitro Studies,Dopaminergic Pathway,Capsule,50mg daily,AstraZeneca,6,Low,Low Risk,Moderate (50-80%),Slow,Enzyme-Specific,Suitable
Levothyroxine,Blood Thinner,Parkinson's,69.02,C13H18O2,HMG-CoA Reductase Inhibitor,Acid Reflux,1994,Ibuprofen,Glucophage,Moderate Risk,Liver Metabolism,Ongoing,Toxicology Report,PI3K-AKT Pathway,Topical Gel,10mg once daily,Merck,6,Moderate,Low Risk,High (>80%),Fast,Renal,Partially Suitable
Aspirin,Acid Reflux,Migraine Treatment,72.62,C4H11N5,HMG-CoA Reductase Inhibitor,Muscle Pain,1994,Metformin Hydrochloride,Advil,Low Risk,Liver Metabolism,Phase 1,Animal Testing,Dopaminergic Pathway,Syrup,As prescribed,AstraZeneca,2,High,High Risk,Moderate (50-80%),Slow,Gut,Suitable
Metformin,Fever,Autoimmune Disorders,85.35,C17H19N3O3S,COX Inhibitor,"Nausea, Dizziness",1971,Ibuprofen,Lipitor,Moderate Risk,Rapid Absorption,Phase 3,In Vitro Studies,Immune Response Pathway,Capsule,250mg every 8 hours,Novartis,6,High,High Risk,Moderate (50-80%),Moderate,Renal,Suitable
Ibuprofen,Inflammation,Alzheimer's,71.66,C9H8O4,AMPK Activator,Gastrointestinal Issues,1994,Omeprazole,Prilosec,Low Risk,Renal Excretion,Phase 2,In Vitro Studies,MAPK Pathway,Injection,50mg daily,AstraZeneca,48,Low,High Risk,High (>80%),Slow,Renal,Not Suitable
Atorvastatin,Blood Thinner,Cardiovascular Disease,87.33,C33H35FN2O5,AMPK Activator,Gastrointestinal Issues,1965,Acetylsalicylic Acid,Aspirin,Low Risk,Renal Excretion,Phase 4,No Preclinical Data,PI3K-AKT Pathway,Injection,500mg twice a day,Pfizer,6,Low,High Risk,Low (<50%),Moderate,Gut,Not Suitable
Omeprazole,Inflammation,Parkinson's,73.25,C13H18O2,AMPK Activator,"Headache, Rash",1994,Acetylsalicylic Acid,Advil,Moderate Risk,High Bioavailability,Phase 4,Animal Testing,Serotonin Pathway,Injection,50mg daily,AstraZeneca,24,Moderate,High Risk,Moderate (50-80%),Moderate,Renal,Partially Suitable
Losartan,Cholesterol Control,Cancer Therapy,77.11,C4H11N5,AMPK Activator,Muscle Pain,1996,Acetylsalicylic Acid,Aspirin,Moderate Risk,Slow Metabolism,Phase 4,In Vitro Studies,Dopaminergic Pathway,Injection,10mg once daily,Merck,24,Moderate,Low Risk,Moderate (50-80%),Slow,Gut,Not Suitable
Paracetamol,Hypertension,Liver Disease,69.86,C4H11N5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1965,Atorvastatin Calcium,Aspirin,High Risk,Slow Metabolism,Phase 1,Toxicology Report,Dopaminergic Pathway,Topical Gel,500mg twice a day,Merck,2,High,Low Risk,Moderate (50-80%),Slow,Liver,Suitable
Ranitidine,Acid Reflux,Cardiovascular Disease,70.39,C4H11N5,COX Inhibitor,"Headache, Rash",1971,Metformin Hydrochloride,Advil,High Risk,Renal Excretion,Phase 2,In Vitro Studies,Serotonin Pathway,Topical Gel,250mg every 8 hours,Pfizer,48,High,High Risk,Moderate (50-80%),Slow,Liver,Not Suitable
Simvastatin,Hypertension,Autoimmune Disorders,57.37,C13H18O2,COX Inhibitor,"Nausea, Dizziness",1965,Acetylsalicylic Acid,Glucophage,Moderate Risk,Renal Excretion,Phase 2,In Vitro Studies,PI3K-AKT Pathway,Injection,500mg twice a day,Novartis,24,Low,High Risk,High (>80%),Moderate,Liver,Not Suitable
Levothyroxine,Acid Reflux,Weight Loss,58.83,C13H18O2,COX Inhibitor,Acid Reflux,1987,Acetylsalicylic Acid,Advil,Moderate Risk,Slow Metabolism,Phase 4,Toxicology Report,PI3K-AKT Pathway,Topical Gel,250mg every 8 hours,Novartis,12,Moderate,High Risk,Moderate (50-80%),Fast,Liver,Partially Suitable
Aspirin,Blood Thinner,Parkinson's,88.34,C13H18O2,COX Inhibitor,Muscle Pain,1994,Omeprazole,Prilosec,Moderate Risk,Rapid Absorption,Phase 3,Toxicology Report,Serotonin Pathway,Capsule,As prescribed,Roche,6,Low,High Risk,High (>80%),Fast,Enzyme-Specific,Not Suitable
Metformin,Thyroid Hormone Replacement,Cancer Therapy,32.97,C4H11N5,AMPK Activator,"Headache, Rash",1994,Ibuprofen,Advil,High Risk,Renal Excretion,Phase 2,Toxicology Report,Immune Response Pathway,Capsule,10mg once daily,AstraZeneca,24,Moderate,Moderate Risk,Low (<50%),Moderate,Enzyme-Specific,Partially Suitable
Ibuprofen,Acid Reflux,Parkinson's,92.8,C4H11N5,HMG-CoA Reductase Inhibitor,Muscle Pain,1994,Atorvastatin Calcium,Prilosec,Moderate Risk,Rapid Absorption,Phase 3,Animal Testing,Serotonin Pathway,Capsule,As prescribed,Roche,6,Moderate,Low Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Partially Suitable
Atorvastatin,Gastric Ulcer,Cancer Therapy,70.02,C9H8O4,HMG-CoA Reductase Inhibitor,Muscle Pain,1994,Acetylsalicylic Acid,Glucophage,High Risk,Rapid Absorption,Phase 3,No Preclinical Data,Serotonin Pathway,Tablet,250mg every 8 hours,Merck,2,Low,Low Risk,Moderate (50-80%),Fast,Gut,Partially Suitable
Omeprazole,Blood Thinner,Anti-Aging,67.65,C17H19N3O3S,Proton Pump Inhibitor,Muscle Pain,1965,Omeprazole,Aspirin,Low Risk,Renal Excretion,Ongoing,Toxicology Report,Dopaminergic Pathway,Syrup,As prescribed,Roche,6,Moderate,Low Risk,Moderate (50-80%),Slow,Renal,Not Suitable
Losartan,Acid Reflux,Cancer Therapy,63.83,C4H11N5,HMG-CoA Reductase Inhibitor,Muscle Pain,1994,Metformin Hydrochloride,Glucophage,Moderate Risk,Renal Excretion,Phase 1,In Vitro Studies,Dopaminergic Pathway,Capsule,As prescribed,Pfizer,12,High,Moderate Risk,High (>80%),Moderate,Enzyme-Specific,Suitable
Paracetamol,Diabetes,Cancer Therapy,75.16,C17H19N3O3S,AMPK Activator,"Nausea, Dizziness",1996,Omeprazole,Prilosec,Moderate Risk,High Bioavailability,Completed,Toxicology Report,Serotonin Pathway,Tablet,500mg twice a day,Roche,6,High,Low Risk,Low (<50%),Fast,Gut,Suitable
Ranitidine,Pain Relief,Cancer Therapy,53.68,C4H11N5,Proton Pump Inhibitor,Muscle Pain,1994,Ibuprofen,Lipitor,Moderate Risk,High Bioavailability,Phase 4,No Preclinical Data,Dopaminergic Pathway,Injection,As prescribed,Merck,12,Moderate,High Risk,Low (<50%),Fast,Renal,Not Suitable
Simvastatin,Gastric Ulcer,Cancer Therapy,70.74,C17H19N3O3S,Proton Pump Inhibitor,Gastrointestinal Issues,1965,Acetylsalicylic Acid,Advil,High Risk,Renal Excretion,Phase 2,Toxicology Report,Serotonin Pathway,Capsule,10mg once daily,Roche,12,High,Moderate Risk,Low (<50%),Slow,Gut,Not Suitable
Levothyroxine,Cholesterol Control,Weight Loss,34.44,C33H35FN2O5,NSAID,"Nausea, Dizziness",1996,Acetylsalicylic Acid,Aspirin,Moderate Risk,Rapid Absorption,Phase 4,In Vitro Studies,PI3K-AKT Pathway,Syrup,500mg twice a day,Roche,2,Low,Moderate Risk,Moderate (50-80%),Slow,Renal,Not Suitable
Aspirin,Thyroid Hormone Replacement,Migraine Treatment,41.44,C33H35FN2O5,AMPK Activator,Gastrointestinal Issues,1971,Acetylsalicylic Acid,Prilosec,Low Risk,Liver Metabolism,Phase 2,In Vitro Studies,Dopaminergic Pathway,Capsule,250mg every 8 hours,Merck,12,Moderate,Moderate Risk,Low (<50%),Moderate,Renal,Partially Suitable
Metformin,Pain Relief,Cancer Therapy,47.51,C9H8O4,COX Inhibitor,"Headache, Rash",1987,Omeprazole,Advil,High Risk,Renal Excretion,Phase 4,In Vitro Studies,PI3K-AKT Pathway,Syrup,500mg twice a day,AstraZeneca,48,High,Moderate Risk,High (>80%),Moderate,Liver,Partially Suitable
Ibuprofen,Thyroid Hormone Replacement,Autoimmune Disorders,34.34,C9H8O4,AMPK Activator,Acid Reflux,1994,Metformin Hydrochloride,Advil,High Risk,Liver Metabolism,Phase 2,Animal Testing,Serotonin Pathway,Syrup,250mg every 8 hours,Pfizer,6,High,Moderate Risk,Low (<50%),Fast,Gut,Not Suitable
Atorvastatin,Cholesterol Control,Weight Loss,38.74,C4H11N5,HMG-CoA Reductase Inhibitor,Muscle Pain,1965,Omeprazole,Lipitor,Moderate Risk,Rapid Absorption,Completed,Toxicology Report,Immune Response Pathway,Syrup,10mg once daily,Pfizer,48,High,Low Risk,Moderate (50-80%),Slow,Enzyme-Specific,Not Suitable
Omeprazole,Blood Thinner,Cardiovascular Disease,45.6,C13H18O2,AMPK Activator,Gastrointestinal Issues,1994,Acetylsalicylic Acid,Lipitor,Moderate Risk,Rapid Absorption,Phase 3,Animal Testing,PI3K-AKT Pathway,Topical Gel,500mg twice a day,Roche,2,High,Moderate Risk,Low (<50%),Slow,Enzyme-Specific,Partially Suitable
Losartan,Thyroid Hormone Replacement,Weight Loss,87.43,C9H8O4,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1987,Omeprazole,Advil,Low Risk,High Bioavailability,Phase 2,In Vitro Studies,PI3K-AKT Pathway,Tablet,As prescribed,Roche,48,Moderate,Moderate Risk,Low (<50%),Moderate,Enzyme-Specific,Suitable
Paracetamol,Pain Relief,Liver Disease,54.02,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1994,Acetylsalicylic Acid,Glucophage,Moderate Risk,Slow Metabolism,Phase 3,In Vitro Studies,Immune Response Pathway,Tablet,50mg daily,AstraZeneca,2,Low,High Risk,High (>80%),Fast,Enzyme-Specific,Partially Suitable
Ranitidine,Pain Relief,Cancer Therapy,62.54,C17H19N3O3S,AMPK Activator,Gastrointestinal Issues,1987,Metformin Hydrochloride,Aspirin,Low Risk,Slow Metabolism,Phase 2,In Vitro Studies,Immune Response Pathway,Tablet,250mg every 8 hours,Roche,2,Low,Low Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Simvastatin,Diabetes,Autoimmune Disorders,50.87,C9H8O4,AMPK Activator,Muscle Pain,1987,Omeprazole,Aspirin,Low Risk,Liver Metabolism,Completed,Toxicology Report,MAPK Pathway,Topical Gel,As prescribed,AstraZeneca,2,High,High Risk,High (>80%),Moderate,Liver,Partially Suitable
Levothyroxine,Acid Reflux,Cancer Therapy,65.99,C13H18O2,AMPK Activator,"Nausea, Dizziness",1971,Atorvastatin Calcium,Aspirin,High Risk,High Bioavailability,Phase 1,In Vitro Studies,PI3K-AKT Pathway,Syrup,50mg daily,Merck,2,Low,High Risk,High (>80%),Slow,Renal,Not Suitable
Aspirin,Thyroid Hormone Replacement,Parkinson's,71.85,C13H18O2,AMPK Activator,Gastrointestinal Issues,1965,Omeprazole,Lipitor,High Risk,Slow Metabolism,Ongoing,Animal Testing,PI3K-AKT Pathway,Topical Gel,50mg daily,AstraZeneca,12,Low,High Risk,High (>80%),Fast,Renal,Partially Suitable
Metformin,Acid Reflux,Alzheimer's,46.81,C9H8O4,NSAID,Muscle Pain,1994,Omeprazole,Lipitor,Moderate Risk,Renal Excretion,Phase 1,Animal Testing,Immune Response Pathway,Topical Gel,10mg once daily,Roche,6,High,Moderate Risk,High (>80%),Fast,Gut,Suitable
Ibuprofen,Diabetes,Antiviral,45.28,C17H19N3O3S,NSAID,Gastrointestinal Issues,1965,Atorvastatin Calcium,Prilosec,High Risk,Renal Excretion,Completed,Toxicology Report,PI3K-AKT Pathway,Tablet,250mg every 8 hours,Novartis,2,Moderate,Moderate Risk,Moderate (50-80%),Slow,Gut,Partially Suitable
Atorvastatin,Fever,Alzheimer's,48.5,C17H19N3O3S,NSAID,Muscle Pain,1987,Acetylsalicylic Acid,Prilosec,High Risk,Renal Excretion,Completed,Animal Testing,MAPK Pathway,Capsule,50mg daily,Pfizer,12,Moderate,Moderate Risk,High (>80%),Fast,Enzyme-Specific,Partially Suitable
Omeprazole,Pain Relief,Cardiovascular Disease,44.73,C9H8O4,Proton Pump Inhibitor,Gastrointestinal Issues,1971,Metformin Hydrochloride,Prilosec,High Risk,Rapid Absorption,Phase 4,Animal Testing,MAPK Pathway,Syrup,250mg every 8 hours,Pfizer,24,Low,Moderate Risk,Moderate (50-80%),Moderate,Renal,Partially Suitable
Losartan,Inflammation,Anti-Aging,87.92,C17H19N3O3S,COX Inhibitor,"Nausea, Dizziness",1971,Acetylsalicylic Acid,Glucophage,High Risk,Renal Excretion,Phase 3,In Vitro Studies,Dopaminergic Pathway,Topical Gel,250mg every 8 hours,Novartis,24,Moderate,High Risk,Moderate (50-80%),Moderate,Gut,Not Suitable
Paracetamol,Blood Thinner,Cardiovascular Disease,45.77,C9H8O4,HMG-CoA Reductase Inhibitor,"Headache, Rash",1996,Omeprazole,Advil,Moderate Risk,Liver Metabolism,Ongoing,Toxicology Report,Dopaminergic Pathway,Syrup,50mg daily,Pfizer,48,Moderate,Low Risk,High (>80%),Slow,Liver,Suitable
Ranitidine,Hypertension,Autoimmune Disorders,47.04,C4H11N5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1996,Metformin Hydrochloride,Advil,High Risk,Liver Metabolism,Completed,Animal Testing,MAPK Pathway,Topical Gel,10mg once daily,Roche,6,Moderate,Moderate Risk,High (>80%),Moderate,Gut,Partially Suitable
Simvastatin,Cholesterol Control,Anti-Aging,42.87,C13H18O2,COX Inhibitor,Muscle Pain,1996,Atorvastatin Calcium,Advil,High Risk,Liver Metabolism,Completed,Animal Testing,Dopaminergic Pathway,Tablet,500mg twice a day,Pfizer,6,Moderate,Low Risk,High (>80%),Moderate,Renal,Not Suitable
Levothyroxine,Thyroid Hormone Replacement,Migraine Treatment,61.96,C9H8O4,HMG-CoA Reductase Inhibitor,Acid Reflux,1971,Acetylsalicylic Acid,Aspirin,Low Risk,Renal Excretion,Phase 4,Toxicology Report,Immune Response Pathway,Syrup,As prescribed,Merck,48,Moderate,High Risk,Low (<50%),Moderate,Liver,Partially Suitable
Aspirin,Hypertension,Liver Disease,71.15,C9H8O4,AMPK Activator,Acid Reflux,1996,Acetylsalicylic Acid,Glucophage,High Risk,High Bioavailability,Phase 2,Toxicology Report,MAPK Pathway,Tablet,50mg daily,Pfizer,24,High,High Risk,Low (<50%),Slow,Renal,Not Suitable
Metformin,Hypertension,Parkinson's,51.77,C13H18O2,Proton Pump Inhibitor,Acid Reflux,1965,Omeprazole,Prilosec,Moderate Risk,Rapid Absorption,Ongoing,Toxicology Report,Dopaminergic Pathway,Topical Gel,50mg daily,Pfizer,6,Moderate,Low Risk,Moderate (50-80%),Moderate,Liver,Partially Suitable
Ibuprofen,Diabetes,Cancer Therapy,39.29,C4H11N5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1971,Ibuprofen,Glucophage,Moderate Risk,Renal Excretion,Phase 4,In Vitro Studies,MAPK Pathway,Capsule,As prescribed,Novartis,48,Low,Moderate Risk,Moderate (50-80%),Moderate,Renal,Not Suitable
Atorvastatin,Inflammation,Alzheimer's,82.6,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1965,Ibuprofen,Aspirin,High Risk,Slow Metabolism,Phase 2,In Vitro Studies,Immune Response Pathway,Injection,10mg once daily,Novartis,2,High,High Risk,Low (<50%),Moderate,Renal,Not Suitable
Omeprazole,Hypertension,Anti-Aging,89.69,C4H11N5,Proton Pump Inhibitor,Gastrointestinal Issues,1971,Metformin Hydrochloride,Glucophage,High Risk,High Bioavailability,Phase 3,Animal Testing,Serotonin Pathway,Syrup,50mg daily,AstraZeneca,12,Low,Moderate Risk,Moderate (50-80%),Fast,Enzyme-Specific,Not Suitable
Losartan,Diabetes,Cancer Therapy,56.65,C9H8O4,AMPK Activator,Gastrointestinal Issues,1987,Atorvastatin Calcium,Lipitor,Moderate Risk,Liver Metabolism,Completed,Toxicology Report,Immune Response Pathway,Capsule,250mg every 8 hours,AstraZeneca,48,Moderate,Moderate Risk,High (>80%),Fast,Enzyme-Specific,Partially Suitable
Paracetamol,Blood Thinner,Cardiovascular Disease,42.2,C33H35FN2O5,NSAID,"Nausea, Dizziness",1971,Omeprazole,Glucophage,High Risk,Liver Metabolism,Phase 4,In Vitro Studies,PI3K-AKT Pathway,Capsule,As prescribed,Pfizer,6,Moderate,Low Risk,Low (<50%),Moderate,Gut,Not Suitable
Ranitidine,Inflammation,Autoimmune Disorders,60.85,C33H35FN2O5,NSAID,Acid Reflux,1996,Atorvastatin Calcium,Advil,High Risk,Slow Metabolism,Phase 1,No Preclinical Data,Serotonin Pathway,Injection,As prescribed,Roche,48,Moderate,High Risk,Low (<50%),Slow,Gut,Suitable
Simvastatin,Thyroid Hormone Replacement,Anti-Aging,49.13,C17H19N3O3S,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1971,Ibuprofen,Prilosec,Moderate Risk,Renal Excretion,Phase 1,No Preclinical Data,Immune Response Pathway,Capsule,As prescribed,Roche,6,High,High Risk,Low (<50%),Fast,Gut,Not Suitable
Levothyroxine,Diabetes,Anti-Aging,54.28,C13H18O2,NSAID,"Nausea, Dizziness",1987,Ibuprofen,Glucophage,Low Risk,Rapid Absorption,Ongoing,Animal Testing,Immune Response Pathway,Capsule,250mg every 8 hours,Merck,12,Moderate,Moderate Risk,High (>80%),Moderate,Renal,Partially Suitable
Aspirin,Cholesterol Control,Cancer Therapy,69.33,C13H18O2,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1965,Metformin Hydrochloride,Aspirin,High Risk,Renal Excretion,Completed,No Preclinical Data,Serotonin Pathway,Tablet,500mg twice a day,Pfizer,2,Moderate,Moderate Risk,Low (<50%),Fast,Enzyme-Specific,Suitable
Metformin,Cholesterol Control,Cardiovascular Disease,88.61,C17H19N3O3S,NSAID,Muscle Pain,1987,Acetylsalicylic Acid,Prilosec,Moderate Risk,Liver Metabolism,Completed,No Preclinical Data,Immune Response Pathway,Syrup,250mg every 8 hours,AstraZeneca,48,High,High Risk,Moderate (50-80%),Moderate,Renal,Partially Suitable
Ibuprofen,Diabetes,Parkinson's,49.6,C17H19N3O3S,COX Inhibitor,"Headache, Rash",1994,Acetylsalicylic Acid,Glucophage,Low Risk,Renal Excretion,Phase 3,Animal Testing,Dopaminergic Pathway,Tablet,250mg every 8 hours,AstraZeneca,24,High,Moderate Risk,Low (<50%),Fast,Gut,Suitable
Atorvastatin,Thyroid Hormone Replacement,Alzheimer's,64.56,C13H18O2,Proton Pump Inhibitor,"Headache, Rash",1996,Metformin Hydrochloride,Prilosec,Moderate Risk,High Bioavailability,Phase 3,No Preclinical Data,PI3K-AKT Pathway,Syrup,50mg daily,Novartis,2,Low,High Risk,Moderate (50-80%),Fast,Renal,Not Suitable
Omeprazole,Pain Relief,Liver Disease,72.71,C4H11N5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1965,Omeprazole,Lipitor,High Risk,High Bioavailability,Phase 3,Animal Testing,Serotonin Pathway,Tablet,250mg every 8 hours,AstraZeneca,24,Moderate,Moderate Risk,Low (<50%),Slow,Enzyme-Specific,Not Suitable
Losartan,Acid Reflux,Autoimmune Disorders,39.78,C4H11N5,HMG-CoA Reductase Inhibitor,Muscle Pain,1971,Acetylsalicylic Acid,Aspirin,Moderate Risk,Liver Metabolism,Phase 3,Toxicology Report,Immune Response Pathway,Syrup,As prescribed,AstraZeneca,6,Low,Moderate Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Paracetamol,Fever,Liver Disease,38.69,C9H8O4,AMPK Activator,Acid Reflux,1965,Acetylsalicylic Acid,Aspirin,Low Risk,Renal Excretion,Phase 3,Animal Testing,MAPK Pathway,Tablet,50mg daily,Merck,48,Low,Moderate Risk,Low (<50%),Fast,Gut,Not Suitable
Ranitidine,Acid Reflux,Migraine Treatment,80.42,C4H11N5,AMPK Activator,Acid Reflux,1965,Omeprazole,Glucophage,Low Risk,Rapid Absorption,Phase 1,In Vitro Studies,Serotonin Pathway,Topical Gel,500mg twice a day,Pfizer,24,Moderate,Low Risk,High (>80%),Moderate,Enzyme-Specific,Not Suitable
Simvastatin,Blood Thinner,Cardiovascular Disease,68.32,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1987,Ibuprofen,Advil,Moderate Risk,High Bioavailability,Phase 4,No Preclinical Data,Immune Response Pathway,Tablet,50mg daily,Novartis,24,Low,Low Risk,Low (<50%),Slow,Renal,Suitable
Levothyroxine,Thyroid Hormone Replacement,Autoimmune Disorders,36.71,C17H19N3O3S,COX Inhibitor,Muscle Pain,1965,Ibuprofen,Prilosec,Low Risk,Renal Excretion,Phase 2,In Vitro Studies,MAPK Pathway,Tablet,50mg daily,Pfizer,2,Moderate,Low Risk,Low (<50%),Fast,Renal,Partially Suitable
Aspirin,Blood Thinner,Antiviral,42.53,C33H35FN2O5,NSAID,"Nausea, Dizziness",1971,Ibuprofen,Glucophage,Moderate Risk,Rapid Absorption,Phase 1,In Vitro Studies,PI3K-AKT Pathway,Syrup,As prescribed,Pfizer,2,High,Low Risk,Low (<50%),Moderate,Liver,Suitable
Metformin,Fever,Autoimmune Disorders,48.25,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Acid Reflux,1994,Omeprazole,Prilosec,Low Risk,Liver Metabolism,Phase 4,In Vitro Studies,Immune Response Pathway,Capsule,250mg every 8 hours,AstraZeneca,6,Moderate,Low Risk,Moderate (50-80%),Slow,Liver,Not Suitable
Ibuprofen,Blood Thinner,Cardiovascular Disease,67.16,C17H19N3O3S,NSAID,"Headache, Rash",1996,Acetylsalicylic Acid,Advil,Low Risk,High Bioavailability,Phase 3,In Vitro Studies,PI3K-AKT Pathway,Capsule,250mg every 8 hours,AstraZeneca,2,Moderate,Moderate Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Atorvastatin,Inflammation,Autoimmune Disorders,67.53,C4H11N5,Proton Pump Inhibitor,Acid Reflux,1971,Metformin Hydrochloride,Prilosec,Low Risk,Liver Metabolism,Phase 3,No Preclinical Data,PI3K-AKT Pathway,Topical Gel,250mg every 8 hours,Merck,6,Low,High Risk,Low (<50%),Fast,Renal,Not Suitable
Omeprazole,Gastric Ulcer,Liver Disease,57.88,C4H11N5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1965,Acetylsalicylic Acid,Prilosec,Low Risk,Slow Metabolism,Ongoing,Animal Testing,Dopaminergic Pathway,Capsule,250mg every 8 hours,AstraZeneca,6,Moderate,Low Risk,Moderate (50-80%),Slow,Liver,Partially Suitable
Losartan,Pain Relief,Migraine Treatment,65.91,C17H19N3O3S,COX Inhibitor,"Nausea, Dizziness",1971,Ibuprofen,Advil,Moderate Risk,Slow Metabolism,Phase 2,In Vitro Studies,Dopaminergic Pathway,Tablet,250mg every 8 hours,Novartis,48,Moderate,Low Risk,High (>80%),Fast,Renal,Partially Suitable
Paracetamol,Acid Reflux,Cardiovascular Disease,37.25,C9H8O4,COX Inhibitor,Acid Reflux,1994,Ibuprofen,Glucophage,High Risk,Rapid Absorption,Phase 3,In Vitro Studies,Immune Response Pathway,Injection,As prescribed,Novartis,24,Low,Low Risk,Moderate (50-80%),Fast,Enzyme-Specific,Suitable
Ranitidine,Blood Thinner,Antiviral,85.04,C33H35FN2O5,AMPK Activator,Muscle Pain,1965,Acetylsalicylic Acid,Glucophage,Moderate Risk,Rapid Absorption,Phase 2,Toxicology Report,PI3K-AKT Pathway,Capsule,500mg twice a day,AstraZeneca,12,Moderate,Low Risk,High (>80%),Slow,Liver,Suitable
Simvastatin,Hypertension,Autoimmune Disorders,71.63,C33H35FN2O5,COX Inhibitor,Acid Reflux,1971,Ibuprofen,Prilosec,High Risk,Rapid Absorption,Phase 2,No Preclinical Data,MAPK Pathway,Injection,500mg twice a day,Pfizer,2,High,Moderate Risk,High (>80%),Moderate,Liver,Suitable
Levothyroxine,Blood Thinner,Antiviral,68.41,C13H18O2,Proton Pump Inhibitor,Muscle Pain,1996,Acetylsalicylic Acid,Glucophage,High Risk,Liver Metabolism,Ongoing,Animal Testing,Dopaminergic Pathway,Injection,10mg once daily,Merck,12,Low,Moderate Risk,Moderate (50-80%),Moderate,Gut,Not Suitable
Aspirin,Gastric Ulcer,Migraine Treatment,56.23,C33H35FN2O5,NSAID,"Nausea, Dizziness",1987,Omeprazole,Aspirin,High Risk,Liver Metabolism,Phase 4,In Vitro Studies,Serotonin Pathway,Syrup,500mg twice a day,Novartis,48,High,High Risk,High (>80%),Slow,Enzyme-Specific,Suitable
Metformin,Inflammation,Autoimmune Disorders,81.5,C13H18O2,HMG-CoA Reductase Inhibitor,"Headache, Rash",1987,Atorvastatin Calcium,Aspirin,Moderate Risk,Renal Excretion,Phase 2,In Vitro Studies,Dopaminergic Pathway,Capsule,250mg every 8 hours,Pfizer,6,Low,Moderate Risk,High (>80%),Slow,Liver,Suitable
Ibuprofen,Blood Thinner,Liver Disease,54.19,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1971,Atorvastatin Calcium,Advil,Low Risk,Slow Metabolism,Phase 2,Animal Testing,MAPK Pathway,Injection,500mg twice a day,AstraZeneca,12,High,Low Risk,Low (<50%),Slow,Renal,Suitable
Atorvastatin,Acid Reflux,Alzheimer's,37.51,C33H35FN2O5,COX Inhibitor,Muscle Pain,1971,Atorvastatin Calcium,Glucophage,Moderate Risk,Renal Excretion,Phase 3,In Vitro Studies,Dopaminergic Pathway,Topical Gel,250mg every 8 hours,Merck,12,Moderate,Low Risk,Moderate (50-80%),Fast,Renal,Suitable
Omeprazole,Blood Thinner,Parkinson's,64.27,C13H18O2,Proton Pump Inhibitor,Gastrointestinal Issues,1994,Acetylsalicylic Acid,Advil,Low Risk,Liver Metabolism,Completed,Toxicology Report,Dopaminergic Pathway,Syrup,250mg every 8 hours,Pfizer,48,Moderate,High Risk,Moderate (50-80%),Slow,Renal,Partially Suitable
Losartan,Acid Reflux,Anti-Aging,30.67,C9H8O4,HMG-CoA Reductase Inhibitor,"Headache, Rash",1971,Acetylsalicylic Acid,Lipitor,Low Risk,High Bioavailability,Completed,In Vitro Studies,Serotonin Pathway,Syrup,250mg every 8 hours,AstraZeneca,48,High,High Risk,High (>80%),Moderate,Enzyme-Specific,Partially Suitable
Paracetamol,Fever,Autoimmune Disorders,60.22,C4H11N5,COX Inhibitor,"Headache, Rash",1965,Omeprazole,Glucophage,Moderate Risk,Renal Excretion,Phase 3,Toxicology Report,PI3K-AKT Pathway,Tablet,As prescribed,Merck,2,High,High Risk,Low (<50%),Moderate,Liver,Not Suitable
Ranitidine,Inflammation,Cardiovascular Disease,87.18,C9H8O4,AMPK Activator,Acid Reflux,1996,Atorvastatin Calcium,Advil,Moderate Risk,Slow Metabolism,Ongoing,Toxicology Report,Dopaminergic Pathway,Tablet,10mg once daily,Pfizer,12,Moderate,Low Risk,Low (<50%),Slow,Enzyme-Specific,Not Suitable
Simvastatin,Hypertension,Weight Loss,65.99,C9H8O4,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1994,Acetylsalicylic Acid,Glucophage,Low Risk,Slow Metabolism,Phase 2,No Preclinical Data,Immune Response Pathway,Topical Gel,250mg every 8 hours,Pfizer,12,Moderate,Moderate Risk,High (>80%),Moderate,Enzyme-Specific,Not Suitable
Levothyroxine,Thyroid Hormone Replacement,Anti-Aging,43.09,C13H18O2,HMG-CoA Reductase Inhibitor,Acid Reflux,1996,Metformin Hydrochloride,Prilosec,High Risk,Slow Metabolism,Phase 3,In Vitro Studies,Immune Response Pathway,Syrup,250mg every 8 hours,Roche,48,Moderate,Low Risk,Moderate (50-80%),Moderate,Renal,Suitable
Aspirin,Fever,Cancer Therapy,41.37,C9H8O4,HMG-CoA Reductase Inhibitor,"Headache, Rash",1965,Acetylsalicylic Acid,Advil,Low Risk,Slow Metabolism,Completed,Toxicology Report,Serotonin Pathway,Topical Gel,500mg twice a day,Merck,6,Low,High Risk,Low (<50%),Slow,Renal,Not Suitable
Metformin,Diabetes,Anti-Aging,40.88,C4H11N5,Proton Pump Inhibitor,Muscle Pain,1994,Metformin Hydrochloride,Glucophage,Low Risk,Liver Metabolism,Phase 2,Toxicology Report,Dopaminergic Pathway,Tablet,500mg twice a day,Novartis,6,Moderate,Low Risk,High (>80%),Moderate,Renal,Not Suitable
Ibuprofen,Pain Relief,Autoimmune Disorders,44.44,C17H19N3O3S,Proton Pump Inhibitor,"Nausea, Dizziness",1971,Omeprazole,Glucophage,High Risk,Rapid Absorption,Phase 2,No Preclinical Data,Immune Response Pathway,Injection,500mg twice a day,Pfizer,2,Low,High Risk,Low (<50%),Slow,Liver,Not Suitable
Atorvastatin,Gastric Ulcer,Migraine Treatment,46.97,C17H19N3O3S,COX Inhibitor,"Nausea, Dizziness",1996,Ibuprofen,Prilosec,High Risk,Rapid Absorption,Completed,No Preclinical Data,PI3K-AKT Pathway,Syrup,250mg every 8 hours,Merck,48,Low,High Risk,Low (<50%),Moderate,Enzyme-Specific,Not Suitable
Omeprazole,Diabetes,Parkinson's,66.36,C4H11N5,COX Inhibitor,Acid Reflux,1971,Acetylsalicylic Acid,Glucophage,Moderate Risk,Slow Metabolism,Phase 1,In Vitro Studies,Serotonin Pathway,Topical Gel,500mg twice a day,Roche,2,Low,Moderate Risk,High (>80%),Moderate,Liver,Not Suitable
Losartan,Fever,Migraine Treatment,38.54,C33H35FN2O5,COX Inhibitor,"Headache, Rash",1987,Acetylsalicylic Acid,Glucophage,Moderate Risk,Renal Excretion,Phase 3,In Vitro Studies,PI3K-AKT Pathway,Tablet,50mg daily,Merck,48,Low,Moderate Risk,Low (<50%),Moderate,Gut,Not Suitable
Paracetamol,Hypertension,Weight Loss,92.5,C17H19N3O3S,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1987,Metformin Hydrochloride,Advil,Low Risk,Liver Metabolism,Phase 3,Animal Testing,Dopaminergic Pathway,Syrup,10mg once daily,Merck,12,Low,Moderate Risk,Moderate (50-80%),Fast,Gut,Partially Suitable
Ranitidine,Blood Thinner,Antiviral,81.7,C9H8O4,AMPK Activator,Gastrointestinal Issues,1994,Omeprazole,Lipitor,Low Risk,Slow Metabolism,Phase 4,In Vitro Studies,MAPK Pathway,Injection,50mg daily,Pfizer,48,Low,High Risk,Moderate (50-80%),Fast,Gut,Not Suitable
Simvastatin,Fever,Liver Disease,42.83,C9H8O4,HMG-CoA Reductase Inhibitor,Acid Reflux,1965,Acetylsalicylic Acid,Prilosec,Low Risk,Renal Excretion,Ongoing,Toxicology Report,Dopaminergic Pathway,Topical Gel,10mg once daily,Roche,12,High,Moderate Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Not Suitable
Levothyroxine,Fever,Weight Loss,63.4,C13H18O2,Proton Pump Inhibitor,Acid Reflux,1987,Atorvastatin Calcium,Aspirin,Moderate Risk,Slow Metabolism,Phase 2,Animal Testing,Serotonin Pathway,Tablet,10mg once daily,AstraZeneca,48,Moderate,Low Risk,High (>80%),Moderate,Gut,Suitable
Aspirin,Blood Thinner,Liver Disease,63.62,C9H8O4,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1971,Omeprazole,Glucophage,Moderate Risk,Liver Metabolism,Ongoing,No Preclinical Data,Serotonin Pathway,Topical Gel,As prescribed,AstraZeneca,2,High,High Risk,Low (<50%),Moderate,Enzyme-Specific,Suitable
Metformin,Acid Reflux,Antiviral,36.63,C13H18O2,AMPK Activator,Acid Reflux,1994,Ibuprofen,Glucophage,Moderate Risk,Renal Excretion,Ongoing,Toxicology Report,MAPK Pathway,Tablet,As prescribed,Pfizer,2,Low,High Risk,Low (<50%),Moderate,Gut,Partially Suitable
Ibuprofen,Thyroid Hormone Replacement,Parkinson's,46.21,C17H19N3O3S,HMG-CoA Reductase Inhibitor,"Headache, Rash",1987,Acetylsalicylic Acid,Aspirin,Moderate Risk,Slow Metabolism,Phase 3,No Preclinical Data,Serotonin Pathway,Tablet,10mg once daily,AstraZeneca,6,Low,Low Risk,Moderate (50-80%),Moderate,Liver,Partially Suitable
Atorvastatin,Hypertension,Cardiovascular Disease,72.86,C13H18O2,Proton Pump Inhibitor,Gastrointestinal Issues,1996,Atorvastatin Calcium,Advil,Moderate Risk,Liver Metabolism,Phase 4,Toxicology Report,PI3K-AKT Pathway,Syrup,50mg daily,Roche,2,Low,Moderate Risk,Moderate (50-80%),Fast,Gut,Partially Suitable
Omeprazole,Diabetes,Anti-Aging,60.92,C9H8O4,AMPK Activator,"Headache, Rash",1996,Omeprazole,Prilosec,High Risk,Rapid Absorption,Phase 4,In Vitro Studies,PI3K-AKT Pathway,Syrup,500mg twice a day,Pfizer,6,High,Low Risk,Moderate (50-80%),Fast,Renal,Partially Suitable
Losartan,Acid Reflux,Anti-Aging,64.43,C33H35FN2O5,AMPK Activator,"Nausea, Dizziness",1994,Ibuprofen,Glucophage,Low Risk,Renal Excretion,Completed,Toxicology Report,MAPK Pathway,Syrup,10mg once daily,AstraZeneca,24,High,High Risk,Moderate (50-80%),Slow,Gut,Suitable
Paracetamol,Diabetes,Cardiovascular Disease,85.28,C13H18O2,HMG-CoA Reductase Inhibitor,Acid Reflux,1987,Omeprazole,Advil,Low Risk,High Bioavailability,Phase 4,Toxicology Report,MAPK Pathway,Syrup,500mg twice a day,Pfizer,48,Moderate,Low Risk,Low (<50%),Slow,Gut,Not Suitable
Ranitidine,Fever,Parkinson's,88.31,C13H18O2,COX Inhibitor,Gastrointestinal Issues,1965,Atorvastatin Calcium,Glucophage,Low Risk,High Bioavailability,Ongoing,No Preclinical Data,Serotonin Pathway,Syrup,50mg daily,Novartis,48,High,High Risk,High (>80%),Slow,Enzyme-Specific,Suitable
Simvastatin,Fever,Weight Loss,86.66,C17H19N3O3S,AMPK Activator,"Headache, Rash",1994,Metformin Hydrochloride,Prilosec,Low Risk,Renal Excretion,Ongoing,In Vitro Studies,PI3K-AKT Pathway,Tablet,As prescribed,Roche,2,Moderate,High Risk,High (>80%),Moderate,Liver,Suitable
Levothyroxine,Inflammation,Antiviral,78.24,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Acid Reflux,1994,Metformin Hydrochloride,Prilosec,Low Risk,Renal Excretion,Phase 2,In Vitro Studies,PI3K-AKT Pathway,Tablet,50mg daily,Novartis,6,Low,High Risk,Low (<50%),Moderate,Renal,Partially Suitable
Aspirin,Thyroid Hormone Replacement,Autoimmune Disorders,59.48,C4H11N5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1965,Acetylsalicylic Acid,Glucophage,High Risk,Slow Metabolism,Completed,Animal Testing,Immune Response Pathway,Injection,250mg every 8 hours,AstraZeneca,6,Low,Low Risk,High (>80%),Moderate,Renal,Not Suitable
Metformin,Diabetes,Alzheimer's,43.06,C13H18O2,COX Inhibitor,Muscle Pain,1965,Atorvastatin Calcium,Advil,High Risk,Renal Excretion,Phase 4,In Vitro Studies,Immune Response Pathway,Topical Gel,250mg every 8 hours,AstraZeneca,2,High,Low Risk,Low (<50%),Slow,Liver,Suitable
Ibuprofen,Cholesterol Control,Autoimmune Disorders,65.35,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1996,Ibuprofen,Aspirin,Low Risk,High Bioavailability,Ongoing,Animal Testing,MAPK Pathway,Topical Gel,50mg daily,Pfizer,2,Moderate,High Risk,Low (<50%),Fast,Gut,Partially Suitable
Atorvastatin,Pain Relief,Autoimmune Disorders,54.2,C4H11N5,NSAID,"Headache, Rash",1994,Ibuprofen,Advil,Moderate Risk,High Bioavailability,Phase 4,Animal Testing,PI3K-AKT Pathway,Tablet,50mg daily,Roche,6,Low,Low Risk,High (>80%),Slow,Gut,Not Suitable
Omeprazole,Hypertension,Alzheimer's,93.78,C9H8O4,Proton Pump Inhibitor,"Nausea, Dizziness",1996,Omeprazole,Prilosec,Moderate Risk,Renal Excretion,Phase 2,No Preclinical Data,MAPK Pathway,Injection,250mg every 8 hours,Roche,48,Low,High Risk,Low (<50%),Slow,Liver,Partially Suitable
Losartan,Pain Relief,Migraine Treatment,56.05,C9H8O4,Proton Pump Inhibitor,Muscle Pain,1996,Acetylsalicylic Acid,Advil,High Risk,Slow Metabolism,Phase 4,No Preclinical Data,Serotonin Pathway,Injection,10mg once daily,Pfizer,48,Low,High Risk,Low (<50%),Slow,Renal,Partially Suitable
Paracetamol,Fever,Parkinson's,57.06,C33H35FN2O5,Proton Pump Inhibitor,Acid Reflux,1965,Ibuprofen,Advil,Moderate Risk,Rapid Absorption,Phase 1,Toxicology Report,Serotonin Pathway,Topical Gel,250mg every 8 hours,Novartis,12,Low,Low Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Not Suitable
Ranitidine,Acid Reflux,Autoimmune Disorders,53.11,C4H11N5,COX Inhibitor,Acid Reflux,1987,Metformin Hydrochloride,Advil,Moderate Risk,Liver Metabolism,Ongoing,Toxicology Report,Serotonin Pathway,Injection,10mg once daily,Novartis,48,Low,Low Risk,Low (<50%),Slow,Liver,Not Suitable
Simvastatin,Thyroid Hormone Replacement,Migraine Treatment,79.23,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1987,Atorvastatin Calcium,Lipitor,High Risk,Liver Metabolism,Phase 3,Animal Testing,PI3K-AKT Pathway,Tablet,50mg daily,Roche,12,High,High Risk,Low (<50%),Moderate,Gut,Partially Suitable
Levothyroxine,Cholesterol Control,Alzheimer's,83.03,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Muscle Pain,1965,Acetylsalicylic Acid,Lipitor,High Risk,Slow Metabolism,Phase 2,Animal Testing,PI3K-AKT Pathway,Tablet,250mg every 8 hours,Pfizer,24,Moderate,Moderate Risk,Low (<50%),Fast,Enzyme-Specific,Suitable
Aspirin,Inflammation,Migraine Treatment,67.66,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1971,Metformin Hydrochloride,Prilosec,Low Risk,Rapid Absorption,Phase 2,Animal Testing,MAPK Pathway,Injection,10mg once daily,Novartis,2,Moderate,Moderate Risk,Low (<50%),Slow,Gut,Partially Suitable
Metformin,Acid Reflux,Migraine Treatment,54.34,C17H19N3O3S,Proton Pump Inhibitor,Acid Reflux,1965,Ibuprofen,Glucophage,Low Risk,High Bioavailability,Completed,In Vitro Studies,MAPK Pathway,Syrup,500mg twice a day,Novartis,24,High,Moderate Risk,Moderate (50-80%),Slow,Enzyme-Specific,Suitable
Ibuprofen,Inflammation,Parkinson's,30.52,C33H35FN2O5,NSAID,Gastrointestinal Issues,1971,Metformin Hydrochloride,Aspirin,Moderate Risk,Liver Metabolism,Phase 2,No Preclinical Data,PI3K-AKT Pathway,Injection,10mg once daily,AstraZeneca,12,Moderate,Moderate Risk,Moderate (50-80%),Moderate,Gut,Partially Suitable
Atorvastatin,Diabetes,Parkinson's,88.72,C9H8O4,Proton Pump Inhibitor,Muscle Pain,1965,Ibuprofen,Prilosec,High Risk,Slow Metabolism,Completed,Toxicology Report,PI3K-AKT Pathway,Injection,10mg once daily,AstraZeneca,48,High,Moderate Risk,High (>80%),Slow,Liver,Suitable
Omeprazole,Thyroid Hormone Replacement,Migraine Treatment,31.11,C33H35FN2O5,COX Inhibitor,Muscle Pain,1965,Acetylsalicylic Acid,Glucophage,Low Risk,Slow Metabolism,Completed,Toxicology Report,MAPK Pathway,Injection,50mg daily,Novartis,48,High,Moderate Risk,Low (<50%),Fast,Gut,Not Suitable
Losartan,Acid Reflux,Autoimmune Disorders,92.02,C17H19N3O3S,COX Inhibitor,Gastrointestinal Issues,1996,Atorvastatin Calcium,Advil,Low Risk,Renal Excretion,Phase 2,Toxicology Report,MAPK Pathway,Syrup,500mg twice a day,Merck,12,Low,High Risk,Moderate (50-80%),Moderate,Liver,Not Suitable
Paracetamol,Hypertension,Alzheimer's,67.11,C33H35FN2O5,AMPK Activator,Muscle Pain,1965,Omeprazole,Aspirin,High Risk,Liver Metabolism,Phase 1,Animal Testing,MAPK Pathway,Syrup,500mg twice a day,Novartis,24,Moderate,High Risk,Low (<50%),Fast,Enzyme-Specific,Not Suitable
Ranitidine,Inflammation,Parkinson's,64.12,C13H18O2,NSAID,Gastrointestinal Issues,1996,Metformin Hydrochloride,Advil,Low Risk,Slow Metabolism,Phase 2,Animal Testing,Immune Response Pathway,Injection,50mg daily,AstraZeneca,48,Moderate,Moderate Risk,Moderate (50-80%),Moderate,Liver,Not Suitable
Simvastatin,Fever,Antiviral,32.6,C17H19N3O3S,AMPK Activator,Muscle Pain,1971,Atorvastatin Calcium,Prilosec,High Risk,Renal Excretion,Phase 4,No Preclinical Data,Serotonin Pathway,Capsule,500mg twice a day,Pfizer,12,High,Low Risk,Moderate (50-80%),Slow,Gut,Not Suitable
Levothyroxine,Diabetes,Weight Loss,89.46,C17H19N3O3S,NSAID,Acid Reflux,1994,Atorvastatin Calcium,Advil,Moderate Risk,Liver Metabolism,Phase 1,Toxicology Report,Immune Response Pathway,Syrup,500mg twice a day,AstraZeneca,6,High,Moderate Risk,High (>80%),Slow,Renal,Partially Suitable
Aspirin,Cholesterol Control,Parkinson's,77.76,C17H19N3O3S,COX Inhibitor,"Nausea, Dizziness",1987,Acetylsalicylic Acid,Prilosec,Moderate Risk,Renal Excretion,Phase 3,In Vitro Studies,Dopaminergic Pathway,Tablet,250mg every 8 hours,Merck,48,Low,Moderate Risk,High (>80%),Fast,Renal,Not Suitable
Metformin,Diabetes,Anti-Aging,41.51,C9H8O4,HMG-CoA Reductase Inhibitor,"Headache, Rash",1994,Omeprazole,Aspirin,Moderate Risk,High Bioavailability,Phase 4,No Preclinical Data,MAPK Pathway,Topical Gel,250mg every 8 hours,Novartis,2,Low,Moderate Risk,Moderate (50-80%),Slow,Liver,Partially Suitable
Ibuprofen,Acid Reflux,Parkinson's,55.17,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1994,Metformin Hydrochloride,Glucophage,High Risk,Liver Metabolism,Phase 3,In Vitro Studies,MAPK Pathway,Injection,250mg every 8 hours,AstraZeneca,6,High,High Risk,Low (<50%),Moderate,Enzyme-Specific,Not Suitable
Atorvastatin,Inflammation,Anti-Aging,68.33,C4H11N5,HMG-CoA Reductase Inhibitor,Acid Reflux,1971,Omeprazole,Aspirin,High Risk,Liver Metabolism,Phase 3,No Preclinical Data,MAPK Pathway,Topical Gel,250mg every 8 hours,Roche,6,Low,Moderate Risk,High (>80%),Slow,Enzyme-Specific,Not Suitable
Omeprazole,Inflammation,Cancer Therapy,37.74,C9H8O4,COX Inhibitor,"Nausea, Dizziness",1971,Acetylsalicylic Acid,Glucophage,Moderate Risk,Renal Excretion,Phase 4,In Vitro Studies,PI3K-AKT Pathway,Tablet,10mg once daily,AstraZeneca,12,Moderate,High Risk,High (>80%),Slow,Renal,Partially Suitable
Losartan,Acid Reflux,Migraine Treatment,67.13,C17H19N3O3S,Proton Pump Inhibitor,"Headache, Rash",1971,Omeprazole,Aspirin,Low Risk,Slow Metabolism,Phase 1,Animal Testing,MAPK Pathway,Injection,50mg daily,Merck,24,High,Low Risk,High (>80%),Slow,Renal,Suitable
Paracetamol,Thyroid Hormone Replacement,Parkinson's,41.38,C17H19N3O3S,NSAID,"Headache, Rash",1996,Ibuprofen,Advil,High Risk,Slow Metabolism,Ongoing,Animal Testing,Immune Response Pathway,Topical Gel,50mg daily,Pfizer,48,High,Low Risk,High (>80%),Slow,Enzyme-Specific,Not Suitable
Ranitidine,Inflammation,Migraine Treatment,37.69,C13H18O2,Proton Pump Inhibitor,Muscle Pain,1965,Omeprazole,Lipitor,Low Risk,High Bioavailability,Phase 3,In Vitro Studies,MAPK Pathway,Tablet,500mg twice a day,Novartis,2,Low,High Risk,Moderate (50-80%),Fast,Liver,Suitable
Simvastatin,Acid Reflux,Autoimmune Disorders,42.2,C9H8O4,Proton Pump Inhibitor,"Headache, Rash",1994,Ibuprofen,Advil,Low Risk,Liver Metabolism,Phase 2,Animal Testing,Dopaminergic Pathway,Tablet,250mg every 8 hours,Roche,6,High,Low Risk,Low (<50%),Slow,Renal,Suitable
Levothyroxine,Diabetes,Migraine Treatment,59.53,C17H19N3O3S,COX Inhibitor,Gastrointestinal Issues,1965,Ibuprofen,Prilosec,Moderate Risk,Renal Excretion,Phase 1,Animal Testing,PI3K-AKT Pathway,Capsule,250mg every 8 hours,AstraZeneca,2,High,Low Risk,Low (<50%),Moderate,Renal,Suitable
Aspirin,Thyroid Hormone Replacement,Autoimmune Disorders,83.79,C17H19N3O3S,COX Inhibitor,Muscle Pain,1965,Atorvastatin Calcium,Advil,Low Risk,Slow Metabolism,Phase 2,In Vitro Studies,MAPK Pathway,Injection,500mg twice a day,AstraZeneca,2,Moderate,Low Risk,High (>80%),Fast,Liver,Partially Suitable
Metformin,Inflammation,Anti-Aging,61.4,C33H35FN2O5,NSAID,"Nausea, Dizziness",1996,Acetylsalicylic Acid,Aspirin,Moderate Risk,Rapid Absorption,Phase 2,Toxicology Report,Dopaminergic Pathway,Tablet,As prescribed,Roche,24,Low,Low Risk,High (>80%),Slow,Gut,Partially Suitable
Ibuprofen,Inflammation,Alzheimer's,69.68,C9H8O4,NSAID,Gastrointestinal Issues,1987,Ibuprofen,Advil,High Risk,Slow Metabolism,Phase 4,Animal Testing,Serotonin Pathway,Syrup,50mg daily,Novartis,2,High,High Risk,Moderate (50-80%),Moderate,Gut,Not Suitable
Atorvastatin,Fever,Weight Loss,81.76,C4H11N5,AMPK Activator,Muscle Pain,1987,Omeprazole,Prilosec,High Risk,Slow Metabolism,Ongoing,No Preclinical Data,Dopaminergic Pathway,Injection,50mg daily,Merck,12,Low,High Risk,Low (<50%),Slow,Liver,Not Suitable
Omeprazole,Hypertension,Liver Disease,60.74,C17H19N3O3S,Proton Pump Inhibitor,Gastrointestinal Issues,1987,Omeprazole,Aspirin,Moderate Risk,Rapid Absorption,Phase 3,In Vitro Studies,Serotonin Pathway,Capsule,As prescribed,Merck,2,Moderate,Moderate Risk,High (>80%),Fast,Liver,Suitable
Losartan,Blood Thinner,Anti-Aging,83.68,C13H18O2,AMPK Activator,Gastrointestinal Issues,1996,Metformin Hydrochloride,Lipitor,Moderate Risk,High Bioavailability,Phase 2,Animal Testing,PI3K-AKT Pathway,Tablet,As prescribed,Roche,12,High,High Risk,Moderate (50-80%),Slow,Renal,Not Suitable
Paracetamol,Acid Reflux,Antiviral,76.48,C4H11N5,AMPK Activator,Acid Reflux,1971,Omeprazole,Lipitor,Low Risk,Liver Metabolism,Phase 3,Toxicology Report,PI3K-AKT Pathway,Topical Gel,50mg daily,Pfizer,48,High,High Risk,Moderate (50-80%),Slow,Gut,Partially Suitable
Ranitidine,Gastric Ulcer,Autoimmune Disorders,31.48,C4H11N5,NSAID,Acid Reflux,1994,Atorvastatin Calcium,Advil,Moderate Risk,Slow Metabolism,Phase 3,No Preclinical Data,Serotonin Pathway,Topical Gel,As prescribed,Pfizer,48,Low,Low Risk,Low (<50%),Slow,Gut,Partially Suitable
Simvastatin,Diabetes,Migraine Treatment,31.64,C9H8O4,NSAID,Acid Reflux,1987,Metformin Hydrochloride,Aspirin,Moderate Risk,Liver Metabolism,Completed,Animal Testing,Immune Response Pathway,Topical Gel,250mg every 8 hours,AstraZeneca,2,Low,High Risk,Low (<50%),Fast,Renal,Suitable
Levothyroxine,Inflammation,Antiviral,60.96,C4H11N5,COX Inhibitor,Acid Reflux,1965,Atorvastatin Calcium,Glucophage,High Risk,Rapid Absorption,Completed,No Preclinical Data,Dopaminergic Pathway,Syrup,250mg every 8 hours,Novartis,6,Low,Moderate Risk,Low (<50%),Slow,Enzyme-Specific,Partially Suitable
Aspirin,Blood Thinner,Liver Disease,70.37,C13H18O2,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1996,Atorvastatin Calcium,Lipitor,Low Risk,Liver Metabolism,Phase 3,Animal Testing,PI3K-AKT Pathway,Syrup,500mg twice a day,AstraZeneca,6,Moderate,Moderate Risk,High (>80%),Moderate,Gut,Suitable
Metformin,Thyroid Hormone Replacement,Weight Loss,89.67,C9H8O4,AMPK Activator,Acid Reflux,1971,Omeprazole,Lipitor,High Risk,High Bioavailability,Phase 3,Animal Testing,Dopaminergic Pathway,Syrup,10mg once daily,Novartis,2,Low,Moderate Risk,Low (<50%),Slow,Enzyme-Specific,Partially Suitable
Ibuprofen,Inflammation,Antiviral,92.85,C17H19N3O3S,Proton Pump Inhibitor,"Nausea, Dizziness",1987,Metformin Hydrochloride,Advil,High Risk,Slow Metabolism,Ongoing,No Preclinical Data,PI3K-AKT Pathway,Capsule,50mg daily,Novartis,24,Moderate,High Risk,High (>80%),Moderate,Renal,Partially Suitable
Atorvastatin,Acid Reflux,Migraine Treatment,33.74,C17H19N3O3S,NSAID,Acid Reflux,1965,Atorvastatin Calcium,Lipitor,High Risk,Slow Metabolism,Phase 4,In Vitro Studies,Immune Response Pathway,Topical Gel,10mg once daily,Roche,6,Low,High Risk,High (>80%),Moderate,Liver,Suitable
Omeprazole,Fever,Cardiovascular Disease,88.63,C9H8O4,NSAID,"Headache, Rash",1987,Acetylsalicylic Acid,Prilosec,Low Risk,Renal Excretion,Phase 1,Animal Testing,PI3K-AKT Pathway,Syrup,10mg once daily,Pfizer,24,High,High Risk,Moderate (50-80%),Moderate,Liver,Not Suitable
Losartan,Pain Relief,Antiviral,42.88,C13H18O2,AMPK Activator,"Headache, Rash",1987,Metformin Hydrochloride,Aspirin,High Risk,High Bioavailability,Ongoing,In Vitro Studies,Dopaminergic Pathway,Topical Gel,250mg every 8 hours,Novartis,6,High,Moderate Risk,High (>80%),Slow,Enzyme-Specific,Not Suitable
Paracetamol,Inflammation,Autoimmune Disorders,46.44,C13H18O2,NSAID,"Headache, Rash",1965,Omeprazole,Advil,Low Risk,High Bioavailability,Phase 1,Toxicology Report,MAPK Pathway,Injection,50mg daily,Pfizer,6,Low,High Risk,Low (<50%),Fast,Renal,Suitable
Ranitidine,Pain Relief,Autoimmune Disorders,30.74,C17H19N3O3S,AMPK Activator,Gastrointestinal Issues,1965,Metformin Hydrochloride,Advil,High Risk,Liver Metabolism,Phase 4,Toxicology Report,PI3K-AKT Pathway,Tablet,500mg twice a day,Novartis,6,Moderate,Moderate Risk,High (>80%),Slow,Liver,Not Suitable
Simvastatin,Thyroid Hormone Replacement,Cancer Therapy,44.42,C13H18O2,NSAID,Acid Reflux,1994,Metformin Hydrochloride,Glucophage,Low Risk,Liver Metabolism,Phase 1,Animal Testing,Immune Response Pathway,Capsule,50mg daily,Pfizer,12,Moderate,Low Risk,Low (<50%),Fast,Renal,Not Suitable
Levothyroxine,Thyroid Hormone Replacement,Liver Disease,92.4,C4H11N5,NSAID,Gastrointestinal Issues,1971,Acetylsalicylic Acid,Aspirin,Moderate Risk,High Bioavailability,Phase 1,Animal Testing,MAPK Pathway,Injection,10mg once daily,Roche,24,High,Moderate Risk,Moderate (50-80%),Moderate,Gut,Suitable
Aspirin,Fever,Antiviral,92.13,C33H35FN2O5,AMPK Activator,Gastrointestinal Issues,1994,Atorvastatin Calcium,Advil,Moderate Risk,Liver Metabolism,Phase 4,Animal Testing,Immune Response Pathway,Capsule,500mg twice a day,Merck,6,Moderate,Moderate Risk,High (>80%),Moderate,Renal,Partially Suitable
Metformin,Thyroid Hormone Replacement,Cancer Therapy,41.22,C13H18O2,Proton Pump Inhibitor,Gastrointestinal Issues,1971,Ibuprofen,Advil,Low Risk,High Bioavailability,Phase 4,Animal Testing,Immune Response Pathway,Syrup,500mg twice a day,AstraZeneca,48,Low,Moderate Risk,Moderate (50-80%),Fast,Gut,Partially Suitable
Ibuprofen,Thyroid Hormone Replacement,Autoimmune Disorders,84.39,C13H18O2,COX Inhibitor,"Nausea, Dizziness",1994,Atorvastatin Calcium,Aspirin,Moderate Risk,Liver Metabolism,Phase 2,No Preclinical Data,PI3K-AKT Pathway,Tablet,10mg once daily,Novartis,24,Moderate,Moderate Risk,High (>80%),Slow,Renal,Suitable
Atorvastatin,Gastric Ulcer,Cardiovascular Disease,62.16,C17H19N3O3S,Proton Pump Inhibitor,Gastrointestinal Issues,1994,Metformin Hydrochloride,Lipitor,Low Risk,Renal Excretion,Completed,In Vitro Studies,MAPK Pathway,Injection,250mg every 8 hours,AstraZeneca,48,High,Moderate Risk,Low (<50%),Slow,Renal,Partially Suitable
Omeprazole,Gastric Ulcer,Antiviral,92.29,C4H11N5,AMPK Activator,Acid Reflux,1965,Omeprazole,Prilosec,High Risk,Renal Excretion,Completed,Animal Testing,Serotonin Pathway,Capsule,As prescribed,AstraZeneca,48,Moderate,Moderate Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Not Suitable
Losartan,Fever,Parkinson's,42.19,C13H18O2,COX Inhibitor,Muscle Pain,1965,Metformin Hydrochloride,Prilosec,Moderate Risk,High Bioavailability,Phase 1,Toxicology Report,MAPK Pathway,Tablet,50mg daily,Merck,12,Low,Low Risk,High (>80%),Fast,Gut,Not Suitable
Paracetamol,Fever,Autoimmune Disorders,67.44,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1996,Ibuprofen,Lipitor,Moderate Risk,High Bioavailability,Phase 1,Toxicology Report,PI3K-AKT Pathway,Injection,50mg daily,Roche,12,Moderate,Low Risk,Low (<50%),Moderate,Renal,Not Suitable
Ranitidine,Diabetes,Alzheimer's,63.25,C13H18O2,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1987,Omeprazole,Glucophage,High Risk,High Bioavailability,Phase 4,In Vitro Studies,Serotonin Pathway,Tablet,50mg daily,Pfizer,2,Moderate,Moderate Risk,Low (<50%),Slow,Enzyme-Specific,Suitable
Simvastatin,Diabetes,Alzheimer's,45.72,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1994,Acetylsalicylic Acid,Glucophage,High Risk,Slow Metabolism,Phase 2,No Preclinical Data,MAPK Pathway,Injection,250mg every 8 hours,Roche,2,Low,Moderate Risk,High (>80%),Fast,Renal,Partially Suitable
Levothyroxine,Inflammation,Weight Loss,56.53,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Acid Reflux,1987,Metformin Hydrochloride,Advil,High Risk,Renal Excretion,Phase 1,Toxicology Report,Serotonin Pathway,Topical Gel,10mg once daily,Merck,48,High,Low Risk,Moderate (50-80%),Moderate,Renal,Not Suitable
Aspirin,Cholesterol Control,Anti-Aging,94.14,C33H35FN2O5,AMPK Activator,Acid Reflux,1987,Omeprazole,Prilosec,Moderate Risk,High Bioavailability,Ongoing,Animal Testing,Immune Response Pathway,Capsule,500mg twice a day,Novartis,48,Low,Low Risk,Moderate (50-80%),Moderate,Liver,Not Suitable
Metformin,Fever,Weight Loss,57.14,C4H11N5,Proton Pump Inhibitor,Muscle Pain,1971,Omeprazole,Lipitor,High Risk,High Bioavailability,Phase 1,No Preclinical Data,Dopaminergic Pathway,Injection,As prescribed,Merck,6,High,Moderate Risk,High (>80%),Moderate,Liver,Suitable
Ibuprofen,Diabetes,Anti-Aging,56.33,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Acid Reflux,1971,Omeprazole,Glucophage,High Risk,High Bioavailability,Completed,In Vitro Studies,MAPK Pathway,Injection,As prescribed,Pfizer,12,Moderate,Moderate Risk,High (>80%),Slow,Enzyme-Specific,Not Suitable
Atorvastatin,Hypertension,Alzheimer's,94.68,C9H8O4,Proton Pump Inhibitor,Gastrointestinal Issues,1971,Acetylsalicylic Acid,Aspirin,Moderate Risk,Renal Excretion,Phase 1,Toxicology Report,Serotonin Pathway,Topical Gel,250mg every 8 hours,Pfizer,48,High,High Risk,High (>80%),Fast,Liver,Not Suitable
Omeprazole,Fever,Liver Disease,92.46,C9H8O4,NSAID,Acid Reflux,1965,Atorvastatin Calcium,Glucophage,Moderate Risk,High Bioavailability,Phase 1,In Vitro Studies,PI3K-AKT Pathway,Injection,250mg every 8 hours,AstraZeneca,24,Low,Low Risk,High (>80%),Fast,Gut,Not Suitable
Losartan,Blood Thinner,Alzheimer's,94.31,C4H11N5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1996,Atorvastatin Calcium,Aspirin,Moderate Risk,Rapid Absorption,Phase 3,No Preclinical Data,Serotonin Pathway,Syrup,50mg daily,Merck,48,Low,Low Risk,Moderate (50-80%),Fast,Enzyme-Specific,Not Suitable
Paracetamol,Cholesterol Control,Cardiovascular Disease,71.1,C9H8O4,NSAID,Gastrointestinal Issues,1965,Acetylsalicylic Acid,Prilosec,High Risk,Liver Metabolism,Phase 1,No Preclinical Data,Immune Response Pathway,Capsule,As prescribed,Pfizer,48,Moderate,Moderate Risk,High (>80%),Moderate,Renal,Suitable
Ranitidine,Acid Reflux,Weight Loss,30.54,C13H18O2,COX Inhibitor,Muscle Pain,1971,Ibuprofen,Prilosec,High Risk,Liver Metabolism,Phase 4,Toxicology Report,Immune Response Pathway,Syrup,250mg every 8 hours,Roche,48,Low,Low Risk,High (>80%),Moderate,Gut,Suitable
Simvastatin,Fever,Cancer Therapy,63.05,C4H11N5,NSAID,Gastrointestinal Issues,1994,Atorvastatin Calcium,Lipitor,Low Risk,Rapid Absorption,Completed,No Preclinical Data,Serotonin Pathway,Injection,10mg once daily,Merck,2,Low,High Risk,Moderate (50-80%),Fast,Enzyme-Specific,Suitable
Levothyroxine,Blood Thinner,Autoimmune Disorders,57.9,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1987,Omeprazole,Prilosec,High Risk,Renal Excretion,Ongoing,In Vitro Studies,MAPK Pathway,Injection,10mg once daily,Novartis,24,Low,Moderate Risk,Moderate (50-80%),Slow,Liver,Not Suitable
Aspirin,Gastric Ulcer,Antiviral,64.64,C13H18O2,Proton Pump Inhibitor,Gastrointestinal Issues,1971,Omeprazole,Prilosec,Moderate Risk,Liver Metabolism,Ongoing,Animal Testing,MAPK Pathway,Tablet,250mg every 8 hours,Merck,2,High,Moderate Risk,Low (<50%),Slow,Gut,Partially Suitable
Metformin,Inflammation,Parkinson's,36.37,C4H11N5,COX Inhibitor,"Headache, Rash",1971,Atorvastatin Calcium,Glucophage,High Risk,Rapid Absorption,Completed,In Vitro Studies,Dopaminergic Pathway,Injection,50mg daily,AstraZeneca,2,High,High Risk,Low (<50%),Fast,Enzyme-Specific,Not Suitable
Ibuprofen,Inflammation,Migraine Treatment,41.32,C9H8O4,AMPK Activator,"Nausea, Dizziness",1994,Omeprazole,Prilosec,Moderate Risk,Liver Metabolism,Phase 1,Animal Testing,Dopaminergic Pathway,Syrup,250mg every 8 hours,Pfizer,12,Low,Moderate Risk,High (>80%),Moderate,Enzyme-Specific,Partially Suitable
Atorvastatin,Diabetes,Cardiovascular Disease,65.58,C13H18O2,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1971,Acetylsalicylic Acid,Aspirin,Low Risk,High Bioavailability,Phase 4,No Preclinical Data,MAPK Pathway,Injection,250mg every 8 hours,Novartis,6,High,Moderate Risk,Low (<50%),Slow,Gut,Not Suitable
Omeprazole,Diabetes,Migraine Treatment,39.09,C9H8O4,Proton Pump Inhibitor,"Nausea, Dizziness",1965,Ibuprofen,Glucophage,High Risk,Rapid Absorption,Phase 4,Toxicology Report,Dopaminergic Pathway,Topical Gel,50mg daily,Pfizer,48,Low,High Risk,Low (<50%),Slow,Enzyme-Specific,Partially Suitable
Losartan,Pain Relief,Alzheimer's,33.38,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Acid Reflux,1996,Acetylsalicylic Acid,Aspirin,Low Risk,Rapid Absorption,Phase 4,Animal Testing,Serotonin Pathway,Syrup,500mg twice a day,Merck,48,Low,Moderate Risk,Low (<50%),Slow,Liver,Not Suitable
Paracetamol,Thyroid Hormone Replacement,Antiviral,50.46,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1996,Ibuprofen,Prilosec,Low Risk,Slow Metabolism,Completed,Toxicology Report,Immune Response Pathway,Syrup,As prescribed,AstraZeneca,2,Low,High Risk,Moderate (50-80%),Slow,Enzyme-Specific,Partially Suitable
Ranitidine,Hypertension,Weight Loss,92.31,C9H8O4,COX Inhibitor,Acid Reflux,1965,Acetylsalicylic Acid,Aspirin,Moderate Risk,Slow Metabolism,Phase 2,No Preclinical Data,PI3K-AKT Pathway,Syrup,As prescribed,Novartis,12,High,Low Risk,Low (<50%),Fast,Gut,Partially Suitable
Simvastatin,Diabetes,Alzheimer's,47.68,C4H11N5,NSAID,Muscle Pain,1965,Omeprazole,Glucophage,Moderate Risk,Liver Metabolism,Ongoing,In Vitro Studies,Serotonin Pathway,Capsule,250mg every 8 hours,Roche,24,High,Moderate Risk,High (>80%),Fast,Enzyme-Specific,Suitable
Levothyroxine,Blood Thinner,Parkinson's,89.22,C9H8O4,COX Inhibitor,Acid Reflux,1971,Metformin Hydrochloride,Aspirin,Moderate Risk,Renal Excretion,Phase 4,Animal Testing,PI3K-AKT Pathway,Capsule,10mg once daily,AstraZeneca,48,High,Moderate Risk,Moderate (50-80%),Moderate,Liver,Suitable
Aspirin,Gastric Ulcer,Autoimmune Disorders,35.43,C33H35FN2O5,AMPK Activator,"Nausea, Dizziness",1994,Metformin Hydrochloride,Glucophage,Moderate Risk,Slow Metabolism,Completed,Animal Testing,MAPK Pathway,Tablet,250mg every 8 hours,AstraZeneca,48,Low,High Risk,Low (<50%),Moderate,Renal,Suitable
Metformin,Fever,Liver Disease,55.11,C17H19N3O3S,AMPK Activator,Acid Reflux,1987,Ibuprofen,Aspirin,Low Risk,Liver Metabolism,Phase 2,No Preclinical Data,Dopaminergic Pathway,Topical Gel,As prescribed,Merck,48,Moderate,Moderate Risk,High (>80%),Fast,Gut,Not Suitable
Ibuprofen,Pain Relief,Migraine Treatment,85.54,C13H18O2,NSAID,Acid Reflux,1987,Atorvastatin Calcium,Lipitor,Low Risk,Renal Excretion,Ongoing,In Vitro Studies,Immune Response Pathway,Topical Gel,500mg twice a day,AstraZeneca,48,Low,High Risk,Low (<50%),Fast,Liver,Not Suitable
Atorvastatin,Gastric Ulcer,Cardiovascular Disease,85.5,C17H19N3O3S,COX Inhibitor,"Headache, Rash",1971,Acetylsalicylic Acid,Glucophage,High Risk,Slow Metabolism,Ongoing,In Vitro Studies,MAPK Pathway,Topical Gel,500mg twice a day,Roche,24,High,High Risk,Low (<50%),Fast,Renal,Partially Suitable
Omeprazole,Acid Reflux,Antiviral,78.27,C33H35FN2O5,COX Inhibitor,"Nausea, Dizziness",1996,Ibuprofen,Advil,Low Risk,Liver Metabolism,Phase 4,Animal Testing,PI3K-AKT Pathway,Tablet,500mg twice a day,Roche,48,Low,Moderate Risk,Moderate (50-80%),Slow,Gut,Suitable
Losartan,Hypertension,Cardiovascular Disease,48.69,C33H35FN2O5,NSAID,Muscle Pain,1965,Ibuprofen,Aspirin,Moderate Risk,High Bioavailability,Completed,No Preclinical Data,PI3K-AKT Pathway,Capsule,500mg twice a day,Merck,24,High,Low Risk,High (>80%),Moderate,Gut,Not Suitable
Paracetamol,Pain Relief,Alzheimer's,33.07,C9H8O4,Proton Pump Inhibitor,Acid Reflux,1971,Acetylsalicylic Acid,Advil,Low Risk,Liver Metabolism,Phase 1,Animal Testing,Immune Response Pathway,Syrup,50mg daily,AstraZeneca,12,High,Low Risk,Moderate (50-80%),Fast,Gut,Not Suitable
Ranitidine,Fever,Cardiovascular Disease,86.03,C9H8O4,NSAID,Acid Reflux,1971,Atorvastatin Calcium,Advil,Low Risk,Slow Metabolism,Completed,Toxicology Report,MAPK Pathway,Syrup,As prescribed,Roche,2,Moderate,Moderate Risk,Moderate (50-80%),Moderate,Gut,Not Suitable
Simvastatin,Pain Relief,Anti-Aging,54.95,C4H11N5,Proton Pump Inhibitor,"Nausea, Dizziness",1996,Metformin Hydrochloride,Aspirin,High Risk,High Bioavailability,Phase 4,In Vitro Studies,Serotonin Pathway,Syrup,10mg once daily,Roche,48,Low,High Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Levothyroxine,Inflammation,Weight Loss,47.11,C9H8O4,NSAID,"Nausea, Dizziness",1971,Atorvastatin Calcium,Prilosec,Moderate Risk,High Bioavailability,Phase 4,Toxicology Report,Serotonin Pathway,Topical Gel,500mg twice a day,AstraZeneca,6,Moderate,Low Risk,Low (<50%),Fast,Liver,Suitable
Aspirin,Fever,Anti-Aging,32.22,C13H18O2,Proton Pump Inhibitor,Muscle Pain,1971,Acetylsalicylic Acid,Aspirin,Moderate Risk,Slow Metabolism,Phase 4,Toxicology Report,Dopaminergic Pathway,Capsule,250mg every 8 hours,AstraZeneca,12,Moderate,Low Risk,Moderate (50-80%),Moderate,Liver,Not Suitable
Metformin,Inflammation,Autoimmune Disorders,87.51,C13H18O2,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1971,Metformin Hydrochloride,Advil,High Risk,Rapid Absorption,Phase 1,Animal Testing,Serotonin Pathway,Topical Gel,As prescribed,Novartis,48,Low,Moderate Risk,High (>80%),Moderate,Liver,Not Suitable
Ibuprofen,Thyroid Hormone Replacement,Anti-Aging,57.85,C13H18O2,NSAID,Muscle Pain,1994,Ibuprofen,Glucophage,Low Risk,Rapid Absorption,Phase 3,No Preclinical Data,Dopaminergic Pathway,Syrup,250mg every 8 hours,Merck,24,Moderate,High Risk,High (>80%),Fast,Liver,Not Suitable
Atorvastatin,Cholesterol Control,Migraine Treatment,36.68,C4H11N5,NSAID,"Nausea, Dizziness",1965,Omeprazole,Aspirin,Moderate Risk,Slow Metabolism,Completed,Toxicology Report,Immune Response Pathway,Tablet,50mg daily,AstraZeneca,24,Moderate,High Risk,High (>80%),Moderate,Renal,Not Suitable
Omeprazole,Gastric Ulcer,Antiviral,78.37,C9H8O4,NSAID,"Nausea, Dizziness",1987,Ibuprofen,Advil,Moderate Risk,Slow Metabolism,Phase 1,No Preclinical Data,Serotonin Pathway,Syrup,500mg twice a day,Pfizer,48,Low,High Risk,Moderate (50-80%),Moderate,Liver,Suitable
Losartan,Thyroid Hormone Replacement,Parkinson's,93.24,C9H8O4,Proton Pump Inhibitor,"Headache, Rash",1965,Acetylsalicylic Acid,Lipitor,Moderate Risk,Slow Metabolism,Completed,No Preclinical Data,PI3K-AKT Pathway,Topical Gel,500mg twice a day,Novartis,48,High,Moderate Risk,Low (<50%),Moderate,Renal,Not Suitable
Paracetamol,Inflammation,Cardiovascular Disease,94.69,C9H8O4,COX Inhibitor,Acid Reflux,1996,Metformin Hydrochloride,Glucophage,Low Risk,Slow Metabolism,Ongoing,Toxicology Report,MAPK Pathway,Capsule,250mg every 8 hours,Novartis,6,Low,Low Risk,High (>80%),Moderate,Gut,Suitable
Ranitidine,Acid Reflux,Antiviral,89.66,C9H8O4,COX Inhibitor,"Headache, Rash",1971,Acetylsalicylic Acid,Lipitor,High Risk,Rapid Absorption,Phase 3,Animal Testing,Serotonin Pathway,Topical Gel,250mg every 8 hours,Merck,12,High,Low Risk,Low (<50%),Slow,Liver,Not Suitable
Simvastatin,Gastric Ulcer,Parkinson's,67.36,C17H19N3O3S,COX Inhibitor,"Nausea, Dizziness",1971,Omeprazole,Glucophage,Moderate Risk,Slow Metabolism,Phase 1,In Vitro Studies,PI3K-AKT Pathway,Topical Gel,As prescribed,Roche,12,High,High Risk,Low (<50%),Slow,Enzyme-Specific,Suitable
Levothyroxine,Cholesterol Control,Cancer Therapy,82.57,C13H18O2,Proton Pump Inhibitor,Muscle Pain,1994,Metformin Hydrochloride,Prilosec,Low Risk,High Bioavailability,Phase 4,In Vitro Studies,MAPK Pathway,Topical Gel,50mg daily,AstraZeneca,6,Moderate,High Risk,Moderate (50-80%),Moderate,Liver,Partially Suitable
Aspirin,Pain Relief,Anti-Aging,62.62,C9H8O4,COX Inhibitor,Muscle Pain,1996,Ibuprofen,Glucophage,High Risk,Rapid Absorption,Completed,Toxicology Report,MAPK Pathway,Capsule,500mg twice a day,Pfizer,6,High,High Risk,Moderate (50-80%),Fast,Gut,Not Suitable
Metformin,Hypertension,Anti-Aging,35.21,C13H18O2,Proton Pump Inhibitor,"Headache, Rash",1996,Ibuprofen,Glucophage,Moderate Risk,Rapid Absorption,Completed,Toxicology Report,Dopaminergic Pathway,Tablet,50mg daily,Roche,24,Low,Moderate Risk,Low (<50%),Slow,Enzyme-Specific,Not Suitable
Ibuprofen,Fever,Weight Loss,72.41,C13H18O2,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1965,Metformin Hydrochloride,Advil,Low Risk,High Bioavailability,Ongoing,Animal Testing,Serotonin Pathway,Syrup,250mg every 8 hours,Pfizer,24,High,Moderate Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Not Suitable
Atorvastatin,Hypertension,Migraine Treatment,74.62,C17H19N3O3S,AMPK Activator,Acid Reflux,1996,Acetylsalicylic Acid,Lipitor,Moderate Risk,Renal Excretion,Phase 1,No Preclinical Data,PI3K-AKT Pathway,Tablet,500mg twice a day,AstraZeneca,48,Low,High Risk,Moderate (50-80%),Slow,Liver,Not Suitable
Omeprazole,Fever,Cardiovascular Disease,54.73,C13H18O2,HMG-CoA Reductase Inhibitor,Acid Reflux,1971,Omeprazole,Advil,Moderate Risk,Liver Metabolism,Phase 4,Toxicology Report,Dopaminergic Pathway,Tablet,As prescribed,AstraZeneca,12,Low,Low Risk,Moderate (50-80%),Slow,Liver,Not Suitable
Losartan,Hypertension,Migraine Treatment,65.81,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Acid Reflux,1994,Omeprazole,Advil,High Risk,Rapid Absorption,Phase 1,Animal Testing,Dopaminergic Pathway,Syrup,10mg once daily,Pfizer,12,Moderate,Low Risk,High (>80%),Fast,Gut,Not Suitable
Paracetamol,Fever,Parkinson's,39.81,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1996,Atorvastatin Calcium,Lipitor,High Risk,Liver Metabolism,Completed,In Vitro Studies,Dopaminergic Pathway,Tablet,10mg once daily,Merck,48,Moderate,Moderate Risk,Low (<50%),Slow,Liver,Partially Suitable
Ranitidine,Fever,Cancer Therapy,87.09,C4H11N5,AMPK Activator,Gastrointestinal Issues,1987,Atorvastatin Calcium,Advil,Low Risk,Renal Excretion,Phase 4,No Preclinical Data,Immune Response Pathway,Syrup,10mg once daily,Roche,2,High,Low Risk,High (>80%),Fast,Renal,Partially Suitable
Simvastatin,Fever,Weight Loss,31.79,C17H19N3O3S,NSAID,Gastrointestinal Issues,1994,Metformin Hydrochloride,Prilosec,Low Risk,Renal Excretion,Phase 3,Animal Testing,PI3K-AKT Pathway,Tablet,10mg once daily,Roche,2,Low,High Risk,High (>80%),Moderate,Liver,Partially Suitable
Levothyroxine,Hypertension,Autoimmune Disorders,71.45,C17H19N3O3S,NSAID,Muscle Pain,1965,Metformin Hydrochloride,Prilosec,Moderate Risk,Slow Metabolism,Completed,No Preclinical Data,Dopaminergic Pathway,Tablet,500mg twice a day,Roche,6,Low,Low Risk,Moderate (50-80%),Fast,Renal,Suitable
Aspirin,Fever,Autoimmune Disorders,74.49,C13H18O2,COX Inhibitor,Muscle Pain,1971,Ibuprofen,Glucophage,Low Risk,Liver Metabolism,Phase 2,Toxicology Report,PI3K-AKT Pathway,Syrup,As prescribed,Pfizer,48,Moderate,High Risk,High (>80%),Moderate,Renal,Not Suitable
Metformin,Blood Thinner,Weight Loss,61.27,C4H11N5,COX Inhibitor,"Headache, Rash",1994,Ibuprofen,Advil,Moderate Risk,Liver Metabolism,Phase 3,No Preclinical Data,MAPK Pathway,Injection,50mg daily,Roche,12,Moderate,Low Risk,High (>80%),Fast,Enzyme-Specific,Partially Suitable
Ibuprofen,Blood Thinner,Anti-Aging,79.16,C9H8O4,Proton Pump Inhibitor,Acid Reflux,1965,Metformin Hydrochloride,Advil,Low Risk,Renal Excretion,Ongoing,Animal Testing,PI3K-AKT Pathway,Injection,10mg once daily,Roche,6,Low,Moderate Risk,High (>80%),Moderate,Liver,Not Suitable
Atorvastatin,Diabetes,Anti-Aging,84.9,C4H11N5,AMPK Activator,Gastrointestinal Issues,1994,Ibuprofen,Aspirin,Moderate Risk,Renal Excretion,Phase 3,Animal Testing,MAPK Pathway,Capsule,500mg twice a day,Roche,2,High,Low Risk,Low (<50%),Fast,Enzyme-Specific,Not Suitable
Omeprazole,Blood Thinner,Parkinson's,40.67,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Muscle Pain,1994,Acetylsalicylic Acid,Prilosec,Low Risk,Renal Excretion,Phase 3,Animal Testing,Immune Response Pathway,Syrup,250mg every 8 hours,Novartis,12,Moderate,High Risk,Low (<50%),Fast,Enzyme-Specific,Suitable
Losartan,Acid Reflux,Anti-Aging,35.41,C33H35FN2O5,Proton Pump Inhibitor,Acid Reflux,1987,Ibuprofen,Lipitor,Low Risk,Renal Excretion,Ongoing,In Vitro Studies,MAPK Pathway,Tablet,10mg once daily,AstraZeneca,48,Moderate,High Risk,High (>80%),Fast,Enzyme-Specific,Partially Suitable
Paracetamol,Thyroid Hormone Replacement,Cancer Therapy,30.4,C17H19N3O3S,Proton Pump Inhibitor,"Nausea, Dizziness",1965,Metformin Hydrochloride,Lipitor,Low Risk,Renal Excretion,Completed,In Vitro Studies,PI3K-AKT Pathway,Injection,50mg daily,Merck,12,High,Moderate Risk,High (>80%),Fast,Gut,Partially Suitable
Ranitidine,Hypertension,Alzheimer's,67.7,C9H8O4,AMPK Activator,"Headache, Rash",1994,Omeprazole,Prilosec,Moderate Risk,High Bioavailability,Phase 2,No Preclinical Data,Immune Response Pathway,Capsule,250mg every 8 hours,Merck,2,Low,Moderate Risk,High (>80%),Slow,Gut,Partially Suitable
Simvastatin,Gastric Ulcer,Autoimmune Disorders,50.29,C17H19N3O3S,AMPK Activator,Acid Reflux,1965,Metformin Hydrochloride,Prilosec,Moderate Risk,High Bioavailability,Phase 4,Animal Testing,MAPK Pathway,Syrup,50mg daily,Pfizer,6,Moderate,Low Risk,Low (<50%),Moderate,Enzyme-Specific,Not Suitable
Levothyroxine,Gastric Ulcer,Liver Disease,74.92,C13H18O2,NSAID,"Headache, Rash",1994,Acetylsalicylic Acid,Advil,Low Risk,Liver Metabolism,Phase 3,Toxicology Report,MAPK Pathway,Tablet,As prescribed,Novartis,12,Low,Low Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Aspirin,Inflammation,Cancer Therapy,68.41,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Muscle Pain,1971,Atorvastatin Calcium,Lipitor,Moderate Risk,Slow Metabolism,Phase 1,Animal Testing,Immune Response Pathway,Syrup,10mg once daily,Merck,24,High,Low Risk,High (>80%),Slow,Enzyme-Specific,Not Suitable
Metformin,Acid Reflux,Liver Disease,61.39,C4H11N5,AMPK Activator,Gastrointestinal Issues,1994,Ibuprofen,Aspirin,Moderate Risk,Renal Excretion,Phase 4,No Preclinical Data,PI3K-AKT Pathway,Capsule,10mg once daily,Pfizer,24,Moderate,High Risk,Low (<50%),Moderate,Enzyme-Specific,Partially Suitable
Ibuprofen,Thyroid Hormone Replacement,Weight Loss,60.43,C9H8O4,COX Inhibitor,Acid Reflux,1971,Omeprazole,Lipitor,Low Risk,Renal Excretion,Phase 2,Animal Testing,PI3K-AKT Pathway,Tablet,500mg twice a day,Roche,6,Low,Moderate Risk,Low (<50%),Slow,Renal,Not Suitable
Atorvastatin,Pain Relief,Cardiovascular Disease,39.79,C33H35FN2O5,AMPK Activator,Acid Reflux,1987,Atorvastatin Calcium,Aspirin,Moderate Risk,High Bioavailability,Phase 2,Toxicology Report,Serotonin Pathway,Syrup,250mg every 8 hours,Roche,6,High,Low Risk,Low (<50%),Slow,Enzyme-Specific,Suitable
Omeprazole,Acid Reflux,Anti-Aging,74.54,C4H11N5,NSAID,Gastrointestinal Issues,1965,Omeprazole,Aspirin,High Risk,Liver Metabolism,Phase 2,In Vitro Studies,PI3K-AKT Pathway,Injection,As prescribed,AstraZeneca,2,Moderate,Low Risk,Moderate (50-80%),Moderate,Gut,Partially Suitable
Losartan,Cholesterol Control,Cancer Therapy,60.17,C33H35FN2O5,COX Inhibitor,"Nausea, Dizziness",1994,Ibuprofen,Advil,Moderate Risk,Liver Metabolism,Phase 1,Toxicology Report,Immune Response Pathway,Tablet,250mg every 8 hours,Merck,24,High,Low Risk,High (>80%),Moderate,Liver,Suitable
Paracetamol,Inflammation,Parkinson's,85.35,C4H11N5,AMPK Activator,"Nausea, Dizziness",1965,Omeprazole,Prilosec,High Risk,High Bioavailability,Phase 1,Toxicology Report,Serotonin Pathway,Syrup,250mg every 8 hours,Pfizer,12,Low,Moderate Risk,High (>80%),Moderate,Gut,Suitable
Ranitidine,Gastric Ulcer,Liver Disease,42.11,C4H11N5,Proton Pump Inhibitor,"Headache, Rash",1987,Atorvastatin Calcium,Aspirin,Moderate Risk,Renal Excretion,Phase 4,In Vitro Studies,Serotonin Pathway,Injection,250mg every 8 hours,Merck,6,Moderate,Low Risk,Moderate (50-80%),Fast,Liver,Suitable
Simvastatin,Blood Thinner,Cancer Therapy,74.29,C33H35FN2O5,NSAID,Gastrointestinal Issues,1965,Ibuprofen,Advil,Moderate Risk,Slow Metabolism,Ongoing,Toxicology Report,MAPK Pathway,Topical Gel,250mg every 8 hours,Novartis,12,Low,High Risk,Low (<50%),Fast,Liver,Not Suitable
Levothyroxine,Gastric Ulcer,Antiviral,75.32,C4H11N5,Proton Pump Inhibitor,"Headache, Rash",1971,Acetylsalicylic Acid,Aspirin,Moderate Risk,Renal Excretion,Ongoing,Animal Testing,MAPK Pathway,Tablet,250mg every 8 hours,Merck,12,Moderate,Low Risk,High (>80%),Slow,Liver,Partially Suitable
Aspirin,Pain Relief,Parkinson's,37.49,C13H18O2,COX Inhibitor,Muscle Pain,1965,Acetylsalicylic Acid,Lipitor,Low Risk,High Bioavailability,Phase 4,In Vitro Studies,PI3K-AKT Pathway,Syrup,50mg daily,Pfizer,2,Low,High Risk,High (>80%),Slow,Liver,Suitable
Metformin,Pain Relief,Anti-Aging,91.23,C4H11N5,AMPK Activator,"Headache, Rash",1987,Ibuprofen,Glucophage,Low Risk,Rapid Absorption,Phase 1,No Preclinical Data,Immune Response Pathway,Capsule,500mg twice a day,Merck,12,Moderate,High Risk,Moderate (50-80%),Fast,Enzyme-Specific,Partially Suitable
Ibuprofen,Diabetes,Antiviral,69.86,C17H19N3O3S,AMPK Activator,Gastrointestinal Issues,1971,Ibuprofen,Advil,High Risk,Renal Excretion,Ongoing,No Preclinical Data,PI3K-AKT Pathway,Tablet,250mg every 8 hours,AstraZeneca,12,High,High Risk,High (>80%),Fast,Liver,Not Suitable
Atorvastatin,Fever,Migraine Treatment,87.24,C13H18O2,AMPK Activator,Acid Reflux,1996,Metformin Hydrochloride,Prilosec,Moderate Risk,Liver Metabolism,Ongoing,No Preclinical Data,Serotonin Pathway,Injection,500mg twice a day,Roche,12,Low,High Risk,High (>80%),Slow,Liver,Not Suitable
Omeprazole,Blood Thinner,Cardiovascular Disease,60.59,C4H11N5,NSAID,"Headache, Rash",1996,Omeprazole,Aspirin,Low Risk,Slow Metabolism,Ongoing,Toxicology Report,PI3K-AKT Pathway,Syrup,As prescribed,Merck,12,High,High Risk,High (>80%),Slow,Gut,Not Suitable
Losartan,Fever,Anti-Aging,41.02,C4H11N5,COX Inhibitor,Muscle Pain,1996,Atorvastatin Calcium,Lipitor,Low Risk,Rapid Absorption,Completed,Toxicology Report,MAPK Pathway,Capsule,As prescribed,Merck,12,High,High Risk,Moderate (50-80%),Moderate,Liver,Not Suitable
Paracetamol,Inflammation,Antiviral,67.66,C9H8O4,HMG-CoA Reductase Inhibitor,Muscle Pain,1996,Omeprazole,Aspirin,High Risk,High Bioavailability,Ongoing,Toxicology Report,PI3K-AKT Pathway,Syrup,250mg every 8 hours,Pfizer,12,Moderate,Low Risk,High (>80%),Fast,Enzyme-Specific,Not Suitable
Ranitidine,Acid Reflux,Cardiovascular Disease,41.35,C33H35FN2O5,AMPK Activator,Muscle Pain,1994,Omeprazole,Lipitor,High Risk,Rapid Absorption,Phase 3,In Vitro Studies,Dopaminergic Pathway,Injection,500mg twice a day,Merck,2,Moderate,Low Risk,Low (<50%),Moderate,Renal,Not Suitable
Simvastatin,Hypertension,Anti-Aging,46.04,C13H18O2,AMPK Activator,"Headache, Rash",1971,Ibuprofen,Glucophage,High Risk,Rapid Absorption,Phase 2,Animal Testing,Serotonin Pathway,Capsule,250mg every 8 hours,Merck,12,Low,High Risk,Low (<50%),Moderate,Renal,Partially Suitable
Levothyroxine,Blood Thinner,Autoimmune Disorders,86.81,C33H35FN2O5,AMPK Activator,"Headache, Rash",1987,Ibuprofen,Prilosec,Moderate Risk,Renal Excretion,Completed,No Preclinical Data,MAPK Pathway,Topical Gel,50mg daily,Roche,12,Low,High Risk,Low (<50%),Moderate,Renal,Suitable
Aspirin,Inflammation,Migraine Treatment,42.97,C9H8O4,Proton Pump Inhibitor,"Headache, Rash",1996,Omeprazole,Lipitor,Moderate Risk,Renal Excretion,Ongoing,Animal Testing,MAPK Pathway,Capsule,10mg once daily,Merck,12,Low,Moderate Risk,Moderate (50-80%),Slow,Liver,Not Suitable
Metformin,Gastric Ulcer,Anti-Aging,91.09,C13H18O2,AMPK Activator,"Nausea, Dizziness",1994,Metformin Hydrochloride,Advil,Low Risk,Liver Metabolism,Phase 4,No Preclinical Data,MAPK Pathway,Tablet,50mg daily,AstraZeneca,12,Low,Moderate Risk,Low (<50%),Fast,Liver,Partially Suitable
Ibuprofen,Diabetes,Liver Disease,31.05,C9H8O4,Proton Pump Inhibitor,Acid Reflux,1994,Metformin Hydrochloride,Glucophage,Low Risk,Liver Metabolism,Completed,Toxicology Report,Serotonin Pathway,Injection,As prescribed,AstraZeneca,12,Moderate,High Risk,Moderate (50-80%),Fast,Enzyme-Specific,Not Suitable
Atorvastatin,Gastric Ulcer,Cancer Therapy,44.9,C17H19N3O3S,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1996,Metformin Hydrochloride,Advil,Low Risk,High Bioavailability,Phase 1,In Vitro Studies,Serotonin Pathway,Capsule,As prescribed,Roche,2,Low,Low Risk,High (>80%),Slow,Enzyme-Specific,Suitable
Omeprazole,Cholesterol Control,Parkinson's,87.92,C9H8O4,AMPK Activator,Gastrointestinal Issues,1971,Atorvastatin Calcium,Lipitor,Moderate Risk,Renal Excretion,Phase 2,Animal Testing,Serotonin Pathway,Injection,500mg twice a day,Roche,24,Moderate,High Risk,Low (<50%),Fast,Renal,Partially Suitable
Losartan,Gastric Ulcer,Anti-Aging,36.56,C13H18O2,AMPK Activator,Gastrointestinal Issues,1994,Ibuprofen,Aspirin,High Risk,Slow Metabolism,Ongoing,In Vitro Studies,Serotonin Pathway,Injection,As prescribed,Novartis,12,Moderate,High Risk,High (>80%),Moderate,Renal,Partially Suitable
Paracetamol,Inflammation,Migraine Treatment,33.2,C9H8O4,COX Inhibitor,Muscle Pain,1996,Atorvastatin Calcium,Glucophage,High Risk,Liver Metabolism,Phase 4,Animal Testing,Serotonin Pathway,Capsule,50mg daily,Novartis,24,High,Moderate Risk,High (>80%),Fast,Enzyme-Specific,Not Suitable
Ranitidine,Cholesterol Control,Anti-Aging,31.04,C13H18O2,COX Inhibitor,"Nausea, Dizziness",1996,Atorvastatin Calcium,Glucophage,Moderate Risk,High Bioavailability,Phase 1,Animal Testing,MAPK Pathway,Syrup,10mg once daily,Merck,48,High,Moderate Risk,Low (<50%),Slow,Renal,Partially Suitable
Simvastatin,Hypertension,Parkinson's,75.82,C4H11N5,NSAID,"Headache, Rash",1965,Acetylsalicylic Acid,Glucophage,High Risk,Renal Excretion,Completed,No Preclinical Data,Serotonin Pathway,Syrup,10mg once daily,Pfizer,24,Low,Moderate Risk,Moderate (50-80%),Moderate,Renal,Partially Suitable
Levothyroxine,Cholesterol Control,Anti-Aging,32.5,C13H18O2,HMG-CoA Reductase Inhibitor,Muscle Pain,1971,Atorvastatin Calcium,Aspirin,High Risk,Slow Metabolism,Completed,Toxicology Report,Dopaminergic Pathway,Tablet,500mg twice a day,Roche,24,Moderate,Moderate Risk,Moderate (50-80%),Moderate,Liver,Not Suitable
Aspirin,Inflammation,Autoimmune Disorders,94.6,C4H11N5,Proton Pump Inhibitor,Muscle Pain,1996,Acetylsalicylic Acid,Lipitor,Moderate Risk,Rapid Absorption,Phase 4,No Preclinical Data,PI3K-AKT Pathway,Syrup,500mg twice a day,AstraZeneca,24,High,High Risk,Low (<50%),Moderate,Renal,Not Suitable
Metformin,Diabetes,Alzheimer's,62.31,C33H35FN2O5,NSAID,Gastrointestinal Issues,1996,Ibuprofen,Aspirin,Moderate Risk,Liver Metabolism,Phase 3,Toxicology Report,Immune Response Pathway,Syrup,50mg daily,Roche,48,Low,Low Risk,Low (<50%),Fast,Liver,Suitable
Ibuprofen,Blood Thinner,Weight Loss,56.29,C17H19N3O3S,AMPK Activator,"Headache, Rash",1996,Metformin Hydrochloride,Advil,High Risk,Renal Excretion,Phase 4,No Preclinical Data,Dopaminergic Pathway,Injection,10mg once daily,Pfizer,2,High,Moderate Risk,Low (<50%),Slow,Renal,Suitable
Atorvastatin,Gastric Ulcer,Cancer Therapy,65.8,C33H35FN2O5,Proton Pump Inhibitor,Acid Reflux,1994,Omeprazole,Advil,Low Risk,High Bioavailability,Phase 3,No Preclinical Data,Immune Response Pathway,Topical Gel,250mg every 8 hours,Merck,2,Low,High Risk,Moderate (50-80%),Moderate,Gut,Partially Suitable
Omeprazole,Blood Thinner,Weight Loss,54.2,C33H35FN2O5,Proton Pump Inhibitor,Acid Reflux,1987,Metformin Hydrochloride,Prilosec,Low Risk,Rapid Absorption,Phase 4,No Preclinical Data,MAPK Pathway,Tablet,500mg twice a day,Pfizer,24,High,Low Risk,Low (<50%),Slow,Liver,Suitable
Losartan,Diabetes,Autoimmune Disorders,66.48,C17H19N3O3S,Proton Pump Inhibitor,"Nausea, Dizziness",1987,Atorvastatin Calcium,Glucophage,Low Risk,Rapid Absorption,Phase 3,Toxicology Report,Serotonin Pathway,Topical Gel,500mg twice a day,Pfizer,6,Low,High Risk,Low (<50%),Slow,Gut,Not Suitable
Paracetamol,Acid Reflux,Cardiovascular Disease,62.11,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1996,Metformin Hydrochloride,Prilosec,High Risk,Slow Metabolism,Ongoing,In Vitro Studies,Dopaminergic Pathway,Syrup,50mg daily,Roche,12,Low,Moderate Risk,High (>80%),Moderate,Enzyme-Specific,Partially Suitable
Ranitidine,Fever,Cardiovascular Disease,42.79,C9H8O4,Proton Pump Inhibitor,Muscle Pain,1971,Metformin Hydrochloride,Aspirin,High Risk,High Bioavailability,Phase 3,Toxicology Report,Serotonin Pathway,Capsule,As prescribed,Merck,12,High,Moderate Risk,Low (<50%),Fast,Enzyme-Specific,Suitable
Simvastatin,Blood Thinner,Autoimmune Disorders,50.42,C13H18O2,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1994,Omeprazole,Glucophage,High Risk,High Bioavailability,Phase 3,In Vitro Studies,MAPK Pathway,Syrup,50mg daily,Pfizer,6,Low,Low Risk,Moderate (50-80%),Slow,Liver,Partially Suitable
Levothyroxine,Blood Thinner,Cardiovascular Disease,93.47,C33H35FN2O5,NSAID,"Nausea, Dizziness",1994,Omeprazole,Prilosec,High Risk,Slow Metabolism,Ongoing,In Vitro Studies,Serotonin Pathway,Syrup,50mg daily,Merck,6,Low,High Risk,High (>80%),Fast,Enzyme-Specific,Suitable
Aspirin,Diabetes,Cancer Therapy,52.65,C33H35FN2O5,NSAID,"Nausea, Dizziness",1996,Omeprazole,Lipitor,Low Risk,Slow Metabolism,Completed,Animal Testing,MAPK Pathway,Topical Gel,500mg twice a day,Roche,2,Moderate,Moderate Risk,Low (<50%),Slow,Gut,Not Suitable
Metformin,Inflammation,Parkinson's,80.38,C13H18O2,AMPK Activator,"Nausea, Dizziness",1971,Acetylsalicylic Acid,Advil,High Risk,Renal Excretion,Phase 1,Animal Testing,PI3K-AKT Pathway,Capsule,10mg once daily,Roche,2,Low,Low Risk,Moderate (50-80%),Slow,Enzyme-Specific,Partially Suitable
Ibuprofen,Cholesterol Control,Weight Loss,31.1,C9H8O4,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1987,Metformin Hydrochloride,Glucophage,Low Risk,Rapid Absorption,Phase 1,Toxicology Report,Serotonin Pathway,Syrup,250mg every 8 hours,AstraZeneca,48,High,Moderate Risk,Low (<50%),Fast,Enzyme-Specific,Partially Suitable
Atorvastatin,Hypertension,Anti-Aging,86.22,C13H18O2,AMPK Activator,"Nausea, Dizziness",1987,Atorvastatin Calcium,Glucophage,Low Risk,Renal Excretion,Ongoing,In Vitro Studies,MAPK Pathway,Capsule,250mg every 8 hours,Pfizer,6,High,Moderate Risk,Low (<50%),Slow,Enzyme-Specific,Not Suitable
Omeprazole,Fever,Alzheimer's,50.69,C9H8O4,COX Inhibitor,Muscle Pain,1971,Acetylsalicylic Acid,Advil,Low Risk,Rapid Absorption,Phase 2,No Preclinical Data,Serotonin Pathway,Tablet,50mg daily,Merck,2,High,High Risk,Low (<50%),Fast,Gut,Suitable
Losartan,Gastric Ulcer,Weight Loss,89.82,C4H11N5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1971,Metformin Hydrochloride,Advil,Moderate Risk,Renal Excretion,Phase 2,In Vitro Studies,Dopaminergic Pathway,Syrup,As prescribed,Roche,6,Low,High Risk,Low (<50%),Slow,Gut,Not Suitable
Paracetamol,Thyroid Hormone Replacement,Cardiovascular Disease,32.04,C13H18O2,COX Inhibitor,"Headache, Rash",1965,Acetylsalicylic Acid,Prilosec,High Risk,Renal Excretion,Phase 4,No Preclinical Data,Dopaminergic Pathway,Tablet,As prescribed,Novartis,48,Moderate,Moderate Risk,High (>80%),Moderate,Gut,Not Suitable
Ranitidine,Cholesterol Control,Autoimmune Disorders,33.43,C33H35FN2O5,NSAID,"Headache, Rash",1994,Metformin Hydrochloride,Lipitor,Low Risk,Slow Metabolism,Phase 1,No Preclinical Data,PI3K-AKT Pathway,Injection,10mg once daily,Pfizer,6,High,High Risk,High (>80%),Fast,Enzyme-Specific,Not Suitable
Simvastatin,Hypertension,Weight Loss,55.77,C13H18O2,AMPK Activator,"Nausea, Dizziness",1987,Metformin Hydrochloride,Advil,High Risk,Liver Metabolism,Phase 4,Animal Testing,Dopaminergic Pathway,Syrup,250mg every 8 hours,AstraZeneca,2,Moderate,Moderate Risk,High (>80%),Fast,Gut,Suitable
Levothyroxine,Thyroid Hormone Replacement,Autoimmune Disorders,92.14,C17H19N3O3S,COX Inhibitor,Muscle Pain,1965,Ibuprofen,Prilosec,Moderate Risk,Renal Excretion,Phase 2,No Preclinical Data,Serotonin Pathway,Injection,500mg twice a day,Novartis,48,High,High Risk,Low (<50%),Moderate,Enzyme-Specific,Partially Suitable
Aspirin,Acid Reflux,Parkinson's,56.12,C13H18O2,NSAID,"Nausea, Dizziness",1987,Ibuprofen,Aspirin,Low Risk,Rapid Absorption,Phase 4,No Preclinical Data,MAPK Pathway,Syrup,50mg daily,Novartis,12,High,Low Risk,High (>80%),Fast,Renal,Not Suitable
Metformin,Hypertension,Alzheimer's,78.41,C13H18O2,AMPK Activator,Muscle Pain,1994,Ibuprofen,Prilosec,Low Risk,Renal Excretion,Phase 1,Toxicology Report,Immune Response Pathway,Capsule,250mg every 8 hours,Novartis,24,Low,High Risk,Low (<50%),Fast,Enzyme-Specific,Suitable
Ibuprofen,Inflammation,Weight Loss,63.17,C17H19N3O3S,COX Inhibitor,"Headache, Rash",1971,Omeprazole,Aspirin,Low Risk,Rapid Absorption,Ongoing,No Preclinical Data,Immune Response Pathway,Injection,500mg twice a day,Merck,6,High,High Risk,Low (<50%),Moderate,Liver,Not Suitable
Atorvastatin,Diabetes,Parkinson's,91.91,C4H11N5,AMPK Activator,Muscle Pain,1987,Acetylsalicylic Acid,Advil,Moderate Risk,Liver Metabolism,Completed,Toxicology Report,Serotonin Pathway,Tablet,500mg twice a day,AstraZeneca,12,Moderate,Low Risk,Low (<50%),Fast,Gut,Not Suitable
Omeprazole,Blood Thinner,Migraine Treatment,73.71,C9H8O4,NSAID,Muscle Pain,1971,Metformin Hydrochloride,Prilosec,Low Risk,Renal Excretion,Phase 1,Animal Testing,Serotonin Pathway,Injection,250mg every 8 hours,Pfizer,6,High,Low Risk,Low (<50%),Fast,Liver,Not Suitable
Losartan,Acid Reflux,Antiviral,86.45,C17H19N3O3S,COX Inhibitor,"Nausea, Dizziness",1965,Acetylsalicylic Acid,Aspirin,Low Risk,Rapid Absorption,Phase 4,Animal Testing,Dopaminergic Pathway,Topical Gel,500mg twice a day,Novartis,6,Moderate,High Risk,Low (<50%),Moderate,Renal,Partially Suitable
Paracetamol,Hypertension,Antiviral,38.55,C4H11N5,NSAID,Muscle Pain,1971,Acetylsalicylic Acid,Lipitor,Low Risk,Slow Metabolism,Phase 4,In Vitro Studies,Serotonin Pathway,Capsule,50mg daily,Pfizer,24,High,Moderate Risk,High (>80%),Fast,Renal,Not Suitable
Ranitidine,Inflammation,Antiviral,91.76,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1987,Acetylsalicylic Acid,Aspirin,High Risk,High Bioavailability,Phase 4,In Vitro Studies,MAPK Pathway,Injection,As prescribed,AstraZeneca,24,High,High Risk,High (>80%),Moderate,Gut,Partially Suitable
Simvastatin,Fever,Liver Disease,59.09,C17H19N3O3S,Proton Pump Inhibitor,Acid Reflux,1971,Metformin Hydrochloride,Glucophage,Moderate Risk,Slow Metabolism,Phase 1,Animal Testing,Serotonin Pathway,Tablet,50mg daily,Pfizer,2,High,Low Risk,Moderate (50-80%),Slow,Enzyme-Specific,Suitable
Levothyroxine,Thyroid Hormone Replacement,Weight Loss,71.38,C9H8O4,AMPK Activator,Gastrointestinal Issues,1996,Atorvastatin Calcium,Prilosec,Low Risk,Renal Excretion,Phase 3,Animal Testing,PI3K-AKT Pathway,Capsule,As prescribed,Novartis,12,Low,Moderate Risk,High (>80%),Moderate,Liver,Not Suitable
Aspirin,Diabetes,Cancer Therapy,45.52,C9H8O4,COX Inhibitor,"Nausea, Dizziness",1971,Acetylsalicylic Acid,Advil,Moderate Risk,High Bioavailability,Phase 1,No Preclinical Data,PI3K-AKT Pathway,Topical Gel,250mg every 8 hours,Pfizer,24,High,Low Risk,Moderate (50-80%),Slow,Gut,Not Suitable
Metformin,Cholesterol Control,Weight Loss,62.11,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1971,Omeprazole,Prilosec,Moderate Risk,Renal Excretion,Ongoing,Animal Testing,MAPK Pathway,Syrup,50mg daily,Pfizer,12,Low,Moderate Risk,High (>80%),Moderate,Liver,Partially Suitable
Ibuprofen,Cholesterol Control,Alzheimer's,81.54,C33H35FN2O5,AMPK Activator,"Headache, Rash",1965,Metformin Hydrochloride,Aspirin,Moderate Risk,Liver Metabolism,Phase 4,No Preclinical Data,Serotonin Pathway,Tablet,500mg twice a day,AstraZeneca,48,High,Low Risk,Moderate (50-80%),Fast,Enzyme-Specific,Suitable
Atorvastatin,Cholesterol Control,Cancer Therapy,87.21,C13H18O2,NSAID,"Headache, Rash",1987,Acetylsalicylic Acid,Lipitor,High Risk,Liver Metabolism,Phase 4,Toxicology Report,Serotonin Pathway,Topical Gel,250mg every 8 hours,Pfizer,12,Moderate,Low Risk,Moderate (50-80%),Fast,Enzyme-Specific,Partially Suitable
Omeprazole,Fever,Alzheimer's,33.26,C17H19N3O3S,Proton Pump Inhibitor,Acid Reflux,1987,Acetylsalicylic Acid,Prilosec,Low Risk,Renal Excretion,Phase 3,Animal Testing,PI3K-AKT Pathway,Tablet,As prescribed,Novartis,6,Moderate,High Risk,Moderate (50-80%),Moderate,Renal,Partially Suitable
Losartan,Diabetes,Cardiovascular Disease,66.45,C33H35FN2O5,COX Inhibitor,"Headache, Rash",1996,Atorvastatin Calcium,Lipitor,Moderate Risk,High Bioavailability,Phase 3,No Preclinical Data,Dopaminergic Pathway,Tablet,500mg twice a day,Pfizer,48,Moderate,High Risk,Moderate (50-80%),Moderate,Liver,Partially Suitable
Paracetamol,Fever,Autoimmune Disorders,41.68,C13H18O2,Proton Pump Inhibitor,Acid Reflux,1971,Omeprazole,Advil,High Risk,High Bioavailability,Completed,No Preclinical Data,PI3K-AKT Pathway,Tablet,500mg twice a day,Pfizer,12,Low,Moderate Risk,Low (<50%),Fast,Enzyme-Specific,Partially Suitable
Ranitidine,Diabetes,Parkinson's,55.83,C13H18O2,HMG-CoA Reductase Inhibitor,"Headache, Rash",1996,Ibuprofen,Prilosec,High Risk,Rapid Absorption,Phase 2,Animal Testing,MAPK Pathway,Tablet,As prescribed,Roche,24,Low,Moderate Risk,High (>80%),Fast,Enzyme-Specific,Partially Suitable
Simvastatin,Thyroid Hormone Replacement,Weight Loss,52.57,C9H8O4,COX Inhibitor,Muscle Pain,1971,Ibuprofen,Prilosec,Low Risk,Rapid Absorption,Phase 4,Animal Testing,MAPK Pathway,Capsule,10mg once daily,Roche,48,High,Low Risk,High (>80%),Moderate,Enzyme-Specific,Suitable
Levothyroxine,Inflammation,Cardiovascular Disease,41.94,C4H11N5,AMPK Activator,Acid Reflux,1971,Metformin Hydrochloride,Advil,Low Risk,Rapid Absorption,Phase 1,Animal Testing,MAPK Pathway,Tablet,250mg every 8 hours,AstraZeneca,12,Moderate,High Risk,Moderate (50-80%),Slow,Liver,Suitable
Aspirin,Pain Relief,Anti-Aging,83.18,C33H35FN2O5,Proton Pump Inhibitor,Gastrointestinal Issues,1965,Omeprazole,Glucophage,High Risk,Slow Metabolism,Phase 2,Animal Testing,PI3K-AKT Pathway,Syrup,250mg every 8 hours,AstraZeneca,24,Low,High Risk,Moderate (50-80%),Slow,Gut,Not Suitable
Metformin,Pain Relief,Cancer Therapy,91.35,C4H11N5,COX Inhibitor,Acid Reflux,1987,Metformin Hydrochloride,Aspirin,Low Risk,Rapid Absorption,Phase 3,Animal Testing,MAPK Pathway,Injection,10mg once daily,Novartis,12,Low,Low Risk,High (>80%),Moderate,Liver,Suitable
Ibuprofen,Hypertension,Alzheimer's,34.33,C9H8O4,AMPK Activator,Gastrointestinal Issues,1965,Atorvastatin Calcium,Lipitor,Low Risk,Rapid Absorption,Phase 1,Toxicology Report,Dopaminergic Pathway,Capsule,10mg once daily,Pfizer,24,Low,Moderate Risk,Low (<50%),Moderate,Liver,Suitable
Atorvastatin,Gastric Ulcer,Anti-Aging,77,C13H18O2,COX Inhibitor,"Headache, Rash",1994,Atorvastatin Calcium,Prilosec,Moderate Risk,Renal Excretion,Phase 1,No Preclinical Data,MAPK Pathway,Tablet,250mg every 8 hours,Merck,12,High,Low Risk,Low (<50%),Slow,Enzyme-Specific,Suitable
Omeprazole,Cholesterol Control,Autoimmune Disorders,42.64,C13H18O2,NSAID,Gastrointestinal Issues,1971,Metformin Hydrochloride,Advil,Moderate Risk,High Bioavailability,Ongoing,In Vitro Studies,PI3K-AKT Pathway,Injection,500mg twice a day,Merck,48,Low,Moderate Risk,Moderate (50-80%),Slow,Gut,Partially Suitable
Losartan,Hypertension,Migraine Treatment,70.25,C4H11N5,AMPK Activator,Gastrointestinal Issues,1996,Acetylsalicylic Acid,Glucophage,Low Risk,Renal Excretion,Phase 1,In Vitro Studies,PI3K-AKT Pathway,Injection,250mg every 8 hours,Novartis,6,Moderate,High Risk,High (>80%),Moderate,Renal,Partially Suitable
Paracetamol,Inflammation,Autoimmune Disorders,85.66,C13H18O2,Proton Pump Inhibitor,"Nausea, Dizziness",1994,Atorvastatin Calcium,Glucophage,Low Risk,Renal Excretion,Ongoing,No Preclinical Data,PI3K-AKT Pathway,Topical Gel,50mg daily,Novartis,24,High,Low Risk,Low (<50%),Moderate,Liver,Not Suitable
Ranitidine,Fever,Antiviral,35.44,C9H8O4,Proton Pump Inhibitor,"Nausea, Dizziness",1996,Ibuprofen,Advil,High Risk,High Bioavailability,Phase 1,Toxicology Report,PI3K-AKT Pathway,Capsule,50mg daily,AstraZeneca,48,Low,Moderate Risk,Moderate (50-80%),Fast,Gut,Suitable
Simvastatin,Acid Reflux,Parkinson's,83.48,C33H35FN2O5,AMPK Activator,Acid Reflux,1971,Metformin Hydrochloride,Glucophage,Low Risk,Rapid Absorption,Phase 3,In Vitro Studies,PI3K-AKT Pathway,Injection,250mg every 8 hours,Merck,48,Low,Low Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Levothyroxine,Blood Thinner,Antiviral,54.93,C17H19N3O3S,Proton Pump Inhibitor,Acid Reflux,1971,Ibuprofen,Aspirin,Low Risk,High Bioavailability,Phase 4,Toxicology Report,PI3K-AKT Pathway,Tablet,500mg twice a day,Roche,12,Low,Low Risk,Low (<50%),Moderate,Liver,Suitable
Aspirin,Blood Thinner,Cardiovascular Disease,87.15,C17H19N3O3S,AMPK Activator,"Nausea, Dizziness",1971,Acetylsalicylic Acid,Prilosec,Low Risk,Slow Metabolism,Phase 3,Animal Testing,Serotonin Pathway,Capsule,250mg every 8 hours,Pfizer,6,High,Low Risk,Low (<50%),Moderate,Gut,Partially Suitable
Metformin,Diabetes,Cardiovascular Disease,87.11,C33H35FN2O5,Proton Pump Inhibitor,Acid Reflux,1965,Ibuprofen,Aspirin,High Risk,Liver Metabolism,Completed,Animal Testing,MAPK Pathway,Syrup,50mg daily,Merck,2,High,Low Risk,Low (<50%),Fast,Liver,Suitable
Ibuprofen,Hypertension,Cardiovascular Disease,80.18,C13H18O2,Proton Pump Inhibitor,"Headache, Rash",1987,Acetylsalicylic Acid,Advil,High Risk,High Bioavailability,Phase 3,In Vitro Studies,MAPK Pathway,Topical Gel,500mg twice a day,Merck,6,High,Moderate Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Atorvastatin,Fever,Cardiovascular Disease,32.32,C17H19N3O3S,AMPK Activator,Gastrointestinal Issues,1994,Omeprazole,Prilosec,High Risk,High Bioavailability,Phase 3,No Preclinical Data,PI3K-AKT Pathway,Tablet,As prescribed,Novartis,48,Moderate,Moderate Risk,High (>80%),Slow,Gut,Suitable
Omeprazole,Inflammation,Anti-Aging,77.93,C17H19N3O3S,COX Inhibitor,"Headache, Rash",1971,Omeprazole,Aspirin,High Risk,Rapid Absorption,Phase 2,Toxicology Report,Immune Response Pathway,Syrup,500mg twice a day,Merck,24,High,High Risk,High (>80%),Slow,Enzyme-Specific,Not Suitable
Losartan,Inflammation,Liver Disease,62.63,C33H35FN2O5,COX Inhibitor,"Nausea, Dizziness",1994,Ibuprofen,Aspirin,Low Risk,Rapid Absorption,Completed,No Preclinical Data,MAPK Pathway,Topical Gel,50mg daily,Merck,24,Low,High Risk,Low (<50%),Slow,Gut,Suitable
Paracetamol,Inflammation,Anti-Aging,68.89,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1996,Atorvastatin Calcium,Lipitor,Low Risk,Rapid Absorption,Phase 2,Animal Testing,MAPK Pathway,Tablet,250mg every 8 hours,Novartis,6,Low,High Risk,High (>80%),Slow,Enzyme-Specific,Suitable
Ranitidine,Diabetes,Alzheimer's,94.24,C33H35FN2O5,NSAID,Muscle Pain,1987,Ibuprofen,Aspirin,Moderate Risk,High Bioavailability,Phase 3,No Preclinical Data,Dopaminergic Pathway,Syrup,10mg once daily,AstraZeneca,48,Low,High Risk,High (>80%),Moderate,Enzyme-Specific,Partially Suitable
Simvastatin,Pain Relief,Parkinson's,65.25,C33H35FN2O5,Proton Pump Inhibitor,Acid Reflux,1996,Metformin Hydrochloride,Glucophage,Moderate Risk,Liver Metabolism,Ongoing,Toxicology Report,PI3K-AKT Pathway,Topical Gel,50mg daily,AstraZeneca,12,High,High Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Suitable
Levothyroxine,Acid Reflux,Alzheimer's,74.01,C13H18O2,NSAID,"Nausea, Dizziness",1996,Metformin Hydrochloride,Aspirin,High Risk,Renal Excretion,Completed,Toxicology Report,Immune Response Pathway,Topical Gel,250mg every 8 hours,Pfizer,24,Low,High Risk,High (>80%),Slow,Liver,Partially Suitable
Aspirin,Gastric Ulcer,Antiviral,44.1,C13H18O2,NSAID,"Headache, Rash",1965,Omeprazole,Aspirin,High Risk,Renal Excretion,Phase 4,Animal Testing,PI3K-AKT Pathway,Injection,10mg once daily,Novartis,6,Moderate,Low Risk,Low (<50%),Fast,Liver,Not Suitable
Metformin,Fever,Cancer Therapy,78.12,C13H18O2,AMPK Activator,Acid Reflux,1994,Omeprazole,Advil,Moderate Risk,Renal Excretion,Ongoing,Animal Testing,Dopaminergic Pathway,Syrup,10mg once daily,AstraZeneca,48,Moderate,High Risk,Low (<50%),Moderate,Renal,Partially Suitable
Ibuprofen,Acid Reflux,Alzheimer's,81.94,C33H35FN2O5,NSAID,"Headache, Rash",1965,Omeprazole,Aspirin,Moderate Risk,High Bioavailability,Phase 3,No Preclinical Data,Immune Response Pathway,Capsule,50mg daily,Roche,12,High,Low Risk,Moderate (50-80%),Fast,Liver,Suitable
Atorvastatin,Gastric Ulcer,Cancer Therapy,30.44,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1996,Omeprazole,Lipitor,Moderate Risk,High Bioavailability,Completed,Animal Testing,PI3K-AKT Pathway,Capsule,500mg twice a day,Merck,6,High,High Risk,Low (<50%),Slow,Enzyme-Specific,Not Suitable
Omeprazole,Diabetes,Migraine Treatment,31.52,C13H18O2,NSAID,Gastrointestinal Issues,1971,Atorvastatin Calcium,Advil,Low Risk,Liver Metabolism,Phase 2,In Vitro Studies,PI3K-AKT Pathway,Syrup,500mg twice a day,AstraZeneca,24,High,High Risk,Low (<50%),Slow,Gut,Not Suitable
Losartan,Inflammation,Parkinson's,66.24,C17H19N3O3S,Proton Pump Inhibitor,"Headache, Rash",1971,Ibuprofen,Lipitor,Moderate Risk,Liver Metabolism,Completed,No Preclinical Data,MAPK Pathway,Syrup,As prescribed,Roche,24,High,Moderate Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Paracetamol,Diabetes,Cardiovascular Disease,72,C9H8O4,NSAID,"Headache, Rash",1996,Omeprazole,Advil,Low Risk,Liver Metabolism,Phase 1,No Preclinical Data,MAPK Pathway,Syrup,10mg once daily,Merck,48,High,Moderate Risk,Low (<50%),Slow,Renal,Not Suitable
Ranitidine,Acid Reflux,Alzheimer's,75.05,C17H19N3O3S,Proton Pump Inhibitor,Acid Reflux,1971,Ibuprofen,Glucophage,High Risk,Liver Metabolism,Phase 2,No Preclinical Data,Immune Response Pathway,Syrup,50mg daily,Novartis,24,Low,Moderate Risk,Moderate (50-80%),Moderate,Liver,Not Suitable
Simvastatin,Pain Relief,Cardiovascular Disease,76.11,C33H35FN2O5,AMPK Activator,Muscle Pain,1996,Metformin Hydrochloride,Prilosec,High Risk,Renal Excretion,Phase 1,No Preclinical Data,PI3K-AKT Pathway,Tablet,10mg once daily,Novartis,6,Low,Low Risk,Low (<50%),Slow,Liver,Not Suitable
Levothyroxine,Diabetes,Antiviral,90.28,C4H11N5,NSAID,Acid Reflux,1994,Metformin Hydrochloride,Glucophage,Low Risk,High Bioavailability,Completed,Animal Testing,Dopaminergic Pathway,Topical Gel,50mg daily,AstraZeneca,2,Moderate,High Risk,Low (<50%),Slow,Renal,Partially Suitable
Aspirin,Thyroid Hormone Replacement,Alzheimer's,47.72,C9H8O4,Proton Pump Inhibitor,"Nausea, Dizziness",1971,Omeprazole,Lipitor,High Risk,Renal Excretion,Phase 3,Animal Testing,Immune Response Pathway,Syrup,250mg every 8 hours,AstraZeneca,24,High,Low Risk,High (>80%),Slow,Renal,Suitable
Metformin,Blood Thinner,Parkinson's,82.49,C17H19N3O3S,Proton Pump Inhibitor,"Headache, Rash",1994,Atorvastatin Calcium,Aspirin,High Risk,Liver Metabolism,Phase 3,In Vitro Studies,Serotonin Pathway,Capsule,50mg daily,Pfizer,48,High,High Risk,High (>80%),Fast,Enzyme-Specific,Suitable
Ibuprofen,Hypertension,Liver Disease,41.14,C17H19N3O3S,Proton Pump Inhibitor,Muscle Pain,1965,Atorvastatin Calcium,Glucophage,Moderate Risk,Rapid Absorption,Completed,In Vitro Studies,Dopaminergic Pathway,Capsule,10mg once daily,AstraZeneca,24,Moderate,Moderate Risk,Low (<50%),Fast,Liver,Suitable
Atorvastatin,Cholesterol Control,Antiviral,64.85,C4H11N5,NSAID,Muscle Pain,1971,Omeprazole,Lipitor,Moderate Risk,Slow Metabolism,Phase 3,Toxicology Report,Serotonin Pathway,Capsule,10mg once daily,Pfizer,2,High,Moderate Risk,Moderate (50-80%),Fast,Enzyme-Specific,Suitable
Omeprazole,Thyroid Hormone Replacement,Cardiovascular Disease,89.08,C17H19N3O3S,NSAID,Muscle Pain,1987,Atorvastatin Calcium,Prilosec,High Risk,Liver Metabolism,Completed,Animal Testing,Dopaminergic Pathway,Syrup,500mg twice a day,AstraZeneca,48,Moderate,High Risk,High (>80%),Moderate,Renal,Suitable
Losartan,Gastric Ulcer,Weight Loss,47.83,C13H18O2,COX Inhibitor,Acid Reflux,1965,Omeprazole,Aspirin,Low Risk,Slow Metabolism,Phase 3,In Vitro Studies,Dopaminergic Pathway,Tablet,250mg every 8 hours,Merck,12,Moderate,Low Risk,Low (<50%),Slow,Renal,Not Suitable
Paracetamol,Hypertension,Cancer Therapy,49.82,C9H8O4,COX Inhibitor,Muscle Pain,1965,Acetylsalicylic Acid,Prilosec,Moderate Risk,High Bioavailability,Completed,No Preclinical Data,Dopaminergic Pathway,Capsule,10mg once daily,AstraZeneca,12,Low,High Risk,Low (<50%),Slow,Gut,Suitable
Ranitidine,Pain Relief,Autoimmune Disorders,63.19,C13H18O2,HMG-CoA Reductase Inhibitor,"Headache, Rash",1994,Ibuprofen,Advil,Low Risk,Liver Metabolism,Phase 2,Toxicology Report,Dopaminergic Pathway,Capsule,250mg every 8 hours,Pfizer,12,Moderate,Low Risk,Low (<50%),Moderate,Gut,Not Suitable
Simvastatin,Fever,Cancer Therapy,71.8,C17H19N3O3S,Proton Pump Inhibitor,Acid Reflux,1994,Omeprazole,Aspirin,High Risk,Rapid Absorption,Ongoing,No Preclinical Data,Serotonin Pathway,Tablet,250mg every 8 hours,Novartis,2,High,High Risk,Low (<50%),Moderate,Enzyme-Specific,Suitable
Levothyroxine,Diabetes,Alzheimer's,44.9,C4H11N5,Proton Pump Inhibitor,"Nausea, Dizziness",1987,Atorvastatin Calcium,Advil,Low Risk,High Bioavailability,Ongoing,No Preclinical Data,Dopaminergic Pathway,Syrup,50mg daily,Pfizer,48,Moderate,Moderate Risk,High (>80%),Fast,Renal,Not Suitable
Aspirin,Gastric Ulcer,Weight Loss,73.37,C33H35FN2O5,NSAID,Muscle Pain,1965,Omeprazole,Advil,Low Risk,High Bioavailability,Phase 1,Toxicology Report,Immune Response Pathway,Capsule,250mg every 8 hours,Roche,6,High,Moderate Risk,Low (<50%),Moderate,Liver,Partially Suitable
Metformin,Inflammation,Cancer Therapy,37.33,C4H11N5,NSAID,Muscle Pain,1996,Atorvastatin Calcium,Lipitor,High Risk,Liver Metabolism,Phase 1,Animal Testing,Dopaminergic Pathway,Syrup,10mg once daily,Pfizer,2,High,Low Risk,Low (<50%),Moderate,Liver,Partially Suitable
Ibuprofen,Diabetes,Autoimmune Disorders,46.75,C4H11N5,Proton Pump Inhibitor,Gastrointestinal Issues,1994,Metformin Hydrochloride,Aspirin,Low Risk,Rapid Absorption,Phase 2,In Vitro Studies,Immune Response Pathway,Injection,As prescribed,Merck,2,High,Moderate Risk,High (>80%),Moderate,Renal,Not Suitable
Atorvastatin,Acid Reflux,Parkinson's,78.33,C17H19N3O3S,NSAID,"Headache, Rash",1971,Metformin Hydrochloride,Advil,High Risk,Slow Metabolism,Phase 4,No Preclinical Data,MAPK Pathway,Capsule,50mg daily,AstraZeneca,24,High,Moderate Risk,Low (<50%),Moderate,Gut,Suitable
Omeprazole,Diabetes,Autoimmune Disorders,53.54,C13H18O2,COX Inhibitor,"Headache, Rash",1987,Acetylsalicylic Acid,Lipitor,Low Risk,Rapid Absorption,Phase 4,Animal Testing,Dopaminergic Pathway,Capsule,10mg once daily,AstraZeneca,24,High,Moderate Risk,High (>80%),Slow,Enzyme-Specific,Not Suitable
Losartan,Acid Reflux,Liver Disease,69.32,C17H19N3O3S,NSAID,"Headache, Rash",1994,Omeprazole,Prilosec,Moderate Risk,Liver Metabolism,Ongoing,In Vitro Studies,Serotonin Pathway,Injection,10mg once daily,Novartis,24,Moderate,Low Risk,Moderate (50-80%),Moderate,Liver,Partially Suitable
Paracetamol,Pain Relief,Antiviral,62.04,C17H19N3O3S,COX Inhibitor,"Nausea, Dizziness",1965,Omeprazole,Advil,Moderate Risk,Renal Excretion,Phase 3,Toxicology Report,Immune Response Pathway,Syrup,As prescribed,Pfizer,48,Moderate,Low Risk,Low (<50%),Moderate,Renal,Partially Suitable
Ranitidine,Blood Thinner,Migraine Treatment,93.53,C4H11N5,Proton Pump Inhibitor,Gastrointestinal Issues,1987,Omeprazole,Advil,High Risk,Rapid Absorption,Phase 4,In Vitro Studies,Dopaminergic Pathway,Capsule,As prescribed,Pfizer,48,Low,High Risk,Moderate (50-80%),Moderate,Gut,Partially Suitable
Simvastatin,Fever,Alzheimer's,91.65,C4H11N5,HMG-CoA Reductase Inhibitor,Muscle Pain,1971,Ibuprofen,Prilosec,Low Risk,Slow Metabolism,Phase 3,Toxicology Report,Immune Response Pathway,Tablet,As prescribed,Pfizer,6,Moderate,Moderate Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Levothyroxine,Thyroid Hormone Replacement,Liver Disease,31.46,C33H35FN2O5,COX Inhibitor,Muscle Pain,1987,Metformin Hydrochloride,Lipitor,Low Risk,Slow Metabolism,Phase 3,Animal Testing,Immune Response Pathway,Topical Gel,As prescribed,Novartis,6,Low,Low Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Aspirin,Inflammation,Autoimmune Disorders,79.55,C17H19N3O3S,Proton Pump Inhibitor,"Nausea, Dizziness",1971,Acetylsalicylic Acid,Glucophage,Low Risk,Slow Metabolism,Completed,No Preclinical Data,MAPK Pathway,Capsule,50mg daily,Merck,12,Low,High Risk,Low (<50%),Slow,Gut,Suitable
Metformin,Diabetes,Antiviral,92.05,C4H11N5,NSAID,Muscle Pain,1971,Ibuprofen,Advil,Low Risk,High Bioavailability,Phase 2,Animal Testing,PI3K-AKT Pathway,Syrup,500mg twice a day,Novartis,2,High,High Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Ibuprofen,Gastric Ulcer,Antiviral,33.22,C13H18O2,COX Inhibitor,Muscle Pain,1987,Ibuprofen,Advil,High Risk,Renal Excretion,Ongoing,No Preclinical Data,MAPK Pathway,Capsule,250mg every 8 hours,Novartis,24,Moderate,Moderate Risk,High (>80%),Fast,Renal,Partially Suitable
Atorvastatin,Hypertension,Weight Loss,92.28,C13H18O2,NSAID,Acid Reflux,1987,Metformin Hydrochloride,Advil,High Risk,Slow Metabolism,Completed,Toxicology Report,MAPK Pathway,Injection,500mg twice a day,Merck,6,High,Low Risk,Moderate (50-80%),Fast,Renal,Not Suitable
Omeprazole,Blood Thinner,Migraine Treatment,82.43,C13H18O2,HMG-CoA Reductase Inhibitor,"Headache, Rash",1965,Acetylsalicylic Acid,Advil,High Risk,Renal Excretion,Phase 4,In Vitro Studies,Immune Response Pathway,Capsule,As prescribed,Pfizer,12,Low,High Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Not Suitable
Losartan,Hypertension,Cancer Therapy,41.96,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1994,Metformin Hydrochloride,Glucophage,Moderate Risk,Slow Metabolism,Ongoing,No Preclinical Data,MAPK Pathway,Topical Gel,50mg daily,Pfizer,24,High,Low Risk,High (>80%),Fast,Renal,Partially Suitable
Paracetamol,Hypertension,Parkinson's,33.51,C9H8O4,Proton Pump Inhibitor,Muscle Pain,1996,Ibuprofen,Aspirin,High Risk,Slow Metabolism,Phase 1,Animal Testing,Immune Response Pathway,Injection,50mg daily,Merck,6,Moderate,Low Risk,Low (<50%),Moderate,Liver,Not Suitable
Ranitidine,Acid Reflux,Weight Loss,87.16,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1994,Atorvastatin Calcium,Prilosec,Low Risk,Liver Metabolism,Phase 4,Toxicology Report,Dopaminergic Pathway,Topical Gel,10mg once daily,Pfizer,48,Low,Moderate Risk,Moderate (50-80%),Moderate,Liver,Partially Suitable
Simvastatin,Acid Reflux,Autoimmune Disorders,46.04,C13H18O2,HMG-CoA Reductase Inhibitor,Acid Reflux,1965,Acetylsalicylic Acid,Glucophage,Moderate Risk,Liver Metabolism,Phase 3,Toxicology Report,Immune Response Pathway,Tablet,As prescribed,Merck,6,High,High Risk,High (>80%),Moderate,Renal,Partially Suitable
Levothyroxine,Blood Thinner,Migraine Treatment,34.27,C17H19N3O3S,NSAID,"Nausea, Dizziness",1965,Ibuprofen,Glucophage,High Risk,High Bioavailability,Phase 2,No Preclinical Data,Immune Response Pathway,Tablet,As prescribed,AstraZeneca,48,Moderate,High Risk,High (>80%),Moderate,Gut,Suitable
Aspirin,Diabetes,Cancer Therapy,58.94,C9H8O4,COX Inhibitor,"Nausea, Dizziness",1994,Atorvastatin Calcium,Glucophage,High Risk,High Bioavailability,Phase 2,No Preclinical Data,Dopaminergic Pathway,Capsule,10mg once daily,Novartis,6,Low,Moderate Risk,Low (<50%),Fast,Enzyme-Specific,Not Suitable
Metformin,Inflammation,Weight Loss,94.02,C4H11N5,Proton Pump Inhibitor,"Nausea, Dizziness",1994,Omeprazole,Advil,Moderate Risk,Rapid Absorption,Phase 2,Toxicology Report,PI3K-AKT Pathway,Capsule,As prescribed,Roche,24,Moderate,Low Risk,Low (<50%),Fast,Gut,Not Suitable
Ibuprofen,Blood Thinner,Anti-Aging,93.98,C4H11N5,Proton Pump Inhibitor,Acid Reflux,1996,Ibuprofen,Prilosec,Moderate Risk,High Bioavailability,Phase 4,In Vitro Studies,Dopaminergic Pathway,Tablet,As prescribed,Pfizer,24,High,High Risk,Low (<50%),Slow,Liver,Not Suitable
Atorvastatin,Inflammation,Weight Loss,89.5,C4H11N5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1971,Ibuprofen,Glucophage,Moderate Risk,Liver Metabolism,Phase 4,In Vitro Studies,PI3K-AKT Pathway,Syrup,50mg daily,Pfizer,12,High,High Risk,Moderate (50-80%),Slow,Liver,Partially Suitable
Omeprazole,Cholesterol Control,Autoimmune Disorders,56.85,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1996,Metformin Hydrochloride,Aspirin,High Risk,Rapid Absorption,Phase 4,In Vitro Studies,PI3K-AKT Pathway,Injection,250mg every 8 hours,AstraZeneca,48,High,Low Risk,Moderate (50-80%),Fast,Renal,Partially Suitable
Losartan,Gastric Ulcer,Antiviral,74.54,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1994,Acetylsalicylic Acid,Aspirin,Low Risk,High Bioavailability,Phase 2,In Vitro Studies,Immune Response Pathway,Topical Gel,10mg once daily,Novartis,24,Low,Moderate Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Paracetamol,Thyroid Hormone Replacement,Parkinson's,43.07,C4H11N5,COX Inhibitor,Muscle Pain,1965,Metformin Hydrochloride,Glucophage,High Risk,Liver Metabolism,Phase 3,Animal Testing,Dopaminergic Pathway,Capsule,As prescribed,AstraZeneca,2,Moderate,Low Risk,High (>80%),Fast,Enzyme-Specific,Partially Suitable
Ranitidine,Gastric Ulcer,Alzheimer's,67.62,C9H8O4,AMPK Activator,Muscle Pain,1996,Atorvastatin Calcium,Aspirin,Low Risk,High Bioavailability,Phase 4,Toxicology Report,MAPK Pathway,Injection,50mg daily,Novartis,12,High,Moderate Risk,Moderate (50-80%),Slow,Liver,Partially Suitable
Simvastatin,Inflammation,Antiviral,38.99,C4H11N5,NSAID,"Nausea, Dizziness",1996,Atorvastatin Calcium,Advil,High Risk,Rapid Absorption,Phase 4,No Preclinical Data,Immune Response Pathway,Tablet,As prescribed,Novartis,6,Low,Moderate Risk,High (>80%),Slow,Renal,Partially Suitable
Levothyroxine,Inflammation,Liver Disease,62.74,C13H18O2,NSAID,"Headache, Rash",1987,Atorvastatin Calcium,Aspirin,High Risk,Renal Excretion,Phase 4,In Vitro Studies,PI3K-AKT Pathway,Injection,10mg once daily,Pfizer,12,High,High Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Partially Suitable
Aspirin,Inflammation,Autoimmune Disorders,76.08,C17H19N3O3S,Proton Pump Inhibitor,Acid Reflux,1971,Metformin Hydrochloride,Prilosec,High Risk,Rapid Absorption,Completed,Animal Testing,PI3K-AKT Pathway,Capsule,10mg once daily,Roche,2,Low,Moderate Risk,Moderate (50-80%),Fast,Renal,Not Suitable
Metformin,Diabetes,Weight Loss,43.48,C9H8O4,AMPK Activator,Muscle Pain,1971,Atorvastatin Calcium,Glucophage,Moderate Risk,Renal Excretion,Phase 2,Animal Testing,PI3K-AKT Pathway,Topical Gel,50mg daily,AstraZeneca,48,Low,Low Risk,Low (<50%),Fast,Renal,Suitable
Ibuprofen,Inflammation,Autoimmune Disorders,87.73,C9H8O4,NSAID,"Nausea, Dizziness",1965,Omeprazole,Glucophage,Moderate Risk,Liver Metabolism,Completed,In Vitro Studies,PI3K-AKT Pathway,Syrup,500mg twice a day,AstraZeneca,48,Low,Moderate Risk,Moderate (50-80%),Fast,Liver,Suitable
Atorvastatin,Gastric Ulcer,Liver Disease,47.73,C13H18O2,HMG-CoA Reductase Inhibitor,Acid Reflux,1987,Acetylsalicylic Acid,Prilosec,Low Risk,High Bioavailability,Phase 1,Toxicology Report,Dopaminergic Pathway,Topical Gel,10mg once daily,Novartis,24,Moderate,High Risk,Moderate (50-80%),Slow,Enzyme-Specific,Suitable
Omeprazole,Diabetes,Migraine Treatment,39.62,C13H18O2,AMPK Activator,Gastrointestinal Issues,1996,Atorvastatin Calcium,Glucophage,High Risk,Liver Metabolism,Completed,No Preclinical Data,Serotonin Pathway,Topical Gel,10mg once daily,Novartis,12,Low,Low Risk,High (>80%),Moderate,Renal,Suitable
Losartan,Thyroid Hormone Replacement,Cancer Therapy,61.68,C4H11N5,NSAID,Muscle Pain,1965,Acetylsalicylic Acid,Prilosec,Low Risk,Liver Metabolism,Phase 2,In Vitro Studies,MAPK Pathway,Tablet,500mg twice a day,Roche,2,Moderate,Moderate Risk,Moderate (50-80%),Moderate,Renal,Not Suitable
Paracetamol,Pain Relief,Parkinson's,86.68,C13H18O2,NSAID,Gastrointestinal Issues,1965,Atorvastatin Calcium,Aspirin,High Risk,High Bioavailability,Ongoing,No Preclinical Data,Serotonin Pathway,Tablet,10mg once daily,Novartis,48,Moderate,High Risk,Moderate (50-80%),Moderate,Gut,Suitable
Ranitidine,Acid Reflux,Alzheimer's,64.18,C17H19N3O3S,NSAID,Gastrointestinal Issues,1996,Omeprazole,Advil,Low Risk,Rapid Absorption,Ongoing,No Preclinical Data,Serotonin Pathway,Capsule,As prescribed,Pfizer,12,High,Low Risk,Moderate (50-80%),Moderate,Gut,Suitable
Simvastatin,Acid Reflux,Parkinson's,68.89,C13H18O2,NSAID,Acid Reflux,1994,Ibuprofen,Prilosec,Low Risk,Rapid Absorption,Phase 1,No Preclinical Data,Dopaminergic Pathway,Capsule,As prescribed,Merck,24,Moderate,Low Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Levothyroxine,Fever,Anti-Aging,63.62,C9H8O4,COX Inhibitor,"Headache, Rash",1994,Atorvastatin Calcium,Glucophage,Moderate Risk,Slow Metabolism,Ongoing,No Preclinical Data,Dopaminergic Pathway,Capsule,250mg every 8 hours,Roche,6,High,Moderate Risk,High (>80%),Slow,Enzyme-Specific,Not Suitable
Aspirin,Pain Relief,Parkinson's,90.14,C4H11N5,COX Inhibitor,"Headache, Rash",1965,Ibuprofen,Prilosec,High Risk,High Bioavailability,Phase 3,Toxicology Report,Serotonin Pathway,Injection,250mg every 8 hours,Pfizer,24,High,Moderate Risk,Low (<50%),Fast,Enzyme-Specific,Not Suitable
Metformin,Thyroid Hormone Replacement,Migraine Treatment,31.53,C9H8O4,NSAID,"Nausea, Dizziness",1965,Atorvastatin Calcium,Advil,Moderate Risk,Liver Metabolism,Phase 4,Toxicology Report,MAPK Pathway,Capsule,500mg twice a day,Novartis,48,Moderate,High Risk,Low (<50%),Slow,Gut,Not Suitable
Ibuprofen,Thyroid Hormone Replacement,Autoimmune Disorders,90.13,C13H18O2,HMG-CoA Reductase Inhibitor,Acid Reflux,1987,Metformin Hydrochloride,Prilosec,High Risk,Liver Metabolism,Phase 4,No Preclinical Data,Immune Response Pathway,Topical Gel,500mg twice a day,Pfizer,2,High,High Risk,Moderate (50-80%),Fast,Renal,Partially Suitable
Atorvastatin,Blood Thinner,Parkinson's,74.11,C13H18O2,HMG-CoA Reductase Inhibitor,"Headache, Rash",1987,Metformin Hydrochloride,Prilosec,Moderate Risk,Renal Excretion,Completed,Animal Testing,MAPK Pathway,Topical Gel,10mg once daily,Novartis,6,Moderate,Low Risk,High (>80%),Moderate,Liver,Suitable
Omeprazole,Diabetes,Autoimmune Disorders,30.61,C9H8O4,Proton Pump Inhibitor,Gastrointestinal Issues,1965,Ibuprofen,Lipitor,High Risk,Slow Metabolism,Phase 4,Animal Testing,MAPK Pathway,Topical Gel,As prescribed,AstraZeneca,12,High,High Risk,Moderate (50-80%),Moderate,Gut,Partially Suitable
Losartan,Pain Relief,Autoimmune Disorders,50.89,C33H35FN2O5,NSAID,"Headache, Rash",1965,Omeprazole,Prilosec,Moderate Risk,Rapid Absorption,Phase 1,Toxicology Report,Dopaminergic Pathway,Syrup,As prescribed,Pfizer,24,High,High Risk,High (>80%),Fast,Enzyme-Specific,Suitable
Paracetamol,Thyroid Hormone Replacement,Autoimmune Disorders,74.53,C13H18O2,Proton Pump Inhibitor,Gastrointestinal Issues,1987,Atorvastatin Calcium,Aspirin,High Risk,Rapid Absorption,Completed,No Preclinical Data,PI3K-AKT Pathway,Tablet,250mg every 8 hours,Novartis,24,High,Low Risk,Moderate (50-80%),Slow,Gut,Not Suitable
Ranitidine,Cholesterol Control,Antiviral,61.15,C13H18O2,Proton Pump Inhibitor,Acid Reflux,1965,Acetylsalicylic Acid,Glucophage,Low Risk,Renal Excretion,Phase 4,No Preclinical Data,MAPK Pathway,Syrup,500mg twice a day,AstraZeneca,2,High,High Risk,Low (<50%),Slow,Liver,Partially Suitable
Simvastatin,Blood Thinner,Parkinson's,59.75,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Acid Reflux,1994,Omeprazole,Glucophage,Moderate Risk,Liver Metabolism,Phase 1,Animal Testing,PI3K-AKT Pathway,Tablet,500mg twice a day,Roche,6,High,High Risk,High (>80%),Moderate,Gut,Partially Suitable
Levothyroxine,Pain Relief,Anti-Aging,93.52,C33H35FN2O5,COX Inhibitor,Muscle Pain,1971,Ibuprofen,Advil,Low Risk,Rapid Absorption,Completed,Toxicology Report,Dopaminergic Pathway,Tablet,250mg every 8 hours,Novartis,6,High,Low Risk,Moderate (50-80%),Fast,Enzyme-Specific,Partially Suitable
Aspirin,Inflammation,Parkinson's,71.36,C17H19N3O3S,COX Inhibitor,Gastrointestinal Issues,1994,Acetylsalicylic Acid,Glucophage,Low Risk,Slow Metabolism,Completed,In Vitro Studies,Immune Response Pathway,Syrup,500mg twice a day,Merck,2,High,Low Risk,Low (<50%),Slow,Renal,Not Suitable
Metformin,Thyroid Hormone Replacement,Cardiovascular Disease,31.08,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1971,Ibuprofen,Lipitor,Moderate Risk,Slow Metabolism,Phase 4,No Preclinical Data,PI3K-AKT Pathway,Capsule,250mg every 8 hours,Roche,12,Moderate,High Risk,High (>80%),Fast,Gut,Not Suitable
Ibuprofen,Acid Reflux,Anti-Aging,32.31,C4H11N5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1971,Metformin Hydrochloride,Aspirin,Moderate Risk,Slow Metabolism,Phase 2,In Vitro Studies,Immune Response Pathway,Tablet,50mg daily,Novartis,2,Low,Low Risk,Low (<50%),Slow,Enzyme-Specific,Suitable
Atorvastatin,Cholesterol Control,Migraine Treatment,91.4,C4H11N5,COX Inhibitor,Acid Reflux,1965,Metformin Hydrochloride,Lipitor,Moderate Risk,High Bioavailability,Phase 1,In Vitro Studies,Serotonin Pathway,Topical Gel,250mg every 8 hours,Pfizer,6,Moderate,Low Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Omeprazole,Thyroid Hormone Replacement,Weight Loss,54.33,C13H18O2,AMPK Activator,Acid Reflux,1994,Metformin Hydrochloride,Glucophage,High Risk,Rapid Absorption,Phase 3,In Vitro Studies,MAPK Pathway,Capsule,As prescribed,Pfizer,48,Low,Low Risk,Low (<50%),Moderate,Liver,Partially Suitable
Losartan,Thyroid Hormone Replacement,Anti-Aging,73.06,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1965,Omeprazole,Advil,Moderate Risk,High Bioavailability,Ongoing,Animal Testing,Serotonin Pathway,Syrup,50mg daily,Novartis,6,Moderate,Low Risk,High (>80%),Slow,Liver,Suitable
Paracetamol,Pain Relief,Anti-Aging,85.7,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1971,Ibuprofen,Aspirin,High Risk,Renal Excretion,Completed,Toxicology Report,Dopaminergic Pathway,Injection,50mg daily,Novartis,12,Moderate,High Risk,Low (<50%),Moderate,Enzyme-Specific,Partially Suitable
Ranitidine,Blood Thinner,Migraine Treatment,61.66,C17H19N3O3S,AMPK Activator,Gastrointestinal Issues,1971,Omeprazole,Aspirin,Moderate Risk,Slow Metabolism,Phase 3,Toxicology Report,Immune Response Pathway,Injection,250mg every 8 hours,Roche,48,Low,High Risk,Low (<50%),Moderate,Gut,Partially Suitable
Simvastatin,Acid Reflux,Autoimmune Disorders,78.31,C9H8O4,COX Inhibitor,Muscle Pain,1987,Ibuprofen,Lipitor,Moderate Risk,Renal Excretion,Phase 4,No Preclinical Data,Serotonin Pathway,Injection,10mg once daily,Pfizer,24,Low,Low Risk,Low (<50%),Moderate,Renal,Not Suitable
Levothyroxine,Fever,Alzheimer's,47.1,C4H11N5,AMPK Activator,"Nausea, Dizziness",1994,Omeprazole,Glucophage,Low Risk,Slow Metabolism,Phase 4,Animal Testing,MAPK Pathway,Injection,500mg twice a day,Pfizer,2,Low,Moderate Risk,Low (<50%),Slow,Gut,Partially Suitable
Aspirin,Blood Thinner,Migraine Treatment,87.27,C9H8O4,AMPK Activator,"Nausea, Dizziness",1994,Atorvastatin Calcium,Lipitor,Moderate Risk,Slow Metabolism,Phase 1,Toxicology Report,MAPK Pathway,Capsule,50mg daily,Merck,12,Moderate,High Risk,High (>80%),Fast,Renal,Not Suitable
Metformin,Inflammation,Antiviral,86.55,C9H8O4,AMPK Activator,Muscle Pain,1971,Acetylsalicylic Acid,Advil,Moderate Risk,Rapid Absorption,Phase 3,Animal Testing,MAPK Pathway,Injection,10mg once daily,Merck,6,High,Moderate Risk,High (>80%),Moderate,Renal,Suitable
Ibuprofen,Fever,Parkinson's,65.75,C4H11N5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1965,Ibuprofen,Prilosec,Moderate Risk,High Bioavailability,Ongoing,No Preclinical Data,MAPK Pathway,Injection,250mg every 8 hours,Novartis,6,Low,Low Risk,Low (<50%),Moderate,Enzyme-Specific,Not Suitable
Atorvastatin,Thyroid Hormone Replacement,Autoimmune Disorders,64.15,C13H18O2,HMG-CoA Reductase Inhibitor,"Headache, Rash",1994,Acetylsalicylic Acid,Glucophage,High Risk,Liver Metabolism,Phase 4,Animal Testing,Dopaminergic Pathway,Capsule,250mg every 8 hours,AstraZeneca,24,High,Moderate Risk,High (>80%),Moderate,Enzyme-Specific,Not Suitable
Omeprazole,Acid Reflux,Cancer Therapy,42.88,C9H8O4,COX Inhibitor,Acid Reflux,1971,Ibuprofen,Aspirin,Moderate Risk,High Bioavailability,Phase 2,No Preclinical Data,Immune Response Pathway,Injection,500mg twice a day,Roche,6,Moderate,Moderate Risk,Moderate (50-80%),Slow,Enzyme-Specific,Suitable
Losartan,Pain Relief,Anti-Aging,79.62,C17H19N3O3S,AMPK Activator,"Nausea, Dizziness",1996,Metformin Hydrochloride,Advil,Low Risk,Liver Metabolism,Completed,Animal Testing,Immune Response Pathway,Syrup,10mg once daily,Novartis,48,Low,Moderate Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Paracetamol,Inflammation,Antiviral,88.12,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Muscle Pain,1996,Atorvastatin Calcium,Prilosec,High Risk,High Bioavailability,Ongoing,No Preclinical Data,Serotonin Pathway,Syrup,50mg daily,Pfizer,24,Moderate,High Risk,High (>80%),Fast,Renal,Suitable
Ranitidine,Fever,Autoimmune Disorders,63.89,C4H11N5,NSAID,"Headache, Rash",1965,Atorvastatin Calcium,Glucophage,High Risk,Rapid Absorption,Phase 2,Animal Testing,Dopaminergic Pathway,Topical Gel,250mg every 8 hours,Merck,12,Low,Low Risk,High (>80%),Moderate,Renal,Not Suitable
Simvastatin,Thyroid Hormone Replacement,Autoimmune Disorders,60.61,C9H8O4,AMPK Activator,"Nausea, Dizziness",1965,Metformin Hydrochloride,Aspirin,High Risk,High Bioavailability,Completed,In Vitro Studies,Dopaminergic Pathway,Capsule,250mg every 8 hours,AstraZeneca,2,High,Low Risk,Moderate (50-80%),Fast,Enzyme-Specific,Partially Suitable
Levothyroxine,Gastric Ulcer,Autoimmune Disorders,73.62,C17H19N3O3S,COX Inhibitor,Acid Reflux,1994,Omeprazole,Lipitor,High Risk,Renal Excretion,Phase 2,Animal Testing,Dopaminergic Pathway,Injection,10mg once daily,Novartis,48,Moderate,Moderate Risk,High (>80%),Moderate,Liver,Not Suitable
Aspirin,Diabetes,Liver Disease,39.9,C33H35FN2O5,Proton Pump Inhibitor,Acid Reflux,1996,Atorvastatin Calcium,Prilosec,High Risk,Liver Metabolism,Completed,No Preclinical Data,Dopaminergic Pathway,Topical Gel,As prescribed,Novartis,24,High,Moderate Risk,High (>80%),Slow,Gut,Suitable
Metformin,Hypertension,Cardiovascular Disease,84.56,C9H8O4,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1994,Omeprazole,Prilosec,Moderate Risk,Slow Metabolism,Phase 1,No Preclinical Data,MAPK Pathway,Tablet,50mg daily,AstraZeneca,12,Low,Moderate Risk,High (>80%),Moderate,Renal,Not Suitable
Ibuprofen,Pain Relief,Autoimmune Disorders,44.94,C13H18O2,AMPK Activator,Gastrointestinal Issues,1996,Acetylsalicylic Acid,Glucophage,Moderate Risk,Liver Metabolism,Phase 1,Toxicology Report,PI3K-AKT Pathway,Syrup,10mg once daily,Merck,48,Low,Low Risk,High (>80%),Slow,Renal,Partially Suitable
Atorvastatin,Hypertension,Autoimmune Disorders,61.43,C13H18O2,COX Inhibitor,Acid Reflux,1996,Metformin Hydrochloride,Lipitor,High Risk,Liver Metabolism,Phase 2,No Preclinical Data,Immune Response Pathway,Injection,250mg every 8 hours,Merck,6,High,Moderate Risk,High (>80%),Fast,Gut,Not Suitable
Omeprazole,Thyroid Hormone Replacement,Cardiovascular Disease,60.94,C13H18O2,NSAID,Acid Reflux,1994,Metformin Hydrochloride,Prilosec,High Risk,High Bioavailability,Phase 2,Animal Testing,PI3K-AKT Pathway,Syrup,250mg every 8 hours,Merck,6,Moderate,High Risk,Low (<50%),Slow,Enzyme-Specific,Partially Suitable
Losartan,Inflammation,Migraine Treatment,43.32,C9H8O4,Proton Pump Inhibitor,"Headache, Rash",1987,Ibuprofen,Aspirin,Moderate Risk,Renal Excretion,Phase 1,Toxicology Report,Immune Response Pathway,Capsule,50mg daily,Merck,24,High,Moderate Risk,Low (<50%),Fast,Renal,Partially Suitable
Paracetamol,Diabetes,Cancer Therapy,35.82,C9H8O4,COX Inhibitor,Gastrointestinal Issues,1965,Metformin Hydrochloride,Advil,Moderate Risk,Rapid Absorption,Phase 3,Animal Testing,Serotonin Pathway,Injection,10mg once daily,Pfizer,6,High,Moderate Risk,Low (<50%),Fast,Liver,Not Suitable
Ranitidine,Pain Relief,Weight Loss,90.51,C4H11N5,COX Inhibitor,Acid Reflux,1987,Metformin Hydrochloride,Prilosec,High Risk,Liver Metabolism,Ongoing,In Vitro Studies,Immune Response Pathway,Injection,500mg twice a day,AstraZeneca,2,High,Moderate Risk,Moderate (50-80%),Fast,Enzyme-Specific,Not Suitable
Simvastatin,Blood Thinner,Antiviral,79.33,C9H8O4,Proton Pump Inhibitor,Acid Reflux,1971,Ibuprofen,Aspirin,High Risk,Renal Excretion,Phase 3,In Vitro Studies,Serotonin Pathway,Capsule,50mg daily,Roche,2,Moderate,Moderate Risk,Low (<50%),Moderate,Liver,Partially Suitable
Levothyroxine,Thyroid Hormone Replacement,Antiviral,65.55,C17H19N3O3S,COX Inhibitor,Muscle Pain,1987,Metformin Hydrochloride,Prilosec,High Risk,Rapid Absorption,Completed,Toxicology Report,Serotonin Pathway,Syrup,250mg every 8 hours,Roche,48,Low,High Risk,Low (<50%),Slow,Renal,Partially Suitable
Aspirin,Hypertension,Weight Loss,34.55,C33H35FN2O5,COX Inhibitor,"Headache, Rash",1994,Acetylsalicylic Acid,Prilosec,Moderate Risk,Rapid Absorption,Phase 4,Toxicology Report,PI3K-AKT Pathway,Capsule,10mg once daily,Pfizer,24,High,Low Risk,High (>80%),Moderate,Renal,Not Suitable
Metformin,Diabetes,Antiviral,39.1,C13H18O2,AMPK Activator,Gastrointestinal Issues,1965,Omeprazole,Advil,High Risk,Slow Metabolism,Phase 4,Animal Testing,PI3K-AKT Pathway,Syrup,50mg daily,Roche,48,Low,Moderate Risk,High (>80%),Fast,Renal,Partially Suitable
Ibuprofen,Blood Thinner,Liver Disease,44.4,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1971,Metformin Hydrochloride,Advil,Low Risk,High Bioavailability,Completed,In Vitro Studies,MAPK Pathway,Tablet,250mg every 8 hours,AstraZeneca,2,Low,Low Risk,Moderate (50-80%),Moderate,Renal,Not Suitable
Atorvastatin,Hypertension,Migraine Treatment,92.41,C33H35FN2O5,COX Inhibitor,"Nausea, Dizziness",1971,Ibuprofen,Glucophage,Low Risk,Slow Metabolism,Phase 1,In Vitro Studies,Serotonin Pathway,Syrup,500mg twice a day,AstraZeneca,12,Moderate,Low Risk,Moderate (50-80%),Moderate,Renal,Partially Suitable
Omeprazole,Thyroid Hormone Replacement,Antiviral,91.88,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1996,Atorvastatin Calcium,Advil,Low Risk,Slow Metabolism,Ongoing,Toxicology Report,Dopaminergic Pathway,Injection,As prescribed,AstraZeneca,48,High,Low Risk,Low (<50%),Fast,Renal,Suitable
Losartan,Inflammation,Antiviral,63.67,C13H18O2,COX Inhibitor,"Nausea, Dizziness",1987,Acetylsalicylic Acid,Advil,Moderate Risk,Liver Metabolism,Phase 2,No Preclinical Data,Dopaminergic Pathway,Tablet,50mg daily,Novartis,48,Low,Moderate Risk,High (>80%),Fast,Liver,Partially Suitable
Paracetamol,Blood Thinner,Parkinson's,75.36,C4H11N5,COX Inhibitor,"Nausea, Dizziness",1965,Acetylsalicylic Acid,Lipitor,Low Risk,Rapid Absorption,Phase 4,Toxicology Report,PI3K-AKT Pathway,Tablet,250mg every 8 hours,AstraZeneca,24,Moderate,Moderate Risk,Moderate (50-80%),Fast,Enzyme-Specific,Partially Suitable
Ranitidine,Gastric Ulcer,Cardiovascular Disease,41.62,C9H8O4,Proton Pump Inhibitor,Muscle Pain,1994,Acetylsalicylic Acid,Aspirin,High Risk,High Bioavailability,Phase 3,No Preclinical Data,Serotonin Pathway,Topical Gel,500mg twice a day,Merck,12,Moderate,High Risk,Low (<50%),Moderate,Liver,Not Suitable
Simvastatin,Cholesterol Control,Cardiovascular Disease,45.4,C13H18O2,HMG-CoA Reductase Inhibitor,Muscle Pain,1987,Atorvastatin Calcium,Lipitor,Moderate Risk,Liver Metabolism,Phase 3,In Vitro Studies,MAPK Pathway,Syrup,500mg twice a day,AstraZeneca,2,Low,Low Risk,Low (<50%),Fast,Enzyme-Specific,Not Suitable
Levothyroxine,Thyroid Hormone Replacement,Liver Disease,77.16,C13H18O2,NSAID,Muscle Pain,1971,Acetylsalicylic Acid,Advil,High Risk,Slow Metabolism,Phase 2,In Vitro Studies,PI3K-AKT Pathway,Capsule,As prescribed,AstraZeneca,48,High,Low Risk,Low (<50%),Moderate,Liver,Partially Suitable
Aspirin,Blood Thinner,Cardiovascular Disease,91.39,C4H11N5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1987,Omeprazole,Aspirin,Moderate Risk,Rapid Absorption,Phase 4,No Preclinical Data,MAPK Pathway,Tablet,10mg once daily,Roche,6,High,High Risk,Low (<50%),Fast,Gut,Partially Suitable
Metformin,Fever,Weight Loss,67.89,C33H35FN2O5,COX Inhibitor,Acid Reflux,1994,Acetylsalicylic Acid,Prilosec,High Risk,Rapid Absorption,Ongoing,Toxicology Report,Dopaminergic Pathway,Topical Gel,10mg once daily,Merck,2,High,Moderate Risk,Low (<50%),Moderate,Renal,Not Suitable
Ibuprofen,Acid Reflux,Anti-Aging,68.91,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1996,Ibuprofen,Glucophage,High Risk,Liver Metabolism,Phase 3,No Preclinical Data,MAPK Pathway,Capsule,250mg every 8 hours,Novartis,48,Moderate,Low Risk,Moderate (50-80%),Moderate,Renal,Suitable
Atorvastatin,Gastric Ulcer,Parkinson's,76.84,C9H8O4,AMPK Activator,Acid Reflux,1971,Ibuprofen,Advil,Moderate Risk,Slow Metabolism,Phase 4,In Vitro Studies,MAPK Pathway,Capsule,As prescribed,AstraZeneca,2,Low,Moderate Risk,Low (<50%),Fast,Renal,Partially Suitable
Omeprazole,Gastric Ulcer,Liver Disease,91.19,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1965,Ibuprofen,Aspirin,Low Risk,Slow Metabolism,Phase 2,In Vitro Studies,Serotonin Pathway,Syrup,As prescribed,AstraZeneca,12,High,Low Risk,Moderate (50-80%),Slow,Gut,Partially Suitable
Losartan,Pain Relief,Weight Loss,84.82,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Muscle Pain,1971,Omeprazole,Lipitor,High Risk,Rapid Absorption,Phase 4,Animal Testing,Dopaminergic Pathway,Topical Gel,500mg twice a day,Merck,24,Moderate,Moderate Risk,Moderate (50-80%),Slow,Enzyme-Specific,Suitable
Paracetamol,Gastric Ulcer,Weight Loss,60.01,C33H35FN2O5,NSAID,"Headache, Rash",1965,Atorvastatin Calcium,Glucophage,High Risk,Rapid Absorption,Phase 3,Animal Testing,Dopaminergic Pathway,Syrup,50mg daily,Novartis,48,High,Moderate Risk,Moderate (50-80%),Fast,Renal,Partially Suitable
Ranitidine,Gastric Ulcer,Parkinson's,34.26,C9H8O4,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1987,Ibuprofen,Aspirin,High Risk,Renal Excretion,Ongoing,Toxicology Report,PI3K-AKT Pathway,Topical Gel,500mg twice a day,Roche,24,Moderate,Moderate Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Simvastatin,Diabetes,Liver Disease,80.6,C9H8O4,NSAID,"Nausea, Dizziness",1996,Ibuprofen,Aspirin,Moderate Risk,High Bioavailability,Phase 2,Animal Testing,PI3K-AKT Pathway,Injection,10mg once daily,Novartis,48,Low,Low Risk,Moderate (50-80%),Slow,Enzyme-Specific,Partially Suitable
Levothyroxine,Cholesterol Control,Cancer Therapy,56.39,C17H19N3O3S,Proton Pump Inhibitor,"Headache, Rash",1987,Ibuprofen,Lipitor,High Risk,Rapid Absorption,Phase 3,Toxicology Report,Serotonin Pathway,Capsule,500mg twice a day,Merck,12,High,Low Risk,Low (<50%),Moderate,Liver,Partially Suitable
Aspirin,Acid Reflux,Cardiovascular Disease,70.46,C4H11N5,AMPK Activator,Gastrointestinal Issues,1994,Atorvastatin Calcium,Prilosec,Low Risk,Rapid Absorption,Completed,Animal Testing,Dopaminergic Pathway,Topical Gel,500mg twice a day,Roche,6,Low,Moderate Risk,High (>80%),Moderate,Renal,Not Suitable
Metformin,Thyroid Hormone Replacement,Antiviral,77.63,C33H35FN2O5,AMPK Activator,Acid Reflux,1987,Ibuprofen,Aspirin,Low Risk,Liver Metabolism,Phase 2,No Preclinical Data,Immune Response Pathway,Topical Gel,500mg twice a day,Pfizer,12,Low,Moderate Risk,High (>80%),Slow,Renal,Not Suitable
Ibuprofen,Cholesterol Control,Liver Disease,75.15,C9H8O4,AMPK Activator,"Nausea, Dizziness",1965,Metformin Hydrochloride,Advil,Low Risk,Slow Metabolism,Phase 1,Toxicology Report,Serotonin Pathway,Tablet,500mg twice a day,Pfizer,48,Low,Low Risk,Low (<50%),Slow,Renal,Suitable
Atorvastatin,Acid Reflux,Cardiovascular Disease,43.02,C13H18O2,COX Inhibitor,Acid Reflux,1965,Acetylsalicylic Acid,Advil,Moderate Risk,Rapid Absorption,Phase 4,No Preclinical Data,Immune Response Pathway,Topical Gel,As prescribed,Roche,2,Moderate,Moderate Risk,High (>80%),Fast,Enzyme-Specific,Not Suitable
Omeprazole,Acid Reflux,Autoimmune Disorders,39.06,C9H8O4,NSAID,Gastrointestinal Issues,1996,Metformin Hydrochloride,Prilosec,Low Risk,Liver Metabolism,Phase 1,Animal Testing,Immune Response Pathway,Topical Gel,50mg daily,Novartis,48,Moderate,Low Risk,High (>80%),Slow,Renal,Partially Suitable
Losartan,Gastric Ulcer,Parkinson's,69.09,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1965,Ibuprofen,Advil,Moderate Risk,Renal Excretion,Phase 2,Toxicology Report,PI3K-AKT Pathway,Tablet,500mg twice a day,Merck,6,Low,High Risk,High (>80%),Moderate,Enzyme-Specific,Suitable
Paracetamol,Hypertension,Cardiovascular Disease,79.49,C13H18O2,NSAID,"Headache, Rash",1971,Atorvastatin Calcium,Advil,Moderate Risk,Rapid Absorption,Phase 1,In Vitro Studies,Dopaminergic Pathway,Topical Gel,As prescribed,Novartis,12,Moderate,Low Risk,Moderate (50-80%),Fast,Renal,Partially Suitable
Ranitidine,Diabetes,Liver Disease,65.27,C13H18O2,AMPK Activator,Acid Reflux,1987,Ibuprofen,Advil,Low Risk,Rapid Absorption,Phase 4,Animal Testing,MAPK Pathway,Syrup,10mg once daily,Merck,6,High,High Risk,High (>80%),Slow,Liver,Not Suitable
Simvastatin,Diabetes,Autoimmune Disorders,47.8,C13H18O2,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1987,Atorvastatin Calcium,Lipitor,High Risk,Renal Excretion,Completed,Toxicology Report,Immune Response Pathway,Injection,500mg twice a day,Pfizer,6,Low,Low Risk,Low (<50%),Fast,Liver,Not Suitable
Levothyroxine,Gastric Ulcer,Cancer Therapy,48.01,C33H35FN2O5,AMPK Activator,"Headache, Rash",1965,Omeprazole,Prilosec,Moderate Risk,Rapid Absorption,Phase 1,No Preclinical Data,PI3K-AKT Pathway,Injection,250mg every 8 hours,Pfizer,6,Moderate,Moderate Risk,Moderate (50-80%),Moderate,Liver,Partially Suitable
Aspirin,Inflammation,Parkinson's,57.37,C9H8O4,NSAID,"Nausea, Dizziness",1965,Acetylsalicylic Acid,Lipitor,High Risk,Rapid Absorption,Phase 2,No Preclinical Data,Dopaminergic Pathway,Capsule,500mg twice a day,Novartis,6,High,Moderate Risk,High (>80%),Fast,Enzyme-Specific,Not Suitable
Metformin,Thyroid Hormone Replacement,Alzheimer's,59.42,C4H11N5,COX Inhibitor,Muscle Pain,1994,Acetylsalicylic Acid,Glucophage,Low Risk,Rapid Absorption,Phase 3,Toxicology Report,Dopaminergic Pathway,Tablet,500mg twice a day,Pfizer,6,Moderate,Moderate Risk,High (>80%),Fast,Liver,Partially Suitable
Ibuprofen,Gastric Ulcer,Migraine Treatment,92.82,C4H11N5,AMPK Activator,Acid Reflux,1994,Atorvastatin Calcium,Lipitor,High Risk,Rapid Absorption,Ongoing,Animal Testing,Dopaminergic Pathway,Syrup,500mg twice a day,Pfizer,6,Low,High Risk,Moderate (50-80%),Slow,Gut,Suitable
Atorvastatin,Blood Thinner,Alzheimer's,79.71,C33H35FN2O5,Proton Pump Inhibitor,Muscle Pain,1971,Atorvastatin Calcium,Lipitor,High Risk,Liver Metabolism,Phase 3,No Preclinical Data,Immune Response Pathway,Capsule,250mg every 8 hours,Pfizer,2,Low,Moderate Risk,Low (<50%),Fast,Liver,Suitable
Omeprazole,Thyroid Hormone Replacement,Liver Disease,91.8,C13H18O2,Proton Pump Inhibitor,Acid Reflux,1996,Atorvastatin Calcium,Aspirin,High Risk,Renal Excretion,Phase 2,In Vitro Studies,Dopaminergic Pathway,Capsule,500mg twice a day,Novartis,12,Moderate,High Risk,Low (<50%),Moderate,Enzyme-Specific,Not Suitable
Losartan,Cholesterol Control,Parkinson's,45.46,C13H18O2,COX Inhibitor,Gastrointestinal Issues,1971,Omeprazole,Lipitor,High Risk,Rapid Absorption,Phase 4,Toxicology Report,Serotonin Pathway,Topical Gel,250mg every 8 hours,Pfizer,48,Moderate,Moderate Risk,Low (<50%),Fast,Gut,Partially Suitable
Paracetamol,Thyroid Hormone Replacement,Parkinson's,91.84,C4H11N5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1994,Ibuprofen,Prilosec,High Risk,Renal Excretion,Phase 2,In Vitro Studies,PI3K-AKT Pathway,Topical Gel,50mg daily,Roche,48,Moderate,Moderate Risk,Low (<50%),Fast,Gut,Partially Suitable
Ranitidine,Inflammation,Antiviral,93.04,C17H19N3O3S,AMPK Activator,"Headache, Rash",1965,Acetylsalicylic Acid,Advil,Low Risk,High Bioavailability,Completed,In Vitro Studies,Dopaminergic Pathway,Tablet,250mg every 8 hours,Roche,6,Moderate,Low Risk,High (>80%),Moderate,Renal,Partially Suitable
Simvastatin,Blood Thinner,Parkinson's,41.92,C17H19N3O3S,COX Inhibitor,Gastrointestinal Issues,1996,Acetylsalicylic Acid,Prilosec,High Risk,Slow Metabolism,Phase 2,Animal Testing,Serotonin Pathway,Tablet,250mg every 8 hours,Pfizer,12,High,Moderate Risk,Low (<50%),Moderate,Liver,Suitable
Levothyroxine,Diabetes,Antiviral,69.41,C9H8O4,COX Inhibitor,"Nausea, Dizziness",1971,Atorvastatin Calcium,Lipitor,Moderate Risk,Slow Metabolism,Phase 1,No Preclinical Data,MAPK Pathway,Syrup,10mg once daily,Novartis,24,Low,Moderate Risk,Moderate (50-80%),Slow,Enzyme-Specific,Suitable
Aspirin,Cholesterol Control,Parkinson's,80.71,C9H8O4,NSAID,Muscle Pain,1987,Omeprazole,Advil,Moderate Risk,Slow Metabolism,Phase 3,Toxicology Report,Dopaminergic Pathway,Capsule,250mg every 8 hours,Novartis,6,Low,Moderate Risk,Low (<50%),Slow,Liver,Partially Suitable
Metformin,Acid Reflux,Alzheimer's,71.93,C13H18O2,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1996,Ibuprofen,Prilosec,Low Risk,Slow Metabolism,Phase 2,No Preclinical Data,PI3K-AKT Pathway,Topical Gel,250mg every 8 hours,Novartis,12,High,Low Risk,Low (<50%),Moderate,Enzyme-Specific,Suitable
Ibuprofen,Diabetes,Liver Disease,56.17,C4H11N5,AMPK Activator,Muscle Pain,1971,Metformin Hydrochloride,Advil,High Risk,Slow Metabolism,Ongoing,In Vitro Studies,Serotonin Pathway,Tablet,250mg every 8 hours,Pfizer,2,High,High Risk,Moderate (50-80%),Fast,Enzyme-Specific,Suitable
Atorvastatin,Blood Thinner,Antiviral,38.82,C4H11N5,AMPK Activator,Acid Reflux,1965,Acetylsalicylic Acid,Prilosec,High Risk,Rapid Absorption,Phase 4,Animal Testing,Immune Response Pathway,Capsule,10mg once daily,Merck,12,Moderate,Moderate Risk,Low (<50%),Moderate,Gut,Partially Suitable
Omeprazole,Diabetes,Anti-Aging,36.09,C13H18O2,Proton Pump Inhibitor,Muscle Pain,1987,Ibuprofen,Aspirin,High Risk,Rapid Absorption,Phase 2,Toxicology Report,Serotonin Pathway,Capsule,As prescribed,AstraZeneca,2,Low,Low Risk,Low (<50%),Moderate,Liver,Not Suitable
Losartan,Diabetes,Cardiovascular Disease,43.62,C13H18O2,NSAID,Gastrointestinal Issues,1987,Omeprazole,Prilosec,Low Risk,High Bioavailability,Phase 2,Toxicology Report,Dopaminergic Pathway,Injection,500mg twice a day,Pfizer,24,Moderate,Low Risk,High (>80%),Moderate,Liver,Not Suitable
Paracetamol,Gastric Ulcer,Cardiovascular Disease,93.66,C4H11N5,COX Inhibitor,Gastrointestinal Issues,1996,Atorvastatin Calcium,Aspirin,Low Risk,Slow Metabolism,Completed,No Preclinical Data,Serotonin Pathway,Capsule,250mg every 8 hours,Merck,2,Low,High Risk,High (>80%),Fast,Enzyme-Specific,Suitable
Ranitidine,Hypertension,Cardiovascular Disease,37.92,C17H19N3O3S,AMPK Activator,Muscle Pain,1971,Atorvastatin Calcium,Advil,Low Risk,High Bioavailability,Phase 2,No Preclinical Data,Serotonin Pathway,Injection,As prescribed,Merck,2,Moderate,High Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Partially Suitable
Simvastatin,Gastric Ulcer,Autoimmune Disorders,57.98,C9H8O4,COX Inhibitor,"Headache, Rash",1987,Acetylsalicylic Acid,Glucophage,High Risk,High Bioavailability,Ongoing,Toxicology Report,MAPK Pathway,Syrup,10mg once daily,AstraZeneca,6,Low,Low Risk,High (>80%),Slow,Enzyme-Specific,Suitable
Levothyroxine,Inflammation,Weight Loss,34.54,C17H19N3O3S,HMG-CoA Reductase Inhibitor,"Headache, Rash",1965,Ibuprofen,Glucophage,Moderate Risk,Slow Metabolism,Phase 2,In Vitro Studies,PI3K-AKT Pathway,Injection,As prescribed,Pfizer,6,High,Low Risk,Low (<50%),Moderate,Renal,Not Suitable
Aspirin,Pain Relief,Alzheimer's,85.53,C33H35FN2O5,COX Inhibitor,"Headache, Rash",1971,Ibuprofen,Aspirin,Moderate Risk,Renal Excretion,Phase 4,Animal Testing,Immune Response Pathway,Injection,500mg twice a day,AstraZeneca,48,Moderate,Low Risk,High (>80%),Fast,Enzyme-Specific,Not Suitable
Metformin,Diabetes,Antiviral,46.84,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Muscle Pain,1965,Acetylsalicylic Acid,Glucophage,High Risk,Rapid Absorption,Completed,In Vitro Studies,Immune Response Pathway,Topical Gel,50mg daily,Merck,6,Moderate,Low Risk,Moderate (50-80%),Slow,Liver,Suitable
Ibuprofen,Thyroid Hormone Replacement,Cardiovascular Disease,56.98,C4H11N5,COX Inhibitor,Muscle Pain,1965,Atorvastatin Calcium,Lipitor,Low Risk,Rapid Absorption,Ongoing,No Preclinical Data,PI3K-AKT Pathway,Topical Gel,As prescribed,Merck,2,High,High Risk,Moderate (50-80%),Slow,Renal,Not Suitable
Atorvastatin,Hypertension,Cardiovascular Disease,74.63,C13H18O2,NSAID,Gastrointestinal Issues,1996,Metformin Hydrochloride,Aspirin,Moderate Risk,Slow Metabolism,Completed,In Vitro Studies,PI3K-AKT Pathway,Syrup,250mg every 8 hours,Merck,48,High,Moderate Risk,High (>80%),Moderate,Renal,Partially Suitable
Omeprazole,Inflammation,Cancer Therapy,53,C9H8O4,Proton Pump Inhibitor,Gastrointestinal Issues,1996,Omeprazole,Lipitor,Low Risk,Rapid Absorption,Ongoing,In Vitro Studies,PI3K-AKT Pathway,Syrup,10mg once daily,AstraZeneca,6,High,High Risk,Moderate (50-80%),Fast,Gut,Not Suitable
Losartan,Gastric Ulcer,Autoimmune Disorders,46.87,C13H18O2,COX Inhibitor,"Nausea, Dizziness",1996,Atorvastatin Calcium,Glucophage,Low Risk,Rapid Absorption,Completed,Animal Testing,Dopaminergic Pathway,Injection,500mg twice a day,AstraZeneca,48,Low,Moderate Risk,Low (<50%),Fast,Renal,Not Suitable
Paracetamol,Acid Reflux,Cardiovascular Disease,77.73,C33H35FN2O5,AMPK Activator,"Headache, Rash",1994,Omeprazole,Lipitor,High Risk,Rapid Absorption,Completed,Toxicology Report,MAPK Pathway,Syrup,As prescribed,Novartis,24,Low,High Risk,Moderate (50-80%),Fast,Enzyme-Specific,Partially Suitable
Ranitidine,Diabetes,Autoimmune Disorders,37.32,C13H18O2,AMPK Activator,Gastrointestinal Issues,1971,Ibuprofen,Glucophage,Moderate Risk,Rapid Absorption,Phase 1,No Preclinical Data,Dopaminergic Pathway,Topical Gel,250mg every 8 hours,AstraZeneca,6,High,Moderate Risk,High (>80%),Moderate,Renal,Not Suitable
Simvastatin,Blood Thinner,Anti-Aging,82.08,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1996,Acetylsalicylic Acid,Lipitor,High Risk,High Bioavailability,Phase 4,Animal Testing,MAPK Pathway,Tablet,250mg every 8 hours,Pfizer,12,Moderate,Moderate Risk,High (>80%),Moderate,Renal,Partially Suitable
Levothyroxine,Thyroid Hormone Replacement,Parkinson's,40.32,C9H8O4,NSAID,"Headache, Rash",1996,Acetylsalicylic Acid,Advil,Moderate Risk,High Bioavailability,Completed,In Vitro Studies,Dopaminergic Pathway,Syrup,50mg daily,Merck,6,Low,Low Risk,Low (<50%),Moderate,Liver,Suitable
Aspirin,Acid Reflux,Cancer Therapy,32.5,C4H11N5,COX Inhibitor,"Headache, Rash",1965,Metformin Hydrochloride,Glucophage,Moderate Risk,Rapid Absorption,Phase 1,Animal Testing,Serotonin Pathway,Syrup,10mg once daily,AstraZeneca,6,Moderate,Low Risk,High (>80%),Slow,Gut,Suitable
Metformin,Diabetes,Cardiovascular Disease,31.64,C9H8O4,Proton Pump Inhibitor,Muscle Pain,1987,Atorvastatin Calcium,Lipitor,High Risk,Renal Excretion,Phase 1,No Preclinical Data,Immune Response Pathway,Injection,As prescribed,Pfizer,48,High,Moderate Risk,Low (<50%),Fast,Gut,Suitable
Ibuprofen,Inflammation,Antiviral,63.13,C4H11N5,HMG-CoA Reductase Inhibitor,Acid Reflux,1965,Atorvastatin Calcium,Advil,High Risk,Renal Excretion,Phase 1,Toxicology Report,Serotonin Pathway,Capsule,250mg every 8 hours,Novartis,6,High,Moderate Risk,High (>80%),Fast,Liver,Suitable
Atorvastatin,Gastric Ulcer,Liver Disease,56.97,C9H8O4,AMPK Activator,Acid Reflux,1971,Omeprazole,Advil,Low Risk,Liver Metabolism,Phase 3,Toxicology Report,Serotonin Pathway,Topical Gel,500mg twice a day,Novartis,12,Low,Low Risk,High (>80%),Slow,Liver,Partially Suitable
Omeprazole,Blood Thinner,Liver Disease,90.55,C17H19N3O3S,NSAID,Muscle Pain,1965,Acetylsalicylic Acid,Aspirin,Moderate Risk,Liver Metabolism,Phase 1,Animal Testing,Serotonin Pathway,Injection,10mg once daily,Novartis,24,Low,Moderate Risk,High (>80%),Moderate,Renal,Not Suitable
Losartan,Diabetes,Migraine Treatment,57.19,C33H35FN2O5,NSAID,Gastrointestinal Issues,1971,Acetylsalicylic Acid,Advil,High Risk,High Bioavailability,Ongoing,Toxicology Report,Dopaminergic Pathway,Syrup,50mg daily,Pfizer,24,High,Moderate Risk,Low (<50%),Fast,Renal,Partially Suitable
Paracetamol,Cholesterol Control,Antiviral,37.94,C4H11N5,COX Inhibitor,"Headache, Rash",1996,Omeprazole,Glucophage,Low Risk,High Bioavailability,Phase 4,No Preclinical Data,MAPK Pathway,Capsule,500mg twice a day,Merck,12,Moderate,High Risk,Low (<50%),Fast,Liver,Suitable
Ranitidine,Hypertension,Antiviral,40.38,C33H35FN2O5,NSAID,"Nausea, Dizziness",1996,Ibuprofen,Lipitor,Low Risk,Slow Metabolism,Phase 1,Toxicology Report,Immune Response Pathway,Tablet,10mg once daily,Roche,6,Low,Low Risk,High (>80%),Moderate,Enzyme-Specific,Not Suitable
Simvastatin,Diabetes,Liver Disease,67,C33H35FN2O5,NSAID,Muscle Pain,1994,Ibuprofen,Glucophage,High Risk,Liver Metabolism,Completed,In Vitro Studies,Immune Response Pathway,Syrup,250mg every 8 hours,Roche,12,High,High Risk,High (>80%),Fast,Liver,Suitable
Levothyroxine,Thyroid Hormone Replacement,Anti-Aging,85.64,C13H18O2,COX Inhibitor,Acid Reflux,1994,Ibuprofen,Aspirin,High Risk,Rapid Absorption,Phase 1,Animal Testing,MAPK Pathway,Capsule,500mg twice a day,Merck,2,High,Moderate Risk,Low (<50%),Slow,Liver,Partially Suitable
Aspirin,Hypertension,Cardiovascular Disease,79.03,C17H19N3O3S,AMPK Activator,Muscle Pain,1994,Acetylsalicylic Acid,Prilosec,High Risk,Slow Metabolism,Ongoing,No Preclinical Data,Serotonin Pathway,Capsule,10mg once daily,Roche,48,Low,Moderate Risk,Low (<50%),Fast,Liver,Partially Suitable
Metformin,Acid Reflux,Anti-Aging,40.23,C4H11N5,HMG-CoA Reductase Inhibitor,Acid Reflux,1965,Atorvastatin Calcium,Aspirin,Moderate Risk,Liver Metabolism,Ongoing,Animal Testing,PI3K-AKT Pathway,Capsule,500mg twice a day,Roche,12,Moderate,Low Risk,High (>80%),Moderate,Gut,Suitable
Ibuprofen,Fever,Antiviral,80.58,C9H8O4,HMG-CoA Reductase Inhibitor,"Headache, Rash",1996,Atorvastatin Calcium,Advil,Low Risk,Rapid Absorption,Phase 2,In Vitro Studies,MAPK Pathway,Topical Gel,50mg daily,Pfizer,24,Moderate,High Risk,High (>80%),Moderate,Liver,Partially Suitable
Atorvastatin,Hypertension,Weight Loss,78.43,C13H18O2,AMPK Activator,"Nausea, Dizziness",1971,Metformin Hydrochloride,Advil,High Risk,Renal Excretion,Phase 4,Toxicology Report,Immune Response Pathway,Syrup,500mg twice a day,Novartis,12,Moderate,High Risk,Moderate (50-80%),Slow,Enzyme-Specific,Not Suitable
Omeprazole,Thyroid Hormone Replacement,Cancer Therapy,77.09,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1971,Acetylsalicylic Acid,Prilosec,Low Risk,High Bioavailability,Completed,In Vitro Studies,Dopaminergic Pathway,Tablet,50mg daily,Merck,2,Low,High Risk,Low (<50%),Fast,Gut,Partially Suitable
Losartan,Gastric Ulcer,Cardiovascular Disease,69.75,C17H19N3O3S,AMPK Activator,"Headache, Rash",1965,Acetylsalicylic Acid,Advil,Moderate Risk,Renal Excretion,Phase 1,Animal Testing,Serotonin Pathway,Topical Gel,50mg daily,Roche,2,Moderate,Low Risk,Low (<50%),Moderate,Enzyme-Specific,Suitable
Paracetamol,Diabetes,Anti-Aging,84.37,C4H11N5,AMPK Activator,"Nausea, Dizziness",1996,Metformin Hydrochloride,Aspirin,Moderate Risk,Slow Metabolism,Ongoing,In Vitro Studies,Serotonin Pathway,Injection,500mg twice a day,Novartis,2,Moderate,Moderate Risk,Moderate (50-80%),Fast,Liver,Suitable
Ranitidine,Hypertension,Alzheimer's,47.31,C4H11N5,COX Inhibitor,Acid Reflux,1965,Ibuprofen,Lipitor,High Risk,Rapid Absorption,Phase 1,Animal Testing,PI3K-AKT Pathway,Syrup,250mg every 8 hours,Roche,24,Low,Moderate Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Suitable
Simvastatin,Thyroid Hormone Replacement,Cardiovascular Disease,86.39,C17H19N3O3S,COX Inhibitor,Acid Reflux,1971,Omeprazole,Aspirin,High Risk,Rapid Absorption,Phase 3,Animal Testing,PI3K-AKT Pathway,Capsule,500mg twice a day,AstraZeneca,6,High,Moderate Risk,Moderate (50-80%),Slow,Renal,Not Suitable
Levothyroxine,Diabetes,Autoimmune Disorders,65.77,C33H35FN2O5,Proton Pump Inhibitor,Acid Reflux,1965,Atorvastatin Calcium,Advil,High Risk,Renal Excretion,Phase 1,No Preclinical Data,PI3K-AKT Pathway,Topical Gel,As prescribed,Roche,48,Low,High Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Partially Suitable
Aspirin,Blood Thinner,Migraine Treatment,45,C17H19N3O3S,AMPK Activator,Gastrointestinal Issues,1987,Acetylsalicylic Acid,Glucophage,Moderate Risk,Slow Metabolism,Phase 1,Animal Testing,MAPK Pathway,Tablet,As prescribed,Pfizer,12,Moderate,High Risk,High (>80%),Slow,Renal,Not Suitable
Metformin,Cholesterol Control,Migraine Treatment,58.4,C4H11N5,COX Inhibitor,"Nausea, Dizziness",1994,Acetylsalicylic Acid,Advil,Moderate Risk,Slow Metabolism,Phase 3,Animal Testing,PI3K-AKT Pathway,Topical Gel,As prescribed,Novartis,2,High,Low Risk,High (>80%),Moderate,Enzyme-Specific,Suitable
Ibuprofen,Fever,Autoimmune Disorders,36.13,C9H8O4,AMPK Activator,"Headache, Rash",1965,Metformin Hydrochloride,Glucophage,Moderate Risk,Renal Excretion,Phase 3,Toxicology Report,PI3K-AKT Pathway,Capsule,10mg once daily,AstraZeneca,24,Low,Moderate Risk,Low (<50%),Slow,Enzyme-Specific,Not Suitable
Atorvastatin,Blood Thinner,Cardiovascular Disease,80.14,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1996,Ibuprofen,Glucophage,Moderate Risk,High Bioavailability,Phase 4,Toxicology Report,Dopaminergic Pathway,Capsule,250mg every 8 hours,Roche,6,Moderate,Low Risk,High (>80%),Slow,Liver,Partially Suitable
Omeprazole,Inflammation,Anti-Aging,67.72,C33H35FN2O5,COX Inhibitor,"Headache, Rash",1965,Metformin Hydrochloride,Advil,Moderate Risk,High Bioavailability,Completed,Toxicology Report,Immune Response Pathway,Topical Gel,50mg daily,AstraZeneca,6,Moderate,Moderate Risk,High (>80%),Moderate,Gut,Not Suitable
Losartan,Hypertension,Migraine Treatment,41.97,C33H35FN2O5,AMPK Activator,"Nausea, Dizziness",1994,Acetylsalicylic Acid,Aspirin,Low Risk,High Bioavailability,Phase 1,In Vitro Studies,PI3K-AKT Pathway,Topical Gel,10mg once daily,Roche,2,High,High Risk,Moderate (50-80%),Slow,Liver,Partially Suitable
Paracetamol,Gastric Ulcer,Antiviral,84.57,C13H18O2,Proton Pump Inhibitor,Gastrointestinal Issues,1965,Atorvastatin Calcium,Prilosec,Low Risk,Slow Metabolism,Phase 1,Toxicology Report,PI3K-AKT Pathway,Topical Gel,50mg daily,Roche,2,Moderate,Moderate Risk,Moderate (50-80%),Fast,Liver,Partially Suitable
Ranitidine,Thyroid Hormone Replacement,Alzheimer's,72.55,C17H19N3O3S,COX Inhibitor,"Nausea, Dizziness",1996,Ibuprofen,Advil,Low Risk,Liver Metabolism,Phase 1,Toxicology Report,Immune Response Pathway,Topical Gel,As prescribed,AstraZeneca,2,Low,High Risk,Moderate (50-80%),Moderate,Liver,Partially Suitable
Simvastatin,Thyroid Hormone Replacement,Cancer Therapy,42.52,C17H19N3O3S,AMPK Activator,Acid Reflux,1965,Omeprazole,Prilosec,Low Risk,Liver Metabolism,Phase 3,No Preclinical Data,Serotonin Pathway,Tablet,250mg every 8 hours,Roche,6,High,Moderate Risk,Low (<50%),Slow,Liver,Partially Suitable
Levothyroxine,Thyroid Hormone Replacement,Alzheimer's,32.36,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1994,Atorvastatin Calcium,Lipitor,High Risk,Renal Excretion,Phase 3,Toxicology Report,Immune Response Pathway,Tablet,500mg twice a day,Roche,12,Moderate,Moderate Risk,High (>80%),Moderate,Enzyme-Specific,Partially Suitable
Aspirin,Gastric Ulcer,Alzheimer's,83.19,C13H18O2,Proton Pump Inhibitor,Muscle Pain,1987,Acetylsalicylic Acid,Aspirin,Low Risk,Slow Metabolism,Completed,No Preclinical Data,MAPK Pathway,Topical Gel,50mg daily,Pfizer,24,High,Low Risk,High (>80%),Fast,Liver,Suitable
Metformin,Gastric Ulcer,Weight Loss,81.69,C17H19N3O3S,Proton Pump Inhibitor,Gastrointestinal Issues,1996,Metformin Hydrochloride,Aspirin,High Risk,Rapid Absorption,Completed,In Vitro Studies,MAPK Pathway,Tablet,As prescribed,Novartis,12,Low,Moderate Risk,High (>80%),Moderate,Renal,Suitable
Ibuprofen,Fever,Cancer Therapy,42.96,C9H8O4,Proton Pump Inhibitor,Acid Reflux,1965,Ibuprofen,Aspirin,Moderate Risk,Slow Metabolism,Phase 4,No Preclinical Data,MAPK Pathway,Syrup,As prescribed,AstraZeneca,6,Low,Low Risk,High (>80%),Fast,Gut,Partially Suitable
Atorvastatin,Fever,Autoimmune Disorders,41.57,C9H8O4,COX Inhibitor,Muscle Pain,1971,Ibuprofen,Glucophage,Low Risk,Liver Metabolism,Phase 1,Toxicology Report,Serotonin Pathway,Syrup,250mg every 8 hours,Novartis,24,High,Moderate Risk,Low (<50%),Fast,Enzyme-Specific,Suitable
Omeprazole,Cholesterol Control,Anti-Aging,49.38,C17H19N3O3S,AMPK Activator,"Nausea, Dizziness",1996,Acetylsalicylic Acid,Lipitor,High Risk,Liver Metabolism,Phase 3,Toxicology Report,Dopaminergic Pathway,Topical Gel,10mg once daily,Roche,24,Moderate,Moderate Risk,High (>80%),Slow,Renal,Suitable
Losartan,Acid Reflux,Liver Disease,40.69,C4H11N5,NSAID,Gastrointestinal Issues,1994,Acetylsalicylic Acid,Aspirin,Low Risk,Slow Metabolism,Phase 3,Animal Testing,Immune Response Pathway,Syrup,10mg once daily,Pfizer,12,Moderate,Moderate Risk,Moderate (50-80%),Fast,Enzyme-Specific,Not Suitable
Paracetamol,Fever,Antiviral,51.68,C13H18O2,COX Inhibitor,Muscle Pain,1987,Ibuprofen,Prilosec,Low Risk,Liver Metabolism,Phase 4,Animal Testing,Dopaminergic Pathway,Injection,10mg once daily,Novartis,24,High,Moderate Risk,Low (<50%),Moderate,Renal,Not Suitable
Ranitidine,Cholesterol Control,Antiviral,88.98,C4H11N5,AMPK Activator,"Headache, Rash",1994,Acetylsalicylic Acid,Prilosec,High Risk,Liver Metabolism,Ongoing,Animal Testing,MAPK Pathway,Tablet,50mg daily,Pfizer,6,Moderate,Low Risk,High (>80%),Slow,Liver,Not Suitable
Simvastatin,Cholesterol Control,Alzheimer's,51.15,C4H11N5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1996,Acetylsalicylic Acid,Glucophage,Moderate Risk,Renal Excretion,Completed,No Preclinical Data,MAPK Pathway,Tablet,As prescribed,AstraZeneca,48,Low,Moderate Risk,Moderate (50-80%),Fast,Enzyme-Specific,Not Suitable
Levothyroxine,Inflammation,Anti-Aging,67.58,C13H18O2,NSAID,"Headache, Rash",1971,Ibuprofen,Prilosec,High Risk,Renal Excretion,Ongoing,In Vitro Studies,Immune Response Pathway,Tablet,250mg every 8 hours,Merck,6,High,Low Risk,High (>80%),Slow,Enzyme-Specific,Not Suitable
Aspirin,Thyroid Hormone Replacement,Liver Disease,71.83,C4H11N5,HMG-CoA Reductase Inhibitor,Muscle Pain,1996,Omeprazole,Glucophage,Low Risk,Slow Metabolism,Ongoing,In Vitro Studies,Immune Response Pathway,Tablet,As prescribed,Novartis,2,Low,Low Risk,Low (<50%),Moderate,Liver,Partially Suitable
Metformin,Diabetes,Weight Loss,76.92,C9H8O4,AMPK Activator,"Nausea, Dizziness",1971,Ibuprofen,Advil,High Risk,Renal Excretion,Phase 4,No Preclinical Data,Serotonin Pathway,Capsule,250mg every 8 hours,AstraZeneca,2,High,Moderate Risk,Low (<50%),Fast,Gut,Partially Suitable
Ibuprofen,Thyroid Hormone Replacement,Migraine Treatment,63.54,C9H8O4,NSAID,"Nausea, Dizziness",1965,Metformin Hydrochloride,Advil,Low Risk,Slow Metabolism,Phase 4,No Preclinical Data,Dopaminergic Pathway,Topical Gel,10mg once daily,Merck,2,High,Low Risk,Low (<50%),Fast,Liver,Not Suitable
Atorvastatin,Diabetes,Cardiovascular Disease,93.97,C9H8O4,COX Inhibitor,Acid Reflux,1994,Ibuprofen,Glucophage,Low Risk,Slow Metabolism,Phase 2,Animal Testing,Dopaminergic Pathway,Syrup,As prescribed,Novartis,2,High,Low Risk,High (>80%),Moderate,Liver,Partially Suitable
Omeprazole,Pain Relief,Anti-Aging,46.12,C33H35FN2O5,Proton Pump Inhibitor,Gastrointestinal Issues,1971,Acetylsalicylic Acid,Lipitor,High Risk,Liver Metabolism,Phase 2,Animal Testing,Immune Response Pathway,Tablet,10mg once daily,Merck,24,Low,Low Risk,Moderate (50-80%),Fast,Gut,Partially Suitable
Losartan,Blood Thinner,Cardiovascular Disease,30.72,C9H8O4,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1965,Acetylsalicylic Acid,Prilosec,Low Risk,Liver Metabolism,Phase 4,No Preclinical Data,PI3K-AKT Pathway,Topical Gel,500mg twice a day,AstraZeneca,6,High,Low Risk,Low (<50%),Slow,Renal,Partially Suitable
Paracetamol,Fever,Antiviral,30.8,C9H8O4,Proton Pump Inhibitor,Acid Reflux,1971,Omeprazole,Lipitor,High Risk,Slow Metabolism,Phase 4,In Vitro Studies,MAPK Pathway,Syrup,250mg every 8 hours,Pfizer,12,Moderate,High Risk,High (>80%),Slow,Liver,Not Suitable
Ranitidine,Pain Relief,Autoimmune Disorders,90.67,C33H35FN2O5,AMPK Activator,Muscle Pain,1987,Ibuprofen,Lipitor,Moderate Risk,Rapid Absorption,Phase 3,Toxicology Report,Serotonin Pathway,Topical Gel,10mg once daily,Merck,48,Moderate,Moderate Risk,Moderate (50-80%),Slow,Renal,Suitable
Simvastatin,Thyroid Hormone Replacement,Parkinson's,76.33,C13H18O2,HMG-CoA Reductase Inhibitor,Muscle Pain,1987,Ibuprofen,Advil,Moderate Risk,Renal Excretion,Phase 2,Toxicology Report,Dopaminergic Pathway,Topical Gel,250mg every 8 hours,AstraZeneca,6,Moderate,Moderate Risk,Moderate (50-80%),Slow,Enzyme-Specific,Suitable
Levothyroxine,Hypertension,Liver Disease,32.49,C13H18O2,NSAID,Gastrointestinal Issues,1971,Atorvastatin Calcium,Aspirin,Low Risk,Rapid Absorption,Phase 2,Animal Testing,Immune Response Pathway,Topical Gel,250mg every 8 hours,AstraZeneca,6,Low,High Risk,High (>80%),Slow,Gut,Not Suitable
Aspirin,Gastric Ulcer,Anti-Aging,50.89,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1987,Acetylsalicylic Acid,Aspirin,Moderate Risk,Slow Metabolism,Phase 4,No Preclinical Data,MAPK Pathway,Tablet,As prescribed,Merck,6,Low,Moderate Risk,Low (<50%),Moderate,Gut,Suitable
Metformin,Gastric Ulcer,Cancer Therapy,67.09,C17H19N3O3S,COX Inhibitor,Gastrointestinal Issues,1971,Omeprazole,Aspirin,High Risk,Liver Metabolism,Phase 3,Animal Testing,MAPK Pathway,Capsule,250mg every 8 hours,Pfizer,6,High,Low Risk,Low (<50%),Slow,Enzyme-Specific,Partially Suitable
Ibuprofen,Thyroid Hormone Replacement,Weight Loss,57.82,C9H8O4,Proton Pump Inhibitor,Acid Reflux,1965,Acetylsalicylic Acid,Prilosec,High Risk,Rapid Absorption,Phase 1,No Preclinical Data,Dopaminergic Pathway,Tablet,250mg every 8 hours,Merck,12,High,High Risk,Moderate (50-80%),Fast,Renal,Not Suitable
Atorvastatin,Cholesterol Control,Migraine Treatment,41.45,C17H19N3O3S,NSAID,Gastrointestinal Issues,1996,Ibuprofen,Advil,Low Risk,Rapid Absorption,Completed,In Vitro Studies,Immune Response Pathway,Capsule,500mg twice a day,Merck,2,Moderate,High Risk,Moderate (50-80%),Slow,Gut,Not Suitable
Omeprazole,Thyroid Hormone Replacement,Liver Disease,87.53,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Acid Reflux,1965,Omeprazole,Prilosec,Moderate Risk,Liver Metabolism,Phase 3,In Vitro Studies,Dopaminergic Pathway,Injection,50mg daily,Roche,24,Low,High Risk,Low (<50%),Moderate,Gut,Partially Suitable
Losartan,Diabetes,Liver Disease,63.95,C17H19N3O3S,HMG-CoA Reductase Inhibitor,"Headache, Rash",1987,Acetylsalicylic Acid,Aspirin,Moderate Risk,Slow Metabolism,Phase 1,Toxicology Report,Immune Response Pathway,Capsule,250mg every 8 hours,Merck,2,High,Low Risk,Moderate (50-80%),Slow,Renal,Not Suitable
Paracetamol,Fever,Anti-Aging,52.48,C17H19N3O3S,NSAID,Gastrointestinal Issues,1996,Atorvastatin Calcium,Lipitor,High Risk,Liver Metabolism,Phase 3,Toxicology Report,MAPK Pathway,Tablet,10mg once daily,Novartis,6,Moderate,Low Risk,High (>80%),Fast,Enzyme-Specific,Not Suitable
Ranitidine,Cholesterol Control,Liver Disease,76.92,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1996,Atorvastatin Calcium,Advil,High Risk,Liver Metabolism,Phase 3,Toxicology Report,PI3K-AKT Pathway,Syrup,50mg daily,Merck,48,High,High Risk,Low (<50%),Fast,Gut,Suitable
Simvastatin,Hypertension,Migraine Treatment,87.1,C33H35FN2O5,NSAID,Acid Reflux,1987,Omeprazole,Lipitor,Moderate Risk,Slow Metabolism,Phase 1,Toxicology Report,Serotonin Pathway,Topical Gel,As prescribed,Merck,6,Low,High Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Levothyroxine,Hypertension,Cancer Therapy,33.28,C4H11N5,COX Inhibitor,Gastrointestinal Issues,1994,Atorvastatin Calcium,Glucophage,High Risk,Rapid Absorption,Ongoing,Animal Testing,Dopaminergic Pathway,Capsule,As prescribed,AstraZeneca,2,Low,High Risk,Moderate (50-80%),Moderate,Renal,Suitable
Aspirin,Blood Thinner,Parkinson's,44.14,C4H11N5,COX Inhibitor,"Headache, Rash",1994,Acetylsalicylic Acid,Aspirin,High Risk,Renal Excretion,Phase 2,Animal Testing,PI3K-AKT Pathway,Capsule,500mg twice a day,Merck,12,Moderate,Low Risk,Moderate (50-80%),Fast,Enzyme-Specific,Not Suitable
Metformin,Acid Reflux,Alzheimer's,64.8,C13H18O2,Proton Pump Inhibitor,Muscle Pain,1994,Metformin Hydrochloride,Lipitor,Low Risk,Renal Excretion,Phase 2,No Preclinical Data,Dopaminergic Pathway,Capsule,As prescribed,Merck,12,Moderate,High Risk,Low (<50%),Slow,Liver,Suitable
Ibuprofen,Pain Relief,Autoimmune Disorders,83.5,C17H19N3O3S,COX Inhibitor,"Nausea, Dizziness",1987,Ibuprofen,Glucophage,Low Risk,Slow Metabolism,Ongoing,Animal Testing,Immune Response Pathway,Injection,As prescribed,Roche,12,Moderate,High Risk,High (>80%),Slow,Liver,Partially Suitable
Atorvastatin,Diabetes,Migraine Treatment,66.21,C9H8O4,AMPK Activator,"Nausea, Dizziness",1965,Metformin Hydrochloride,Aspirin,High Risk,Rapid Absorption,Phase 2,Toxicology Report,Serotonin Pathway,Injection,500mg twice a day,Pfizer,12,High,Moderate Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Partially Suitable
Omeprazole,Diabetes,Cancer Therapy,83.41,C9H8O4,COX Inhibitor,Acid Reflux,1994,Ibuprofen,Prilosec,Moderate Risk,Renal Excretion,Ongoing,In Vitro Studies,Serotonin Pathway,Topical Gel,10mg once daily,Novartis,24,High,High Risk,Moderate (50-80%),Slow,Enzyme-Specific,Not Suitable
Losartan,Fever,Alzheimer's,46.41,C33H35FN2O5,Proton Pump Inhibitor,"Headache, Rash",1971,Omeprazole,Lipitor,Moderate Risk,Renal Excretion,Phase 2,Animal Testing,Serotonin Pathway,Syrup,As prescribed,Pfizer,24,Low,Moderate Risk,High (>80%),Slow,Gut,Partially Suitable
Paracetamol,Inflammation,Anti-Aging,52.33,C4H11N5,NSAID,Acid Reflux,1965,Atorvastatin Calcium,Lipitor,High Risk,Liver Metabolism,Ongoing,No Preclinical Data,PI3K-AKT Pathway,Topical Gel,250mg every 8 hours,Merck,2,High,Moderate Risk,High (>80%),Fast,Gut,Suitable
Ranitidine,Hypertension,Parkinson's,84.39,C17H19N3O3S,AMPK Activator,Gastrointestinal Issues,1994,Omeprazole,Prilosec,Low Risk,Slow Metabolism,Ongoing,Toxicology Report,PI3K-AKT Pathway,Injection,As prescribed,Roche,48,High,Moderate Risk,Low (<50%),Fast,Enzyme-Specific,Not Suitable
Simvastatin,Pain Relief,Migraine Treatment,57.81,C9H8O4,NSAID,"Nausea, Dizziness",1971,Ibuprofen,Advil,High Risk,Liver Metabolism,Phase 3,Toxicology Report,Serotonin Pathway,Tablet,250mg every 8 hours,AstraZeneca,6,High,High Risk,High (>80%),Moderate,Liver,Suitable
Levothyroxine,Diabetes,Liver Disease,87.49,C33H35FN2O5,AMPK Activator,Gastrointestinal Issues,1996,Omeprazole,Advil,High Risk,Liver Metabolism,Phase 3,Toxicology Report,MAPK Pathway,Topical Gel,10mg once daily,Roche,12,Low,Low Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Not Suitable
Aspirin,Acid Reflux,Weight Loss,87,C4H11N5,HMG-CoA Reductase Inhibitor,Acid Reflux,1965,Ibuprofen,Prilosec,Moderate Risk,Slow Metabolism,Completed,Toxicology Report,Dopaminergic Pathway,Syrup,10mg once daily,Novartis,24,High,High Risk,Moderate (50-80%),Slow,Gut,Partially Suitable
Metformin,Fever,Alzheimer's,40.64,C4H11N5,Proton Pump Inhibitor,"Nausea, Dizziness",1994,Atorvastatin Calcium,Glucophage,Low Risk,Renal Excretion,Phase 3,In Vitro Studies,Immune Response Pathway,Capsule,50mg daily,Roche,2,Moderate,Low Risk,High (>80%),Slow,Gut,Partially Suitable
Ibuprofen,Thyroid Hormone Replacement,Weight Loss,57.31,C4H11N5,HMG-CoA Reductase Inhibitor,Acid Reflux,1996,Metformin Hydrochloride,Prilosec,Low Risk,Renal Excretion,Phase 3,Toxicology Report,Dopaminergic Pathway,Topical Gel,50mg daily,Roche,24,Moderate,Low Risk,Low (<50%),Moderate,Renal,Not Suitable
Atorvastatin,Gastric Ulcer,Weight Loss,53.35,C4H11N5,Proton Pump Inhibitor,Gastrointestinal Issues,1965,Acetylsalicylic Acid,Lipitor,Low Risk,High Bioavailability,Phase 3,In Vitro Studies,Serotonin Pathway,Tablet,250mg every 8 hours,Novartis,12,High,High Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Omeprazole,Inflammation,Cancer Therapy,58.33,C9H8O4,AMPK Activator,Muscle Pain,1987,Acetylsalicylic Acid,Prilosec,Low Risk,Renal Excretion,Phase 2,Animal Testing,MAPK Pathway,Syrup,10mg once daily,Pfizer,12,Low,Moderate Risk,High (>80%),Moderate,Enzyme-Specific,Partially Suitable
Losartan,Blood Thinner,Anti-Aging,83.54,C13H18O2,NSAID,Acid Reflux,1996,Metformin Hydrochloride,Advil,Low Risk,Slow Metabolism,Phase 3,Toxicology Report,Dopaminergic Pathway,Syrup,As prescribed,Merck,24,Low,High Risk,Moderate (50-80%),Fast,Renal,Suitable
Paracetamol,Acid Reflux,Parkinson's,75.69,C4H11N5,Proton Pump Inhibitor,Muscle Pain,1994,Metformin Hydrochloride,Glucophage,High Risk,Liver Metabolism,Phase 3,Toxicology Report,PI3K-AKT Pathway,Injection,As prescribed,Roche,24,Moderate,Moderate Risk,High (>80%),Slow,Gut,Not Suitable
Ranitidine,Cholesterol Control,Migraine Treatment,82.44,C17H19N3O3S,NSAID,"Nausea, Dizziness",1994,Metformin Hydrochloride,Glucophage,High Risk,Renal Excretion,Completed,Animal Testing,Immune Response Pathway,Syrup,500mg twice a day,Novartis,24,Low,Moderate Risk,High (>80%),Fast,Enzyme-Specific,Partially Suitable
Simvastatin,Acid Reflux,Liver Disease,90.82,C13H18O2,COX Inhibitor,Gastrointestinal Issues,1996,Metformin Hydrochloride,Prilosec,High Risk,Rapid Absorption,Phase 2,Toxicology Report,Immune Response Pathway,Syrup,500mg twice a day,Novartis,6,Moderate,Moderate Risk,Moderate (50-80%),Slow,Enzyme-Specific,Partially Suitable
Levothyroxine,Blood Thinner,Liver Disease,80.72,C17H19N3O3S,COX Inhibitor,Acid Reflux,1996,Acetylsalicylic Acid,Advil,Moderate Risk,Rapid Absorption,Ongoing,Toxicology Report,Immune Response Pathway,Capsule,As prescribed,Merck,6,Moderate,Low Risk,Moderate (50-80%),Slow,Renal,Partially Suitable
Aspirin,Thyroid Hormone Replacement,Autoimmune Disorders,65.49,C4H11N5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1965,Ibuprofen,Glucophage,High Risk,Liver Metabolism,Phase 1,Animal Testing,PI3K-AKT Pathway,Tablet,10mg once daily,Roche,48,Low,High Risk,Low (<50%),Slow,Enzyme-Specific,Not Suitable
Metformin,Inflammation,Anti-Aging,93.19,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1965,Metformin Hydrochloride,Glucophage,Low Risk,Slow Metabolism,Completed,Toxicology Report,Immune Response Pathway,Injection,As prescribed,Merck,12,Low,High Risk,High (>80%),Moderate,Liver,Partially Suitable
Ibuprofen,Fever,Alzheimer's,61,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1965,Acetylsalicylic Acid,Aspirin,Moderate Risk,High Bioavailability,Phase 1,No Preclinical Data,Dopaminergic Pathway,Capsule,250mg every 8 hours,Novartis,2,Moderate,Moderate Risk,Moderate (50-80%),Slow,Liver,Not Suitable
Atorvastatin,Thyroid Hormone Replacement,Liver Disease,83.36,C4H11N5,Proton Pump Inhibitor,"Nausea, Dizziness",1965,Omeprazole,Aspirin,Low Risk,High Bioavailability,Completed,In Vitro Studies,Dopaminergic Pathway,Injection,As prescribed,Novartis,12,High,Low Risk,Low (<50%),Fast,Liver,Not Suitable
Omeprazole,Fever,Alzheimer's,94.72,C33H35FN2O5,AMPK Activator,"Headache, Rash",1987,Ibuprofen,Glucophage,High Risk,Slow Metabolism,Ongoing,In Vitro Studies,Dopaminergic Pathway,Topical Gel,250mg every 8 hours,Roche,24,Low,Moderate Risk,High (>80%),Fast,Gut,Not Suitable
Losartan,Blood Thinner,Weight Loss,52.43,C33H35FN2O5,NSAID,"Nausea, Dizziness",1987,Atorvastatin Calcium,Glucophage,High Risk,Renal Excretion,Phase 4,No Preclinical Data,Immune Response Pathway,Injection,50mg daily,Novartis,12,Low,Moderate Risk,Moderate (50-80%),Moderate,Renal,Partially Suitable
Paracetamol,Pain Relief,Migraine Treatment,67.57,C33H35FN2O5,COX Inhibitor,"Headache, Rash",1996,Acetylsalicylic Acid,Lipitor,High Risk,Slow Metabolism,Phase 4,Toxicology Report,Immune Response Pathway,Tablet,250mg every 8 hours,Merck,24,Moderate,Moderate Risk,High (>80%),Fast,Renal,Suitable
Ranitidine,Hypertension,Antiviral,36.1,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Muscle Pain,1971,Acetylsalicylic Acid,Lipitor,High Risk,High Bioavailability,Ongoing,Animal Testing,Immune Response Pathway,Capsule,10mg once daily,Merck,2,Low,High Risk,Low (<50%),Moderate,Liver,Suitable
Simvastatin,Acid Reflux,Autoimmune Disorders,44.68,C9H8O4,HMG-CoA Reductase Inhibitor,"Headache, Rash",1965,Metformin Hydrochloride,Advil,Moderate Risk,High Bioavailability,Ongoing,Animal Testing,Immune Response Pathway,Injection,500mg twice a day,AstraZeneca,24,Low,Low Risk,Moderate (50-80%),Slow,Liver,Partially Suitable
Levothyroxine,Inflammation,Alzheimer's,91.91,C9H8O4,NSAID,Muscle Pain,1987,Atorvastatin Calcium,Prilosec,Moderate Risk,Slow Metabolism,Phase 3,In Vitro Studies,Immune Response Pathway,Syrup,10mg once daily,Pfizer,24,High,High Risk,Moderate (50-80%),Fast,Enzyme-Specific,Not Suitable
Aspirin,Hypertension,Liver Disease,87.45,C4H11N5,NSAID,"Headache, Rash",1965,Ibuprofen,Lipitor,Moderate Risk,Rapid Absorption,Phase 4,Animal Testing,Serotonin Pathway,Topical Gel,500mg twice a day,Pfizer,24,Low,Moderate Risk,Moderate (50-80%),Slow,Gut,Partially Suitable
Metformin,Blood Thinner,Anti-Aging,60.95,C9H8O4,Proton Pump Inhibitor,"Headache, Rash",1971,Acetylsalicylic Acid,Aspirin,Moderate Risk,Slow Metabolism,Phase 3,In Vitro Studies,Serotonin Pathway,Injection,250mg every 8 hours,Novartis,6,High,Moderate Risk,Low (<50%),Fast,Enzyme-Specific,Suitable
Ibuprofen,Fever,Alzheimer's,44.77,C13H18O2,Proton Pump Inhibitor,"Nausea, Dizziness",1971,Ibuprofen,Prilosec,Low Risk,Renal Excretion,Phase 3,Animal Testing,PI3K-AKT Pathway,Topical Gel,50mg daily,Novartis,24,High,Moderate Risk,Low (<50%),Moderate,Renal,Partially Suitable
Atorvastatin,Blood Thinner,Migraine Treatment,81.75,C13H18O2,Proton Pump Inhibitor,Muscle Pain,1996,Ibuprofen,Aspirin,Low Risk,High Bioavailability,Phase 3,Toxicology Report,Dopaminergic Pathway,Tablet,250mg every 8 hours,Roche,48,Low,High Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Partially Suitable
Omeprazole,Hypertension,Antiviral,45.94,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Acid Reflux,1987,Metformin Hydrochloride,Advil,High Risk,Slow Metabolism,Phase 1,Toxicology Report,Serotonin Pathway,Injection,500mg twice a day,Pfizer,6,High,Low Risk,Moderate (50-80%),Moderate,Renal,Partially Suitable
Losartan,Inflammation,Cardiovascular Disease,77.2,C17H19N3O3S,Proton Pump Inhibitor,"Nausea, Dizziness",1996,Ibuprofen,Advil,High Risk,High Bioavailability,Phase 4,Toxicology Report,PI3K-AKT Pathway,Topical Gel,10mg once daily,AstraZeneca,24,Moderate,High Risk,Moderate (50-80%),Fast,Renal,Suitable
Paracetamol,Cholesterol Control,Antiviral,30.91,C13H18O2,COX Inhibitor,Acid Reflux,1987,Metformin Hydrochloride,Advil,Low Risk,Rapid Absorption,Phase 2,In Vitro Studies,PI3K-AKT Pathway,Injection,As prescribed,Novartis,24,Moderate,High Risk,High (>80%),Fast,Renal,Partially Suitable
Ranitidine,Inflammation,Migraine Treatment,45.61,C4H11N5,Proton Pump Inhibitor,"Headache, Rash",1994,Acetylsalicylic Acid,Glucophage,Moderate Risk,Rapid Absorption,Phase 3,No Preclinical Data,Dopaminergic Pathway,Capsule,10mg once daily,Novartis,24,Low,Low Risk,Low (<50%),Slow,Liver,Not Suitable
Simvastatin,Acid Reflux,Parkinson's,89.59,C13H18O2,AMPK Activator,"Headache, Rash",1996,Acetylsalicylic Acid,Prilosec,High Risk,Rapid Absorption,Phase 1,In Vitro Studies,MAPK Pathway,Topical Gel,As prescribed,Merck,2,High,Low Risk,High (>80%),Slow,Gut,Suitable
Levothyroxine,Acid Reflux,Antiviral,58.63,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1996,Atorvastatin Calcium,Lipitor,High Risk,High Bioavailability,Phase 2,In Vitro Studies,MAPK Pathway,Topical Gel,250mg every 8 hours,AstraZeneca,12,Low,Moderate Risk,High (>80%),Slow,Gut,Partially Suitable
Aspirin,Acid Reflux,Cardiovascular Disease,83.34,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1971,Atorvastatin Calcium,Advil,Moderate Risk,High Bioavailability,Completed,In Vitro Studies,Immune Response Pathway,Topical Gel,250mg every 8 hours,Merck,48,High,Moderate Risk,High (>80%),Moderate,Liver,Not Suitable
Metformin,Inflammation,Cancer Therapy,41.24,C13H18O2,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1971,Atorvastatin Calcium,Glucophage,High Risk,High Bioavailability,Phase 2,Animal Testing,Dopaminergic Pathway,Injection,500mg twice a day,Novartis,2,Moderate,Low Risk,Moderate (50-80%),Fast,Gut,Not Suitable
Ibuprofen,Acid Reflux,Liver Disease,30.94,C33H35FN2O5,AMPK Activator,Gastrointestinal Issues,1971,Acetylsalicylic Acid,Prilosec,Moderate Risk,Liver Metabolism,Phase 1,Toxicology Report,PI3K-AKT Pathway,Tablet,250mg every 8 hours,AstraZeneca,12,Low,Low Risk,High (>80%),Moderate,Enzyme-Specific,Not Suitable
Atorvastatin,Inflammation,Parkinson's,30.88,C13H18O2,COX Inhibitor,"Nausea, Dizziness",1996,Metformin Hydrochloride,Lipitor,Low Risk,Liver Metabolism,Phase 1,Toxicology Report,MAPK Pathway,Tablet,As prescribed,Roche,48,Low,Moderate Risk,Low (<50%),Slow,Liver,Partially Suitable
Omeprazole,Thyroid Hormone Replacement,Migraine Treatment,94.68,C17H19N3O3S,AMPK Activator,"Headache, Rash",1994,Atorvastatin Calcium,Lipitor,Moderate Risk,Liver Metabolism,Completed,In Vitro Studies,PI3K-AKT Pathway,Syrup,50mg daily,Novartis,12,Low,Low Risk,High (>80%),Moderate,Enzyme-Specific,Not Suitable
Losartan,Pain Relief,Anti-Aging,31.34,C9H8O4,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1987,Omeprazole,Lipitor,Low Risk,High Bioavailability,Ongoing,In Vitro Studies,PI3K-AKT Pathway,Capsule,500mg twice a day,Roche,12,Low,High Risk,Moderate (50-80%),Fast,Liver,Partially Suitable
Paracetamol,Inflammation,Alzheimer's,44.38,C9H8O4,HMG-CoA Reductase Inhibitor,Muscle Pain,1965,Acetylsalicylic Acid,Prilosec,High Risk,Slow Metabolism,Phase 3,Toxicology Report,Serotonin Pathway,Injection,250mg every 8 hours,Merck,2,High,High Risk,High (>80%),Moderate,Liver,Partially Suitable
Ranitidine,Blood Thinner,Alzheimer's,46.37,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1971,Omeprazole,Advil,Moderate Risk,Liver Metabolism,Phase 3,In Vitro Studies,Immune Response Pathway,Syrup,As prescribed,AstraZeneca,2,Low,High Risk,High (>80%),Slow,Enzyme-Specific,Suitable
Simvastatin,Thyroid Hormone Replacement,Liver Disease,38.21,C17H19N3O3S,COX Inhibitor,Muscle Pain,1996,Acetylsalicylic Acid,Glucophage,Low Risk,Rapid Absorption,Phase 3,Toxicology Report,Dopaminergic Pathway,Syrup,500mg twice a day,Roche,12,High,High Risk,High (>80%),Moderate,Liver,Partially Suitable
Levothyroxine,Gastric Ulcer,Alzheimer's,58.34,C13H18O2,Proton Pump Inhibitor,Gastrointestinal Issues,1971,Metformin Hydrochloride,Prilosec,Moderate Risk,High Bioavailability,Phase 4,In Vitro Studies,Dopaminergic Pathway,Capsule,10mg once daily,AstraZeneca,12,Low,Low Risk,Moderate (50-80%),Moderate,Renal,Partially Suitable
Aspirin,Fever,Antiviral,94.87,C17H19N3O3S,COX Inhibitor,Acid Reflux,1971,Metformin Hydrochloride,Glucophage,Low Risk,Rapid Absorption,Phase 2,Animal Testing,Dopaminergic Pathway,Injection,250mg every 8 hours,Pfizer,48,Low,Moderate Risk,Low (<50%),Slow,Renal,Not Suitable
Metformin,Pain Relief,Migraine Treatment,79.79,C9H8O4,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1987,Omeprazole,Lipitor,High Risk,Liver Metabolism,Completed,Animal Testing,PI3K-AKT Pathway,Syrup,10mg once daily,Pfizer,6,High,Low Risk,Low (<50%),Fast,Renal,Not Suitable
Ibuprofen,Fever,Antiviral,30.91,C33H35FN2O5,NSAID,Muscle Pain,1994,Metformin Hydrochloride,Glucophage,High Risk,Rapid Absorption,Phase 3,No Preclinical Data,Serotonin Pathway,Topical Gel,250mg every 8 hours,Roche,2,Low,Low Risk,Low (<50%),Moderate,Liver,Suitable
Atorvastatin,Inflammation,Liver Disease,92.75,C33H35FN2O5,AMPK Activator,"Headache, Rash",1965,Omeprazole,Advil,Low Risk,Renal Excretion,Phase 4,No Preclinical Data,MAPK Pathway,Syrup,10mg once daily,Roche,48,Low,Moderate Risk,High (>80%),Slow,Renal,Suitable
Omeprazole,Thyroid Hormone Replacement,Anti-Aging,79.15,C9H8O4,COX Inhibitor,Gastrointestinal Issues,1996,Acetylsalicylic Acid,Glucophage,Moderate Risk,Liver Metabolism,Phase 4,In Vitro Studies,MAPK Pathway,Injection,50mg daily,Merck,24,High,High Risk,Low (<50%),Fast,Liver,Not Suitable
Losartan,Diabetes,Autoimmune Disorders,84.16,C4H11N5,COX Inhibitor,Acid Reflux,1987,Omeprazole,Advil,High Risk,Slow Metabolism,Phase 2,No Preclinical Data,PI3K-AKT Pathway,Tablet,500mg twice a day,Roche,12,Moderate,Low Risk,Low (<50%),Fast,Renal,Suitable
Paracetamol,Diabetes,Weight Loss,81.94,C33H35FN2O5,NSAID,Muscle Pain,1987,Metformin Hydrochloride,Glucophage,Low Risk,Renal Excretion,Ongoing,Animal Testing,Immune Response Pathway,Topical Gel,10mg once daily,Pfizer,24,Moderate,Moderate Risk,High (>80%),Moderate,Renal,Partially Suitable
Ranitidine,Cholesterol Control,Migraine Treatment,65.17,C17H19N3O3S,NSAID,Muscle Pain,1987,Ibuprofen,Lipitor,Low Risk,High Bioavailability,Phase 2,In Vitro Studies,MAPK Pathway,Syrup,As prescribed,AstraZeneca,24,Moderate,Moderate Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Simvastatin,Inflammation,Migraine Treatment,78.1,C33H35FN2O5,NSAID,Muscle Pain,1994,Atorvastatin Calcium,Advil,Low Risk,Rapid Absorption,Phase 3,Toxicology Report,Serotonin Pathway,Syrup,As prescribed,Novartis,48,Low,High Risk,High (>80%),Slow,Renal,Partially Suitable
Levothyroxine,Diabetes,Cardiovascular Disease,37.1,C13H18O2,Proton Pump Inhibitor,"Headache, Rash",1965,Metformin Hydrochloride,Advil,High Risk,Slow Metabolism,Phase 1,Toxicology Report,Dopaminergic Pathway,Tablet,10mg once daily,Merck,48,Low,High Risk,Low (<50%),Fast,Liver,Partially Suitable
Aspirin,Fever,Liver Disease,37.74,C33H35FN2O5,NSAID,Gastrointestinal Issues,1965,Atorvastatin Calcium,Glucophage,Low Risk,Slow Metabolism,Ongoing,Animal Testing,Immune Response Pathway,Syrup,50mg daily,Roche,24,High,Low Risk,Low (<50%),Fast,Enzyme-Specific,Not Suitable
Metformin,Inflammation,Alzheimer's,75.77,C17H19N3O3S,NSAID,Acid Reflux,1971,Acetylsalicylic Acid,Advil,High Risk,Slow Metabolism,Phase 2,Animal Testing,MAPK Pathway,Capsule,500mg twice a day,AstraZeneca,6,High,Moderate Risk,High (>80%),Fast,Renal,Not Suitable
Ibuprofen,Gastric Ulcer,Migraine Treatment,86.78,C9H8O4,NSAID,Acid Reflux,1971,Metformin Hydrochloride,Aspirin,High Risk,High Bioavailability,Phase 1,Toxicology Report,Serotonin Pathway,Capsule,50mg daily,Merck,24,Moderate,Low Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Not Suitable
Atorvastatin,Thyroid Hormone Replacement,Weight Loss,73.38,C17H19N3O3S,Proton Pump Inhibitor,"Nausea, Dizziness",1965,Metformin Hydrochloride,Prilosec,Moderate Risk,Liver Metabolism,Phase 2,Toxicology Report,PI3K-AKT Pathway,Syrup,10mg once daily,Merck,24,High,High Risk,High (>80%),Moderate,Gut,Not Suitable
Omeprazole,Fever,Anti-Aging,50.3,C13H18O2,COX Inhibitor,"Headache, Rash",1987,Ibuprofen,Aspirin,High Risk,Liver Metabolism,Phase 2,Animal Testing,Immune Response Pathway,Syrup,As prescribed,Novartis,12,High,Moderate Risk,High (>80%),Moderate,Liver,Partially Suitable
Losartan,Cholesterol Control,Cancer Therapy,39.19,C4H11N5,Proton Pump Inhibitor,Acid Reflux,1994,Ibuprofen,Prilosec,Moderate Risk,Slow Metabolism,Ongoing,No Preclinical Data,PI3K-AKT Pathway,Tablet,As prescribed,Novartis,12,Low,High Risk,Moderate (50-80%),Slow,Gut,Not Suitable
Paracetamol,Acid Reflux,Antiviral,90.24,C4H11N5,AMPK Activator,Acid Reflux,1994,Ibuprofen,Prilosec,High Risk,Renal Excretion,Phase 2,Animal Testing,Serotonin Pathway,Injection,10mg once daily,Pfizer,6,Low,Moderate Risk,High (>80%),Slow,Gut,Not Suitable
Ranitidine,Fever,Antiviral,57.79,C4H11N5,AMPK Activator,"Headache, Rash",1987,Atorvastatin Calcium,Prilosec,Low Risk,Slow Metabolism,Phase 3,No Preclinical Data,Dopaminergic Pathway,Capsule,As prescribed,AstraZeneca,2,High,High Risk,Low (<50%),Fast,Liver,Suitable
Simvastatin,Thyroid Hormone Replacement,Weight Loss,93.42,C9H8O4,Proton Pump Inhibitor,Acid Reflux,1971,Metformin Hydrochloride,Lipitor,High Risk,Rapid Absorption,Completed,No Preclinical Data,Immune Response Pathway,Tablet,50mg daily,Novartis,48,Moderate,Low Risk,Low (<50%),Slow,Liver,Not Suitable
Levothyroxine,Cholesterol Control,Autoimmune Disorders,49.55,C9H8O4,COX Inhibitor,Acid Reflux,1987,Metformin Hydrochloride,Glucophage,Moderate Risk,Liver Metabolism,Phase 1,Animal Testing,PI3K-AKT Pathway,Tablet,500mg twice a day,Novartis,6,Low,Moderate Risk,Low (<50%),Slow,Renal,Not Suitable
Aspirin,Thyroid Hormone Replacement,Anti-Aging,73.92,C13H18O2,NSAID,Gastrointestinal Issues,1971,Ibuprofen,Aspirin,Moderate Risk,Rapid Absorption,Phase 1,Toxicology Report,Dopaminergic Pathway,Syrup,500mg twice a day,Novartis,12,High,Low Risk,High (>80%),Slow,Liver,Not Suitable
Metformin,Blood Thinner,Cancer Therapy,68.11,C4H11N5,NSAID,"Headache, Rash",1996,Ibuprofen,Prilosec,Low Risk,Rapid Absorption,Ongoing,No Preclinical Data,PI3K-AKT Pathway,Topical Gel,50mg daily,Pfizer,12,Low,High Risk,High (>80%),Fast,Enzyme-Specific,Partially Suitable
Ibuprofen,Gastric Ulcer,Parkinson's,58.13,C33H35FN2O5,COX Inhibitor,Acid Reflux,1971,Omeprazole,Lipitor,Low Risk,High Bioavailability,Phase 1,Toxicology Report,PI3K-AKT Pathway,Tablet,500mg twice a day,AstraZeneca,6,Moderate,Moderate Risk,High (>80%),Slow,Liver,Suitable
Atorvastatin,Thyroid Hormone Replacement,Parkinson's,71.09,C9H8O4,Proton Pump Inhibitor,"Nausea, Dizziness",1971,Omeprazole,Lipitor,Moderate Risk,High Bioavailability,Phase 1,No Preclinical Data,PI3K-AKT Pathway,Tablet,500mg twice a day,Novartis,12,Moderate,Low Risk,Moderate (50-80%),Fast,Renal,Not Suitable
Omeprazole,Acid Reflux,Antiviral,30.53,C4H11N5,COX Inhibitor,Acid Reflux,1987,Acetylsalicylic Acid,Glucophage,Moderate Risk,Liver Metabolism,Phase 4,In Vitro Studies,MAPK Pathway,Tablet,10mg once daily,AstraZeneca,2,Low,Low Risk,Moderate (50-80%),Slow,Renal,Not Suitable
Losartan,Diabetes,Weight Loss,32.3,C17H19N3O3S,Proton Pump Inhibitor,Acid Reflux,1996,Metformin Hydrochloride,Prilosec,Moderate Risk,Renal Excretion,Phase 2,Animal Testing,Immune Response Pathway,Topical Gel,10mg once daily,Merck,2,Moderate,Moderate Risk,High (>80%),Moderate,Gut,Partially Suitable
Paracetamol,Fever,Weight Loss,84.49,C17H19N3O3S,AMPK Activator,"Nausea, Dizziness",1987,Atorvastatin Calcium,Glucophage,Moderate Risk,Renal Excretion,Completed,No Preclinical Data,Dopaminergic Pathway,Tablet,As prescribed,Pfizer,48,Moderate,Low Risk,Low (<50%),Fast,Renal,Not Suitable
Ranitidine,Thyroid Hormone Replacement,Liver Disease,85.48,C17H19N3O3S,NSAID,Gastrointestinal Issues,1965,Ibuprofen,Aspirin,Moderate Risk,Liver Metabolism,Phase 3,In Vitro Studies,PI3K-AKT Pathway,Tablet,50mg daily,Pfizer,24,Low,High Risk,High (>80%),Moderate,Gut,Partially Suitable
Simvastatin,Fever,Weight Loss,41.74,C13H18O2,Proton Pump Inhibitor,"Headache, Rash",1996,Metformin Hydrochloride,Aspirin,Low Risk,Renal Excretion,Phase 1,No Preclinical Data,PI3K-AKT Pathway,Syrup,250mg every 8 hours,Pfizer,12,High,High Risk,Low (<50%),Slow,Liver,Suitable
Levothyroxine,Blood Thinner,Alzheimer's,89.66,C17H19N3O3S,Proton Pump Inhibitor,"Headache, Rash",1987,Omeprazole,Aspirin,High Risk,Liver Metabolism,Phase 2,In Vitro Studies,Dopaminergic Pathway,Injection,50mg daily,AstraZeneca,6,High,Moderate Risk,High (>80%),Moderate,Renal,Suitable
Aspirin,Pain Relief,Parkinson's,77.67,C4H11N5,AMPK Activator,Gastrointestinal Issues,1965,Acetylsalicylic Acid,Aspirin,High Risk,Liver Metabolism,Phase 2,In Vitro Studies,PI3K-AKT Pathway,Capsule,500mg twice a day,Merck,24,Moderate,High Risk,Moderate (50-80%),Moderate,Renal,Not Suitable
Metformin,Blood Thinner,Autoimmune Disorders,64.11,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Acid Reflux,1987,Metformin Hydrochloride,Prilosec,High Risk,Rapid Absorption,Completed,In Vitro Studies,Dopaminergic Pathway,Topical Gel,As prescribed,AstraZeneca,12,High,Low Risk,High (>80%),Moderate,Gut,Partially Suitable
Ibuprofen,Acid Reflux,Autoimmune Disorders,36.94,C17H19N3O3S,COX Inhibitor,Acid Reflux,1994,Ibuprofen,Glucophage,Low Risk,Liver Metabolism,Phase 2,Toxicology Report,Serotonin Pathway,Tablet,500mg twice a day,AstraZeneca,48,Moderate,Moderate Risk,High (>80%),Moderate,Enzyme-Specific,Partially Suitable
Atorvastatin,Acid Reflux,Parkinson's,48.06,C9H8O4,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1994,Metformin Hydrochloride,Glucophage,Low Risk,High Bioavailability,Phase 3,No Preclinical Data,MAPK Pathway,Topical Gel,500mg twice a day,AstraZeneca,48,Low,Low Risk,Moderate (50-80%),Slow,Enzyme-Specific,Not Suitable
Omeprazole,Cholesterol Control,Cancer Therapy,34.5,C13H18O2,COX Inhibitor,Muscle Pain,1987,Omeprazole,Aspirin,High Risk,Rapid Absorption,Completed,In Vitro Studies,Dopaminergic Pathway,Capsule,250mg every 8 hours,Roche,48,Low,Low Risk,Low (<50%),Fast,Gut,Partially Suitable
Losartan,Thyroid Hormone Replacement,Parkinson's,80.89,C13H18O2,NSAID,Gastrointestinal Issues,1971,Acetylsalicylic Acid,Glucophage,Moderate Risk,Liver Metabolism,Phase 2,In Vitro Studies,Serotonin Pathway,Syrup,As prescribed,Merck,2,Moderate,High Risk,Moderate (50-80%),Slow,Renal,Not Suitable
Paracetamol,Thyroid Hormone Replacement,Autoimmune Disorders,88.48,C17H19N3O3S,NSAID,Gastrointestinal Issues,1996,Acetylsalicylic Acid,Lipitor,High Risk,Renal Excretion,Completed,Toxicology Report,MAPK Pathway,Syrup,As prescribed,Pfizer,24,Low,High Risk,Low (<50%),Moderate,Enzyme-Specific,Suitable
Ranitidine,Thyroid Hormone Replacement,Liver Disease,56.62,C4H11N5,AMPK Activator,"Headache, Rash",1996,Atorvastatin Calcium,Aspirin,High Risk,Renal Excretion,Phase 3,Animal Testing,Serotonin Pathway,Tablet,500mg twice a day,Novartis,2,High,Low Risk,Low (<50%),Moderate,Enzyme-Specific,Suitable
Simvastatin,Pain Relief,Antiviral,44.6,C33H35FN2O5,NSAID,Muscle Pain,1994,Acetylsalicylic Acid,Aspirin,Low Risk,Renal Excretion,Phase 2,No Preclinical Data,PI3K-AKT Pathway,Tablet,10mg once daily,Roche,2,High,Moderate Risk,Low (<50%),Fast,Enzyme-Specific,Suitable
Levothyroxine,Gastric Ulcer,Liver Disease,92.14,C4H11N5,AMPK Activator,Gastrointestinal Issues,1965,Ibuprofen,Advil,High Risk,Renal Excretion,Phase 2,Animal Testing,Serotonin Pathway,Topical Gel,250mg every 8 hours,Pfizer,6,High,Low Risk,High (>80%),Fast,Renal,Partially Suitable
Aspirin,Fever,Parkinson's,60.82,C17H19N3O3S,COX Inhibitor,Muscle Pain,1996,Atorvastatin Calcium,Prilosec,Low Risk,Liver Metabolism,Phase 3,In Vitro Studies,Dopaminergic Pathway,Syrup,500mg twice a day,AstraZeneca,24,High,Low Risk,Moderate (50-80%),Fast,Gut,Partially Suitable
Metformin,Blood Thinner,Cancer Therapy,81.04,C9H8O4,Proton Pump Inhibitor,Acid Reflux,1965,Omeprazole,Aspirin,Moderate Risk,Liver Metabolism,Phase 3,Toxicology Report,Immune Response Pathway,Injection,250mg every 8 hours,Merck,2,Low,Moderate Risk,High (>80%),Moderate,Gut,Suitable
Ibuprofen,Pain Relief,Weight Loss,57.51,C17H19N3O3S,NSAID,"Nausea, Dizziness",1996,Ibuprofen,Glucophage,Low Risk,Rapid Absorption,Phase 3,No Preclinical Data,Serotonin Pathway,Syrup,As prescribed,Novartis,12,Low,Low Risk,High (>80%),Fast,Liver,Suitable
Atorvastatin,Diabetes,Cardiovascular Disease,87.18,C33H35FN2O5,AMPK Activator,"Headache, Rash",1965,Acetylsalicylic Acid,Lipitor,High Risk,Liver Metabolism,Completed,In Vitro Studies,Serotonin Pathway,Tablet,500mg twice a day,Pfizer,2,Moderate,High Risk,Moderate (50-80%),Fast,Liver,Suitable
Omeprazole,Diabetes,Anti-Aging,65.81,C9H8O4,NSAID,Gastrointestinal Issues,1971,Acetylsalicylic Acid,Lipitor,Moderate Risk,Slow Metabolism,Phase 4,Toxicology Report,Dopaminergic Pathway,Capsule,50mg daily,AstraZeneca,24,Moderate,High Risk,Low (<50%),Moderate,Gut,Suitable
Losartan,Acid Reflux,Alzheimer's,64.69,C4H11N5,AMPK Activator,Gastrointestinal Issues,1996,Omeprazole,Aspirin,High Risk,Rapid Absorption,Phase 3,In Vitro Studies,PI3K-AKT Pathway,Injection,As prescribed,Novartis,6,Low,High Risk,Moderate (50-80%),Slow,Renal,Partially Suitable
Paracetamol,Diabetes,Weight Loss,84.6,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1987,Omeprazole,Prilosec,Moderate Risk,Renal Excretion,Ongoing,Animal Testing,PI3K-AKT Pathway,Injection,500mg twice a day,Roche,48,Moderate,Moderate Risk,Low (<50%),Moderate,Liver,Not Suitable
Ranitidine,Blood Thinner,Antiviral,71.24,C4H11N5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1965,Acetylsalicylic Acid,Glucophage,Moderate Risk,Renal Excretion,Phase 1,No Preclinical Data,PI3K-AKT Pathway,Injection,250mg every 8 hours,Merck,24,Moderate,Moderate Risk,High (>80%),Slow,Renal,Suitable
Simvastatin,Cholesterol Control,Antiviral,67.47,C17H19N3O3S,NSAID,Muscle Pain,1971,Acetylsalicylic Acid,Aspirin,Moderate Risk,Renal Excretion,Completed,Animal Testing,MAPK Pathway,Capsule,As prescribed,Pfizer,48,Low,Moderate Risk,Low (<50%),Moderate,Gut,Not Suitable
Levothyroxine,Hypertension,Weight Loss,76.8,C4H11N5,COX Inhibitor,"Headache, Rash",1996,Metformin Hydrochloride,Lipitor,Low Risk,Liver Metabolism,Phase 3,In Vitro Studies,PI3K-AKT Pathway,Capsule,As prescribed,Novartis,12,High,Low Risk,High (>80%),Moderate,Liver,Suitable
Aspirin,Hypertension,Cardiovascular Disease,71.8,C17H19N3O3S,AMPK Activator,Acid Reflux,1971,Ibuprofen,Prilosec,Low Risk,Rapid Absorption,Phase 1,In Vitro Studies,Dopaminergic Pathway,Tablet,250mg every 8 hours,Novartis,24,High,Low Risk,Moderate (50-80%),Slow,Gut,Not Suitable
Metformin,Thyroid Hormone Replacement,Migraine Treatment,67.76,C13H18O2,HMG-CoA Reductase Inhibitor,Muscle Pain,1965,Metformin Hydrochloride,Advil,Low Risk,High Bioavailability,Phase 2,No Preclinical Data,Immune Response Pathway,Injection,250mg every 8 hours,Pfizer,24,Low,Moderate Risk,Low (<50%),Moderate,Renal,Partially Suitable
Ibuprofen,Blood Thinner,Weight Loss,57.44,C17H19N3O3S,AMPK Activator,Muscle Pain,1994,Atorvastatin Calcium,Lipitor,High Risk,High Bioavailability,Phase 2,Toxicology Report,Dopaminergic Pathway,Syrup,50mg daily,Merck,24,High,Moderate Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Suitable
Atorvastatin,Fever,Anti-Aging,85.32,C9H8O4,COX Inhibitor,"Headache, Rash",1971,Omeprazole,Aspirin,Low Risk,High Bioavailability,Phase 3,No Preclinical Data,Dopaminergic Pathway,Injection,250mg every 8 hours,AstraZeneca,6,Moderate,High Risk,Low (<50%),Fast,Enzyme-Specific,Suitable
Omeprazole,Cholesterol Control,Cancer Therapy,58.29,C33H35FN2O5,Proton Pump Inhibitor,Muscle Pain,1987,Acetylsalicylic Acid,Lipitor,Low Risk,High Bioavailability,Completed,Animal Testing,Immune Response Pathway,Tablet,50mg daily,Novartis,48,High,Moderate Risk,Low (<50%),Moderate,Gut,Suitable
Losartan,Pain Relief,Weight Loss,48.83,C13H18O2,HMG-CoA Reductase Inhibitor,Acid Reflux,1994,Acetylsalicylic Acid,Glucophage,Moderate Risk,Renal Excretion,Phase 4,No Preclinical Data,Dopaminergic Pathway,Capsule,250mg every 8 hours,Roche,12,High,Moderate Risk,High (>80%),Fast,Renal,Suitable
Paracetamol,Fever,Weight Loss,30.74,C4H11N5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1994,Acetylsalicylic Acid,Aspirin,Low Risk,Rapid Absorption,Phase 1,Animal Testing,Serotonin Pathway,Syrup,10mg once daily,Merck,24,Low,High Risk,High (>80%),Fast,Enzyme-Specific,Partially Suitable
Ranitidine,Cholesterol Control,Anti-Aging,92.78,C9H8O4,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1971,Metformin Hydrochloride,Prilosec,Moderate Risk,Liver Metabolism,Completed,In Vitro Studies,Serotonin Pathway,Syrup,10mg once daily,Merck,48,Low,Moderate Risk,High (>80%),Fast,Enzyme-Specific,Not Suitable
Simvastatin,Diabetes,Antiviral,33.92,C13H18O2,COX Inhibitor,"Headache, Rash",1971,Omeprazole,Prilosec,High Risk,Rapid Absorption,Ongoing,Animal Testing,PI3K-AKT Pathway,Syrup,As prescribed,AstraZeneca,6,Low,High Risk,High (>80%),Moderate,Gut,Partially Suitable
Levothyroxine,Thyroid Hormone Replacement,Parkinson's,51.96,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1987,Metformin Hydrochloride,Lipitor,Low Risk,Slow Metabolism,Phase 4,In Vitro Studies,Dopaminergic Pathway,Injection,500mg twice a day,Novartis,12,High,Moderate Risk,Low (<50%),Moderate,Gut,Suitable
Aspirin,Hypertension,Liver Disease,56.46,C33H35FN2O5,Proton Pump Inhibitor,Gastrointestinal Issues,1965,Ibuprofen,Prilosec,Moderate Risk,High Bioavailability,Phase 2,In Vitro Studies,Serotonin Pathway,Topical Gel,50mg daily,Pfizer,2,High,High Risk,Low (<50%),Fast,Gut,Not Suitable
Metformin,Thyroid Hormone Replacement,Liver Disease,51.65,C13H18O2,HMG-CoA Reductase Inhibitor,Acid Reflux,1996,Atorvastatin Calcium,Prilosec,High Risk,Slow Metabolism,Phase 3,No Preclinical Data,Immune Response Pathway,Injection,50mg daily,Merck,48,Moderate,Moderate Risk,Low (<50%),Slow,Enzyme-Specific,Partially Suitable
Ibuprofen,Blood Thinner,Cardiovascular Disease,59.66,C33H35FN2O5,COX Inhibitor,"Headache, Rash",1987,Metformin Hydrochloride,Lipitor,High Risk,Rapid Absorption,Ongoing,Animal Testing,Serotonin Pathway,Tablet,50mg daily,Roche,24,Moderate,Low Risk,Moderate (50-80%),Moderate,Gut,Not Suitable
Atorvastatin,Hypertension,Weight Loss,89.89,C13H18O2,Proton Pump Inhibitor,"Nausea, Dizziness",1965,Acetylsalicylic Acid,Glucophage,High Risk,Renal Excretion,Phase 4,In Vitro Studies,Immune Response Pathway,Syrup,250mg every 8 hours,Roche,12,High,High Risk,Moderate (50-80%),Fast,Liver,Suitable
Omeprazole,Fever,Alzheimer's,35.6,C17H19N3O3S,AMPK Activator,"Nausea, Dizziness",1996,Metformin Hydrochloride,Prilosec,High Risk,Liver Metabolism,Phase 1,Toxicology Report,PI3K-AKT Pathway,Syrup,10mg once daily,Merck,48,High,Moderate Risk,Low (<50%),Fast,Renal,Suitable
Losartan,Fever,Alzheimer's,62.94,C17H19N3O3S,COX Inhibitor,"Headache, Rash",1965,Omeprazole,Lipitor,Moderate Risk,Slow Metabolism,Phase 4,In Vitro Studies,PI3K-AKT Pathway,Capsule,500mg twice a day,Novartis,24,Low,Low Risk,Moderate (50-80%),Fast,Renal,Partially Suitable
Paracetamol,Pain Relief,Migraine Treatment,69.27,C13H18O2,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1987,Atorvastatin Calcium,Advil,Moderate Risk,Liver Metabolism,Phase 2,In Vitro Studies,Immune Response Pathway,Capsule,As prescribed,Novartis,48,Moderate,Low Risk,Moderate (50-80%),Moderate,Gut,Not Suitable
Ranitidine,Hypertension,Liver Disease,68.75,C33H35FN2O5,COX Inhibitor,"Headache, Rash",1965,Metformin Hydrochloride,Advil,High Risk,High Bioavailability,Completed,No Preclinical Data,Dopaminergic Pathway,Capsule,10mg once daily,Roche,12,Low,High Risk,Low (<50%),Fast,Enzyme-Specific,Partially Suitable
Simvastatin,Gastric Ulcer,Weight Loss,72.68,C9H8O4,NSAID,"Nausea, Dizziness",1987,Metformin Hydrochloride,Prilosec,High Risk,High Bioavailability,Ongoing,In Vitro Studies,Immune Response Pathway,Syrup,250mg every 8 hours,Roche,48,Low,High Risk,High (>80%),Moderate,Renal,Suitable
Levothyroxine,Diabetes,Alzheimer's,57.67,C9H8O4,HMG-CoA Reductase Inhibitor,Muscle Pain,1971,Acetylsalicylic Acid,Glucophage,Moderate Risk,Slow Metabolism,Phase 1,Toxicology Report,Serotonin Pathway,Syrup,10mg once daily,Roche,48,Low,High Risk,Moderate (50-80%),Slow,Liver,Not Suitable
Aspirin,Pain Relief,Liver Disease,56.35,C33H35FN2O5,Proton Pump Inhibitor,Acid Reflux,1994,Atorvastatin Calcium,Lipitor,High Risk,Rapid Absorption,Phase 3,Animal Testing,PI3K-AKT Pathway,Syrup,500mg twice a day,Pfizer,12,Low,High Risk,Low (<50%),Moderate,Enzyme-Specific,Not Suitable
Metformin,Inflammation,Parkinson's,49.37,C4H11N5,AMPK Activator,"Headache, Rash",1994,Atorvastatin Calcium,Prilosec,High Risk,Slow Metabolism,Phase 3,Animal Testing,PI3K-AKT Pathway,Topical Gel,10mg once daily,Pfizer,6,High,High Risk,High (>80%),Fast,Renal,Not Suitable
Ibuprofen,Fever,Anti-Aging,46.99,C13H18O2,NSAID,"Nausea, Dizziness",1996,Omeprazole,Glucophage,Low Risk,Slow Metabolism,Phase 2,Animal Testing,Serotonin Pathway,Tablet,10mg once daily,Pfizer,24,Moderate,High Risk,Moderate (50-80%),Slow,Liver,Not Suitable
Atorvastatin,Cholesterol Control,Alzheimer's,34.94,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1994,Acetylsalicylic Acid,Glucophage,Low Risk,Slow Metabolism,Completed,No Preclinical Data,Serotonin Pathway,Syrup,500mg twice a day,AstraZeneca,12,High,High Risk,High (>80%),Slow,Renal,Suitable
Omeprazole,Gastric Ulcer,Alzheimer's,42.02,C13H18O2,NSAID,"Headache, Rash",1971,Omeprazole,Aspirin,Moderate Risk,Slow Metabolism,Phase 1,Toxicology Report,Immune Response Pathway,Capsule,As prescribed,Novartis,12,Moderate,Moderate Risk,High (>80%),Moderate,Renal,Partially Suitable
Losartan,Diabetes,Liver Disease,90.53,C17H19N3O3S,Proton Pump Inhibitor,Gastrointestinal Issues,1994,Omeprazole,Prilosec,Moderate Risk,Rapid Absorption,Phase 2,Animal Testing,Dopaminergic Pathway,Syrup,50mg daily,Merck,48,Moderate,High Risk,Low (<50%),Slow,Gut,Suitable
Paracetamol,Pain Relief,Autoimmune Disorders,66.34,C17H19N3O3S,COX Inhibitor,Acid Reflux,1994,Metformin Hydrochloride,Advil,Moderate Risk,Slow Metabolism,Phase 3,Animal Testing,PI3K-AKT Pathway,Capsule,50mg daily,Roche,24,High,High Risk,High (>80%),Slow,Gut,Not Suitable
Ranitidine,Thyroid Hormone Replacement,Cancer Therapy,45.18,C33H35FN2O5,NSAID,Gastrointestinal Issues,1987,Acetylsalicylic Acid,Prilosec,Moderate Risk,Liver Metabolism,Completed,Animal Testing,PI3K-AKT Pathway,Topical Gel,10mg once daily,Roche,24,High,Low Risk,Low (<50%),Moderate,Gut,Suitable
Simvastatin,Inflammation,Liver Disease,52.77,C4H11N5,NSAID,"Headache, Rash",1965,Metformin Hydrochloride,Aspirin,Low Risk,Slow Metabolism,Phase 3,No Preclinical Data,PI3K-AKT Pathway,Topical Gel,As prescribed,Merck,2,High,Low Risk,Low (<50%),Fast,Liver,Partially Suitable
Levothyroxine,Diabetes,Autoimmune Disorders,53.89,C9H8O4,HMG-CoA Reductase Inhibitor,"Headache, Rash",1987,Ibuprofen,Prilosec,Low Risk,Rapid Absorption,Phase 2,No Preclinical Data,Dopaminergic Pathway,Injection,50mg daily,Roche,12,Low,Moderate Risk,Moderate (50-80%),Fast,Gut,Suitable
Aspirin,Thyroid Hormone Replacement,Antiviral,78.76,C17H19N3O3S,COX Inhibitor,Acid Reflux,1965,Atorvastatin Calcium,Lipitor,Moderate Risk,Rapid Absorption,Phase 2,Toxicology Report,PI3K-AKT Pathway,Syrup,500mg twice a day,AstraZeneca,6,Moderate,Moderate Risk,Low (<50%),Fast,Renal,Not Suitable
Metformin,Thyroid Hormone Replacement,Cancer Therapy,54.93,C17H19N3O3S,COX Inhibitor,Muscle Pain,1965,Atorvastatin Calcium,Lipitor,High Risk,Slow Metabolism,Phase 2,Animal Testing,MAPK Pathway,Syrup,250mg every 8 hours,Roche,48,High,Moderate Risk,High (>80%),Slow,Gut,Partially Suitable
Ibuprofen,Inflammation,Cardiovascular Disease,35.33,C13H18O2,NSAID,Acid Reflux,1996,Ibuprofen,Advil,Moderate Risk,Renal Excretion,Completed,In Vitro Studies,Dopaminergic Pathway,Syrup,50mg daily,AstraZeneca,48,Moderate,High Risk,Low (<50%),Moderate,Gut,Suitable
Atorvastatin,Inflammation,Liver Disease,42.87,C4H11N5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1994,Acetylsalicylic Acid,Aspirin,High Risk,Rapid Absorption,Ongoing,Toxicology Report,MAPK Pathway,Injection,As prescribed,Novartis,2,Moderate,Moderate Risk,High (>80%),Fast,Liver,Not Suitable
Omeprazole,Thyroid Hormone Replacement,Migraine Treatment,85.1,C33H35FN2O5,Proton Pump Inhibitor,Gastrointestinal Issues,1987,Omeprazole,Prilosec,Low Risk,Renal Excretion,Phase 4,Toxicology Report,Serotonin Pathway,Syrup,250mg every 8 hours,Pfizer,24,Moderate,Moderate Risk,High (>80%),Moderate,Renal,Suitable
Losartan,Cholesterol Control,Liver Disease,38.25,C4H11N5,NSAID,Muscle Pain,1994,Metformin Hydrochloride,Prilosec,Low Risk,Renal Excretion,Phase 4,No Preclinical Data,Serotonin Pathway,Capsule,10mg once daily,Novartis,6,Low,High Risk,Moderate (50-80%),Slow,Renal,Suitable
Paracetamol,Gastric Ulcer,Migraine Treatment,68.32,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Acid Reflux,1965,Omeprazole,Glucophage,Low Risk,Liver Metabolism,Completed,Toxicology Report,Immune Response Pathway,Syrup,10mg once daily,AstraZeneca,24,Moderate,Moderate Risk,Low (<50%),Slow,Renal,Not Suitable
Ranitidine,Thyroid Hormone Replacement,Antiviral,56.35,C17H19N3O3S,Proton Pump Inhibitor,"Nausea, Dizziness",1996,Omeprazole,Advil,Low Risk,Rapid Absorption,Phase 4,In Vitro Studies,Immune Response Pathway,Capsule,250mg every 8 hours,Merck,48,High,High Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Simvastatin,Inflammation,Antiviral,72.84,C9H8O4,HMG-CoA Reductase Inhibitor,"Headache, Rash",1971,Omeprazole,Advil,Moderate Risk,High Bioavailability,Phase 3,Animal Testing,Immune Response Pathway,Injection,10mg once daily,Roche,12,Low,Moderate Risk,Low (<50%),Moderate,Renal,Partially Suitable
Levothyroxine,Diabetes,Parkinson's,76.7,C33H35FN2O5,NSAID,Acid Reflux,1994,Ibuprofen,Aspirin,Low Risk,Slow Metabolism,Phase 2,In Vitro Studies,Immune Response Pathway,Topical Gel,500mg twice a day,Novartis,48,High,High Risk,High (>80%),Fast,Liver,Partially Suitable
Aspirin,Pain Relief,Cardiovascular Disease,45.4,C17H19N3O3S,NSAID,Muscle Pain,1965,Atorvastatin Calcium,Aspirin,Low Risk,Liver Metabolism,Phase 3,In Vitro Studies,PI3K-AKT Pathway,Capsule,500mg twice a day,Novartis,6,Low,Low Risk,Low (<50%),Slow,Gut,Not Suitable
Metformin,Pain Relief,Cardiovascular Disease,69.09,C4H11N5,Proton Pump Inhibitor,"Headache, Rash",1971,Acetylsalicylic Acid,Aspirin,Moderate Risk,Renal Excretion,Phase 2,No Preclinical Data,PI3K-AKT Pathway,Injection,250mg every 8 hours,Merck,24,Moderate,Low Risk,Moderate (50-80%),Fast,Enzyme-Specific,Suitable
Ibuprofen,Hypertension,Cancer Therapy,47.16,C9H8O4,NSAID,Gastrointestinal Issues,1987,Ibuprofen,Lipitor,Low Risk,Slow Metabolism,Phase 3,Animal Testing,PI3K-AKT Pathway,Topical Gel,10mg once daily,Novartis,6,Moderate,High Risk,Low (<50%),Slow,Renal,Partially Suitable
Atorvastatin,Diabetes,Liver Disease,62.28,C13H18O2,Proton Pump Inhibitor,Acid Reflux,1987,Atorvastatin Calcium,Advil,Moderate Risk,Rapid Absorption,Completed,Animal Testing,Dopaminergic Pathway,Injection,250mg every 8 hours,Pfizer,24,High,High Risk,Moderate (50-80%),Slow,Enzyme-Specific,Suitable
Omeprazole,Gastric Ulcer,Alzheimer's,93.34,C17H19N3O3S,AMPK Activator,"Nausea, Dizziness",1994,Acetylsalicylic Acid,Prilosec,Moderate Risk,Rapid Absorption,Phase 3,Animal Testing,MAPK Pathway,Injection,250mg every 8 hours,Roche,6,Low,Moderate Risk,Low (<50%),Moderate,Enzyme-Specific,Suitable
Losartan,Blood Thinner,Cancer Therapy,80.43,C17H19N3O3S,COX Inhibitor,Acid Reflux,1996,Atorvastatin Calcium,Aspirin,Moderate Risk,Liver Metabolism,Phase 3,Animal Testing,Dopaminergic Pathway,Tablet,As prescribed,Pfizer,2,Low,Moderate Risk,Low (<50%),Slow,Enzyme-Specific,Suitable
Paracetamol,Blood Thinner,Anti-Aging,69.95,C9H8O4,AMPK Activator,Acid Reflux,1994,Omeprazole,Glucophage,High Risk,Slow Metabolism,Completed,Animal Testing,Serotonin Pathway,Topical Gel,250mg every 8 hours,Novartis,12,Moderate,Low Risk,Low (<50%),Fast,Gut,Suitable
Ranitidine,Gastric Ulcer,Cancer Therapy,66.05,C33H35FN2O5,AMPK Activator,"Nausea, Dizziness",1994,Omeprazole,Aspirin,High Risk,High Bioavailability,Phase 4,Toxicology Report,PI3K-AKT Pathway,Topical Gel,10mg once daily,Novartis,2,Moderate,Low Risk,Moderate (50-80%),Fast,Enzyme-Specific,Not Suitable
Simvastatin,Diabetes,Migraine Treatment,32.29,C17H19N3O3S,AMPK Activator,Acid Reflux,1996,Metformin Hydrochloride,Glucophage,High Risk,Rapid Absorption,Ongoing,In Vitro Studies,PI3K-AKT Pathway,Injection,250mg every 8 hours,AstraZeneca,24,Low,Low Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Suitable
Levothyroxine,Gastric Ulcer,Antiviral,37.7,C9H8O4,HMG-CoA Reductase Inhibitor,"Headache, Rash",1994,Atorvastatin Calcium,Advil,Moderate Risk,Renal Excretion,Phase 3,Toxicology Report,Serotonin Pathway,Syrup,50mg daily,Pfizer,24,Low,Low Risk,Low (<50%),Moderate,Liver,Suitable
Aspirin,Thyroid Hormone Replacement,Weight Loss,83.95,C4H11N5,AMPK Activator,Muscle Pain,1994,Atorvastatin Calcium,Lipitor,High Risk,Renal Excretion,Phase 4,Animal Testing,MAPK Pathway,Syrup,As prescribed,AstraZeneca,12,Low,Low Risk,Low (<50%),Moderate,Liver,Partially Suitable
Metformin,Hypertension,Antiviral,38.24,C4H11N5,AMPK Activator,Acid Reflux,1987,Atorvastatin Calcium,Aspirin,High Risk,Renal Excretion,Ongoing,In Vitro Studies,Serotonin Pathway,Syrup,As prescribed,Roche,2,Moderate,Moderate Risk,Low (<50%),Slow,Liver,Partially Suitable
Ibuprofen,Gastric Ulcer,Cardiovascular Disease,50.08,C4H11N5,NSAID,Gastrointestinal Issues,1987,Acetylsalicylic Acid,Glucophage,High Risk,Liver Metabolism,Phase 1,No Preclinical Data,Immune Response Pathway,Tablet,500mg twice a day,Merck,24,Moderate,High Risk,Moderate (50-80%),Moderate,Liver,Not Suitable
Atorvastatin,Inflammation,Alzheimer's,74.71,C13H18O2,COX Inhibitor,Acid Reflux,1987,Ibuprofen,Advil,Low Risk,High Bioavailability,Phase 1,Animal Testing,Dopaminergic Pathway,Topical Gel,10mg once daily,Merck,2,High,High Risk,Moderate (50-80%),Fast,Renal,Suitable
Omeprazole,Fever,Antiviral,53.89,C9H8O4,NSAID,Acid Reflux,1994,Metformin Hydrochloride,Aspirin,High Risk,Liver Metabolism,Phase 3,Animal Testing,PI3K-AKT Pathway,Syrup,500mg twice a day,Novartis,6,High,High Risk,Moderate (50-80%),Slow,Renal,Not Suitable
Losartan,Hypertension,Anti-Aging,50.94,C33H35FN2O5,Proton Pump Inhibitor,Muscle Pain,1994,Acetylsalicylic Acid,Aspirin,Moderate Risk,Renal Excretion,Completed,In Vitro Studies,Immune Response Pathway,Topical Gel,250mg every 8 hours,Roche,12,Low,High Risk,Moderate (50-80%),Slow,Liver,Suitable
Paracetamol,Acid Reflux,Cardiovascular Disease,47.34,C13H18O2,AMPK Activator,"Nausea, Dizziness",1996,Acetylsalicylic Acid,Aspirin,Moderate Risk,Liver Metabolism,Phase 3,In Vitro Studies,Serotonin Pathway,Injection,250mg every 8 hours,Merck,24,High,Low Risk,Low (<50%),Moderate,Liver,Suitable
Ranitidine,Acid Reflux,Cardiovascular Disease,45.14,C33H35FN2O5,NSAID,Gastrointestinal Issues,1965,Metformin Hydrochloride,Glucophage,High Risk,Renal Excretion,Completed,Animal Testing,Serotonin Pathway,Injection,250mg every 8 hours,Roche,6,Low,High Risk,High (>80%),Fast,Liver,Partially Suitable
Simvastatin,Pain Relief,Anti-Aging,52.57,C9H8O4,Proton Pump Inhibitor,Acid Reflux,1996,Atorvastatin Calcium,Prilosec,High Risk,High Bioavailability,Phase 1,Animal Testing,Dopaminergic Pathway,Tablet,50mg daily,Novartis,6,High,High Risk,Low (<50%),Fast,Liver,Not Suitable
Levothyroxine,Hypertension,Anti-Aging,51.99,C9H8O4,AMPK Activator,"Headache, Rash",1994,Metformin Hydrochloride,Lipitor,Moderate Risk,Liver Metabolism,Phase 4,Animal Testing,Immune Response Pathway,Tablet,As prescribed,Novartis,12,High,Moderate Risk,Low (<50%),Moderate,Enzyme-Specific,Not Suitable
Aspirin,Thyroid Hormone Replacement,Antiviral,73.33,C9H8O4,NSAID,Gastrointestinal Issues,1996,Ibuprofen,Aspirin,Moderate Risk,Rapid Absorption,Ongoing,In Vitro Studies,Dopaminergic Pathway,Tablet,10mg once daily,Novartis,6,High,Low Risk,Low (<50%),Fast,Liver,Not Suitable
Metformin,Blood Thinner,Cancer Therapy,30.54,C33H35FN2O5,AMPK Activator,Acid Reflux,1996,Metformin Hydrochloride,Lipitor,Moderate Risk,Rapid Absorption,Phase 4,In Vitro Studies,MAPK Pathway,Injection,250mg every 8 hours,Pfizer,2,Moderate,Low Risk,Moderate (50-80%),Slow,Gut,Partially Suitable
Ibuprofen,Acid Reflux,Weight Loss,84.72,C9H8O4,COX Inhibitor,"Headache, Rash",1971,Omeprazole,Prilosec,Moderate Risk,Renal Excretion,Completed,No Preclinical Data,Serotonin Pathway,Tablet,10mg once daily,Merck,24,High,Moderate Risk,Moderate (50-80%),Fast,Gut,Suitable
Atorvastatin,Blood Thinner,Autoimmune Disorders,67.92,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Muscle Pain,1994,Metformin Hydrochloride,Glucophage,High Risk,Slow Metabolism,Completed,In Vitro Studies,Immune Response Pathway,Syrup,50mg daily,Novartis,2,High,Low Risk,Low (<50%),Slow,Gut,Not Suitable
Omeprazole,Cholesterol Control,Autoimmune Disorders,38.82,C9H8O4,COX Inhibitor,Muscle Pain,1971,Omeprazole,Aspirin,Low Risk,Liver Metabolism,Phase 1,In Vitro Studies,Serotonin Pathway,Tablet,As prescribed,Pfizer,48,Moderate,Low Risk,High (>80%),Slow,Gut,Suitable
Losartan,Cholesterol Control,Migraine Treatment,71.49,C9H8O4,Proton Pump Inhibitor,Muscle Pain,1987,Atorvastatin Calcium,Prilosec,Low Risk,High Bioavailability,Phase 4,In Vitro Studies,Serotonin Pathway,Capsule,250mg every 8 hours,Merck,12,Low,Moderate Risk,High (>80%),Slow,Renal,Not Suitable
Paracetamol,Pain Relief,Parkinson's,74.96,C13H18O2,COX Inhibitor,Acid Reflux,1996,Acetylsalicylic Acid,Lipitor,High Risk,Liver Metabolism,Phase 3,Animal Testing,MAPK Pathway,Capsule,250mg every 8 hours,Novartis,24,Moderate,Moderate Risk,High (>80%),Slow,Renal,Not Suitable
Ranitidine,Inflammation,Weight Loss,67.94,C4H11N5,NSAID,Gastrointestinal Issues,1987,Ibuprofen,Advil,High Risk,Renal Excretion,Completed,Animal Testing,Serotonin Pathway,Topical Gel,10mg once daily,Merck,24,Moderate,Low Risk,Moderate (50-80%),Moderate,Gut,Partially Suitable
Simvastatin,Cholesterol Control,Cardiovascular Disease,49.44,C17H19N3O3S,Proton Pump Inhibitor,Gastrointestinal Issues,1965,Metformin Hydrochloride,Advil,Moderate Risk,Renal Excretion,Phase 3,No Preclinical Data,Dopaminergic Pathway,Injection,As prescribed,Merck,24,High,Low Risk,Low (<50%),Slow,Enzyme-Specific,Partially Suitable
Levothyroxine,Inflammation,Cardiovascular Disease,78.46,C13H18O2,Proton Pump Inhibitor,"Nausea, Dizziness",1987,Ibuprofen,Glucophage,Moderate Risk,High Bioavailability,Completed,No Preclinical Data,Dopaminergic Pathway,Syrup,10mg once daily,Novartis,12,High,High Risk,Moderate (50-80%),Fast,Enzyme-Specific,Not Suitable
Aspirin,Blood Thinner,Anti-Aging,41.65,C13H18O2,NSAID,Gastrointestinal Issues,1994,Acetylsalicylic Acid,Advil,Low Risk,Renal Excretion,Phase 3,In Vitro Studies,Serotonin Pathway,Topical Gel,250mg every 8 hours,Novartis,12,High,Low Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Not Suitable
Metformin,Pain Relief,Antiviral,70.15,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Acid Reflux,1965,Atorvastatin Calcium,Lipitor,Low Risk,High Bioavailability,Phase 2,Animal Testing,MAPK Pathway,Tablet,As prescribed,Novartis,48,Low,High Risk,High (>80%),Slow,Renal,Suitable
Ibuprofen,Diabetes,Alzheimer's,58.87,C4H11N5,AMPK Activator,"Headache, Rash",1971,Acetylsalicylic Acid,Advil,Moderate Risk,Rapid Absorption,Phase 1,In Vitro Studies,PI3K-AKT Pathway,Tablet,250mg every 8 hours,Merck,12,Moderate,Low Risk,High (>80%),Moderate,Renal,Suitable
Atorvastatin,Cholesterol Control,Antiviral,34.86,C9H8O4,HMG-CoA Reductase Inhibitor,Acid Reflux,1971,Omeprazole,Advil,Moderate Risk,Liver Metabolism,Phase 1,Animal Testing,Immune Response Pathway,Injection,50mg daily,Roche,12,High,Moderate Risk,High (>80%),Slow,Liver,Partially Suitable
Omeprazole,Gastric Ulcer,Antiviral,66.36,C4H11N5,COX Inhibitor,Gastrointestinal Issues,1994,Atorvastatin Calcium,Advil,Moderate Risk,High Bioavailability,Ongoing,No Preclinical Data,Serotonin Pathway,Injection,10mg once daily,Roche,2,High,Moderate Risk,Low (<50%),Moderate,Liver,Suitable
Losartan,Diabetes,Antiviral,86.33,C13H18O2,NSAID,"Nausea, Dizziness",1996,Omeprazole,Glucophage,Moderate Risk,Liver Metabolism,Phase 3,No Preclinical Data,Serotonin Pathway,Capsule,50mg daily,Novartis,2,Moderate,Moderate Risk,Moderate (50-80%),Fast,Renal,Not Suitable
Paracetamol,Inflammation,Parkinson's,42.4,C17H19N3O3S,AMPK Activator,"Headache, Rash",1994,Omeprazole,Advil,Moderate Risk,Slow Metabolism,Ongoing,Toxicology Report,MAPK Pathway,Injection,50mg daily,Pfizer,2,Moderate,High Risk,Moderate (50-80%),Fast,Renal,Partially Suitable
Ranitidine,Pain Relief,Anti-Aging,68.37,C17H19N3O3S,COX Inhibitor,"Headache, Rash",1965,Atorvastatin Calcium,Glucophage,Moderate Risk,Slow Metabolism,Phase 1,In Vitro Studies,Dopaminergic Pathway,Topical Gel,250mg every 8 hours,AstraZeneca,2,Low,Low Risk,Moderate (50-80%),Moderate,Renal,Suitable
Simvastatin,Hypertension,Parkinson's,32.78,C33H35FN2O5,Proton Pump Inhibitor,Muscle Pain,1965,Acetylsalicylic Acid,Lipitor,Low Risk,Renal Excretion,Ongoing,Animal Testing,PI3K-AKT Pathway,Topical Gel,50mg daily,Pfizer,12,Low,High Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Levothyroxine,Pain Relief,Autoimmune Disorders,63.04,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1996,Omeprazole,Aspirin,Moderate Risk,High Bioavailability,Ongoing,Toxicology Report,Serotonin Pathway,Syrup,As prescribed,Novartis,24,Low,High Risk,Moderate (50-80%),Slow,Gut,Suitable
Aspirin,Acid Reflux,Autoimmune Disorders,63.12,C13H18O2,HMG-CoA Reductase Inhibitor,Acid Reflux,1994,Acetylsalicylic Acid,Prilosec,Low Risk,Slow Metabolism,Phase 3,Animal Testing,PI3K-AKT Pathway,Injection,10mg once daily,Merck,2,High,Low Risk,Low (<50%),Slow,Enzyme-Specific,Suitable
Metformin,Inflammation,Anti-Aging,66.93,C17H19N3O3S,COX Inhibitor,Muscle Pain,1971,Metformin Hydrochloride,Lipitor,Low Risk,Renal Excretion,Phase 2,Animal Testing,PI3K-AKT Pathway,Tablet,50mg daily,Merck,12,High,Moderate Risk,Moderate (50-80%),Fast,Enzyme-Specific,Partially Suitable
Ibuprofen,Blood Thinner,Migraine Treatment,42.36,C17H19N3O3S,Proton Pump Inhibitor,Muscle Pain,1965,Atorvastatin Calcium,Glucophage,Moderate Risk,Slow Metabolism,Phase 1,Toxicology Report,Immune Response Pathway,Tablet,500mg twice a day,Pfizer,2,Low,Low Risk,Moderate (50-80%),Slow,Liver,Not Suitable
Atorvastatin,Blood Thinner,Cardiovascular Disease,62.73,C9H8O4,NSAID,Acid Reflux,1965,Atorvastatin Calcium,Lipitor,Low Risk,Rapid Absorption,Ongoing,Toxicology Report,Immune Response Pathway,Syrup,10mg once daily,Pfizer,12,Low,Moderate Risk,High (>80%),Moderate,Renal,Suitable
Omeprazole,Diabetes,Anti-Aging,47.94,C33H35FN2O5,Proton Pump Inhibitor,Gastrointestinal Issues,1996,Atorvastatin Calcium,Prilosec,Moderate Risk,Renal Excretion,Completed,No Preclinical Data,Serotonin Pathway,Capsule,50mg daily,Roche,12,High,Low Risk,Low (<50%),Fast,Gut,Suitable
Losartan,Diabetes,Cardiovascular Disease,42.16,C9H8O4,Proton Pump Inhibitor,"Nausea, Dizziness",1971,Ibuprofen,Aspirin,High Risk,High Bioavailability,Completed,No Preclinical Data,PI3K-AKT Pathway,Tablet,250mg every 8 hours,Merck,24,Moderate,Moderate Risk,Moderate (50-80%),Fast,Renal,Suitable
Paracetamol,Pain Relief,Liver Disease,53.67,C33H35FN2O5,NSAID,Acid Reflux,1971,Ibuprofen,Advil,Low Risk,Rapid Absorption,Phase 1,No Preclinical Data,Immune Response Pathway,Tablet,As prescribed,Roche,12,Low,Low Risk,Low (<50%),Fast,Gut,Partially Suitable
Ranitidine,Inflammation,Antiviral,62.44,C17H19N3O3S,Proton Pump Inhibitor,"Nausea, Dizziness",1971,Metformin Hydrochloride,Aspirin,Low Risk,High Bioavailability,Completed,Animal Testing,PI3K-AKT Pathway,Tablet,50mg daily,Pfizer,48,High,Low Risk,Low (<50%),Moderate,Gut,Not Suitable
Simvastatin,Hypertension,Autoimmune Disorders,34.46,C4H11N5,Proton Pump Inhibitor,"Headache, Rash",1971,Ibuprofen,Prilosec,Moderate Risk,Slow Metabolism,Phase 1,No Preclinical Data,Serotonin Pathway,Syrup,50mg daily,Roche,24,Moderate,Low Risk,Moderate (50-80%),Fast,Renal,Partially Suitable
Levothyroxine,Inflammation,Anti-Aging,40.71,C13H18O2,NSAID,"Headache, Rash",1971,Acetylsalicylic Acid,Glucophage,Low Risk,Rapid Absorption,Ongoing,No Preclinical Data,Immune Response Pathway,Injection,250mg every 8 hours,Merck,24,Low,High Risk,Moderate (50-80%),Moderate,Gut,Partially Suitable
Aspirin,Gastric Ulcer,Alzheimer's,58.51,C33H35FN2O5,AMPK Activator,"Headache, Rash",1971,Atorvastatin Calcium,Glucophage,Moderate Risk,High Bioavailability,Phase 4,No Preclinical Data,PI3K-AKT Pathway,Syrup,50mg daily,Novartis,24,Low,High Risk,Low (<50%),Fast,Enzyme-Specific,Suitable
Metformin,Diabetes,Cancer Therapy,35.69,C33H35FN2O5,NSAID,"Headache, Rash",1987,Omeprazole,Aspirin,High Risk,High Bioavailability,Phase 4,Toxicology Report,Immune Response Pathway,Syrup,250mg every 8 hours,Roche,6,High,Low Risk,Moderate (50-80%),Slow,Enzyme-Specific,Suitable
Ibuprofen,Inflammation,Migraine Treatment,76.36,C17H19N3O3S,Proton Pump Inhibitor,"Nausea, Dizziness",1996,Atorvastatin Calcium,Prilosec,Moderate Risk,Slow Metabolism,Completed,No Preclinical Data,PI3K-AKT Pathway,Injection,500mg twice a day,AstraZeneca,12,High,Moderate Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Not Suitable
Atorvastatin,Fever,Parkinson's,85.67,C17H19N3O3S,Proton Pump Inhibitor,Acid Reflux,1987,Omeprazole,Advil,High Risk,Renal Excretion,Completed,No Preclinical Data,MAPK Pathway,Injection,50mg daily,AstraZeneca,24,Moderate,Moderate Risk,Moderate (50-80%),Moderate,Gut,Partially Suitable
Omeprazole,Blood Thinner,Parkinson's,77.41,C13H18O2,COX Inhibitor,Muscle Pain,1994,Ibuprofen,Glucophage,Moderate Risk,Liver Metabolism,Completed,Toxicology Report,PI3K-AKT Pathway,Injection,500mg twice a day,Roche,24,Moderate,Low Risk,Moderate (50-80%),Fast,Renal,Not Suitable
Losartan,Cholesterol Control,Migraine Treatment,48.6,C4H11N5,AMPK Activator,"Nausea, Dizziness",1965,Ibuprofen,Aspirin,Moderate Risk,Liver Metabolism,Ongoing,Animal Testing,MAPK Pathway,Tablet,500mg twice a day,Merck,48,High,High Risk,Low (<50%),Slow,Gut,Not Suitable
Paracetamol,Inflammation,Parkinson's,38.74,C4H11N5,Proton Pump Inhibitor,Muscle Pain,1971,Omeprazole,Prilosec,Low Risk,High Bioavailability,Phase 2,Toxicology Report,Serotonin Pathway,Topical Gel,As prescribed,Roche,6,High,Moderate Risk,High (>80%),Moderate,Gut,Not Suitable
Ranitidine,Hypertension,Antiviral,52.94,C33H35FN2O5,AMPK Activator,Gastrointestinal Issues,1965,Metformin Hydrochloride,Glucophage,Moderate Risk,High Bioavailability,Completed,Animal Testing,PI3K-AKT Pathway,Syrup,250mg every 8 hours,AstraZeneca,12,Low,Low Risk,Moderate (50-80%),Slow,Liver,Not Suitable
Simvastatin,Pain Relief,Liver Disease,88.76,C9H8O4,Proton Pump Inhibitor,"Headache, Rash",1965,Acetylsalicylic Acid,Lipitor,High Risk,Liver Metabolism,Phase 3,Toxicology Report,MAPK Pathway,Syrup,50mg daily,Pfizer,24,Moderate,High Risk,Moderate (50-80%),Moderate,Gut,Not Suitable
Levothyroxine,Fever,Liver Disease,50.01,C9H8O4,NSAID,Muscle Pain,1996,Omeprazole,Advil,High Risk,Renal Excretion,Phase 3,No Preclinical Data,Immune Response Pathway,Syrup,As prescribed,Novartis,24,Moderate,Moderate Risk,Moderate (50-80%),Moderate,Renal,Partially Suitable
Aspirin,Gastric Ulcer,Cardiovascular Disease,50.82,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Acid Reflux,1971,Ibuprofen,Advil,Low Risk,Renal Excretion,Phase 1,Toxicology Report,Immune Response Pathway,Injection,500mg twice a day,Pfizer,6,Moderate,High Risk,High (>80%),Fast,Liver,Not Suitable
Metformin,Thyroid Hormone Replacement,Weight Loss,40.46,C9H8O4,Proton Pump Inhibitor,"Headache, Rash",1996,Acetylsalicylic Acid,Lipitor,High Risk,High Bioavailability,Phase 4,In Vitro Studies,MAPK Pathway,Injection,500mg twice a day,Novartis,48,Moderate,Moderate Risk,Low (<50%),Slow,Gut,Partially Suitable
Ibuprofen,Blood Thinner,Cancer Therapy,72.09,C4H11N5,COX Inhibitor,"Nausea, Dizziness",1965,Ibuprofen,Aspirin,Moderate Risk,Renal Excretion,Completed,Toxicology Report,Immune Response Pathway,Capsule,250mg every 8 hours,Novartis,2,High,High Risk,Moderate (50-80%),Fast,Gut,Suitable
Atorvastatin,Acid Reflux,Cardiovascular Disease,58.92,C33H35FN2O5,AMPK Activator,"Headache, Rash",1996,Atorvastatin Calcium,Prilosec,Low Risk,High Bioavailability,Phase 4,Animal Testing,Serotonin Pathway,Syrup,250mg every 8 hours,Merck,2,Low,Moderate Risk,High (>80%),Fast,Liver,Not Suitable
Omeprazole,Gastric Ulcer,Cancer Therapy,83.41,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1996,Acetylsalicylic Acid,Aspirin,High Risk,Renal Excretion,Phase 2,No Preclinical Data,Dopaminergic Pathway,Injection,250mg every 8 hours,AstraZeneca,48,Low,High Risk,Low (<50%),Moderate,Renal,Not Suitable
Losartan,Thyroid Hormone Replacement,Parkinson's,55.82,C17H19N3O3S,Proton Pump Inhibitor,Muscle Pain,1965,Metformin Hydrochloride,Advil,Moderate Risk,Rapid Absorption,Phase 2,Toxicology Report,Serotonin Pathway,Capsule,50mg daily,AstraZeneca,12,Low,High Risk,High (>80%),Moderate,Gut,Not Suitable
Paracetamol,Diabetes,Cardiovascular Disease,71.47,C13H18O2,NSAID,Acid Reflux,1994,Atorvastatin Calcium,Advil,High Risk,Renal Excretion,Phase 3,In Vitro Studies,MAPK Pathway,Capsule,500mg twice a day,Roche,2,High,Moderate Risk,Moderate (50-80%),Slow,Gut,Partially Suitable
Ranitidine,Thyroid Hormone Replacement,Cardiovascular Disease,85.62,C33H35FN2O5,NSAID,Acid Reflux,1987,Atorvastatin Calcium,Aspirin,High Risk,Rapid Absorption,Phase 2,No Preclinical Data,Immune Response Pathway,Injection,10mg once daily,AstraZeneca,48,High,High Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Simvastatin,Hypertension,Alzheimer's,43.46,C17H19N3O3S,NSAID,Acid Reflux,1965,Acetylsalicylic Acid,Aspirin,Moderate Risk,Renal Excretion,Completed,In Vitro Studies,MAPK Pathway,Capsule,10mg once daily,Roche,2,Moderate,Low Risk,Moderate (50-80%),Moderate,Gut,Partially Suitable
Levothyroxine,Acid Reflux,Parkinson's,30.33,C13H18O2,Proton Pump Inhibitor,Muscle Pain,1965,Atorvastatin Calcium,Glucophage,Low Risk,Slow Metabolism,Phase 4,Animal Testing,Immune Response Pathway,Capsule,250mg every 8 hours,Merck,6,Moderate,Moderate Risk,Low (<50%),Fast,Enzyme-Specific,Suitable
Aspirin,Diabetes,Alzheimer's,94.67,C17H19N3O3S,NSAID,Acid Reflux,1965,Metformin Hydrochloride,Aspirin,High Risk,High Bioavailability,Ongoing,Animal Testing,PI3K-AKT Pathway,Injection,500mg twice a day,Novartis,6,Moderate,Low Risk,High (>80%),Moderate,Liver,Suitable
Metformin,Thyroid Hormone Replacement,Cancer Therapy,38.62,C13H18O2,AMPK Activator,Muscle Pain,1971,Acetylsalicylic Acid,Aspirin,Low Risk,Rapid Absorption,Ongoing,Toxicology Report,Immune Response Pathway,Topical Gel,10mg once daily,Pfizer,12,Moderate,Low Risk,High (>80%),Slow,Liver,Partially Suitable
Ibuprofen,Acid Reflux,Liver Disease,83.77,C17H19N3O3S,NSAID,"Nausea, Dizziness",1996,Omeprazole,Glucophage,High Risk,Slow Metabolism,Phase 2,Toxicology Report,Serotonin Pathway,Capsule,500mg twice a day,Roche,2,High,Low Risk,High (>80%),Fast,Enzyme-Specific,Not Suitable
Atorvastatin,Blood Thinner,Cardiovascular Disease,76.3,C13H18O2,NSAID,Gastrointestinal Issues,1994,Ibuprofen,Glucophage,Moderate Risk,High Bioavailability,Phase 4,In Vitro Studies,Dopaminergic Pathway,Injection,500mg twice a day,Pfizer,24,Low,Low Risk,Moderate (50-80%),Slow,Enzyme-Specific,Partially Suitable
Omeprazole,Pain Relief,Parkinson's,88.2,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1996,Acetylsalicylic Acid,Lipitor,Low Risk,High Bioavailability,Phase 4,No Preclinical Data,Immune Response Pathway,Tablet,50mg daily,Novartis,48,Moderate,Moderate Risk,High (>80%),Moderate,Gut,Partially Suitable
Losartan,Thyroid Hormone Replacement,Antiviral,93.51,C9H8O4,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1996,Ibuprofen,Prilosec,Low Risk,Slow Metabolism,Phase 1,Toxicology Report,PI3K-AKT Pathway,Syrup,10mg once daily,Novartis,12,High,Moderate Risk,Low (<50%),Moderate,Renal,Partially Suitable
Paracetamol,Pain Relief,Anti-Aging,83.98,C4H11N5,AMPK Activator,"Headache, Rash",1971,Metformin Hydrochloride,Prilosec,High Risk,High Bioavailability,Phase 1,In Vitro Studies,Serotonin Pathway,Topical Gel,10mg once daily,AstraZeneca,24,Moderate,Low Risk,Low (<50%),Moderate,Gut,Partially Suitable
Ranitidine,Hypertension,Antiviral,43.88,C33H35FN2O5,COX Inhibitor,"Headache, Rash",1965,Acetylsalicylic Acid,Glucophage,High Risk,Renal Excretion,Completed,Animal Testing,Dopaminergic Pathway,Injection,10mg once daily,Merck,24,Moderate,High Risk,Moderate (50-80%),Fast,Renal,Suitable
Simvastatin,Cholesterol Control,Cardiovascular Disease,60.94,C9H8O4,AMPK Activator,Muscle Pain,1996,Atorvastatin Calcium,Lipitor,Moderate Risk,High Bioavailability,Phase 3,In Vitro Studies,PI3K-AKT Pathway,Syrup,As prescribed,Roche,2,High,Low Risk,High (>80%),Fast,Enzyme-Specific,Partially Suitable
Levothyroxine,Hypertension,Cardiovascular Disease,53.24,C17H19N3O3S,AMPK Activator,Gastrointestinal Issues,1987,Metformin Hydrochloride,Aspirin,Low Risk,Slow Metabolism,Ongoing,Animal Testing,PI3K-AKT Pathway,Capsule,10mg once daily,Roche,12,Low,Low Risk,Moderate (50-80%),Moderate,Liver,Suitable
Aspirin,Fever,Migraine Treatment,37.61,C17H19N3O3S,AMPK Activator,Gastrointestinal Issues,1987,Ibuprofen,Advil,Moderate Risk,Renal Excretion,Phase 4,In Vitro Studies,Serotonin Pathway,Capsule,As prescribed,Pfizer,6,High,Moderate Risk,High (>80%),Moderate,Enzyme-Specific,Not Suitable
Metformin,Gastric Ulcer,Cancer Therapy,75.24,C33H35FN2O5,AMPK Activator,"Nausea, Dizziness",1971,Atorvastatin Calcium,Advil,High Risk,High Bioavailability,Completed,In Vitro Studies,PI3K-AKT Pathway,Injection,50mg daily,AstraZeneca,48,Low,High Risk,Low (<50%),Moderate,Enzyme-Specific,Not Suitable
Ibuprofen,Thyroid Hormone Replacement,Alzheimer's,71.14,C13H18O2,COX Inhibitor,Muscle Pain,1996,Metformin Hydrochloride,Lipitor,Moderate Risk,Renal Excretion,Phase 3,No Preclinical Data,MAPK Pathway,Injection,10mg once daily,Pfizer,48,High,High Risk,Low (<50%),Slow,Liver,Suitable
Atorvastatin,Gastric Ulcer,Weight Loss,88.74,C17H19N3O3S,COX Inhibitor,Gastrointestinal Issues,1994,Ibuprofen,Prilosec,High Risk,Slow Metabolism,Phase 4,Animal Testing,Dopaminergic Pathway,Tablet,As prescribed,AstraZeneca,6,High,Moderate Risk,Low (<50%),Fast,Enzyme-Specific,Partially Suitable
Omeprazole,Hypertension,Autoimmune Disorders,50.83,C17H19N3O3S,NSAID,"Nausea, Dizziness",1994,Metformin Hydrochloride,Advil,Low Risk,High Bioavailability,Phase 4,Animal Testing,MAPK Pathway,Tablet,10mg once daily,AstraZeneca,24,Moderate,High Risk,High (>80%),Fast,Renal,Suitable
Losartan,Pain Relief,Migraine Treatment,77.84,C17H19N3O3S,NSAID,Gastrointestinal Issues,1965,Ibuprofen,Prilosec,Low Risk,Liver Metabolism,Phase 2,Animal Testing,Dopaminergic Pathway,Injection,50mg daily,Pfizer,48,High,Moderate Risk,High (>80%),Slow,Enzyme-Specific,Not Suitable
Paracetamol,Fever,Migraine Treatment,53.07,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1987,Acetylsalicylic Acid,Glucophage,Low Risk,High Bioavailability,Phase 1,No Preclinical Data,MAPK Pathway,Capsule,500mg twice a day,Roche,6,High,Low Risk,Moderate (50-80%),Slow,Liver,Partially Suitable
Ranitidine,Blood Thinner,Autoimmune Disorders,43.03,C13H18O2,HMG-CoA Reductase Inhibitor,"Headache, Rash",1994,Acetylsalicylic Acid,Aspirin,High Risk,Slow Metabolism,Completed,No Preclinical Data,PI3K-AKT Pathway,Syrup,500mg twice a day,Roche,24,High,High Risk,Moderate (50-80%),Slow,Enzyme-Specific,Not Suitable
Simvastatin,Acid Reflux,Liver Disease,53.11,C4H11N5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1987,Omeprazole,Glucophage,High Risk,Renal Excretion,Phase 3,In Vitro Studies,Dopaminergic Pathway,Capsule,50mg daily,Pfizer,24,Moderate,High Risk,High (>80%),Fast,Renal,Suitable
Levothyroxine,Gastric Ulcer,Antiviral,30.64,C33H35FN2O5,Proton Pump Inhibitor,Muscle Pain,1987,Metformin Hydrochloride,Lipitor,Low Risk,Liver Metabolism,Phase 4,In Vitro Studies,Immune Response Pathway,Capsule,10mg once daily,Novartis,6,High,High Risk,Moderate (50-80%),Slow,Enzyme-Specific,Not Suitable
Aspirin,Thyroid Hormone Replacement,Autoimmune Disorders,31.63,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Acid Reflux,1996,Omeprazole,Advil,High Risk,Liver Metabolism,Phase 2,Toxicology Report,PI3K-AKT Pathway,Topical Gel,As prescribed,Novartis,24,High,High Risk,High (>80%),Moderate,Renal,Suitable
Metformin,Blood Thinner,Liver Disease,32.92,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Muscle Pain,1971,Omeprazole,Lipitor,Low Risk,Renal Excretion,Completed,No Preclinical Data,Immune Response Pathway,Syrup,As prescribed,Roche,48,High,Low Risk,Low (<50%),Moderate,Enzyme-Specific,Partially Suitable
Ibuprofen,Fever,Weight Loss,62.35,C9H8O4,COX Inhibitor,Acid Reflux,1965,Acetylsalicylic Acid,Aspirin,Low Risk,Liver Metabolism,Phase 2,No Preclinical Data,PI3K-AKT Pathway,Injection,500mg twice a day,AstraZeneca,24,Low,High Risk,Low (<50%),Fast,Renal,Not Suitable
Atorvastatin,Cholesterol Control,Antiviral,65.74,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1971,Omeprazole,Lipitor,Low Risk,Renal Excretion,Phase 3,No Preclinical Data,PI3K-AKT Pathway,Capsule,As prescribed,Roche,48,Low,High Risk,Moderate (50-80%),Slow,Renal,Not Suitable
Omeprazole,Hypertension,Autoimmune Disorders,59.62,C4H11N5,AMPK Activator,Muscle Pain,1994,Acetylsalicylic Acid,Lipitor,Low Risk,Renal Excretion,Ongoing,Toxicology Report,MAPK Pathway,Injection,250mg every 8 hours,Merck,2,Moderate,High Risk,Low (<50%),Slow,Renal,Not Suitable
Losartan,Cholesterol Control,Liver Disease,67.21,C17H19N3O3S,AMPK Activator,Acid Reflux,1994,Ibuprofen,Glucophage,High Risk,Renal Excretion,Ongoing,No Preclinical Data,Dopaminergic Pathway,Topical Gel,500mg twice a day,Pfizer,12,Low,Low Risk,Low (<50%),Moderate,Liver,Not Suitable
Paracetamol,Gastric Ulcer,Weight Loss,94.96,C9H8O4,COX Inhibitor,Acid Reflux,1965,Ibuprofen,Advil,Low Risk,Renal Excretion,Phase 2,Toxicology Report,PI3K-AKT Pathway,Topical Gel,10mg once daily,Merck,24,Moderate,Low Risk,Low (<50%),Fast,Enzyme-Specific,Suitable
Ranitidine,Cholesterol Control,Migraine Treatment,59.2,C9H8O4,COX Inhibitor,Gastrointestinal Issues,1965,Ibuprofen,Advil,Low Risk,Rapid Absorption,Phase 4,Animal Testing,Immune Response Pathway,Topical Gel,250mg every 8 hours,Pfizer,12,Low,High Risk,Low (<50%),Slow,Liver,Not Suitable
Simvastatin,Gastric Ulcer,Anti-Aging,66.86,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Muscle Pain,1996,Atorvastatin Calcium,Lipitor,High Risk,Slow Metabolism,Phase 4,No Preclinical Data,MAPK Pathway,Tablet,250mg every 8 hours,Roche,2,High,High Risk,High (>80%),Moderate,Renal,Not Suitable
Levothyroxine,Cholesterol Control,Antiviral,33.79,C17H19N3O3S,AMPK Activator,"Headache, Rash",1971,Ibuprofen,Aspirin,High Risk,Renal Excretion,Phase 4,Toxicology Report,MAPK Pathway,Syrup,250mg every 8 hours,Roche,2,High,High Risk,High (>80%),Fast,Renal,Not Suitable
Aspirin,Cholesterol Control,Alzheimer's,52.28,C4H11N5,COX Inhibitor,"Headache, Rash",1996,Metformin Hydrochloride,Aspirin,Moderate Risk,Renal Excretion,Ongoing,No Preclinical Data,PI3K-AKT Pathway,Injection,As prescribed,Novartis,2,Low,Moderate Risk,High (>80%),Slow,Liver,Partially Suitable
Metformin,Cholesterol Control,Alzheimer's,84.3,C33H35FN2O5,AMPK Activator,"Headache, Rash",1987,Metformin Hydrochloride,Advil,Moderate Risk,High Bioavailability,Phase 3,Toxicology Report,PI3K-AKT Pathway,Capsule,10mg once daily,Roche,48,Moderate,Low Risk,Moderate (50-80%),Fast,Liver,Suitable
Ibuprofen,Blood Thinner,Cardiovascular Disease,77.06,C17H19N3O3S,HMG-CoA Reductase Inhibitor,"Headache, Rash",1971,Metformin Hydrochloride,Advil,High Risk,Renal Excretion,Phase 3,Animal Testing,Serotonin Pathway,Topical Gel,500mg twice a day,AstraZeneca,48,High,Low Risk,High (>80%),Slow,Gut,Partially Suitable
Atorvastatin,Cholesterol Control,Cardiovascular Disease,66.09,C9H8O4,Proton Pump Inhibitor,Gastrointestinal Issues,1971,Omeprazole,Prilosec,Low Risk,Rapid Absorption,Phase 4,Animal Testing,MAPK Pathway,Tablet,50mg daily,Merck,24,Moderate,Low Risk,Low (<50%),Slow,Renal,Suitable
Omeprazole,Blood Thinner,Cancer Therapy,76.8,C17H19N3O3S,NSAID,"Headache, Rash",1965,Omeprazole,Advil,Moderate Risk,Slow Metabolism,Completed,Toxicology Report,MAPK Pathway,Syrup,As prescribed,AstraZeneca,6,High,High Risk,High (>80%),Fast,Liver,Suitable
Losartan,Pain Relief,Alzheimer's,56.01,C33H35FN2O5,COX Inhibitor,Acid Reflux,1971,Ibuprofen,Glucophage,High Risk,Slow Metabolism,Phase 4,In Vitro Studies,PI3K-AKT Pathway,Capsule,250mg every 8 hours,Novartis,24,Moderate,Moderate Risk,Low (<50%),Fast,Renal,Not Suitable
Paracetamol,Cholesterol Control,Parkinson's,30.21,C9H8O4,Proton Pump Inhibitor,Gastrointestinal Issues,1994,Metformin Hydrochloride,Aspirin,Low Risk,Liver Metabolism,Phase 2,In Vitro Studies,Immune Response Pathway,Injection,50mg daily,Roche,48,Low,High Risk,High (>80%),Fast,Gut,Not Suitable
Ranitidine,Diabetes,Antiviral,51.87,C9H8O4,HMG-CoA Reductase Inhibitor,"Headache, Rash",1994,Ibuprofen,Prilosec,Moderate Risk,Rapid Absorption,Ongoing,Toxicology Report,MAPK Pathway,Topical Gel,10mg once daily,Roche,2,Moderate,Low Risk,Low (<50%),Fast,Liver,Suitable
Simvastatin,Diabetes,Cardiovascular Disease,36.81,C4H11N5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1965,Acetylsalicylic Acid,Glucophage,High Risk,Liver Metabolism,Phase 4,In Vitro Studies,PI3K-AKT Pathway,Topical Gel,500mg twice a day,Merck,12,Low,High Risk,Moderate (50-80%),Fast,Renal,Partially Suitable
Levothyroxine,Diabetes,Liver Disease,65.61,C17H19N3O3S,Proton Pump Inhibitor,Acid Reflux,1971,Metformin Hydrochloride,Prilosec,Low Risk,Renal Excretion,Phase 4,Animal Testing,MAPK Pathway,Syrup,50mg daily,AstraZeneca,12,Low,Low Risk,Low (<50%),Slow,Gut,Partially Suitable
Aspirin,Fever,Cancer Therapy,82.53,C9H8O4,NSAID,"Headache, Rash",1996,Acetylsalicylic Acid,Prilosec,High Risk,High Bioavailability,Completed,No Preclinical Data,Serotonin Pathway,Capsule,10mg once daily,Roche,6,Low,Low Risk,Moderate (50-80%),Fast,Renal,Suitable
Metformin,Pain Relief,Cancer Therapy,38.95,C17H19N3O3S,Proton Pump Inhibitor,Muscle Pain,1987,Acetylsalicylic Acid,Glucophage,Moderate Risk,Renal Excretion,Completed,Toxicology Report,Serotonin Pathway,Injection,As prescribed,Roche,12,Moderate,Low Risk,Low (<50%),Fast,Enzyme-Specific,Partially Suitable
Ibuprofen,Cholesterol Control,Liver Disease,40.09,C33H35FN2O5,Proton Pump Inhibitor,Gastrointestinal Issues,1971,Metformin Hydrochloride,Prilosec,Low Risk,High Bioavailability,Phase 1,No Preclinical Data,Immune Response Pathway,Syrup,10mg once daily,Roche,48,High,Moderate Risk,Moderate (50-80%),Slow,Enzyme-Specific,Not Suitable
Atorvastatin,Thyroid Hormone Replacement,Alzheimer's,53.45,C4H11N5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1987,Metformin Hydrochloride,Lipitor,High Risk,Slow Metabolism,Phase 3,No Preclinical Data,Dopaminergic Pathway,Topical Gel,As prescribed,Novartis,24,Moderate,Moderate Risk,Moderate (50-80%),Moderate,Renal,Partially Suitable
Omeprazole,Inflammation,Cardiovascular Disease,40.63,C4H11N5,AMPK Activator,Acid Reflux,1996,Acetylsalicylic Acid,Lipitor,Moderate Risk,Liver Metabolism,Phase 3,Animal Testing,Dopaminergic Pathway,Syrup,50mg daily,Novartis,2,Low,High Risk,High (>80%),Moderate,Liver,Suitable
Losartan,Blood Thinner,Weight Loss,53.27,C9H8O4,HMG-CoA Reductase Inhibitor,Acid Reflux,1987,Metformin Hydrochloride,Prilosec,High Risk,Rapid Absorption,Phase 4,Animal Testing,Immune Response Pathway,Syrup,50mg daily,Merck,6,High,High Risk,High (>80%),Moderate,Gut,Not Suitable
Paracetamol,Inflammation,Antiviral,51.43,C13H18O2,AMPK Activator,Gastrointestinal Issues,1965,Acetylsalicylic Acid,Glucophage,Low Risk,Rapid Absorption,Phase 1,No Preclinical Data,Dopaminergic Pathway,Capsule,As prescribed,AstraZeneca,2,High,Moderate Risk,High (>80%),Fast,Renal,Not Suitable
Ranitidine,Gastric Ulcer,Weight Loss,59.51,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1987,Omeprazole,Lipitor,Moderate Risk,Rapid Absorption,Completed,In Vitro Studies,PI3K-AKT Pathway,Syrup,As prescribed,Pfizer,12,Moderate,Low Risk,High (>80%),Moderate,Renal,Suitable
Simvastatin,Gastric Ulcer,Liver Disease,84.22,C13H18O2,Proton Pump Inhibitor,"Headache, Rash",1987,Acetylsalicylic Acid,Aspirin,Low Risk,Slow Metabolism,Completed,No Preclinical Data,Dopaminergic Pathway,Capsule,50mg daily,AstraZeneca,12,Moderate,Moderate Risk,High (>80%),Fast,Enzyme-Specific,Not Suitable
Levothyroxine,Gastric Ulcer,Cardiovascular Disease,40.26,C4H11N5,AMPK Activator,Acid Reflux,1987,Omeprazole,Advil,High Risk,Renal Excretion,Phase 3,In Vitro Studies,Dopaminergic Pathway,Syrup,500mg twice a day,Roche,48,Moderate,Moderate Risk,Moderate (50-80%),Moderate,Liver,Partially Suitable
Aspirin,Inflammation,Anti-Aging,68.74,C17H19N3O3S,AMPK Activator,"Nausea, Dizziness",1996,Atorvastatin Calcium,Lipitor,Low Risk,Renal Excretion,Phase 2,In Vitro Studies,Immune Response Pathway,Topical Gel,250mg every 8 hours,AstraZeneca,24,Low,High Risk,Moderate (50-80%),Fast,Renal,Suitable
Metformin,Blood Thinner,Parkinson's,66.48,C13H18O2,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1965,Ibuprofen,Glucophage,High Risk,Slow Metabolism,Phase 3,Animal Testing,MAPK Pathway,Tablet,500mg twice a day,Merck,48,Moderate,Moderate Risk,Moderate (50-80%),Slow,Enzyme-Specific,Not Suitable
Ibuprofen,Acid Reflux,Liver Disease,82.3,C13H18O2,Proton Pump Inhibitor,Muscle Pain,1994,Ibuprofen,Glucophage,Moderate Risk,Slow Metabolism,Phase 2,No Preclinical Data,Serotonin Pathway,Injection,250mg every 8 hours,Pfizer,6,Low,High Risk,High (>80%),Moderate,Enzyme-Specific,Suitable
Atorvastatin,Cholesterol Control,Parkinson's,94.02,C4H11N5,NSAID,Gastrointestinal Issues,1994,Acetylsalicylic Acid,Prilosec,Low Risk,High Bioavailability,Completed,Toxicology Report,MAPK Pathway,Topical Gel,250mg every 8 hours,Roche,12,High,Moderate Risk,Low (<50%),Fast,Gut,Partially Suitable
Omeprazole,Acid Reflux,Antiviral,72.07,C33H35FN2O5,AMPK Activator,"Nausea, Dizziness",1987,Atorvastatin Calcium,Glucophage,Moderate Risk,Rapid Absorption,Phase 2,No Preclinical Data,MAPK Pathway,Topical Gel,50mg daily,Roche,12,Low,Moderate Risk,Moderate (50-80%),Fast,Gut,Suitable
Losartan,Gastric Ulcer,Weight Loss,49.78,C33H35FN2O5,NSAID,Gastrointestinal Issues,1971,Atorvastatin Calcium,Lipitor,High Risk,Rapid Absorption,Phase 4,Toxicology Report,Serotonin Pathway,Tablet,10mg once daily,Pfizer,24,High,Moderate Risk,Low (<50%),Slow,Enzyme-Specific,Partially Suitable
Paracetamol,Blood Thinner,Liver Disease,75.94,C33H35FN2O5,Proton Pump Inhibitor,Gastrointestinal Issues,1996,Omeprazole,Aspirin,Moderate Risk,Slow Metabolism,Ongoing,No Preclinical Data,Immune Response Pathway,Syrup,As prescribed,Roche,2,Moderate,High Risk,Low (<50%),Slow,Gut,Partially Suitable
Ranitidine,Blood Thinner,Cardiovascular Disease,61.5,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1987,Ibuprofen,Advil,High Risk,Liver Metabolism,Phase 4,No Preclinical Data,Serotonin Pathway,Topical Gel,50mg daily,Pfizer,48,High,High Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Not Suitable
Simvastatin,Pain Relief,Weight Loss,81.96,C4H11N5,Proton Pump Inhibitor,Muscle Pain,1996,Omeprazole,Lipitor,Low Risk,Renal Excretion,Phase 3,In Vitro Studies,Dopaminergic Pathway,Syrup,250mg every 8 hours,AstraZeneca,2,Low,High Risk,High (>80%),Fast,Gut,Partially Suitable
Levothyroxine,Cholesterol Control,Autoimmune Disorders,31.55,C4H11N5,AMPK Activator,"Headache, Rash",1996,Ibuprofen,Aspirin,Moderate Risk,High Bioavailability,Phase 1,In Vitro Studies,MAPK Pathway,Capsule,10mg once daily,Pfizer,48,Low,Moderate Risk,Low (<50%),Moderate,Liver,Suitable
Aspirin,Hypertension,Cardiovascular Disease,73.91,C13H18O2,NSAID,Muscle Pain,1971,Acetylsalicylic Acid,Lipitor,High Risk,High Bioavailability,Completed,Animal Testing,PI3K-AKT Pathway,Topical Gel,50mg daily,Roche,6,High,High Risk,High (>80%),Fast,Enzyme-Specific,Suitable
Metformin,Hypertension,Parkinson's,78.26,C4H11N5,AMPK Activator,Gastrointestinal Issues,1994,Acetylsalicylic Acid,Advil,High Risk,Renal Excretion,Phase 4,Toxicology Report,MAPK Pathway,Topical Gel,50mg daily,Merck,2,Moderate,High Risk,Moderate (50-80%),Fast,Liver,Partially Suitable
Ibuprofen,Diabetes,Anti-Aging,81.33,C4H11N5,AMPK Activator,Gastrointestinal Issues,1987,Omeprazole,Glucophage,Low Risk,Slow Metabolism,Phase 2,Toxicology Report,Immune Response Pathway,Injection,As prescribed,AstraZeneca,2,Moderate,High Risk,High (>80%),Slow,Renal,Not Suitable
Atorvastatin,Acid Reflux,Parkinson's,51.48,C13H18O2,Proton Pump Inhibitor,Gastrointestinal Issues,1996,Ibuprofen,Advil,Low Risk,Liver Metabolism,Phase 4,In Vitro Studies,Dopaminergic Pathway,Topical Gel,10mg once daily,Merck,6,High,Moderate Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Omeprazole,Pain Relief,Alzheimer's,48.26,C33H35FN2O5,NSAID,Acid Reflux,1971,Omeprazole,Aspirin,Moderate Risk,Renal Excretion,Phase 4,Animal Testing,PI3K-AKT Pathway,Topical Gel,50mg daily,Roche,48,Moderate,Moderate Risk,Low (<50%),Moderate,Gut,Partially Suitable
Losartan,Fever,Cancer Therapy,77.27,C4H11N5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1965,Atorvastatin Calcium,Prilosec,Moderate Risk,Rapid Absorption,Phase 2,Animal Testing,Dopaminergic Pathway,Tablet,250mg every 8 hours,AstraZeneca,12,Low,High Risk,Moderate (50-80%),Moderate,Gut,Not Suitable
Paracetamol,Hypertension,Liver Disease,62.11,C33H35FN2O5,COX Inhibitor,Muscle Pain,1994,Ibuprofen,Lipitor,High Risk,Rapid Absorption,Phase 1,In Vitro Studies,Dopaminergic Pathway,Syrup,10mg once daily,Roche,48,Moderate,Low Risk,High (>80%),Moderate,Renal,Not Suitable
Ranitidine,Fever,Autoimmune Disorders,60.97,C9H8O4,COX Inhibitor,"Nausea, Dizziness",1965,Omeprazole,Aspirin,Moderate Risk,Slow Metabolism,Phase 4,No Preclinical Data,Serotonin Pathway,Topical Gel,As prescribed,Novartis,6,Low,Low Risk,Low (<50%),Fast,Renal,Not Suitable
Simvastatin,Thyroid Hormone Replacement,Parkinson's,73.58,C9H8O4,NSAID,Acid Reflux,1965,Acetylsalicylic Acid,Lipitor,Moderate Risk,Liver Metabolism,Phase 1,In Vitro Studies,Dopaminergic Pathway,Injection,500mg twice a day,Roche,12,Moderate,Moderate Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Suitable
Levothyroxine,Blood Thinner,Cardiovascular Disease,88.07,C9H8O4,AMPK Activator,Gastrointestinal Issues,1996,Metformin Hydrochloride,Prilosec,Moderate Risk,Liver Metabolism,Phase 3,No Preclinical Data,MAPK Pathway,Injection,500mg twice a day,Pfizer,24,Low,Moderate Risk,Low (<50%),Slow,Gut,Suitable
Aspirin,Thyroid Hormone Replacement,Cardiovascular Disease,79.54,C13H18O2,COX Inhibitor,"Headache, Rash",1987,Metformin Hydrochloride,Lipitor,High Risk,Rapid Absorption,Phase 2,Animal Testing,Dopaminergic Pathway,Injection,10mg once daily,Merck,6,Low,Moderate Risk,Moderate (50-80%),Moderate,Gut,Suitable
Metformin,Cholesterol Control,Alzheimer's,55.5,C33H35FN2O5,COX Inhibitor,"Nausea, Dizziness",1971,Atorvastatin Calcium,Glucophage,High Risk,Liver Metabolism,Phase 2,Toxicology Report,Immune Response Pathway,Capsule,10mg once daily,Novartis,48,High,Low Risk,Moderate (50-80%),Slow,Renal,Suitable
Ibuprofen,Inflammation,Parkinson's,40.57,C13H18O2,Proton Pump Inhibitor,"Headache, Rash",1994,Ibuprofen,Advil,Low Risk,Rapid Absorption,Phase 3,Animal Testing,Immune Response Pathway,Tablet,50mg daily,AstraZeneca,12,Low,Moderate Risk,Moderate (50-80%),Moderate,Gut,Suitable
Atorvastatin,Gastric Ulcer,Antiviral,87.26,C33H35FN2O5,NSAID,"Nausea, Dizziness",1965,Atorvastatin Calcium,Prilosec,Moderate Risk,Slow Metabolism,Phase 3,Animal Testing,Serotonin Pathway,Tablet,250mg every 8 hours,Pfizer,48,High,Low Risk,High (>80%),Moderate,Gut,Not Suitable
Omeprazole,Thyroid Hormone Replacement,Anti-Aging,64.62,C17H19N3O3S,AMPK Activator,Muscle Pain,1987,Atorvastatin Calcium,Advil,High Risk,Slow Metabolism,Phase 1,Toxicology Report,Dopaminergic Pathway,Injection,50mg daily,Pfizer,48,High,Moderate Risk,Low (<50%),Slow,Gut,Not Suitable
Losartan,Diabetes,Antiviral,70.09,C33H35FN2O5,AMPK Activator,Acid Reflux,1996,Ibuprofen,Glucophage,Low Risk,High Bioavailability,Phase 1,Animal Testing,MAPK Pathway,Capsule,50mg daily,Novartis,2,Moderate,Low Risk,Moderate (50-80%),Slow,Liver,Suitable
Paracetamol,Fever,Weight Loss,65.41,C9H8O4,Proton Pump Inhibitor,Muscle Pain,1971,Atorvastatin Calcium,Glucophage,Low Risk,Slow Metabolism,Completed,Animal Testing,Serotonin Pathway,Capsule,50mg daily,Roche,12,Moderate,Low Risk,Moderate (50-80%),Slow,Liver,Suitable
Ranitidine,Acid Reflux,Cancer Therapy,83.89,C4H11N5,Proton Pump Inhibitor,Gastrointestinal Issues,1965,Omeprazole,Prilosec,Moderate Risk,Liver Metabolism,Phase 3,In Vitro Studies,MAPK Pathway,Capsule,10mg once daily,Novartis,24,Moderate,Moderate Risk,High (>80%),Moderate,Renal,Suitable
Simvastatin,Pain Relief,Weight Loss,62.32,C33H35FN2O5,AMPK Activator,"Nausea, Dizziness",1971,Acetylsalicylic Acid,Advil,Moderate Risk,Renal Excretion,Phase 1,Toxicology Report,Serotonin Pathway,Syrup,As prescribed,Pfizer,48,Moderate,Moderate Risk,High (>80%),Fast,Liver,Suitable
Levothyroxine,Fever,Cancer Therapy,91.22,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1965,Ibuprofen,Prilosec,Low Risk,Slow Metabolism,Phase 3,Toxicology Report,Dopaminergic Pathway,Topical Gel,As prescribed,Roche,12,High,Low Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Aspirin,Blood Thinner,Liver Disease,68.07,C9H8O4,AMPK Activator,Muscle Pain,1965,Ibuprofen,Lipitor,Moderate Risk,Slow Metabolism,Completed,Toxicology Report,MAPK Pathway,Topical Gel,10mg once daily,Roche,12,High,Moderate Risk,High (>80%),Moderate,Renal,Not Suitable
Metformin,Gastric Ulcer,Liver Disease,30.45,C13H18O2,Proton Pump Inhibitor,"Nausea, Dizziness",1971,Acetylsalicylic Acid,Aspirin,Moderate Risk,Liver Metabolism,Phase 2,Animal Testing,Serotonin Pathway,Topical Gel,As prescribed,Pfizer,24,High,High Risk,Low (<50%),Moderate,Enzyme-Specific,Not Suitable
Ibuprofen,Fever,Cardiovascular Disease,69.45,C33H35FN2O5,NSAID,Gastrointestinal Issues,1987,Omeprazole,Lipitor,Moderate Risk,Rapid Absorption,Completed,In Vitro Studies,PI3K-AKT Pathway,Tablet,50mg daily,Merck,48,Moderate,Low Risk,High (>80%),Slow,Renal,Not Suitable
Atorvastatin,Inflammation,Parkinson's,51.34,C33H35FN2O5,AMPK Activator,Muscle Pain,1994,Ibuprofen,Advil,High Risk,Liver Metabolism,Phase 2,In Vitro Studies,PI3K-AKT Pathway,Topical Gel,10mg once daily,Merck,12,Moderate,Moderate Risk,Moderate (50-80%),Slow,Gut,Not Suitable
Omeprazole,Gastric Ulcer,Liver Disease,67.82,C4H11N5,COX Inhibitor,Gastrointestinal Issues,1971,Omeprazole,Prilosec,Moderate Risk,Liver Metabolism,Phase 3,No Preclinical Data,Dopaminergic Pathway,Capsule,10mg once daily,Pfizer,6,Low,High Risk,Low (<50%),Moderate,Gut,Partially Suitable
Losartan,Diabetes,Antiviral,56.49,C9H8O4,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1971,Ibuprofen,Glucophage,Moderate Risk,Rapid Absorption,Phase 4,No Preclinical Data,MAPK Pathway,Topical Gel,250mg every 8 hours,Merck,6,Low,High Risk,Moderate (50-80%),Moderate,Liver,Suitable
Paracetamol,Inflammation,Cardiovascular Disease,50.47,C4H11N5,COX Inhibitor,"Nausea, Dizziness",1971,Atorvastatin Calcium,Advil,Moderate Risk,Slow Metabolism,Phase 3,Animal Testing,MAPK Pathway,Syrup,As prescribed,Roche,6,High,Moderate Risk,Moderate (50-80%),Slow,Liver,Partially Suitable
Ranitidine,Inflammation,Anti-Aging,44.77,C4H11N5,AMPK Activator,"Headache, Rash",1996,Atorvastatin Calcium,Prilosec,Low Risk,Liver Metabolism,Ongoing,Animal Testing,Serotonin Pathway,Syrup,500mg twice a day,Roche,6,High,Low Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Simvastatin,Fever,Parkinson's,83.35,C33H35FN2O5,COX Inhibitor,Acid Reflux,1971,Metformin Hydrochloride,Glucophage,Low Risk,Renal Excretion,Phase 4,Toxicology Report,Serotonin Pathway,Topical Gel,500mg twice a day,Novartis,24,Low,Low Risk,Moderate (50-80%),Slow,Enzyme-Specific,Suitable
Levothyroxine,Blood Thinner,Autoimmune Disorders,94.43,C4H11N5,COX Inhibitor,Acid Reflux,1987,Atorvastatin Calcium,Advil,Low Risk,Renal Excretion,Phase 1,Toxicology Report,PI3K-AKT Pathway,Tablet,500mg twice a day,Novartis,48,Moderate,Low Risk,Low (<50%),Moderate,Gut,Partially Suitable
Aspirin,Thyroid Hormone Replacement,Cancer Therapy,49.19,C33H35FN2O5,COX Inhibitor,"Nausea, Dizziness",1971,Acetylsalicylic Acid,Aspirin,Moderate Risk,Renal Excretion,Phase 2,In Vitro Studies,Dopaminergic Pathway,Capsule,250mg every 8 hours,Pfizer,6,High,Low Risk,Low (<50%),Fast,Renal,Suitable
Metformin,Cholesterol Control,Cancer Therapy,58.84,C17H19N3O3S,NSAID,"Nausea, Dizziness",1996,Omeprazole,Aspirin,Low Risk,Slow Metabolism,Phase 1,Animal Testing,MAPK Pathway,Tablet,As prescribed,Pfizer,48,Low,Low Risk,High (>80%),Fast,Gut,Partially Suitable
Ibuprofen,Diabetes,Antiviral,34.35,C4H11N5,AMPK Activator,Acid Reflux,1965,Omeprazole,Lipitor,Moderate Risk,High Bioavailability,Completed,Animal Testing,MAPK Pathway,Injection,500mg twice a day,Roche,48,Moderate,Low Risk,Low (<50%),Moderate,Gut,Partially Suitable
Atorvastatin,Thyroid Hormone Replacement,Weight Loss,87.78,C17H19N3O3S,NSAID,Muscle Pain,1965,Acetylsalicylic Acid,Prilosec,Moderate Risk,Slow Metabolism,Phase 4,Animal Testing,Serotonin Pathway,Topical Gel,50mg daily,Merck,24,High,Moderate Risk,Low (<50%),Moderate,Renal,Partially Suitable
Omeprazole,Cholesterol Control,Anti-Aging,76.59,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1996,Atorvastatin Calcium,Prilosec,Low Risk,Rapid Absorption,Ongoing,In Vitro Studies,PI3K-AKT Pathway,Topical Gel,10mg once daily,Merck,24,Low,High Risk,Low (<50%),Moderate,Enzyme-Specific,Partially Suitable
Losartan,Diabetes,Cardiovascular Disease,61.93,C33H35FN2O5,NSAID,"Headache, Rash",1994,Ibuprofen,Aspirin,Low Risk,Rapid Absorption,Ongoing,In Vitro Studies,PI3K-AKT Pathway,Syrup,500mg twice a day,AstraZeneca,48,Low,Moderate Risk,Moderate (50-80%),Slow,Renal,Partially Suitable
Paracetamol,Acid Reflux,Cancer Therapy,81.69,C13H18O2,AMPK Activator,"Nausea, Dizziness",1971,Metformin Hydrochloride,Advil,Moderate Risk,Rapid Absorption,Phase 1,Toxicology Report,Serotonin Pathway,Syrup,50mg daily,Pfizer,12,Low,Low Risk,High (>80%),Slow,Gut,Suitable
Ranitidine,Gastric Ulcer,Anti-Aging,84.42,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Muscle Pain,1994,Atorvastatin Calcium,Glucophage,Low Risk,Rapid Absorption,Phase 2,Animal Testing,PI3K-AKT Pathway,Topical Gel,500mg twice a day,AstraZeneca,6,Moderate,Moderate Risk,Low (<50%),Moderate,Gut,Suitable
Simvastatin,Fever,Parkinson's,46.68,C4H11N5,NSAID,Acid Reflux,1996,Omeprazole,Advil,Moderate Risk,Rapid Absorption,Phase 1,Toxicology Report,Dopaminergic Pathway,Tablet,500mg twice a day,Merck,6,Moderate,High Risk,High (>80%),Fast,Enzyme-Specific,Suitable
Levothyroxine,Thyroid Hormone Replacement,Anti-Aging,43.24,C4H11N5,COX Inhibitor,Gastrointestinal Issues,1996,Omeprazole,Prilosec,Low Risk,Rapid Absorption,Phase 4,Toxicology Report,Dopaminergic Pathway,Tablet,50mg daily,Pfizer,12,Low,Low Risk,Moderate (50-80%),Fast,Renal,Not Suitable
Aspirin,Thyroid Hormone Replacement,Cancer Therapy,79.9,C17H19N3O3S,NSAID,"Headache, Rash",1965,Atorvastatin Calcium,Prilosec,Low Risk,Slow Metabolism,Phase 3,No Preclinical Data,PI3K-AKT Pathway,Topical Gel,500mg twice a day,AstraZeneca,6,Low,Moderate Risk,Low (<50%),Moderate,Gut,Not Suitable
Metformin,Fever,Parkinson's,86.53,C13H18O2,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1971,Omeprazole,Lipitor,Low Risk,Slow Metabolism,Phase 2,No Preclinical Data,Immune Response Pathway,Injection,10mg once daily,AstraZeneca,2,High,High Risk,High (>80%),Fast,Enzyme-Specific,Partially Suitable
Ibuprofen,Acid Reflux,Liver Disease,75.74,C13H18O2,HMG-CoA Reductase Inhibitor,Acid Reflux,1987,Atorvastatin Calcium,Aspirin,Moderate Risk,High Bioavailability,Phase 1,Animal Testing,Immune Response Pathway,Injection,250mg every 8 hours,Roche,12,High,High Risk,Moderate (50-80%),Fast,Enzyme-Specific,Suitable
Atorvastatin,Acid Reflux,Cancer Therapy,71.21,C4H11N5,COX Inhibitor,"Nausea, Dizziness",1996,Acetylsalicylic Acid,Glucophage,High Risk,High Bioavailability,Phase 4,In Vitro Studies,Dopaminergic Pathway,Injection,10mg once daily,AstraZeneca,48,Low,Low Risk,Moderate (50-80%),Moderate,Renal,Partially Suitable
Omeprazole,Blood Thinner,Parkinson's,54.23,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1965,Acetylsalicylic Acid,Glucophage,Low Risk,Slow Metabolism,Ongoing,No Preclinical Data,Serotonin Pathway,Tablet,250mg every 8 hours,AstraZeneca,12,High,Low Risk,High (>80%),Moderate,Renal,Not Suitable
Losartan,Gastric Ulcer,Weight Loss,92.03,C13H18O2,Proton Pump Inhibitor,"Headache, Rash",1994,Atorvastatin Calcium,Advil,High Risk,High Bioavailability,Phase 3,Toxicology Report,Serotonin Pathway,Syrup,10mg once daily,Novartis,12,High,Low Risk,Low (<50%),Moderate,Renal,Not Suitable
Paracetamol,Cholesterol Control,Antiviral,72.31,C9H8O4,AMPK Activator,"Nausea, Dizziness",1987,Omeprazole,Lipitor,Moderate Risk,Renal Excretion,Ongoing,Toxicology Report,Dopaminergic Pathway,Syrup,50mg daily,Roche,6,High,Moderate Risk,Moderate (50-80%),Slow,Gut,Not Suitable
Ranitidine,Blood Thinner,Parkinson's,64.91,C4H11N5,COX Inhibitor,"Nausea, Dizziness",1987,Acetylsalicylic Acid,Glucophage,Moderate Risk,Renal Excretion,Completed,Toxicology Report,PI3K-AKT Pathway,Capsule,10mg once daily,Merck,12,Moderate,Moderate Risk,Low (<50%),Fast,Liver,Suitable
Simvastatin,Blood Thinner,Liver Disease,36.94,C13H18O2,NSAID,Gastrointestinal Issues,1971,Atorvastatin Calcium,Prilosec,Low Risk,Slow Metabolism,Ongoing,No Preclinical Data,Immune Response Pathway,Injection,50mg daily,AstraZeneca,48,Moderate,Low Risk,Moderate (50-80%),Fast,Gut,Partially Suitable
Levothyroxine,Acid Reflux,Cardiovascular Disease,71.39,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1996,Atorvastatin Calcium,Advil,Low Risk,Rapid Absorption,Completed,Animal Testing,Immune Response Pathway,Syrup,500mg twice a day,Novartis,2,Moderate,High Risk,Low (<50%),Slow,Enzyme-Specific,Partially Suitable
Aspirin,Hypertension,Parkinson's,78.2,C9H8O4,NSAID,"Nausea, Dizziness",1994,Omeprazole,Prilosec,Moderate Risk,Renal Excretion,Phase 2,In Vitro Studies,MAPK Pathway,Injection,As prescribed,Merck,48,Moderate,Low Risk,Low (<50%),Slow,Enzyme-Specific,Not Suitable
Metformin,Cholesterol Control,Cancer Therapy,45.22,C13H18O2,NSAID,Muscle Pain,1994,Ibuprofen,Glucophage,High Risk,Slow Metabolism,Completed,Toxicology Report,Immune Response Pathway,Syrup,10mg once daily,Roche,12,Low,Low Risk,High (>80%),Fast,Liver,Suitable
Ibuprofen,Inflammation,Liver Disease,87.66,C17H19N3O3S,Proton Pump Inhibitor,"Headache, Rash",1971,Omeprazole,Advil,Moderate Risk,Rapid Absorption,Phase 3,Toxicology Report,Immune Response Pathway,Syrup,50mg daily,Pfizer,12,High,Moderate Risk,High (>80%),Slow,Enzyme-Specific,Suitable
Atorvastatin,Pain Relief,Autoimmune Disorders,32.92,C17H19N3O3S,COX Inhibitor,"Nausea, Dizziness",1987,Atorvastatin Calcium,Prilosec,Moderate Risk,Slow Metabolism,Ongoing,Toxicology Report,PI3K-AKT Pathway,Injection,50mg daily,Roche,24,Moderate,Low Risk,High (>80%),Fast,Enzyme-Specific,Partially Suitable
Omeprazole,Cholesterol Control,Cancer Therapy,31.92,C9H8O4,NSAID,Gastrointestinal Issues,1996,Metformin Hydrochloride,Advil,High Risk,High Bioavailability,Phase 1,Toxicology Report,Immune Response Pathway,Syrup,500mg twice a day,AstraZeneca,2,High,High Risk,High (>80%),Moderate,Gut,Partially Suitable
Losartan,Diabetes,Cancer Therapy,58.57,C17H19N3O3S,COX Inhibitor,Muscle Pain,1987,Omeprazole,Prilosec,High Risk,Liver Metabolism,Phase 1,In Vitro Studies,MAPK Pathway,Syrup,As prescribed,Pfizer,6,Moderate,High Risk,High (>80%),Fast,Renal,Not Suitable
Paracetamol,Acid Reflux,Autoimmune Disorders,42.17,C4H11N5,Proton Pump Inhibitor,"Nausea, Dizziness",1965,Omeprazole,Aspirin,High Risk,Renal Excretion,Phase 1,No Preclinical Data,Immune Response Pathway,Tablet,250mg every 8 hours,Roche,24,Low,Moderate Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Ranitidine,Inflammation,Antiviral,33.89,C33H35FN2O5,AMPK Activator,"Nausea, Dizziness",1971,Acetylsalicylic Acid,Prilosec,Low Risk,Rapid Absorption,Completed,Animal Testing,Immune Response Pathway,Topical Gel,50mg daily,Roche,48,Moderate,Low Risk,High (>80%),Fast,Renal,Suitable
Simvastatin,Hypertension,Parkinson's,62.31,C33H35FN2O5,AMPK Activator,"Headache, Rash",1965,Ibuprofen,Glucophage,Low Risk,Rapid Absorption,Phase 4,Animal Testing,Dopaminergic Pathway,Tablet,500mg twice a day,Novartis,6,Low,Moderate Risk,High (>80%),Moderate,Liver,Not Suitable
Levothyroxine,Fever,Migraine Treatment,82.16,C4H11N5,AMPK Activator,Acid Reflux,1987,Acetylsalicylic Acid,Prilosec,Moderate Risk,Rapid Absorption,Phase 2,Toxicology Report,Immune Response Pathway,Tablet,As prescribed,Novartis,6,Moderate,Moderate Risk,Low (<50%),Moderate,Liver,Partially Suitable
Aspirin,Blood Thinner,Cancer Therapy,51.54,C4H11N5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1971,Ibuprofen,Lipitor,Low Risk,Liver Metabolism,Ongoing,No Preclinical Data,Immune Response Pathway,Capsule,50mg daily,AstraZeneca,2,High,Low Risk,Low (<50%),Fast,Gut,Not Suitable
Metformin,Hypertension,Antiviral,84.41,C17H19N3O3S,NSAID,Acid Reflux,1971,Ibuprofen,Glucophage,Moderate Risk,Liver Metabolism,Phase 4,Toxicology Report,Serotonin Pathway,Injection,As prescribed,AstraZeneca,48,Moderate,Low Risk,High (>80%),Slow,Gut,Suitable
Ibuprofen,Hypertension,Liver Disease,30.69,C13H18O2,COX Inhibitor,Muscle Pain,1987,Acetylsalicylic Acid,Prilosec,High Risk,Slow Metabolism,Phase 3,Animal Testing,Dopaminergic Pathway,Syrup,50mg daily,Pfizer,48,Moderate,Moderate Risk,Low (<50%),Slow,Renal,Partially Suitable
Atorvastatin,Gastric Ulcer,Weight Loss,74.22,C9H8O4,COX Inhibitor,Gastrointestinal Issues,1987,Ibuprofen,Prilosec,Moderate Risk,Rapid Absorption,Phase 1,No Preclinical Data,Dopaminergic Pathway,Injection,250mg every 8 hours,Pfizer,12,Low,Low Risk,Moderate (50-80%),Moderate,Renal,Partially Suitable
Omeprazole,Pain Relief,Autoimmune Disorders,84.76,C13H18O2,COX Inhibitor,Muscle Pain,1996,Metformin Hydrochloride,Advil,Low Risk,Rapid Absorption,Completed,In Vitro Studies,Serotonin Pathway,Topical Gel,500mg twice a day,Novartis,6,Moderate,Moderate Risk,Moderate (50-80%),Fast,Enzyme-Specific,Suitable
Losartan,Acid Reflux,Alzheimer's,42.04,C33H35FN2O5,Proton Pump Inhibitor,Acid Reflux,1971,Atorvastatin Calcium,Prilosec,Moderate Risk,Renal Excretion,Phase 1,Animal Testing,Dopaminergic Pathway,Topical Gel,500mg twice a day,AstraZeneca,2,High,Moderate Risk,High (>80%),Fast,Enzyme-Specific,Not Suitable
Paracetamol,Fever,Cancer Therapy,80.6,C9H8O4,COX Inhibitor,Muscle Pain,1996,Acetylsalicylic Acid,Lipitor,Low Risk,Rapid Absorption,Completed,In Vitro Studies,MAPK Pathway,Injection,10mg once daily,AstraZeneca,6,High,High Risk,High (>80%),Slow,Liver,Partially Suitable
Ranitidine,Hypertension,Parkinson's,45.15,C9H8O4,AMPK Activator,"Headache, Rash",1971,Omeprazole,Glucophage,Moderate Risk,Slow Metabolism,Phase 3,No Preclinical Data,Dopaminergic Pathway,Topical Gel,250mg every 8 hours,AstraZeneca,48,Low,Low Risk,High (>80%),Moderate,Enzyme-Specific,Partially Suitable
Simvastatin,Pain Relief,Alzheimer's,41.13,C9H8O4,NSAID,"Nausea, Dizziness",1987,Atorvastatin Calcium,Advil,Moderate Risk,Liver Metabolism,Completed,Toxicology Report,Immune Response Pathway,Tablet,500mg twice a day,AstraZeneca,6,Low,Low Risk,Low (<50%),Moderate,Liver,Not Suitable
Levothyroxine,Pain Relief,Anti-Aging,69.74,C13H18O2,AMPK Activator,Muscle Pain,1965,Ibuprofen,Lipitor,High Risk,High Bioavailability,Phase 2,Toxicology Report,MAPK Pathway,Capsule,500mg twice a day,Merck,48,Low,Moderate Risk,Low (<50%),Slow,Enzyme-Specific,Not Suitable
Aspirin,Pain Relief,Liver Disease,34.19,C17H19N3O3S,NSAID,Gastrointestinal Issues,1971,Omeprazole,Advil,Moderate Risk,Slow Metabolism,Phase 4,Animal Testing,Dopaminergic Pathway,Tablet,250mg every 8 hours,Roche,24,Low,Low Risk,Low (<50%),Fast,Liver,Partially Suitable
Metformin,Diabetes,Autoimmune Disorders,88.85,C9H8O4,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1987,Metformin Hydrochloride,Advil,Moderate Risk,High Bioavailability,Phase 1,Toxicology Report,MAPK Pathway,Topical Gel,250mg every 8 hours,Roche,6,High,Low Risk,High (>80%),Moderate,Enzyme-Specific,Suitable
Ibuprofen,Hypertension,Anti-Aging,36.05,C4H11N5,AMPK Activator,Muscle Pain,1996,Metformin Hydrochloride,Prilosec,Moderate Risk,Slow Metabolism,Ongoing,No Preclinical Data,Serotonin Pathway,Capsule,50mg daily,Roche,2,Moderate,Moderate Risk,High (>80%),Fast,Enzyme-Specific,Suitable
Atorvastatin,Fever,Antiviral,49.83,C17H19N3O3S,Proton Pump Inhibitor,"Nausea, Dizziness",1994,Acetylsalicylic Acid,Glucophage,High Risk,Slow Metabolism,Completed,Toxicology Report,Serotonin Pathway,Tablet,50mg daily,Roche,6,Moderate,Moderate Risk,Low (<50%),Moderate,Liver,Suitable
Omeprazole,Hypertension,Anti-Aging,94.14,C17H19N3O3S,NSAID,"Nausea, Dizziness",1987,Atorvastatin Calcium,Advil,Low Risk,Rapid Absorption,Phase 4,No Preclinical Data,Dopaminergic Pathway,Syrup,10mg once daily,Novartis,6,Moderate,High Risk,Moderate (50-80%),Slow,Gut,Suitable
Losartan,Thyroid Hormone Replacement,Alzheimer's,85.84,C33H35FN2O5,AMPK Activator,Acid Reflux,1994,Atorvastatin Calcium,Lipitor,Moderate Risk,High Bioavailability,Completed,Toxicology Report,PI3K-AKT Pathway,Syrup,10mg once daily,Merck,2,Low,Low Risk,Moderate (50-80%),Slow,Renal,Suitable
Paracetamol,Blood Thinner,Migraine Treatment,68.28,C9H8O4,NSAID,"Headache, Rash",1996,Metformin Hydrochloride,Prilosec,High Risk,Renal Excretion,Phase 2,Animal Testing,Dopaminergic Pathway,Injection,50mg daily,Roche,6,Low,Low Risk,Low (<50%),Slow,Liver,Not Suitable
Ranitidine,Cholesterol Control,Autoimmune Disorders,94.55,C13H18O2,HMG-CoA Reductase Inhibitor,"Headache, Rash",1987,Atorvastatin Calcium,Aspirin,Low Risk,Renal Excretion,Phase 1,Animal Testing,Serotonin Pathway,Topical Gel,10mg once daily,Merck,48,High,Low Risk,High (>80%),Fast,Renal,Not Suitable
Simvastatin,Acid Reflux,Antiviral,53.75,C13H18O2,NSAID,Muscle Pain,1965,Atorvastatin Calcium,Advil,Moderate Risk,Renal Excretion,Phase 4,Animal Testing,Immune Response Pathway,Tablet,As prescribed,Novartis,24,Low,High Risk,Low (<50%),Moderate,Renal,Suitable
Levothyroxine,Acid Reflux,Parkinson's,90.12,C4H11N5,NSAID,Gastrointestinal Issues,1996,Ibuprofen,Prilosec,Moderate Risk,High Bioavailability,Phase 2,Toxicology Report,Serotonin Pathway,Topical Gel,As prescribed,AstraZeneca,12,Moderate,High Risk,Moderate (50-80%),Slow,Gut,Suitable
Aspirin,Cholesterol Control,Weight Loss,34.87,C4H11N5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1996,Metformin Hydrochloride,Aspirin,Moderate Risk,Slow Metabolism,Phase 1,Animal Testing,Dopaminergic Pathway,Capsule,500mg twice a day,Merck,6,High,High Risk,High (>80%),Slow,Renal,Not Suitable
Metformin,Fever,Anti-Aging,79.34,C4H11N5,Proton Pump Inhibitor,"Headache, Rash",1994,Omeprazole,Prilosec,High Risk,Renal Excretion,Phase 2,No Preclinical Data,Dopaminergic Pathway,Syrup,250mg every 8 hours,Novartis,2,Moderate,Moderate Risk,Moderate (50-80%),Fast,Enzyme-Specific,Not Suitable
Ibuprofen,Diabetes,Weight Loss,59.17,C33H35FN2O5,AMPK Activator,"Nausea, Dizziness",1965,Ibuprofen,Prilosec,Moderate Risk,Rapid Absorption,Phase 2,Animal Testing,Serotonin Pathway,Capsule,50mg daily,AstraZeneca,2,Moderate,High Risk,High (>80%),Fast,Enzyme-Specific,Partially Suitable
Atorvastatin,Cholesterol Control,Autoimmune Disorders,40.53,C33H35FN2O5,NSAID,"Nausea, Dizziness",1965,Atorvastatin Calcium,Advil,Moderate Risk,Rapid Absorption,Phase 2,Toxicology Report,MAPK Pathway,Syrup,500mg twice a day,Pfizer,2,Low,High Risk,Low (<50%),Fast,Renal,Partially Suitable
Omeprazole,Diabetes,Migraine Treatment,51.14,C33H35FN2O5,NSAID,Gastrointestinal Issues,1965,Metformin Hydrochloride,Aspirin,Moderate Risk,Renal Excretion,Completed,No Preclinical Data,Immune Response Pathway,Topical Gel,250mg every 8 hours,Merck,6,High,Low Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Partially Suitable
Losartan,Acid Reflux,Alzheimer's,87.06,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Muscle Pain,1996,Omeprazole,Lipitor,High Risk,Renal Excretion,Ongoing,In Vitro Studies,PI3K-AKT Pathway,Topical Gel,As prescribed,Merck,2,Low,Low Risk,High (>80%),Fast,Liver,Suitable
Paracetamol,Thyroid Hormone Replacement,Migraine Treatment,31.75,C13H18O2,NSAID,"Nausea, Dizziness",1965,Metformin Hydrochloride,Aspirin,Moderate Risk,Slow Metabolism,Phase 3,Toxicology Report,Immune Response Pathway,Injection,As prescribed,Novartis,48,High,Low Risk,Moderate (50-80%),Moderate,Renal,Partially Suitable
Ranitidine,Cholesterol Control,Anti-Aging,74.27,C17H19N3O3S,AMPK Activator,"Headache, Rash",1965,Ibuprofen,Prilosec,High Risk,High Bioavailability,Phase 1,In Vitro Studies,Immune Response Pathway,Tablet,50mg daily,Novartis,24,Moderate,Moderate Risk,High (>80%),Moderate,Liver,Suitable
Simvastatin,Fever,Anti-Aging,73.34,C13H18O2,Proton Pump Inhibitor,"Headache, Rash",1987,Metformin Hydrochloride,Advil,High Risk,Slow Metabolism,Phase 1,Animal Testing,PI3K-AKT Pathway,Capsule,As prescribed,Pfizer,2,Moderate,High Risk,High (>80%),Fast,Liver,Suitable
Levothyroxine,Fever,Weight Loss,50.53,C33H35FN2O5,COX Inhibitor,"Headache, Rash",1994,Ibuprofen,Lipitor,Low Risk,Renal Excretion,Phase 4,Animal Testing,Dopaminergic Pathway,Capsule,As prescribed,AstraZeneca,2,High,High Risk,Low (<50%),Fast,Gut,Suitable
Aspirin,Diabetes,Cardiovascular Disease,53.69,C9H8O4,HMG-CoA Reductase Inhibitor,Acid Reflux,1994,Metformin Hydrochloride,Prilosec,Moderate Risk,Liver Metabolism,Phase 2,Animal Testing,MAPK Pathway,Tablet,As prescribed,Pfizer,48,Low,High Risk,Low (<50%),Fast,Liver,Partially Suitable
Metformin,Diabetes,Antiviral,68.64,C9H8O4,AMPK Activator,"Headache, Rash",1965,Atorvastatin Calcium,Prilosec,Moderate Risk,Renal Excretion,Ongoing,No Preclinical Data,MAPK Pathway,Topical Gel,As prescribed,AstraZeneca,2,Moderate,High Risk,Low (<50%),Moderate,Renal,Suitable
Ibuprofen,Acid Reflux,Parkinson's,94.41,C4H11N5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1994,Atorvastatin Calcium,Advil,High Risk,Renal Excretion,Completed,Toxicology Report,Immune Response Pathway,Capsule,50mg daily,Roche,24,Moderate,Low Risk,High (>80%),Moderate,Gut,Partially Suitable
Atorvastatin,Diabetes,Cancer Therapy,71.42,C4H11N5,COX Inhibitor,Acid Reflux,1996,Metformin Hydrochloride,Glucophage,Low Risk,Liver Metabolism,Phase 3,In Vitro Studies,Immune Response Pathway,Tablet,500mg twice a day,Novartis,48,Moderate,Low Risk,Low (<50%),Moderate,Gut,Suitable
Omeprazole,Diabetes,Cancer Therapy,56.21,C17H19N3O3S,NSAID,Muscle Pain,1965,Atorvastatin Calcium,Glucophage,Moderate Risk,Rapid Absorption,Completed,Animal Testing,PI3K-AKT Pathway,Tablet,500mg twice a day,Novartis,6,Moderate,Low Risk,Low (<50%),Moderate,Renal,Partially Suitable
Losartan,Hypertension,Alzheimer's,46.18,C9H8O4,Proton Pump Inhibitor,"Headache, Rash",1987,Omeprazole,Advil,High Risk,Renal Excretion,Completed,Toxicology Report,Immune Response Pathway,Injection,500mg twice a day,Novartis,24,High,High Risk,High (>80%),Fast,Liver,Not Suitable
Paracetamol,Blood Thinner,Cardiovascular Disease,48.62,C13H18O2,AMPK Activator,Gastrointestinal Issues,1987,Atorvastatin Calcium,Glucophage,Moderate Risk,Rapid Absorption,Phase 4,No Preclinical Data,Immune Response Pathway,Capsule,10mg once daily,Roche,12,High,High Risk,Moderate (50-80%),Fast,Enzyme-Specific,Not Suitable
Ranitidine,Pain Relief,Migraine Treatment,46.28,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1987,Atorvastatin Calcium,Advil,Moderate Risk,High Bioavailability,Phase 1,In Vitro Studies,MAPK Pathway,Topical Gel,10mg once daily,Pfizer,48,Low,Low Risk,High (>80%),Slow,Enzyme-Specific,Not Suitable
Simvastatin,Fever,Liver Disease,51.34,C9H8O4,COX Inhibitor,"Nausea, Dizziness",1965,Atorvastatin Calcium,Aspirin,Moderate Risk,Rapid Absorption,Phase 2,Toxicology Report,Serotonin Pathway,Syrup,10mg once daily,AstraZeneca,12,Moderate,Low Risk,High (>80%),Slow,Renal,Not Suitable
Levothyroxine,Cholesterol Control,Cancer Therapy,81.54,C9H8O4,NSAID,"Nausea, Dizziness",1987,Omeprazole,Lipitor,Moderate Risk,Slow Metabolism,Phase 2,Toxicology Report,Dopaminergic Pathway,Injection,As prescribed,AstraZeneca,2,High,High Risk,Low (<50%),Moderate,Enzyme-Specific,Partially Suitable
Aspirin,Inflammation,Anti-Aging,30.89,C33H35FN2O5,NSAID,"Headache, Rash",1965,Atorvastatin Calcium,Advil,Moderate Risk,Slow Metabolism,Phase 2,In Vitro Studies,MAPK Pathway,Tablet,250mg every 8 hours,AstraZeneca,12,Moderate,Low Risk,Moderate (50-80%),Fast,Liver,Partially Suitable
Metformin,Thyroid Hormone Replacement,Weight Loss,89.04,C13H18O2,AMPK Activator,"Nausea, Dizziness",1971,Ibuprofen,Advil,Moderate Risk,Liver Metabolism,Phase 3,In Vitro Studies,Immune Response Pathway,Capsule,10mg once daily,Merck,6,Moderate,Low Risk,Moderate (50-80%),Slow,Gut,Partially Suitable
Ibuprofen,Hypertension,Anti-Aging,42.15,C13H18O2,Proton Pump Inhibitor,Acid Reflux,1987,Metformin Hydrochloride,Prilosec,High Risk,Rapid Absorption,Phase 1,Animal Testing,MAPK Pathway,Injection,10mg once daily,Pfizer,2,Low,High Risk,High (>80%),Moderate,Enzyme-Specific,Suitable
Atorvastatin,Blood Thinner,Anti-Aging,41.66,C13H18O2,Proton Pump Inhibitor,"Nausea, Dizziness",1994,Metformin Hydrochloride,Aspirin,Low Risk,Renal Excretion,Completed,Animal Testing,Dopaminergic Pathway,Topical Gel,As prescribed,Pfizer,24,Low,Low Risk,Moderate (50-80%),Slow,Gut,Not Suitable
Omeprazole,Diabetes,Alzheimer's,49.46,C9H8O4,NSAID,Acid Reflux,1987,Atorvastatin Calcium,Glucophage,Moderate Risk,Rapid Absorption,Phase 3,In Vitro Studies,MAPK Pathway,Capsule,As prescribed,Pfizer,6,Low,Low Risk,Moderate (50-80%),Slow,Gut,Suitable
Losartan,Blood Thinner,Liver Disease,89.93,C17H19N3O3S,COX Inhibitor,Muscle Pain,1987,Acetylsalicylic Acid,Advil,Moderate Risk,Slow Metabolism,Phase 2,Animal Testing,MAPK Pathway,Capsule,500mg twice a day,Novartis,48,Low,High Risk,High (>80%),Slow,Renal,Not Suitable
Paracetamol,Pain Relief,Liver Disease,72.61,C17H19N3O3S,COX Inhibitor,Muscle Pain,1996,Omeprazole,Prilosec,Moderate Risk,High Bioavailability,Phase 1,No Preclinical Data,Dopaminergic Pathway,Topical Gel,500mg twice a day,Roche,12,Low,High Risk,Low (<50%),Slow,Liver,Suitable
Ranitidine,Blood Thinner,Anti-Aging,37.34,C4H11N5,NSAID,"Nausea, Dizziness",1971,Omeprazole,Aspirin,High Risk,Slow Metabolism,Phase 3,Toxicology Report,Immune Response Pathway,Topical Gel,As prescribed,Pfizer,12,High,Low Risk,High (>80%),Moderate,Renal,Partially Suitable
Simvastatin,Acid Reflux,Antiviral,88.07,C13H18O2,NSAID,Acid Reflux,1994,Omeprazole,Advil,High Risk,Liver Metabolism,Ongoing,Animal Testing,Dopaminergic Pathway,Tablet,500mg twice a day,Merck,12,Low,Moderate Risk,Low (<50%),Fast,Gut,Not Suitable
Levothyroxine,Acid Reflux,Parkinson's,53.09,C17H19N3O3S,AMPK Activator,"Headache, Rash",1971,Metformin Hydrochloride,Glucophage,Moderate Risk,Rapid Absorption,Phase 2,No Preclinical Data,Serotonin Pathway,Syrup,As prescribed,Roche,24,Moderate,Low Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Aspirin,Acid Reflux,Anti-Aging,72.87,C13H18O2,NSAID,Gastrointestinal Issues,1987,Atorvastatin Calcium,Prilosec,Low Risk,High Bioavailability,Phase 1,Toxicology Report,MAPK Pathway,Capsule,10mg once daily,Merck,2,High,Moderate Risk,Low (<50%),Slow,Gut,Not Suitable
Metformin,Hypertension,Parkinson's,51.74,C33H35FN2O5,COX Inhibitor,Acid Reflux,1996,Omeprazole,Aspirin,Moderate Risk,Slow Metabolism,Ongoing,Toxicology Report,Dopaminergic Pathway,Capsule,500mg twice a day,Novartis,12,Low,High Risk,Low (<50%),Fast,Gut,Not Suitable
Ibuprofen,Gastric Ulcer,Parkinson's,47.44,C9H8O4,AMPK Activator,"Headache, Rash",1965,Atorvastatin Calcium,Prilosec,Moderate Risk,Rapid Absorption,Phase 1,Animal Testing,PI3K-AKT Pathway,Tablet,10mg once daily,Merck,6,Moderate,Low Risk,Moderate (50-80%),Slow,Liver,Not Suitable
Atorvastatin,Blood Thinner,Liver Disease,34.67,C4H11N5,AMPK Activator,"Nausea, Dizziness",1994,Acetylsalicylic Acid,Prilosec,High Risk,Liver Metabolism,Phase 3,No Preclinical Data,PI3K-AKT Pathway,Injection,10mg once daily,Pfizer,12,Moderate,Moderate Risk,Moderate (50-80%),Fast,Enzyme-Specific,Suitable
Omeprazole,Acid Reflux,Antiviral,55.26,C4H11N5,Proton Pump Inhibitor,"Nausea, Dizziness",1965,Atorvastatin Calcium,Advil,Moderate Risk,Liver Metabolism,Completed,In Vitro Studies,Immune Response Pathway,Tablet,10mg once daily,AstraZeneca,24,Moderate,Moderate Risk,Low (<50%),Fast,Gut,Partially Suitable
Losartan,Pain Relief,Autoimmune Disorders,31.99,C4H11N5,AMPK Activator,"Headache, Rash",1996,Acetylsalicylic Acid,Aspirin,Moderate Risk,High Bioavailability,Phase 3,Animal Testing,MAPK Pathway,Syrup,500mg twice a day,Roche,24,Low,Low Risk,Low (<50%),Slow,Renal,Partially Suitable
Paracetamol,Fever,Anti-Aging,45.8,C9H8O4,AMPK Activator,Acid Reflux,1965,Omeprazole,Glucophage,Moderate Risk,Renal Excretion,Phase 3,No Preclinical Data,PI3K-AKT Pathway,Tablet,10mg once daily,AstraZeneca,2,High,High Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Suitable
Ranitidine,Blood Thinner,Cardiovascular Disease,51.22,C33H35FN2O5,AMPK Activator,"Nausea, Dizziness",1965,Ibuprofen,Glucophage,Moderate Risk,High Bioavailability,Phase 1,No Preclinical Data,PI3K-AKT Pathway,Syrup,50mg daily,Pfizer,48,Moderate,Moderate Risk,Moderate (50-80%),Slow,Renal,Not Suitable
Simvastatin,Gastric Ulcer,Weight Loss,36.84,C13H18O2,AMPK Activator,Acid Reflux,1994,Acetylsalicylic Acid,Glucophage,Moderate Risk,Renal Excretion,Phase 3,Animal Testing,MAPK Pathway,Tablet,As prescribed,Merck,2,Low,Moderate Risk,Low (<50%),Slow,Enzyme-Specific,Partially Suitable
Levothyroxine,Blood Thinner,Migraine Treatment,41.33,C4H11N5,AMPK Activator,Gastrointestinal Issues,1987,Omeprazole,Advil,Low Risk,Rapid Absorption,Phase 4,Animal Testing,Dopaminergic Pathway,Capsule,50mg daily,AstraZeneca,48,Low,High Risk,High (>80%),Fast,Enzyme-Specific,Suitable
Aspirin,Hypertension,Alzheimer's,71.66,C4H11N5,AMPK Activator,Acid Reflux,1994,Ibuprofen,Glucophage,Moderate Risk,Rapid Absorption,Phase 1,In Vitro Studies,Serotonin Pathway,Tablet,10mg once daily,Merck,48,Moderate,High Risk,Moderate (50-80%),Slow,Liver,Not Suitable
Metformin,Thyroid Hormone Replacement,Antiviral,63,C4H11N5,NSAID,"Headache, Rash",1987,Ibuprofen,Prilosec,Moderate Risk,Rapid Absorption,Ongoing,Toxicology Report,PI3K-AKT Pathway,Syrup,As prescribed,Roche,48,Low,Moderate Risk,Low (<50%),Slow,Enzyme-Specific,Not Suitable
Ibuprofen,Pain Relief,Cancer Therapy,31.65,C17H19N3O3S,Proton Pump Inhibitor,"Nausea, Dizziness",1996,Acetylsalicylic Acid,Glucophage,High Risk,Rapid Absorption,Phase 3,In Vitro Studies,PI3K-AKT Pathway,Tablet,10mg once daily,AstraZeneca,24,High,Moderate Risk,Low (<50%),Slow,Gut,Partially Suitable
Atorvastatin,Cholesterol Control,Parkinson's,55.66,C9H8O4,Proton Pump Inhibitor,"Headache, Rash",1965,Metformin Hydrochloride,Glucophage,Moderate Risk,Rapid Absorption,Phase 1,Toxicology Report,Dopaminergic Pathway,Topical Gel,250mg every 8 hours,Novartis,2,High,High Risk,High (>80%),Moderate,Renal,Not Suitable
Omeprazole,Diabetes,Anti-Aging,54.95,C13H18O2,HMG-CoA Reductase Inhibitor,Acid Reflux,1987,Acetylsalicylic Acid,Aspirin,High Risk,High Bioavailability,Completed,Toxicology Report,Serotonin Pathway,Capsule,50mg daily,Novartis,12,Low,High Risk,Moderate (50-80%),Moderate,Gut,Suitable
Losartan,Thyroid Hormone Replacement,Migraine Treatment,86.08,C17H19N3O3S,COX Inhibitor,Muscle Pain,1987,Metformin Hydrochloride,Prilosec,Low Risk,Rapid Absorption,Phase 2,Toxicology Report,Dopaminergic Pathway,Injection,10mg once daily,Roche,12,Low,High Risk,High (>80%),Slow,Renal,Suitable
Paracetamol,Inflammation,Cancer Therapy,55.3,C9H8O4,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1987,Acetylsalicylic Acid,Advil,Low Risk,Liver Metabolism,Ongoing,Toxicology Report,MAPK Pathway,Injection,500mg twice a day,Novartis,12,High,Moderate Risk,Low (<50%),Slow,Renal,Partially Suitable
Ranitidine,Thyroid Hormone Replacement,Liver Disease,61.67,C17H19N3O3S,Proton Pump Inhibitor,"Headache, Rash",1971,Atorvastatin Calcium,Advil,High Risk,Rapid Absorption,Ongoing,In Vitro Studies,Dopaminergic Pathway,Injection,As prescribed,Pfizer,6,Low,High Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Simvastatin,Cholesterol Control,Autoimmune Disorders,67.94,C4H11N5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1994,Atorvastatin Calcium,Prilosec,High Risk,Liver Metabolism,Phase 2,Animal Testing,Dopaminergic Pathway,Topical Gel,250mg every 8 hours,Merck,24,Low,Low Risk,High (>80%),Slow,Renal,Partially Suitable
Levothyroxine,Fever,Weight Loss,56.07,C9H8O4,Proton Pump Inhibitor,Muscle Pain,1994,Ibuprofen,Prilosec,High Risk,High Bioavailability,Phase 3,In Vitro Studies,Dopaminergic Pathway,Tablet,500mg twice a day,Roche,12,Moderate,Moderate Risk,High (>80%),Fast,Renal,Not Suitable
Aspirin,Gastric Ulcer,Cardiovascular Disease,71.28,C33H35FN2O5,COX Inhibitor,Acid Reflux,1987,Ibuprofen,Aspirin,Moderate Risk,Liver Metabolism,Ongoing,In Vitro Studies,Dopaminergic Pathway,Capsule,10mg once daily,AstraZeneca,2,Low,Moderate Risk,Low (<50%),Moderate,Liver,Suitable
Metformin,Inflammation,Antiviral,44.43,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1987,Omeprazole,Advil,High Risk,High Bioavailability,Phase 3,No Preclinical Data,MAPK Pathway,Syrup,As prescribed,Roche,12,Moderate,Moderate Risk,Low (<50%),Fast,Gut,Not Suitable
Ibuprofen,Pain Relief,Parkinson's,42.5,C4H11N5,NSAID,"Nausea, Dizziness",1965,Acetylsalicylic Acid,Aspirin,Low Risk,Slow Metabolism,Phase 4,No Preclinical Data,PI3K-AKT Pathway,Topical Gel,500mg twice a day,Merck,24,High,Low Risk,High (>80%),Fast,Renal,Not Suitable
Atorvastatin,Fever,Anti-Aging,47.74,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1994,Atorvastatin Calcium,Aspirin,Moderate Risk,High Bioavailability,Phase 2,Animal Testing,PI3K-AKT Pathway,Syrup,As prescribed,Merck,24,Moderate,Moderate Risk,Moderate (50-80%),Fast,Liver,Suitable
Omeprazole,Cholesterol Control,Migraine Treatment,46.18,C9H8O4,COX Inhibitor,"Headache, Rash",1996,Ibuprofen,Lipitor,High Risk,High Bioavailability,Phase 4,No Preclinical Data,PI3K-AKT Pathway,Topical Gel,250mg every 8 hours,Roche,24,Moderate,Moderate Risk,Low (<50%),Slow,Renal,Suitable
Losartan,Fever,Weight Loss,69.28,C9H8O4,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1971,Atorvastatin Calcium,Aspirin,High Risk,Renal Excretion,Phase 4,Toxicology Report,Immune Response Pathway,Syrup,500mg twice a day,Merck,6,Moderate,Low Risk,High (>80%),Fast,Liver,Suitable
Paracetamol,Fever,Alzheimer's,86.8,C9H8O4,AMPK Activator,Acid Reflux,1996,Ibuprofen,Glucophage,Low Risk,High Bioavailability,Phase 2,Animal Testing,Dopaminergic Pathway,Capsule,As prescribed,AstraZeneca,24,Low,Moderate Risk,High (>80%),Slow,Gut,Not Suitable
Ranitidine,Acid Reflux,Liver Disease,35.63,C9H8O4,NSAID,"Headache, Rash",1994,Acetylsalicylic Acid,Advil,Moderate Risk,Renal Excretion,Ongoing,Animal Testing,Immune Response Pathway,Capsule,250mg every 8 hours,AstraZeneca,48,Moderate,High Risk,Low (<50%),Moderate,Enzyme-Specific,Suitable
Simvastatin,Hypertension,Antiviral,89.9,C13H18O2,NSAID,Muscle Pain,1994,Metformin Hydrochloride,Lipitor,Moderate Risk,Liver Metabolism,Phase 4,Animal Testing,Serotonin Pathway,Capsule,50mg daily,AstraZeneca,12,Low,Low Risk,Low (<50%),Moderate,Liver,Partially Suitable
Levothyroxine,Fever,Antiviral,77.54,C33H35FN2O5,COX Inhibitor,Acid Reflux,1965,Metformin Hydrochloride,Aspirin,High Risk,Rapid Absorption,Completed,Animal Testing,Serotonin Pathway,Syrup,As prescribed,Pfizer,24,High,Low Risk,Moderate (50-80%),Moderate,Liver,Partially Suitable
Aspirin,Blood Thinner,Autoimmune Disorders,82.7,C13H18O2,HMG-CoA Reductase Inhibitor,Acid Reflux,1987,Metformin Hydrochloride,Glucophage,High Risk,High Bioavailability,Phase 4,In Vitro Studies,PI3K-AKT Pathway,Tablet,50mg daily,Pfizer,48,High,Low Risk,Low (<50%),Fast,Gut,Partially Suitable
Metformin,Inflammation,Antiviral,42.88,C9H8O4,Proton Pump Inhibitor,"Nausea, Dizziness",1971,Acetylsalicylic Acid,Prilosec,Moderate Risk,Rapid Absorption,Phase 3,In Vitro Studies,MAPK Pathway,Topical Gel,500mg twice a day,Merck,2,Low,Low Risk,Low (<50%),Moderate,Gut,Not Suitable
Ibuprofen,Inflammation,Weight Loss,47.63,C4H11N5,AMPK Activator,Muscle Pain,1971,Acetylsalicylic Acid,Glucophage,Moderate Risk,Rapid Absorption,Ongoing,Toxicology Report,Serotonin Pathway,Syrup,10mg once daily,AstraZeneca,12,Moderate,Moderate Risk,High (>80%),Fast,Liver,Suitable
Atorvastatin,Diabetes,Autoimmune Disorders,76.41,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1965,Metformin Hydrochloride,Lipitor,Moderate Risk,Liver Metabolism,Phase 3,No Preclinical Data,Dopaminergic Pathway,Topical Gel,500mg twice a day,AstraZeneca,24,Moderate,Moderate Risk,Low (<50%),Fast,Gut,Not Suitable
Omeprazole,Pain Relief,Liver Disease,34.41,C17H19N3O3S,AMPK Activator,Muscle Pain,1996,Metformin Hydrochloride,Prilosec,Low Risk,Slow Metabolism,Phase 4,Animal Testing,PI3K-AKT Pathway,Injection,As prescribed,Pfizer,6,Moderate,High Risk,High (>80%),Fast,Renal,Not Suitable
Losartan,Diabetes,Cancer Therapy,46.44,C33H35FN2O5,Proton Pump Inhibitor,Muscle Pain,1987,Atorvastatin Calcium,Lipitor,Low Risk,Rapid Absorption,Ongoing,Toxicology Report,Dopaminergic Pathway,Injection,50mg daily,Pfizer,48,Low,High Risk,Moderate (50-80%),Slow,Liver,Partially Suitable
Paracetamol,Fever,Parkinson's,35.13,C17H19N3O3S,AMPK Activator,Muscle Pain,1994,Metformin Hydrochloride,Advil,High Risk,Liver Metabolism,Phase 4,Animal Testing,Dopaminergic Pathway,Injection,10mg once daily,Novartis,48,Low,Moderate Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Not Suitable
Ranitidine,Hypertension,Cardiovascular Disease,82.18,C9H8O4,Proton Pump Inhibitor,Gastrointestinal Issues,1987,Metformin Hydrochloride,Advil,Moderate Risk,Liver Metabolism,Phase 2,No Preclinical Data,Serotonin Pathway,Syrup,As prescribed,Merck,2,Moderate,Low Risk,Moderate (50-80%),Fast,Liver,Suitable
Simvastatin,Fever,Weight Loss,80.66,C9H8O4,Proton Pump Inhibitor,"Nausea, Dizziness",1996,Atorvastatin Calcium,Prilosec,Moderate Risk,High Bioavailability,Completed,No Preclinical Data,Dopaminergic Pathway,Topical Gel,As prescribed,Merck,48,Low,Moderate Risk,Low (<50%),Slow,Gut,Partially Suitable
Levothyroxine,Cholesterol Control,Cardiovascular Disease,57.18,C9H8O4,NSAID,Gastrointestinal Issues,1971,Omeprazole,Glucophage,High Risk,Slow Metabolism,Phase 3,No Preclinical Data,Immune Response Pathway,Capsule,50mg daily,AstraZeneca,12,Moderate,Low Risk,High (>80%),Slow,Gut,Suitable
Aspirin,Fever,Weight Loss,68.14,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1987,Metformin Hydrochloride,Prilosec,High Risk,High Bioavailability,Ongoing,Toxicology Report,PI3K-AKT Pathway,Syrup,50mg daily,AstraZeneca,2,Low,Low Risk,High (>80%),Slow,Renal,Not Suitable
Metformin,Blood Thinner,Parkinson's,42.39,C17H19N3O3S,Proton Pump Inhibitor,Acid Reflux,1996,Atorvastatin Calcium,Aspirin,High Risk,Liver Metabolism,Completed,Toxicology Report,Immune Response Pathway,Capsule,10mg once daily,Roche,2,High,High Risk,Low (<50%),Moderate,Liver,Partially Suitable
Ibuprofen,Cholesterol Control,Cancer Therapy,48.9,C17H19N3O3S,NSAID,"Nausea, Dizziness",1987,Acetylsalicylic Acid,Prilosec,Moderate Risk,Slow Metabolism,Ongoing,Animal Testing,PI3K-AKT Pathway,Capsule,500mg twice a day,Roche,6,Moderate,Moderate Risk,Low (<50%),Slow,Enzyme-Specific,Suitable
Atorvastatin,Inflammation,Migraine Treatment,33.35,C9H8O4,HMG-CoA Reductase Inhibitor,"Headache, Rash",1987,Acetylsalicylic Acid,Prilosec,High Risk,Slow Metabolism,Phase 2,No Preclinical Data,Dopaminergic Pathway,Tablet,As prescribed,Pfizer,24,Low,Moderate Risk,Moderate (50-80%),Fast,Liver,Partially Suitable
Omeprazole,Acid Reflux,Antiviral,49.76,C9H8O4,Proton Pump Inhibitor,"Headache, Rash",1965,Acetylsalicylic Acid,Prilosec,High Risk,Liver Metabolism,Phase 4,Animal Testing,Dopaminergic Pathway,Syrup,250mg every 8 hours,Pfizer,6,Low,High Risk,High (>80%),Slow,Renal,Not Suitable
Losartan,Acid Reflux,Cancer Therapy,38.75,C9H8O4,AMPK Activator,Acid Reflux,1987,Atorvastatin Calcium,Glucophage,High Risk,Slow Metabolism,Phase 2,In Vitro Studies,Dopaminergic Pathway,Capsule,50mg daily,Pfizer,12,High,High Risk,Moderate (50-80%),Fast,Renal,Partially Suitable
Paracetamol,Cholesterol Control,Parkinson's,63.77,C33H35FN2O5,Proton Pump Inhibitor,"Headache, Rash",1971,Atorvastatin Calcium,Prilosec,High Risk,Rapid Absorption,Phase 2,Toxicology Report,PI3K-AKT Pathway,Tablet,500mg twice a day,AstraZeneca,48,High,High Risk,Low (<50%),Slow,Renal,Not Suitable
Ranitidine,Pain Relief,Cardiovascular Disease,78.23,C17H19N3O3S,AMPK Activator,Acid Reflux,1996,Metformin Hydrochloride,Glucophage,Moderate Risk,Rapid Absorption,Phase 1,Animal Testing,MAPK Pathway,Capsule,10mg once daily,Roche,6,Low,Moderate Risk,Moderate (50-80%),Slow,Enzyme-Specific,Suitable
Simvastatin,Hypertension,Migraine Treatment,41.51,C9H8O4,AMPK Activator,Gastrointestinal Issues,1971,Atorvastatin Calcium,Lipitor,High Risk,Liver Metabolism,Phase 2,No Preclinical Data,Serotonin Pathway,Capsule,10mg once daily,Novartis,6,Moderate,High Risk,Moderate (50-80%),Moderate,Renal,Partially Suitable
Levothyroxine,Diabetes,Weight Loss,49.95,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1965,Metformin Hydrochloride,Advil,High Risk,Renal Excretion,Phase 1,Animal Testing,Dopaminergic Pathway,Injection,10mg once daily,Roche,48,Low,High Risk,Moderate (50-80%),Slow,Gut,Partially Suitable
Aspirin,Fever,Liver Disease,89.8,C9H8O4,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1971,Atorvastatin Calcium,Advil,High Risk,Slow Metabolism,Completed,Toxicology Report,MAPK Pathway,Tablet,50mg daily,Pfizer,6,Low,Low Risk,High (>80%),Slow,Liver,Partially Suitable
Metformin,Fever,Parkinson's,32.63,C9H8O4,COX Inhibitor,Gastrointestinal Issues,1965,Atorvastatin Calcium,Advil,High Risk,Liver Metabolism,Phase 4,In Vitro Studies,Dopaminergic Pathway,Capsule,10mg once daily,Pfizer,12,High,Low Risk,Moderate (50-80%),Slow,Liver,Not Suitable
Ibuprofen,Blood Thinner,Antiviral,51.94,C13H18O2,Proton Pump Inhibitor,"Nausea, Dizziness",1987,Acetylsalicylic Acid,Lipitor,High Risk,Renal Excretion,Phase 3,Animal Testing,Immune Response Pathway,Topical Gel,As prescribed,Roche,12,Low,High Risk,Moderate (50-80%),Moderate,Renal,Partially Suitable
Atorvastatin,Diabetes,Antiviral,91.41,C13H18O2,NSAID,Gastrointestinal Issues,1965,Omeprazole,Prilosec,High Risk,High Bioavailability,Ongoing,Animal Testing,Dopaminergic Pathway,Topical Gel,50mg daily,Novartis,12,Low,Moderate Risk,Low (<50%),Slow,Gut,Partially Suitable
Omeprazole,Thyroid Hormone Replacement,Cardiovascular Disease,47.57,C4H11N5,NSAID,"Headache, Rash",1994,Atorvastatin Calcium,Advil,High Risk,Rapid Absorption,Completed,No Preclinical Data,Dopaminergic Pathway,Syrup,250mg every 8 hours,AstraZeneca,12,Low,Low Risk,Moderate (50-80%),Slow,Enzyme-Specific,Not Suitable
Losartan,Acid Reflux,Alzheimer's,79.27,C4H11N5,Proton Pump Inhibitor,Gastrointestinal Issues,1994,Atorvastatin Calcium,Glucophage,Moderate Risk,High Bioavailability,Phase 4,In Vitro Studies,PI3K-AKT Pathway,Topical Gel,500mg twice a day,Roche,12,Moderate,Low Risk,High (>80%),Moderate,Liver,Not Suitable
Paracetamol,Gastric Ulcer,Weight Loss,33.35,C4H11N5,AMPK Activator,"Headache, Rash",1996,Omeprazole,Advil,Moderate Risk,Liver Metabolism,Phase 4,Toxicology Report,PI3K-AKT Pathway,Injection,50mg daily,AstraZeneca,12,Low,Low Risk,Low (<50%),Moderate,Liver,Partially Suitable
Ranitidine,Hypertension,Cardiovascular Disease,44.33,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Acid Reflux,1965,Omeprazole,Lipitor,Low Risk,Rapid Absorption,Phase 2,No Preclinical Data,PI3K-AKT Pathway,Tablet,500mg twice a day,Roche,24,Low,Moderate Risk,High (>80%),Moderate,Renal,Suitable
Simvastatin,Gastric Ulcer,Antiviral,55.7,C17H19N3O3S,AMPK Activator,Acid Reflux,1987,Ibuprofen,Prilosec,Moderate Risk,Slow Metabolism,Completed,Toxicology Report,Serotonin Pathway,Syrup,As prescribed,AstraZeneca,6,High,Moderate Risk,Low (<50%),Moderate,Renal,Suitable
Levothyroxine,Gastric Ulcer,Liver Disease,79.42,C13H18O2,AMPK Activator,Muscle Pain,1965,Acetylsalicylic Acid,Prilosec,High Risk,High Bioavailability,Completed,In Vitro Studies,Immune Response Pathway,Injection,50mg daily,Pfizer,12,Low,Low Risk,High (>80%),Moderate,Renal,Suitable
Aspirin,Acid Reflux,Cancer Therapy,71.34,C4H11N5,HMG-CoA Reductase Inhibitor,Acid Reflux,1965,Omeprazole,Prilosec,Low Risk,Slow Metabolism,Phase 3,Toxicology Report,Serotonin Pathway,Topical Gel,10mg once daily,Novartis,6,Moderate,Moderate Risk,High (>80%),Moderate,Liver,Partially Suitable
Metformin,Hypertension,Migraine Treatment,31.82,C4H11N5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1996,Acetylsalicylic Acid,Lipitor,Low Risk,Renal Excretion,Phase 4,No Preclinical Data,MAPK Pathway,Syrup,500mg twice a day,Novartis,6,High,Moderate Risk,High (>80%),Moderate,Liver,Partially Suitable
Ibuprofen,Inflammation,Cancer Therapy,35.73,C9H8O4,HMG-CoA Reductase Inhibitor,Muscle Pain,1994,Omeprazole,Lipitor,High Risk,Slow Metabolism,Ongoing,No Preclinical Data,Immune Response Pathway,Topical Gel,500mg twice a day,Merck,24,Low,Moderate Risk,Low (<50%),Fast,Liver,Partially Suitable
Atorvastatin,Cholesterol Control,Cancer Therapy,47.11,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Muscle Pain,1965,Ibuprofen,Lipitor,High Risk,Renal Excretion,Phase 2,Toxicology Report,MAPK Pathway,Topical Gel,250mg every 8 hours,Pfizer,24,Low,Low Risk,Low (<50%),Fast,Liver,Partially Suitable
Omeprazole,Acid Reflux,Weight Loss,52.11,C4H11N5,NSAID,Gastrointestinal Issues,1996,Acetylsalicylic Acid,Prilosec,Low Risk,High Bioavailability,Completed,In Vitro Studies,PI3K-AKT Pathway,Topical Gel,500mg twice a day,Roche,6,Moderate,Low Risk,Low (<50%),Moderate,Renal,Suitable
Losartan,Gastric Ulcer,Liver Disease,90.19,C33H35FN2O5,AMPK Activator,"Headache, Rash",1971,Atorvastatin Calcium,Lipitor,Moderate Risk,Slow Metabolism,Ongoing,Toxicology Report,PI3K-AKT Pathway,Capsule,500mg twice a day,Novartis,2,High,Moderate Risk,High (>80%),Slow,Renal,Suitable
Paracetamol,Gastric Ulcer,Liver Disease,42.46,C13H18O2,COX Inhibitor,Acid Reflux,1987,Metformin Hydrochloride,Lipitor,Moderate Risk,Liver Metabolism,Phase 2,In Vitro Studies,PI3K-AKT Pathway,Tablet,250mg every 8 hours,Pfizer,12,High,Low Risk,Moderate (50-80%),Slow,Gut,Not Suitable
Ranitidine,Blood Thinner,Migraine Treatment,36.52,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Acid Reflux,1987,Ibuprofen,Glucophage,Moderate Risk,Liver Metabolism,Phase 3,Toxicology Report,MAPK Pathway,Injection,As prescribed,Novartis,6,High,Moderate Risk,Moderate (50-80%),Fast,Enzyme-Specific,Suitable
Simvastatin,Diabetes,Liver Disease,93.49,C33H35FN2O5,NSAID,Acid Reflux,1996,Omeprazole,Glucophage,Moderate Risk,Renal Excretion,Phase 2,Animal Testing,Immune Response Pathway,Capsule,250mg every 8 hours,AstraZeneca,12,High,Moderate Risk,Low (<50%),Slow,Renal,Partially Suitable
Levothyroxine,Fever,Liver Disease,60.83,C17H19N3O3S,NSAID,Gastrointestinal Issues,1987,Ibuprofen,Prilosec,High Risk,High Bioavailability,Phase 4,Toxicology Report,Serotonin Pathway,Topical Gel,10mg once daily,Novartis,2,High,Moderate Risk,High (>80%),Moderate,Renal,Partially Suitable
Aspirin,Gastric Ulcer,Antiviral,62.45,C13H18O2,Proton Pump Inhibitor,Gastrointestinal Issues,1996,Acetylsalicylic Acid,Aspirin,Low Risk,Liver Metabolism,Phase 3,No Preclinical Data,PI3K-AKT Pathway,Tablet,As prescribed,Pfizer,2,Low,Moderate Risk,Low (<50%),Fast,Enzyme-Specific,Suitable
Metformin,Acid Reflux,Migraine Treatment,39.45,C17H19N3O3S,Proton Pump Inhibitor,"Headache, Rash",1994,Ibuprofen,Aspirin,High Risk,Rapid Absorption,Phase 1,Animal Testing,MAPK Pathway,Tablet,250mg every 8 hours,Merck,48,High,Low Risk,Low (<50%),Slow,Gut,Partially Suitable
Ibuprofen,Inflammation,Weight Loss,36.55,C9H8O4,Proton Pump Inhibitor,Acid Reflux,1994,Ibuprofen,Advil,High Risk,Rapid Absorption,Phase 1,Toxicology Report,Serotonin Pathway,Syrup,250mg every 8 hours,Merck,12,Low,Low Risk,Low (<50%),Moderate,Enzyme-Specific,Suitable
Atorvastatin,Acid Reflux,Anti-Aging,68.81,C13H18O2,NSAID,"Headache, Rash",1996,Metformin Hydrochloride,Advil,Moderate Risk,Liver Metabolism,Completed,No Preclinical Data,Serotonin Pathway,Capsule,500mg twice a day,Merck,6,Moderate,High Risk,High (>80%),Moderate,Liver,Partially Suitable
Omeprazole,Acid Reflux,Parkinson's,84.22,C9H8O4,AMPK Activator,Gastrointestinal Issues,1994,Acetylsalicylic Acid,Prilosec,Moderate Risk,Rapid Absorption,Phase 1,Animal Testing,Dopaminergic Pathway,Tablet,As prescribed,Novartis,12,Moderate,High Risk,High (>80%),Moderate,Liver,Not Suitable
Losartan,Acid Reflux,Migraine Treatment,66.65,C9H8O4,AMPK Activator,Acid Reflux,1971,Omeprazole,Lipitor,High Risk,Liver Metabolism,Completed,No Preclinical Data,MAPK Pathway,Syrup,As prescribed,Pfizer,6,High,High Risk,Low (<50%),Slow,Gut,Not Suitable
Paracetamol,Thyroid Hormone Replacement,Liver Disease,33.64,C13H18O2,HMG-CoA Reductase Inhibitor,"Headache, Rash",1994,Metformin Hydrochloride,Glucophage,Low Risk,High Bioavailability,Phase 4,No Preclinical Data,PI3K-AKT Pathway,Capsule,500mg twice a day,Roche,12,Low,High Risk,Moderate (50-80%),Slow,Renal,Not Suitable
Ranitidine,Thyroid Hormone Replacement,Parkinson's,38.65,C13H18O2,Proton Pump Inhibitor,Muscle Pain,1971,Acetylsalicylic Acid,Prilosec,Moderate Risk,Liver Metabolism,Completed,Toxicology Report,Dopaminergic Pathway,Capsule,10mg once daily,Pfizer,24,Low,Low Risk,High (>80%),Slow,Gut,Not Suitable
Simvastatin,Hypertension,Autoimmune Disorders,90.36,C9H8O4,HMG-CoA Reductase Inhibitor,"Headache, Rash",1965,Acetylsalicylic Acid,Lipitor,Moderate Risk,Liver Metabolism,Phase 2,In Vitro Studies,Serotonin Pathway,Topical Gel,50mg daily,Pfizer,48,Moderate,High Risk,Moderate (50-80%),Fast,Enzyme-Specific,Not Suitable
Levothyroxine,Gastric Ulcer,Liver Disease,80.04,C4H11N5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1994,Omeprazole,Glucophage,Low Risk,Rapid Absorption,Completed,Animal Testing,MAPK Pathway,Syrup,250mg every 8 hours,Roche,48,Low,Moderate Risk,Low (<50%),Moderate,Enzyme-Specific,Suitable
Aspirin,Hypertension,Migraine Treatment,72.17,C9H8O4,HMG-CoA Reductase Inhibitor,"Headache, Rash",1971,Atorvastatin Calcium,Lipitor,Low Risk,High Bioavailability,Phase 2,No Preclinical Data,Serotonin Pathway,Topical Gel,50mg daily,Roche,12,High,Moderate Risk,Moderate (50-80%),Moderate,Gut,Partially Suitable
Metformin,Hypertension,Cardiovascular Disease,81.51,C4H11N5,COX Inhibitor,"Nausea, Dizziness",1996,Omeprazole,Aspirin,High Risk,Renal Excretion,Phase 2,Animal Testing,MAPK Pathway,Injection,10mg once daily,Roche,24,Moderate,Moderate Risk,High (>80%),Moderate,Enzyme-Specific,Suitable
Ibuprofen,Fever,Liver Disease,88.22,C13H18O2,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1971,Metformin Hydrochloride,Aspirin,Moderate Risk,Rapid Absorption,Ongoing,Toxicology Report,PI3K-AKT Pathway,Injection,10mg once daily,Merck,48,Moderate,High Risk,Low (<50%),Moderate,Renal,Partially Suitable
Atorvastatin,Pain Relief,Autoimmune Disorders,90.22,C17H19N3O3S,AMPK Activator,"Nausea, Dizziness",1987,Atorvastatin Calcium,Glucophage,Moderate Risk,Renal Excretion,Phase 1,No Preclinical Data,Immune Response Pathway,Topical Gel,250mg every 8 hours,Pfizer,2,High,Moderate Risk,Low (<50%),Fast,Renal,Suitable
Omeprazole,Blood Thinner,Antiviral,76.65,C9H8O4,HMG-CoA Reductase Inhibitor,Muscle Pain,1971,Ibuprofen,Lipitor,Moderate Risk,Liver Metabolism,Ongoing,No Preclinical Data,Immune Response Pathway,Syrup,As prescribed,Pfizer,48,Low,High Risk,Moderate (50-80%),Moderate,Liver,Partially Suitable
Losartan,Diabetes,Weight Loss,80.68,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1965,Ibuprofen,Lipitor,Moderate Risk,Rapid Absorption,Ongoing,Toxicology Report,PI3K-AKT Pathway,Injection,500mg twice a day,Roche,12,Low,High Risk,High (>80%),Fast,Renal,Suitable
Paracetamol,Thyroid Hormone Replacement,Migraine Treatment,53.87,C13H18O2,NSAID,"Nausea, Dizziness",1994,Atorvastatin Calcium,Aspirin,High Risk,High Bioavailability,Completed,No Preclinical Data,Dopaminergic Pathway,Syrup,50mg daily,AstraZeneca,6,Moderate,High Risk,Moderate (50-80%),Fast,Renal,Partially Suitable
Ranitidine,Fever,Weight Loss,85.03,C33H35FN2O5,AMPK Activator,Acid Reflux,1965,Acetylsalicylic Acid,Lipitor,High Risk,High Bioavailability,Completed,Toxicology Report,PI3K-AKT Pathway,Topical Gel,10mg once daily,Pfizer,2,Moderate,Low Risk,Low (<50%),Slow,Enzyme-Specific,Not Suitable
Simvastatin,Fever,Anti-Aging,40.22,C4H11N5,AMPK Activator,"Headache, Rash",1965,Atorvastatin Calcium,Aspirin,High Risk,Rapid Absorption,Phase 3,In Vitro Studies,MAPK Pathway,Capsule,500mg twice a day,AstraZeneca,24,Moderate,Moderate Risk,Low (<50%),Fast,Gut,Suitable
Levothyroxine,Thyroid Hormone Replacement,Parkinson's,91.05,C13H18O2,AMPK Activator,Gastrointestinal Issues,1965,Metformin Hydrochloride,Lipitor,High Risk,Liver Metabolism,Phase 1,Animal Testing,Serotonin Pathway,Tablet,As prescribed,Merck,6,Moderate,High Risk,Low (<50%),Slow,Gut,Partially Suitable
Aspirin,Pain Relief,Parkinson's,43.15,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Muscle Pain,1971,Omeprazole,Advil,Moderate Risk,Liver Metabolism,Phase 3,Toxicology Report,Serotonin Pathway,Capsule,50mg daily,Novartis,24,High,Moderate Risk,High (>80%),Moderate,Renal,Partially Suitable
Metformin,Pain Relief,Cardiovascular Disease,92.61,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Acid Reflux,1965,Ibuprofen,Glucophage,Moderate Risk,High Bioavailability,Completed,Toxicology Report,Immune Response Pathway,Capsule,50mg daily,Merck,6,High,Moderate Risk,Low (<50%),Moderate,Liver,Suitable
Ibuprofen,Blood Thinner,Autoimmune Disorders,80.22,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1994,Ibuprofen,Lipitor,Moderate Risk,Renal Excretion,Phase 3,In Vitro Studies,Immune Response Pathway,Capsule,500mg twice a day,AstraZeneca,6,Moderate,High Risk,Low (<50%),Moderate,Gut,Partially Suitable
Atorvastatin,Fever,Antiviral,46.08,C33H35FN2O5,NSAID,Muscle Pain,1994,Omeprazole,Prilosec,Moderate Risk,Renal Excretion,Phase 3,No Preclinical Data,MAPK Pathway,Tablet,250mg every 8 hours,Novartis,12,Moderate,Low Risk,Low (<50%),Slow,Liver,Partially Suitable
Omeprazole,Gastric Ulcer,Autoimmune Disorders,77.09,C4H11N5,Proton Pump Inhibitor,Gastrointestinal Issues,1994,Ibuprofen,Aspirin,Moderate Risk,Liver Metabolism,Completed,Toxicology Report,PI3K-AKT Pathway,Tablet,As prescribed,Pfizer,24,High,Low Risk,Low (<50%),Moderate,Enzyme-Specific,Partially Suitable
Losartan,Diabetes,Alzheimer's,67.08,C33H35FN2O5,Proton Pump Inhibitor,Gastrointestinal Issues,1965,Atorvastatin Calcium,Lipitor,Moderate Risk,Slow Metabolism,Phase 3,In Vitro Studies,Immune Response Pathway,Tablet,50mg daily,Roche,6,Moderate,High Risk,Low (<50%),Moderate,Enzyme-Specific,Not Suitable
Paracetamol,Hypertension,Autoimmune Disorders,51.29,C4H11N5,NSAID,Acid Reflux,1987,Metformin Hydrochloride,Glucophage,Moderate Risk,Renal Excretion,Phase 2,No Preclinical Data,Immune Response Pathway,Tablet,500mg twice a day,Novartis,48,Low,Moderate Risk,High (>80%),Fast,Renal,Partially Suitable
Ranitidine,Fever,Weight Loss,84.87,C13H18O2,NSAID,"Nausea, Dizziness",1987,Omeprazole,Prilosec,High Risk,High Bioavailability,Phase 3,Toxicology Report,PI3K-AKT Pathway,Syrup,As prescribed,Novartis,12,Low,Low Risk,Low (<50%),Slow,Gut,Partially Suitable
Simvastatin,Fever,Cancer Therapy,75.32,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1971,Omeprazole,Aspirin,Low Risk,High Bioavailability,Phase 2,Animal Testing,Immune Response Pathway,Capsule,10mg once daily,Merck,24,High,Moderate Risk,Moderate (50-80%),Moderate,Gut,Suitable
Levothyroxine,Hypertension,Cancer Therapy,70.38,C17H19N3O3S,Proton Pump Inhibitor,"Headache, Rash",1996,Acetylsalicylic Acid,Lipitor,High Risk,Renal Excretion,Phase 1,In Vitro Studies,Dopaminergic Pathway,Injection,250mg every 8 hours,Pfizer,6,Low,Low Risk,Low (<50%),Moderate,Liver,Suitable
Aspirin,Cholesterol Control,Weight Loss,78.78,C13H18O2,NSAID,Muscle Pain,1965,Acetylsalicylic Acid,Glucophage,Low Risk,Slow Metabolism,Phase 4,In Vitro Studies,Immune Response Pathway,Tablet,10mg once daily,AstraZeneca,6,High,Moderate Risk,High (>80%),Fast,Gut,Partially Suitable
Metformin,Diabetes,Liver Disease,69.48,C33H35FN2O5,AMPK Activator,Muscle Pain,1994,Omeprazole,Aspirin,High Risk,High Bioavailability,Phase 1,Animal Testing,Immune Response Pathway,Injection,500mg twice a day,AstraZeneca,48,Moderate,Low Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Suitable
Ibuprofen,Diabetes,Alzheimer's,51.66,C4H11N5,Proton Pump Inhibitor,"Nausea, Dizziness",1996,Atorvastatin Calcium,Prilosec,High Risk,Liver Metabolism,Phase 3,No Preclinical Data,Dopaminergic Pathway,Capsule,10mg once daily,Pfizer,6,Moderate,Moderate Risk,High (>80%),Moderate,Liver,Partially Suitable
Atorvastatin,Inflammation,Parkinson's,83.72,C9H8O4,Proton Pump Inhibitor,Muscle Pain,1965,Acetylsalicylic Acid,Advil,Moderate Risk,Liver Metabolism,Phase 3,No Preclinical Data,Immune Response Pathway,Syrup,50mg daily,Pfizer,48,High,Low Risk,Low (<50%),Slow,Enzyme-Specific,Not Suitable
Omeprazole,Thyroid Hormone Replacement,Alzheimer's,61.04,C33H35FN2O5,Proton Pump Inhibitor,Gastrointestinal Issues,1965,Metformin Hydrochloride,Prilosec,Moderate Risk,Renal Excretion,Completed,Toxicology Report,PI3K-AKT Pathway,Topical Gel,10mg once daily,Novartis,12,Low,Low Risk,Moderate (50-80%),Moderate,Renal,Suitable
Losartan,Inflammation,Migraine Treatment,82.07,C13H18O2,COX Inhibitor,Acid Reflux,1965,Omeprazole,Advil,Moderate Risk,Slow Metabolism,Phase 1,Animal Testing,MAPK Pathway,Topical Gel,50mg daily,Pfizer,2,High,Moderate Risk,Moderate (50-80%),Slow,Gut,Partially Suitable
Paracetamol,Pain Relief,Autoimmune Disorders,71.96,C9H8O4,HMG-CoA Reductase Inhibitor,"Headache, Rash",1987,Metformin Hydrochloride,Glucophage,High Risk,Slow Metabolism,Ongoing,Animal Testing,MAPK Pathway,Injection,500mg twice a day,Merck,2,High,High Risk,High (>80%),Slow,Renal,Not Suitable
Ranitidine,Hypertension,Liver Disease,36.17,C4H11N5,NSAID,Muscle Pain,1996,Ibuprofen,Aspirin,Moderate Risk,Renal Excretion,Ongoing,Animal Testing,PI3K-AKT Pathway,Topical Gel,500mg twice a day,Pfizer,12,High,High Risk,Moderate (50-80%),Fast,Gut,Partially Suitable
Simvastatin,Thyroid Hormone Replacement,Weight Loss,38.4,C4H11N5,NSAID,Muscle Pain,1994,Atorvastatin Calcium,Aspirin,Moderate Risk,High Bioavailability,Phase 3,Animal Testing,MAPK Pathway,Syrup,250mg every 8 hours,Novartis,2,Low,Moderate Risk,Moderate (50-80%),Slow,Liver,Suitable
Levothyroxine,Cholesterol Control,Migraine Treatment,56.44,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Acid Reflux,1994,Omeprazole,Advil,Low Risk,Renal Excretion,Completed,In Vitro Studies,MAPK Pathway,Injection,10mg once daily,Roche,48,High,High Risk,Low (<50%),Slow,Enzyme-Specific,Not Suitable
Aspirin,Acid Reflux,Liver Disease,79.82,C9H8O4,Proton Pump Inhibitor,Gastrointestinal Issues,1996,Acetylsalicylic Acid,Aspirin,Moderate Risk,Rapid Absorption,Phase 2,Animal Testing,PI3K-AKT Pathway,Tablet,250mg every 8 hours,AstraZeneca,6,Low,High Risk,High (>80%),Moderate,Liver,Suitable
Metformin,Gastric Ulcer,Anti-Aging,38.27,C13H18O2,HMG-CoA Reductase Inhibitor,Muscle Pain,1994,Omeprazole,Glucophage,Low Risk,Liver Metabolism,Phase 4,Toxicology Report,Immune Response Pathway,Capsule,10mg once daily,Roche,2,Low,Moderate Risk,Moderate (50-80%),Fast,Liver,Suitable
Ibuprofen,Inflammation,Antiviral,65.92,C17H19N3O3S,Proton Pump Inhibitor,"Nausea, Dizziness",1987,Omeprazole,Advil,Low Risk,Slow Metabolism,Phase 2,In Vitro Studies,Serotonin Pathway,Topical Gel,As prescribed,Novartis,6,Low,Low Risk,Low (<50%),Moderate,Renal,Partially Suitable
Atorvastatin,Thyroid Hormone Replacement,Autoimmune Disorders,87.21,C4H11N5,HMG-CoA Reductase Inhibitor,Acid Reflux,1971,Acetylsalicylic Acid,Advil,Low Risk,Slow Metabolism,Phase 1,Toxicology Report,MAPK Pathway,Syrup,10mg once daily,Novartis,2,Moderate,High Risk,Moderate (50-80%),Slow,Liver,Not Suitable
Omeprazole,Diabetes,Antiviral,61.56,C4H11N5,AMPK Activator,Gastrointestinal Issues,1994,Atorvastatin Calcium,Aspirin,Moderate Risk,Slow Metabolism,Ongoing,Animal Testing,Serotonin Pathway,Injection,As prescribed,Novartis,24,Moderate,High Risk,High (>80%),Slow,Enzyme-Specific,Suitable
Losartan,Fever,Cardiovascular Disease,47.88,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Muscle Pain,1971,Omeprazole,Aspirin,High Risk,Slow Metabolism,Completed,Animal Testing,Immune Response Pathway,Topical Gel,50mg daily,Merck,48,Moderate,Low Risk,Moderate (50-80%),Slow,Renal,Not Suitable
Paracetamol,Thyroid Hormone Replacement,Cancer Therapy,64.12,C13H18O2,AMPK Activator,"Nausea, Dizziness",1996,Omeprazole,Advil,Low Risk,Renal Excretion,Completed,Animal Testing,PI3K-AKT Pathway,Tablet,500mg twice a day,Novartis,2,High,High Risk,High (>80%),Moderate,Liver,Partially Suitable
Ranitidine,Diabetes,Liver Disease,40.49,C4H11N5,Proton Pump Inhibitor,Acid Reflux,1996,Omeprazole,Aspirin,High Risk,Rapid Absorption,Phase 1,Toxicology Report,Dopaminergic Pathway,Syrup,500mg twice a day,Pfizer,6,Low,Moderate Risk,Low (<50%),Fast,Enzyme-Specific,Not Suitable
Simvastatin,Acid Reflux,Cancer Therapy,64.67,C4H11N5,HMG-CoA Reductase Inhibitor,Muscle Pain,1965,Acetylsalicylic Acid,Lipitor,High Risk,Slow Metabolism,Phase 3,No Preclinical Data,Immune Response Pathway,Capsule,As prescribed,Novartis,6,Low,Moderate Risk,High (>80%),Fast,Liver,Not Suitable
Levothyroxine,Hypertension,Anti-Aging,94.82,C33H35FN2O5,NSAID,Muscle Pain,1996,Atorvastatin Calcium,Prilosec,High Risk,Slow Metabolism,Phase 2,No Preclinical Data,Dopaminergic Pathway,Syrup,500mg twice a day,AstraZeneca,6,High,Low Risk,High (>80%),Moderate,Liver,Suitable
Aspirin,Thyroid Hormone Replacement,Weight Loss,76.59,C13H18O2,Proton Pump Inhibitor,Acid Reflux,1987,Atorvastatin Calcium,Prilosec,Low Risk,Slow Metabolism,Completed,No Preclinical Data,PI3K-AKT Pathway,Injection,As prescribed,Novartis,2,Low,Moderate Risk,High (>80%),Moderate,Enzyme-Specific,Suitable
Metformin,Fever,Alzheimer's,69.95,C4H11N5,COX Inhibitor,"Nausea, Dizziness",1965,Acetylsalicylic Acid,Glucophage,High Risk,Renal Excretion,Phase 4,Animal Testing,Serotonin Pathway,Injection,250mg every 8 hours,Roche,2,Low,Low Risk,High (>80%),Moderate,Renal,Suitable
Ibuprofen,Cholesterol Control,Autoimmune Disorders,42.81,C9H8O4,AMPK Activator,Muscle Pain,1994,Ibuprofen,Prilosec,Low Risk,Rapid Absorption,Phase 1,Toxicology Report,PI3K-AKT Pathway,Capsule,10mg once daily,Pfizer,2,High,Moderate Risk,Low (<50%),Moderate,Enzyme-Specific,Suitable
Atorvastatin,Pain Relief,Anti-Aging,62.51,C9H8O4,Proton Pump Inhibitor,Acid Reflux,1987,Ibuprofen,Aspirin,Low Risk,Rapid Absorption,Phase 3,Toxicology Report,Immune Response Pathway,Capsule,250mg every 8 hours,Roche,48,Low,Moderate Risk,Moderate (50-80%),Fast,Renal,Not Suitable
Omeprazole,Gastric Ulcer,Cardiovascular Disease,85.46,C13H18O2,COX Inhibitor,Acid Reflux,1971,Ibuprofen,Aspirin,High Risk,High Bioavailability,Ongoing,Toxicology Report,Immune Response Pathway,Syrup,250mg every 8 hours,Roche,12,Low,Moderate Risk,Moderate (50-80%),Slow,Liver,Suitable
Losartan,Cholesterol Control,Autoimmune Disorders,78.01,C13H18O2,AMPK Activator,Muscle Pain,1994,Omeprazole,Lipitor,High Risk,Liver Metabolism,Phase 2,In Vitro Studies,PI3K-AKT Pathway,Capsule,50mg daily,Novartis,6,Moderate,Low Risk,Low (<50%),Moderate,Liver,Suitable
Paracetamol,Blood Thinner,Migraine Treatment,34.58,C9H8O4,Proton Pump Inhibitor,Gastrointestinal Issues,1965,Omeprazole,Glucophage,Low Risk,Rapid Absorption,Phase 1,Animal Testing,MAPK Pathway,Syrup,250mg every 8 hours,Roche,12,High,Moderate Risk,Low (<50%),Moderate,Gut,Partially Suitable
Ranitidine,Acid Reflux,Cardiovascular Disease,82.99,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Muscle Pain,1971,Ibuprofen,Lipitor,Low Risk,Slow Metabolism,Phase 1,Animal Testing,Dopaminergic Pathway,Topical Gel,500mg twice a day,Novartis,48,Low,Moderate Risk,Moderate (50-80%),Slow,Liver,Partially Suitable
Simvastatin,Cholesterol Control,Autoimmune Disorders,69.83,C17H19N3O3S,NSAID,Muscle Pain,1994,Metformin Hydrochloride,Advil,Moderate Risk,Liver Metabolism,Phase 3,Animal Testing,PI3K-AKT Pathway,Topical Gel,500mg twice a day,Roche,48,Low,Low Risk,High (>80%),Fast,Liver,Not Suitable
Levothyroxine,Fever,Alzheimer's,49.47,C4H11N5,Proton Pump Inhibitor,Gastrointestinal Issues,1971,Omeprazole,Advil,Moderate Risk,Renal Excretion,Phase 2,Toxicology Report,MAPK Pathway,Syrup,50mg daily,Roche,6,High,High Risk,Moderate (50-80%),Fast,Liver,Partially Suitable
Aspirin,Gastric Ulcer,Anti-Aging,56.65,C13H18O2,AMPK Activator,Acid Reflux,1994,Atorvastatin Calcium,Prilosec,High Risk,High Bioavailability,Phase 1,No Preclinical Data,MAPK Pathway,Capsule,500mg twice a day,Roche,48,Low,High Risk,Moderate (50-80%),Moderate,Liver,Not Suitable
Metformin,Blood Thinner,Antiviral,44.82,C4H11N5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1971,Omeprazole,Glucophage,Moderate Risk,Slow Metabolism,Ongoing,Toxicology Report,Immune Response Pathway,Topical Gel,250mg every 8 hours,Pfizer,6,High,Low Risk,Moderate (50-80%),Fast,Renal,Suitable
Ibuprofen,Hypertension,Cancer Therapy,85.76,C17H19N3O3S,NSAID,Acid Reflux,1965,Ibuprofen,Lipitor,Low Risk,High Bioavailability,Phase 2,No Preclinical Data,PI3K-AKT Pathway,Injection,250mg every 8 hours,AstraZeneca,12,Low,Low Risk,Low (<50%),Fast,Enzyme-Specific,Suitable
Atorvastatin,Gastric Ulcer,Autoimmune Disorders,55.77,C13H18O2,NSAID,"Headache, Rash",1971,Atorvastatin Calcium,Aspirin,Moderate Risk,Rapid Absorption,Phase 3,In Vitro Studies,PI3K-AKT Pathway,Capsule,As prescribed,Merck,48,Low,Low Risk,Low (<50%),Slow,Renal,Not Suitable
Omeprazole,Thyroid Hormone Replacement,Cancer Therapy,81.01,C33H35FN2O5,AMPK Activator,"Headache, Rash",1996,Ibuprofen,Advil,High Risk,Liver Metabolism,Completed,Toxicology Report,PI3K-AKT Pathway,Topical Gel,500mg twice a day,Novartis,2,High,Low Risk,Low (<50%),Moderate,Renal,Partially Suitable
Losartan,Blood Thinner,Cancer Therapy,83.18,C9H8O4,NSAID,Muscle Pain,1965,Atorvastatin Calcium,Prilosec,Moderate Risk,Slow Metabolism,Ongoing,Animal Testing,MAPK Pathway,Topical Gel,250mg every 8 hours,Novartis,48,Low,Moderate Risk,Low (<50%),Fast,Liver,Not Suitable
Paracetamol,Hypertension,Alzheimer's,67.9,C4H11N5,Proton Pump Inhibitor,Acid Reflux,1994,Ibuprofen,Prilosec,Moderate Risk,Liver Metabolism,Ongoing,No Preclinical Data,Immune Response Pathway,Capsule,50mg daily,Roche,48,Low,Moderate Risk,High (>80%),Slow,Renal,Partially Suitable
Ranitidine,Cholesterol Control,Weight Loss,89.16,C13H18O2,Proton Pump Inhibitor,Gastrointestinal Issues,1965,Metformin Hydrochloride,Aspirin,Moderate Risk,Renal Excretion,Phase 3,Toxicology Report,MAPK Pathway,Syrup,As prescribed,Novartis,6,Low,Low Risk,High (>80%),Slow,Enzyme-Specific,Suitable
Simvastatin,Diabetes,Autoimmune Disorders,94.86,C9H8O4,Proton Pump Inhibitor,Gastrointestinal Issues,1996,Omeprazole,Lipitor,Moderate Risk,High Bioavailability,Ongoing,In Vitro Studies,Dopaminergic Pathway,Injection,500mg twice a day,Merck,6,Low,Low Risk,Moderate (50-80%),Fast,Enzyme-Specific,Partially Suitable
Levothyroxine,Fever,Anti-Aging,82.1,C17H19N3O3S,NSAID,Gastrointestinal Issues,1971,Atorvastatin Calcium,Advil,Moderate Risk,Rapid Absorption,Phase 3,Animal Testing,PI3K-AKT Pathway,Tablet,50mg daily,Pfizer,48,Moderate,High Risk,High (>80%),Moderate,Renal,Suitable
Aspirin,Fever,Anti-Aging,58.73,C9H8O4,AMPK Activator,"Headache, Rash",1987,Atorvastatin Calcium,Advil,High Risk,Liver Metabolism,Phase 4,No Preclinical Data,Dopaminergic Pathway,Injection,50mg daily,Novartis,6,High,Low Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Partially Suitable
Metformin,Blood Thinner,Weight Loss,76.12,C4H11N5,NSAID,Acid Reflux,1965,Omeprazole,Advil,High Risk,Renal Excretion,Phase 3,Animal Testing,Dopaminergic Pathway,Tablet,250mg every 8 hours,Pfizer,6,High,Low Risk,High (>80%),Fast,Gut,Not Suitable
Ibuprofen,Hypertension,Cancer Therapy,46.4,C13H18O2,HMG-CoA Reductase Inhibitor,"Headache, Rash",1996,Metformin Hydrochloride,Prilosec,High Risk,Slow Metabolism,Ongoing,No Preclinical Data,Immune Response Pathway,Tablet,500mg twice a day,Novartis,24,High,Low Risk,High (>80%),Moderate,Renal,Not Suitable
Atorvastatin,Blood Thinner,Antiviral,33.84,C4H11N5,Proton Pump Inhibitor,"Headache, Rash",1971,Atorvastatin Calcium,Advil,High Risk,Rapid Absorption,Ongoing,In Vitro Studies,Serotonin Pathway,Syrup,500mg twice a day,Roche,48,Low,Moderate Risk,Moderate (50-80%),Slow,Enzyme-Specific,Suitable
Omeprazole,Blood Thinner,Anti-Aging,55.03,C33H35FN2O5,Proton Pump Inhibitor,Gastrointestinal Issues,1996,Omeprazole,Aspirin,High Risk,Renal Excretion,Phase 1,Toxicology Report,MAPK Pathway,Topical Gel,50mg daily,AstraZeneca,48,High,Low Risk,High (>80%),Moderate,Renal,Partially Suitable
Losartan,Hypertension,Cardiovascular Disease,88.57,C33H35FN2O5,AMPK Activator,Muscle Pain,1965,Atorvastatin Calcium,Prilosec,Moderate Risk,Slow Metabolism,Phase 1,In Vitro Studies,PI3K-AKT Pathway,Capsule,As prescribed,Roche,2,Low,Low Risk,Moderate (50-80%),Moderate,Renal,Suitable
Paracetamol,Fever,Autoimmune Disorders,34.47,C33H35FN2O5,AMPK Activator,Acid Reflux,1994,Acetylsalicylic Acid,Prilosec,Moderate Risk,High Bioavailability,Phase 3,In Vitro Studies,Dopaminergic Pathway,Capsule,250mg every 8 hours,Merck,24,Low,High Risk,Low (<50%),Moderate,Enzyme-Specific,Partially Suitable
Ranitidine,Pain Relief,Anti-Aging,55.25,C9H8O4,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1996,Omeprazole,Prilosec,Moderate Risk,Slow Metabolism,Completed,Toxicology Report,Immune Response Pathway,Syrup,500mg twice a day,AstraZeneca,24,Moderate,Low Risk,Low (<50%),Slow,Gut,Suitable
Simvastatin,Acid Reflux,Autoimmune Disorders,93.8,C17H19N3O3S,HMG-CoA Reductase Inhibitor,"Headache, Rash",1987,Ibuprofen,Glucophage,Low Risk,Liver Metabolism,Phase 3,No Preclinical Data,MAPK Pathway,Tablet,10mg once daily,Roche,6,Low,High Risk,Low (<50%),Slow,Enzyme-Specific,Partially Suitable
Levothyroxine,Cholesterol Control,Cardiovascular Disease,91.95,C33H35FN2O5,COX Inhibitor,"Nausea, Dizziness",1965,Atorvastatin Calcium,Aspirin,High Risk,High Bioavailability,Phase 2,Animal Testing,Immune Response Pathway,Tablet,250mg every 8 hours,Novartis,6,High,High Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Aspirin,Hypertension,Autoimmune Disorders,50.32,C9H8O4,Proton Pump Inhibitor,"Headache, Rash",1996,Omeprazole,Prilosec,Moderate Risk,Slow Metabolism,Phase 1,Animal Testing,Immune Response Pathway,Tablet,50mg daily,Merck,48,High,Low Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Not Suitable
Metformin,Blood Thinner,Parkinson's,81.23,C13H18O2,NSAID,Acid Reflux,1971,Omeprazole,Lipitor,High Risk,High Bioavailability,Phase 3,No Preclinical Data,Dopaminergic Pathway,Injection,250mg every 8 hours,Pfizer,6,Moderate,High Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Ibuprofen,Gastric Ulcer,Alzheimer's,65.07,C9H8O4,AMPK Activator,Muscle Pain,1965,Ibuprofen,Glucophage,Moderate Risk,Rapid Absorption,Phase 1,No Preclinical Data,Immune Response Pathway,Injection,500mg twice a day,Merck,48,High,Moderate Risk,Low (<50%),Fast,Renal,Partially Suitable
Atorvastatin,Blood Thinner,Anti-Aging,39.89,C33H35FN2O5,NSAID,Gastrointestinal Issues,1996,Acetylsalicylic Acid,Glucophage,Moderate Risk,Liver Metabolism,Phase 4,No Preclinical Data,PI3K-AKT Pathway,Capsule,As prescribed,Pfizer,12,Low,Moderate Risk,Moderate (50-80%),Moderate,Gut,Suitable
Omeprazole,Hypertension,Anti-Aging,83.01,C17H19N3O3S,COX Inhibitor,"Nausea, Dizziness",1971,Acetylsalicylic Acid,Glucophage,High Risk,Slow Metabolism,Ongoing,No Preclinical Data,MAPK Pathway,Capsule,50mg daily,Roche,12,Moderate,High Risk,Moderate (50-80%),Fast,Gut,Suitable
Losartan,Cholesterol Control,Autoimmune Disorders,75.97,C33H35FN2O5,Proton Pump Inhibitor,Acid Reflux,1987,Omeprazole,Prilosec,Low Risk,High Bioavailability,Phase 2,Animal Testing,Dopaminergic Pathway,Topical Gel,250mg every 8 hours,Merck,12,High,Low Risk,High (>80%),Slow,Renal,Not Suitable
Paracetamol,Pain Relief,Antiviral,56.2,C17H19N3O3S,COX Inhibitor,"Headache, Rash",1996,Atorvastatin Calcium,Lipitor,High Risk,Slow Metabolism,Ongoing,Toxicology Report,Dopaminergic Pathway,Capsule,500mg twice a day,Novartis,2,Low,High Risk,Low (<50%),Slow,Liver,Partially Suitable
Ranitidine,Pain Relief,Alzheimer's,56.83,C13H18O2,Proton Pump Inhibitor,"Nausea, Dizziness",1971,Atorvastatin Calcium,Lipitor,Moderate Risk,High Bioavailability,Phase 4,In Vitro Studies,Serotonin Pathway,Topical Gel,As prescribed,AstraZeneca,6,Moderate,Moderate Risk,Moderate (50-80%),Slow,Gut,Not Suitable
Simvastatin,Blood Thinner,Cancer Therapy,52.04,C33H35FN2O5,COX Inhibitor,Muscle Pain,1971,Ibuprofen,Aspirin,Low Risk,Rapid Absorption,Phase 2,No Preclinical Data,Dopaminergic Pathway,Topical Gel,250mg every 8 hours,AstraZeneca,6,High,Moderate Risk,High (>80%),Moderate,Gut,Not Suitable
Levothyroxine,Pain Relief,Parkinson's,74.6,C4H11N5,AMPK Activator,Muscle Pain,1996,Omeprazole,Advil,Moderate Risk,Liver Metabolism,Phase 4,No Preclinical Data,PI3K-AKT Pathway,Injection,10mg once daily,Pfizer,24,High,Moderate Risk,Low (<50%),Fast,Liver,Suitable
Aspirin,Diabetes,Cardiovascular Disease,93.94,C33H35FN2O5,COX Inhibitor,Acid Reflux,1994,Acetylsalicylic Acid,Aspirin,Low Risk,Slow Metabolism,Phase 2,In Vitro Studies,PI3K-AKT Pathway,Capsule,50mg daily,AstraZeneca,2,Low,High Risk,Moderate (50-80%),Slow,Enzyme-Specific,Suitable
Metformin,Gastric Ulcer,Migraine Treatment,73.16,C17H19N3O3S,Proton Pump Inhibitor,Muscle Pain,1996,Ibuprofen,Aspirin,Moderate Risk,Rapid Absorption,Phase 2,In Vitro Studies,MAPK Pathway,Capsule,As prescribed,Novartis,24,Low,High Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Not Suitable
Ibuprofen,Hypertension,Liver Disease,69.3,C9H8O4,HMG-CoA Reductase Inhibitor,"Headache, Rash",1965,Ibuprofen,Advil,Moderate Risk,Renal Excretion,Phase 2,No Preclinical Data,Dopaminergic Pathway,Syrup,As prescribed,Merck,12,High,Moderate Risk,Low (<50%),Moderate,Gut,Suitable
Atorvastatin,Thyroid Hormone Replacement,Migraine Treatment,81.34,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1965,Acetylsalicylic Acid,Lipitor,Moderate Risk,Rapid Absorption,Phase 3,Animal Testing,Serotonin Pathway,Topical Gel,50mg daily,Novartis,6,High,High Risk,Moderate (50-80%),Slow,Renal,Partially Suitable
Omeprazole,Hypertension,Migraine Treatment,46.11,C33H35FN2O5,NSAID,"Nausea, Dizziness",1971,Omeprazole,Advil,High Risk,Slow Metabolism,Phase 4,No Preclinical Data,Immune Response Pathway,Capsule,As prescribed,Novartis,6,High,Moderate Risk,Moderate (50-80%),Moderate,Gut,Partially Suitable
Losartan,Acid Reflux,Migraine Treatment,62.19,C9H8O4,AMPK Activator,Gastrointestinal Issues,1965,Metformin Hydrochloride,Advil,Low Risk,Liver Metabolism,Completed,In Vitro Studies,Dopaminergic Pathway,Tablet,250mg every 8 hours,Merck,2,Low,High Risk,Moderate (50-80%),Moderate,Renal,Not Suitable
Paracetamol,Blood Thinner,Weight Loss,54.55,C4H11N5,COX Inhibitor,Muscle Pain,1996,Omeprazole,Advil,Low Risk,Rapid Absorption,Phase 2,Animal Testing,Immune Response Pathway,Topical Gel,As prescribed,Pfizer,12,High,Moderate Risk,Low (<50%),Fast,Liver,Suitable
Ranitidine,Gastric Ulcer,Cardiovascular Disease,75.55,C13H18O2,COX Inhibitor,Acid Reflux,1996,Metformin Hydrochloride,Advil,Low Risk,Slow Metabolism,Completed,In Vitro Studies,Immune Response Pathway,Capsule,250mg every 8 hours,Pfizer,2,Moderate,High Risk,Low (<50%),Slow,Enzyme-Specific,Suitable
Simvastatin,Thyroid Hormone Replacement,Anti-Aging,67.76,C17H19N3O3S,AMPK Activator,Muscle Pain,1965,Acetylsalicylic Acid,Glucophage,Low Risk,Renal Excretion,Phase 2,In Vitro Studies,MAPK Pathway,Syrup,250mg every 8 hours,AstraZeneca,48,Low,Low Risk,Low (<50%),Moderate,Enzyme-Specific,Partially Suitable
Levothyroxine,Acid Reflux,Alzheimer's,49.33,C33H35FN2O5,Proton Pump Inhibitor,"Headache, Rash",1994,Metformin Hydrochloride,Lipitor,High Risk,Renal Excretion,Phase 4,Animal Testing,Serotonin Pathway,Tablet,As prescribed,Novartis,12,Moderate,Low Risk,Low (<50%),Fast,Gut,Partially Suitable
Aspirin,Gastric Ulcer,Anti-Aging,79.74,C17H19N3O3S,AMPK Activator,Gastrointestinal Issues,1987,Omeprazole,Advil,High Risk,Liver Metabolism,Ongoing,Toxicology Report,Immune Response Pathway,Injection,10mg once daily,Roche,2,Moderate,Moderate Risk,Low (<50%),Slow,Enzyme-Specific,Partially Suitable
Metformin,Acid Reflux,Parkinson's,89.25,C4H11N5,Proton Pump Inhibitor,Gastrointestinal Issues,1994,Acetylsalicylic Acid,Glucophage,Moderate Risk,Liver Metabolism,Phase 3,Toxicology Report,Dopaminergic Pathway,Syrup,500mg twice a day,Pfizer,6,Low,Low Risk,Low (<50%),Fast,Renal,Not Suitable
Ibuprofen,Gastric Ulcer,Liver Disease,49.54,C4H11N5,HMG-CoA Reductase Inhibitor,Acid Reflux,1996,Acetylsalicylic Acid,Advil,High Risk,Slow Metabolism,Completed,Animal Testing,MAPK Pathway,Tablet,500mg twice a day,Roche,6,Moderate,Low Risk,Moderate (50-80%),Moderate,Gut,Not Suitable
Atorvastatin,Hypertension,Alzheimer's,48.38,C33H35FN2O5,NSAID,Gastrointestinal Issues,1996,Acetylsalicylic Acid,Aspirin,High Risk,Rapid Absorption,Ongoing,Animal Testing,Serotonin Pathway,Tablet,50mg daily,Pfizer,6,Low,Moderate Risk,Low (<50%),Slow,Liver,Not Suitable
Omeprazole,Gastric Ulcer,Anti-Aging,54.79,C9H8O4,AMPK Activator,Gastrointestinal Issues,1971,Omeprazole,Glucophage,Moderate Risk,Slow Metabolism,Phase 1,Animal Testing,PI3K-AKT Pathway,Injection,500mg twice a day,Roche,12,Low,Low Risk,Low (<50%),Moderate,Enzyme-Specific,Suitable
Losartan,Blood Thinner,Cancer Therapy,87.48,C13H18O2,Proton Pump Inhibitor,Muscle Pain,1971,Atorvastatin Calcium,Advil,Moderate Risk,Slow Metabolism,Ongoing,In Vitro Studies,Immune Response Pathway,Topical Gel,50mg daily,Merck,6,Moderate,Low Risk,High (>80%),Moderate,Renal,Suitable
Paracetamol,Fever,Alzheimer's,61.97,C17H19N3O3S,NSAID,Gastrointestinal Issues,1971,Acetylsalicylic Acid,Aspirin,Low Risk,Renal Excretion,Phase 2,In Vitro Studies,Immune Response Pathway,Injection,50mg daily,AstraZeneca,6,High,High Risk,High (>80%),Moderate,Renal,Not Suitable
Ranitidine,Hypertension,Cardiovascular Disease,39.1,C4H11N5,AMPK Activator,"Nausea, Dizziness",1996,Ibuprofen,Advil,Moderate Risk,Slow Metabolism,Phase 1,In Vitro Studies,Immune Response Pathway,Injection,As prescribed,Pfizer,2,High,Moderate Risk,High (>80%),Moderate,Enzyme-Specific,Not Suitable
Simvastatin,Fever,Autoimmune Disorders,68.13,C4H11N5,Proton Pump Inhibitor,"Headache, Rash",1987,Acetylsalicylic Acid,Aspirin,Moderate Risk,Liver Metabolism,Completed,In Vitro Studies,MAPK Pathway,Tablet,250mg every 8 hours,AstraZeneca,12,Low,Low Risk,High (>80%),Slow,Enzyme-Specific,Suitable
Levothyroxine,Hypertension,Weight Loss,47.25,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1965,Metformin Hydrochloride,Advil,Moderate Risk,Rapid Absorption,Phase 1,Toxicology Report,Serotonin Pathway,Tablet,50mg daily,Novartis,48,Moderate,High Risk,High (>80%),Slow,Liver,Suitable
Aspirin,Diabetes,Anti-Aging,60.05,C13H18O2,COX Inhibitor,"Headache, Rash",1994,Ibuprofen,Lipitor,Low Risk,High Bioavailability,Phase 1,In Vitro Studies,PI3K-AKT Pathway,Tablet,10mg once daily,Novartis,24,High,High Risk,Low (<50%),Fast,Enzyme-Specific,Not Suitable
Metformin,Pain Relief,Liver Disease,59.28,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1965,Acetylsalicylic Acid,Aspirin,Low Risk,Renal Excretion,Phase 3,In Vitro Studies,Dopaminergic Pathway,Capsule,500mg twice a day,Novartis,24,Moderate,Low Risk,Low (<50%),Moderate,Renal,Not Suitable
Ibuprofen,Pain Relief,Liver Disease,73.72,C17H19N3O3S,COX Inhibitor,Gastrointestinal Issues,1971,Acetylsalicylic Acid,Glucophage,Low Risk,Slow Metabolism,Phase 1,In Vitro Studies,Immune Response Pathway,Injection,250mg every 8 hours,Roche,6,Low,Moderate Risk,High (>80%),Moderate,Renal,Partially Suitable
Atorvastatin,Thyroid Hormone Replacement,Antiviral,46.17,C17H19N3O3S,NSAID,Acid Reflux,1965,Acetylsalicylic Acid,Aspirin,Low Risk,Liver Metabolism,Phase 2,Animal Testing,Immune Response Pathway,Injection,10mg once daily,Pfizer,24,Moderate,Low Risk,Low (<50%),Moderate,Enzyme-Specific,Not Suitable
Omeprazole,Fever,Migraine Treatment,74.66,C13H18O2,NSAID,Muscle Pain,1965,Metformin Hydrochloride,Prilosec,Low Risk,Slow Metabolism,Ongoing,Toxicology Report,Immune Response Pathway,Capsule,500mg twice a day,Roche,12,Low,Moderate Risk,High (>80%),Slow,Gut,Suitable
Losartan,Pain Relief,Anti-Aging,75.18,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1965,Acetylsalicylic Acid,Prilosec,High Risk,Rapid Absorption,Phase 1,In Vitro Studies,Immune Response Pathway,Injection,50mg daily,Novartis,12,Low,Moderate Risk,High (>80%),Fast,Gut,Suitable
Paracetamol,Cholesterol Control,Alzheimer's,84.79,C17H19N3O3S,COX Inhibitor,"Nausea, Dizziness",1987,Atorvastatin Calcium,Aspirin,Low Risk,High Bioavailability,Phase 3,No Preclinical Data,MAPK Pathway,Capsule,10mg once daily,Roche,6,High,Low Risk,Low (<50%),Moderate,Renal,Partially Suitable
Ranitidine,Acid Reflux,Antiviral,60.35,C9H8O4,COX Inhibitor,Gastrointestinal Issues,1987,Ibuprofen,Prilosec,High Risk,High Bioavailability,Phase 4,Toxicology Report,MAPK Pathway,Injection,250mg every 8 hours,Merck,6,High,Low Risk,Low (<50%),Moderate,Gut,Suitable
Simvastatin,Fever,Migraine Treatment,87.81,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1994,Ibuprofen,Lipitor,Moderate Risk,Liver Metabolism,Phase 2,Toxicology Report,MAPK Pathway,Topical Gel,500mg twice a day,Merck,2,Moderate,Low Risk,High (>80%),Moderate,Renal,Suitable
Levothyroxine,Blood Thinner,Migraine Treatment,34.46,C17H19N3O3S,NSAID,Gastrointestinal Issues,1994,Acetylsalicylic Acid,Advil,High Risk,Liver Metabolism,Phase 2,In Vitro Studies,Immune Response Pathway,Topical Gel,500mg twice a day,Roche,48,Moderate,Low Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Not Suitable
Aspirin,Thyroid Hormone Replacement,Alzheimer's,40.9,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1971,Metformin Hydrochloride,Advil,Moderate Risk,High Bioavailability,Ongoing,Toxicology Report,MAPK Pathway,Tablet,250mg every 8 hours,Merck,2,High,Moderate Risk,Low (<50%),Moderate,Enzyme-Specific,Not Suitable
Metformin,Cholesterol Control,Anti-Aging,53.98,C13H18O2,Proton Pump Inhibitor,"Headache, Rash",1994,Omeprazole,Advil,Low Risk,Liver Metabolism,Phase 3,Animal Testing,Serotonin Pathway,Syrup,50mg daily,Pfizer,6,Low,High Risk,High (>80%),Moderate,Liver,Not Suitable
Ibuprofen,Cholesterol Control,Alzheimer's,61.37,C17H19N3O3S,HMG-CoA Reductase Inhibitor,"Headache, Rash",1971,Ibuprofen,Lipitor,Moderate Risk,Renal Excretion,Phase 2,No Preclinical Data,PI3K-AKT Pathway,Syrup,10mg once daily,Roche,6,Moderate,Moderate Risk,High (>80%),Moderate,Enzyme-Specific,Partially Suitable
Atorvastatin,Acid Reflux,Cardiovascular Disease,71.14,C33H35FN2O5,Proton Pump Inhibitor,Acid Reflux,1996,Omeprazole,Lipitor,High Risk,Slow Metabolism,Phase 3,No Preclinical Data,Immune Response Pathway,Tablet,50mg daily,Pfizer,6,Low,Low Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Suitable
Omeprazole,Diabetes,Cardiovascular Disease,56.64,C17H19N3O3S,Proton Pump Inhibitor,Acid Reflux,1971,Atorvastatin Calcium,Glucophage,Low Risk,Rapid Absorption,Phase 3,No Preclinical Data,Dopaminergic Pathway,Capsule,As prescribed,Novartis,12,High,Moderate Risk,Low (<50%),Slow,Liver,Partially Suitable
Losartan,Acid Reflux,Antiviral,51.03,C13H18O2,AMPK Activator,"Headache, Rash",1996,Ibuprofen,Prilosec,Low Risk,Slow Metabolism,Phase 3,No Preclinical Data,Dopaminergic Pathway,Syrup,As prescribed,Novartis,6,High,High Risk,High (>80%),Fast,Gut,Suitable
Paracetamol,Diabetes,Alzheimer's,46.99,C17H19N3O3S,HMG-CoA Reductase Inhibitor,"Headache, Rash",1996,Atorvastatin Calcium,Advil,Low Risk,Renal Excretion,Phase 1,Animal Testing,Serotonin Pathway,Tablet,50mg daily,AstraZeneca,48,High,High Risk,Moderate (50-80%),Moderate,Liver,Not Suitable
Ranitidine,Cholesterol Control,Anti-Aging,41.87,C4H11N5,Proton Pump Inhibitor,Acid Reflux,1965,Ibuprofen,Advil,High Risk,Renal Excretion,Phase 1,In Vitro Studies,Dopaminergic Pathway,Capsule,250mg every 8 hours,AstraZeneca,12,High,High Risk,High (>80%),Moderate,Liver,Partially Suitable
Simvastatin,Hypertension,Anti-Aging,66.56,C4H11N5,Proton Pump Inhibitor,"Headache, Rash",1996,Ibuprofen,Prilosec,Moderate Risk,Rapid Absorption,Ongoing,No Preclinical Data,Serotonin Pathway,Tablet,250mg every 8 hours,Pfizer,24,High,High Risk,Low (<50%),Moderate,Liver,Suitable
Levothyroxine,Gastric Ulcer,Alzheimer's,81.31,C9H8O4,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1994,Omeprazole,Lipitor,Moderate Risk,Slow Metabolism,Ongoing,Toxicology Report,Dopaminergic Pathway,Tablet,As prescribed,AstraZeneca,2,Low,Low Risk,Moderate (50-80%),Moderate,Renal,Not Suitable
Aspirin,Inflammation,Autoimmune Disorders,76.32,C4H11N5,Proton Pump Inhibitor,Gastrointestinal Issues,1994,Atorvastatin Calcium,Advil,High Risk,High Bioavailability,Ongoing,Toxicology Report,MAPK Pathway,Capsule,500mg twice a day,Novartis,2,Low,Low Risk,Moderate (50-80%),Slow,Enzyme-Specific,Suitable
Metformin,Inflammation,Alzheimer's,34.95,C17H19N3O3S,COX Inhibitor,Muscle Pain,1987,Acetylsalicylic Acid,Lipitor,High Risk,High Bioavailability,Ongoing,No Preclinical Data,Immune Response Pathway,Capsule,As prescribed,AstraZeneca,24,High,Low Risk,Moderate (50-80%),Moderate,Renal,Suitable
Ibuprofen,Gastric Ulcer,Parkinson's,80.77,C9H8O4,HMG-CoA Reductase Inhibitor,Acid Reflux,1996,Ibuprofen,Advil,Low Risk,High Bioavailability,Ongoing,Animal Testing,PI3K-AKT Pathway,Tablet,250mg every 8 hours,Novartis,2,Low,Low Risk,Low (<50%),Moderate,Enzyme-Specific,Suitable
Atorvastatin,Gastric Ulcer,Cancer Therapy,76.94,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Acid Reflux,1996,Ibuprofen,Glucophage,Low Risk,Liver Metabolism,Phase 1,Animal Testing,Immune Response Pathway,Tablet,As prescribed,Pfizer,6,Low,High Risk,High (>80%),Moderate,Renal,Suitable
Omeprazole,Inflammation,Liver Disease,71.63,C33H35FN2O5,NSAID,Muscle Pain,1994,Omeprazole,Aspirin,High Risk,Slow Metabolism,Phase 2,Toxicology Report,MAPK Pathway,Injection,500mg twice a day,Novartis,12,High,Low Risk,Moderate (50-80%),Slow,Gut,Suitable
Losartan,Cholesterol Control,Antiviral,83.75,C33H35FN2O5,NSAID,Acid Reflux,1965,Ibuprofen,Prilosec,Low Risk,Rapid Absorption,Phase 4,Toxicology Report,Serotonin Pathway,Tablet,10mg once daily,Pfizer,48,Low,Low Risk,Moderate (50-80%),Moderate,Liver,Not Suitable
Paracetamol,Cholesterol Control,Autoimmune Disorders,89,C17H19N3O3S,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1965,Atorvastatin Calcium,Aspirin,Low Risk,Renal Excretion,Completed,No Preclinical Data,Dopaminergic Pathway,Syrup,250mg every 8 hours,Merck,12,Moderate,High Risk,Low (<50%),Moderate,Enzyme-Specific,Suitable
Ranitidine,Fever,Autoimmune Disorders,85.39,C17H19N3O3S,AMPK Activator,"Headache, Rash",1971,Omeprazole,Aspirin,Low Risk,Liver Metabolism,Phase 3,In Vitro Studies,Dopaminergic Pathway,Tablet,500mg twice a day,Pfizer,12,Moderate,Moderate Risk,Low (<50%),Slow,Renal,Suitable
Simvastatin,Hypertension,Antiviral,68.21,C9H8O4,HMG-CoA Reductase Inhibitor,Muscle Pain,1965,Omeprazole,Advil,Moderate Risk,Rapid Absorption,Completed,In Vitro Studies,MAPK Pathway,Topical Gel,As prescribed,AstraZeneca,12,High,Moderate Risk,Moderate (50-80%),Fast,Enzyme-Specific,Partially Suitable
Levothyroxine,Gastric Ulcer,Weight Loss,83.85,C4H11N5,Proton Pump Inhibitor,Muscle Pain,1987,Ibuprofen,Prilosec,Low Risk,High Bioavailability,Ongoing,Animal Testing,Immune Response Pathway,Tablet,10mg once daily,AstraZeneca,24,Moderate,Moderate Risk,Low (<50%),Fast,Renal,Suitable
Aspirin,Cholesterol Control,Cardiovascular Disease,34.43,C9H8O4,NSAID,"Nausea, Dizziness",1996,Metformin Hydrochloride,Glucophage,Moderate Risk,Liver Metabolism,Ongoing,Toxicology Report,PI3K-AKT Pathway,Capsule,500mg twice a day,Pfizer,2,High,High Risk,High (>80%),Slow,Renal,Not Suitable
Metformin,Gastric Ulcer,Autoimmune Disorders,85.69,C17H19N3O3S,AMPK Activator,Muscle Pain,1971,Omeprazole,Aspirin,High Risk,Rapid Absorption,Phase 3,Animal Testing,Immune Response Pathway,Topical Gel,500mg twice a day,Novartis,2,High,Low Risk,High (>80%),Fast,Renal,Not Suitable
Ibuprofen,Acid Reflux,Antiviral,48.57,C4H11N5,HMG-CoA Reductase Inhibitor,Acid Reflux,1971,Omeprazole,Lipitor,Low Risk,Liver Metabolism,Phase 2,Animal Testing,Dopaminergic Pathway,Topical Gel,As prescribed,Merck,48,Low,Low Risk,Moderate (50-80%),Slow,Renal,Suitable
Atorvastatin,Diabetes,Migraine Treatment,63.17,C4H11N5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1971,Acetylsalicylic Acid,Lipitor,High Risk,Slow Metabolism,Phase 4,In Vitro Studies,PI3K-AKT Pathway,Topical Gel,250mg every 8 hours,Roche,6,Moderate,Moderate Risk,Low (<50%),Moderate,Renal,Partially Suitable
Omeprazole,Hypertension,Antiviral,30.7,C17H19N3O3S,AMPK Activator,"Nausea, Dizziness",1996,Omeprazole,Prilosec,Low Risk,Rapid Absorption,Ongoing,Animal Testing,PI3K-AKT Pathway,Injection,As prescribed,Merck,24,Low,Low Risk,Low (<50%),Slow,Liver,Partially Suitable
Losartan,Pain Relief,Autoimmune Disorders,62.94,C4H11N5,COX Inhibitor,Gastrointestinal Issues,1996,Metformin Hydrochloride,Lipitor,Low Risk,High Bioavailability,Phase 2,No Preclinical Data,Dopaminergic Pathway,Topical Gel,500mg twice a day,Merck,2,Moderate,High Risk,High (>80%),Slow,Gut,Not Suitable
Paracetamol,Cholesterol Control,Autoimmune Disorders,66.39,C4H11N5,AMPK Activator,Gastrointestinal Issues,1987,Acetylsalicylic Acid,Aspirin,High Risk,High Bioavailability,Ongoing,Toxicology Report,MAPK Pathway,Topical Gel,500mg twice a day,Novartis,2,Low,Low Risk,Moderate (50-80%),Slow,Enzyme-Specific,Partially Suitable
Ranitidine,Diabetes,Antiviral,62.85,C9H8O4,HMG-CoA Reductase Inhibitor,Acid Reflux,1971,Acetylsalicylic Acid,Advil,Moderate Risk,Slow Metabolism,Phase 4,In Vitro Studies,Dopaminergic Pathway,Syrup,500mg twice a day,AstraZeneca,2,High,High Risk,Moderate (50-80%),Fast,Gut,Not Suitable
Simvastatin,Thyroid Hormone Replacement,Antiviral,64.68,C4H11N5,AMPK Activator,"Headache, Rash",1994,Metformin Hydrochloride,Advil,High Risk,Rapid Absorption,Ongoing,No Preclinical Data,PI3K-AKT Pathway,Topical Gel,10mg once daily,AstraZeneca,6,Moderate,Moderate Risk,Low (<50%),Moderate,Enzyme-Specific,Suitable
Levothyroxine,Pain Relief,Cancer Therapy,49.51,C4H11N5,Proton Pump Inhibitor,Muscle Pain,1987,Metformin Hydrochloride,Prilosec,Moderate Risk,High Bioavailability,Ongoing,Animal Testing,Dopaminergic Pathway,Injection,10mg once daily,Roche,12,Low,Moderate Risk,Moderate (50-80%),Slow,Renal,Not Suitable
Aspirin,Hypertension,Autoimmune Disorders,62.11,C9H8O4,AMPK Activator,Muscle Pain,1996,Acetylsalicylic Acid,Advil,High Risk,Liver Metabolism,Phase 3,No Preclinical Data,Dopaminergic Pathway,Syrup,50mg daily,AstraZeneca,2,Moderate,Low Risk,Low (<50%),Slow,Enzyme-Specific,Partially Suitable
Metformin,Gastric Ulcer,Liver Disease,68.24,C13H18O2,HMG-CoA Reductase Inhibitor,Acid Reflux,1994,Acetylsalicylic Acid,Glucophage,Low Risk,Renal Excretion,Ongoing,Animal Testing,Dopaminergic Pathway,Injection,50mg daily,Novartis,24,Low,High Risk,Low (<50%),Fast,Enzyme-Specific,Suitable
Ibuprofen,Hypertension,Weight Loss,82.99,C4H11N5,AMPK Activator,Muscle Pain,1996,Ibuprofen,Prilosec,High Risk,Slow Metabolism,Ongoing,In Vitro Studies,Dopaminergic Pathway,Injection,50mg daily,Roche,48,Moderate,Moderate Risk,Moderate (50-80%),Slow,Renal,Partially Suitable
Atorvastatin,Hypertension,Cancer Therapy,69.6,C4H11N5,Proton Pump Inhibitor,"Headache, Rash",1965,Omeprazole,Lipitor,High Risk,Renal Excretion,Phase 3,Toxicology Report,Dopaminergic Pathway,Topical Gel,250mg every 8 hours,AstraZeneca,48,Moderate,Low Risk,Low (<50%),Slow,Liver,Partially Suitable
Omeprazole,Gastric Ulcer,Cardiovascular Disease,76.94,C4H11N5,NSAID,"Nausea, Dizziness",1971,Omeprazole,Aspirin,Low Risk,Rapid Absorption,Phase 1,Toxicology Report,Dopaminergic Pathway,Injection,As prescribed,Novartis,48,Low,Low Risk,Moderate (50-80%),Fast,Liver,Partially Suitable
Losartan,Diabetes,Cardiovascular Disease,64.27,C4H11N5,COX Inhibitor,Acid Reflux,1994,Metformin Hydrochloride,Lipitor,Moderate Risk,Slow Metabolism,Ongoing,Animal Testing,PI3K-AKT Pathway,Capsule,500mg twice a day,AstraZeneca,12,Moderate,Low Risk,Low (<50%),Slow,Liver,Partially Suitable
Paracetamol,Blood Thinner,Alzheimer's,72.32,C17H19N3O3S,AMPK Activator,Gastrointestinal Issues,1994,Atorvastatin Calcium,Prilosec,High Risk,High Bioavailability,Phase 4,Animal Testing,MAPK Pathway,Syrup,As prescribed,Pfizer,24,Moderate,High Risk,High (>80%),Fast,Liver,Not Suitable
Ranitidine,Thyroid Hormone Replacement,Anti-Aging,82.66,C9H8O4,AMPK Activator,Acid Reflux,1965,Atorvastatin Calcium,Prilosec,High Risk,High Bioavailability,Completed,Animal Testing,PI3K-AKT Pathway,Syrup,500mg twice a day,Pfizer,12,High,Moderate Risk,Low (<50%),Slow,Liver,Partially Suitable
Simvastatin,Gastric Ulcer,Weight Loss,64.07,C13H18O2,NSAID,Muscle Pain,1994,Atorvastatin Calcium,Advil,Low Risk,Rapid Absorption,Ongoing,Toxicology Report,MAPK Pathway,Tablet,250mg every 8 hours,Novartis,24,Low,High Risk,Moderate (50-80%),Slow,Liver,Not Suitable
Levothyroxine,Thyroid Hormone Replacement,Migraine Treatment,66.39,C9H8O4,AMPK Activator,Muscle Pain,1965,Metformin Hydrochloride,Prilosec,Moderate Risk,High Bioavailability,Phase 1,Toxicology Report,Serotonin Pathway,Capsule,500mg twice a day,Merck,2,High,High Risk,Low (<50%),Moderate,Liver,Suitable
Aspirin,Blood Thinner,Parkinson's,92.57,C17H19N3O3S,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1996,Atorvastatin Calcium,Aspirin,Moderate Risk,Rapid Absorption,Phase 2,No Preclinical Data,PI3K-AKT Pathway,Injection,50mg daily,Roche,48,Low,Moderate Risk,High (>80%),Fast,Enzyme-Specific,Partially Suitable
Metformin,Acid Reflux,Migraine Treatment,80.73,C33H35FN2O5,AMPK Activator,"Nausea, Dizziness",1987,Atorvastatin Calcium,Lipitor,Low Risk,Slow Metabolism,Completed,No Preclinical Data,Dopaminergic Pathway,Tablet,10mg once daily,AstraZeneca,12,Moderate,Low Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Ibuprofen,Fever,Anti-Aging,71.47,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1965,Acetylsalicylic Acid,Prilosec,Moderate Risk,High Bioavailability,Phase 2,No Preclinical Data,Immune Response Pathway,Capsule,50mg daily,Roche,24,Low,High Risk,Moderate (50-80%),Slow,Liver,Partially Suitable
Atorvastatin,Acid Reflux,Weight Loss,58.83,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1996,Acetylsalicylic Acid,Prilosec,High Risk,Renal Excretion,Phase 4,In Vitro Studies,PI3K-AKT Pathway,Tablet,500mg twice a day,Novartis,48,Low,High Risk,High (>80%),Slow,Gut,Suitable
Omeprazole,Fever,Anti-Aging,71.11,C13H18O2,Proton Pump Inhibitor,Muscle Pain,1987,Omeprazole,Advil,Moderate Risk,Rapid Absorption,Completed,Toxicology Report,MAPK Pathway,Injection,50mg daily,Pfizer,48,High,High Risk,High (>80%),Fast,Liver,Suitable
Losartan,Pain Relief,Antiviral,75.39,C33H35FN2O5,NSAID,Acid Reflux,1987,Omeprazole,Lipitor,Low Risk,Rapid Absorption,Ongoing,In Vitro Studies,PI3K-AKT Pathway,Topical Gel,10mg once daily,Novartis,48,Low,High Risk,Low (<50%),Fast,Gut,Not Suitable
Paracetamol,Diabetes,Cardiovascular Disease,37.79,C17H19N3O3S,AMPK Activator,Gastrointestinal Issues,1965,Omeprazole,Advil,Moderate Risk,Slow Metabolism,Completed,No Preclinical Data,MAPK Pathway,Capsule,50mg daily,Merck,12,Low,Moderate Risk,Low (<50%),Moderate,Renal,Not Suitable
Ranitidine,Thyroid Hormone Replacement,Alzheimer's,85.28,C9H8O4,NSAID,"Nausea, Dizziness",1987,Metformin Hydrochloride,Lipitor,Low Risk,Liver Metabolism,Ongoing,Animal Testing,MAPK Pathway,Topical Gel,250mg every 8 hours,AstraZeneca,48,Low,High Risk,Low (<50%),Fast,Gut,Suitable
Simvastatin,Gastric Ulcer,Autoimmune Disorders,72.92,C17H19N3O3S,Proton Pump Inhibitor,Acid Reflux,1987,Omeprazole,Advil,High Risk,Renal Excretion,Ongoing,No Preclinical Data,Serotonin Pathway,Capsule,As prescribed,AstraZeneca,2,Moderate,Low Risk,Low (<50%),Slow,Enzyme-Specific,Suitable
Levothyroxine,Inflammation,Cancer Therapy,86.63,C17H19N3O3S,COX Inhibitor,"Headache, Rash",1994,Atorvastatin Calcium,Lipitor,Low Risk,Liver Metabolism,Phase 4,Toxicology Report,Serotonin Pathway,Injection,As prescribed,Roche,2,High,High Risk,High (>80%),Moderate,Renal,Suitable
Aspirin,Hypertension,Antiviral,38.62,C33H35FN2O5,COX Inhibitor,Acid Reflux,1996,Acetylsalicylic Acid,Glucophage,Moderate Risk,High Bioavailability,Phase 4,No Preclinical Data,MAPK Pathway,Capsule,10mg once daily,Merck,12,High,Low Risk,Moderate (50-80%),Slow,Liver,Suitable
Metformin,Blood Thinner,Autoimmune Disorders,80.9,C4H11N5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1965,Atorvastatin Calcium,Advil,High Risk,Renal Excretion,Phase 4,In Vitro Studies,MAPK Pathway,Topical Gel,250mg every 8 hours,Pfizer,48,Moderate,High Risk,Low (<50%),Fast,Liver,Suitable
Ibuprofen,Blood Thinner,Liver Disease,50.62,C17H19N3O3S,Proton Pump Inhibitor,Muscle Pain,1994,Acetylsalicylic Acid,Glucophage,Low Risk,Slow Metabolism,Phase 2,Animal Testing,Immune Response Pathway,Tablet,500mg twice a day,Novartis,24,Moderate,High Risk,Moderate (50-80%),Fast,Enzyme-Specific,Not Suitable
Atorvastatin,Blood Thinner,Parkinson's,91.12,C33H35FN2O5,Proton Pump Inhibitor,Gastrointestinal Issues,1987,Omeprazole,Glucophage,High Risk,Slow Metabolism,Phase 4,Animal Testing,Immune Response Pathway,Syrup,As prescribed,Merck,2,Low,Low Risk,High (>80%),Fast,Enzyme-Specific,Suitable
Omeprazole,Blood Thinner,Parkinson's,32.44,C4H11N5,COX Inhibitor,Gastrointestinal Issues,1965,Ibuprofen,Advil,Moderate Risk,Slow Metabolism,Phase 4,In Vitro Studies,PI3K-AKT Pathway,Tablet,As prescribed,Roche,2,High,High Risk,High (>80%),Slow,Liver,Suitable
Losartan,Inflammation,Weight Loss,35.76,C13H18O2,Proton Pump Inhibitor,Muscle Pain,1971,Ibuprofen,Advil,Moderate Risk,Liver Metabolism,Phase 3,No Preclinical Data,MAPK Pathway,Topical Gel,50mg daily,AstraZeneca,12,Moderate,Low Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Paracetamol,Fever,Anti-Aging,71.21,C13H18O2,NSAID,"Headache, Rash",1987,Acetylsalicylic Acid,Glucophage,High Risk,Liver Metabolism,Phase 3,Toxicology Report,PI3K-AKT Pathway,Tablet,250mg every 8 hours,Roche,24,Low,Low Risk,Low (<50%),Fast,Renal,Suitable
Ranitidine,Fever,Autoimmune Disorders,64.54,C9H8O4,HMG-CoA Reductase Inhibitor,Acid Reflux,1971,Omeprazole,Lipitor,Moderate Risk,Liver Metabolism,Completed,Toxicology Report,MAPK Pathway,Topical Gel,50mg daily,Roche,48,High,High Risk,Low (<50%),Moderate,Renal,Suitable
Simvastatin,Acid Reflux,Alzheimer's,58.44,C33H35FN2O5,Proton Pump Inhibitor,Acid Reflux,1994,Metformin Hydrochloride,Glucophage,Moderate Risk,High Bioavailability,Phase 2,Toxicology Report,Immune Response Pathway,Capsule,250mg every 8 hours,Novartis,24,High,Moderate Risk,High (>80%),Moderate,Gut,Not Suitable
Levothyroxine,Cholesterol Control,Cancer Therapy,88.21,C17H19N3O3S,AMPK Activator,Muscle Pain,1965,Acetylsalicylic Acid,Aspirin,High Risk,Rapid Absorption,Phase 3,In Vitro Studies,Serotonin Pathway,Syrup,10mg once daily,Novartis,12,Low,Low Risk,Moderate (50-80%),Fast,Enzyme-Specific,Suitable
Aspirin,Gastric Ulcer,Weight Loss,85.94,C4H11N5,COX Inhibitor,"Nausea, Dizziness",1965,Omeprazole,Lipitor,Moderate Risk,Liver Metabolism,Phase 4,In Vitro Studies,Serotonin Pathway,Syrup,500mg twice a day,Merck,2,Moderate,Moderate Risk,Low (<50%),Slow,Liver,Suitable
Metformin,Diabetes,Parkinson's,66.15,C4H11N5,NSAID,Acid Reflux,1994,Atorvastatin Calcium,Glucophage,Moderate Risk,Liver Metabolism,Ongoing,Animal Testing,PI3K-AKT Pathway,Injection,500mg twice a day,Pfizer,2,Low,High Risk,High (>80%),Moderate,Renal,Not Suitable
Ibuprofen,Pain Relief,Anti-Aging,90.16,C13H18O2,NSAID,Muscle Pain,1987,Omeprazole,Lipitor,Moderate Risk,High Bioavailability,Ongoing,Animal Testing,MAPK Pathway,Tablet,250mg every 8 hours,Novartis,48,Moderate,High Risk,Low (<50%),Moderate,Liver,Partially Suitable
Atorvastatin,Hypertension,Antiviral,54.94,C13H18O2,Proton Pump Inhibitor,"Headache, Rash",1965,Ibuprofen,Prilosec,Low Risk,High Bioavailability,Completed,Toxicology Report,MAPK Pathway,Tablet,250mg every 8 hours,Roche,48,Moderate,Low Risk,Moderate (50-80%),Slow,Renal,Not Suitable
Omeprazole,Thyroid Hormone Replacement,Autoimmune Disorders,42.56,C9H8O4,COX Inhibitor,Muscle Pain,1965,Omeprazole,Glucophage,Low Risk,Slow Metabolism,Phase 2,In Vitro Studies,PI3K-AKT Pathway,Syrup,500mg twice a day,Novartis,6,Low,High Risk,Low (<50%),Moderate,Gut,Partially Suitable
Losartan,Acid Reflux,Antiviral,34.14,C13H18O2,COX Inhibitor,Acid Reflux,1996,Metformin Hydrochloride,Prilosec,High Risk,High Bioavailability,Completed,No Preclinical Data,MAPK Pathway,Capsule,50mg daily,Novartis,48,Low,Moderate Risk,High (>80%),Fast,Enzyme-Specific,Partially Suitable
Paracetamol,Thyroid Hormone Replacement,Autoimmune Disorders,52.13,C33H35FN2O5,NSAID,Muscle Pain,1971,Omeprazole,Lipitor,Moderate Risk,High Bioavailability,Phase 3,No Preclinical Data,Immune Response Pathway,Syrup,500mg twice a day,Pfizer,12,High,Low Risk,High (>80%),Moderate,Renal,Suitable
Ranitidine,Cholesterol Control,Migraine Treatment,94.3,C4H11N5,NSAID,"Nausea, Dizziness",1987,Omeprazole,Aspirin,High Risk,Slow Metabolism,Phase 1,In Vitro Studies,Immune Response Pathway,Tablet,As prescribed,Novartis,2,Low,High Risk,High (>80%),Moderate,Gut,Not Suitable
Simvastatin,Hypertension,Migraine Treatment,69.21,C9H8O4,Proton Pump Inhibitor,Muscle Pain,1965,Atorvastatin Calcium,Glucophage,Low Risk,Renal Excretion,Completed,No Preclinical Data,Dopaminergic Pathway,Topical Gel,As prescribed,Novartis,6,Moderate,Low Risk,Low (<50%),Slow,Renal,Not Suitable
Levothyroxine,Acid Reflux,Alzheimer's,49.06,C9H8O4,Proton Pump Inhibitor,Acid Reflux,1994,Ibuprofen,Glucophage,Moderate Risk,Liver Metabolism,Ongoing,Animal Testing,Immune Response Pathway,Capsule,As prescribed,AstraZeneca,12,High,Moderate Risk,High (>80%),Slow,Renal,Not Suitable
Aspirin,Pain Relief,Anti-Aging,94.42,C13H18O2,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1971,Acetylsalicylic Acid,Lipitor,High Risk,Liver Metabolism,Phase 3,Toxicology Report,PI3K-AKT Pathway,Topical Gel,250mg every 8 hours,Roche,48,Moderate,High Risk,Low (<50%),Slow,Gut,Not Suitable
Metformin,Inflammation,Antiviral,87.99,C9H8O4,Proton Pump Inhibitor,"Nausea, Dizziness",1987,Atorvastatin Calcium,Aspirin,Low Risk,Renal Excretion,Ongoing,Toxicology Report,PI3K-AKT Pathway,Capsule,500mg twice a day,AstraZeneca,24,Low,High Risk,Low (<50%),Fast,Gut,Suitable
Ibuprofen,Cholesterol Control,Migraine Treatment,56.93,C9H8O4,Proton Pump Inhibitor,Muscle Pain,1994,Omeprazole,Aspirin,High Risk,High Bioavailability,Phase 2,In Vitro Studies,Dopaminergic Pathway,Injection,50mg daily,AstraZeneca,24,Low,High Risk,High (>80%),Slow,Liver,Partially Suitable
Atorvastatin,Inflammation,Alzheimer's,73.71,C4H11N5,NSAID,Gastrointestinal Issues,1987,Omeprazole,Prilosec,Low Risk,Rapid Absorption,Phase 3,In Vitro Studies,Serotonin Pathway,Tablet,50mg daily,Merck,6,Low,Low Risk,Low (<50%),Moderate,Gut,Partially Suitable
Omeprazole,Pain Relief,Alzheimer's,90.74,C13H18O2,COX Inhibitor,Acid Reflux,1994,Acetylsalicylic Acid,Lipitor,Moderate Risk,Renal Excretion,Phase 1,No Preclinical Data,Immune Response Pathway,Capsule,500mg twice a day,Pfizer,24,High,Low Risk,Low (<50%),Moderate,Liver,Partially Suitable
Losartan,Gastric Ulcer,Cardiovascular Disease,73.11,C4H11N5,Proton Pump Inhibitor,Muscle Pain,1987,Atorvastatin Calcium,Lipitor,High Risk,High Bioavailability,Completed,Toxicology Report,PI3K-AKT Pathway,Topical Gel,250mg every 8 hours,Merck,2,Low,Low Risk,Low (<50%),Fast,Liver,Suitable
Paracetamol,Fever,Cancer Therapy,85.27,C13H18O2,COX Inhibitor,Gastrointestinal Issues,1971,Acetylsalicylic Acid,Advil,Low Risk,Liver Metabolism,Phase 2,In Vitro Studies,Serotonin Pathway,Topical Gel,50mg daily,Pfizer,48,High,High Risk,Low (<50%),Moderate,Liver,Suitable
Ranitidine,Pain Relief,Liver Disease,50.32,C9H8O4,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1971,Metformin Hydrochloride,Advil,Moderate Risk,Liver Metabolism,Phase 4,No Preclinical Data,MAPK Pathway,Injection,250mg every 8 hours,Novartis,2,High,Moderate Risk,Moderate (50-80%),Fast,Renal,Not Suitable
Simvastatin,Thyroid Hormone Replacement,Weight Loss,66.97,C4H11N5,NSAID,Acid Reflux,1971,Omeprazole,Glucophage,Low Risk,High Bioavailability,Phase 2,No Preclinical Data,Serotonin Pathway,Capsule,50mg daily,Roche,48,Low,Low Risk,High (>80%),Moderate,Gut,Suitable
Levothyroxine,Blood Thinner,Parkinson's,74.1,C13H18O2,Proton Pump Inhibitor,Muscle Pain,1965,Metformin Hydrochloride,Lipitor,Moderate Risk,Renal Excretion,Phase 4,Toxicology Report,PI3K-AKT Pathway,Topical Gel,As prescribed,Merck,48,Moderate,High Risk,High (>80%),Slow,Enzyme-Specific,Not Suitable
Aspirin,Acid Reflux,Autoimmune Disorders,59.66,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1987,Metformin Hydrochloride,Prilosec,High Risk,Slow Metabolism,Phase 1,In Vitro Studies,Serotonin Pathway,Capsule,250mg every 8 hours,Merck,6,High,Low Risk,Moderate (50-80%),Moderate,Liver,Suitable
Metformin,Acid Reflux,Antiviral,45.72,C4H11N5,COX Inhibitor,Muscle Pain,1994,Acetylsalicylic Acid,Glucophage,Moderate Risk,Slow Metabolism,Phase 2,Animal Testing,Immune Response Pathway,Injection,As prescribed,AstraZeneca,12,High,Low Risk,Low (<50%),Fast,Enzyme-Specific,Partially Suitable
Ibuprofen,Pain Relief,Anti-Aging,56.01,C9H8O4,Proton Pump Inhibitor,Muscle Pain,1994,Ibuprofen,Glucophage,High Risk,High Bioavailability,Ongoing,No Preclinical Data,Immune Response Pathway,Syrup,50mg daily,Pfizer,2,High,High Risk,Moderate (50-80%),Slow,Gut,Suitable
Atorvastatin,Blood Thinner,Antiviral,58.42,C13H18O2,AMPK Activator,Acid Reflux,1994,Metformin Hydrochloride,Prilosec,High Risk,Slow Metabolism,Phase 4,No Preclinical Data,Serotonin Pathway,Tablet,50mg daily,Merck,12,Moderate,Low Risk,High (>80%),Fast,Renal,Not Suitable
Omeprazole,Gastric Ulcer,Parkinson's,36.8,C4H11N5,Proton Pump Inhibitor,Acid Reflux,1971,Metformin Hydrochloride,Advil,Low Risk,High Bioavailability,Completed,Toxicology Report,PI3K-AKT Pathway,Tablet,As prescribed,AstraZeneca,6,Moderate,Moderate Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Suitable
Losartan,Diabetes,Cardiovascular Disease,77.75,C4H11N5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1987,Metformin Hydrochloride,Lipitor,High Risk,Rapid Absorption,Completed,Toxicology Report,Dopaminergic Pathway,Tablet,10mg once daily,AstraZeneca,48,High,Moderate Risk,Low (<50%),Moderate,Gut,Partially Suitable
Paracetamol,Hypertension,Migraine Treatment,90.92,C13H18O2,AMPK Activator,"Nausea, Dizziness",1996,Acetylsalicylic Acid,Prilosec,High Risk,High Bioavailability,Phase 2,No Preclinical Data,MAPK Pathway,Topical Gel,500mg twice a day,Merck,12,Low,Moderate Risk,Low (<50%),Moderate,Renal,Suitable
Ranitidine,Diabetes,Anti-Aging,54.39,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1994,Atorvastatin Calcium,Aspirin,High Risk,Liver Metabolism,Phase 4,No Preclinical Data,PI3K-AKT Pathway,Capsule,10mg once daily,Pfizer,48,High,Moderate Risk,Low (<50%),Fast,Renal,Suitable
Simvastatin,Blood Thinner,Cardiovascular Disease,54.62,C4H11N5,AMPK Activator,Muscle Pain,1987,Acetylsalicylic Acid,Advil,High Risk,Slow Metabolism,Phase 4,No Preclinical Data,Dopaminergic Pathway,Syrup,10mg once daily,Novartis,48,Low,High Risk,Moderate (50-80%),Slow,Renal,Partially Suitable
Levothyroxine,Hypertension,Anti-Aging,77.57,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Acid Reflux,1994,Metformin Hydrochloride,Advil,High Risk,Liver Metabolism,Phase 3,In Vitro Studies,PI3K-AKT Pathway,Injection,250mg every 8 hours,Merck,48,Low,Low Risk,Low (<50%),Slow,Liver,Not Suitable
Aspirin,Acid Reflux,Antiviral,42.83,C17H19N3O3S,Proton Pump Inhibitor,Muscle Pain,1965,Atorvastatin Calcium,Glucophage,High Risk,Slow Metabolism,Ongoing,Animal Testing,Immune Response Pathway,Capsule,10mg once daily,Pfizer,6,High,Low Risk,Moderate (50-80%),Moderate,Liver,Suitable
Metformin,Fever,Anti-Aging,62.04,C33H35FN2O5,AMPK Activator,Acid Reflux,1996,Omeprazole,Prilosec,Low Risk,Rapid Absorption,Phase 4,Animal Testing,PI3K-AKT Pathway,Tablet,As prescribed,AstraZeneca,48,High,Moderate Risk,High (>80%),Slow,Liver,Partially Suitable
Ibuprofen,Gastric Ulcer,Autoimmune Disorders,92.97,C4H11N5,Proton Pump Inhibitor,Acid Reflux,1987,Acetylsalicylic Acid,Advil,High Risk,Slow Metabolism,Phase 3,Toxicology Report,Immune Response Pathway,Capsule,500mg twice a day,AstraZeneca,12,Low,Low Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Atorvastatin,Cholesterol Control,Cardiovascular Disease,48.1,C9H8O4,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1971,Omeprazole,Lipitor,High Risk,High Bioavailability,Ongoing,Animal Testing,PI3K-AKT Pathway,Topical Gel,250mg every 8 hours,Pfizer,12,Moderate,Low Risk,High (>80%),Fast,Enzyme-Specific,Not Suitable
Omeprazole,Acid Reflux,Cardiovascular Disease,81.18,C9H8O4,COX Inhibitor,"Nausea, Dizziness",1971,Atorvastatin Calcium,Aspirin,Low Risk,Renal Excretion,Completed,In Vitro Studies,Serotonin Pathway,Tablet,10mg once daily,Pfizer,2,Moderate,Moderate Risk,High (>80%),Fast,Liver,Not Suitable
Losartan,Fever,Anti-Aging,50.95,C33H35FN2O5,COX Inhibitor,"Nausea, Dizziness",1971,Ibuprofen,Lipitor,Low Risk,Liver Metabolism,Completed,No Preclinical Data,Serotonin Pathway,Topical Gel,As prescribed,Merck,2,Moderate,Moderate Risk,Moderate (50-80%),Slow,Gut,Suitable
Paracetamol,Acid Reflux,Migraine Treatment,48.98,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Muscle Pain,1996,Omeprazole,Aspirin,Moderate Risk,Rapid Absorption,Ongoing,No Preclinical Data,Dopaminergic Pathway,Tablet,10mg once daily,Novartis,24,High,Moderate Risk,High (>80%),Fast,Enzyme-Specific,Partially Suitable
Ranitidine,Hypertension,Autoimmune Disorders,54.03,C9H8O4,Proton Pump Inhibitor,Gastrointestinal Issues,1971,Metformin Hydrochloride,Aspirin,Moderate Risk,Rapid Absorption,Phase 2,In Vitro Studies,Dopaminergic Pathway,Syrup,250mg every 8 hours,Novartis,48,High,Low Risk,Moderate (50-80%),Moderate,Liver,Not Suitable
Simvastatin,Thyroid Hormone Replacement,Alzheimer's,61.29,C13H18O2,NSAID,"Nausea, Dizziness",1994,Atorvastatin Calcium,Aspirin,Moderate Risk,Renal Excretion,Completed,In Vitro Studies,Immune Response Pathway,Capsule,50mg daily,Pfizer,12,High,Low Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Levothyroxine,Hypertension,Antiviral,84.64,C9H8O4,Proton Pump Inhibitor,Muscle Pain,1996,Ibuprofen,Aspirin,High Risk,Renal Excretion,Phase 4,Toxicology Report,Immune Response Pathway,Syrup,500mg twice a day,Roche,12,Low,High Risk,Low (<50%),Slow,Gut,Not Suitable
Aspirin,Diabetes,Autoimmune Disorders,39.65,C9H8O4,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1987,Ibuprofen,Glucophage,High Risk,Rapid Absorption,Phase 4,In Vitro Studies,Serotonin Pathway,Tablet,50mg daily,Roche,2,Low,High Risk,Moderate (50-80%),Moderate,Renal,Partially Suitable
Metformin,Pain Relief,Autoimmune Disorders,33.2,C17H19N3O3S,Proton Pump Inhibitor,"Headache, Rash",1996,Metformin Hydrochloride,Lipitor,Low Risk,Rapid Absorption,Phase 1,In Vitro Studies,MAPK Pathway,Capsule,10mg once daily,Pfizer,12,Moderate,Moderate Risk,Low (<50%),Slow,Renal,Not Suitable
Ibuprofen,Acid Reflux,Antiviral,47.43,C33H35FN2O5,NSAID,Muscle Pain,1965,Ibuprofen,Advil,Moderate Risk,Renal Excretion,Phase 4,No Preclinical Data,Serotonin Pathway,Topical Gel,10mg once daily,Roche,24,Low,Low Risk,High (>80%),Fast,Renal,Partially Suitable
Atorvastatin,Diabetes,Migraine Treatment,77.17,C33H35FN2O5,AMPK Activator,Acid Reflux,1987,Ibuprofen,Glucophage,Moderate Risk,Rapid Absorption,Phase 2,No Preclinical Data,Immune Response Pathway,Syrup,50mg daily,Roche,2,High,Moderate Risk,High (>80%),Moderate,Liver,Suitable
Omeprazole,Thyroid Hormone Replacement,Cancer Therapy,68.08,C13H18O2,AMPK Activator,"Nausea, Dizziness",1994,Ibuprofen,Lipitor,Low Risk,High Bioavailability,Phase 2,Toxicology Report,PI3K-AKT Pathway,Topical Gel,50mg daily,Novartis,12,High,High Risk,Low (<50%),Moderate,Enzyme-Specific,Suitable
Losartan,Inflammation,Alzheimer's,72.17,C17H19N3O3S,NSAID,"Nausea, Dizziness",1987,Acetylsalicylic Acid,Lipitor,High Risk,High Bioavailability,Phase 1,No Preclinical Data,Immune Response Pathway,Capsule,500mg twice a day,Roche,48,Low,Low Risk,Low (<50%),Fast,Liver,Suitable
Paracetamol,Cholesterol Control,Migraine Treatment,57.73,C17H19N3O3S,Proton Pump Inhibitor,Acid Reflux,1971,Ibuprofen,Prilosec,Low Risk,Slow Metabolism,Completed,In Vitro Studies,Serotonin Pathway,Tablet,50mg daily,AstraZeneca,12,Moderate,High Risk,High (>80%),Moderate,Liver,Suitable
Ranitidine,Blood Thinner,Cancer Therapy,94.83,C33H35FN2O5,AMPK Activator,Muscle Pain,1994,Ibuprofen,Prilosec,Moderate Risk,Liver Metabolism,Completed,Animal Testing,Immune Response Pathway,Topical Gel,500mg twice a day,Merck,6,Moderate,Low Risk,Moderate (50-80%),Slow,Enzyme-Specific,Partially Suitable
Simvastatin,Inflammation,Cardiovascular Disease,79.64,C9H8O4,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1965,Atorvastatin Calcium,Glucophage,High Risk,High Bioavailability,Phase 2,No Preclinical Data,Immune Response Pathway,Syrup,250mg every 8 hours,AstraZeneca,2,Low,Low Risk,Moderate (50-80%),Slow,Liver,Partially Suitable
Levothyroxine,Cholesterol Control,Cancer Therapy,81.35,C13H18O2,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1996,Metformin Hydrochloride,Prilosec,Low Risk,Renal Excretion,Phase 3,Toxicology Report,Immune Response Pathway,Topical Gel,250mg every 8 hours,Novartis,48,Low,Moderate Risk,High (>80%),Moderate,Gut,Partially Suitable
Aspirin,Pain Relief,Migraine Treatment,66.53,C17H19N3O3S,COX Inhibitor,Muscle Pain,1994,Atorvastatin Calcium,Aspirin,Low Risk,High Bioavailability,Phase 3,Animal Testing,Dopaminergic Pathway,Topical Gel,50mg daily,AstraZeneca,48,Moderate,High Risk,Moderate (50-80%),Slow,Gut,Suitable
Metformin,Gastric Ulcer,Cancer Therapy,45.39,C4H11N5,COX Inhibitor,Gastrointestinal Issues,1965,Omeprazole,Glucophage,Moderate Risk,Liver Metabolism,Phase 1,Animal Testing,Serotonin Pathway,Tablet,As prescribed,Merck,12,Low,Low Risk,Low (<50%),Fast,Renal,Not Suitable
Ibuprofen,Thyroid Hormone Replacement,Liver Disease,74.4,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Muscle Pain,1996,Acetylsalicylic Acid,Lipitor,High Risk,High Bioavailability,Phase 4,In Vitro Studies,Serotonin Pathway,Topical Gel,As prescribed,Merck,48,Moderate,Low Risk,Moderate (50-80%),Fast,Gut,Partially Suitable
Atorvastatin,Blood Thinner,Migraine Treatment,54.23,C13H18O2,AMPK Activator,Acid Reflux,1987,Omeprazole,Lipitor,High Risk,Rapid Absorption,Phase 4,No Preclinical Data,Immune Response Pathway,Topical Gel,10mg once daily,Pfizer,24,Low,High Risk,High (>80%),Moderate,Renal,Not Suitable
Omeprazole,Inflammation,Weight Loss,71.24,C9H8O4,NSAID,"Nausea, Dizziness",1996,Atorvastatin Calcium,Prilosec,Low Risk,Slow Metabolism,Ongoing,Animal Testing,Immune Response Pathway,Tablet,10mg once daily,Roche,2,Low,Moderate Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Suitable
Losartan,Hypertension,Migraine Treatment,46.58,C33H35FN2O5,Proton Pump Inhibitor,"Headache, Rash",1994,Omeprazole,Prilosec,High Risk,Slow Metabolism,Ongoing,Animal Testing,Immune Response Pathway,Injection,10mg once daily,Roche,2,Moderate,Low Risk,High (>80%),Fast,Liver,Partially Suitable
Paracetamol,Inflammation,Parkinson's,50.04,C33H35FN2O5,NSAID,Muscle Pain,1994,Ibuprofen,Lipitor,Moderate Risk,High Bioavailability,Phase 2,In Vitro Studies,Immune Response Pathway,Injection,50mg daily,Pfizer,6,Low,Moderate Risk,High (>80%),Moderate,Renal,Suitable
Ranitidine,Diabetes,Alzheimer's,47.7,C17H19N3O3S,Proton Pump Inhibitor,"Headache, Rash",1987,Acetylsalicylic Acid,Glucophage,High Risk,High Bioavailability,Phase 2,In Vitro Studies,MAPK Pathway,Topical Gel,50mg daily,Novartis,12,High,Moderate Risk,High (>80%),Fast,Gut,Not Suitable
Simvastatin,Gastric Ulcer,Weight Loss,64.34,C9H8O4,Proton Pump Inhibitor,"Nausea, Dizziness",1965,Acetylsalicylic Acid,Advil,Low Risk,Renal Excretion,Phase 2,Animal Testing,Serotonin Pathway,Topical Gel,As prescribed,Novartis,6,High,Moderate Risk,Low (<50%),Moderate,Enzyme-Specific,Suitable
Levothyroxine,Diabetes,Antiviral,33.66,C17H19N3O3S,AMPK Activator,"Nausea, Dizziness",1965,Atorvastatin Calcium,Lipitor,Low Risk,Rapid Absorption,Phase 2,No Preclinical Data,MAPK Pathway,Topical Gel,500mg twice a day,AstraZeneca,12,High,Low Risk,Low (<50%),Fast,Renal,Suitable
Aspirin,Gastric Ulcer,Cardiovascular Disease,88.73,C33H35FN2O5,Proton Pump Inhibitor,Gastrointestinal Issues,1987,Acetylsalicylic Acid,Glucophage,Low Risk,Liver Metabolism,Phase 3,No Preclinical Data,PI3K-AKT Pathway,Syrup,As prescribed,Novartis,48,High,Moderate Risk,Moderate (50-80%),Moderate,Gut,Partially Suitable
Metformin,Gastric Ulcer,Migraine Treatment,62.14,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1965,Metformin Hydrochloride,Glucophage,High Risk,High Bioavailability,Completed,Animal Testing,Dopaminergic Pathway,Topical Gel,250mg every 8 hours,Merck,2,Moderate,Moderate Risk,Low (<50%),Moderate,Gut,Not Suitable
Ibuprofen,Hypertension,Antiviral,42.06,C33H35FN2O5,COX Inhibitor,Muscle Pain,1994,Ibuprofen,Aspirin,Moderate Risk,High Bioavailability,Phase 3,No Preclinical Data,Dopaminergic Pathway,Topical Gel,500mg twice a day,Pfizer,48,High,High Risk,Low (<50%),Slow,Enzyme-Specific,Partially Suitable
Atorvastatin,Acid Reflux,Cardiovascular Disease,81.26,C4H11N5,NSAID,Muscle Pain,1994,Metformin Hydrochloride,Lipitor,Low Risk,Rapid Absorption,Ongoing,No Preclinical Data,Serotonin Pathway,Topical Gel,250mg every 8 hours,Roche,24,High,High Risk,Low (<50%),Slow,Enzyme-Specific,Suitable
Omeprazole,Inflammation,Cancer Therapy,73.99,C9H8O4,NSAID,"Headache, Rash",1971,Metformin Hydrochloride,Prilosec,Low Risk,Rapid Absorption,Phase 1,In Vitro Studies,Dopaminergic Pathway,Capsule,50mg daily,Roche,12,Moderate,Low Risk,Low (<50%),Fast,Renal,Not Suitable
Losartan,Inflammation,Autoimmune Disorders,48.34,C17H19N3O3S,NSAID,Gastrointestinal Issues,1965,Omeprazole,Aspirin,High Risk,Liver Metabolism,Phase 1,In Vitro Studies,MAPK Pathway,Capsule,As prescribed,Novartis,48,High,Moderate Risk,Moderate (50-80%),Fast,Renal,Suitable
Paracetamol,Thyroid Hormone Replacement,Migraine Treatment,77.1,C9H8O4,NSAID,Gastrointestinal Issues,1996,Metformin Hydrochloride,Glucophage,Moderate Risk,Rapid Absorption,Phase 4,Toxicology Report,PI3K-AKT Pathway,Injection,10mg once daily,Roche,6,High,Low Risk,Moderate (50-80%),Fast,Enzyme-Specific,Partially Suitable
Ranitidine,Pain Relief,Weight Loss,80.31,C17H19N3O3S,AMPK Activator,"Headache, Rash",1965,Omeprazole,Prilosec,Moderate Risk,Slow Metabolism,Completed,Toxicology Report,MAPK Pathway,Capsule,250mg every 8 hours,Pfizer,24,High,High Risk,Moderate (50-80%),Slow,Liver,Not Suitable
Simvastatin,Inflammation,Liver Disease,33.43,C17H19N3O3S,AMPK Activator,"Headache, Rash",1996,Atorvastatin Calcium,Aspirin,Moderate Risk,Liver Metabolism,Phase 2,No Preclinical Data,Immune Response Pathway,Topical Gel,As prescribed,Roche,12,High,Moderate Risk,High (>80%),Slow,Liver,Partially Suitable
Levothyroxine,Pain Relief,Parkinson's,39.97,C4H11N5,Proton Pump Inhibitor,Gastrointestinal Issues,1965,Ibuprofen,Lipitor,Low Risk,Liver Metabolism,Phase 3,Animal Testing,Dopaminergic Pathway,Syrup,10mg once daily,AstraZeneca,6,High,Low Risk,Low (<50%),Fast,Gut,Not Suitable
Aspirin,Pain Relief,Liver Disease,57.1,C4H11N5,Proton Pump Inhibitor,Acid Reflux,1971,Metformin Hydrochloride,Advil,Moderate Risk,Renal Excretion,Phase 3,In Vitro Studies,MAPK Pathway,Injection,As prescribed,AstraZeneca,48,High,Low Risk,Moderate (50-80%),Slow,Renal,Suitable
Metformin,Hypertension,Parkinson's,32.33,C13H18O2,AMPK Activator,"Headache, Rash",1971,Atorvastatin Calcium,Advil,Low Risk,Renal Excretion,Phase 1,In Vitro Studies,Dopaminergic Pathway,Injection,10mg once daily,Pfizer,12,Moderate,Low Risk,Moderate (50-80%),Slow,Liver,Not Suitable
Ibuprofen,Pain Relief,Autoimmune Disorders,55.32,C9H8O4,NSAID,Acid Reflux,1987,Omeprazole,Glucophage,High Risk,High Bioavailability,Completed,In Vitro Studies,PI3K-AKT Pathway,Syrup,50mg daily,Merck,2,High,Low Risk,Moderate (50-80%),Moderate,Liver,Not Suitable
Atorvastatin,Blood Thinner,Liver Disease,66.73,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Muscle Pain,1965,Ibuprofen,Glucophage,High Risk,Rapid Absorption,Phase 2,In Vitro Studies,MAPK Pathway,Injection,50mg daily,Novartis,12,Low,Moderate Risk,High (>80%),Fast,Renal,Partially Suitable
Omeprazole,Cholesterol Control,Anti-Aging,35.72,C13H18O2,COX Inhibitor,Acid Reflux,1996,Ibuprofen,Advil,Low Risk,Rapid Absorption,Phase 4,No Preclinical Data,Immune Response Pathway,Tablet,50mg daily,Novartis,6,High,High Risk,Moderate (50-80%),Slow,Renal,Partially Suitable
Losartan,Cholesterol Control,Migraine Treatment,54.9,C17H19N3O3S,HMG-CoA Reductase Inhibitor,"Headache, Rash",1996,Omeprazole,Lipitor,High Risk,Liver Metabolism,Completed,Toxicology Report,PI3K-AKT Pathway,Topical Gel,As prescribed,Novartis,48,High,High Risk,Low (<50%),Fast,Gut,Not Suitable
Paracetamol,Inflammation,Cancer Therapy,64.85,C17H19N3O3S,Proton Pump Inhibitor,Gastrointestinal Issues,1987,Omeprazole,Advil,Moderate Risk,Liver Metabolism,Phase 3,Toxicology Report,MAPK Pathway,Syrup,10mg once daily,Merck,2,Moderate,Low Risk,Low (<50%),Fast,Gut,Partially Suitable
Ranitidine,Hypertension,Weight Loss,48.93,C9H8O4,HMG-CoA Reductase Inhibitor,"Headache, Rash",1996,Ibuprofen,Advil,Low Risk,High Bioavailability,Phase 3,Animal Testing,MAPK Pathway,Injection,50mg daily,Novartis,2,High,High Risk,Low (<50%),Moderate,Liver,Suitable
Simvastatin,Diabetes,Cancer Therapy,69.91,C9H8O4,NSAID,Acid Reflux,1987,Ibuprofen,Aspirin,Low Risk,High Bioavailability,Phase 3,Animal Testing,Immune Response Pathway,Injection,500mg twice a day,Roche,24,High,Low Risk,High (>80%),Moderate,Liver,Suitable
Levothyroxine,Fever,Autoimmune Disorders,88.85,C9H8O4,AMPK Activator,Muscle Pain,1987,Metformin Hydrochloride,Prilosec,Moderate Risk,Slow Metabolism,Phase 4,Toxicology Report,MAPK Pathway,Injection,10mg once daily,Merck,6,Low,Low Risk,High (>80%),Moderate,Gut,Suitable
Aspirin,Blood Thinner,Migraine Treatment,62.3,C4H11N5,Proton Pump Inhibitor,"Nausea, Dizziness",1996,Atorvastatin Calcium,Aspirin,Low Risk,Slow Metabolism,Phase 4,Toxicology Report,PI3K-AKT Pathway,Capsule,500mg twice a day,Novartis,24,Low,Moderate Risk,High (>80%),Slow,Enzyme-Specific,Not Suitable
Metformin,Cholesterol Control,Cardiovascular Disease,67.72,C13H18O2,NSAID,Muscle Pain,1987,Metformin Hydrochloride,Lipitor,Moderate Risk,Rapid Absorption,Ongoing,In Vitro Studies,Dopaminergic Pathway,Syrup,As prescribed,AstraZeneca,48,High,High Risk,Low (<50%),Slow,Liver,Not Suitable
Ibuprofen,Blood Thinner,Migraine Treatment,38.44,C17H19N3O3S,NSAID,Muscle Pain,1965,Ibuprofen,Prilosec,Low Risk,High Bioavailability,Phase 3,Toxicology Report,Immune Response Pathway,Syrup,10mg once daily,Roche,6,High,High Risk,Moderate (50-80%),Fast,Enzyme-Specific,Not Suitable
Atorvastatin,Cholesterol Control,Alzheimer's,52.71,C17H19N3O3S,AMPK Activator,Acid Reflux,1987,Acetylsalicylic Acid,Prilosec,Moderate Risk,Renal Excretion,Ongoing,In Vitro Studies,PI3K-AKT Pathway,Tablet,250mg every 8 hours,Pfizer,6,Low,High Risk,Low (<50%),Moderate,Renal,Not Suitable
Omeprazole,Acid Reflux,Antiviral,41.25,C9H8O4,AMPK Activator,Gastrointestinal Issues,1994,Metformin Hydrochloride,Lipitor,Moderate Risk,High Bioavailability,Ongoing,Animal Testing,PI3K-AKT Pathway,Topical Gel,500mg twice a day,Merck,12,Moderate,Low Risk,Moderate (50-80%),Fast,Liver,Partially Suitable
Losartan,Acid Reflux,Parkinson's,58.61,C33H35FN2O5,COX Inhibitor,Acid Reflux,1971,Atorvastatin Calcium,Glucophage,High Risk,Rapid Absorption,Phase 2,In Vitro Studies,Serotonin Pathway,Injection,50mg daily,Roche,6,Moderate,Low Risk,High (>80%),Moderate,Enzyme-Specific,Partially Suitable
Paracetamol,Inflammation,Liver Disease,82.16,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1994,Acetylsalicylic Acid,Prilosec,Moderate Risk,High Bioavailability,Phase 2,In Vitro Studies,Serotonin Pathway,Tablet,500mg twice a day,AstraZeneca,2,High,Low Risk,Low (<50%),Slow,Gut,Not Suitable
Ranitidine,Acid Reflux,Cancer Therapy,94.6,C13H18O2,COX Inhibitor,Acid Reflux,1971,Metformin Hydrochloride,Aspirin,Low Risk,Rapid Absorption,Phase 4,In Vitro Studies,PI3K-AKT Pathway,Topical Gel,500mg twice a day,Merck,48,High,Moderate Risk,High (>80%),Slow,Gut,Partially Suitable
Simvastatin,Cholesterol Control,Antiviral,51.61,C9H8O4,NSAID,Muscle Pain,1971,Ibuprofen,Prilosec,Moderate Risk,High Bioavailability,Phase 1,No Preclinical Data,Dopaminergic Pathway,Injection,250mg every 8 hours,Pfizer,24,Low,Low Risk,Low (<50%),Fast,Liver,Partially Suitable
Levothyroxine,Fever,Antiviral,38.19,C4H11N5,AMPK Activator,Muscle Pain,1971,Acetylsalicylic Acid,Aspirin,High Risk,High Bioavailability,Phase 2,Animal Testing,Immune Response Pathway,Capsule,10mg once daily,Merck,6,Moderate,Moderate Risk,Moderate (50-80%),Fast,Liver,Suitable
Aspirin,Inflammation,Liver Disease,81.37,C9H8O4,NSAID,"Headache, Rash",1965,Omeprazole,Aspirin,Low Risk,Renal Excretion,Phase 4,Toxicology Report,Serotonin Pathway,Tablet,500mg twice a day,Novartis,2,Low,Low Risk,Low (<50%),Slow,Liver,Not Suitable
Metformin,Diabetes,Autoimmune Disorders,70.81,C4H11N5,Proton Pump Inhibitor,Gastrointestinal Issues,1994,Ibuprofen,Glucophage,High Risk,Rapid Absorption,Phase 4,Animal Testing,PI3K-AKT Pathway,Tablet,250mg every 8 hours,AstraZeneca,2,High,High Risk,Low (<50%),Moderate,Liver,Partially Suitable
Ibuprofen,Acid Reflux,Parkinson's,43.2,C17H19N3O3S,NSAID,Muscle Pain,1996,Ibuprofen,Lipitor,Moderate Risk,Renal Excretion,Phase 3,In Vitro Studies,MAPK Pathway,Tablet,250mg every 8 hours,Novartis,48,High,Low Risk,Low (<50%),Moderate,Enzyme-Specific,Not Suitable
Atorvastatin,Thyroid Hormone Replacement,Cardiovascular Disease,84.26,C4H11N5,Proton Pump Inhibitor,Gastrointestinal Issues,1987,Omeprazole,Glucophage,High Risk,Liver Metabolism,Phase 3,In Vitro Studies,PI3K-AKT Pathway,Syrup,As prescribed,AstraZeneca,6,Low,Low Risk,High (>80%),Moderate,Renal,Not Suitable
Omeprazole,Thyroid Hormone Replacement,Cardiovascular Disease,48.29,C9H8O4,COX Inhibitor,Muscle Pain,1971,Ibuprofen,Aspirin,High Risk,High Bioavailability,Completed,Toxicology Report,Serotonin Pathway,Syrup,500mg twice a day,Roche,12,High,Moderate Risk,High (>80%),Slow,Gut,Not Suitable
Losartan,Inflammation,Cardiovascular Disease,63.33,C4H11N5,NSAID,"Nausea, Dizziness",1987,Omeprazole,Lipitor,High Risk,Renal Excretion,Ongoing,No Preclinical Data,Serotonin Pathway,Injection,250mg every 8 hours,Novartis,24,Low,Moderate Risk,High (>80%),Moderate,Renal,Partially Suitable
Paracetamol,Pain Relief,Parkinson's,30.76,C9H8O4,NSAID,Gastrointestinal Issues,1994,Atorvastatin Calcium,Lipitor,Moderate Risk,High Bioavailability,Phase 4,No Preclinical Data,Serotonin Pathway,Syrup,500mg twice a day,Pfizer,24,Moderate,High Risk,Low (<50%),Slow,Liver,Not Suitable
Ranitidine,Blood Thinner,Liver Disease,72.21,C13H18O2,COX Inhibitor,Acid Reflux,1996,Ibuprofen,Advil,High Risk,Rapid Absorption,Phase 3,No Preclinical Data,PI3K-AKT Pathway,Syrup,250mg every 8 hours,Merck,48,High,High Risk,Moderate (50-80%),Fast,Enzyme-Specific,Not Suitable
Simvastatin,Cholesterol Control,Anti-Aging,57.19,C4H11N5,Proton Pump Inhibitor,Acid Reflux,1994,Atorvastatin Calcium,Glucophage,Low Risk,Rapid Absorption,Phase 2,No Preclinical Data,Serotonin Pathway,Capsule,50mg daily,AstraZeneca,48,High,Moderate Risk,High (>80%),Fast,Enzyme-Specific,Not Suitable
Levothyroxine,Gastric Ulcer,Parkinson's,86.54,C9H8O4,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1994,Acetylsalicylic Acid,Prilosec,Low Risk,Slow Metabolism,Phase 3,No Preclinical Data,MAPK Pathway,Tablet,10mg once daily,Novartis,12,Moderate,Moderate Risk,Moderate (50-80%),Slow,Gut,Suitable
Aspirin,Inflammation,Antiviral,44.15,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1996,Metformin Hydrochloride,Lipitor,High Risk,High Bioavailability,Ongoing,No Preclinical Data,MAPK Pathway,Capsule,500mg twice a day,AstraZeneca,12,Low,Low Risk,Low (<50%),Slow,Renal,Partially Suitable
Metformin,Thyroid Hormone Replacement,Alzheimer's,36.73,C4H11N5,NSAID,Gastrointestinal Issues,1994,Atorvastatin Calcium,Advil,Moderate Risk,Renal Excretion,Phase 1,No Preclinical Data,MAPK Pathway,Topical Gel,500mg twice a day,Novartis,24,High,Moderate Risk,Moderate (50-80%),Moderate,Renal,Suitable
Ibuprofen,Pain Relief,Autoimmune Disorders,91.33,C4H11N5,COX Inhibitor,"Headache, Rash",1996,Omeprazole,Prilosec,Low Risk,Liver Metabolism,Ongoing,Animal Testing,Serotonin Pathway,Tablet,500mg twice a day,Merck,48,Moderate,Moderate Risk,Low (<50%),Fast,Gut,Partially Suitable
Atorvastatin,Gastric Ulcer,Weight Loss,83.76,C4H11N5,AMPK Activator,"Headache, Rash",1971,Ibuprofen,Lipitor,Moderate Risk,Liver Metabolism,Phase 1,In Vitro Studies,PI3K-AKT Pathway,Syrup,250mg every 8 hours,Merck,48,High,High Risk,High (>80%),Moderate,Liver,Partially Suitable
Omeprazole,Inflammation,Parkinson's,37.63,C13H18O2,Proton Pump Inhibitor,Acid Reflux,1987,Ibuprofen,Advil,Low Risk,Liver Metabolism,Completed,No Preclinical Data,Immune Response Pathway,Tablet,50mg daily,AstraZeneca,24,Moderate,High Risk,Moderate (50-80%),Fast,Liver,Suitable
Losartan,Pain Relief,Liver Disease,77.11,C4H11N5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1971,Acetylsalicylic Acid,Lipitor,High Risk,Renal Excretion,Completed,No Preclinical Data,MAPK Pathway,Topical Gel,250mg every 8 hours,Roche,2,Moderate,High Risk,High (>80%),Moderate,Gut,Partially Suitable
Paracetamol,Inflammation,Migraine Treatment,55.28,C33H35FN2O5,NSAID,"Headache, Rash",1965,Acetylsalicylic Acid,Lipitor,Low Risk,High Bioavailability,Phase 2,In Vitro Studies,Serotonin Pathway,Tablet,10mg once daily,Pfizer,24,High,Low Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Ranitidine,Fever,Parkinson's,64.12,C17H19N3O3S,AMPK Activator,Gastrointestinal Issues,1996,Atorvastatin Calcium,Prilosec,Moderate Risk,Liver Metabolism,Phase 4,Toxicology Report,MAPK Pathway,Capsule,50mg daily,Pfizer,24,Low,Low Risk,Moderate (50-80%),Fast,Gut,Suitable
Simvastatin,Diabetes,Parkinson's,78.97,C17H19N3O3S,Proton Pump Inhibitor,Gastrointestinal Issues,1965,Ibuprofen,Aspirin,Low Risk,Rapid Absorption,Completed,In Vitro Studies,Immune Response Pathway,Tablet,10mg once daily,AstraZeneca,12,High,Low Risk,Low (<50%),Slow,Liver,Not Suitable
Levothyroxine,Blood Thinner,Migraine Treatment,48.66,C4H11N5,NSAID,Muscle Pain,1994,Acetylsalicylic Acid,Prilosec,Moderate Risk,Slow Metabolism,Completed,Animal Testing,Dopaminergic Pathway,Capsule,250mg every 8 hours,Pfizer,2,High,Low Risk,Moderate (50-80%),Slow,Renal,Suitable
Aspirin,Cholesterol Control,Antiviral,69.23,C13H18O2,Proton Pump Inhibitor,"Nausea, Dizziness",1987,Ibuprofen,Glucophage,High Risk,Liver Metabolism,Phase 3,No Preclinical Data,Dopaminergic Pathway,Topical Gel,50mg daily,Merck,24,High,Low Risk,Moderate (50-80%),Slow,Liver,Suitable
Metformin,Thyroid Hormone Replacement,Autoimmune Disorders,70.08,C13H18O2,AMPK Activator,Muscle Pain,1994,Metformin Hydrochloride,Glucophage,High Risk,Liver Metabolism,Phase 1,In Vitro Studies,Serotonin Pathway,Tablet,50mg daily,Pfizer,6,Moderate,Moderate Risk,Low (<50%),Slow,Renal,Suitable
Ibuprofen,Acid Reflux,Antiviral,93.63,C4H11N5,AMPK Activator,Gastrointestinal Issues,1971,Acetylsalicylic Acid,Aspirin,Low Risk,Rapid Absorption,Phase 2,Animal Testing,Dopaminergic Pathway,Tablet,250mg every 8 hours,Novartis,2,High,Moderate Risk,Low (<50%),Moderate,Renal,Not Suitable
Atorvastatin,Thyroid Hormone Replacement,Parkinson's,41.09,C9H8O4,COX Inhibitor,Acid Reflux,1971,Atorvastatin Calcium,Prilosec,High Risk,Rapid Absorption,Phase 3,Animal Testing,MAPK Pathway,Tablet,50mg daily,Merck,12,High,Low Risk,High (>80%),Moderate,Renal,Not Suitable
Omeprazole,Diabetes,Autoimmune Disorders,46.24,C9H8O4,NSAID,Acid Reflux,1971,Omeprazole,Aspirin,High Risk,Liver Metabolism,Phase 2,No Preclinical Data,Dopaminergic Pathway,Tablet,As prescribed,Pfizer,24,Moderate,High Risk,High (>80%),Moderate,Renal,Not Suitable
Losartan,Gastric Ulcer,Migraine Treatment,85.25,C4H11N5,Proton Pump Inhibitor,"Headache, Rash",1987,Acetylsalicylic Acid,Glucophage,High Risk,Rapid Absorption,Completed,Animal Testing,MAPK Pathway,Tablet,50mg daily,Roche,24,High,Moderate Risk,High (>80%),Moderate,Gut,Partially Suitable
Paracetamol,Hypertension,Cancer Therapy,79.07,C33H35FN2O5,COX Inhibitor,"Nausea, Dizziness",1965,Atorvastatin Calcium,Glucophage,Low Risk,Rapid Absorption,Completed,Toxicology Report,Serotonin Pathway,Syrup,250mg every 8 hours,AstraZeneca,6,High,High Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Partially Suitable
Ranitidine,Gastric Ulcer,Cancer Therapy,50.46,C9H8O4,NSAID,Muscle Pain,1996,Ibuprofen,Aspirin,Moderate Risk,Slow Metabolism,Phase 2,In Vitro Studies,Dopaminergic Pathway,Injection,50mg daily,Pfizer,2,Moderate,Moderate Risk,Moderate (50-80%),Slow,Gut,Not Suitable
Simvastatin,Gastric Ulcer,Liver Disease,59.58,C13H18O2,AMPK Activator,Gastrointestinal Issues,1971,Atorvastatin Calcium,Lipitor,Low Risk,Renal Excretion,Phase 3,No Preclinical Data,PI3K-AKT Pathway,Tablet,500mg twice a day,Novartis,2,Low,Low Risk,High (>80%),Slow,Renal,Partially Suitable
Levothyroxine,Cholesterol Control,Migraine Treatment,39.9,C13H18O2,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1987,Ibuprofen,Advil,Moderate Risk,Liver Metabolism,Phase 3,Animal Testing,Dopaminergic Pathway,Capsule,As prescribed,Pfizer,2,Moderate,High Risk,Moderate (50-80%),Moderate,Gut,Partially Suitable
Aspirin,Inflammation,Parkinson's,82.69,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Muscle Pain,1965,Acetylsalicylic Acid,Advil,Moderate Risk,Rapid Absorption,Phase 1,Animal Testing,Immune Response Pathway,Capsule,50mg daily,Novartis,2,Low,Moderate Risk,Moderate (50-80%),Slow,Gut,Suitable
Metformin,Gastric Ulcer,Anti-Aging,59.49,C13H18O2,AMPK Activator,Gastrointestinal Issues,1987,Acetylsalicylic Acid,Aspirin,High Risk,Renal Excretion,Ongoing,Toxicology Report,Serotonin Pathway,Injection,10mg once daily,AstraZeneca,2,Moderate,High Risk,Moderate (50-80%),Moderate,Renal,Not Suitable
Ibuprofen,Gastric Ulcer,Parkinson's,93.89,C13H18O2,HMG-CoA Reductase Inhibitor,"Headache, Rash",1987,Atorvastatin Calcium,Lipitor,Low Risk,Liver Metabolism,Phase 2,Toxicology Report,PI3K-AKT Pathway,Tablet,10mg once daily,Merck,2,High,Moderate Risk,High (>80%),Moderate,Gut,Partially Suitable
Atorvastatin,Acid Reflux,Parkinson's,80.43,C33H35FN2O5,NSAID,Acid Reflux,1994,Acetylsalicylic Acid,Lipitor,High Risk,Slow Metabolism,Phase 4,Animal Testing,Serotonin Pathway,Topical Gel,500mg twice a day,AstraZeneca,2,Low,Moderate Risk,Low (<50%),Fast,Renal,Partially Suitable
Omeprazole,Blood Thinner,Liver Disease,71.9,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Muscle Pain,1971,Omeprazole,Prilosec,Moderate Risk,Liver Metabolism,Phase 4,No Preclinical Data,Serotonin Pathway,Syrup,500mg twice a day,Roche,48,Low,High Risk,Moderate (50-80%),Slow,Renal,Suitable
Losartan,Gastric Ulcer,Autoimmune Disorders,60.51,C17H19N3O3S,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1965,Ibuprofen,Glucophage,Moderate Risk,Slow Metabolism,Phase 4,In Vitro Studies,Dopaminergic Pathway,Topical Gel,250mg every 8 hours,Pfizer,48,Moderate,Moderate Risk,High (>80%),Moderate,Enzyme-Specific,Suitable
Paracetamol,Blood Thinner,Migraine Treatment,92.12,C33H35FN2O5,AMPK Activator,"Headache, Rash",1987,Omeprazole,Aspirin,Moderate Risk,High Bioavailability,Phase 3,No Preclinical Data,Dopaminergic Pathway,Topical Gel,250mg every 8 hours,AstraZeneca,2,Low,High Risk,Low (<50%),Slow,Gut,Partially Suitable
Ranitidine,Inflammation,Migraine Treatment,65.7,C33H35FN2O5,AMPK Activator,Muscle Pain,1965,Atorvastatin Calcium,Lipitor,High Risk,Slow Metabolism,Phase 3,Animal Testing,Dopaminergic Pathway,Tablet,As prescribed,Roche,48,Moderate,High Risk,Moderate (50-80%),Moderate,Renal,Suitable
Simvastatin,Cholesterol Control,Alzheimer's,44.59,C4H11N5,COX Inhibitor,Muscle Pain,1987,Omeprazole,Aspirin,Moderate Risk,Rapid Absorption,Phase 4,Toxicology Report,Serotonin Pathway,Capsule,500mg twice a day,Roche,48,High,Moderate Risk,Low (<50%),Moderate,Enzyme-Specific,Partially Suitable
Levothyroxine,Pain Relief,Cardiovascular Disease,57.87,C17H19N3O3S,COX Inhibitor,"Headache, Rash",1994,Metformin Hydrochloride,Lipitor,Low Risk,Liver Metabolism,Phase 1,No Preclinical Data,Immune Response Pathway,Injection,500mg twice a day,Novartis,12,High,Low Risk,Moderate (50-80%),Fast,Gut,Partially Suitable
Aspirin,Inflammation,Autoimmune Disorders,61.38,C4H11N5,HMG-CoA Reductase Inhibitor,Acid Reflux,1994,Atorvastatin Calcium,Advil,Moderate Risk,Slow Metabolism,Ongoing,Animal Testing,PI3K-AKT Pathway,Injection,10mg once daily,Roche,2,Moderate,Moderate Risk,Low (<50%),Slow,Liver,Partially Suitable
Metformin,Inflammation,Cancer Therapy,68.05,C17H19N3O3S,NSAID,"Nausea, Dizziness",1965,Omeprazole,Advil,Low Risk,High Bioavailability,Phase 4,No Preclinical Data,MAPK Pathway,Tablet,50mg daily,Roche,48,Moderate,Low Risk,Low (<50%),Fast,Gut,Not Suitable
Ibuprofen,Cholesterol Control,Migraine Treatment,38.53,C9H8O4,NSAID,Acid Reflux,1994,Metformin Hydrochloride,Aspirin,Low Risk,Liver Metabolism,Completed,Toxicology Report,Immune Response Pathway,Injection,10mg once daily,Pfizer,12,High,High Risk,Moderate (50-80%),Fast,Gut,Partially Suitable
Atorvastatin,Inflammation,Migraine Treatment,69.91,C17H19N3O3S,AMPK Activator,Muscle Pain,1996,Metformin Hydrochloride,Advil,High Risk,Liver Metabolism,Completed,Animal Testing,PI3K-AKT Pathway,Syrup,50mg daily,AstraZeneca,48,Moderate,High Risk,Moderate (50-80%),Moderate,Liver,Not Suitable
Omeprazole,Diabetes,Autoimmune Disorders,71.63,C33H35FN2O5,NSAID,"Headache, Rash",1965,Acetylsalicylic Acid,Aspirin,Low Risk,High Bioavailability,Ongoing,Animal Testing,MAPK Pathway,Syrup,500mg twice a day,Pfizer,6,Low,Moderate Risk,High (>80%),Fast,Enzyme-Specific,Partially Suitable
Losartan,Blood Thinner,Liver Disease,74.89,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1996,Ibuprofen,Glucophage,Low Risk,Slow Metabolism,Phase 3,Toxicology Report,Serotonin Pathway,Topical Gel,10mg once daily,Merck,24,High,High Risk,High (>80%),Fast,Liver,Suitable
Paracetamol,Inflammation,Cardiovascular Disease,45.64,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Muscle Pain,1965,Omeprazole,Lipitor,Low Risk,High Bioavailability,Completed,No Preclinical Data,MAPK Pathway,Syrup,250mg every 8 hours,AstraZeneca,48,Low,High Risk,Moderate (50-80%),Fast,Enzyme-Specific,Partially Suitable
Ranitidine,Cholesterol Control,Alzheimer's,49.66,C13H18O2,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1987,Atorvastatin Calcium,Lipitor,Low Risk,Slow Metabolism,Phase 2,Toxicology Report,MAPK Pathway,Injection,500mg twice a day,Novartis,2,Low,Low Risk,High (>80%),Moderate,Gut,Not Suitable
Simvastatin,Blood Thinner,Antiviral,74.76,C17H19N3O3S,COX Inhibitor,Gastrointestinal Issues,1996,Atorvastatin Calcium,Lipitor,High Risk,Renal Excretion,Phase 4,Toxicology Report,MAPK Pathway,Injection,250mg every 8 hours,Merck,6,Low,High Risk,High (>80%),Moderate,Liver,Not Suitable
Levothyroxine,Cholesterol Control,Cancer Therapy,67.99,C33H35FN2O5,NSAID,Gastrointestinal Issues,1996,Ibuprofen,Advil,High Risk,Rapid Absorption,Phase 2,In Vitro Studies,Immune Response Pathway,Capsule,10mg once daily,Pfizer,24,Low,High Risk,Low (<50%),Slow,Renal,Partially Suitable
Aspirin,Cholesterol Control,Migraine Treatment,63.84,C9H8O4,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1965,Ibuprofen,Prilosec,High Risk,Slow Metabolism,Phase 2,In Vitro Studies,Immune Response Pathway,Injection,50mg daily,Novartis,2,Low,Moderate Risk,Low (<50%),Fast,Liver,Partially Suitable
Metformin,Inflammation,Migraine Treatment,50.33,C17H19N3O3S,COX Inhibitor,"Nausea, Dizziness",1994,Acetylsalicylic Acid,Advil,Low Risk,Liver Metabolism,Phase 4,Toxicology Report,Serotonin Pathway,Syrup,As prescribed,Pfizer,6,Moderate,High Risk,Low (<50%),Slow,Renal,Suitable
Ibuprofen,Pain Relief,Parkinson's,46.5,C9H8O4,COX Inhibitor,Gastrointestinal Issues,1971,Ibuprofen,Lipitor,Low Risk,Renal Excretion,Completed,Toxicology Report,Dopaminergic Pathway,Topical Gel,10mg once daily,Novartis,12,Low,High Risk,Low (<50%),Moderate,Renal,Partially Suitable
Atorvastatin,Pain Relief,Cancer Therapy,88.98,C9H8O4,NSAID,Muscle Pain,1965,Ibuprofen,Prilosec,Low Risk,Liver Metabolism,Phase 2,No Preclinical Data,Immune Response Pathway,Capsule,500mg twice a day,Roche,12,Low,Moderate Risk,Moderate (50-80%),Slow,Enzyme-Specific,Suitable
Omeprazole,Diabetes,Cardiovascular Disease,92.97,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1965,Ibuprofen,Lipitor,Low Risk,Rapid Absorption,Ongoing,In Vitro Studies,Serotonin Pathway,Topical Gel,500mg twice a day,Novartis,6,High,High Risk,Moderate (50-80%),Fast,Liver,Suitable
Losartan,Inflammation,Cardiovascular Disease,35.52,C9H8O4,AMPK Activator,Gastrointestinal Issues,1987,Acetylsalicylic Acid,Lipitor,Low Risk,Slow Metabolism,Phase 2,No Preclinical Data,MAPK Pathway,Topical Gel,250mg every 8 hours,AstraZeneca,6,Moderate,High Risk,Low (<50%),Slow,Gut,Suitable
Paracetamol,Fever,Autoimmune Disorders,94.11,C33H35FN2O5,NSAID,"Headache, Rash",1965,Metformin Hydrochloride,Prilosec,Moderate Risk,Renal Excretion,Phase 4,No Preclinical Data,Serotonin Pathway,Capsule,500mg twice a day,Roche,6,Low,High Risk,Moderate (50-80%),Slow,Renal,Suitable
Ranitidine,Diabetes,Cancer Therapy,93.79,C33H35FN2O5,NSAID,Acid Reflux,1971,Atorvastatin Calcium,Lipitor,Moderate Risk,Rapid Absorption,Phase 2,Toxicology Report,MAPK Pathway,Topical Gel,As prescribed,Merck,12,High,High Risk,Low (<50%),Fast,Enzyme-Specific,Not Suitable
Simvastatin,Fever,Anti-Aging,56.29,C17H19N3O3S,HMG-CoA Reductase Inhibitor,"Headache, Rash",1971,Omeprazole,Advil,Low Risk,Slow Metabolism,Ongoing,No Preclinical Data,MAPK Pathway,Tablet,50mg daily,Pfizer,48,Low,Moderate Risk,High (>80%),Moderate,Enzyme-Specific,Not Suitable
Levothyroxine,Inflammation,Cardiovascular Disease,33.41,C33H35FN2O5,NSAID,"Headache, Rash",1965,Ibuprofen,Lipitor,High Risk,Slow Metabolism,Completed,Animal Testing,PI3K-AKT Pathway,Tablet,250mg every 8 hours,AstraZeneca,6,Moderate,Low Risk,Moderate (50-80%),Fast,Enzyme-Specific,Partially Suitable
Aspirin,Fever,Cancer Therapy,56.06,C4H11N5,NSAID,Gastrointestinal Issues,1971,Omeprazole,Aspirin,Low Risk,Rapid Absorption,Phase 4,Toxicology Report,MAPK Pathway,Tablet,As prescribed,Merck,48,High,Low Risk,Moderate (50-80%),Fast,Enzyme-Specific,Suitable
Metformin,Diabetes,Anti-Aging,41.29,C4H11N5,COX Inhibitor,"Headache, Rash",1965,Metformin Hydrochloride,Lipitor,Moderate Risk,Renal Excretion,Phase 1,Toxicology Report,Immune Response Pathway,Tablet,As prescribed,AstraZeneca,48,Low,High Risk,Low (<50%),Moderate,Enzyme-Specific,Not Suitable
Ibuprofen,Hypertension,Parkinson's,50.71,C17H19N3O3S,COX Inhibitor,"Nausea, Dizziness",1971,Metformin Hydrochloride,Lipitor,High Risk,High Bioavailability,Phase 1,Animal Testing,Dopaminergic Pathway,Capsule,As prescribed,Pfizer,6,Moderate,High Risk,High (>80%),Fast,Enzyme-Specific,Not Suitable
Atorvastatin,Hypertension,Antiviral,92.37,C17H19N3O3S,Proton Pump Inhibitor,Gastrointestinal Issues,1987,Metformin Hydrochloride,Prilosec,Moderate Risk,High Bioavailability,Phase 2,Animal Testing,Dopaminergic Pathway,Topical Gel,As prescribed,Novartis,2,Moderate,Low Risk,Moderate (50-80%),Fast,Gut,Suitable
Omeprazole,Hypertension,Liver Disease,77.43,C13H18O2,COX Inhibitor,Muscle Pain,1965,Atorvastatin Calcium,Glucophage,Low Risk,High Bioavailability,Phase 2,No Preclinical Data,Dopaminergic Pathway,Capsule,250mg every 8 hours,Merck,2,Moderate,Moderate Risk,High (>80%),Moderate,Liver,Suitable
Losartan,Blood Thinner,Autoimmune Disorders,53.67,C33H35FN2O5,NSAID,Gastrointestinal Issues,1987,Atorvastatin Calcium,Advil,High Risk,Renal Excretion,Phase 1,In Vitro Studies,Serotonin Pathway,Tablet,10mg once daily,AstraZeneca,12,Low,Moderate Risk,High (>80%),Fast,Gut,Not Suitable
Paracetamol,Inflammation,Cancer Therapy,87.84,C13H18O2,COX Inhibitor,Muscle Pain,1994,Ibuprofen,Glucophage,High Risk,Renal Excretion,Completed,Toxicology Report,Dopaminergic Pathway,Capsule,500mg twice a day,Novartis,6,High,Low Risk,Low (<50%),Slow,Liver,Partially Suitable
Ranitidine,Acid Reflux,Antiviral,94.42,C13H18O2,NSAID,Muscle Pain,1971,Ibuprofen,Advil,High Risk,High Bioavailability,Phase 2,Toxicology Report,Serotonin Pathway,Injection,500mg twice a day,Novartis,2,High,High Risk,Moderate (50-80%),Moderate,Renal,Not Suitable
Simvastatin,Gastric Ulcer,Migraine Treatment,36.54,C13H18O2,NSAID,Acid Reflux,1987,Atorvastatin Calcium,Glucophage,Low Risk,High Bioavailability,Phase 3,No Preclinical Data,Serotonin Pathway,Injection,50mg daily,Roche,48,Moderate,Low Risk,Moderate (50-80%),Moderate,Gut,Partially Suitable
Levothyroxine,Diabetes,Cancer Therapy,44.55,C4H11N5,COX Inhibitor,Acid Reflux,1996,Atorvastatin Calcium,Prilosec,Low Risk,Slow Metabolism,Phase 4,In Vitro Studies,Immune Response Pathway,Topical Gel,As prescribed,Merck,24,Low,Moderate Risk,High (>80%),Moderate,Enzyme-Specific,Suitable
Aspirin,Cholesterol Control,Migraine Treatment,54.86,C4H11N5,Proton Pump Inhibitor,"Headache, Rash",1965,Metformin Hydrochloride,Aspirin,Moderate Risk,Slow Metabolism,Phase 1,No Preclinical Data,PI3K-AKT Pathway,Capsule,500mg twice a day,AstraZeneca,12,Moderate,Moderate Risk,Moderate (50-80%),Slow,Liver,Suitable
Metformin,Acid Reflux,Anti-Aging,74.1,C17H19N3O3S,NSAID,"Nausea, Dizziness",1987,Omeprazole,Aspirin,High Risk,Rapid Absorption,Phase 4,No Preclinical Data,PI3K-AKT Pathway,Capsule,50mg daily,Pfizer,12,Moderate,High Risk,High (>80%),Slow,Gut,Not Suitable
Ibuprofen,Inflammation,Parkinson's,71.03,C13H18O2,Proton Pump Inhibitor,Gastrointestinal Issues,1987,Acetylsalicylic Acid,Glucophage,High Risk,Rapid Absorption,Completed,No Preclinical Data,Serotonin Pathway,Tablet,500mg twice a day,Roche,2,Moderate,Low Risk,High (>80%),Fast,Enzyme-Specific,Not Suitable
Atorvastatin,Diabetes,Weight Loss,68.12,C13H18O2,Proton Pump Inhibitor,Muscle Pain,1971,Atorvastatin Calcium,Lipitor,High Risk,High Bioavailability,Ongoing,Toxicology Report,PI3K-AKT Pathway,Topical Gel,250mg every 8 hours,Roche,48,High,High Risk,High (>80%),Slow,Liver,Suitable
Omeprazole,Cholesterol Control,Cardiovascular Disease,83.2,C9H8O4,NSAID,Muscle Pain,1987,Atorvastatin Calcium,Aspirin,High Risk,High Bioavailability,Phase 4,No Preclinical Data,Serotonin Pathway,Tablet,500mg twice a day,Roche,24,Moderate,Moderate Risk,Low (<50%),Fast,Gut,Not Suitable
Losartan,Fever,Alzheimer's,47.72,C33H35FN2O5,NSAID,"Headache, Rash",1971,Acetylsalicylic Acid,Advil,Low Risk,Renal Excretion,Completed,In Vitro Studies,Immune Response Pathway,Syrup,50mg daily,Merck,48,High,Low Risk,High (>80%),Fast,Renal,Not Suitable
Paracetamol,Fever,Autoimmune Disorders,52.21,C17H19N3O3S,Proton Pump Inhibitor,"Headache, Rash",1994,Omeprazole,Prilosec,Low Risk,High Bioavailability,Phase 3,Animal Testing,Serotonin Pathway,Capsule,10mg once daily,Novartis,12,Moderate,Moderate Risk,Low (<50%),Moderate,Enzyme-Specific,Not Suitable
Ranitidine,Pain Relief,Antiviral,48.51,C17H19N3O3S,NSAID,Gastrointestinal Issues,1996,Metformin Hydrochloride,Aspirin,High Risk,Liver Metabolism,Phase 1,No Preclinical Data,Immune Response Pathway,Topical Gel,10mg once daily,AstraZeneca,2,Moderate,High Risk,Low (<50%),Moderate,Gut,Suitable
Simvastatin,Diabetes,Antiviral,62.27,C13H18O2,HMG-CoA Reductase Inhibitor,Muscle Pain,1987,Omeprazole,Glucophage,Moderate Risk,Rapid Absorption,Completed,No Preclinical Data,PI3K-AKT Pathway,Syrup,10mg once daily,AstraZeneca,2,Low,Low Risk,Low (<50%),Fast,Gut,Not Suitable
Levothyroxine,Pain Relief,Weight Loss,50.71,C33H35FN2O5,AMPK Activator,"Nausea, Dizziness",1971,Omeprazole,Glucophage,Moderate Risk,Rapid Absorption,Completed,Animal Testing,MAPK Pathway,Injection,500mg twice a day,AstraZeneca,2,Moderate,Moderate Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Not Suitable
Aspirin,Fever,Parkinson's,35.08,C13H18O2,Proton Pump Inhibitor,Acid Reflux,1996,Acetylsalicylic Acid,Aspirin,Low Risk,Slow Metabolism,Phase 3,In Vitro Studies,PI3K-AKT Pathway,Injection,10mg once daily,Merck,48,Moderate,Moderate Risk,High (>80%),Fast,Enzyme-Specific,Suitable
Metformin,Thyroid Hormone Replacement,Weight Loss,32.89,C9H8O4,COX Inhibitor,Muscle Pain,1994,Omeprazole,Advil,Low Risk,Rapid Absorption,Ongoing,Animal Testing,PI3K-AKT Pathway,Injection,10mg once daily,Merck,12,Low,Moderate Risk,Low (<50%),Fast,Gut,Partially Suitable
Ibuprofen,Hypertension,Alzheimer's,31.07,C17H19N3O3S,AMPK Activator,"Headache, Rash",1965,Ibuprofen,Prilosec,Low Risk,Slow Metabolism,Phase 2,No Preclinical Data,Immune Response Pathway,Capsule,250mg every 8 hours,Pfizer,6,Moderate,High Risk,High (>80%),Moderate,Renal,Partially Suitable
Atorvastatin,Hypertension,Migraine Treatment,89.7,C9H8O4,AMPK Activator,"Nausea, Dizziness",1965,Metformin Hydrochloride,Lipitor,High Risk,Liver Metabolism,Ongoing,Animal Testing,MAPK Pathway,Capsule,10mg once daily,Pfizer,6,Low,Low Risk,Moderate (50-80%),Slow,Enzyme-Specific,Partially Suitable
Omeprazole,Cholesterol Control,Weight Loss,56.31,C13H18O2,COX Inhibitor,Gastrointestinal Issues,1965,Ibuprofen,Aspirin,High Risk,High Bioavailability,Phase 3,Toxicology Report,PI3K-AKT Pathway,Capsule,10mg once daily,Roche,12,High,Moderate Risk,High (>80%),Slow,Liver,Suitable
Losartan,Diabetes,Alzheimer's,51.26,C4H11N5,NSAID,"Headache, Rash",1987,Metformin Hydrochloride,Lipitor,High Risk,Rapid Absorption,Ongoing,Animal Testing,Immune Response Pathway,Injection,10mg once daily,Merck,2,High,Moderate Risk,Low (<50%),Slow,Liver,Suitable
Paracetamol,Pain Relief,Liver Disease,40.44,C9H8O4,COX Inhibitor,Gastrointestinal Issues,1987,Acetylsalicylic Acid,Lipitor,Low Risk,High Bioavailability,Phase 3,Animal Testing,MAPK Pathway,Injection,As prescribed,Novartis,24,Moderate,Low Risk,Low (<50%),Slow,Gut,Suitable
Ranitidine,Inflammation,Migraine Treatment,93.15,C4H11N5,COX Inhibitor,Gastrointestinal Issues,1965,Metformin Hydrochloride,Glucophage,Moderate Risk,Rapid Absorption,Phase 3,No Preclinical Data,MAPK Pathway,Injection,As prescribed,Merck,24,Moderate,Moderate Risk,Low (<50%),Slow,Renal,Not Suitable
Simvastatin,Pain Relief,Weight Loss,33.84,C33H35FN2O5,AMPK Activator,Muscle Pain,1965,Omeprazole,Glucophage,High Risk,Rapid Absorption,Completed,Toxicology Report,PI3K-AKT Pathway,Topical Gel,500mg twice a day,Merck,12,High,High Risk,Low (<50%),Moderate,Enzyme-Specific,Not Suitable
Levothyroxine,Diabetes,Cardiovascular Disease,51.45,C9H8O4,AMPK Activator,Acid Reflux,1996,Ibuprofen,Lipitor,High Risk,Rapid Absorption,Phase 2,No Preclinical Data,Immune Response Pathway,Topical Gel,As prescribed,Merck,48,Low,High Risk,Moderate (50-80%),Slow,Liver,Suitable
Aspirin,Blood Thinner,Parkinson's,63.94,C13H18O2,Proton Pump Inhibitor,Acid Reflux,1971,Atorvastatin Calcium,Lipitor,Moderate Risk,Renal Excretion,Completed,In Vitro Studies,MAPK Pathway,Topical Gel,As prescribed,Pfizer,2,High,Moderate Risk,High (>80%),Moderate,Gut,Not Suitable
Metformin,Diabetes,Autoimmune Disorders,56.11,C17H19N3O3S,COX Inhibitor,"Nausea, Dizziness",1996,Omeprazole,Aspirin,High Risk,Rapid Absorption,Phase 2,No Preclinical Data,Serotonin Pathway,Capsule,500mg twice a day,AstraZeneca,48,High,High Risk,Moderate (50-80%),Fast,Renal,Suitable
Ibuprofen,Cholesterol Control,Weight Loss,50.64,C13H18O2,COX Inhibitor,Muscle Pain,1994,Acetylsalicylic Acid,Glucophage,High Risk,Slow Metabolism,Phase 3,In Vitro Studies,Immune Response Pathway,Topical Gel,10mg once daily,Pfizer,6,Low,High Risk,Moderate (50-80%),Slow,Liver,Not Suitable
Atorvastatin,Gastric Ulcer,Cancer Therapy,61.25,C9H8O4,COX Inhibitor,"Headache, Rash",1971,Ibuprofen,Glucophage,Moderate Risk,Rapid Absorption,Completed,Animal Testing,Immune Response Pathway,Syrup,As prescribed,Novartis,6,High,Moderate Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Omeprazole,Thyroid Hormone Replacement,Antiviral,72.43,C13H18O2,AMPK Activator,Gastrointestinal Issues,1965,Ibuprofen,Advil,High Risk,Rapid Absorption,Ongoing,In Vitro Studies,PI3K-AKT Pathway,Topical Gel,250mg every 8 hours,AstraZeneca,24,Moderate,High Risk,Low (<50%),Moderate,Liver,Partially Suitable
Losartan,Inflammation,Antiviral,49.86,C33H35FN2O5,COX Inhibitor,Acid Reflux,1994,Omeprazole,Aspirin,Low Risk,Liver Metabolism,Phase 1,No Preclinical Data,Dopaminergic Pathway,Syrup,As prescribed,AstraZeneca,12,Low,Low Risk,High (>80%),Moderate,Liver,Suitable
Paracetamol,Diabetes,Liver Disease,42.53,C33H35FN2O5,NSAID,Gastrointestinal Issues,1996,Ibuprofen,Glucophage,Moderate Risk,Renal Excretion,Phase 2,No Preclinical Data,Serotonin Pathway,Topical Gel,500mg twice a day,Pfizer,2,Low,Low Risk,High (>80%),Moderate,Liver,Suitable
Ranitidine,Hypertension,Antiviral,63.96,C4H11N5,NSAID,Muscle Pain,1965,Metformin Hydrochloride,Advil,Low Risk,Liver Metabolism,Phase 3,Toxicology Report,Serotonin Pathway,Tablet,10mg once daily,Pfizer,48,High,Moderate Risk,High (>80%),Fast,Gut,Partially Suitable
Simvastatin,Diabetes,Autoimmune Disorders,44.76,C13H18O2,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1987,Ibuprofen,Prilosec,Moderate Risk,Slow Metabolism,Phase 3,In Vitro Studies,Serotonin Pathway,Topical Gel,10mg once daily,Roche,24,Low,Low Risk,High (>80%),Slow,Renal,Partially Suitable
Levothyroxine,Fever,Parkinson's,84.81,C4H11N5,Proton Pump Inhibitor,Muscle Pain,1965,Omeprazole,Prilosec,Moderate Risk,Rapid Absorption,Completed,Toxicology Report,Serotonin Pathway,Tablet,As prescribed,Novartis,6,Low,Low Risk,High (>80%),Moderate,Gut,Suitable
Aspirin,Blood Thinner,Cancer Therapy,33.77,C4H11N5,AMPK Activator,"Nausea, Dizziness",1971,Omeprazole,Aspirin,Moderate Risk,Renal Excretion,Phase 1,In Vitro Studies,Immune Response Pathway,Tablet,10mg once daily,Roche,48,Low,Moderate Risk,High (>80%),Slow,Liver,Not Suitable
Metformin,Thyroid Hormone Replacement,Weight Loss,92.52,C17H19N3O3S,NSAID,"Nausea, Dizziness",1994,Ibuprofen,Lipitor,Low Risk,Renal Excretion,Phase 2,No Preclinical Data,Immune Response Pathway,Injection,250mg every 8 hours,Roche,24,Low,Low Risk,Low (<50%),Fast,Renal,Suitable
Ibuprofen,Inflammation,Liver Disease,42.21,C33H35FN2O5,Proton Pump Inhibitor,Muscle Pain,1994,Acetylsalicylic Acid,Advil,High Risk,Slow Metabolism,Phase 3,In Vitro Studies,MAPK Pathway,Syrup,50mg daily,AstraZeneca,6,High,Low Risk,High (>80%),Moderate,Liver,Not Suitable
Atorvastatin,Blood Thinner,Autoimmune Disorders,82.91,C4H11N5,AMPK Activator,"Headache, Rash",1965,Acetylsalicylic Acid,Prilosec,Moderate Risk,Rapid Absorption,Completed,Toxicology Report,Serotonin Pathway,Capsule,50mg daily,Merck,6,Moderate,Low Risk,Moderate (50-80%),Moderate,Gut,Not Suitable
Omeprazole,Hypertension,Parkinson's,89.93,C17H19N3O3S,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1965,Metformin Hydrochloride,Advil,Low Risk,Liver Metabolism,Phase 4,In Vitro Studies,MAPK Pathway,Topical Gel,50mg daily,Merck,12,Moderate,High Risk,High (>80%),Moderate,Gut,Suitable
Losartan,Gastric Ulcer,Parkinson's,93.07,C13H18O2,COX Inhibitor,Muscle Pain,1965,Omeprazole,Lipitor,Moderate Risk,Renal Excretion,Phase 4,Animal Testing,MAPK Pathway,Topical Gel,10mg once daily,Novartis,6,Moderate,Low Risk,Moderate (50-80%),Fast,Liver,Suitable
Paracetamol,Blood Thinner,Cancer Therapy,76.71,C17H19N3O3S,COX Inhibitor,Acid Reflux,1994,Acetylsalicylic Acid,Advil,Low Risk,Rapid Absorption,Ongoing,Toxicology Report,PI3K-AKT Pathway,Tablet,250mg every 8 hours,Merck,6,Moderate,Moderate Risk,High (>80%),Slow,Renal,Suitable
Ranitidine,Fever,Migraine Treatment,62.17,C13H18O2,NSAID,Acid Reflux,1987,Ibuprofen,Lipitor,Low Risk,Rapid Absorption,Phase 1,In Vitro Studies,Dopaminergic Pathway,Tablet,50mg daily,Roche,6,Low,High Risk,Low (<50%),Slow,Renal,Suitable
Simvastatin,Pain Relief,Autoimmune Disorders,59.02,C9H8O4,NSAID,"Headache, Rash",1987,Atorvastatin Calcium,Lipitor,Moderate Risk,Liver Metabolism,Phase 2,No Preclinical Data,Immune Response Pathway,Capsule,500mg twice a day,Merck,24,Low,High Risk,Moderate (50-80%),Slow,Enzyme-Specific,Partially Suitable
Levothyroxine,Diabetes,Parkinson's,94.39,C33H35FN2O5,NSAID,Gastrointestinal Issues,1965,Omeprazole,Aspirin,High Risk,Slow Metabolism,Phase 3,In Vitro Studies,MAPK Pathway,Tablet,500mg twice a day,Novartis,6,High,High Risk,High (>80%),Moderate,Liver,Suitable
Aspirin,Diabetes,Migraine Treatment,38.96,C9H8O4,AMPK Activator,Gastrointestinal Issues,1965,Metformin Hydrochloride,Aspirin,High Risk,Liver Metabolism,Completed,In Vitro Studies,Immune Response Pathway,Syrup,10mg once daily,Pfizer,12,Moderate,Moderate Risk,High (>80%),Slow,Renal,Not Suitable
Metformin,Diabetes,Cardiovascular Disease,79.91,C17H19N3O3S,AMPK Activator,"Headache, Rash",1996,Metformin Hydrochloride,Advil,Moderate Risk,Rapid Absorption,Phase 4,Animal Testing,Serotonin Pathway,Topical Gel,500mg twice a day,Pfizer,24,Low,Moderate Risk,Low (<50%),Fast,Enzyme-Specific,Partially Suitable
Ibuprofen,Pain Relief,Parkinson's,77.84,C9H8O4,NSAID,"Headache, Rash",1987,Metformin Hydrochloride,Advil,Low Risk,High Bioavailability,Phase 3,In Vitro Studies,Serotonin Pathway,Injection,500mg twice a day,Roche,24,High,Moderate Risk,High (>80%),Moderate,Liver,Not Suitable
Atorvastatin,Diabetes,Migraine Treatment,91.81,C17H19N3O3S,COX Inhibitor,"Headache, Rash",1996,Ibuprofen,Aspirin,Moderate Risk,Slow Metabolism,Phase 3,Toxicology Report,PI3K-AKT Pathway,Tablet,500mg twice a day,AstraZeneca,24,High,Low Risk,Low (<50%),Slow,Enzyme-Specific,Partially Suitable
Omeprazole,Acid Reflux,Anti-Aging,78.74,C9H8O4,AMPK Activator,Gastrointestinal Issues,1996,Metformin Hydrochloride,Aspirin,Low Risk,High Bioavailability,Completed,No Preclinical Data,MAPK Pathway,Syrup,500mg twice a day,Merck,48,High,High Risk,High (>80%),Fast,Enzyme-Specific,Suitable
Losartan,Blood Thinner,Autoimmune Disorders,42.03,C4H11N5,COX Inhibitor,Muscle Pain,1987,Metformin Hydrochloride,Prilosec,Low Risk,Renal Excretion,Completed,Animal Testing,Dopaminergic Pathway,Capsule,10mg once daily,AstraZeneca,48,High,Moderate Risk,High (>80%),Fast,Liver,Partially Suitable
Paracetamol,Blood Thinner,Parkinson's,56.08,C17H19N3O3S,COX Inhibitor,"Nausea, Dizziness",1987,Atorvastatin Calcium,Glucophage,High Risk,Renal Excretion,Phase 3,No Preclinical Data,MAPK Pathway,Topical Gel,250mg every 8 hours,Merck,24,Moderate,High Risk,High (>80%),Fast,Renal,Not Suitable
Ranitidine,Thyroid Hormone Replacement,Anti-Aging,40.37,C33H35FN2O5,AMPK Activator,"Nausea, Dizziness",1965,Acetylsalicylic Acid,Glucophage,Moderate Risk,High Bioavailability,Phase 3,In Vitro Studies,Dopaminergic Pathway,Syrup,As prescribed,AstraZeneca,48,Low,Low Risk,Low (<50%),Fast,Enzyme-Specific,Partially Suitable
Simvastatin,Fever,Antiviral,64.95,C17H19N3O3S,NSAID,Acid Reflux,1996,Metformin Hydrochloride,Prilosec,Low Risk,Renal Excretion,Phase 3,Toxicology Report,Serotonin Pathway,Injection,250mg every 8 hours,Pfizer,6,Low,Moderate Risk,Low (<50%),Slow,Gut,Not Suitable
Levothyroxine,Gastric Ulcer,Autoimmune Disorders,70.57,C33H35FN2O5,NSAID,Muscle Pain,1971,Metformin Hydrochloride,Glucophage,Low Risk,Slow Metabolism,Ongoing,In Vitro Studies,Serotonin Pathway,Capsule,500mg twice a day,Roche,2,Low,Moderate Risk,Moderate (50-80%),Slow,Renal,Suitable
Aspirin,Cholesterol Control,Cancer Therapy,34.91,C9H8O4,Proton Pump Inhibitor,Gastrointestinal Issues,1996,Metformin Hydrochloride,Prilosec,Low Risk,Liver Metabolism,Phase 1,Animal Testing,Dopaminergic Pathway,Capsule,500mg twice a day,Novartis,24,Low,Low Risk,Moderate (50-80%),Slow,Renal,Partially Suitable
Metformin,Acid Reflux,Weight Loss,52.88,C13H18O2,HMG-CoA Reductase Inhibitor,Muscle Pain,1994,Ibuprofen,Aspirin,High Risk,Slow Metabolism,Completed,Toxicology Report,Serotonin Pathway,Capsule,250mg every 8 hours,AstraZeneca,2,High,High Risk,High (>80%),Moderate,Gut,Partially Suitable
Ibuprofen,Hypertension,Weight Loss,44.03,C33H35FN2O5,AMPK Activator,Gastrointestinal Issues,1994,Ibuprofen,Lipitor,Low Risk,Liver Metabolism,Phase 4,Toxicology Report,PI3K-AKT Pathway,Injection,As prescribed,Merck,24,Low,Low Risk,High (>80%),Moderate,Enzyme-Specific,Suitable
Atorvastatin,Thyroid Hormone Replacement,Liver Disease,32.84,C33H35FN2O5,AMPK Activator,Acid Reflux,1965,Metformin Hydrochloride,Advil,High Risk,Slow Metabolism,Phase 1,No Preclinical Data,MAPK Pathway,Syrup,10mg once daily,AstraZeneca,2,High,High Risk,Low (<50%),Slow,Liver,Partially Suitable
Omeprazole,Thyroid Hormone Replacement,Cardiovascular Disease,33.21,C4H11N5,AMPK Activator,Acid Reflux,1996,Metformin Hydrochloride,Glucophage,High Risk,Slow Metabolism,Ongoing,Animal Testing,Immune Response Pathway,Syrup,10mg once daily,Roche,2,High,Moderate Risk,Moderate (50-80%),Fast,Renal,Partially Suitable
Losartan,Fever,Parkinson's,83.3,C9H8O4,AMPK Activator,Acid Reflux,1971,Ibuprofen,Prilosec,Moderate Risk,High Bioavailability,Phase 1,Animal Testing,Dopaminergic Pathway,Topical Gel,10mg once daily,AstraZeneca,2,Moderate,High Risk,Moderate (50-80%),Moderate,Renal,Suitable
Paracetamol,Hypertension,Parkinson's,94.39,C33H35FN2O5,NSAID,Gastrointestinal Issues,1971,Atorvastatin Calcium,Glucophage,Low Risk,Slow Metabolism,Completed,Toxicology Report,Dopaminergic Pathway,Capsule,500mg twice a day,Pfizer,24,Moderate,High Risk,High (>80%),Slow,Renal,Partially Suitable
Ranitidine,Diabetes,Antiviral,93.23,C17H19N3O3S,NSAID,Gastrointestinal Issues,1971,Ibuprofen,Aspirin,High Risk,High Bioavailability,Phase 2,In Vitro Studies,Immune Response Pathway,Injection,10mg once daily,AstraZeneca,24,Low,High Risk,High (>80%),Fast,Enzyme-Specific,Not Suitable
Simvastatin,Fever,Liver Disease,75.22,C13H18O2,NSAID,"Headache, Rash",1994,Ibuprofen,Lipitor,High Risk,Renal Excretion,Phase 2,Animal Testing,MAPK Pathway,Topical Gel,500mg twice a day,Merck,2,Moderate,Low Risk,Moderate (50-80%),Moderate,Renal,Not Suitable
Levothyroxine,Fever,Liver Disease,75.56,C13H18O2,Proton Pump Inhibitor,Muscle Pain,1996,Omeprazole,Advil,High Risk,Slow Metabolism,Phase 4,No Preclinical Data,Serotonin Pathway,Capsule,10mg once daily,Merck,2,Low,Low Risk,High (>80%),Fast,Liver,Partially Suitable
Aspirin,Hypertension,Migraine Treatment,92.19,C4H11N5,NSAID,"Nausea, Dizziness",1971,Ibuprofen,Advil,Low Risk,Renal Excretion,Phase 2,In Vitro Studies,Serotonin Pathway,Syrup,10mg once daily,AstraZeneca,48,Moderate,Moderate Risk,Moderate (50-80%),Slow,Liver,Not Suitable
Metformin,Gastric Ulcer,Parkinson's,34.02,C13H18O2,COX Inhibitor,Gastrointestinal Issues,1987,Ibuprofen,Glucophage,Moderate Risk,Rapid Absorption,Ongoing,Toxicology Report,MAPK Pathway,Syrup,500mg twice a day,Novartis,6,Moderate,High Risk,High (>80%),Fast,Enzyme-Specific,Partially Suitable
Ibuprofen,Cholesterol Control,Weight Loss,53.96,C17H19N3O3S,HMG-CoA Reductase Inhibitor,"Headache, Rash",1971,Ibuprofen,Advil,Low Risk,Rapid Absorption,Phase 4,Toxicology Report,Immune Response Pathway,Capsule,500mg twice a day,Pfizer,2,High,Low Risk,Low (<50%),Fast,Renal,Not Suitable
Atorvastatin,Acid Reflux,Autoimmune Disorders,61.69,C13H18O2,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1965,Acetylsalicylic Acid,Prilosec,Moderate Risk,Rapid Absorption,Completed,Toxicology Report,Immune Response Pathway,Tablet,10mg once daily,Novartis,2,Moderate,Moderate Risk,Low (<50%),Moderate,Gut,Not Suitable
Omeprazole,Inflammation,Migraine Treatment,38.91,C4H11N5,COX Inhibitor,"Nausea, Dizziness",1987,Metformin Hydrochloride,Advil,High Risk,Liver Metabolism,Ongoing,No Preclinical Data,Serotonin Pathway,Injection,50mg daily,Pfizer,24,High,Moderate Risk,Moderate (50-80%),Fast,Enzyme-Specific,Suitable
Losartan,Acid Reflux,Migraine Treatment,72.52,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1994,Acetylsalicylic Acid,Prilosec,Moderate Risk,High Bioavailability,Ongoing,Toxicology Report,PI3K-AKT Pathway,Injection,500mg twice a day,Merck,6,Moderate,High Risk,High (>80%),Moderate,Gut,Partially Suitable
Paracetamol,Gastric Ulcer,Weight Loss,49.59,C9H8O4,HMG-CoA Reductase Inhibitor,Acid Reflux,1994,Ibuprofen,Glucophage,Low Risk,Liver Metabolism,Phase 1,No Preclinical Data,Immune Response Pathway,Capsule,50mg daily,Merck,6,Low,High Risk,Moderate (50-80%),Slow,Liver,Partially Suitable
Ranitidine,Hypertension,Migraine Treatment,51.47,C33H35FN2O5,COX Inhibitor,Muscle Pain,1965,Atorvastatin Calcium,Lipitor,High Risk,Rapid Absorption,Ongoing,No Preclinical Data,Dopaminergic Pathway,Syrup,50mg daily,AstraZeneca,2,Low,Low Risk,Moderate (50-80%),Fast,Gut,Suitable
Simvastatin,Inflammation,Cardiovascular Disease,91.72,C13H18O2,NSAID,Muscle Pain,1987,Ibuprofen,Lipitor,Low Risk,High Bioavailability,Phase 1,In Vitro Studies,PI3K-AKT Pathway,Tablet,10mg once daily,Merck,2,High,High Risk,High (>80%),Slow,Liver,Not Suitable
Levothyroxine,Acid Reflux,Liver Disease,60.62,C17H19N3O3S,COX Inhibitor,Gastrointestinal Issues,1996,Omeprazole,Prilosec,High Risk,Slow Metabolism,Completed,No Preclinical Data,Serotonin Pathway,Topical Gel,500mg twice a day,AstraZeneca,2,High,Moderate Risk,High (>80%),Fast,Liver,Suitable
Aspirin,Diabetes,Alzheimer's,64.13,C4H11N5,HMG-CoA Reductase Inhibitor,Muscle Pain,1994,Acetylsalicylic Acid,Aspirin,Moderate Risk,High Bioavailability,Phase 2,No Preclinical Data,Immune Response Pathway,Syrup,As prescribed,Novartis,2,Moderate,Moderate Risk,High (>80%),Fast,Gut,Not Suitable
Metformin,Pain Relief,Anti-Aging,56.79,C17H19N3O3S,Proton Pump Inhibitor,Acid Reflux,1994,Metformin Hydrochloride,Prilosec,Moderate Risk,Rapid Absorption,Phase 3,Animal Testing,Serotonin Pathway,Tablet,10mg once daily,AstraZeneca,24,Moderate,Low Risk,High (>80%),Slow,Enzyme-Specific,Not Suitable
Ibuprofen,Gastric Ulcer,Antiviral,66.05,C4H11N5,AMPK Activator,Acid Reflux,1965,Metformin Hydrochloride,Aspirin,Low Risk,Renal Excretion,Phase 1,No Preclinical Data,Serotonin Pathway,Injection,As prescribed,Merck,24,Moderate,High Risk,High (>80%),Fast,Enzyme-Specific,Partially Suitable
Atorvastatin,Blood Thinner,Parkinson's,50.52,C17H19N3O3S,Proton Pump Inhibitor,"Nausea, Dizziness",1996,Metformin Hydrochloride,Aspirin,Moderate Risk,Slow Metabolism,Ongoing,Animal Testing,PI3K-AKT Pathway,Capsule,As prescribed,Novartis,48,High,Low Risk,High (>80%),Fast,Gut,Suitable
Omeprazole,Fever,Parkinson's,71.11,C13H18O2,NSAID,"Nausea, Dizziness",1965,Acetylsalicylic Acid,Prilosec,Moderate Risk,Slow Metabolism,Completed,Animal Testing,Immune Response Pathway,Topical Gel,500mg twice a day,Merck,48,Low,Moderate Risk,Low (<50%),Fast,Enzyme-Specific,Not Suitable
Losartan,Hypertension,Weight Loss,77.38,C17H19N3O3S,AMPK Activator,Acid Reflux,1996,Acetylsalicylic Acid,Aspirin,Moderate Risk,Liver Metabolism,Phase 2,Toxicology Report,PI3K-AKT Pathway,Syrup,As prescribed,Roche,48,Moderate,High Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Paracetamol,Fever,Parkinson's,38.85,C33H35FN2O5,AMPK Activator,"Headache, Rash",1965,Metformin Hydrochloride,Lipitor,High Risk,High Bioavailability,Phase 3,Toxicology Report,MAPK Pathway,Capsule,250mg every 8 hours,Merck,48,Moderate,High Risk,High (>80%),Fast,Gut,Suitable
Ranitidine,Inflammation,Liver Disease,88.92,C9H8O4,AMPK Activator,Acid Reflux,1965,Ibuprofen,Prilosec,High Risk,High Bioavailability,Completed,Animal Testing,PI3K-AKT Pathway,Syrup,As prescribed,Roche,2,Low,Low Risk,Low (<50%),Fast,Renal,Not Suitable
Simvastatin,Diabetes,Weight Loss,32.98,C33H35FN2O5,Proton Pump Inhibitor,Muscle Pain,1971,Atorvastatin Calcium,Prilosec,Moderate Risk,High Bioavailability,Phase 2,Animal Testing,Dopaminergic Pathway,Capsule,As prescribed,Pfizer,6,Moderate,High Risk,Low (<50%),Moderate,Liver,Partially Suitable
Levothyroxine,Diabetes,Antiviral,56.67,C4H11N5,COX Inhibitor,Muscle Pain,1994,Atorvastatin Calcium,Prilosec,Low Risk,Renal Excretion,Completed,Toxicology Report,PI3K-AKT Pathway,Topical Gel,As prescribed,AstraZeneca,24,High,Low Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Aspirin,Hypertension,Alzheimer's,45.14,C33H35FN2O5,Proton Pump Inhibitor,"Headache, Rash",1965,Omeprazole,Lipitor,Low Risk,High Bioavailability,Phase 1,No Preclinical Data,PI3K-AKT Pathway,Injection,As prescribed,Roche,2,High,Moderate Risk,High (>80%),Fast,Enzyme-Specific,Partially Suitable
Metformin,Gastric Ulcer,Cardiovascular Disease,62.05,C13H18O2,HMG-CoA Reductase Inhibitor,Muscle Pain,1971,Acetylsalicylic Acid,Prilosec,High Risk,Slow Metabolism,Phase 4,Toxicology Report,MAPK Pathway,Syrup,As prescribed,Roche,24,Low,Low Risk,High (>80%),Fast,Renal,Partially Suitable
Ibuprofen,Hypertension,Liver Disease,59.1,C4H11N5,COX Inhibitor,"Nausea, Dizziness",1994,Atorvastatin Calcium,Prilosec,Low Risk,Slow Metabolism,Completed,Animal Testing,Dopaminergic Pathway,Topical Gel,250mg every 8 hours,Roche,2,Moderate,High Risk,Low (<50%),Fast,Renal,Suitable
Atorvastatin,Thyroid Hormone Replacement,Anti-Aging,40.86,C9H8O4,Proton Pump Inhibitor,Acid Reflux,1971,Metformin Hydrochloride,Aspirin,Low Risk,Slow Metabolism,Phase 3,In Vitro Studies,Dopaminergic Pathway,Topical Gel,10mg once daily,Pfizer,48,Low,High Risk,Low (<50%),Fast,Liver,Suitable
Omeprazole,Pain Relief,Anti-Aging,67.39,C13H18O2,HMG-CoA Reductase Inhibitor,Acid Reflux,1994,Atorvastatin Calcium,Glucophage,High Risk,Renal Excretion,Completed,No Preclinical Data,Immune Response Pathway,Topical Gel,50mg daily,Roche,12,Low,Low Risk,High (>80%),Moderate,Renal,Suitable
Losartan,Gastric Ulcer,Weight Loss,46.57,C17H19N3O3S,Proton Pump Inhibitor,"Nausea, Dizziness",1987,Atorvastatin Calcium,Prilosec,Low Risk,Rapid Absorption,Phase 3,Animal Testing,MAPK Pathway,Tablet,500mg twice a day,Merck,48,High,Moderate Risk,Low (<50%),Moderate,Liver,Suitable
Paracetamol,Gastric Ulcer,Alzheimer's,88.68,C4H11N5,COX Inhibitor,"Headache, Rash",1965,Ibuprofen,Lipitor,Low Risk,Rapid Absorption,Completed,Animal Testing,Serotonin Pathway,Syrup,As prescribed,Merck,48,High,Moderate Risk,Moderate (50-80%),Fast,Renal,Partially Suitable
Ranitidine,Fever,Cardiovascular Disease,62.23,C4H11N5,HMG-CoA Reductase Inhibitor,Acid Reflux,1994,Metformin Hydrochloride,Aspirin,Moderate Risk,Slow Metabolism,Phase 2,In Vitro Studies,Serotonin Pathway,Tablet,250mg every 8 hours,Roche,2,Low,Low Risk,High (>80%),Moderate,Enzyme-Specific,Partially Suitable
Simvastatin,Pain Relief,Migraine Treatment,72.36,C17H19N3O3S,AMPK Activator,"Headache, Rash",1994,Acetylsalicylic Acid,Advil,Low Risk,High Bioavailability,Phase 2,Toxicology Report,Immune Response Pathway,Syrup,250mg every 8 hours,AstraZeneca,24,Moderate,Low Risk,Moderate (50-80%),Fast,Enzyme-Specific,Not Suitable
Levothyroxine,Acid Reflux,Autoimmune Disorders,88.85,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Muscle Pain,1965,Acetylsalicylic Acid,Prilosec,High Risk,Renal Excretion,Phase 3,In Vitro Studies,Immune Response Pathway,Capsule,500mg twice a day,Pfizer,48,Moderate,Low Risk,Low (<50%),Fast,Renal,Partially Suitable
Aspirin,Inflammation,Migraine Treatment,59.78,C9H8O4,HMG-CoA Reductase Inhibitor,"Headache, Rash",1987,Ibuprofen,Lipitor,Low Risk,Renal Excretion,Phase 3,Animal Testing,PI3K-AKT Pathway,Injection,As prescribed,Novartis,48,Moderate,Low Risk,Low (<50%),Fast,Gut,Not Suitable
Metformin,Inflammation,Migraine Treatment,37.53,C9H8O4,NSAID,Acid Reflux,1996,Atorvastatin Calcium,Advil,High Risk,High Bioavailability,Phase 3,Toxicology Report,MAPK Pathway,Injection,10mg once daily,Novartis,6,Low,High Risk,Moderate (50-80%),Slow,Liver,Partially Suitable
Ibuprofen,Blood Thinner,Cancer Therapy,46.32,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1994,Metformin Hydrochloride,Prilosec,Moderate Risk,Slow Metabolism,Phase 3,Toxicology Report,PI3K-AKT Pathway,Syrup,As prescribed,AstraZeneca,48,High,High Risk,High (>80%),Fast,Liver,Suitable
Atorvastatin,Cholesterol Control,Parkinson's,57.96,C4H11N5,Proton Pump Inhibitor,"Nausea, Dizziness",1987,Acetylsalicylic Acid,Aspirin,Moderate Risk,Renal Excretion,Completed,Animal Testing,Dopaminergic Pathway,Tablet,50mg daily,AstraZeneca,48,Moderate,Low Risk,Low (<50%),Slow,Liver,Not Suitable
Omeprazole,Diabetes,Weight Loss,50.96,C4H11N5,Proton Pump Inhibitor,"Nausea, Dizziness",1987,Ibuprofen,Lipitor,Low Risk,Slow Metabolism,Completed,In Vitro Studies,MAPK Pathway,Tablet,250mg every 8 hours,Novartis,6,High,Low Risk,High (>80%),Fast,Gut,Not Suitable
Losartan,Inflammation,Alzheimer's,85.14,C17H19N3O3S,AMPK Activator,Acid Reflux,1965,Metformin Hydrochloride,Advil,Moderate Risk,High Bioavailability,Phase 1,No Preclinical Data,Serotonin Pathway,Topical Gel,250mg every 8 hours,Pfizer,12,Moderate,Moderate Risk,Moderate (50-80%),Moderate,Gut,Partially Suitable
Paracetamol,Hypertension,Alzheimer's,68.61,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Acid Reflux,1996,Atorvastatin Calcium,Glucophage,High Risk,Renal Excretion,Phase 4,In Vitro Studies,MAPK Pathway,Topical Gel,250mg every 8 hours,AstraZeneca,12,High,High Risk,Moderate (50-80%),Moderate,Liver,Partially Suitable
Ranitidine,Cholesterol Control,Cancer Therapy,76.72,C4H11N5,NSAID,"Nausea, Dizziness",1987,Atorvastatin Calcium,Glucophage,Moderate Risk,Slow Metabolism,Completed,In Vitro Studies,Dopaminergic Pathway,Capsule,50mg daily,Roche,12,High,High Risk,Low (<50%),Fast,Renal,Not Suitable
Simvastatin,Fever,Parkinson's,56.81,C9H8O4,COX Inhibitor,"Nausea, Dizziness",1987,Metformin Hydrochloride,Glucophage,High Risk,Slow Metabolism,Ongoing,Animal Testing,Dopaminergic Pathway,Injection,250mg every 8 hours,Roche,6,Low,Low Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Suitable
Levothyroxine,Diabetes,Migraine Treatment,63.05,C4H11N5,Proton Pump Inhibitor,"Headache, Rash",1965,Atorvastatin Calcium,Advil,Moderate Risk,High Bioavailability,Completed,No Preclinical Data,Serotonin Pathway,Injection,500mg twice a day,AstraZeneca,2,Moderate,High Risk,Moderate (50-80%),Slow,Gut,Suitable
Aspirin,Inflammation,Anti-Aging,79.34,C17H19N3O3S,COX Inhibitor,Acid Reflux,1996,Atorvastatin Calcium,Lipitor,High Risk,Slow Metabolism,Phase 2,Toxicology Report,Serotonin Pathway,Topical Gel,500mg twice a day,Novartis,12,Moderate,Low Risk,Moderate (50-80%),Moderate,Gut,Partially Suitable
Metformin,Acid Reflux,Antiviral,71.45,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Muscle Pain,1987,Atorvastatin Calcium,Lipitor,High Risk,Liver Metabolism,Ongoing,Animal Testing,PI3K-AKT Pathway,Injection,500mg twice a day,AstraZeneca,48,Low,Moderate Risk,Moderate (50-80%),Fast,Gut,Suitable
Ibuprofen,Inflammation,Migraine Treatment,64.76,C13H18O2,AMPK Activator,Acid Reflux,1994,Omeprazole,Aspirin,Low Risk,High Bioavailability,Phase 4,Toxicology Report,Dopaminergic Pathway,Capsule,As prescribed,Pfizer,24,High,Low Risk,Moderate (50-80%),Slow,Gut,Partially Suitable
Atorvastatin,Inflammation,Migraine Treatment,89.62,C17H19N3O3S,COX Inhibitor,"Nausea, Dizziness",1987,Omeprazole,Prilosec,Moderate Risk,Slow Metabolism,Completed,Toxicology Report,MAPK Pathway,Injection,As prescribed,Pfizer,6,High,Low Risk,Low (<50%),Fast,Renal,Not Suitable
Omeprazole,Cholesterol Control,Migraine Treatment,77.07,C13H18O2,NSAID,Muscle Pain,1987,Atorvastatin Calcium,Advil,Low Risk,Slow Metabolism,Phase 4,No Preclinical Data,Immune Response Pathway,Injection,50mg daily,Novartis,48,Low,High Risk,Moderate (50-80%),Slow,Gut,Not Suitable
Losartan,Diabetes,Antiviral,53.48,C13H18O2,NSAID,Muscle Pain,1971,Atorvastatin Calcium,Advil,High Risk,High Bioavailability,Phase 2,Animal Testing,Dopaminergic Pathway,Injection,As prescribed,Pfizer,48,Moderate,Moderate Risk,Low (<50%),Slow,Enzyme-Specific,Not Suitable
Paracetamol,Blood Thinner,Autoimmune Disorders,32.83,C17H19N3O3S,COX Inhibitor,Acid Reflux,1971,Metformin Hydrochloride,Advil,Moderate Risk,Liver Metabolism,Phase 1,No Preclinical Data,Immune Response Pathway,Syrup,250mg every 8 hours,Roche,24,High,Low Risk,Moderate (50-80%),Moderate,Renal,Partially Suitable
Ranitidine,Pain Relief,Autoimmune Disorders,86.78,C13H18O2,NSAID,Gastrointestinal Issues,1971,Omeprazole,Aspirin,Moderate Risk,Liver Metabolism,Phase 3,Toxicology Report,Immune Response Pathway,Topical Gel,500mg twice a day,Pfizer,2,Low,Low Risk,High (>80%),Slow,Liver,Suitable
Simvastatin,Inflammation,Antiviral,35.58,C4H11N5,HMG-CoA Reductase Inhibitor,Muscle Pain,1996,Omeprazole,Prilosec,Moderate Risk,High Bioavailability,Ongoing,In Vitro Studies,Immune Response Pathway,Syrup,500mg twice a day,Merck,48,High,Moderate Risk,Low (<50%),Slow,Liver,Suitable
Levothyroxine,Fever,Antiviral,68.42,C13H18O2,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1996,Atorvastatin Calcium,Advil,Moderate Risk,Liver Metabolism,Completed,In Vitro Studies,Dopaminergic Pathway,Tablet,As prescribed,Novartis,2,High,Low Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Partially Suitable
Aspirin,Fever,Anti-Aging,93.89,C17H19N3O3S,NSAID,"Headache, Rash",1996,Ibuprofen,Prilosec,Moderate Risk,Rapid Absorption,Phase 2,Toxicology Report,MAPK Pathway,Syrup,500mg twice a day,Roche,2,Low,High Risk,Low (<50%),Fast,Liver,Not Suitable
Metformin,Acid Reflux,Anti-Aging,78.33,C4H11N5,COX Inhibitor,Muscle Pain,1971,Metformin Hydrochloride,Advil,Moderate Risk,High Bioavailability,Completed,Animal Testing,MAPK Pathway,Injection,50mg daily,Roche,6,High,Moderate Risk,Moderate (50-80%),Moderate,Liver,Partially Suitable
Ibuprofen,Pain Relief,Liver Disease,88.59,C17H19N3O3S,Proton Pump Inhibitor,Acid Reflux,1971,Metformin Hydrochloride,Advil,Low Risk,Rapid Absorption,Ongoing,Toxicology Report,PI3K-AKT Pathway,Tablet,As prescribed,AstraZeneca,2,Low,Moderate Risk,High (>80%),Moderate,Liver,Partially Suitable
Atorvastatin,Diabetes,Parkinson's,84.87,C33H35FN2O5,Proton Pump Inhibitor,Muscle Pain,1994,Atorvastatin Calcium,Advil,High Risk,Slow Metabolism,Phase 4,Toxicology Report,Dopaminergic Pathway,Tablet,250mg every 8 hours,AstraZeneca,12,Low,High Risk,Low (<50%),Moderate,Gut,Suitable
Omeprazole,Diabetes,Migraine Treatment,34.7,C17H19N3O3S,COX Inhibitor,Acid Reflux,1996,Metformin Hydrochloride,Lipitor,Low Risk,High Bioavailability,Ongoing,In Vitro Studies,PI3K-AKT Pathway,Topical Gel,As prescribed,Merck,2,Moderate,High Risk,Low (<50%),Moderate,Renal,Suitable
Losartan,Pain Relief,Parkinson's,49.69,C33H35FN2O5,COX Inhibitor,"Headache, Rash",1965,Metformin Hydrochloride,Glucophage,Moderate Risk,Slow Metabolism,Phase 2,Animal Testing,Immune Response Pathway,Syrup,As prescribed,Pfizer,2,Moderate,Low Risk,Moderate (50-80%),Slow,Renal,Not Suitable
Paracetamol,Thyroid Hormone Replacement,Autoimmune Disorders,48.06,C4H11N5,HMG-CoA Reductase Inhibitor,Acid Reflux,1996,Atorvastatin Calcium,Aspirin,Low Risk,Renal Excretion,Phase 3,Animal Testing,Immune Response Pathway,Syrup,As prescribed,Novartis,12,Low,High Risk,Moderate (50-80%),Moderate,Renal,Partially Suitable
Ranitidine,Thyroid Hormone Replacement,Weight Loss,84.79,C9H8O4,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1971,Omeprazole,Glucophage,Moderate Risk,Rapid Absorption,Phase 1,No Preclinical Data,Serotonin Pathway,Topical Gel,As prescribed,AstraZeneca,48,High,High Risk,Low (<50%),Slow,Liver,Not Suitable
Simvastatin,Gastric Ulcer,Antiviral,78.66,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Acid Reflux,1996,Omeprazole,Lipitor,High Risk,Rapid Absorption,Completed,In Vitro Studies,MAPK Pathway,Syrup,500mg twice a day,Novartis,12,Low,High Risk,High (>80%),Slow,Renal,Partially Suitable
Levothyroxine,Pain Relief,Autoimmune Disorders,94.91,C33H35FN2O5,Proton Pump Inhibitor,Gastrointestinal Issues,1971,Atorvastatin Calcium,Aspirin,Low Risk,Renal Excretion,Ongoing,In Vitro Studies,Serotonin Pathway,Capsule,As prescribed,Pfizer,12,Low,Low Risk,High (>80%),Slow,Enzyme-Specific,Suitable
Aspirin,Hypertension,Anti-Aging,73.03,C33H35FN2O5,COX Inhibitor,"Headache, Rash",1996,Metformin Hydrochloride,Prilosec,High Risk,Renal Excretion,Phase 3,No Preclinical Data,Serotonin Pathway,Topical Gel,250mg every 8 hours,AstraZeneca,24,High,High Risk,Low (<50%),Slow,Liver,Partially Suitable
Metformin,Inflammation,Cardiovascular Disease,72.27,C9H8O4,HMG-CoA Reductase Inhibitor,"Headache, Rash",1965,Omeprazole,Glucophage,Low Risk,Liver Metabolism,Phase 1,In Vitro Studies,Immune Response Pathway,Topical Gel,As prescribed,AstraZeneca,2,Moderate,High Risk,Moderate (50-80%),Fast,Renal,Suitable
Ibuprofen,Acid Reflux,Anti-Aging,33.34,C13H18O2,AMPK Activator,"Nausea, Dizziness",1994,Metformin Hydrochloride,Advil,Low Risk,High Bioavailability,Completed,Toxicology Report,MAPK Pathway,Tablet,250mg every 8 hours,Pfizer,12,High,High Risk,High (>80%),Fast,Renal,Not Suitable
Atorvastatin,Gastric Ulcer,Alzheimer's,86.87,C33H35FN2O5,AMPK Activator,"Headache, Rash",1994,Omeprazole,Prilosec,Low Risk,Renal Excretion,Completed,Toxicology Report,Serotonin Pathway,Tablet,As prescribed,Roche,48,Moderate,Moderate Risk,High (>80%),Moderate,Liver,Partially Suitable
Omeprazole,Pain Relief,Parkinson's,76.36,C9H8O4,HMG-CoA Reductase Inhibitor,Acid Reflux,1971,Ibuprofen,Glucophage,Low Risk,Rapid Absorption,Phase 2,Animal Testing,PI3K-AKT Pathway,Capsule,As prescribed,Merck,12,High,Moderate Risk,Moderate (50-80%),Fast,Renal,Suitable
Losartan,Gastric Ulcer,Autoimmune Disorders,62.29,C13H18O2,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1994,Atorvastatin Calcium,Prilosec,Low Risk,High Bioavailability,Phase 2,In Vitro Studies,Serotonin Pathway,Tablet,As prescribed,Merck,48,Low,Moderate Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Paracetamol,Cholesterol Control,Weight Loss,44.14,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Acid Reflux,1971,Omeprazole,Advil,Moderate Risk,Slow Metabolism,Phase 4,Toxicology Report,Immune Response Pathway,Tablet,As prescribed,Pfizer,12,High,High Risk,Low (<50%),Fast,Liver,Partially Suitable
Ranitidine,Diabetes,Anti-Aging,74.01,C4H11N5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1987,Atorvastatin Calcium,Lipitor,Moderate Risk,Slow Metabolism,Phase 2,In Vitro Studies,Immune Response Pathway,Topical Gel,250mg every 8 hours,Pfizer,6,Low,High Risk,Moderate (50-80%),Fast,Liver,Suitable
Simvastatin,Hypertension,Cardiovascular Disease,75.56,C13H18O2,COX Inhibitor,"Headache, Rash",1971,Atorvastatin Calcium,Lipitor,High Risk,High Bioavailability,Phase 3,In Vitro Studies,MAPK Pathway,Capsule,As prescribed,Novartis,24,Low,Moderate Risk,Low (<50%),Fast,Renal,Not Suitable
Levothyroxine,Hypertension,Parkinson's,48.35,C33H35FN2O5,AMPK Activator,Gastrointestinal Issues,1996,Atorvastatin Calcium,Lipitor,Low Risk,High Bioavailability,Phase 1,Animal Testing,Immune Response Pathway,Syrup,As prescribed,Pfizer,2,High,Low Risk,High (>80%),Moderate,Gut,Not Suitable
Aspirin,Acid Reflux,Parkinson's,59.33,C33H35FN2O5,Proton Pump Inhibitor,Gastrointestinal Issues,1971,Atorvastatin Calcium,Lipitor,Low Risk,Slow Metabolism,Phase 1,Toxicology Report,Dopaminergic Pathway,Tablet,50mg daily,Roche,12,High,Moderate Risk,Moderate (50-80%),Slow,Liver,Not Suitable
Metformin,Blood Thinner,Liver Disease,39.47,C17H19N3O3S,NSAID,Gastrointestinal Issues,1994,Metformin Hydrochloride,Advil,Low Risk,Rapid Absorption,Ongoing,No Preclinical Data,PI3K-AKT Pathway,Tablet,50mg daily,Pfizer,6,Moderate,Low Risk,Moderate (50-80%),Slow,Gut,Not Suitable
Ibuprofen,Inflammation,Alzheimer's,85.71,C9H8O4,Proton Pump Inhibitor,"Nausea, Dizziness",1971,Omeprazole,Glucophage,Low Risk,Liver Metabolism,Phase 2,Toxicology Report,Serotonin Pathway,Syrup,10mg once daily,Pfizer,6,Low,High Risk,Low (<50%),Moderate,Enzyme-Specific,Partially Suitable
Atorvastatin,Gastric Ulcer,Cardiovascular Disease,44.72,C13H18O2,Proton Pump Inhibitor,"Nausea, Dizziness",1965,Ibuprofen,Lipitor,Low Risk,Renal Excretion,Completed,Animal Testing,MAPK Pathway,Tablet,250mg every 8 hours,Novartis,6,Moderate,Moderate Risk,High (>80%),Slow,Renal,Suitable
Omeprazole,Pain Relief,Cancer Therapy,87.56,C4H11N5,AMPK Activator,Gastrointestinal Issues,1965,Atorvastatin Calcium,Aspirin,High Risk,Renal Excretion,Phase 4,In Vitro Studies,MAPK Pathway,Capsule,250mg every 8 hours,Roche,2,High,Moderate Risk,Low (<50%),Slow,Liver,Suitable
Losartan,Diabetes,Weight Loss,89.55,C9H8O4,NSAID,"Nausea, Dizziness",1994,Atorvastatin Calcium,Aspirin,Low Risk,Slow Metabolism,Completed,In Vitro Studies,Dopaminergic Pathway,Topical Gel,500mg twice a day,Novartis,2,Moderate,Low Risk,High (>80%),Fast,Liver,Suitable
Paracetamol,Inflammation,Liver Disease,37.91,C33H35FN2O5,Proton Pump Inhibitor,Gastrointestinal Issues,1996,Metformin Hydrochloride,Glucophage,Moderate Risk,High Bioavailability,Phase 4,Animal Testing,PI3K-AKT Pathway,Injection,50mg daily,Roche,48,Low,Moderate Risk,Moderate (50-80%),Slow,Renal,Not Suitable
Ranitidine,Hypertension,Cancer Therapy,66.35,C4H11N5,HMG-CoA Reductase Inhibitor,Acid Reflux,1971,Atorvastatin Calcium,Advil,Low Risk,Rapid Absorption,Phase 2,Toxicology Report,Serotonin Pathway,Topical Gel,250mg every 8 hours,Pfizer,2,High,High Risk,Low (<50%),Moderate,Enzyme-Specific,Partially Suitable
Simvastatin,Blood Thinner,Migraine Treatment,32.27,C9H8O4,Proton Pump Inhibitor,"Nausea, Dizziness",1965,Acetylsalicylic Acid,Advil,Low Risk,High Bioavailability,Phase 4,No Preclinical Data,Immune Response Pathway,Syrup,250mg every 8 hours,Pfizer,6,High,Low Risk,Low (<50%),Fast,Liver,Not Suitable
Levothyroxine,Fever,Anti-Aging,50.33,C4H11N5,NSAID,Gastrointestinal Issues,1987,Metformin Hydrochloride,Glucophage,High Risk,High Bioavailability,Completed,Animal Testing,Dopaminergic Pathway,Capsule,10mg once daily,Novartis,12,Moderate,Low Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Aspirin,Hypertension,Weight Loss,76.22,C4H11N5,NSAID,Gastrointestinal Issues,1965,Ibuprofen,Advil,High Risk,High Bioavailability,Phase 2,Animal Testing,Immune Response Pathway,Syrup,250mg every 8 hours,Pfizer,6,High,Moderate Risk,High (>80%),Slow,Renal,Partially Suitable
Metformin,Hypertension,Autoimmune Disorders,54.58,C13H18O2,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1987,Omeprazole,Lipitor,High Risk,High Bioavailability,Phase 3,In Vitro Studies,PI3K-AKT Pathway,Syrup,10mg once daily,Merck,6,Moderate,Low Risk,Low (<50%),Fast,Renal,Partially Suitable
Ibuprofen,Fever,Autoimmune Disorders,34.54,C4H11N5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1965,Acetylsalicylic Acid,Prilosec,Moderate Risk,Rapid Absorption,Phase 3,Animal Testing,Dopaminergic Pathway,Capsule,250mg every 8 hours,Roche,24,Moderate,Moderate Risk,Low (<50%),Fast,Renal,Suitable
Atorvastatin,Diabetes,Migraine Treatment,93.74,C13H18O2,COX Inhibitor,Acid Reflux,1965,Atorvastatin Calcium,Advil,Low Risk,High Bioavailability,Phase 1,In Vitro Studies,Serotonin Pathway,Syrup,500mg twice a day,Novartis,2,High,Moderate Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Partially Suitable
Omeprazole,Thyroid Hormone Replacement,Weight Loss,53.52,C9H8O4,HMG-CoA Reductase Inhibitor,Muscle Pain,1996,Omeprazole,Glucophage,Moderate Risk,Rapid Absorption,Phase 3,In Vitro Studies,Immune Response Pathway,Syrup,250mg every 8 hours,Merck,48,Moderate,Low Risk,Low (<50%),Fast,Liver,Not Suitable
Losartan,Pain Relief,Antiviral,83.68,C17H19N3O3S,Proton Pump Inhibitor,"Headache, Rash",1987,Metformin Hydrochloride,Glucophage,High Risk,Rapid Absorption,Ongoing,Animal Testing,MAPK Pathway,Injection,10mg once daily,Roche,48,Low,Low Risk,High (>80%),Slow,Gut,Suitable
Paracetamol,Cholesterol Control,Liver Disease,64.73,C9H8O4,COX Inhibitor,"Nausea, Dizziness",1965,Atorvastatin Calcium,Glucophage,High Risk,Slow Metabolism,Phase 3,Toxicology Report,PI3K-AKT Pathway,Injection,10mg once daily,Novartis,2,High,High Risk,Moderate (50-80%),Slow,Liver,Not Suitable
Ranitidine,Fever,Autoimmune Disorders,61.26,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1987,Metformin Hydrochloride,Glucophage,High Risk,Renal Excretion,Phase 2,No Preclinical Data,Serotonin Pathway,Topical Gel,As prescribed,Roche,48,Moderate,Low Risk,High (>80%),Slow,Renal,Suitable
Simvastatin,Diabetes,Anti-Aging,53.63,C33H35FN2O5,COX Inhibitor,"Nausea, Dizziness",1965,Omeprazole,Lipitor,High Risk,Rapid Absorption,Phase 3,Toxicology Report,Serotonin Pathway,Syrup,50mg daily,Pfizer,2,Low,Low Risk,Moderate (50-80%),Fast,Renal,Not Suitable
Levothyroxine,Cholesterol Control,Anti-Aging,82.58,C13H18O2,COX Inhibitor,Gastrointestinal Issues,1987,Metformin Hydrochloride,Lipitor,Low Risk,High Bioavailability,Completed,In Vitro Studies,PI3K-AKT Pathway,Injection,250mg every 8 hours,Pfizer,48,Moderate,Low Risk,High (>80%),Slow,Liver,Suitable
Aspirin,Thyroid Hormone Replacement,Liver Disease,79.99,C17H19N3O3S,NSAID,Acid Reflux,1994,Atorvastatin Calcium,Lipitor,Low Risk,Rapid Absorption,Phase 4,Animal Testing,Immune Response Pathway,Capsule,250mg every 8 hours,Novartis,2,High,High Risk,Moderate (50-80%),Slow,Enzyme-Specific,Not Suitable
Metformin,Fever,Alzheimer's,94.91,C33H35FN2O5,NSAID,Muscle Pain,1971,Acetylsalicylic Acid,Advil,Low Risk,Liver Metabolism,Phase 2,Toxicology Report,Immune Response Pathway,Syrup,As prescribed,Merck,24,Moderate,Moderate Risk,Moderate (50-80%),Moderate,Renal,Not Suitable
Ibuprofen,Blood Thinner,Cancer Therapy,40.87,C4H11N5,HMG-CoA Reductase Inhibitor,Acid Reflux,1994,Atorvastatin Calcium,Prilosec,High Risk,Liver Metabolism,Phase 2,Animal Testing,MAPK Pathway,Topical Gel,50mg daily,Novartis,24,Low,Moderate Risk,Moderate (50-80%),Moderate,Liver,Suitable
Atorvastatin,Thyroid Hormone Replacement,Liver Disease,62.81,C33H35FN2O5,AMPK Activator,"Headache, Rash",1987,Metformin Hydrochloride,Lipitor,Moderate Risk,High Bioavailability,Phase 1,Toxicology Report,PI3K-AKT Pathway,Topical Gel,500mg twice a day,Merck,12,Low,Moderate Risk,Moderate (50-80%),Fast,Enzyme-Specific,Partially Suitable
Omeprazole,Gastric Ulcer,Anti-Aging,84,C33H35FN2O5,AMPK Activator,"Nausea, Dizziness",1971,Ibuprofen,Advil,Moderate Risk,Rapid Absorption,Completed,In Vitro Studies,Dopaminergic Pathway,Capsule,50mg daily,AstraZeneca,2,Low,Low Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Losartan,Acid Reflux,Migraine Treatment,92.05,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1987,Ibuprofen,Lipitor,Low Risk,Renal Excretion,Phase 4,In Vitro Studies,Immune Response Pathway,Syrup,50mg daily,Novartis,48,Low,Moderate Risk,Moderate (50-80%),Fast,Gut,Suitable
Paracetamol,Diabetes,Migraine Treatment,66.27,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1965,Atorvastatin Calcium,Prilosec,Low Risk,High Bioavailability,Completed,Toxicology Report,MAPK Pathway,Syrup,10mg once daily,AstraZeneca,24,Moderate,High Risk,Low (<50%),Fast,Liver,Suitable
Ranitidine,Acid Reflux,Antiviral,71.42,C13H18O2,AMPK Activator,"Headache, Rash",1971,Atorvastatin Calcium,Glucophage,Low Risk,Renal Excretion,Phase 1,Toxicology Report,Serotonin Pathway,Topical Gel,500mg twice a day,Novartis,6,Moderate,Low Risk,High (>80%),Moderate,Gut,Not Suitable
Simvastatin,Hypertension,Cardiovascular Disease,85.63,C9H8O4,Proton Pump Inhibitor,Gastrointestinal Issues,1987,Metformin Hydrochloride,Lipitor,Low Risk,Rapid Absorption,Ongoing,Animal Testing,PI3K-AKT Pathway,Capsule,As prescribed,AstraZeneca,12,High,Moderate Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Suitable
Levothyroxine,Pain Relief,Parkinson's,68.25,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Muscle Pain,1965,Acetylsalicylic Acid,Aspirin,Low Risk,Slow Metabolism,Phase 4,Toxicology Report,Dopaminergic Pathway,Tablet,250mg every 8 hours,Pfizer,6,Moderate,High Risk,High (>80%),Moderate,Liver,Not Suitable
Aspirin,Pain Relief,Anti-Aging,79.09,C13H18O2,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1994,Atorvastatin Calcium,Aspirin,High Risk,Renal Excretion,Ongoing,No Preclinical Data,Serotonin Pathway,Syrup,50mg daily,Novartis,48,High,High Risk,Moderate (50-80%),Moderate,Gut,Suitable
Metformin,Pain Relief,Anti-Aging,50.24,C13H18O2,NSAID,"Nausea, Dizziness",1994,Ibuprofen,Lipitor,High Risk,Rapid Absorption,Phase 1,Toxicology Report,MAPK Pathway,Tablet,As prescribed,Merck,24,Moderate,Moderate Risk,Low (<50%),Slow,Renal,Not Suitable
Ibuprofen,Gastric Ulcer,Alzheimer's,62.05,C13H18O2,AMPK Activator,"Nausea, Dizziness",1987,Ibuprofen,Glucophage,Low Risk,Slow Metabolism,Phase 3,No Preclinical Data,PI3K-AKT Pathway,Tablet,250mg every 8 hours,Pfizer,24,Moderate,High Risk,Low (<50%),Moderate,Gut,Partially Suitable
Atorvastatin,Cholesterol Control,Cardiovascular Disease,61.08,C4H11N5,Proton Pump Inhibitor,"Headache, Rash",1971,Acetylsalicylic Acid,Prilosec,Low Risk,Liver Metabolism,Phase 3,Toxicology Report,PI3K-AKT Pathway,Tablet,50mg daily,Merck,2,Low,High Risk,High (>80%),Moderate,Liver,Suitable
Omeprazole,Acid Reflux,Weight Loss,34.73,C33H35FN2O5,NSAID,"Headache, Rash",1965,Metformin Hydrochloride,Prilosec,Low Risk,Rapid Absorption,Ongoing,Animal Testing,MAPK Pathway,Topical Gel,500mg twice a day,Roche,24,High,Moderate Risk,High (>80%),Moderate,Liver,Suitable
Losartan,Blood Thinner,Alzheimer's,69.79,C33H35FN2O5,AMPK Activator,"Headache, Rash",1965,Omeprazole,Lipitor,Low Risk,Renal Excretion,Phase 1,Toxicology Report,Serotonin Pathway,Syrup,500mg twice a day,AstraZeneca,2,Low,Low Risk,High (>80%),Fast,Renal,Partially Suitable
Paracetamol,Blood Thinner,Autoimmune Disorders,61.83,C9H8O4,Proton Pump Inhibitor,Muscle Pain,1994,Omeprazole,Advil,Low Risk,Renal Excretion,Phase 2,Toxicology Report,MAPK Pathway,Injection,10mg once daily,Pfizer,24,Moderate,Low Risk,High (>80%),Moderate,Enzyme-Specific,Suitable
Ranitidine,Inflammation,Anti-Aging,38.1,C17H19N3O3S,NSAID,Acid Reflux,1996,Omeprazole,Advil,Moderate Risk,Renal Excretion,Phase 1,In Vitro Studies,Dopaminergic Pathway,Tablet,250mg every 8 hours,Pfizer,12,Low,High Risk,High (>80%),Moderate,Enzyme-Specific,Partially Suitable
Simvastatin,Thyroid Hormone Replacement,Migraine Treatment,59.88,C33H35FN2O5,AMPK Activator,Acid Reflux,1987,Ibuprofen,Lipitor,High Risk,Slow Metabolism,Phase 1,No Preclinical Data,PI3K-AKT Pathway,Capsule,50mg daily,Pfizer,12,Low,Low Risk,Low (<50%),Moderate,Enzyme-Specific,Suitable
Levothyroxine,Cholesterol Control,Alzheimer's,81.82,C17H19N3O3S,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1987,Acetylsalicylic Acid,Advil,High Risk,High Bioavailability,Phase 4,Animal Testing,Immune Response Pathway,Injection,10mg once daily,Merck,24,Low,High Risk,High (>80%),Moderate,Gut,Partially Suitable
Aspirin,Hypertension,Alzheimer's,77.07,C17H19N3O3S,COX Inhibitor,"Nausea, Dizziness",1971,Metformin Hydrochloride,Advil,Moderate Risk,Rapid Absorption,Phase 1,Toxicology Report,Immune Response Pathway,Syrup,50mg daily,AstraZeneca,12,Moderate,Moderate Risk,Low (<50%),Moderate,Gut,Not Suitable
Metformin,Acid Reflux,Autoimmune Disorders,77.5,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1971,Acetylsalicylic Acid,Prilosec,Low Risk,Rapid Absorption,Phase 4,In Vitro Studies,Immune Response Pathway,Syrup,250mg every 8 hours,Pfizer,24,High,Moderate Risk,Low (<50%),Moderate,Renal,Partially Suitable
Ibuprofen,Fever,Antiviral,49.28,C4H11N5,Proton Pump Inhibitor,Gastrointestinal Issues,1994,Ibuprofen,Lipitor,High Risk,High Bioavailability,Ongoing,In Vitro Studies,Dopaminergic Pathway,Syrup,50mg daily,Roche,48,Low,High Risk,Low (<50%),Fast,Gut,Not Suitable
Atorvastatin,Blood Thinner,Cancer Therapy,73.18,C17H19N3O3S,Proton Pump Inhibitor,Gastrointestinal Issues,1996,Atorvastatin Calcium,Aspirin,Low Risk,Liver Metabolism,Phase 2,Animal Testing,MAPK Pathway,Topical Gel,As prescribed,AstraZeneca,48,Low,Moderate Risk,High (>80%),Slow,Liver,Suitable
Omeprazole,Fever,Anti-Aging,47.52,C13H18O2,Proton Pump Inhibitor,Gastrointestinal Issues,1987,Acetylsalicylic Acid,Glucophage,Low Risk,Renal Excretion,Completed,Toxicology Report,Dopaminergic Pathway,Capsule,As prescribed,Pfizer,12,High,Low Risk,Moderate (50-80%),Slow,Gut,Not Suitable
Losartan,Fever,Antiviral,91.91,C9H8O4,NSAID,Muscle Pain,1996,Ibuprofen,Lipitor,High Risk,Slow Metabolism,Ongoing,Animal Testing,Dopaminergic Pathway,Topical Gel,50mg daily,Roche,12,Low,Moderate Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Suitable
Paracetamol,Inflammation,Parkinson's,36.08,C4H11N5,Proton Pump Inhibitor,"Headache, Rash",1965,Acetylsalicylic Acid,Prilosec,Moderate Risk,Liver Metabolism,Phase 4,Animal Testing,Dopaminergic Pathway,Tablet,As prescribed,Pfizer,6,Moderate,High Risk,Low (<50%),Slow,Gut,Not Suitable
Ranitidine,Fever,Antiviral,89.05,C9H8O4,AMPK Activator,"Headache, Rash",1965,Omeprazole,Aspirin,High Risk,Renal Excretion,Completed,Animal Testing,PI3K-AKT Pathway,Capsule,As prescribed,Novartis,48,Low,Low Risk,High (>80%),Slow,Gut,Suitable
Simvastatin,Blood Thinner,Alzheimer's,66.27,C4H11N5,AMPK Activator,Gastrointestinal Issues,1965,Acetylsalicylic Acid,Prilosec,High Risk,Renal Excretion,Phase 1,Animal Testing,Dopaminergic Pathway,Topical Gel,10mg once daily,Pfizer,6,Moderate,Low Risk,Low (<50%),Slow,Liver,Not Suitable
Levothyroxine,Hypertension,Antiviral,30.27,C13H18O2,NSAID,"Nausea, Dizziness",1994,Metformin Hydrochloride,Advil,Low Risk,Renal Excretion,Completed,No Preclinical Data,Serotonin Pathway,Tablet,250mg every 8 hours,Novartis,6,Low,High Risk,Moderate (50-80%),Moderate,Liver,Partially Suitable
Aspirin,Thyroid Hormone Replacement,Autoimmune Disorders,53.58,C13H18O2,Proton Pump Inhibitor,"Headache, Rash",1996,Metformin Hydrochloride,Prilosec,High Risk,Renal Excretion,Completed,No Preclinical Data,MAPK Pathway,Syrup,50mg daily,Merck,2,High,High Risk,Low (<50%),Slow,Enzyme-Specific,Partially Suitable
Metformin,Diabetes,Anti-Aging,37.01,C9H8O4,AMPK Activator,Muscle Pain,1987,Ibuprofen,Prilosec,High Risk,Slow Metabolism,Phase 3,Toxicology Report,Dopaminergic Pathway,Capsule,500mg twice a day,Roche,6,Low,High Risk,High (>80%),Moderate,Renal,Partially Suitable
Ibuprofen,Pain Relief,Autoimmune Disorders,53.49,C17H19N3O3S,NSAID,Muscle Pain,1987,Atorvastatin Calcium,Glucophage,Low Risk,High Bioavailability,Phase 2,Animal Testing,PI3K-AKT Pathway,Capsule,10mg once daily,Pfizer,12,Low,High Risk,Low (<50%),Fast,Renal,Not Suitable
Atorvastatin,Gastric Ulcer,Liver Disease,79.62,C9H8O4,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1971,Ibuprofen,Prilosec,Low Risk,High Bioavailability,Phase 3,In Vitro Studies,Serotonin Pathway,Tablet,500mg twice a day,Novartis,12,Moderate,Moderate Risk,Moderate (50-80%),Fast,Enzyme-Specific,Suitable
Omeprazole,Thyroid Hormone Replacement,Antiviral,86.63,C13H18O2,COX Inhibitor,Gastrointestinal Issues,1996,Omeprazole,Lipitor,High Risk,Liver Metabolism,Phase 3,Animal Testing,PI3K-AKT Pathway,Tablet,10mg once daily,Pfizer,12,Moderate,Low Risk,High (>80%),Slow,Liver,Not Suitable
Losartan,Thyroid Hormone Replacement,Alzheimer's,30.39,C13H18O2,Proton Pump Inhibitor,Gastrointestinal Issues,1996,Omeprazole,Glucophage,Moderate Risk,Rapid Absorption,Phase 4,No Preclinical Data,Dopaminergic Pathway,Tablet,250mg every 8 hours,Novartis,2,Moderate,Moderate Risk,High (>80%),Fast,Enzyme-Specific,Not Suitable
Paracetamol,Pain Relief,Autoimmune Disorders,73.44,C13H18O2,COX Inhibitor,Gastrointestinal Issues,1965,Acetylsalicylic Acid,Advil,Low Risk,Liver Metabolism,Phase 1,No Preclinical Data,Immune Response Pathway,Capsule,As prescribed,AstraZeneca,48,Moderate,High Risk,Moderate (50-80%),Fast,Renal,Partially Suitable
Ranitidine,Blood Thinner,Weight Loss,65.37,C33H35FN2O5,NSAID,Muscle Pain,1987,Metformin Hydrochloride,Advil,High Risk,Rapid Absorption,Phase 4,Toxicology Report,PI3K-AKT Pathway,Tablet,500mg twice a day,Novartis,24,High,Low Risk,High (>80%),Moderate,Enzyme-Specific,Partially Suitable
Simvastatin,Inflammation,Migraine Treatment,61.52,C4H11N5,Proton Pump Inhibitor,"Nausea, Dizziness",1987,Atorvastatin Calcium,Aspirin,Low Risk,Slow Metabolism,Phase 4,Animal Testing,Immune Response Pathway,Tablet,500mg twice a day,Roche,6,Moderate,High Risk,Moderate (50-80%),Fast,Gut,Not Suitable
Levothyroxine,Hypertension,Autoimmune Disorders,55.3,C4H11N5,Proton Pump Inhibitor,"Nausea, Dizziness",1994,Metformin Hydrochloride,Prilosec,Low Risk,High Bioavailability,Phase 2,In Vitro Studies,PI3K-AKT Pathway,Injection,As prescribed,Novartis,6,High,High Risk,High (>80%),Slow,Liver,Suitable
Aspirin,Cholesterol Control,Migraine Treatment,92.94,C13H18O2,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1994,Acetylsalicylic Acid,Advil,Moderate Risk,Liver Metabolism,Phase 3,Animal Testing,MAPK Pathway,Topical Gel,250mg every 8 hours,Pfizer,6,High,High Risk,Moderate (50-80%),Fast,Renal,Suitable
Metformin,Blood Thinner,Alzheimer's,90.34,C17H19N3O3S,NSAID,"Headache, Rash",1994,Atorvastatin Calcium,Glucophage,Low Risk,Renal Excretion,Phase 3,Toxicology Report,Serotonin Pathway,Injection,250mg every 8 hours,Roche,2,Moderate,High Risk,Moderate (50-80%),Fast,Renal,Not Suitable
Ibuprofen,Hypertension,Cancer Therapy,31.03,C33H35FN2O5,AMPK Activator,"Headache, Rash",1994,Acetylsalicylic Acid,Advil,Low Risk,Renal Excretion,Phase 1,No Preclinical Data,MAPK Pathway,Syrup,As prescribed,Pfizer,24,High,Low Risk,Moderate (50-80%),Moderate,Gut,Not Suitable
Atorvastatin,Hypertension,Parkinson's,93.88,C33H35FN2O5,AMPK Activator,"Headache, Rash",1971,Acetylsalicylic Acid,Aspirin,Low Risk,Slow Metabolism,Phase 3,Toxicology Report,Serotonin Pathway,Topical Gel,50mg daily,Pfizer,12,Low,Moderate Risk,Moderate (50-80%),Moderate,Gut,Not Suitable
Omeprazole,Thyroid Hormone Replacement,Autoimmune Disorders,58.66,C33H35FN2O5,NSAID,"Headache, Rash",1994,Atorvastatin Calcium,Glucophage,High Risk,Liver Metabolism,Phase 1,Toxicology Report,Serotonin Pathway,Syrup,500mg twice a day,Novartis,6,High,Moderate Risk,Low (<50%),Fast,Gut,Partially Suitable
Losartan,Blood Thinner,Liver Disease,72.7,C4H11N5,AMPK Activator,Muscle Pain,1994,Atorvastatin Calcium,Prilosec,High Risk,Liver Metabolism,Phase 2,Animal Testing,Immune Response Pathway,Syrup,250mg every 8 hours,Pfizer,48,Moderate,Low Risk,Moderate (50-80%),Fast,Renal,Suitable
Paracetamol,Fever,Alzheimer's,82.95,C17H19N3O3S,COX Inhibitor,Acid Reflux,1987,Omeprazole,Prilosec,Moderate Risk,Liver Metabolism,Completed,No Preclinical Data,Serotonin Pathway,Capsule,50mg daily,Merck,12,Low,High Risk,High (>80%),Moderate,Enzyme-Specific,Suitable
Ranitidine,Gastric Ulcer,Alzheimer's,84.64,C9H8O4,COX Inhibitor,Muscle Pain,1987,Atorvastatin Calcium,Glucophage,Moderate Risk,Slow Metabolism,Phase 3,In Vitro Studies,Dopaminergic Pathway,Tablet,As prescribed,Roche,12,Moderate,Moderate Risk,Moderate (50-80%),Fast,Gut,Suitable
Simvastatin,Hypertension,Autoimmune Disorders,81.69,C13H18O2,Proton Pump Inhibitor,"Nausea, Dizziness",1965,Metformin Hydrochloride,Prilosec,Moderate Risk,Slow Metabolism,Phase 3,In Vitro Studies,PI3K-AKT Pathway,Topical Gel,10mg once daily,AstraZeneca,2,Low,High Risk,Moderate (50-80%),Slow,Gut,Suitable
Levothyroxine,Fever,Liver Disease,39.48,C9H8O4,COX Inhibitor,Acid Reflux,1994,Omeprazole,Advil,Moderate Risk,High Bioavailability,Phase 4,No Preclinical Data,Immune Response Pathway,Capsule,500mg twice a day,Roche,48,Moderate,Low Risk,Moderate (50-80%),Moderate,Liver,Suitable
Aspirin,Blood Thinner,Alzheimer's,74.04,C9H8O4,AMPK Activator,Muscle Pain,1987,Omeprazole,Prilosec,Low Risk,Rapid Absorption,Ongoing,Animal Testing,Dopaminergic Pathway,Syrup,50mg daily,Pfizer,2,Low,Moderate Risk,Low (<50%),Slow,Liver,Suitable
Metformin,Fever,Antiviral,87.37,C13H18O2,AMPK Activator,Gastrointestinal Issues,1987,Atorvastatin Calcium,Glucophage,Low Risk,Liver Metabolism,Ongoing,No Preclinical Data,Immune Response Pathway,Injection,500mg twice a day,Novartis,12,High,High Risk,Low (<50%),Slow,Liver,Not Suitable
Ibuprofen,Pain Relief,Alzheimer's,45.54,C4H11N5,Proton Pump Inhibitor,"Headache, Rash",1996,Atorvastatin Calcium,Lipitor,High Risk,Liver Metabolism,Completed,In Vitro Studies,Immune Response Pathway,Tablet,500mg twice a day,Roche,12,High,Moderate Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Suitable
Atorvastatin,Pain Relief,Liver Disease,53.44,C9H8O4,COX Inhibitor,"Nausea, Dizziness",1994,Ibuprofen,Glucophage,Low Risk,Slow Metabolism,Completed,Toxicology Report,MAPK Pathway,Syrup,500mg twice a day,Merck,24,High,High Risk,High (>80%),Moderate,Liver,Suitable
Omeprazole,Hypertension,Autoimmune Disorders,45.95,C9H8O4,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1994,Ibuprofen,Prilosec,Moderate Risk,Slow Metabolism,Completed,No Preclinical Data,Serotonin Pathway,Tablet,250mg every 8 hours,Novartis,12,Low,High Risk,Low (<50%),Slow,Renal,Suitable
Losartan,Diabetes,Cardiovascular Disease,51.07,C9H8O4,COX Inhibitor,Gastrointestinal Issues,1987,Ibuprofen,Prilosec,Low Risk,Renal Excretion,Phase 2,In Vitro Studies,Dopaminergic Pathway,Syrup,500mg twice a day,Pfizer,12,High,Moderate Risk,High (>80%),Fast,Liver,Partially Suitable
Paracetamol,Gastric Ulcer,Liver Disease,37.64,C13H18O2,AMPK Activator,"Nausea, Dizziness",1987,Acetylsalicylic Acid,Advil,Moderate Risk,High Bioavailability,Phase 1,No Preclinical Data,MAPK Pathway,Tablet,50mg daily,Pfizer,12,Moderate,High Risk,Low (<50%),Slow,Enzyme-Specific,Partially Suitable
Ranitidine,Cholesterol Control,Autoimmune Disorders,51.06,C17H19N3O3S,AMPK Activator,"Headache, Rash",1994,Acetylsalicylic Acid,Aspirin,High Risk,Renal Excretion,Ongoing,Animal Testing,Immune Response Pathway,Tablet,50mg daily,Merck,6,Moderate,Moderate Risk,Moderate (50-80%),Fast,Liver,Suitable
Simvastatin,Cholesterol Control,Anti-Aging,40.38,C33H35FN2O5,Proton Pump Inhibitor,Muscle Pain,1987,Atorvastatin Calcium,Prilosec,Low Risk,Liver Metabolism,Completed,Toxicology Report,Serotonin Pathway,Capsule,500mg twice a day,Merck,6,Moderate,Low Risk,Moderate (50-80%),Moderate,Gut,Suitable
Levothyroxine,Thyroid Hormone Replacement,Migraine Treatment,77.98,C33H35FN2O5,COX Inhibitor,"Headache, Rash",1987,Acetylsalicylic Acid,Aspirin,Low Risk,Rapid Absorption,Phase 2,No Preclinical Data,PI3K-AKT Pathway,Capsule,500mg twice a day,Pfizer,2,High,High Risk,Low (<50%),Slow,Renal,Partially Suitable
Aspirin,Cholesterol Control,Parkinson's,91.44,C17H19N3O3S,Proton Pump Inhibitor,Gastrointestinal Issues,1987,Acetylsalicylic Acid,Glucophage,Moderate Risk,Slow Metabolism,Phase 4,Toxicology Report,Serotonin Pathway,Injection,10mg once daily,Novartis,12,Moderate,Moderate Risk,Moderate (50-80%),Fast,Renal,Suitable
Metformin,Blood Thinner,Autoimmune Disorders,81.02,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1971,Atorvastatin Calcium,Prilosec,Low Risk,Renal Excretion,Phase 2,Animal Testing,Dopaminergic Pathway,Injection,500mg twice a day,Merck,24,Low,High Risk,Moderate (50-80%),Slow,Gut,Not Suitable
Ibuprofen,Acid Reflux,Alzheimer's,57.21,C4H11N5,AMPK Activator,Muscle Pain,1996,Omeprazole,Advil,High Risk,Slow Metabolism,Ongoing,In Vitro Studies,Serotonin Pathway,Topical Gel,As prescribed,Roche,24,High,Low Risk,Moderate (50-80%),Slow,Liver,Partially Suitable
Atorvastatin,Diabetes,Weight Loss,73.51,C33H35FN2O5,NSAID,Gastrointestinal Issues,1994,Omeprazole,Advil,Moderate Risk,Slow Metabolism,Ongoing,Animal Testing,Serotonin Pathway,Capsule,250mg every 8 hours,Roche,6,High,High Risk,Low (<50%),Fast,Gut,Not Suitable
Omeprazole,Pain Relief,Liver Disease,79.32,C17H19N3O3S,NSAID,"Nausea, Dizziness",1965,Omeprazole,Prilosec,Moderate Risk,High Bioavailability,Phase 4,In Vitro Studies,Immune Response Pathway,Capsule,10mg once daily,Pfizer,2,High,Low Risk,Low (<50%),Moderate,Liver,Partially Suitable
Losartan,Thyroid Hormone Replacement,Cardiovascular Disease,82.88,C33H35FN2O5,COX Inhibitor,"Headache, Rash",1971,Atorvastatin Calcium,Advil,High Risk,Liver Metabolism,Ongoing,Animal Testing,MAPK Pathway,Tablet,50mg daily,Novartis,12,Moderate,High Risk,Low (<50%),Slow,Gut,Suitable
Paracetamol,Blood Thinner,Cancer Therapy,64.09,C4H11N5,COX Inhibitor,"Nausea, Dizziness",1987,Atorvastatin Calcium,Glucophage,High Risk,Liver Metabolism,Phase 4,No Preclinical Data,PI3K-AKT Pathway,Topical Gel,250mg every 8 hours,AstraZeneca,24,High,Low Risk,Low (<50%),Fast,Liver,Not Suitable
Ranitidine,Inflammation,Cancer Therapy,86.47,C17H19N3O3S,AMPK Activator,"Headache, Rash",1994,Omeprazole,Glucophage,Moderate Risk,High Bioavailability,Completed,Toxicology Report,Immune Response Pathway,Topical Gel,250mg every 8 hours,Novartis,2,Low,High Risk,High (>80%),Slow,Renal,Suitable
Simvastatin,Cholesterol Control,Migraine Treatment,56.66,C4H11N5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1987,Atorvastatin Calcium,Advil,High Risk,Rapid Absorption,Phase 4,No Preclinical Data,Serotonin Pathway,Syrup,500mg twice a day,Novartis,48,Moderate,Moderate Risk,Moderate (50-80%),Slow,Enzyme-Specific,Not Suitable
Levothyroxine,Fever,Parkinson's,94.35,C4H11N5,AMPK Activator,"Nausea, Dizziness",1996,Acetylsalicylic Acid,Glucophage,Low Risk,Slow Metabolism,Phase 1,In Vitro Studies,Dopaminergic Pathway,Topical Gel,As prescribed,Pfizer,48,Low,Low Risk,Moderate (50-80%),Moderate,Liver,Not Suitable
Aspirin,Cholesterol Control,Cancer Therapy,69.48,C33H35FN2O5,NSAID,"Headache, Rash",1971,Omeprazole,Aspirin,High Risk,High Bioavailability,Completed,In Vitro Studies,Immune Response Pathway,Capsule,10mg once daily,Roche,48,Low,High Risk,Low (<50%),Moderate,Gut,Partially Suitable
Metformin,Gastric Ulcer,Autoimmune Disorders,60.76,C13H18O2,Proton Pump Inhibitor,"Nausea, Dizziness",1994,Acetylsalicylic Acid,Lipitor,Moderate Risk,Liver Metabolism,Phase 3,Animal Testing,PI3K-AKT Pathway,Tablet,500mg twice a day,Novartis,6,High,Moderate Risk,High (>80%),Moderate,Enzyme-Specific,Partially Suitable
Ibuprofen,Thyroid Hormone Replacement,Autoimmune Disorders,82.83,C13H18O2,Proton Pump Inhibitor,"Headache, Rash",1987,Metformin Hydrochloride,Lipitor,Low Risk,Rapid Absorption,Phase 2,Animal Testing,Serotonin Pathway,Topical Gel,As prescribed,Merck,6,High,High Risk,Low (<50%),Moderate,Gut,Suitable
Atorvastatin,Pain Relief,Anti-Aging,44.64,C13H18O2,NSAID,"Headache, Rash",1996,Ibuprofen,Glucophage,Low Risk,Slow Metabolism,Completed,No Preclinical Data,PI3K-AKT Pathway,Topical Gel,As prescribed,Merck,12,Moderate,Moderate Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Partially Suitable
Omeprazole,Blood Thinner,Migraine Treatment,88.76,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1994,Metformin Hydrochloride,Aspirin,Moderate Risk,Slow Metabolism,Phase 1,In Vitro Studies,PI3K-AKT Pathway,Capsule,250mg every 8 hours,AstraZeneca,12,Moderate,Moderate Risk,Low (<50%),Slow,Renal,Suitable
Losartan,Gastric Ulcer,Parkinson's,70.3,C4H11N5,HMG-CoA Reductase Inhibitor,Muscle Pain,1971,Atorvastatin Calcium,Lipitor,Low Risk,Renal Excretion,Phase 3,Toxicology Report,PI3K-AKT Pathway,Syrup,250mg every 8 hours,Merck,48,Low,Moderate Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Not Suitable
Paracetamol,Cholesterol Control,Liver Disease,54.41,C13H18O2,Proton Pump Inhibitor,"Headache, Rash",1987,Ibuprofen,Advil,Moderate Risk,High Bioavailability,Phase 2,Toxicology Report,PI3K-AKT Pathway,Tablet,As prescribed,Novartis,24,Low,Moderate Risk,Low (<50%),Slow,Liver,Suitable
Ranitidine,Blood Thinner,Anti-Aging,32.2,C17H19N3O3S,Proton Pump Inhibitor,Muscle Pain,1996,Ibuprofen,Aspirin,Low Risk,Liver Metabolism,Phase 3,In Vitro Studies,MAPK Pathway,Syrup,500mg twice a day,Novartis,48,High,Moderate Risk,Moderate (50-80%),Moderate,Renal,Suitable
Simvastatin,Blood Thinner,Migraine Treatment,56.79,C4H11N5,HMG-CoA Reductase Inhibitor,Acid Reflux,1971,Omeprazole,Prilosec,Moderate Risk,High Bioavailability,Completed,Toxicology Report,Serotonin Pathway,Syrup,250mg every 8 hours,Roche,6,Low,Low Risk,Moderate (50-80%),Slow,Enzyme-Specific,Partially Suitable
Levothyroxine,Diabetes,Alzheimer's,40.17,C4H11N5,COX Inhibitor,Gastrointestinal Issues,1996,Atorvastatin Calcium,Prilosec,Moderate Risk,Rapid Absorption,Phase 2,Toxicology Report,Serotonin Pathway,Tablet,50mg daily,Pfizer,6,Moderate,Moderate Risk,High (>80%),Moderate,Renal,Partially Suitable
Aspirin,Pain Relief,Liver Disease,74.52,C13H18O2,AMPK Activator,Muscle Pain,1994,Omeprazole,Advil,Moderate Risk,Rapid Absorption,Ongoing,Animal Testing,Immune Response Pathway,Capsule,10mg once daily,Roche,24,High,Low Risk,Moderate (50-80%),Slow,Liver,Not Suitable
Metformin,Hypertension,Cancer Therapy,52.49,C13H18O2,NSAID,Muscle Pain,1987,Acetylsalicylic Acid,Glucophage,Low Risk,Rapid Absorption,Phase 4,In Vitro Studies,Dopaminergic Pathway,Injection,250mg every 8 hours,Merck,48,Low,Low Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Ibuprofen,Diabetes,Cardiovascular Disease,60.83,C4H11N5,Proton Pump Inhibitor,"Headache, Rash",1971,Omeprazole,Advil,Moderate Risk,Slow Metabolism,Phase 3,Toxicology Report,Serotonin Pathway,Injection,50mg daily,Pfizer,12,Low,Low Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Atorvastatin,Inflammation,Cardiovascular Disease,61.06,C4H11N5,COX Inhibitor,Gastrointestinal Issues,1971,Omeprazole,Prilosec,High Risk,Rapid Absorption,Phase 1,Toxicology Report,Immune Response Pathway,Injection,As prescribed,AstraZeneca,6,High,High Risk,Moderate (50-80%),Fast,Renal,Suitable
Omeprazole,Fever,Antiviral,87.36,C4H11N5,COX Inhibitor,"Nausea, Dizziness",1971,Omeprazole,Prilosec,Low Risk,Slow Metabolism,Completed,No Preclinical Data,Dopaminergic Pathway,Syrup,50mg daily,Merck,6,High,Moderate Risk,High (>80%),Moderate,Liver,Suitable
Losartan,Hypertension,Alzheimer's,62.66,C9H8O4,AMPK Activator,Muscle Pain,1971,Metformin Hydrochloride,Advil,Moderate Risk,Liver Metabolism,Phase 1,Animal Testing,Immune Response Pathway,Capsule,10mg once daily,Novartis,24,Low,Moderate Risk,Moderate (50-80%),Moderate,Renal,Not Suitable
Paracetamol,Thyroid Hormone Replacement,Anti-Aging,83.84,C13H18O2,AMPK Activator,Acid Reflux,1965,Metformin Hydrochloride,Advil,Low Risk,Slow Metabolism,Ongoing,No Preclinical Data,Dopaminergic Pathway,Capsule,As prescribed,AstraZeneca,12,Low,Moderate Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Suitable
Ranitidine,Blood Thinner,Cancer Therapy,86,C33H35FN2O5,NSAID,"Nausea, Dizziness",1987,Omeprazole,Glucophage,High Risk,Liver Metabolism,Phase 1,No Preclinical Data,Dopaminergic Pathway,Tablet,10mg once daily,AstraZeneca,6,Moderate,High Risk,Low (<50%),Slow,Gut,Suitable
Simvastatin,Hypertension,Antiviral,67.47,C17H19N3O3S,HMG-CoA Reductase Inhibitor,"Headache, Rash",1971,Ibuprofen,Prilosec,High Risk,Renal Excretion,Phase 1,In Vitro Studies,Dopaminergic Pathway,Capsule,50mg daily,AstraZeneca,24,High,High Risk,Low (<50%),Slow,Enzyme-Specific,Not Suitable
Levothyroxine,Thyroid Hormone Replacement,Weight Loss,47.73,C33H35FN2O5,COX Inhibitor,Muscle Pain,1996,Metformin Hydrochloride,Aspirin,High Risk,Slow Metabolism,Phase 2,Toxicology Report,Serotonin Pathway,Injection,250mg every 8 hours,Novartis,12,High,Low Risk,Low (<50%),Fast,Enzyme-Specific,Suitable
Aspirin,Cholesterol Control,Liver Disease,87.07,C9H8O4,AMPK Activator,"Nausea, Dizziness",1965,Ibuprofen,Lipitor,High Risk,Liver Metabolism,Ongoing,No Preclinical Data,Immune Response Pathway,Tablet,50mg daily,Merck,12,Low,Moderate Risk,Moderate (50-80%),Fast,Renal,Partially Suitable
Metformin,Diabetes,Autoimmune Disorders,57.54,C13H18O2,AMPK Activator,"Nausea, Dizziness",1994,Omeprazole,Aspirin,Low Risk,Renal Excretion,Ongoing,No Preclinical Data,PI3K-AKT Pathway,Tablet,10mg once daily,Roche,6,High,Moderate Risk,Low (<50%),Slow,Gut,Partially Suitable
Ibuprofen,Blood Thinner,Autoimmune Disorders,81.66,C9H8O4,Proton Pump Inhibitor,Muscle Pain,1996,Atorvastatin Calcium,Lipitor,High Risk,Rapid Absorption,Phase 2,Animal Testing,Serotonin Pathway,Capsule,250mg every 8 hours,AstraZeneca,24,High,Low Risk,Low (<50%),Slow,Enzyme-Specific,Partially Suitable
Atorvastatin,Hypertension,Autoimmune Disorders,79.24,C4H11N5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1965,Metformin Hydrochloride,Advil,High Risk,Renal Excretion,Phase 4,Toxicology Report,Serotonin Pathway,Injection,500mg twice a day,Merck,24,Low,Low Risk,Moderate (50-80%),Fast,Renal,Suitable
Omeprazole,Gastric Ulcer,Alzheimer's,76.01,C17H19N3O3S,AMPK Activator,Muscle Pain,1996,Atorvastatin Calcium,Prilosec,Low Risk,High Bioavailability,Phase 2,No Preclinical Data,PI3K-AKT Pathway,Syrup,50mg daily,AstraZeneca,24,Low,High Risk,Moderate (50-80%),Moderate,Liver,Suitable
Losartan,Diabetes,Anti-Aging,39.75,C17H19N3O3S,NSAID,"Nausea, Dizziness",1996,Ibuprofen,Advil,Moderate Risk,Liver Metabolism,Phase 1,Animal Testing,MAPK Pathway,Topical Gel,250mg every 8 hours,Merck,2,High,Moderate Risk,Moderate (50-80%),Moderate,Gut,Suitable
Paracetamol,Blood Thinner,Cardiovascular Disease,58.21,C17H19N3O3S,NSAID,"Nausea, Dizziness",1971,Metformin Hydrochloride,Glucophage,High Risk,High Bioavailability,Completed,No Preclinical Data,Immune Response Pathway,Capsule,10mg once daily,AstraZeneca,24,Moderate,High Risk,Moderate (50-80%),Fast,Gut,Not Suitable
Ranitidine,Cholesterol Control,Weight Loss,74.91,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Muscle Pain,1971,Acetylsalicylic Acid,Glucophage,High Risk,Slow Metabolism,Phase 4,In Vitro Studies,MAPK Pathway,Tablet,500mg twice a day,Merck,12,Low,Moderate Risk,Moderate (50-80%),Moderate,Renal,Suitable
Simvastatin,Thyroid Hormone Replacement,Cardiovascular Disease,57.94,C9H8O4,Proton Pump Inhibitor,Muscle Pain,1965,Atorvastatin Calcium,Prilosec,Moderate Risk,Renal Excretion,Phase 4,Animal Testing,MAPK Pathway,Injection,As prescribed,Pfizer,2,Low,High Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Levothyroxine,Acid Reflux,Alzheimer's,78.65,C9H8O4,Proton Pump Inhibitor,"Nausea, Dizziness",1965,Atorvastatin Calcium,Advil,Moderate Risk,Liver Metabolism,Phase 4,In Vitro Studies,MAPK Pathway,Injection,250mg every 8 hours,Pfizer,2,High,Low Risk,Low (<50%),Slow,Renal,Partially Suitable
Aspirin,Blood Thinner,Anti-Aging,83.74,C17H19N3O3S,COX Inhibitor,Gastrointestinal Issues,1971,Acetylsalicylic Acid,Prilosec,Low Risk,Slow Metabolism,Completed,No Preclinical Data,PI3K-AKT Pathway,Syrup,250mg every 8 hours,Novartis,24,High,Low Risk,High (>80%),Fast,Enzyme-Specific,Suitable
Metformin,Inflammation,Alzheimer's,65.42,C9H8O4,Proton Pump Inhibitor,Acid Reflux,1965,Omeprazole,Aspirin,High Risk,Liver Metabolism,Phase 3,In Vitro Studies,PI3K-AKT Pathway,Capsule,As prescribed,Pfizer,6,Moderate,Moderate Risk,Low (<50%),Slow,Gut,Suitable
Ibuprofen,Acid Reflux,Migraine Treatment,35.03,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Acid Reflux,1996,Atorvastatin Calcium,Prilosec,High Risk,Slow Metabolism,Phase 3,In Vitro Studies,PI3K-AKT Pathway,Tablet,As prescribed,Novartis,48,Moderate,Moderate Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Atorvastatin,Blood Thinner,Weight Loss,33.76,C9H8O4,AMPK Activator,Gastrointestinal Issues,1965,Ibuprofen,Glucophage,High Risk,Rapid Absorption,Phase 1,Toxicology Report,MAPK Pathway,Topical Gel,As prescribed,Merck,12,Moderate,High Risk,High (>80%),Moderate,Renal,Not Suitable
Omeprazole,Fever,Cancer Therapy,33.14,C4H11N5,AMPK Activator,"Headache, Rash",1994,Atorvastatin Calcium,Lipitor,High Risk,High Bioavailability,Phase 2,No Preclinical Data,Dopaminergic Pathway,Tablet,250mg every 8 hours,Novartis,12,High,Moderate Risk,High (>80%),Fast,Liver,Partially Suitable
Losartan,Thyroid Hormone Replacement,Anti-Aging,60.04,C13H18O2,HMG-CoA Reductase Inhibitor,Muscle Pain,1965,Metformin Hydrochloride,Aspirin,High Risk,High Bioavailability,Phase 1,Animal Testing,Serotonin Pathway,Syrup,50mg daily,Roche,12,High,Low Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Suitable
Paracetamol,Diabetes,Weight Loss,62.62,C13H18O2,AMPK Activator,"Nausea, Dizziness",1965,Ibuprofen,Aspirin,Low Risk,Renal Excretion,Completed,Toxicology Report,Immune Response Pathway,Topical Gel,10mg once daily,Novartis,48,Moderate,Low Risk,High (>80%),Slow,Renal,Suitable
Ranitidine,Pain Relief,Parkinson's,84.82,C13H18O2,AMPK Activator,"Nausea, Dizziness",1994,Acetylsalicylic Acid,Prilosec,Moderate Risk,Liver Metabolism,Phase 4,In Vitro Studies,Immune Response Pathway,Injection,10mg once daily,Merck,6,High,Low Risk,Moderate (50-80%),Moderate,Liver,Suitable
Simvastatin,Pain Relief,Migraine Treatment,55.08,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1965,Acetylsalicylic Acid,Aspirin,High Risk,Liver Metabolism,Phase 2,Toxicology Report,Immune Response Pathway,Topical Gel,50mg daily,Roche,24,Low,Low Risk,High (>80%),Moderate,Gut,Suitable
Levothyroxine,Hypertension,Migraine Treatment,41.97,C17H19N3O3S,NSAID,Gastrointestinal Issues,1994,Acetylsalicylic Acid,Prilosec,High Risk,Rapid Absorption,Phase 1,Toxicology Report,Immune Response Pathway,Injection,50mg daily,Roche,48,Low,Moderate Risk,Low (<50%),Slow,Liver,Partially Suitable
Aspirin,Acid Reflux,Antiviral,86.91,C9H8O4,AMPK Activator,"Headache, Rash",1971,Acetylsalicylic Acid,Advil,Moderate Risk,Rapid Absorption,Phase 1,Toxicology Report,Serotonin Pathway,Injection,As prescribed,Roche,12,Moderate,High Risk,Moderate (50-80%),Slow,Liver,Partially Suitable
Metformin,Hypertension,Cardiovascular Disease,46.86,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Acid Reflux,1996,Metformin Hydrochloride,Prilosec,High Risk,High Bioavailability,Completed,Toxicology Report,MAPK Pathway,Syrup,50mg daily,Pfizer,24,Low,Low Risk,Low (<50%),Moderate,Gut,Partially Suitable
Ibuprofen,Pain Relief,Weight Loss,86.93,C17H19N3O3S,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1994,Atorvastatin Calcium,Prilosec,Low Risk,Rapid Absorption,Ongoing,No Preclinical Data,Serotonin Pathway,Tablet,As prescribed,Pfizer,6,Moderate,Moderate Risk,Low (<50%),Moderate,Gut,Not Suitable
Atorvastatin,Gastric Ulcer,Weight Loss,88.45,C13H18O2,COX Inhibitor,Acid Reflux,1994,Atorvastatin Calcium,Advil,Low Risk,Liver Metabolism,Phase 2,Toxicology Report,Dopaminergic Pathway,Capsule,As prescribed,Novartis,48,Moderate,Low Risk,Moderate (50-80%),Fast,Liver,Suitable
Omeprazole,Diabetes,Anti-Aging,68.51,C4H11N5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1971,Metformin Hydrochloride,Glucophage,Moderate Risk,Liver Metabolism,Completed,Toxicology Report,PI3K-AKT Pathway,Injection,250mg every 8 hours,AstraZeneca,2,High,Moderate Risk,Moderate (50-80%),Fast,Enzyme-Specific,Suitable
Losartan,Acid Reflux,Liver Disease,46.01,C4H11N5,COX Inhibitor,"Headache, Rash",1996,Metformin Hydrochloride,Prilosec,Low Risk,Rapid Absorption,Phase 1,Toxicology Report,MAPK Pathway,Topical Gel,10mg once daily,AstraZeneca,48,High,Low Risk,Moderate (50-80%),Moderate,Liver,Not Suitable
Paracetamol,Acid Reflux,Alzheimer's,89.29,C4H11N5,COX Inhibitor,Muscle Pain,1965,Ibuprofen,Glucophage,High Risk,High Bioavailability,Phase 3,No Preclinical Data,Immune Response Pathway,Capsule,250mg every 8 hours,Merck,48,Low,Low Risk,High (>80%),Moderate,Enzyme-Specific,Not Suitable
Ranitidine,Diabetes,Migraine Treatment,35.05,C13H18O2,AMPK Activator,"Headache, Rash",1971,Omeprazole,Glucophage,High Risk,Slow Metabolism,Phase 3,In Vitro Studies,MAPK Pathway,Topical Gel,10mg once daily,Merck,6,Moderate,Moderate Risk,Low (<50%),Fast,Liver,Not Suitable
Simvastatin,Thyroid Hormone Replacement,Cancer Therapy,50,C17H19N3O3S,AMPK Activator,Acid Reflux,1971,Metformin Hydrochloride,Advil,High Risk,Slow Metabolism,Phase 4,No Preclinical Data,Immune Response Pathway,Syrup,As prescribed,AstraZeneca,6,Moderate,High Risk,Low (<50%),Fast,Gut,Suitable
Levothyroxine,Hypertension,Weight Loss,94.62,C13H18O2,AMPK Activator,Acid Reflux,1965,Atorvastatin Calcium,Aspirin,Moderate Risk,High Bioavailability,Ongoing,Toxicology Report,MAPK Pathway,Injection,500mg twice a day,AstraZeneca,12,Low,Low Risk,High (>80%),Slow,Enzyme-Specific,Not Suitable
Aspirin,Gastric Ulcer,Migraine Treatment,88.64,C9H8O4,NSAID,Gastrointestinal Issues,1965,Atorvastatin Calcium,Prilosec,Moderate Risk,Rapid Absorption,Completed,In Vitro Studies,Serotonin Pathway,Topical Gel,50mg daily,AstraZeneca,48,Low,High Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Metformin,Inflammation,Anti-Aging,58.46,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1987,Metformin Hydrochloride,Aspirin,Low Risk,Liver Metabolism,Completed,No Preclinical Data,Immune Response Pathway,Injection,500mg twice a day,Merck,48,Low,Moderate Risk,High (>80%),Fast,Renal,Partially Suitable
Ibuprofen,Diabetes,Liver Disease,65.8,C9H8O4,COX Inhibitor,Gastrointestinal Issues,1994,Omeprazole,Glucophage,High Risk,Slow Metabolism,Phase 2,Toxicology Report,MAPK Pathway,Capsule,500mg twice a day,Merck,6,Low,Moderate Risk,Low (<50%),Moderate,Gut,Partially Suitable
Atorvastatin,Cholesterol Control,Autoimmune Disorders,87.04,C9H8O4,AMPK Activator,Gastrointestinal Issues,1994,Acetylsalicylic Acid,Aspirin,Moderate Risk,Renal Excretion,Phase 4,Animal Testing,PI3K-AKT Pathway,Capsule,500mg twice a day,Merck,6,Moderate,Low Risk,Moderate (50-80%),Fast,Renal,Partially Suitable
Omeprazole,Diabetes,Cardiovascular Disease,80.25,C9H8O4,Proton Pump Inhibitor,Gastrointestinal Issues,1994,Acetylsalicylic Acid,Prilosec,Moderate Risk,Liver Metabolism,Phase 4,Toxicology Report,Serotonin Pathway,Capsule,500mg twice a day,Pfizer,24,High,Low Risk,Low (<50%),Moderate,Gut,Partially Suitable
Losartan,Pain Relief,Antiviral,65.18,C17H19N3O3S,COX Inhibitor,"Nausea, Dizziness",1996,Atorvastatin Calcium,Prilosec,High Risk,Liver Metabolism,Phase 3,Animal Testing,MAPK Pathway,Capsule,10mg once daily,Merck,2,Low,High Risk,Moderate (50-80%),Fast,Enzyme-Specific,Suitable
Paracetamol,Diabetes,Autoimmune Disorders,74.6,C13H18O2,COX Inhibitor,Muscle Pain,1994,Atorvastatin Calcium,Prilosec,Moderate Risk,Rapid Absorption,Completed,Animal Testing,MAPK Pathway,Topical Gel,As prescribed,Roche,6,Low,High Risk,Low (<50%),Fast,Liver,Suitable
Ranitidine,Pain Relief,Liver Disease,94.35,C9H8O4,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1994,Acetylsalicylic Acid,Advil,High Risk,Rapid Absorption,Phase 2,In Vitro Studies,Serotonin Pathway,Injection,500mg twice a day,Pfizer,24,High,Moderate Risk,Moderate (50-80%),Slow,Gut,Partially Suitable
Simvastatin,Fever,Cardiovascular Disease,81.03,C4H11N5,Proton Pump Inhibitor,Gastrointestinal Issues,1996,Acetylsalicylic Acid,Prilosec,High Risk,Renal Excretion,Ongoing,No Preclinical Data,Dopaminergic Pathway,Injection,10mg once daily,Pfizer,6,Moderate,Low Risk,High (>80%),Moderate,Gut,Suitable
Levothyroxine,Diabetes,Alzheimer's,68.66,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Muscle Pain,1965,Ibuprofen,Advil,Moderate Risk,Slow Metabolism,Phase 4,In Vitro Studies,MAPK Pathway,Topical Gel,10mg once daily,Novartis,6,Low,Low Risk,Low (<50%),Fast,Renal,Partially Suitable
Aspirin,Diabetes,Cardiovascular Disease,61.74,C9H8O4,HMG-CoA Reductase Inhibitor,"Headache, Rash",1971,Omeprazole,Advil,Low Risk,High Bioavailability,Phase 3,Toxicology Report,MAPK Pathway,Capsule,250mg every 8 hours,Roche,24,High,Low Risk,High (>80%),Fast,Liver,Partially Suitable
Metformin,Thyroid Hormone Replacement,Cancer Therapy,56.04,C13H18O2,COX Inhibitor,Gastrointestinal Issues,1987,Atorvastatin Calcium,Prilosec,Moderate Risk,Rapid Absorption,Phase 3,Toxicology Report,PI3K-AKT Pathway,Syrup,500mg twice a day,Pfizer,2,Low,Low Risk,High (>80%),Fast,Gut,Partially Suitable
Ibuprofen,Inflammation,Anti-Aging,57.4,C17H19N3O3S,AMPK Activator,Acid Reflux,1996,Atorvastatin Calcium,Lipitor,Moderate Risk,Renal Excretion,Phase 4,Animal Testing,Dopaminergic Pathway,Syrup,50mg daily,Pfizer,48,Low,Low Risk,High (>80%),Moderate,Enzyme-Specific,Not Suitable
Atorvastatin,Hypertension,Anti-Aging,68.37,C17H19N3O3S,HMG-CoA Reductase Inhibitor,"Headache, Rash",1996,Metformin Hydrochloride,Advil,Moderate Risk,Renal Excretion,Phase 1,No Preclinical Data,Immune Response Pathway,Tablet,500mg twice a day,Pfizer,6,High,Low Risk,High (>80%),Slow,Liver,Suitable
Omeprazole,Fever,Cancer Therapy,90.03,C17H19N3O3S,NSAID,"Headache, Rash",1965,Ibuprofen,Glucophage,Moderate Risk,Slow Metabolism,Phase 2,Animal Testing,MAPK Pathway,Topical Gel,50mg daily,AstraZeneca,48,High,High Risk,Moderate (50-80%),Slow,Gut,Partially Suitable
Losartan,Thyroid Hormone Replacement,Antiviral,47.38,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1987,Ibuprofen,Prilosec,Moderate Risk,Liver Metabolism,Phase 3,Toxicology Report,Serotonin Pathway,Tablet,250mg every 8 hours,Roche,12,High,Moderate Risk,Moderate (50-80%),Fast,Enzyme-Specific,Partially Suitable
Paracetamol,Pain Relief,Cardiovascular Disease,64.69,C9H8O4,AMPK Activator,"Headache, Rash",1994,Ibuprofen,Advil,Moderate Risk,Slow Metabolism,Phase 3,No Preclinical Data,Immune Response Pathway,Capsule,50mg daily,Pfizer,24,High,Low Risk,High (>80%),Fast,Liver,Not Suitable
Ranitidine,Acid Reflux,Weight Loss,83.45,C4H11N5,COX Inhibitor,Muscle Pain,1971,Atorvastatin Calcium,Lipitor,Low Risk,Rapid Absorption,Phase 1,In Vitro Studies,PI3K-AKT Pathway,Capsule,500mg twice a day,Pfizer,12,High,Moderate Risk,Moderate (50-80%),Moderate,Gut,Partially Suitable
Simvastatin,Hypertension,Antiviral,38.22,C4H11N5,Proton Pump Inhibitor,"Headache, Rash",1996,Atorvastatin Calcium,Glucophage,High Risk,High Bioavailability,Ongoing,Animal Testing,Serotonin Pathway,Topical Gel,250mg every 8 hours,Novartis,2,High,Low Risk,Low (<50%),Slow,Liver,Not Suitable
Levothyroxine,Fever,Parkinson's,61.77,C9H8O4,NSAID,"Headache, Rash",1965,Ibuprofen,Advil,Moderate Risk,Liver Metabolism,Completed,In Vitro Studies,PI3K-AKT Pathway,Topical Gel,250mg every 8 hours,Merck,24,High,High Risk,Low (<50%),Moderate,Renal,Partially Suitable
Aspirin,Fever,Parkinson's,74.05,C13H18O2,COX Inhibitor,"Nausea, Dizziness",1965,Omeprazole,Glucophage,Moderate Risk,High Bioavailability,Phase 4,In Vitro Studies,PI3K-AKT Pathway,Syrup,50mg daily,AstraZeneca,6,Moderate,High Risk,High (>80%),Fast,Renal,Not Suitable
Metformin,Fever,Liver Disease,65.66,C13H18O2,COX Inhibitor,Gastrointestinal Issues,1994,Omeprazole,Advil,Moderate Risk,Liver Metabolism,Phase 3,In Vitro Studies,Dopaminergic Pathway,Capsule,50mg daily,Merck,12,High,Low Risk,Low (<50%),Slow,Enzyme-Specific,Partially Suitable
Ibuprofen,Thyroid Hormone Replacement,Alzheimer's,46.03,C17H19N3O3S,COX Inhibitor,Muscle Pain,1987,Ibuprofen,Lipitor,High Risk,Renal Excretion,Phase 2,No Preclinical Data,MAPK Pathway,Topical Gel,50mg daily,Novartis,2,Moderate,Low Risk,Moderate (50-80%),Moderate,Liver,Not Suitable
Atorvastatin,Hypertension,Migraine Treatment,66.92,C4H11N5,COX Inhibitor,Muscle Pain,1994,Ibuprofen,Lipitor,High Risk,High Bioavailability,Phase 4,Animal Testing,Immune Response Pathway,Syrup,10mg once daily,Merck,48,Low,Moderate Risk,High (>80%),Moderate,Renal,Suitable
Omeprazole,Acid Reflux,Autoimmune Disorders,72.58,C4H11N5,NSAID,Acid Reflux,1994,Acetylsalicylic Acid,Glucophage,High Risk,High Bioavailability,Phase 1,Animal Testing,Dopaminergic Pathway,Capsule,500mg twice a day,Merck,6,Low,Low Risk,Moderate (50-80%),Moderate,Gut,Not Suitable
Losartan,Diabetes,Autoimmune Disorders,46.98,C13H18O2,COX Inhibitor,Acid Reflux,1971,Ibuprofen,Lipitor,Low Risk,Renal Excretion,Phase 1,Animal Testing,Dopaminergic Pathway,Tablet,500mg twice a day,Merck,2,Low,Moderate Risk,High (>80%),Slow,Gut,Partially Suitable
Paracetamol,Fever,Weight Loss,64.04,C33H35FN2O5,AMPK Activator,"Headache, Rash",1987,Metformin Hydrochloride,Aspirin,Low Risk,Rapid Absorption,Ongoing,No Preclinical Data,Serotonin Pathway,Topical Gel,250mg every 8 hours,Novartis,2,Low,Moderate Risk,Moderate (50-80%),Slow,Enzyme-Specific,Partially Suitable
Ranitidine,Pain Relief,Alzheimer's,34.37,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1996,Metformin Hydrochloride,Glucophage,High Risk,Liver Metabolism,Phase 1,Animal Testing,Serotonin Pathway,Tablet,50mg daily,Novartis,48,Moderate,Moderate Risk,Moderate (50-80%),Slow,Gut,Partially Suitable
Simvastatin,Cholesterol Control,Liver Disease,89.59,C13H18O2,Proton Pump Inhibitor,"Nausea, Dizziness",1994,Atorvastatin Calcium,Glucophage,High Risk,Slow Metabolism,Phase 1,Animal Testing,MAPK Pathway,Tablet,250mg every 8 hours,Pfizer,24,Low,High Risk,Low (<50%),Moderate,Enzyme-Specific,Not Suitable
Levothyroxine,Pain Relief,Anti-Aging,42.44,C4H11N5,Proton Pump Inhibitor,Acid Reflux,1965,Metformin Hydrochloride,Prilosec,High Risk,Slow Metabolism,Phase 4,In Vitro Studies,MAPK Pathway,Topical Gel,500mg twice a day,Pfizer,24,High,High Risk,Low (<50%),Moderate,Liver,Partially Suitable
Aspirin,Gastric Ulcer,Antiviral,31.69,C13H18O2,COX Inhibitor,"Nausea, Dizziness",1987,Acetylsalicylic Acid,Advil,High Risk,Rapid Absorption,Ongoing,In Vitro Studies,MAPK Pathway,Tablet,50mg daily,Merck,24,High,Moderate Risk,Moderate (50-80%),Fast,Liver,Suitable
Metformin,Cholesterol Control,Cancer Therapy,91.86,C4H11N5,HMG-CoA Reductase Inhibitor,Acid Reflux,1971,Omeprazole,Aspirin,Moderate Risk,Rapid Absorption,Phase 2,Animal Testing,PI3K-AKT Pathway,Tablet,500mg twice a day,AstraZeneca,48,Low,High Risk,Moderate (50-80%),Fast,Renal,Not Suitable
Ibuprofen,Cholesterol Control,Antiviral,71.5,C13H18O2,Proton Pump Inhibitor,Gastrointestinal Issues,1996,Omeprazole,Aspirin,Moderate Risk,Slow Metabolism,Ongoing,Toxicology Report,Dopaminergic Pathway,Capsule,250mg every 8 hours,AstraZeneca,48,High,High Risk,High (>80%),Slow,Gut,Suitable
Atorvastatin,Hypertension,Cancer Therapy,92.99,C17H19N3O3S,AMPK Activator,"Headache, Rash",1971,Metformin Hydrochloride,Aspirin,Low Risk,Liver Metabolism,Completed,Toxicology Report,PI3K-AKT Pathway,Capsule,50mg daily,Roche,12,High,Low Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Omeprazole,Hypertension,Weight Loss,77.13,C33H35FN2O5,AMPK Activator,Gastrointestinal Issues,1971,Acetylsalicylic Acid,Lipitor,Low Risk,Rapid Absorption,Completed,Animal Testing,MAPK Pathway,Capsule,500mg twice a day,Pfizer,24,Moderate,High Risk,Low (<50%),Slow,Renal,Partially Suitable
Losartan,Fever,Parkinson's,49.43,C17H19N3O3S,COX Inhibitor,Muscle Pain,1987,Metformin Hydrochloride,Aspirin,Moderate Risk,Renal Excretion,Phase 4,No Preclinical Data,Serotonin Pathway,Capsule,250mg every 8 hours,Novartis,2,Moderate,High Risk,Moderate (50-80%),Fast,Gut,Suitable
Paracetamol,Inflammation,Liver Disease,72.44,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Muscle Pain,1987,Acetylsalicylic Acid,Prilosec,Moderate Risk,Rapid Absorption,Phase 3,No Preclinical Data,Serotonin Pathway,Topical Gel,As prescribed,Novartis,2,Moderate,Low Risk,Moderate (50-80%),Moderate,Liver,Not Suitable
Ranitidine,Cholesterol Control,Liver Disease,37.14,C9H8O4,HMG-CoA Reductase Inhibitor,"Headache, Rash",1965,Acetylsalicylic Acid,Prilosec,High Risk,High Bioavailability,Ongoing,No Preclinical Data,PI3K-AKT Pathway,Topical Gel,50mg daily,Novartis,6,Moderate,High Risk,Low (<50%),Fast,Renal,Not Suitable
Simvastatin,Gastric Ulcer,Parkinson's,70.64,C33H35FN2O5,Proton Pump Inhibitor,"Headache, Rash",1994,Omeprazole,Lipitor,High Risk,Slow Metabolism,Phase 1,In Vitro Studies,Serotonin Pathway,Capsule,10mg once daily,Merck,48,Moderate,High Risk,High (>80%),Moderate,Gut,Suitable
Levothyroxine,Pain Relief,Cancer Therapy,45.15,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1987,Ibuprofen,Advil,Moderate Risk,Slow Metabolism,Phase 3,Animal Testing,Serotonin Pathway,Topical Gel,50mg daily,Pfizer,2,High,High Risk,Moderate (50-80%),Slow,Gut,Partially Suitable
Aspirin,Thyroid Hormone Replacement,Alzheimer's,32.58,C17H19N3O3S,Proton Pump Inhibitor,Gastrointestinal Issues,1965,Metformin Hydrochloride,Aspirin,Moderate Risk,Slow Metabolism,Phase 2,No Preclinical Data,PI3K-AKT Pathway,Tablet,10mg once daily,Merck,12,Low,High Risk,Moderate (50-80%),Slow,Enzyme-Specific,Not Suitable
Metformin,Hypertension,Cancer Therapy,62.04,C4H11N5,AMPK Activator,"Nausea, Dizziness",1994,Ibuprofen,Prilosec,Moderate Risk,Slow Metabolism,Phase 1,Animal Testing,Serotonin Pathway,Injection,50mg daily,Roche,24,High,Moderate Risk,High (>80%),Moderate,Liver,Suitable
Ibuprofen,Hypertension,Alzheimer's,76.38,C4H11N5,COX Inhibitor,Muscle Pain,1971,Metformin Hydrochloride,Prilosec,Moderate Risk,High Bioavailability,Phase 3,In Vitro Studies,Dopaminergic Pathway,Injection,10mg once daily,Roche,2,Moderate,High Risk,Low (<50%),Fast,Enzyme-Specific,Partially Suitable
Atorvastatin,Thyroid Hormone Replacement,Anti-Aging,80.37,C33H35FN2O5,AMPK Activator,Acid Reflux,1965,Omeprazole,Advil,Moderate Risk,High Bioavailability,Completed,No Preclinical Data,Dopaminergic Pathway,Topical Gel,250mg every 8 hours,Merck,12,Moderate,Low Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Omeprazole,Inflammation,Anti-Aging,94.16,C4H11N5,HMG-CoA Reductase Inhibitor,Muscle Pain,1996,Metformin Hydrochloride,Glucophage,High Risk,Liver Metabolism,Phase 3,No Preclinical Data,PI3K-AKT Pathway,Capsule,500mg twice a day,Merck,24,Moderate,Moderate Risk,High (>80%),Slow,Liver,Partially Suitable
Losartan,Blood Thinner,Migraine Treatment,51.04,C17H19N3O3S,Proton Pump Inhibitor,"Headache, Rash",1965,Ibuprofen,Prilosec,Low Risk,Slow Metabolism,Phase 3,Toxicology Report,Serotonin Pathway,Injection,50mg daily,Novartis,2,High,High Risk,Moderate (50-80%),Slow,Enzyme-Specific,Suitable
Paracetamol,Pain Relief,Alzheimer's,67.36,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Acid Reflux,1965,Atorvastatin Calcium,Advil,Low Risk,Liver Metabolism,Phase 4,In Vitro Studies,Immune Response Pathway,Topical Gel,250mg every 8 hours,AstraZeneca,12,High,Moderate Risk,Moderate (50-80%),Fast,Liver,Suitable
Ranitidine,Gastric Ulcer,Migraine Treatment,77.52,C4H11N5,COX Inhibitor,Gastrointestinal Issues,1971,Omeprazole,Prilosec,Moderate Risk,Rapid Absorption,Phase 4,No Preclinical Data,Serotonin Pathway,Tablet,10mg once daily,Pfizer,6,Low,High Risk,Moderate (50-80%),Moderate,Renal,Not Suitable
Simvastatin,Fever,Autoimmune Disorders,37.21,C9H8O4,COX Inhibitor,"Headache, Rash",1965,Metformin Hydrochloride,Advil,High Risk,Slow Metabolism,Phase 3,Toxicology Report,Serotonin Pathway,Injection,50mg daily,Novartis,48,Low,Moderate Risk,Moderate (50-80%),Moderate,Renal,Partially Suitable
Levothyroxine,Inflammation,Antiviral,70.47,C4H11N5,COX Inhibitor,"Nausea, Dizziness",1965,Omeprazole,Lipitor,Moderate Risk,Slow Metabolism,Phase 4,Toxicology Report,Serotonin Pathway,Tablet,10mg once daily,Roche,6,Moderate,High Risk,High (>80%),Moderate,Renal,Not Suitable
Aspirin,Hypertension,Cancer Therapy,67.95,C13H18O2,COX Inhibitor,Acid Reflux,1971,Acetylsalicylic Acid,Glucophage,High Risk,High Bioavailability,Phase 4,No Preclinical Data,MAPK Pathway,Tablet,10mg once daily,Novartis,2,Moderate,Moderate Risk,High (>80%),Fast,Enzyme-Specific,Not Suitable
Metformin,Thyroid Hormone Replacement,Autoimmune Disorders,31.83,C13H18O2,NSAID,Acid Reflux,1971,Atorvastatin Calcium,Aspirin,Low Risk,Liver Metabolism,Phase 2,No Preclinical Data,PI3K-AKT Pathway,Injection,As prescribed,Merck,6,Moderate,Moderate Risk,Moderate (50-80%),Fast,Enzyme-Specific,Not Suitable
Ibuprofen,Blood Thinner,Alzheimer's,83.65,C4H11N5,AMPK Activator,Muscle Pain,1996,Metformin Hydrochloride,Glucophage,Moderate Risk,High Bioavailability,Phase 3,No Preclinical Data,Serotonin Pathway,Topical Gel,500mg twice a day,Roche,6,Moderate,High Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Suitable
Atorvastatin,Gastric Ulcer,Migraine Treatment,77.2,C13H18O2,Proton Pump Inhibitor,Gastrointestinal Issues,1987,Metformin Hydrochloride,Advil,High Risk,Rapid Absorption,Phase 1,In Vitro Studies,MAPK Pathway,Tablet,50mg daily,Pfizer,6,Moderate,Moderate Risk,Moderate (50-80%),Moderate,Liver,Partially Suitable
Omeprazole,Acid Reflux,Liver Disease,70.73,C9H8O4,AMPK Activator,"Nausea, Dizziness",1965,Omeprazole,Aspirin,Moderate Risk,Liver Metabolism,Phase 2,No Preclinical Data,PI3K-AKT Pathway,Syrup,250mg every 8 hours,Roche,48,Moderate,Moderate Risk,Low (<50%),Fast,Gut,Partially Suitable
Losartan,Acid Reflux,Alzheimer's,83.49,C17H19N3O3S,COX Inhibitor,"Headache, Rash",1965,Ibuprofen,Advil,High Risk,High Bioavailability,Phase 2,Toxicology Report,Immune Response Pathway,Capsule,250mg every 8 hours,Pfizer,6,Low,Moderate Risk,High (>80%),Fast,Liver,Partially Suitable
Paracetamol,Pain Relief,Cancer Therapy,42.37,C4H11N5,HMG-CoA Reductase Inhibitor,Acid Reflux,1994,Metformin Hydrochloride,Lipitor,High Risk,Slow Metabolism,Ongoing,No Preclinical Data,MAPK Pathway,Topical Gel,10mg once daily,Roche,12,Moderate,High Risk,High (>80%),Slow,Enzyme-Specific,Suitable
Ranitidine,Pain Relief,Antiviral,71.52,C33H35FN2O5,AMPK Activator,"Nausea, Dizziness",1965,Ibuprofen,Lipitor,High Risk,Slow Metabolism,Phase 1,In Vitro Studies,Serotonin Pathway,Capsule,50mg daily,Roche,12,Low,Low Risk,Moderate (50-80%),Moderate,Liver,Not Suitable
Simvastatin,Diabetes,Cancer Therapy,79,C4H11N5,Proton Pump Inhibitor,Acid Reflux,1965,Atorvastatin Calcium,Aspirin,High Risk,Liver Metabolism,Ongoing,No Preclinical Data,Serotonin Pathway,Capsule,As prescribed,AstraZeneca,24,Low,Low Risk,High (>80%),Slow,Gut,Suitable
Levothyroxine,Inflammation,Autoimmune Disorders,89.13,C17H19N3O3S,COX Inhibitor,"Headache, Rash",1996,Atorvastatin Calcium,Lipitor,Moderate Risk,Renal Excretion,Phase 4,No Preclinical Data,Immune Response Pathway,Syrup,50mg daily,Novartis,2,Low,High Risk,Moderate (50-80%),Fast,Renal,Not Suitable
Aspirin,Fever,Cardiovascular Disease,62.17,C13H18O2,Proton Pump Inhibitor,"Nausea, Dizziness",1987,Acetylsalicylic Acid,Aspirin,High Risk,Rapid Absorption,Phase 1,Toxicology Report,MAPK Pathway,Topical Gel,250mg every 8 hours,Merck,12,Moderate,Moderate Risk,Moderate (50-80%),Slow,Liver,Not Suitable
Metformin,Inflammation,Antiviral,46.29,C4H11N5,Proton Pump Inhibitor,"Nausea, Dizziness",1971,Acetylsalicylic Acid,Prilosec,High Risk,Slow Metabolism,Phase 1,No Preclinical Data,Dopaminergic Pathway,Syrup,10mg once daily,Roche,12,Moderate,Moderate Risk,High (>80%),Moderate,Renal,Not Suitable
Ibuprofen,Gastric Ulcer,Parkinson's,72.88,C4H11N5,COX Inhibitor,Gastrointestinal Issues,1971,Metformin Hydrochloride,Aspirin,Moderate Risk,Renal Excretion,Completed,No Preclinical Data,Serotonin Pathway,Tablet,500mg twice a day,Pfizer,2,High,Moderate Risk,Low (<50%),Moderate,Enzyme-Specific,Not Suitable
Atorvastatin,Thyroid Hormone Replacement,Alzheimer's,45.06,C4H11N5,AMPK Activator,Acid Reflux,1965,Omeprazole,Prilosec,Moderate Risk,High Bioavailability,Phase 2,Animal Testing,Serotonin Pathway,Tablet,10mg once daily,Roche,12,Low,Moderate Risk,High (>80%),Moderate,Gut,Not Suitable
Omeprazole,Cholesterol Control,Cancer Therapy,83.14,C17H19N3O3S,COX Inhibitor,"Headache, Rash",1996,Metformin Hydrochloride,Lipitor,Moderate Risk,Slow Metabolism,Completed,Animal Testing,Immune Response Pathway,Topical Gel,250mg every 8 hours,AstraZeneca,6,Low,Moderate Risk,High (>80%),Moderate,Gut,Suitable
Losartan,Pain Relief,Autoimmune Disorders,31.56,C17H19N3O3S,AMPK Activator,Acid Reflux,1994,Ibuprofen,Prilosec,High Risk,Rapid Absorption,Phase 2,In Vitro Studies,Dopaminergic Pathway,Injection,As prescribed,Merck,6,Low,Low Risk,High (>80%),Moderate,Gut,Suitable
Paracetamol,Cholesterol Control,Autoimmune Disorders,39.52,C4H11N5,COX Inhibitor,"Headache, Rash",1994,Acetylsalicylic Acid,Prilosec,Moderate Risk,Renal Excretion,Ongoing,No Preclinical Data,Immune Response Pathway,Topical Gel,50mg daily,Pfizer,12,Moderate,Moderate Risk,High (>80%),Slow,Gut,Partially Suitable
Ranitidine,Hypertension,Migraine Treatment,74.17,C13H18O2,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1996,Omeprazole,Glucophage,Moderate Risk,High Bioavailability,Phase 1,In Vitro Studies,Dopaminergic Pathway,Capsule,As prescribed,Novartis,2,High,High Risk,High (>80%),Fast,Enzyme-Specific,Partially Suitable
Simvastatin,Thyroid Hormone Replacement,Liver Disease,76.67,C17H19N3O3S,NSAID,Muscle Pain,1987,Acetylsalicylic Acid,Glucophage,High Risk,Renal Excretion,Phase 2,Animal Testing,Serotonin Pathway,Tablet,10mg once daily,Merck,24,Low,High Risk,Low (<50%),Moderate,Renal,Not Suitable
Levothyroxine,Pain Relief,Cancer Therapy,37.32,C17H19N3O3S,NSAID,Gastrointestinal Issues,1996,Ibuprofen,Aspirin,Moderate Risk,High Bioavailability,Ongoing,Animal Testing,Serotonin Pathway,Topical Gel,50mg daily,Roche,12,Moderate,Low Risk,Low (<50%),Fast,Gut,Partially Suitable
Aspirin,Blood Thinner,Cancer Therapy,35.92,C33H35FN2O5,AMPK Activator,Acid Reflux,1965,Omeprazole,Glucophage,Low Risk,High Bioavailability,Ongoing,In Vitro Studies,PI3K-AKT Pathway,Topical Gel,50mg daily,Novartis,6,High,High Risk,Moderate (50-80%),Slow,Gut,Not Suitable
Metformin,Cholesterol Control,Autoimmune Disorders,58.21,C17H19N3O3S,NSAID,Acid Reflux,1971,Ibuprofen,Aspirin,Low Risk,Slow Metabolism,Completed,Toxicology Report,Serotonin Pathway,Tablet,10mg once daily,Pfizer,6,Moderate,High Risk,High (>80%),Moderate,Liver,Not Suitable
Ibuprofen,Acid Reflux,Weight Loss,57.67,C33H35FN2O5,AMPK Activator,Acid Reflux,1971,Metformin Hydrochloride,Glucophage,Low Risk,Renal Excretion,Completed,Animal Testing,MAPK Pathway,Tablet,10mg once daily,Pfizer,48,High,Moderate Risk,Low (<50%),Slow,Renal,Not Suitable
Atorvastatin,Thyroid Hormone Replacement,Liver Disease,79.02,C9H8O4,HMG-CoA Reductase Inhibitor,Acid Reflux,1987,Acetylsalicylic Acid,Glucophage,Moderate Risk,Slow Metabolism,Phase 3,Toxicology Report,Immune Response Pathway,Syrup,10mg once daily,Novartis,48,High,Low Risk,High (>80%),Slow,Gut,Partially Suitable
Omeprazole,Acid Reflux,Anti-Aging,59.6,C13H18O2,AMPK Activator,Acid Reflux,1965,Omeprazole,Prilosec,Moderate Risk,Rapid Absorption,Ongoing,Toxicology Report,Immune Response Pathway,Capsule,50mg daily,Roche,12,High,High Risk,Low (<50%),Fast,Liver,Suitable
Losartan,Gastric Ulcer,Autoimmune Disorders,38.52,C17H19N3O3S,NSAID,Muscle Pain,1987,Omeprazole,Lipitor,Moderate Risk,Liver Metabolism,Phase 3,In Vitro Studies,Serotonin Pathway,Tablet,50mg daily,Novartis,48,Low,Moderate Risk,Low (<50%),Moderate,Enzyme-Specific,Partially Suitable
Paracetamol,Thyroid Hormone Replacement,Autoimmune Disorders,45.73,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Muscle Pain,1971,Metformin Hydrochloride,Advil,Low Risk,Rapid Absorption,Completed,Animal Testing,PI3K-AKT Pathway,Topical Gel,250mg every 8 hours,AstraZeneca,24,Low,Moderate Risk,High (>80%),Slow,Liver,Suitable
Ranitidine,Gastric Ulcer,Cardiovascular Disease,60.78,C4H11N5,Proton Pump Inhibitor,Acid Reflux,1996,Atorvastatin Calcium,Glucophage,High Risk,Liver Metabolism,Phase 2,In Vitro Studies,Dopaminergic Pathway,Syrup,500mg twice a day,AstraZeneca,12,Low,High Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Suitable
Simvastatin,Gastric Ulcer,Migraine Treatment,65.08,C13H18O2,NSAID,Gastrointestinal Issues,1965,Atorvastatin Calcium,Glucophage,Moderate Risk,High Bioavailability,Completed,Animal Testing,Serotonin Pathway,Tablet,250mg every 8 hours,Merck,24,Low,Moderate Risk,Moderate (50-80%),Fast,Gut,Suitable
Levothyroxine,Blood Thinner,Cancer Therapy,83.8,C9H8O4,AMPK Activator,Acid Reflux,1965,Atorvastatin Calcium,Aspirin,Moderate Risk,Slow Metabolism,Completed,No Preclinical Data,Serotonin Pathway,Capsule,10mg once daily,Novartis,48,Moderate,Low Risk,High (>80%),Slow,Gut,Partially Suitable
Aspirin,Cholesterol Control,Autoimmune Disorders,43.67,C13H18O2,Proton Pump Inhibitor,"Nausea, Dizziness",1994,Metformin Hydrochloride,Glucophage,Moderate Risk,Slow Metabolism,Phase 4,Toxicology Report,Serotonin Pathway,Topical Gel,As prescribed,Novartis,24,Low,Moderate Risk,High (>80%),Fast,Renal,Suitable
Metformin,Hypertension,Liver Disease,54.66,C13H18O2,NSAID,"Nausea, Dizziness",1965,Omeprazole,Advil,Low Risk,Renal Excretion,Completed,In Vitro Studies,MAPK Pathway,Injection,250mg every 8 hours,AstraZeneca,48,Low,Moderate Risk,High (>80%),Fast,Enzyme-Specific,Partially Suitable
Ibuprofen,Blood Thinner,Parkinson's,78.28,C17H19N3O3S,NSAID,Gastrointestinal Issues,1996,Acetylsalicylic Acid,Advil,Moderate Risk,High Bioavailability,Completed,Animal Testing,PI3K-AKT Pathway,Tablet,50mg daily,AstraZeneca,48,Low,Low Risk,Low (<50%),Slow,Liver,Partially Suitable
Atorvastatin,Thyroid Hormone Replacement,Migraine Treatment,47.72,C9H8O4,NSAID,"Headache, Rash",1994,Metformin Hydrochloride,Prilosec,Low Risk,Liver Metabolism,Phase 2,Toxicology Report,Immune Response Pathway,Topical Gel,10mg once daily,Roche,6,Low,Low Risk,High (>80%),Slow,Gut,Suitable
Omeprazole,Hypertension,Cardiovascular Disease,35.05,C33H35FN2O5,AMPK Activator,"Headache, Rash",1987,Ibuprofen,Advil,Low Risk,Rapid Absorption,Completed,Toxicology Report,Dopaminergic Pathway,Tablet,10mg once daily,Roche,48,Low,Low Risk,Low (<50%),Moderate,Enzyme-Specific,Suitable
Losartan,Gastric Ulcer,Weight Loss,54.81,C9H8O4,NSAID,Muscle Pain,1987,Metformin Hydrochloride,Prilosec,Moderate Risk,Renal Excretion,Completed,Toxicology Report,MAPK Pathway,Injection,50mg daily,Pfizer,2,High,High Risk,Low (<50%),Moderate,Renal,Suitable
Paracetamol,Pain Relief,Cardiovascular Disease,44.98,C13H18O2,NSAID,"Nausea, Dizziness",1987,Acetylsalicylic Acid,Advil,Moderate Risk,Renal Excretion,Phase 1,No Preclinical Data,MAPK Pathway,Syrup,50mg daily,Novartis,48,High,Moderate Risk,Moderate (50-80%),Fast,Renal,Not Suitable
Ranitidine,Fever,Autoimmune Disorders,67.89,C13H18O2,AMPK Activator,"Nausea, Dizziness",1996,Acetylsalicylic Acid,Aspirin,High Risk,Renal Excretion,Phase 2,No Preclinical Data,Dopaminergic Pathway,Syrup,50mg daily,Roche,48,Low,Low Risk,Low (<50%),Moderate,Liver,Suitable
Simvastatin,Thyroid Hormone Replacement,Autoimmune Disorders,42.43,C33H35FN2O5,COX Inhibitor,Muscle Pain,1996,Acetylsalicylic Acid,Advil,Low Risk,Slow Metabolism,Phase 2,No Preclinical Data,Dopaminergic Pathway,Syrup,500mg twice a day,Roche,48,Moderate,High Risk,Low (<50%),Slow,Enzyme-Specific,Suitable
Levothyroxine,Hypertension,Autoimmune Disorders,49.88,C4H11N5,AMPK Activator,"Nausea, Dizziness",1994,Omeprazole,Prilosec,Moderate Risk,High Bioavailability,Phase 2,Animal Testing,PI3K-AKT Pathway,Injection,500mg twice a day,Roche,12,Low,Moderate Risk,High (>80%),Moderate,Enzyme-Specific,Partially Suitable
Aspirin,Acid Reflux,Cardiovascular Disease,66.41,C33H35FN2O5,NSAID,Gastrointestinal Issues,1965,Acetylsalicylic Acid,Lipitor,Moderate Risk,Rapid Absorption,Completed,Animal Testing,Dopaminergic Pathway,Topical Gel,500mg twice a day,AstraZeneca,6,Low,Moderate Risk,Moderate (50-80%),Fast,Liver,Suitable
Metformin,Thyroid Hormone Replacement,Cardiovascular Disease,33.67,C33H35FN2O5,AMPK Activator,Muscle Pain,1994,Metformin Hydrochloride,Glucophage,Moderate Risk,Rapid Absorption,Phase 4,No Preclinical Data,Dopaminergic Pathway,Topical Gel,10mg once daily,Roche,48,High,Moderate Risk,High (>80%),Fast,Liver,Not Suitable
Ibuprofen,Diabetes,Antiviral,45.29,C17H19N3O3S,HMG-CoA Reductase Inhibitor,"Headache, Rash",1994,Metformin Hydrochloride,Glucophage,Low Risk,Liver Metabolism,Completed,Toxicology Report,MAPK Pathway,Topical Gel,As prescribed,Merck,12,High,High Risk,High (>80%),Moderate,Renal,Partially Suitable
Atorvastatin,Cholesterol Control,Anti-Aging,44.36,C9H8O4,COX Inhibitor,"Headache, Rash",1996,Ibuprofen,Glucophage,Moderate Risk,Slow Metabolism,Phase 1,Toxicology Report,Serotonin Pathway,Syrup,As prescribed,Roche,12,Low,Low Risk,High (>80%),Moderate,Liver,Not Suitable
Omeprazole,Inflammation,Liver Disease,55.13,C17H19N3O3S,AMPK Activator,Acid Reflux,1996,Acetylsalicylic Acid,Lipitor,Moderate Risk,Liver Metabolism,Phase 3,Toxicology Report,Serotonin Pathway,Topical Gel,As prescribed,AstraZeneca,2,Low,High Risk,High (>80%),Moderate,Liver,Suitable
Losartan,Pain Relief,Anti-Aging,78.26,C33H35FN2O5,COX Inhibitor,"Headache, Rash",1971,Acetylsalicylic Acid,Advil,Moderate Risk,Slow Metabolism,Phase 3,No Preclinical Data,PI3K-AKT Pathway,Tablet,10mg once daily,Novartis,48,High,Low Risk,High (>80%),Slow,Gut,Partially Suitable
Paracetamol,Blood Thinner,Anti-Aging,55.91,C4H11N5,Proton Pump Inhibitor,"Headache, Rash",1965,Ibuprofen,Glucophage,High Risk,Slow Metabolism,Completed,In Vitro Studies,Immune Response Pathway,Capsule,50mg daily,Novartis,24,High,Low Risk,Moderate (50-80%),Moderate,Gut,Not Suitable
Ranitidine,Thyroid Hormone Replacement,Alzheimer's,71.65,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1965,Ibuprofen,Prilosec,Moderate Risk,Renal Excretion,Phase 2,Toxicology Report,Dopaminergic Pathway,Capsule,As prescribed,Merck,6,High,Moderate Risk,Low (<50%),Fast,Renal,Suitable
Simvastatin,Diabetes,Weight Loss,57.2,C4H11N5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1996,Atorvastatin Calcium,Prilosec,Low Risk,High Bioavailability,Phase 2,No Preclinical Data,Dopaminergic Pathway,Capsule,250mg every 8 hours,AstraZeneca,24,Moderate,High Risk,Low (<50%),Slow,Enzyme-Specific,Suitable
Levothyroxine,Pain Relief,Cardiovascular Disease,58.19,C4H11N5,AMPK Activator,Acid Reflux,1994,Metformin Hydrochloride,Lipitor,Moderate Risk,High Bioavailability,Phase 4,Animal Testing,Dopaminergic Pathway,Injection,500mg twice a day,Roche,24,High,High Risk,High (>80%),Moderate,Enzyme-Specific,Partially Suitable
Aspirin,Acid Reflux,Antiviral,42.26,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1996,Atorvastatin Calcium,Advil,Low Risk,High Bioavailability,Phase 4,Animal Testing,Dopaminergic Pathway,Syrup,500mg twice a day,Merck,12,Low,Low Risk,Low (<50%),Moderate,Renal,Suitable
Metformin,Inflammation,Alzheimer's,57.05,C4H11N5,AMPK Activator,Muscle Pain,1987,Ibuprofen,Aspirin,High Risk,Renal Excretion,Ongoing,No Preclinical Data,PI3K-AKT Pathway,Syrup,500mg twice a day,Roche,48,Low,Low Risk,Low (<50%),Slow,Enzyme-Specific,Suitable
Ibuprofen,Acid Reflux,Migraine Treatment,40.9,C33H35FN2O5,AMPK Activator,"Headache, Rash",1965,Acetylsalicylic Acid,Glucophage,Low Risk,Rapid Absorption,Phase 1,Animal Testing,PI3K-AKT Pathway,Injection,250mg every 8 hours,Merck,2,Low,Low Risk,Low (<50%),Fast,Renal,Not Suitable
Atorvastatin,Hypertension,Cancer Therapy,32.4,C17H19N3O3S,AMPK Activator,Gastrointestinal Issues,1965,Metformin Hydrochloride,Lipitor,High Risk,Renal Excretion,Completed,Animal Testing,PI3K-AKT Pathway,Syrup,As prescribed,Novartis,24,Low,High Risk,High (>80%),Slow,Gut,Not Suitable
Omeprazole,Fever,Migraine Treatment,53.02,C13H18O2,HMG-CoA Reductase Inhibitor,Acid Reflux,1996,Ibuprofen,Prilosec,Moderate Risk,Rapid Absorption,Phase 4,In Vitro Studies,Immune Response Pathway,Capsule,500mg twice a day,Novartis,12,Low,Low Risk,High (>80%),Fast,Liver,Not Suitable
Losartan,Fever,Liver Disease,57.23,C13H18O2,Proton Pump Inhibitor,Acid Reflux,1971,Ibuprofen,Aspirin,High Risk,Liver Metabolism,Phase 1,Animal Testing,MAPK Pathway,Capsule,500mg twice a day,Novartis,12,Low,Low Risk,Moderate (50-80%),Moderate,Gut,Partially Suitable
Paracetamol,Thyroid Hormone Replacement,Parkinson's,44.38,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1994,Acetylsalicylic Acid,Glucophage,Moderate Risk,Liver Metabolism,Ongoing,Animal Testing,PI3K-AKT Pathway,Syrup,50mg daily,AstraZeneca,48,Moderate,Low Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Suitable
Ranitidine,Inflammation,Liver Disease,93.68,C17H19N3O3S,Proton Pump Inhibitor,Gastrointestinal Issues,1971,Omeprazole,Prilosec,Moderate Risk,Renal Excretion,Phase 1,No Preclinical Data,Dopaminergic Pathway,Injection,250mg every 8 hours,Pfizer,24,Moderate,Low Risk,Moderate (50-80%),Slow,Liver,Suitable
Simvastatin,Inflammation,Anti-Aging,59.65,C17H19N3O3S,COX Inhibitor,Acid Reflux,1965,Ibuprofen,Prilosec,Low Risk,Renal Excretion,Phase 4,No Preclinical Data,MAPK Pathway,Syrup,50mg daily,AstraZeneca,24,High,High Risk,High (>80%),Moderate,Enzyme-Specific,Partially Suitable
Levothyroxine,Fever,Antiviral,30.93,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1996,Acetylsalicylic Acid,Aspirin,Low Risk,Renal Excretion,Completed,Toxicology Report,Immune Response Pathway,Capsule,500mg twice a day,AstraZeneca,48,Low,Low Risk,Moderate (50-80%),Moderate,Renal,Suitable
Aspirin,Cholesterol Control,Liver Disease,46.93,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1971,Metformin Hydrochloride,Lipitor,Low Risk,High Bioavailability,Phase 1,No Preclinical Data,MAPK Pathway,Capsule,10mg once daily,Pfizer,6,Low,Low Risk,Moderate (50-80%),Moderate,Gut,Not Suitable
Metformin,Gastric Ulcer,Liver Disease,53.67,C9H8O4,AMPK Activator,"Nausea, Dizziness",1987,Ibuprofen,Advil,Low Risk,Liver Metabolism,Phase 3,No Preclinical Data,Dopaminergic Pathway,Syrup,10mg once daily,Novartis,12,Moderate,Moderate Risk,Low (<50%),Moderate,Renal,Suitable
Ibuprofen,Hypertension,Parkinson's,87.96,C33H35FN2O5,NSAID,Gastrointestinal Issues,1994,Metformin Hydrochloride,Aspirin,High Risk,Liver Metabolism,Ongoing,In Vitro Studies,MAPK Pathway,Capsule,50mg daily,Roche,2,High,Low Risk,Low (<50%),Moderate,Enzyme-Specific,Partially Suitable
Atorvastatin,Hypertension,Migraine Treatment,55.07,C13H18O2,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1987,Atorvastatin Calcium,Prilosec,Low Risk,High Bioavailability,Phase 2,Toxicology Report,PI3K-AKT Pathway,Capsule,500mg twice a day,AstraZeneca,24,Moderate,Moderate Risk,High (>80%),Moderate,Renal,Partially Suitable
Omeprazole,Thyroid Hormone Replacement,Weight Loss,36.48,C4H11N5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1996,Metformin Hydrochloride,Aspirin,Low Risk,Liver Metabolism,Completed,No Preclinical Data,PI3K-AKT Pathway,Injection,10mg once daily,Novartis,12,Low,Low Risk,Low (<50%),Moderate,Liver,Not Suitable
Losartan,Blood Thinner,Liver Disease,88.72,C9H8O4,NSAID,Gastrointestinal Issues,1987,Atorvastatin Calcium,Aspirin,Moderate Risk,Rapid Absorption,Ongoing,In Vitro Studies,MAPK Pathway,Syrup,50mg daily,Merck,12,High,Moderate Risk,High (>80%),Fast,Renal,Not Suitable
Paracetamol,Fever,Weight Loss,34.17,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Acid Reflux,1971,Metformin Hydrochloride,Lipitor,Low Risk,High Bioavailability,Phase 1,Animal Testing,MAPK Pathway,Topical Gel,250mg every 8 hours,Roche,6,High,Moderate Risk,Low (<50%),Fast,Renal,Not Suitable
Ranitidine,Fever,Parkinson's,62.04,C4H11N5,HMG-CoA Reductase Inhibitor,Acid Reflux,1965,Omeprazole,Prilosec,Low Risk,High Bioavailability,Phase 2,In Vitro Studies,Immune Response Pathway,Injection,250mg every 8 hours,Merck,6,High,Low Risk,Low (<50%),Moderate,Enzyme-Specific,Not Suitable
Simvastatin,Fever,Liver Disease,63.06,C13H18O2,NSAID,"Nausea, Dizziness",1965,Atorvastatin Calcium,Prilosec,Moderate Risk,High Bioavailability,Phase 2,Animal Testing,MAPK Pathway,Tablet,50mg daily,AstraZeneca,2,High,Low Risk,High (>80%),Fast,Renal,Partially Suitable
Levothyroxine,Diabetes,Cardiovascular Disease,46.28,C4H11N5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1996,Acetylsalicylic Acid,Advil,Moderate Risk,Renal Excretion,Phase 1,Toxicology Report,Immune Response Pathway,Topical Gel,50mg daily,Pfizer,6,Low,Moderate Risk,High (>80%),Slow,Liver,Suitable
Aspirin,Acid Reflux,Liver Disease,57.04,C17H19N3O3S,NSAID,Gastrointestinal Issues,1965,Omeprazole,Prilosec,Moderate Risk,Renal Excretion,Completed,Toxicology Report,MAPK Pathway,Capsule,500mg twice a day,AstraZeneca,6,Low,Low Risk,Moderate (50-80%),Moderate,Gut,Partially Suitable
Metformin,Diabetes,Liver Disease,67.77,C17H19N3O3S,NSAID,Acid Reflux,1971,Metformin Hydrochloride,Lipitor,High Risk,Liver Metabolism,Phase 3,Animal Testing,Immune Response Pathway,Injection,10mg once daily,Pfizer,12,Moderate,Low Risk,Moderate (50-80%),Fast,Renal,Suitable
Ibuprofen,Blood Thinner,Weight Loss,92.88,C13H18O2,COX Inhibitor,Acid Reflux,1965,Metformin Hydrochloride,Glucophage,Moderate Risk,High Bioavailability,Phase 2,No Preclinical Data,Serotonin Pathway,Topical Gel,10mg once daily,AstraZeneca,24,Low,High Risk,Low (<50%),Fast,Renal,Not Suitable
Atorvastatin,Inflammation,Parkinson's,56.6,C9H8O4,COX Inhibitor,Muscle Pain,1996,Ibuprofen,Aspirin,Moderate Risk,Slow Metabolism,Ongoing,No Preclinical Data,MAPK Pathway,Injection,As prescribed,Merck,12,High,Moderate Risk,Low (<50%),Slow,Liver,Suitable
Omeprazole,Blood Thinner,Autoimmune Disorders,61.21,C9H8O4,HMG-CoA Reductase Inhibitor,Muscle Pain,1996,Atorvastatin Calcium,Glucophage,High Risk,Slow Metabolism,Phase 4,No Preclinical Data,Dopaminergic Pathway,Topical Gel,250mg every 8 hours,Novartis,48,Moderate,High Risk,Low (<50%),Slow,Liver,Suitable
Losartan,Thyroid Hormone Replacement,Alzheimer's,34.04,C17H19N3O3S,NSAID,Gastrointestinal Issues,1994,Ibuprofen,Aspirin,Moderate Risk,Rapid Absorption,Phase 2,In Vitro Studies,Dopaminergic Pathway,Injection,250mg every 8 hours,AstraZeneca,12,Moderate,Low Risk,High (>80%),Moderate,Liver,Not Suitable
Paracetamol,Pain Relief,Autoimmune Disorders,30.24,C4H11N5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1996,Ibuprofen,Advil,Moderate Risk,Renal Excretion,Phase 2,Animal Testing,Serotonin Pathway,Injection,250mg every 8 hours,Novartis,2,Moderate,High Risk,Moderate (50-80%),Moderate,Liver,Partially Suitable
Ranitidine,Pain Relief,Cardiovascular Disease,83.38,C9H8O4,Proton Pump Inhibitor,"Headache, Rash",1971,Omeprazole,Aspirin,Low Risk,Slow Metabolism,Phase 1,No Preclinical Data,PI3K-AKT Pathway,Injection,As prescribed,Merck,48,High,High Risk,Low (<50%),Fast,Liver,Not Suitable
Simvastatin,Blood Thinner,Anti-Aging,67.25,C33H35FN2O5,COX Inhibitor,"Headache, Rash",1965,Acetylsalicylic Acid,Aspirin,Low Risk,Liver Metabolism,Completed,Toxicology Report,Immune Response Pathway,Tablet,As prescribed,Roche,6,Low,High Risk,Low (<50%),Moderate,Gut,Partially Suitable
Levothyroxine,Thyroid Hormone Replacement,Autoimmune Disorders,87.7,C4H11N5,AMPK Activator,Gastrointestinal Issues,1994,Atorvastatin Calcium,Advil,High Risk,Renal Excretion,Phase 4,Animal Testing,Immune Response Pathway,Tablet,10mg once daily,Pfizer,2,High,High Risk,High (>80%),Moderate,Renal,Suitable
Aspirin,Inflammation,Antiviral,38.04,C9H8O4,NSAID,"Nausea, Dizziness",1994,Metformin Hydrochloride,Lipitor,High Risk,High Bioavailability,Phase 2,Toxicology Report,PI3K-AKT Pathway,Syrup,250mg every 8 hours,Roche,6,High,High Risk,Low (<50%),Fast,Gut,Suitable
Metformin,Fever,Alzheimer's,90.93,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1987,Metformin Hydrochloride,Advil,Low Risk,High Bioavailability,Phase 1,No Preclinical Data,Immune Response Pathway,Topical Gel,As prescribed,Roche,12,High,Moderate Risk,High (>80%),Slow,Renal,Partially Suitable
Ibuprofen,Acid Reflux,Parkinson's,41.47,C33H35FN2O5,AMPK Activator,"Nausea, Dizziness",1965,Acetylsalicylic Acid,Lipitor,Moderate Risk,Rapid Absorption,Phase 1,Toxicology Report,Serotonin Pathway,Syrup,500mg twice a day,Merck,24,Moderate,High Risk,High (>80%),Moderate,Liver,Partially Suitable
Atorvastatin,Thyroid Hormone Replacement,Alzheimer's,45.81,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1965,Acetylsalicylic Acid,Aspirin,High Risk,Liver Metabolism,Phase 4,Toxicology Report,Serotonin Pathway,Topical Gel,500mg twice a day,Roche,6,Low,High Risk,High (>80%),Moderate,Gut,Partially Suitable
Omeprazole,Hypertension,Cardiovascular Disease,80.6,C13H18O2,AMPK Activator,"Nausea, Dizziness",1994,Ibuprofen,Lipitor,Low Risk,Rapid Absorption,Phase 2,In Vitro Studies,MAPK Pathway,Syrup,As prescribed,Roche,2,Low,Low Risk,Low (<50%),Slow,Gut,Partially Suitable
Losartan,Blood Thinner,Parkinson's,55.31,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1987,Ibuprofen,Advil,Moderate Risk,Rapid Absorption,Phase 1,No Preclinical Data,Immune Response Pathway,Syrup,As prescribed,Roche,24,High,High Risk,Moderate (50-80%),Moderate,Gut,Suitable
Paracetamol,Diabetes,Cancer Therapy,85.52,C4H11N5,HMG-CoA Reductase Inhibitor,Muscle Pain,1994,Omeprazole,Glucophage,Moderate Risk,High Bioavailability,Phase 2,In Vitro Studies,Immune Response Pathway,Capsule,250mg every 8 hours,Novartis,12,Low,High Risk,Moderate (50-80%),Slow,Gut,Not Suitable
Ranitidine,Gastric Ulcer,Autoimmune Disorders,81.24,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Muscle Pain,1987,Metformin Hydrochloride,Aspirin,Moderate Risk,Liver Metabolism,Phase 4,In Vitro Studies,MAPK Pathway,Capsule,500mg twice a day,Pfizer,2,Low,Low Risk,High (>80%),Slow,Liver,Suitable
Simvastatin,Diabetes,Migraine Treatment,85.22,C17H19N3O3S,COX Inhibitor,Gastrointestinal Issues,1971,Atorvastatin Calcium,Prilosec,High Risk,Renal Excretion,Phase 1,In Vitro Studies,MAPK Pathway,Syrup,250mg every 8 hours,Roche,24,High,High Risk,Low (<50%),Fast,Enzyme-Specific,Not Suitable
Levothyroxine,Gastric Ulcer,Liver Disease,91.14,C4H11N5,Proton Pump Inhibitor,Muscle Pain,1971,Ibuprofen,Aspirin,Moderate Risk,Renal Excretion,Phase 4,No Preclinical Data,Immune Response Pathway,Injection,500mg twice a day,Roche,12,Low,High Risk,Low (<50%),Slow,Renal,Not Suitable
Aspirin,Thyroid Hormone Replacement,Parkinson's,41.02,C33H35FN2O5,NSAID,"Nausea, Dizziness",1971,Metformin Hydrochloride,Glucophage,Moderate Risk,Renal Excretion,Phase 1,In Vitro Studies,Serotonin Pathway,Injection,As prescribed,Merck,2,High,Low Risk,High (>80%),Moderate,Enzyme-Specific,Partially Suitable
Metformin,Thyroid Hormone Replacement,Liver Disease,75.45,C17H19N3O3S,AMPK Activator,"Nausea, Dizziness",1996,Ibuprofen,Lipitor,High Risk,Rapid Absorption,Completed,Animal Testing,PI3K-AKT Pathway,Syrup,500mg twice a day,Novartis,24,High,Moderate Risk,Moderate (50-80%),Slow,Liver,Not Suitable
Ibuprofen,Diabetes,Cardiovascular Disease,71.58,C33H35FN2O5,COX Inhibitor,Muscle Pain,1971,Acetylsalicylic Acid,Aspirin,High Risk,Rapid Absorption,Phase 3,In Vitro Studies,Dopaminergic Pathway,Capsule,10mg once daily,Merck,24,High,Moderate Risk,High (>80%),Fast,Enzyme-Specific,Suitable
Atorvastatin,Cholesterol Control,Autoimmune Disorders,54,C4H11N5,COX Inhibitor,Acid Reflux,1965,Atorvastatin Calcium,Advil,Moderate Risk,Liver Metabolism,Phase 4,Toxicology Report,Dopaminergic Pathway,Injection,50mg daily,Merck,2,Low,Low Risk,Low (<50%),Moderate,Gut,Not Suitable
Omeprazole,Gastric Ulcer,Migraine Treatment,81.36,C33H35FN2O5,COX Inhibitor,"Headache, Rash",1994,Omeprazole,Advil,Moderate Risk,Slow Metabolism,Completed,No Preclinical Data,MAPK Pathway,Injection,500mg twice a day,Pfizer,24,High,Moderate Risk,High (>80%),Moderate,Enzyme-Specific,Partially Suitable
Losartan,Acid Reflux,Anti-Aging,82.5,C9H8O4,Proton Pump Inhibitor,Gastrointestinal Issues,1965,Ibuprofen,Lipitor,Low Risk,Rapid Absorption,Ongoing,In Vitro Studies,Immune Response Pathway,Injection,10mg once daily,Roche,24,Low,High Risk,Low (<50%),Moderate,Liver,Not Suitable
Paracetamol,Pain Relief,Alzheimer's,64.11,C17H19N3O3S,Proton Pump Inhibitor,Muscle Pain,1996,Omeprazole,Prilosec,Low Risk,High Bioavailability,Completed,In Vitro Studies,PI3K-AKT Pathway,Tablet,500mg twice a day,Roche,6,Moderate,High Risk,Moderate (50-80%),Moderate,Renal,Not Suitable
Ranitidine,Cholesterol Control,Parkinson's,73.62,C17H19N3O3S,HMG-CoA Reductase Inhibitor,"Headache, Rash",1994,Acetylsalicylic Acid,Prilosec,Low Risk,Renal Excretion,Completed,Animal Testing,Dopaminergic Pathway,Injection,500mg twice a day,Roche,48,Low,Moderate Risk,Moderate (50-80%),Fast,Gut,Not Suitable
Simvastatin,Pain Relief,Autoimmune Disorders,51.23,C9H8O4,AMPK Activator,Gastrointestinal Issues,1994,Atorvastatin Calcium,Prilosec,Low Risk,Slow Metabolism,Completed,Animal Testing,Dopaminergic Pathway,Capsule,250mg every 8 hours,Roche,24,Low,Moderate Risk,High (>80%),Fast,Enzyme-Specific,Not Suitable
Levothyroxine,Gastric Ulcer,Migraine Treatment,92.95,C13H18O2,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1987,Ibuprofen,Advil,Low Risk,Slow Metabolism,Phase 1,In Vitro Studies,Dopaminergic Pathway,Syrup,10mg once daily,Roche,6,Low,Moderate Risk,High (>80%),Slow,Liver,Partially Suitable
Aspirin,Gastric Ulcer,Anti-Aging,63.33,C9H8O4,COX Inhibitor,"Nausea, Dizziness",1994,Atorvastatin Calcium,Glucophage,Low Risk,Rapid Absorption,Phase 1,Animal Testing,PI3K-AKT Pathway,Tablet,250mg every 8 hours,Roche,48,Low,Moderate Risk,High (>80%),Fast,Enzyme-Specific,Partially Suitable
Metformin,Pain Relief,Cancer Therapy,92.75,C9H8O4,AMPK Activator,Gastrointestinal Issues,1987,Ibuprofen,Prilosec,High Risk,High Bioavailability,Completed,In Vitro Studies,PI3K-AKT Pathway,Injection,250mg every 8 hours,Roche,48,High,Low Risk,High (>80%),Slow,Renal,Suitable
Ibuprofen,Thyroid Hormone Replacement,Cardiovascular Disease,51.22,C4H11N5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1996,Ibuprofen,Glucophage,Moderate Risk,Slow Metabolism,Phase 3,No Preclinical Data,Serotonin Pathway,Injection,500mg twice a day,Merck,12,Low,Moderate Risk,Low (<50%),Moderate,Liver,Not Suitable
Atorvastatin,Diabetes,Liver Disease,80.57,C13H18O2,NSAID,Gastrointestinal Issues,1994,Ibuprofen,Prilosec,Low Risk,Liver Metabolism,Phase 3,No Preclinical Data,MAPK Pathway,Capsule,As prescribed,AstraZeneca,24,Moderate,Low Risk,Moderate (50-80%),Fast,Renal,Partially Suitable
Omeprazole,Hypertension,Migraine Treatment,42.01,C17H19N3O3S,AMPK Activator,"Nausea, Dizziness",1965,Metformin Hydrochloride,Glucophage,High Risk,Renal Excretion,Phase 2,Animal Testing,Serotonin Pathway,Topical Gel,As prescribed,AstraZeneca,6,Moderate,Moderate Risk,Low (<50%),Fast,Enzyme-Specific,Not Suitable
Losartan,Thyroid Hormone Replacement,Cancer Therapy,82.39,C13H18O2,HMG-CoA Reductase Inhibitor,"Headache, Rash",1971,Atorvastatin Calcium,Glucophage,Moderate Risk,Rapid Absorption,Phase 3,No Preclinical Data,Immune Response Pathway,Syrup,As prescribed,Pfizer,24,Moderate,Low Risk,High (>80%),Slow,Renal,Partially Suitable
Paracetamol,Gastric Ulcer,Liver Disease,45.5,C4H11N5,Proton Pump Inhibitor,Gastrointestinal Issues,1994,Acetylsalicylic Acid,Lipitor,Moderate Risk,Slow Metabolism,Phase 2,In Vitro Studies,Dopaminergic Pathway,Capsule,50mg daily,Roche,12,Moderate,Low Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Ranitidine,Hypertension,Liver Disease,64.64,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1971,Omeprazole,Prilosec,High Risk,Renal Excretion,Phase 4,Toxicology Report,MAPK Pathway,Capsule,50mg daily,Roche,6,Low,High Risk,Moderate (50-80%),Fast,Renal,Partially Suitable
Simvastatin,Gastric Ulcer,Liver Disease,54.88,C9H8O4,AMPK Activator,Gastrointestinal Issues,1971,Atorvastatin Calcium,Lipitor,Moderate Risk,Rapid Absorption,Phase 1,In Vitro Studies,Immune Response Pathway,Tablet,As prescribed,AstraZeneca,6,High,Low Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Levothyroxine,Pain Relief,Parkinson's,54.18,C4H11N5,COX Inhibitor,Acid Reflux,1996,Atorvastatin Calcium,Lipitor,Moderate Risk,Liver Metabolism,Completed,Animal Testing,MAPK Pathway,Injection,50mg daily,Merck,48,Low,High Risk,Low (<50%),Fast,Gut,Partially Suitable
Aspirin,Thyroid Hormone Replacement,Migraine Treatment,41.26,C33H35FN2O5,COX Inhibitor,Muscle Pain,1987,Atorvastatin Calcium,Aspirin,Moderate Risk,High Bioavailability,Completed,Animal Testing,MAPK Pathway,Capsule,250mg every 8 hours,Novartis,6,Moderate,High Risk,Moderate (50-80%),Moderate,Liver,Partially Suitable
Metformin,Blood Thinner,Migraine Treatment,92.09,C13H18O2,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1971,Omeprazole,Advil,Moderate Risk,Liver Metabolism,Ongoing,Toxicology Report,Immune Response Pathway,Syrup,250mg every 8 hours,Roche,12,Moderate,Low Risk,Moderate (50-80%),Slow,Renal,Not Suitable
Ibuprofen,Pain Relief,Weight Loss,89.93,C13H18O2,Proton Pump Inhibitor,"Nausea, Dizziness",1971,Atorvastatin Calcium,Lipitor,Low Risk,Rapid Absorption,Ongoing,Animal Testing,PI3K-AKT Pathway,Topical Gel,250mg every 8 hours,Roche,48,Low,Moderate Risk,Low (<50%),Slow,Gut,Partially Suitable
Atorvastatin,Gastric Ulcer,Alzheimer's,52.95,C9H8O4,Proton Pump Inhibitor,Gastrointestinal Issues,1996,Metformin Hydrochloride,Glucophage,High Risk,Rapid Absorption,Phase 1,In Vitro Studies,Immune Response Pathway,Capsule,250mg every 8 hours,Merck,6,Moderate,Moderate Risk,High (>80%),Moderate,Enzyme-Specific,Suitable
Omeprazole,Acid Reflux,Parkinson's,49.31,C17H19N3O3S,Proton Pump Inhibitor,Acid Reflux,1994,Acetylsalicylic Acid,Prilosec,High Risk,Slow Metabolism,Ongoing,Toxicology Report,Serotonin Pathway,Tablet,250mg every 8 hours,AstraZeneca,12,High,High Risk,Low (<50%),Moderate,Renal,Partially Suitable
Losartan,Pain Relief,Parkinson's,86.35,C17H19N3O3S,AMPK Activator,Muscle Pain,1987,Atorvastatin Calcium,Prilosec,Low Risk,Slow Metabolism,Phase 2,In Vitro Studies,Dopaminergic Pathway,Injection,50mg daily,Novartis,48,High,Moderate Risk,Moderate (50-80%),Fast,Renal,Partially Suitable
Paracetamol,Inflammation,Parkinson's,30.8,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1987,Omeprazole,Lipitor,Moderate Risk,Slow Metabolism,Phase 2,In Vitro Studies,PI3K-AKT Pathway,Syrup,10mg once daily,AstraZeneca,24,Low,High Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Ranitidine,Hypertension,Anti-Aging,30.42,C13H18O2,HMG-CoA Reductase Inhibitor,Muscle Pain,1987,Acetylsalicylic Acid,Advil,Low Risk,High Bioavailability,Completed,Toxicology Report,Dopaminergic Pathway,Injection,250mg every 8 hours,Merck,2,Moderate,Moderate Risk,Low (<50%),Slow,Gut,Suitable
Simvastatin,Pain Relief,Liver Disease,73.92,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Muscle Pain,1994,Metformin Hydrochloride,Prilosec,Low Risk,Liver Metabolism,Ongoing,Toxicology Report,PI3K-AKT Pathway,Injection,250mg every 8 hours,Roche,6,High,Moderate Risk,Low (<50%),Fast,Gut,Partially Suitable
Levothyroxine,Acid Reflux,Migraine Treatment,63.33,C9H8O4,AMPK Activator,Acid Reflux,1987,Ibuprofen,Lipitor,High Risk,Rapid Absorption,Ongoing,Animal Testing,Dopaminergic Pathway,Injection,250mg every 8 hours,AstraZeneca,2,Low,Moderate Risk,High (>80%),Moderate,Renal,Suitable
Aspirin,Thyroid Hormone Replacement,Liver Disease,70.53,C33H35FN2O5,Proton Pump Inhibitor,Muscle Pain,1994,Ibuprofen,Lipitor,Low Risk,Rapid Absorption,Phase 4,Toxicology Report,Immune Response Pathway,Topical Gel,As prescribed,Merck,6,High,High Risk,Low (<50%),Slow,Enzyme-Specific,Not Suitable
Metformin,Blood Thinner,Cardiovascular Disease,65.98,C13H18O2,Proton Pump Inhibitor,Acid Reflux,1971,Acetylsalicylic Acid,Advil,Low Risk,Liver Metabolism,Completed,Animal Testing,MAPK Pathway,Injection,10mg once daily,AstraZeneca,12,Low,Moderate Risk,Moderate (50-80%),Fast,Gut,Partially Suitable
Ibuprofen,Hypertension,Parkinson's,31.41,C9H8O4,NSAID,Acid Reflux,1971,Omeprazole,Advil,High Risk,Rapid Absorption,Phase 4,Animal Testing,Serotonin Pathway,Injection,500mg twice a day,Merck,48,High,Moderate Risk,Low (<50%),Slow,Gut,Suitable
Atorvastatin,Diabetes,Antiviral,92.51,C9H8O4,AMPK Activator,"Nausea, Dizziness",1996,Metformin Hydrochloride,Lipitor,Low Risk,Rapid Absorption,Phase 3,In Vitro Studies,Dopaminergic Pathway,Topical Gel,50mg daily,Pfizer,24,Low,Low Risk,High (>80%),Moderate,Enzyme-Specific,Suitable
Omeprazole,Cholesterol Control,Alzheimer's,41.85,C4H11N5,Proton Pump Inhibitor,Muscle Pain,1994,Acetylsalicylic Acid,Aspirin,Moderate Risk,Liver Metabolism,Phase 2,Animal Testing,PI3K-AKT Pathway,Tablet,As prescribed,AstraZeneca,12,High,Low Risk,Low (<50%),Moderate,Gut,Suitable
Losartan,Pain Relief,Migraine Treatment,31.42,C13H18O2,Proton Pump Inhibitor,Gastrointestinal Issues,1996,Acetylsalicylic Acid,Lipitor,Low Risk,Slow Metabolism,Ongoing,In Vitro Studies,MAPK Pathway,Injection,250mg every 8 hours,Merck,12,Moderate,Low Risk,Low (<50%),Moderate,Liver,Partially Suitable
Paracetamol,Fever,Weight Loss,46.65,C33H35FN2O5,COX Inhibitor,"Nausea, Dizziness",1996,Atorvastatin Calcium,Prilosec,Moderate Risk,High Bioavailability,Phase 2,Animal Testing,Serotonin Pathway,Injection,500mg twice a day,Pfizer,6,Low,High Risk,Low (<50%),Fast,Enzyme-Specific,Not Suitable
Ranitidine,Hypertension,Cardiovascular Disease,47.04,C33H35FN2O5,NSAID,Muscle Pain,1965,Ibuprofen,Advil,Moderate Risk,Renal Excretion,Phase 2,Toxicology Report,MAPK Pathway,Capsule,250mg every 8 hours,Novartis,12,High,Moderate Risk,Moderate (50-80%),Slow,Gut,Partially Suitable
Simvastatin,Inflammation,Liver Disease,47.19,C13H18O2,NSAID,Acid Reflux,1965,Ibuprofen,Advil,Low Risk,Renal Excretion,Phase 1,In Vitro Studies,Dopaminergic Pathway,Tablet,500mg twice a day,Merck,48,Low,Low Risk,Low (<50%),Moderate,Renal,Suitable
Levothyroxine,Diabetes,Parkinson's,56.09,C9H8O4,AMPK Activator,"Headache, Rash",1996,Ibuprofen,Glucophage,Moderate Risk,Liver Metabolism,Completed,No Preclinical Data,Dopaminergic Pathway,Topical Gel,10mg once daily,Merck,24,High,Moderate Risk,Low (<50%),Fast,Gut,Partially Suitable
Aspirin,Fever,Alzheimer's,91.34,C33H35FN2O5,COX Inhibitor,Acid Reflux,1994,Atorvastatin Calcium,Glucophage,High Risk,Slow Metabolism,Phase 4,Toxicology Report,PI3K-AKT Pathway,Syrup,50mg daily,Roche,6,Low,Low Risk,Low (<50%),Fast,Renal,Partially Suitable
Metformin,Pain Relief,Cardiovascular Disease,84.02,C4H11N5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1971,Metformin Hydrochloride,Advil,Low Risk,Liver Metabolism,Completed,No Preclinical Data,PI3K-AKT Pathway,Syrup,500mg twice a day,Merck,48,High,Low Risk,High (>80%),Moderate,Gut,Not Suitable
Ibuprofen,Cholesterol Control,Alzheimer's,74.88,C33H35FN2O5,COX Inhibitor,"Headache, Rash",1971,Ibuprofen,Prilosec,Moderate Risk,Rapid Absorption,Phase 1,No Preclinical Data,Dopaminergic Pathway,Topical Gel,50mg daily,Roche,12,High,Low Risk,High (>80%),Moderate,Enzyme-Specific,Suitable
Atorvastatin,Pain Relief,Anti-Aging,79.21,C17H19N3O3S,Proton Pump Inhibitor,Gastrointestinal Issues,1971,Omeprazole,Lipitor,Low Risk,High Bioavailability,Ongoing,No Preclinical Data,Serotonin Pathway,Topical Gel,50mg daily,AstraZeneca,6,Moderate,High Risk,Moderate (50-80%),Moderate,Renal,Not Suitable
Omeprazole,Fever,Liver Disease,62.81,C17H19N3O3S,Proton Pump Inhibitor,"Headache, Rash",1996,Metformin Hydrochloride,Lipitor,High Risk,Rapid Absorption,Phase 3,In Vitro Studies,Immune Response Pathway,Injection,50mg daily,Merck,2,Moderate,Low Risk,Low (<50%),Slow,Gut,Not Suitable
Losartan,Cholesterol Control,Autoimmune Disorders,75.19,C17H19N3O3S,COX Inhibitor,"Headache, Rash",1965,Omeprazole,Glucophage,Low Risk,Liver Metabolism,Phase 1,No Preclinical Data,MAPK Pathway,Topical Gel,250mg every 8 hours,Roche,6,Low,High Risk,Moderate (50-80%),Fast,Enzyme-Specific,Suitable
Paracetamol,Acid Reflux,Alzheimer's,50.97,C9H8O4,COX Inhibitor,"Headache, Rash",1987,Metformin Hydrochloride,Lipitor,Low Risk,Rapid Absorption,Completed,In Vitro Studies,Immune Response Pathway,Capsule,10mg once daily,AstraZeneca,24,Low,Moderate Risk,High (>80%),Slow,Liver,Partially Suitable
Ranitidine,Diabetes,Cardiovascular Disease,39.08,C13H18O2,COX Inhibitor,Gastrointestinal Issues,1965,Omeprazole,Prilosec,Low Risk,Renal Excretion,Ongoing,Animal Testing,MAPK Pathway,Injection,500mg twice a day,Pfizer,2,Moderate,Moderate Risk,Moderate (50-80%),Moderate,Liver,Not Suitable
Simvastatin,Acid Reflux,Cancer Therapy,56.47,C4H11N5,Proton Pump Inhibitor,Gastrointestinal Issues,1987,Ibuprofen,Aspirin,Moderate Risk,Rapid Absorption,Phase 2,No Preclinical Data,Dopaminergic Pathway,Injection,50mg daily,Novartis,2,Moderate,Low Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Partially Suitable
Levothyroxine,Thyroid Hormone Replacement,Autoimmune Disorders,34.84,C17H19N3O3S,AMPK Activator,Acid Reflux,1971,Omeprazole,Aspirin,Low Risk,Liver Metabolism,Ongoing,Animal Testing,Serotonin Pathway,Syrup,As prescribed,Merck,48,Moderate,Moderate Risk,Moderate (50-80%),Slow,Liver,Suitable
Aspirin,Pain Relief,Autoimmune Disorders,74.02,C4H11N5,NSAID,Gastrointestinal Issues,1996,Atorvastatin Calcium,Glucophage,Moderate Risk,Slow Metabolism,Phase 3,Animal Testing,Serotonin Pathway,Syrup,10mg once daily,Novartis,24,High,Low Risk,High (>80%),Moderate,Liver,Partially Suitable
Metformin,Acid Reflux,Cancer Therapy,76.11,C33H35FN2O5,NSAID,Gastrointestinal Issues,1996,Omeprazole,Glucophage,High Risk,High Bioavailability,Completed,Animal Testing,Serotonin Pathway,Topical Gel,As prescribed,Pfizer,6,Moderate,High Risk,Low (<50%),Moderate,Renal,Not Suitable
Ibuprofen,Acid Reflux,Cancer Therapy,50.46,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1994,Atorvastatin Calcium,Aspirin,Moderate Risk,Slow Metabolism,Phase 4,In Vitro Studies,MAPK Pathway,Topical Gel,50mg daily,Merck,2,High,High Risk,High (>80%),Fast,Renal,Not Suitable
Atorvastatin,Pain Relief,Parkinson's,66.79,C17H19N3O3S,COX Inhibitor,"Headache, Rash",1971,Ibuprofen,Lipitor,Low Risk,Slow Metabolism,Phase 4,No Preclinical Data,PI3K-AKT Pathway,Capsule,500mg twice a day,Novartis,12,Moderate,Moderate Risk,Low (<50%),Slow,Enzyme-Specific,Suitable
Omeprazole,Pain Relief,Antiviral,65.39,C9H8O4,COX Inhibitor,Gastrointestinal Issues,1971,Omeprazole,Aspirin,High Risk,High Bioavailability,Ongoing,Animal Testing,Serotonin Pathway,Syrup,As prescribed,Merck,24,Moderate,Low Risk,High (>80%),Slow,Renal,Partially Suitable
Losartan,Gastric Ulcer,Antiviral,80.15,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1996,Metformin Hydrochloride,Advil,Moderate Risk,High Bioavailability,Phase 4,No Preclinical Data,Dopaminergic Pathway,Syrup,50mg daily,Novartis,6,Low,Low Risk,High (>80%),Fast,Enzyme-Specific,Suitable
Paracetamol,Thyroid Hormone Replacement,Migraine Treatment,46.39,C33H35FN2O5,NSAID,"Headache, Rash",1965,Atorvastatin Calcium,Prilosec,Low Risk,Liver Metabolism,Phase 2,No Preclinical Data,PI3K-AKT Pathway,Capsule,250mg every 8 hours,Novartis,2,Low,High Risk,Moderate (50-80%),Fast,Liver,Suitable
Ranitidine,Gastric Ulcer,Antiviral,65.2,C33H35FN2O5,NSAID,Acid Reflux,1994,Metformin Hydrochloride,Prilosec,Low Risk,Liver Metabolism,Phase 1,Toxicology Report,MAPK Pathway,Tablet,50mg daily,Novartis,12,Low,High Risk,High (>80%),Moderate,Enzyme-Specific,Partially Suitable
Simvastatin,Pain Relief,Cardiovascular Disease,66.89,C9H8O4,NSAID,Gastrointestinal Issues,1965,Ibuprofen,Advil,Moderate Risk,Liver Metabolism,Phase 3,No Preclinical Data,PI3K-AKT Pathway,Injection,50mg daily,Roche,24,Moderate,Low Risk,High (>80%),Fast,Gut,Partially Suitable
Levothyroxine,Fever,Alzheimer's,54.9,C9H8O4,NSAID,Muscle Pain,1965,Ibuprofen,Glucophage,Low Risk,Renal Excretion,Phase 4,Animal Testing,PI3K-AKT Pathway,Injection,500mg twice a day,Merck,48,High,High Risk,Moderate (50-80%),Slow,Gut,Partially Suitable
Aspirin,Thyroid Hormone Replacement,Migraine Treatment,79.41,C9H8O4,HMG-CoA Reductase Inhibitor,Muscle Pain,1994,Metformin Hydrochloride,Prilosec,High Risk,Renal Excretion,Phase 3,Toxicology Report,Serotonin Pathway,Topical Gel,50mg daily,Merck,2,Low,Low Risk,Low (<50%),Moderate,Enzyme-Specific,Partially Suitable
Metformin,Gastric Ulcer,Anti-Aging,88.3,C33H35FN2O5,AMPK Activator,"Headache, Rash",1994,Metformin Hydrochloride,Glucophage,Low Risk,Rapid Absorption,Phase 3,Toxicology Report,Serotonin Pathway,Injection,250mg every 8 hours,Pfizer,12,Low,Moderate Risk,Low (<50%),Fast,Gut,Not Suitable
Ibuprofen,Hypertension,Liver Disease,34.1,C9H8O4,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1965,Omeprazole,Advil,High Risk,Slow Metabolism,Completed,Toxicology Report,Serotonin Pathway,Capsule,500mg twice a day,Merck,48,High,Moderate Risk,Low (<50%),Fast,Liver,Partially Suitable
Atorvastatin,Pain Relief,Liver Disease,63.15,C13H18O2,AMPK Activator,Muscle Pain,1965,Metformin Hydrochloride,Advil,Low Risk,Rapid Absorption,Phase 2,Toxicology Report,PI3K-AKT Pathway,Injection,50mg daily,AstraZeneca,6,Low,High Risk,Moderate (50-80%),Slow,Enzyme-Specific,Not Suitable
Omeprazole,Acid Reflux,Liver Disease,73.83,C17H19N3O3S,NSAID,Muscle Pain,1996,Atorvastatin Calcium,Glucophage,High Risk,Rapid Absorption,Phase 1,In Vitro Studies,Dopaminergic Pathway,Syrup,10mg once daily,Pfizer,12,Low,Low Risk,High (>80%),Slow,Enzyme-Specific,Suitable
Losartan,Inflammation,Liver Disease,84.96,C13H18O2,COX Inhibitor,Acid Reflux,1994,Omeprazole,Advil,Moderate Risk,Renal Excretion,Phase 3,No Preclinical Data,PI3K-AKT Pathway,Tablet,10mg once daily,Novartis,2,Low,Moderate Risk,High (>80%),Moderate,Enzyme-Specific,Not Suitable
Paracetamol,Inflammation,Anti-Aging,73.43,C9H8O4,Proton Pump Inhibitor,"Nausea, Dizziness",1987,Ibuprofen,Lipitor,Moderate Risk,Liver Metabolism,Phase 1,Animal Testing,Dopaminergic Pathway,Injection,50mg daily,Pfizer,6,Moderate,Moderate Risk,Moderate (50-80%),Moderate,Renal,Not Suitable
Ranitidine,Thyroid Hormone Replacement,Cancer Therapy,89.33,C17H19N3O3S,Proton Pump Inhibitor,Muscle Pain,1987,Acetylsalicylic Acid,Prilosec,Moderate Risk,Renal Excretion,Phase 1,Animal Testing,Dopaminergic Pathway,Syrup,10mg once daily,Merck,24,High,Moderate Risk,Low (<50%),Fast,Renal,Not Suitable
Simvastatin,Pain Relief,Weight Loss,83.77,C9H8O4,HMG-CoA Reductase Inhibitor,Acid Reflux,1996,Omeprazole,Glucophage,Low Risk,Renal Excretion,Ongoing,Animal Testing,MAPK Pathway,Syrup,As prescribed,Roche,24,High,Low Risk,High (>80%),Moderate,Liver,Suitable
Levothyroxine,Thyroid Hormone Replacement,Autoimmune Disorders,38.07,C9H8O4,NSAID,Gastrointestinal Issues,1996,Omeprazole,Glucophage,Low Risk,High Bioavailability,Ongoing,Toxicology Report,Dopaminergic Pathway,Capsule,As prescribed,Novartis,48,High,Moderate Risk,Low (<50%),Slow,Enzyme-Specific,Partially Suitable
Aspirin,Acid Reflux,Liver Disease,77.71,C13H18O2,COX Inhibitor,"Nausea, Dizziness",1987,Ibuprofen,Lipitor,Low Risk,Liver Metabolism,Phase 3,No Preclinical Data,Dopaminergic Pathway,Capsule,As prescribed,Merck,24,High,Moderate Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Not Suitable
Metformin,Fever,Autoimmune Disorders,34,C13H18O2,NSAID,Gastrointestinal Issues,1996,Metformin Hydrochloride,Glucophage,High Risk,High Bioavailability,Phase 4,Toxicology Report,Immune Response Pathway,Capsule,10mg once daily,Pfizer,24,Low,Moderate Risk,Moderate (50-80%),Fast,Gut,Suitable
Ibuprofen,Pain Relief,Weight Loss,62.94,C9H8O4,NSAID,Muscle Pain,1965,Atorvastatin Calcium,Advil,Moderate Risk,Liver Metabolism,Phase 1,Toxicology Report,Dopaminergic Pathway,Capsule,10mg once daily,Merck,48,Moderate,Low Risk,Moderate (50-80%),Slow,Enzyme-Specific,Not Suitable
Atorvastatin,Cholesterol Control,Anti-Aging,78.24,C4H11N5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1996,Acetylsalicylic Acid,Aspirin,Moderate Risk,Liver Metabolism,Phase 4,Toxicology Report,Dopaminergic Pathway,Syrup,50mg daily,AstraZeneca,6,Low,Moderate Risk,Low (<50%),Slow,Gut,Partially Suitable
Omeprazole,Blood Thinner,Autoimmune Disorders,69.52,C17H19N3O3S,COX Inhibitor,"Headache, Rash",1971,Omeprazole,Lipitor,Moderate Risk,Renal Excretion,Phase 4,No Preclinical Data,Immune Response Pathway,Capsule,500mg twice a day,Novartis,6,Low,High Risk,Low (<50%),Moderate,Gut,Not Suitable
Losartan,Acid Reflux,Anti-Aging,31.04,C13H18O2,HMG-CoA Reductase Inhibitor,Acid Reflux,1987,Omeprazole,Glucophage,High Risk,Rapid Absorption,Ongoing,In Vitro Studies,Serotonin Pathway,Tablet,50mg daily,Novartis,2,High,Low Risk,High (>80%),Slow,Gut,Not Suitable
Paracetamol,Hypertension,Anti-Aging,92.4,C33H35FN2O5,AMPK Activator,Acid Reflux,1996,Acetylsalicylic Acid,Prilosec,Moderate Risk,Slow Metabolism,Completed,No Preclinical Data,Immune Response Pathway,Capsule,10mg once daily,AstraZeneca,48,High,High Risk,High (>80%),Moderate,Renal,Suitable
Ranitidine,Diabetes,Weight Loss,52.07,C9H8O4,AMPK Activator,Gastrointestinal Issues,1965,Atorvastatin Calcium,Prilosec,Low Risk,Slow Metabolism,Phase 2,Animal Testing,PI3K-AKT Pathway,Topical Gel,10mg once daily,Novartis,2,High,Moderate Risk,Low (<50%),Moderate,Liver,Suitable
Simvastatin,Hypertension,Anti-Aging,92.55,C33H35FN2O5,AMPK Activator,Acid Reflux,1965,Atorvastatin Calcium,Lipitor,High Risk,Renal Excretion,Phase 2,In Vitro Studies,Dopaminergic Pathway,Syrup,As prescribed,Novartis,6,Moderate,Moderate Risk,Moderate (50-80%),Fast,Enzyme-Specific,Suitable
Levothyroxine,Inflammation,Migraine Treatment,55.9,C17H19N3O3S,AMPK Activator,"Headache, Rash",1994,Acetylsalicylic Acid,Glucophage,High Risk,High Bioavailability,Completed,In Vitro Studies,Dopaminergic Pathway,Tablet,250mg every 8 hours,Pfizer,12,Moderate,Moderate Risk,Low (<50%),Slow,Liver,Not Suitable
Aspirin,Cholesterol Control,Alzheimer's,56.34,C4H11N5,AMPK Activator,"Headache, Rash",1965,Atorvastatin Calcium,Lipitor,Moderate Risk,Rapid Absorption,Phase 2,Toxicology Report,Immune Response Pathway,Tablet,50mg daily,Pfizer,48,Moderate,High Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Suitable
Metformin,Inflammation,Anti-Aging,55.54,C17H19N3O3S,Proton Pump Inhibitor,Gastrointestinal Issues,1996,Metformin Hydrochloride,Prilosec,Moderate Risk,Liver Metabolism,Phase 3,Toxicology Report,Immune Response Pathway,Syrup,250mg every 8 hours,Novartis,24,High,Low Risk,High (>80%),Fast,Renal,Suitable
Ibuprofen,Pain Relief,Liver Disease,93.16,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1965,Metformin Hydrochloride,Glucophage,Low Risk,Renal Excretion,Ongoing,In Vitro Studies,MAPK Pathway,Topical Gel,10mg once daily,Roche,6,High,Moderate Risk,Low (<50%),Fast,Enzyme-Specific,Partially Suitable
Atorvastatin,Cholesterol Control,Anti-Aging,60.22,C33H35FN2O5,Proton Pump Inhibitor,"Headache, Rash",1987,Ibuprofen,Aspirin,High Risk,Liver Metabolism,Phase 2,Animal Testing,Dopaminergic Pathway,Topical Gel,500mg twice a day,Merck,48,High,Low Risk,Low (<50%),Fast,Enzyme-Specific,Suitable
Omeprazole,Inflammation,Autoimmune Disorders,46.84,C17H19N3O3S,COX Inhibitor,Muscle Pain,1994,Metformin Hydrochloride,Glucophage,Moderate Risk,High Bioavailability,Phase 1,No Preclinical Data,Serotonin Pathway,Capsule,As prescribed,Novartis,24,High,Low Risk,Moderate (50-80%),Fast,Gut,Suitable
Losartan,Diabetes,Cardiovascular Disease,89.43,C13H18O2,COX Inhibitor,"Headache, Rash",1971,Atorvastatin Calcium,Advil,High Risk,Rapid Absorption,Phase 1,Toxicology Report,Immune Response Pathway,Topical Gel,50mg daily,Roche,2,Moderate,Low Risk,High (>80%),Slow,Enzyme-Specific,Suitable
Paracetamol,Blood Thinner,Alzheimer's,72.42,C4H11N5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1996,Omeprazole,Aspirin,Moderate Risk,Rapid Absorption,Completed,Toxicology Report,Immune Response Pathway,Syrup,250mg every 8 hours,Roche,6,Low,Low Risk,Moderate (50-80%),Slow,Enzyme-Specific,Not Suitable
Ranitidine,Cholesterol Control,Migraine Treatment,40.08,C17H19N3O3S,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1987,Acetylsalicylic Acid,Lipitor,Low Risk,Slow Metabolism,Phase 1,In Vitro Studies,PI3K-AKT Pathway,Capsule,As prescribed,Merck,48,Moderate,High Risk,Low (<50%),Slow,Gut,Suitable
Simvastatin,Fever,Alzheimer's,43.52,C13H18O2,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1987,Ibuprofen,Advil,Moderate Risk,Slow Metabolism,Phase 4,No Preclinical Data,PI3K-AKT Pathway,Capsule,As prescribed,Merck,12,Moderate,Moderate Risk,High (>80%),Slow,Gut,Suitable
Levothyroxine,Diabetes,Liver Disease,79.93,C17H19N3O3S,AMPK Activator,"Nausea, Dizziness",1996,Omeprazole,Aspirin,High Risk,Liver Metabolism,Phase 1,Animal Testing,PI3K-AKT Pathway,Capsule,250mg every 8 hours,Roche,24,Low,Moderate Risk,Low (<50%),Slow,Enzyme-Specific,Partially Suitable
Aspirin,Diabetes,Liver Disease,41.81,C4H11N5,HMG-CoA Reductase Inhibitor,Acid Reflux,1987,Omeprazole,Advil,High Risk,Liver Metabolism,Phase 4,Toxicology Report,Immune Response Pathway,Syrup,10mg once daily,AstraZeneca,24,Low,Moderate Risk,High (>80%),Slow,Renal,Partially Suitable
Metformin,Inflammation,Parkinson's,71.76,C9H8O4,AMPK Activator,Gastrointestinal Issues,1994,Omeprazole,Aspirin,Low Risk,Renal Excretion,Completed,In Vitro Studies,Serotonin Pathway,Injection,50mg daily,AstraZeneca,2,High,High Risk,High (>80%),Fast,Liver,Partially Suitable
Ibuprofen,Gastric Ulcer,Alzheimer's,56.44,C9H8O4,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1994,Metformin Hydrochloride,Glucophage,Moderate Risk,Liver Metabolism,Ongoing,Animal Testing,Dopaminergic Pathway,Syrup,As prescribed,AstraZeneca,24,Moderate,Moderate Risk,Moderate (50-80%),Moderate,Renal,Suitable
Atorvastatin,Hypertension,Autoimmune Disorders,78.76,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1987,Atorvastatin Calcium,Lipitor,Moderate Risk,Slow Metabolism,Phase 1,No Preclinical Data,Immune Response Pathway,Capsule,As prescribed,Pfizer,48,High,Low Risk,High (>80%),Moderate,Liver,Not Suitable
Omeprazole,Inflammation,Autoimmune Disorders,59.55,C9H8O4,Proton Pump Inhibitor,Muscle Pain,1987,Acetylsalicylic Acid,Glucophage,High Risk,Slow Metabolism,Completed,Animal Testing,Immune Response Pathway,Injection,As prescribed,Merck,2,High,Low Risk,High (>80%),Slow,Renal,Partially Suitable
Losartan,Gastric Ulcer,Alzheimer's,73.73,C17H19N3O3S,AMPK Activator,"Headache, Rash",1987,Metformin Hydrochloride,Lipitor,Low Risk,High Bioavailability,Phase 2,No Preclinical Data,MAPK Pathway,Capsule,10mg once daily,Merck,48,Moderate,Low Risk,Low (<50%),Slow,Liver,Not Suitable
Paracetamol,Inflammation,Weight Loss,40.72,C17H19N3O3S,COX Inhibitor,"Nausea, Dizziness",1965,Ibuprofen,Advil,Low Risk,High Bioavailability,Phase 2,In Vitro Studies,Immune Response Pathway,Capsule,10mg once daily,Novartis,2,Moderate,High Risk,Low (<50%),Fast,Enzyme-Specific,Partially Suitable
Ranitidine,Pain Relief,Weight Loss,82.66,C9H8O4,HMG-CoA Reductase Inhibitor,Muscle Pain,1996,Ibuprofen,Prilosec,High Risk,Slow Metabolism,Phase 3,Toxicology Report,PI3K-AKT Pathway,Capsule,10mg once daily,Novartis,24,High,Low Risk,High (>80%),Slow,Gut,Partially Suitable
Simvastatin,Gastric Ulcer,Anti-Aging,93.16,C9H8O4,AMPK Activator,Gastrointestinal Issues,1994,Acetylsalicylic Acid,Lipitor,High Risk,Liver Metabolism,Completed,Animal Testing,Dopaminergic Pathway,Topical Gel,250mg every 8 hours,Roche,6,Low,High Risk,Moderate (50-80%),Fast,Gut,Suitable
Levothyroxine,Fever,Cancer Therapy,31.89,C4H11N5,AMPK Activator,Gastrointestinal Issues,1987,Ibuprofen,Prilosec,Moderate Risk,High Bioavailability,Ongoing,In Vitro Studies,Serotonin Pathway,Injection,50mg daily,Novartis,2,Low,Moderate Risk,Moderate (50-80%),Moderate,Liver,Not Suitable
Aspirin,Inflammation,Antiviral,43.01,C9H8O4,NSAID,"Nausea, Dizziness",1996,Ibuprofen,Prilosec,High Risk,Rapid Absorption,Completed,Animal Testing,Serotonin Pathway,Injection,10mg once daily,Pfizer,2,High,Low Risk,Low (<50%),Moderate,Enzyme-Specific,Partially Suitable
Metformin,Acid Reflux,Antiviral,31.88,C17H19N3O3S,Proton Pump Inhibitor,Acid Reflux,1965,Metformin Hydrochloride,Lipitor,Low Risk,Slow Metabolism,Phase 3,In Vitro Studies,MAPK Pathway,Tablet,10mg once daily,Pfizer,6,High,Moderate Risk,Low (<50%),Fast,Enzyme-Specific,Suitable
Ibuprofen,Diabetes,Antiviral,81.11,C4H11N5,HMG-CoA Reductase Inhibitor,Muscle Pain,1987,Omeprazole,Lipitor,Moderate Risk,High Bioavailability,Phase 3,In Vitro Studies,MAPK Pathway,Syrup,50mg daily,Merck,48,Moderate,High Risk,Low (<50%),Slow,Renal,Partially Suitable
Atorvastatin,Fever,Liver Disease,43.76,C13H18O2,Proton Pump Inhibitor,"Nausea, Dizziness",1971,Metformin Hydrochloride,Aspirin,High Risk,Liver Metabolism,Completed,No Preclinical Data,Dopaminergic Pathway,Topical Gel,As prescribed,Roche,24,Low,High Risk,Moderate (50-80%),Fast,Renal,Suitable
Omeprazole,Thyroid Hormone Replacement,Weight Loss,73.93,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Acid Reflux,1965,Atorvastatin Calcium,Glucophage,High Risk,Slow Metabolism,Phase 2,No Preclinical Data,MAPK Pathway,Tablet,250mg every 8 hours,AstraZeneca,12,Moderate,Low Risk,Moderate (50-80%),Moderate,Renal,Not Suitable
Losartan,Thyroid Hormone Replacement,Autoimmune Disorders,88.23,C13H18O2,AMPK Activator,"Headache, Rash",1994,Metformin Hydrochloride,Lipitor,Low Risk,High Bioavailability,Ongoing,Toxicology Report,Immune Response Pathway,Capsule,50mg daily,AstraZeneca,24,High,High Risk,Low (<50%),Fast,Gut,Partially Suitable
Paracetamol,Diabetes,Alzheimer's,59.55,C33H35FN2O5,NSAID,Muscle Pain,1996,Atorvastatin Calcium,Lipitor,Low Risk,High Bioavailability,Phase 1,Toxicology Report,Serotonin Pathway,Syrup,10mg once daily,Novartis,6,Low,Low Risk,Moderate (50-80%),Moderate,Renal,Suitable
Ranitidine,Inflammation,Weight Loss,42.56,C17H19N3O3S,Proton Pump Inhibitor,"Headache, Rash",1996,Metformin Hydrochloride,Aspirin,Moderate Risk,Renal Excretion,Phase 3,Animal Testing,PI3K-AKT Pathway,Capsule,10mg once daily,Roche,2,High,High Risk,High (>80%),Moderate,Renal,Suitable
Simvastatin,Hypertension,Parkinson's,40.43,C13H18O2,NSAID,Acid Reflux,1965,Omeprazole,Glucophage,High Risk,Liver Metabolism,Ongoing,Animal Testing,Serotonin Pathway,Capsule,250mg every 8 hours,Merck,48,High,High Risk,Moderate (50-80%),Fast,Renal,Not Suitable
Levothyroxine,Blood Thinner,Weight Loss,47.29,C4H11N5,HMG-CoA Reductase Inhibitor,Acid Reflux,1971,Omeprazole,Lipitor,High Risk,High Bioavailability,Ongoing,Toxicology Report,PI3K-AKT Pathway,Syrup,50mg daily,Novartis,24,High,High Risk,Low (<50%),Moderate,Gut,Not Suitable
Aspirin,Cholesterol Control,Liver Disease,72.71,C33H35FN2O5,AMPK Activator,Acid Reflux,1971,Atorvastatin Calcium,Aspirin,Moderate Risk,High Bioavailability,Phase 1,Animal Testing,PI3K-AKT Pathway,Syrup,250mg every 8 hours,AstraZeneca,12,Moderate,Low Risk,Low (<50%),Slow,Liver,Not Suitable
Metformin,Gastric Ulcer,Migraine Treatment,65.02,C4H11N5,NSAID,Gastrointestinal Issues,1987,Acetylsalicylic Acid,Glucophage,High Risk,Liver Metabolism,Completed,In Vitro Studies,PI3K-AKT Pathway,Capsule,50mg daily,Pfizer,6,High,Moderate Risk,High (>80%),Moderate,Renal,Suitable
Ibuprofen,Hypertension,Alzheimer's,54.48,C13H18O2,COX Inhibitor,Gastrointestinal Issues,1996,Atorvastatin Calcium,Glucophage,High Risk,Slow Metabolism,Ongoing,In Vitro Studies,Immune Response Pathway,Injection,50mg daily,Pfizer,24,High,High Risk,Moderate (50-80%),Moderate,Gut,Partially Suitable
Atorvastatin,Gastric Ulcer,Alzheimer's,49.8,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1971,Ibuprofen,Prilosec,Low Risk,Liver Metabolism,Ongoing,No Preclinical Data,Dopaminergic Pathway,Tablet,As prescribed,Pfizer,12,High,High Risk,High (>80%),Moderate,Gut,Not Suitable
Omeprazole,Blood Thinner,Parkinson's,71.39,C13H18O2,AMPK Activator,"Headache, Rash",1996,Ibuprofen,Aspirin,Moderate Risk,Renal Excretion,Phase 4,Toxicology Report,Serotonin Pathway,Tablet,250mg every 8 hours,AstraZeneca,48,High,High Risk,Low (<50%),Fast,Liver,Partially Suitable
Losartan,Thyroid Hormone Replacement,Liver Disease,61.17,C17H19N3O3S,AMPK Activator,Muscle Pain,1994,Acetylsalicylic Acid,Glucophage,Moderate Risk,Rapid Absorption,Completed,Toxicology Report,Serotonin Pathway,Tablet,50mg daily,Roche,6,Low,Moderate Risk,Low (<50%),Fast,Enzyme-Specific,Not Suitable
Paracetamol,Inflammation,Liver Disease,77.5,C33H35FN2O5,AMPK Activator,Gastrointestinal Issues,1965,Metformin Hydrochloride,Prilosec,Moderate Risk,Slow Metabolism,Phase 1,In Vitro Studies,PI3K-AKT Pathway,Topical Gel,As prescribed,AstraZeneca,48,High,Low Risk,High (>80%),Slow,Renal,Not Suitable
Ranitidine,Hypertension,Cardiovascular Disease,83,C33H35FN2O5,NSAID,Acid Reflux,1996,Acetylsalicylic Acid,Aspirin,High Risk,High Bioavailability,Phase 4,Toxicology Report,PI3K-AKT Pathway,Syrup,500mg twice a day,Pfizer,24,High,Moderate Risk,Moderate (50-80%),Slow,Gut,Suitable
Simvastatin,Pain Relief,Antiviral,41.46,C4H11N5,HMG-CoA Reductase Inhibitor,Acid Reflux,1971,Metformin Hydrochloride,Glucophage,High Risk,Rapid Absorption,Ongoing,In Vitro Studies,PI3K-AKT Pathway,Topical Gel,250mg every 8 hours,Merck,12,Moderate,Low Risk,Low (<50%),Moderate,Gut,Partially Suitable
Levothyroxine,Thyroid Hormone Replacement,Anti-Aging,40.38,C17H19N3O3S,AMPK Activator,"Nausea, Dizziness",1987,Metformin Hydrochloride,Prilosec,High Risk,Liver Metabolism,Phase 1,In Vitro Studies,PI3K-AKT Pathway,Tablet,250mg every 8 hours,Roche,24,Low,Moderate Risk,Moderate (50-80%),Slow,Liver,Not Suitable
Aspirin,Hypertension,Liver Disease,44.56,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Muscle Pain,1965,Metformin Hydrochloride,Lipitor,Moderate Risk,High Bioavailability,Completed,Toxicology Report,Immune Response Pathway,Topical Gel,10mg once daily,Merck,48,High,Moderate Risk,Low (<50%),Fast,Gut,Not Suitable
Metformin,Hypertension,Migraine Treatment,59.91,C17H19N3O3S,COX Inhibitor,Acid Reflux,1996,Atorvastatin Calcium,Advil,Low Risk,Slow Metabolism,Phase 1,Animal Testing,Serotonin Pathway,Syrup,10mg once daily,Roche,24,Low,High Risk,Moderate (50-80%),Fast,Enzyme-Specific,Suitable
Ibuprofen,Thyroid Hormone Replacement,Alzheimer's,70.86,C13H18O2,AMPK Activator,Acid Reflux,1996,Ibuprofen,Advil,Moderate Risk,Rapid Absorption,Phase 3,Toxicology Report,MAPK Pathway,Topical Gel,As prescribed,Roche,24,Low,Moderate Risk,High (>80%),Moderate,Liver,Partially Suitable
Atorvastatin,Acid Reflux,Anti-Aging,90.53,C17H19N3O3S,NSAID,Acid Reflux,1965,Ibuprofen,Lipitor,High Risk,Slow Metabolism,Phase 2,Toxicology Report,Serotonin Pathway,Injection,500mg twice a day,Pfizer,2,High,Moderate Risk,High (>80%),Moderate,Renal,Suitable
Omeprazole,Pain Relief,Cancer Therapy,43.98,C33H35FN2O5,NSAID,"Headache, Rash",1994,Acetylsalicylic Acid,Prilosec,Low Risk,Rapid Absorption,Ongoing,Toxicology Report,MAPK Pathway,Syrup,10mg once daily,Roche,2,Low,Moderate Risk,High (>80%),Slow,Enzyme-Specific,Suitable
Losartan,Acid Reflux,Alzheimer's,36.65,C9H8O4,COX Inhibitor,"Nausea, Dizziness",1965,Omeprazole,Advil,Low Risk,Liver Metabolism,Ongoing,Toxicology Report,MAPK Pathway,Capsule,500mg twice a day,AstraZeneca,2,Moderate,Moderate Risk,Low (<50%),Fast,Liver,Not Suitable
Paracetamol,Acid Reflux,Migraine Treatment,92.48,C9H8O4,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1987,Acetylsalicylic Acid,Advil,Low Risk,High Bioavailability,Ongoing,Animal Testing,Serotonin Pathway,Capsule,10mg once daily,AstraZeneca,6,Low,Low Risk,Low (<50%),Slow,Renal,Not Suitable
Ranitidine,Inflammation,Weight Loss,30.85,C4H11N5,Proton Pump Inhibitor,Acid Reflux,1971,Ibuprofen,Prilosec,High Risk,Liver Metabolism,Phase 2,In Vitro Studies,Serotonin Pathway,Syrup,500mg twice a day,Pfizer,24,High,Moderate Risk,Moderate (50-80%),Moderate,Liver,Suitable
Simvastatin,Gastric Ulcer,Weight Loss,40.47,C13H18O2,AMPK Activator,Gastrointestinal Issues,1971,Metformin Hydrochloride,Advil,Moderate Risk,High Bioavailability,Phase 1,Toxicology Report,PI3K-AKT Pathway,Topical Gel,10mg once daily,Roche,48,Moderate,High Risk,High (>80%),Fast,Enzyme-Specific,Partially Suitable
Levothyroxine,Thyroid Hormone Replacement,Liver Disease,75.42,C9H8O4,HMG-CoA Reductase Inhibitor,"Headache, Rash",1996,Metformin Hydrochloride,Aspirin,Moderate Risk,Liver Metabolism,Ongoing,No Preclinical Data,Serotonin Pathway,Injection,250mg every 8 hours,Merck,2,High,Moderate Risk,Moderate (50-80%),Slow,Enzyme-Specific,Not Suitable
Aspirin,Acid Reflux,Alzheimer's,73.74,C33H35FN2O5,COX Inhibitor,Muscle Pain,1965,Acetylsalicylic Acid,Prilosec,High Risk,Renal Excretion,Phase 1,In Vitro Studies,Immune Response Pathway,Capsule,500mg twice a day,Novartis,12,High,Moderate Risk,Low (<50%),Moderate,Renal,Partially Suitable
Metformin,Inflammation,Anti-Aging,47.67,C9H8O4,Proton Pump Inhibitor,Gastrointestinal Issues,1965,Ibuprofen,Aspirin,High Risk,Renal Excretion,Phase 3,Toxicology Report,Serotonin Pathway,Topical Gel,500mg twice a day,AstraZeneca,12,Low,High Risk,Moderate (50-80%),Slow,Gut,Not Suitable
Ibuprofen,Gastric Ulcer,Antiviral,72.99,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1994,Metformin Hydrochloride,Lipitor,Moderate Risk,Renal Excretion,Ongoing,Toxicology Report,MAPK Pathway,Syrup,10mg once daily,Merck,2,Moderate,Low Risk,Moderate (50-80%),Fast,Liver,Suitable
Atorvastatin,Gastric Ulcer,Parkinson's,61.33,C9H8O4,AMPK Activator,"Nausea, Dizziness",1965,Ibuprofen,Prilosec,Moderate Risk,High Bioavailability,Phase 2,Animal Testing,Dopaminergic Pathway,Syrup,250mg every 8 hours,AstraZeneca,2,Moderate,Low Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Partially Suitable
Omeprazole,Fever,Autoimmune Disorders,57.36,C4H11N5,NSAID,Muscle Pain,1996,Atorvastatin Calcium,Prilosec,Moderate Risk,Liver Metabolism,Ongoing,Toxicology Report,MAPK Pathway,Tablet,50mg daily,AstraZeneca,48,Low,Low Risk,High (>80%),Moderate,Renal,Not Suitable
Losartan,Blood Thinner,Cancer Therapy,82.36,C33H35FN2O5,AMPK Activator,Acid Reflux,1965,Metformin Hydrochloride,Glucophage,High Risk,Renal Excretion,Phase 3,No Preclinical Data,MAPK Pathway,Tablet,50mg daily,Novartis,6,Moderate,Low Risk,High (>80%),Moderate,Enzyme-Specific,Not Suitable
Paracetamol,Thyroid Hormone Replacement,Liver Disease,32.04,C4H11N5,NSAID,"Headache, Rash",1996,Ibuprofen,Prilosec,High Risk,Renal Excretion,Phase 1,No Preclinical Data,MAPK Pathway,Injection,250mg every 8 hours,Roche,6,Low,Low Risk,Low (<50%),Slow,Liver,Suitable
Ranitidine,Pain Relief,Anti-Aging,73.28,C13H18O2,Proton Pump Inhibitor,"Headache, Rash",1987,Acetylsalicylic Acid,Advil,Low Risk,Rapid Absorption,Phase 4,Animal Testing,Immune Response Pathway,Capsule,500mg twice a day,AstraZeneca,24,Moderate,Moderate Risk,Moderate (50-80%),Slow,Enzyme-Specific,Not Suitable
Simvastatin,Pain Relief,Migraine Treatment,39.47,C13H18O2,AMPK Activator,Gastrointestinal Issues,1987,Omeprazole,Prilosec,Low Risk,Renal Excretion,Phase 3,Toxicology Report,PI3K-AKT Pathway,Syrup,As prescribed,Novartis,6,High,Low Risk,High (>80%),Fast,Enzyme-Specific,Not Suitable
Levothyroxine,Inflammation,Migraine Treatment,66.85,C9H8O4,HMG-CoA Reductase Inhibitor,Muscle Pain,1971,Omeprazole,Glucophage,Low Risk,Slow Metabolism,Phase 4,In Vitro Studies,Immune Response Pathway,Syrup,10mg once daily,Roche,12,Moderate,Moderate Risk,High (>80%),Fast,Liver,Suitable
Aspirin,Inflammation,Antiviral,71.99,C17H19N3O3S,COX Inhibitor,"Nausea, Dizziness",1965,Omeprazole,Glucophage,High Risk,Rapid Absorption,Phase 4,Toxicology Report,MAPK Pathway,Syrup,250mg every 8 hours,Roche,48,High,High Risk,Moderate (50-80%),Slow,Gut,Not Suitable
Metformin,Thyroid Hormone Replacement,Parkinson's,32.25,C13H18O2,COX Inhibitor,Gastrointestinal Issues,1971,Ibuprofen,Prilosec,Low Risk,Liver Metabolism,Phase 2,Animal Testing,Serotonin Pathway,Injection,250mg every 8 hours,Novartis,6,Low,Low Risk,Moderate (50-80%),Moderate,Gut,Partially Suitable
Ibuprofen,Gastric Ulcer,Anti-Aging,65.37,C17H19N3O3S,Proton Pump Inhibitor,Acid Reflux,1996,Metformin Hydrochloride,Advil,Low Risk,Slow Metabolism,Phase 4,No Preclinical Data,Dopaminergic Pathway,Capsule,500mg twice a day,Merck,12,High,Low Risk,Moderate (50-80%),Fast,Gut,Partially Suitable
Atorvastatin,Inflammation,Migraine Treatment,56.5,C13H18O2,HMG-CoA Reductase Inhibitor,Muscle Pain,1987,Ibuprofen,Lipitor,Low Risk,Liver Metabolism,Completed,No Preclinical Data,Dopaminergic Pathway,Syrup,50mg daily,Novartis,24,High,High Risk,Moderate (50-80%),Moderate,Gut,Partially Suitable
Omeprazole,Blood Thinner,Autoimmune Disorders,94.46,C13H18O2,AMPK Activator,Gastrointestinal Issues,1965,Metformin Hydrochloride,Advil,Low Risk,Liver Metabolism,Phase 1,No Preclinical Data,Dopaminergic Pathway,Injection,500mg twice a day,Roche,12,High,Low Risk,High (>80%),Slow,Liver,Suitable
Losartan,Inflammation,Antiviral,72.1,C17H19N3O3S,AMPK Activator,Muscle Pain,1965,Ibuprofen,Prilosec,Moderate Risk,High Bioavailability,Phase 2,In Vitro Studies,Serotonin Pathway,Capsule,50mg daily,Roche,12,Low,Low Risk,High (>80%),Moderate,Enzyme-Specific,Not Suitable
Paracetamol,Gastric Ulcer,Autoimmune Disorders,80.94,C13H18O2,COX Inhibitor,Gastrointestinal Issues,1996,Omeprazole,Prilosec,Low Risk,Renal Excretion,Phase 3,No Preclinical Data,Dopaminergic Pathway,Capsule,50mg daily,Pfizer,24,Low,Moderate Risk,Low (<50%),Slow,Liver,Suitable
Ranitidine,Diabetes,Liver Disease,81.25,C13H18O2,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1971,Ibuprofen,Glucophage,Moderate Risk,Slow Metabolism,Phase 2,No Preclinical Data,Immune Response Pathway,Injection,10mg once daily,Roche,48,Low,Moderate Risk,Moderate (50-80%),Fast,Liver,Suitable
Simvastatin,Diabetes,Parkinson's,92.62,C13H18O2,Proton Pump Inhibitor,"Headache, Rash",1965,Metformin Hydrochloride,Aspirin,High Risk,Rapid Absorption,Completed,Toxicology Report,Dopaminergic Pathway,Tablet,50mg daily,AstraZeneca,48,Moderate,Moderate Risk,Low (<50%),Slow,Liver,Partially Suitable
Levothyroxine,Fever,Weight Loss,42.82,C13H18O2,Proton Pump Inhibitor,"Nausea, Dizziness",1994,Acetylsalicylic Acid,Aspirin,Low Risk,Renal Excretion,Phase 1,In Vitro Studies,PI3K-AKT Pathway,Tablet,250mg every 8 hours,Roche,24,High,High Risk,Low (<50%),Moderate,Gut,Not Suitable
Aspirin,Diabetes,Cardiovascular Disease,77.71,C33H35FN2O5,COX Inhibitor,"Nausea, Dizziness",1971,Atorvastatin Calcium,Advil,Moderate Risk,High Bioavailability,Phase 1,Toxicology Report,Serotonin Pathway,Topical Gel,10mg once daily,AstraZeneca,12,Moderate,High Risk,Moderate (50-80%),Slow,Gut,Suitable
Metformin,Blood Thinner,Antiviral,33.63,C33H35FN2O5,COX Inhibitor,"Headache, Rash",1971,Atorvastatin Calcium,Aspirin,Moderate Risk,Rapid Absorption,Phase 2,In Vitro Studies,MAPK Pathway,Syrup,500mg twice a day,Pfizer,2,High,High Risk,High (>80%),Fast,Renal,Partially Suitable
Ibuprofen,Blood Thinner,Anti-Aging,93.06,C13H18O2,COX Inhibitor,Acid Reflux,1994,Acetylsalicylic Acid,Lipitor,High Risk,Liver Metabolism,Phase 4,In Vitro Studies,Serotonin Pathway,Syrup,500mg twice a day,Roche,6,Low,Moderate Risk,Low (<50%),Fast,Renal,Suitable
Atorvastatin,Cholesterol Control,Cancer Therapy,81.4,C9H8O4,AMPK Activator,"Headache, Rash",1996,Omeprazole,Glucophage,High Risk,Renal Excretion,Phase 3,Toxicology Report,MAPK Pathway,Syrup,10mg once daily,Roche,12,Moderate,Moderate Risk,High (>80%),Fast,Liver,Not Suitable
Omeprazole,Inflammation,Liver Disease,64.04,C4H11N5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1987,Atorvastatin Calcium,Aspirin,Low Risk,Liver Metabolism,Phase 1,Animal Testing,MAPK Pathway,Capsule,500mg twice a day,Novartis,24,Low,Low Risk,High (>80%),Moderate,Enzyme-Specific,Not Suitable
Losartan,Acid Reflux,Parkinson's,58.44,C17H19N3O3S,AMPK Activator,"Headache, Rash",1996,Omeprazole,Glucophage,Low Risk,Liver Metabolism,Completed,Animal Testing,Immune Response Pathway,Capsule,10mg once daily,AstraZeneca,2,Low,Moderate Risk,Low (<50%),Fast,Liver,Not Suitable
Paracetamol,Diabetes,Cardiovascular Disease,58.28,C4H11N5,NSAID,Acid Reflux,1965,Metformin Hydrochloride,Prilosec,Low Risk,Renal Excretion,Phase 4,No Preclinical Data,Dopaminergic Pathway,Tablet,As prescribed,AstraZeneca,24,Low,High Risk,Low (<50%),Moderate,Enzyme-Specific,Partially Suitable
Ranitidine,Hypertension,Antiviral,85,C33H35FN2O5,NSAID,Gastrointestinal Issues,1965,Ibuprofen,Glucophage,Low Risk,Slow Metabolism,Completed,Toxicology Report,Immune Response Pathway,Tablet,50mg daily,Pfizer,2,High,Moderate Risk,Low (<50%),Slow,Renal,Not Suitable
Simvastatin,Gastric Ulcer,Cancer Therapy,62.84,C17H19N3O3S,Proton Pump Inhibitor,Acid Reflux,1971,Acetylsalicylic Acid,Lipitor,Moderate Risk,Renal Excretion,Phase 4,Toxicology Report,Dopaminergic Pathway,Injection,10mg once daily,Merck,12,High,Moderate Risk,Low (<50%),Moderate,Liver,Suitable
Levothyroxine,Blood Thinner,Weight Loss,86.66,C13H18O2,Proton Pump Inhibitor,"Nausea, Dizziness",1971,Omeprazole,Advil,Low Risk,Renal Excretion,Phase 3,Animal Testing,MAPK Pathway,Syrup,250mg every 8 hours,AstraZeneca,48,High,High Risk,Low (<50%),Fast,Gut,Suitable
Aspirin,Diabetes,Antiviral,76.52,C9H8O4,COX Inhibitor,"Headache, Rash",1996,Acetylsalicylic Acid,Glucophage,High Risk,Rapid Absorption,Phase 1,No Preclinical Data,Immune Response Pathway,Capsule,10mg once daily,Novartis,48,Moderate,Low Risk,Moderate (50-80%),Slow,Gut,Suitable
Metformin,Acid Reflux,Liver Disease,30.22,C9H8O4,COX Inhibitor,"Nausea, Dizziness",1971,Acetylsalicylic Acid,Glucophage,Low Risk,High Bioavailability,Ongoing,In Vitro Studies,MAPK Pathway,Capsule,10mg once daily,AstraZeneca,48,High,Low Risk,Moderate (50-80%),Slow,Gut,Not Suitable
Ibuprofen,Cholesterol Control,Anti-Aging,63.76,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1996,Ibuprofen,Advil,Moderate Risk,High Bioavailability,Phase 2,Animal Testing,Immune Response Pathway,Injection,500mg twice a day,Merck,48,Moderate,Moderate Risk,Moderate (50-80%),Moderate,Renal,Not Suitable
Atorvastatin,Diabetes,Cardiovascular Disease,79.42,C4H11N5,Proton Pump Inhibitor,"Nausea, Dizziness",1996,Acetylsalicylic Acid,Glucophage,Moderate Risk,Renal Excretion,Phase 1,Toxicology Report,PI3K-AKT Pathway,Tablet,250mg every 8 hours,Merck,24,Low,High Risk,High (>80%),Slow,Gut,Partially Suitable
Omeprazole,Cholesterol Control,Anti-Aging,54.96,C4H11N5,Proton Pump Inhibitor,"Headache, Rash",1965,Ibuprofen,Lipitor,High Risk,Liver Metabolism,Phase 4,Animal Testing,MAPK Pathway,Tablet,500mg twice a day,AstraZeneca,48,Moderate,Moderate Risk,Moderate (50-80%),Moderate,Liver,Not Suitable
Losartan,Pain Relief,Cardiovascular Disease,87.27,C17H19N3O3S,Proton Pump Inhibitor,"Nausea, Dizziness",1971,Ibuprofen,Glucophage,Low Risk,Rapid Absorption,Phase 2,In Vitro Studies,MAPK Pathway,Tablet,As prescribed,Pfizer,2,High,Moderate Risk,Low (<50%),Fast,Enzyme-Specific,Suitable
Paracetamol,Blood Thinner,Parkinson's,32.37,C4H11N5,Proton Pump Inhibitor,Muscle Pain,1987,Acetylsalicylic Acid,Advil,Low Risk,High Bioavailability,Phase 1,Toxicology Report,Serotonin Pathway,Syrup,50mg daily,Roche,24,Moderate,High Risk,High (>80%),Fast,Renal,Partially Suitable
Ranitidine,Hypertension,Weight Loss,79.01,C9H8O4,Proton Pump Inhibitor,"Nausea, Dizziness",1965,Ibuprofen,Aspirin,High Risk,Renal Excretion,Phase 4,Toxicology Report,Serotonin Pathway,Injection,As prescribed,Novartis,6,Low,High Risk,Low (<50%),Moderate,Renal,Suitable
Simvastatin,Fever,Alzheimer's,44.49,C13H18O2,NSAID,"Headache, Rash",1971,Ibuprofen,Lipitor,Low Risk,Rapid Absorption,Completed,In Vitro Studies,PI3K-AKT Pathway,Capsule,10mg once daily,AstraZeneca,12,Low,Moderate Risk,High (>80%),Slow,Liver,Partially Suitable
Levothyroxine,Fever,Autoimmune Disorders,61.75,C9H8O4,NSAID,Acid Reflux,1987,Metformin Hydrochloride,Glucophage,High Risk,Rapid Absorption,Phase 4,Animal Testing,MAPK Pathway,Tablet,250mg every 8 hours,Pfizer,2,Moderate,Moderate Risk,Moderate (50-80%),Fast,Gut,Not Suitable
Aspirin,Hypertension,Cancer Therapy,92.25,C17H19N3O3S,Proton Pump Inhibitor,"Nausea, Dizziness",1994,Ibuprofen,Lipitor,Moderate Risk,Rapid Absorption,Completed,In Vitro Studies,Dopaminergic Pathway,Tablet,500mg twice a day,Novartis,48,Low,Moderate Risk,Moderate (50-80%),Slow,Renal,Partially Suitable
Metformin,Diabetes,Cancer Therapy,77.48,C33H35FN2O5,NSAID,Muscle Pain,1994,Acetylsalicylic Acid,Advil,Low Risk,Rapid Absorption,Ongoing,No Preclinical Data,PI3K-AKT Pathway,Injection,As prescribed,AstraZeneca,2,Moderate,Low Risk,Moderate (50-80%),Slow,Liver,Suitable
Ibuprofen,Acid Reflux,Anti-Aging,49.89,C13H18O2,AMPK Activator,Acid Reflux,1965,Metformin Hydrochloride,Advil,Low Risk,Rapid Absorption,Ongoing,Toxicology Report,Serotonin Pathway,Syrup,250mg every 8 hours,AstraZeneca,12,High,Moderate Risk,Low (<50%),Fast,Liver,Not Suitable
Atorvastatin,Cholesterol Control,Liver Disease,33.24,C17H19N3O3S,AMPK Activator,"Nausea, Dizziness",1965,Atorvastatin Calcium,Lipitor,High Risk,Slow Metabolism,Phase 1,No Preclinical Data,Dopaminergic Pathway,Tablet,50mg daily,Pfizer,24,High,High Risk,Low (<50%),Slow,Liver,Partially Suitable
Omeprazole,Acid Reflux,Antiviral,74.3,C4H11N5,HMG-CoA Reductase Inhibitor,Muscle Pain,1965,Atorvastatin Calcium,Advil,Low Risk,Liver Metabolism,Ongoing,In Vitro Studies,Dopaminergic Pathway,Capsule,10mg once daily,AstraZeneca,48,Low,Moderate Risk,High (>80%),Slow,Liver,Partially Suitable
Losartan,Gastric Ulcer,Weight Loss,39.55,C33H35FN2O5,Proton Pump Inhibitor,Acid Reflux,1987,Atorvastatin Calcium,Advil,High Risk,Rapid Absorption,Phase 2,No Preclinical Data,PI3K-AKT Pathway,Topical Gel,50mg daily,Roche,24,Low,Moderate Risk,High (>80%),Fast,Enzyme-Specific,Not Suitable
Paracetamol,Gastric Ulcer,Cancer Therapy,89.95,C17H19N3O3S,AMPK Activator,Gastrointestinal Issues,1994,Acetylsalicylic Acid,Advil,Moderate Risk,Slow Metabolism,Phase 2,In Vitro Studies,Serotonin Pathway,Injection,250mg every 8 hours,Pfizer,2,Low,Low Risk,Moderate (50-80%),Slow,Gut,Not Suitable
Ranitidine,Thyroid Hormone Replacement,Autoimmune Disorders,62.56,C9H8O4,Proton Pump Inhibitor,Acid Reflux,1965,Omeprazole,Aspirin,Low Risk,High Bioavailability,Phase 4,Toxicology Report,MAPK Pathway,Injection,50mg daily,Novartis,2,Moderate,Moderate Risk,High (>80%),Fast,Enzyme-Specific,Not Suitable
Simvastatin,Acid Reflux,Weight Loss,41.46,C4H11N5,COX Inhibitor,Muscle Pain,1965,Metformin Hydrochloride,Prilosec,Moderate Risk,Renal Excretion,Phase 1,Toxicology Report,Immune Response Pathway,Syrup,As prescribed,Novartis,24,High,Moderate Risk,Low (<50%),Fast,Liver,Not Suitable
Levothyroxine,Blood Thinner,Anti-Aging,56.85,C4H11N5,NSAID,Muscle Pain,1971,Omeprazole,Prilosec,Low Risk,High Bioavailability,Phase 3,In Vitro Studies,PI3K-AKT Pathway,Capsule,As prescribed,Roche,24,Moderate,Low Risk,Moderate (50-80%),Slow,Gut,Suitable
Aspirin,Blood Thinner,Alzheimer's,33.15,C17H19N3O3S,AMPK Activator,Acid Reflux,1965,Omeprazole,Advil,High Risk,Rapid Absorption,Phase 2,Animal Testing,PI3K-AKT Pathway,Syrup,250mg every 8 hours,Pfizer,48,Low,High Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Metformin,Fever,Antiviral,94.01,C4H11N5,NSAID,"Headache, Rash",1987,Atorvastatin Calcium,Lipitor,Low Risk,Liver Metabolism,Phase 4,Animal Testing,Dopaminergic Pathway,Topical Gel,50mg daily,Roche,2,Low,High Risk,High (>80%),Moderate,Renal,Not Suitable
Ibuprofen,Gastric Ulcer,Weight Loss,48.45,C9H8O4,COX Inhibitor,"Nausea, Dizziness",1994,Acetylsalicylic Acid,Glucophage,Moderate Risk,Renal Excretion,Phase 4,Toxicology Report,Dopaminergic Pathway,Syrup,As prescribed,Merck,12,Low,Moderate Risk,Low (<50%),Fast,Enzyme-Specific,Suitable
Atorvastatin,Thyroid Hormone Replacement,Liver Disease,75.92,C4H11N5,NSAID,Acid Reflux,1996,Atorvastatin Calcium,Aspirin,Moderate Risk,Liver Metabolism,Phase 2,No Preclinical Data,Dopaminergic Pathway,Tablet,As prescribed,Pfizer,48,Low,Moderate Risk,High (>80%),Fast,Renal,Suitable
Omeprazole,Thyroid Hormone Replacement,Liver Disease,39.56,C17H19N3O3S,AMPK Activator,Gastrointestinal Issues,1987,Ibuprofen,Lipitor,High Risk,High Bioavailability,Phase 1,Animal Testing,Immune Response Pathway,Topical Gel,As prescribed,Merck,2,Moderate,High Risk,Low (<50%),Slow,Enzyme-Specific,Not Suitable
Losartan,Cholesterol Control,Alzheimer's,77.98,C13H18O2,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1987,Atorvastatin Calcium,Advil,High Risk,Slow Metabolism,Phase 2,Animal Testing,MAPK Pathway,Injection,As prescribed,Roche,2,Moderate,Moderate Risk,Moderate (50-80%),Fast,Liver,Suitable
Paracetamol,Fever,Cardiovascular Disease,78.81,C9H8O4,COX Inhibitor,"Headache, Rash",1965,Metformin Hydrochloride,Aspirin,Low Risk,Renal Excretion,Ongoing,No Preclinical Data,Immune Response Pathway,Capsule,As prescribed,Novartis,6,Moderate,High Risk,Low (<50%),Slow,Renal,Not Suitable
Ranitidine,Cholesterol Control,Weight Loss,78.09,C4H11N5,AMPK Activator,Muscle Pain,1965,Acetylsalicylic Acid,Aspirin,Low Risk,Liver Metabolism,Phase 4,In Vitro Studies,MAPK Pathway,Topical Gel,500mg twice a day,Roche,24,Moderate,Low Risk,Moderate (50-80%),Fast,Enzyme-Specific,Partially Suitable
Simvastatin,Diabetes,Cardiovascular Disease,33.61,C13H18O2,COX Inhibitor,"Headache, Rash",1996,Omeprazole,Prilosec,High Risk,High Bioavailability,Phase 2,Animal Testing,Serotonin Pathway,Syrup,50mg daily,AstraZeneca,2,High,Low Risk,High (>80%),Fast,Renal,Suitable
Levothyroxine,Pain Relief,Autoimmune Disorders,83.13,C13H18O2,NSAID,Acid Reflux,1994,Metformin Hydrochloride,Prilosec,Moderate Risk,High Bioavailability,Phase 3,Toxicology Report,Dopaminergic Pathway,Tablet,250mg every 8 hours,Novartis,6,Low,Low Risk,High (>80%),Slow,Liver,Not Suitable
Aspirin,Cholesterol Control,Weight Loss,38.02,C9H8O4,Proton Pump Inhibitor,Gastrointestinal Issues,1965,Atorvastatin Calcium,Prilosec,High Risk,Slow Metabolism,Ongoing,Toxicology Report,PI3K-AKT Pathway,Topical Gel,As prescribed,Novartis,48,High,Low Risk,High (>80%),Fast,Gut,Suitable
Metformin,Acid Reflux,Cancer Therapy,39.78,C17H19N3O3S,COX Inhibitor,"Nausea, Dizziness",1965,Atorvastatin Calcium,Advil,Moderate Risk,High Bioavailability,Phase 3,Toxicology Report,PI3K-AKT Pathway,Syrup,500mg twice a day,Novartis,2,High,Low Risk,High (>80%),Slow,Gut,Suitable
Ibuprofen,Fever,Anti-Aging,79.25,C33H35FN2O5,NSAID,Muscle Pain,1971,Metformin Hydrochloride,Advil,Moderate Risk,Rapid Absorption,Phase 3,No Preclinical Data,Immune Response Pathway,Topical Gel,50mg daily,Novartis,6,Moderate,Moderate Risk,Low (<50%),Moderate,Liver,Not Suitable
Atorvastatin,Acid Reflux,Alzheimer's,91.33,C9H8O4,AMPK Activator,"Nausea, Dizziness",1994,Omeprazole,Prilosec,Moderate Risk,High Bioavailability,Phase 2,No Preclinical Data,PI3K-AKT Pathway,Injection,500mg twice a day,Merck,48,Moderate,High Risk,High (>80%),Fast,Liver,Not Suitable
Omeprazole,Blood Thinner,Liver Disease,76.27,C9H8O4,COX Inhibitor,"Headache, Rash",1965,Atorvastatin Calcium,Prilosec,Low Risk,Rapid Absorption,Phase 4,No Preclinical Data,Dopaminergic Pathway,Topical Gel,50mg daily,Roche,12,Low,Low Risk,High (>80%),Slow,Gut,Partially Suitable
Losartan,Diabetes,Cancer Therapy,31.05,C9H8O4,Proton Pump Inhibitor,Muscle Pain,1971,Omeprazole,Aspirin,High Risk,Rapid Absorption,Phase 2,Toxicology Report,Dopaminergic Pathway,Tablet,250mg every 8 hours,AstraZeneca,48,High,High Risk,Low (<50%),Slow,Enzyme-Specific,Partially Suitable
Paracetamol,Cholesterol Control,Cancer Therapy,73.91,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Muscle Pain,1965,Acetylsalicylic Acid,Aspirin,High Risk,Liver Metabolism,Phase 2,Toxicology Report,PI3K-AKT Pathway,Syrup,50mg daily,Pfizer,24,High,High Risk,High (>80%),Fast,Renal,Partially Suitable
Ranitidine,Hypertension,Autoimmune Disorders,85.92,C33H35FN2O5,COX Inhibitor,"Nausea, Dizziness",1971,Atorvastatin Calcium,Advil,High Risk,High Bioavailability,Completed,Toxicology Report,Immune Response Pathway,Syrup,250mg every 8 hours,Pfizer,6,High,High Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Simvastatin,Hypertension,Autoimmune Disorders,90.8,C13H18O2,HMG-CoA Reductase Inhibitor,Acid Reflux,1971,Acetylsalicylic Acid,Glucophage,High Risk,Liver Metabolism,Phase 3,No Preclinical Data,MAPK Pathway,Tablet,As prescribed,Roche,12,Low,Moderate Risk,High (>80%),Fast,Gut,Suitable
Levothyroxine,Diabetes,Alzheimer's,34.27,C4H11N5,Proton Pump Inhibitor,Muscle Pain,1996,Acetylsalicylic Acid,Glucophage,Moderate Risk,Renal Excretion,Ongoing,Toxicology Report,Immune Response Pathway,Tablet,10mg once daily,Roche,2,Moderate,High Risk,High (>80%),Moderate,Renal,Partially Suitable
Aspirin,Inflammation,Migraine Treatment,52.54,C9H8O4,Proton Pump Inhibitor,Acid Reflux,1987,Ibuprofen,Glucophage,Moderate Risk,Rapid Absorption,Phase 1,Toxicology Report,MAPK Pathway,Injection,250mg every 8 hours,Pfizer,24,Moderate,High Risk,Low (<50%),Moderate,Gut,Suitable
Metformin,Fever,Parkinson's,65.35,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1996,Ibuprofen,Prilosec,Low Risk,Rapid Absorption,Phase 3,In Vitro Studies,Dopaminergic Pathway,Tablet,250mg every 8 hours,Pfizer,48,High,Low Risk,High (>80%),Slow,Liver,Not Suitable
Ibuprofen,Acid Reflux,Migraine Treatment,48.17,C33H35FN2O5,AMPK Activator,Acid Reflux,1996,Omeprazole,Aspirin,Moderate Risk,Slow Metabolism,Phase 4,In Vitro Studies,MAPK Pathway,Capsule,50mg daily,AstraZeneca,2,Moderate,Moderate Risk,High (>80%),Moderate,Enzyme-Specific,Not Suitable
Atorvastatin,Fever,Anti-Aging,87.54,C13H18O2,Proton Pump Inhibitor,Muscle Pain,1996,Acetylsalicylic Acid,Prilosec,High Risk,High Bioavailability,Ongoing,In Vitro Studies,PI3K-AKT Pathway,Capsule,10mg once daily,Roche,48,High,High Risk,High (>80%),Fast,Renal,Partially Suitable
Omeprazole,Blood Thinner,Antiviral,30.56,C13H18O2,COX Inhibitor,Muscle Pain,1987,Metformin Hydrochloride,Aspirin,Moderate Risk,Slow Metabolism,Completed,Toxicology Report,MAPK Pathway,Injection,As prescribed,Novartis,6,Moderate,Low Risk,Low (<50%),Slow,Enzyme-Specific,Not Suitable
Losartan,Inflammation,Cancer Therapy,72.79,C13H18O2,AMPK Activator,Gastrointestinal Issues,1971,Omeprazole,Glucophage,Low Risk,Rapid Absorption,Phase 4,In Vitro Studies,MAPK Pathway,Injection,250mg every 8 hours,Novartis,2,Moderate,Moderate Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Paracetamol,Inflammation,Cardiovascular Disease,41.84,C17H19N3O3S,NSAID,Muscle Pain,1971,Atorvastatin Calcium,Aspirin,Low Risk,Renal Excretion,Phase 2,Animal Testing,MAPK Pathway,Tablet,500mg twice a day,Roche,48,High,Low Risk,Low (<50%),Slow,Enzyme-Specific,Not Suitable
Ranitidine,Fever,Antiviral,52.48,C33H35FN2O5,NSAID,Gastrointestinal Issues,1994,Acetylsalicylic Acid,Prilosec,High Risk,Rapid Absorption,Ongoing,Animal Testing,Serotonin Pathway,Syrup,50mg daily,Novartis,12,Moderate,Moderate Risk,Moderate (50-80%),Moderate,Gut,Not Suitable
Simvastatin,Cholesterol Control,Parkinson's,93,C9H8O4,HMG-CoA Reductase Inhibitor,"Headache, Rash",1994,Omeprazole,Aspirin,Moderate Risk,Renal Excretion,Ongoing,In Vitro Studies,PI3K-AKT Pathway,Tablet,50mg daily,AstraZeneca,24,Moderate,High Risk,Moderate (50-80%),Moderate,Liver,Not Suitable
Levothyroxine,Diabetes,Weight Loss,49.75,C4H11N5,AMPK Activator,Acid Reflux,1996,Ibuprofen,Glucophage,High Risk,High Bioavailability,Phase 3,In Vitro Studies,Dopaminergic Pathway,Syrup,500mg twice a day,Novartis,24,High,Moderate Risk,Low (<50%),Moderate,Liver,Suitable
Aspirin,Cholesterol Control,Liver Disease,33.97,C17H19N3O3S,AMPK Activator,"Nausea, Dizziness",1971,Ibuprofen,Prilosec,Moderate Risk,Rapid Absorption,Phase 4,Animal Testing,Immune Response Pathway,Capsule,250mg every 8 hours,Merck,24,Moderate,Moderate Risk,Low (<50%),Fast,Renal,Suitable
Metformin,Fever,Liver Disease,68.8,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1994,Acetylsalicylic Acid,Lipitor,Moderate Risk,Liver Metabolism,Phase 3,Toxicology Report,MAPK Pathway,Tablet,250mg every 8 hours,Merck,12,High,Moderate Risk,High (>80%),Moderate,Renal,Partially Suitable
Ibuprofen,Hypertension,Anti-Aging,67.14,C13H18O2,Proton Pump Inhibitor,"Headache, Rash",1996,Ibuprofen,Aspirin,High Risk,High Bioavailability,Phase 4,No Preclinical Data,MAPK Pathway,Injection,250mg every 8 hours,Pfizer,48,Moderate,Moderate Risk,High (>80%),Moderate,Gut,Partially Suitable
Atorvastatin,Cholesterol Control,Parkinson's,73.41,C13H18O2,NSAID,"Headache, Rash",1965,Omeprazole,Prilosec,High Risk,High Bioavailability,Phase 1,Toxicology Report,Serotonin Pathway,Syrup,250mg every 8 hours,Roche,24,Moderate,High Risk,High (>80%),Fast,Enzyme-Specific,Not Suitable
Omeprazole,Diabetes,Migraine Treatment,34.44,C9H8O4,HMG-CoA Reductase Inhibitor,"Headache, Rash",1996,Omeprazole,Glucophage,High Risk,Liver Metabolism,Ongoing,In Vitro Studies,Immune Response Pathway,Injection,50mg daily,Pfizer,12,Moderate,Low Risk,Moderate (50-80%),Moderate,Liver,Partially Suitable
Losartan,Fever,Anti-Aging,35.66,C33H35FN2O5,Proton Pump Inhibitor,Acid Reflux,1987,Metformin Hydrochloride,Advil,Moderate Risk,Liver Metabolism,Phase 1,Animal Testing,Serotonin Pathway,Tablet,As prescribed,Merck,6,Moderate,High Risk,Moderate (50-80%),Moderate,Gut,Suitable
Paracetamol,Inflammation,Autoimmune Disorders,35.03,C4H11N5,COX Inhibitor,"Headache, Rash",1965,Omeprazole,Prilosec,Moderate Risk,High Bioavailability,Phase 4,In Vitro Studies,Immune Response Pathway,Topical Gel,250mg every 8 hours,Roche,24,High,Moderate Risk,High (>80%),Moderate,Enzyme-Specific,Partially Suitable
Ranitidine,Diabetes,Autoimmune Disorders,48.27,C4H11N5,COX Inhibitor,"Nausea, Dizziness",1996,Metformin Hydrochloride,Lipitor,High Risk,Slow Metabolism,Completed,Toxicology Report,MAPK Pathway,Injection,500mg twice a day,Merck,48,Moderate,Low Risk,High (>80%),Fast,Renal,Suitable
Simvastatin,Inflammation,Parkinson's,90.87,C33H35FN2O5,AMPK Activator,Muscle Pain,1987,Acetylsalicylic Acid,Advil,Low Risk,Liver Metabolism,Phase 2,No Preclinical Data,Serotonin Pathway,Topical Gel,50mg daily,Novartis,2,High,Low Risk,Low (<50%),Moderate,Enzyme-Specific,Not Suitable
Levothyroxine,Gastric Ulcer,Antiviral,47.47,C4H11N5,AMPK Activator,Muscle Pain,1996,Omeprazole,Glucophage,High Risk,High Bioavailability,Phase 3,No Preclinical Data,Dopaminergic Pathway,Tablet,500mg twice a day,Pfizer,6,High,Low Risk,Low (<50%),Fast,Renal,Partially Suitable
Aspirin,Thyroid Hormone Replacement,Parkinson's,74.03,C13H18O2,NSAID,Muscle Pain,1996,Metformin Hydrochloride,Glucophage,Moderate Risk,Rapid Absorption,Phase 2,Animal Testing,MAPK Pathway,Tablet,500mg twice a day,Pfizer,48,Low,Low Risk,High (>80%),Moderate,Gut,Not Suitable
Metformin,Fever,Alzheimer's,42.91,C13H18O2,NSAID,Muscle Pain,1996,Atorvastatin Calcium,Advil,Moderate Risk,Renal Excretion,Completed,Toxicology Report,Serotonin Pathway,Topical Gel,50mg daily,Novartis,12,High,Moderate Risk,Moderate (50-80%),Slow,Gut,Not Suitable
Ibuprofen,Gastric Ulcer,Liver Disease,94.12,C33H35FN2O5,Proton Pump Inhibitor,Muscle Pain,1996,Ibuprofen,Aspirin,Moderate Risk,High Bioavailability,Completed,No Preclinical Data,Serotonin Pathway,Topical Gel,10mg once daily,Merck,12,Low,High Risk,Low (<50%),Slow,Gut,Partially Suitable
Atorvastatin,Gastric Ulcer,Alzheimer's,60.11,C9H8O4,AMPK Activator,Muscle Pain,1971,Atorvastatin Calcium,Advil,Low Risk,High Bioavailability,Phase 3,Toxicology Report,Immune Response Pathway,Capsule,As prescribed,Roche,6,Moderate,Low Risk,High (>80%),Fast,Liver,Not Suitable
Omeprazole,Acid Reflux,Parkinson's,87.06,C4H11N5,AMPK Activator,"Headache, Rash",1994,Ibuprofen,Glucophage,Moderate Risk,Rapid Absorption,Phase 3,In Vitro Studies,PI3K-AKT Pathway,Syrup,As prescribed,Roche,48,Low,Moderate Risk,Low (<50%),Slow,Renal,Partially Suitable
Losartan,Thyroid Hormone Replacement,Anti-Aging,65.19,C9H8O4,COX Inhibitor,"Nausea, Dizziness",1987,Acetylsalicylic Acid,Advil,Moderate Risk,Slow Metabolism,Phase 2,Animal Testing,MAPK Pathway,Injection,50mg daily,Pfizer,24,Moderate,Low Risk,Moderate (50-80%),Slow,Enzyme-Specific,Suitable
Paracetamol,Acid Reflux,Migraine Treatment,69.22,C13H18O2,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1994,Acetylsalicylic Acid,Lipitor,High Risk,Renal Excretion,Phase 1,Toxicology Report,PI3K-AKT Pathway,Tablet,50mg daily,Pfizer,2,Low,Low Risk,Low (<50%),Moderate,Enzyme-Specific,Suitable
Ranitidine,Cholesterol Control,Alzheimer's,63.01,C13H18O2,NSAID,"Headache, Rash",1994,Ibuprofen,Lipitor,High Risk,Liver Metabolism,Phase 1,Animal Testing,Immune Response Pathway,Injection,500mg twice a day,Merck,48,Moderate,Moderate Risk,Moderate (50-80%),Slow,Enzyme-Specific,Not Suitable
Simvastatin,Hypertension,Anti-Aging,31.45,C17H19N3O3S,AMPK Activator,Gastrointestinal Issues,1996,Metformin Hydrochloride,Aspirin,High Risk,High Bioavailability,Phase 1,Animal Testing,Serotonin Pathway,Capsule,10mg once daily,Roche,12,Moderate,Low Risk,High (>80%),Slow,Renal,Suitable
Levothyroxine,Thyroid Hormone Replacement,Liver Disease,88.68,C17H19N3O3S,AMPK Activator,Gastrointestinal Issues,1971,Omeprazole,Advil,High Risk,Liver Metabolism,Completed,Animal Testing,Dopaminergic Pathway,Topical Gel,As prescribed,Novartis,2,Moderate,High Risk,Low (<50%),Fast,Liver,Not Suitable
Aspirin,Acid Reflux,Cancer Therapy,88.85,C4H11N5,Proton Pump Inhibitor,Muscle Pain,1996,Omeprazole,Prilosec,High Risk,Liver Metabolism,Phase 1,In Vitro Studies,Immune Response Pathway,Injection,250mg every 8 hours,Merck,12,Low,High Risk,Low (<50%),Fast,Gut,Partially Suitable
Metformin,Gastric Ulcer,Cancer Therapy,42.5,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1996,Acetylsalicylic Acid,Aspirin,Moderate Risk,Rapid Absorption,Phase 3,Toxicology Report,MAPK Pathway,Tablet,10mg once daily,Roche,6,High,High Risk,Low (<50%),Fast,Liver,Suitable
Ibuprofen,Diabetes,Anti-Aging,50.23,C33H35FN2O5,NSAID,Acid Reflux,1996,Atorvastatin Calcium,Advil,Moderate Risk,Renal Excretion,Ongoing,No Preclinical Data,MAPK Pathway,Topical Gel,50mg daily,AstraZeneca,6,Moderate,Low Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Suitable
Atorvastatin,Pain Relief,Autoimmune Disorders,42.03,C13H18O2,HMG-CoA Reductase Inhibitor,Muscle Pain,1996,Acetylsalicylic Acid,Lipitor,Low Risk,Rapid Absorption,Phase 3,In Vitro Studies,Serotonin Pathway,Capsule,10mg once daily,Pfizer,48,Moderate,Moderate Risk,High (>80%),Moderate,Gut,Not Suitable
Omeprazole,Inflammation,Cancer Therapy,54.15,C33H35FN2O5,AMPK Activator,Muscle Pain,1987,Omeprazole,Advil,Moderate Risk,High Bioavailability,Phase 3,Toxicology Report,PI3K-AKT Pathway,Capsule,10mg once daily,Merck,48,High,High Risk,Moderate (50-80%),Slow,Liver,Partially Suitable
Losartan,Blood Thinner,Weight Loss,65.05,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1994,Metformin Hydrochloride,Lipitor,High Risk,Liver Metabolism,Phase 3,Animal Testing,MAPK Pathway,Injection,250mg every 8 hours,Pfizer,6,Low,High Risk,Moderate (50-80%),Fast,Gut,Suitable
Paracetamol,Inflammation,Anti-Aging,89.55,C9H8O4,COX Inhibitor,"Nausea, Dizziness",1996,Metformin Hydrochloride,Lipitor,High Risk,High Bioavailability,Phase 1,In Vitro Studies,MAPK Pathway,Topical Gel,As prescribed,AstraZeneca,24,Moderate,Low Risk,High (>80%),Fast,Enzyme-Specific,Suitable
Ranitidine,Pain Relief,Cardiovascular Disease,50.29,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Acid Reflux,1987,Atorvastatin Calcium,Glucophage,High Risk,Slow Metabolism,Phase 4,Toxicology Report,Immune Response Pathway,Injection,500mg twice a day,AstraZeneca,48,Moderate,Low Risk,High (>80%),Fast,Renal,Not Suitable
Simvastatin,Thyroid Hormone Replacement,Parkinson's,58.39,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1994,Atorvastatin Calcium,Lipitor,High Risk,Rapid Absorption,Phase 2,No Preclinical Data,PI3K-AKT Pathway,Syrup,10mg once daily,AstraZeneca,2,Moderate,Moderate Risk,Moderate (50-80%),Moderate,Liver,Suitable
Levothyroxine,Cholesterol Control,Weight Loss,52.16,C17H19N3O3S,NSAID,Acid Reflux,1965,Atorvastatin Calcium,Advil,High Risk,Rapid Absorption,Phase 3,In Vitro Studies,Dopaminergic Pathway,Tablet,50mg daily,Novartis,6,Moderate,High Risk,Moderate (50-80%),Fast,Renal,Partially Suitable
Aspirin,Acid Reflux,Anti-Aging,89.91,C9H8O4,Proton Pump Inhibitor,Acid Reflux,1996,Acetylsalicylic Acid,Advil,Low Risk,Liver Metabolism,Ongoing,Animal Testing,PI3K-AKT Pathway,Tablet,50mg daily,Roche,2,Moderate,High Risk,Low (<50%),Slow,Liver,Partially Suitable
Metformin,Diabetes,Alzheimer's,40.07,C13H18O2,NSAID,Muscle Pain,1971,Metformin Hydrochloride,Aspirin,High Risk,Slow Metabolism,Phase 1,Toxicology Report,MAPK Pathway,Injection,500mg twice a day,Roche,24,High,Low Risk,Moderate (50-80%),Slow,Enzyme-Specific,Partially Suitable
Ibuprofen,Pain Relief,Cardiovascular Disease,36.41,C9H8O4,AMPK Activator,Muscle Pain,1971,Acetylsalicylic Acid,Advil,Moderate Risk,Slow Metabolism,Phase 4,Animal Testing,PI3K-AKT Pathway,Capsule,250mg every 8 hours,Novartis,6,Low,Moderate Risk,Moderate (50-80%),Fast,Gut,Partially Suitable
Atorvastatin,Pain Relief,Cardiovascular Disease,57.9,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1971,Omeprazole,Glucophage,High Risk,Slow Metabolism,Phase 3,No Preclinical Data,MAPK Pathway,Capsule,10mg once daily,AstraZeneca,6,Low,High Risk,Moderate (50-80%),Slow,Liver,Partially Suitable
Omeprazole,Thyroid Hormone Replacement,Migraine Treatment,31.4,C13H18O2,NSAID,"Headache, Rash",1965,Ibuprofen,Advil,Low Risk,Slow Metabolism,Phase 3,Toxicology Report,Immune Response Pathway,Tablet,As prescribed,Pfizer,48,High,High Risk,Moderate (50-80%),Moderate,Renal,Partially Suitable
Losartan,Blood Thinner,Parkinson's,32.82,C13H18O2,COX Inhibitor,Muscle Pain,1987,Acetylsalicylic Acid,Prilosec,High Risk,High Bioavailability,Completed,Animal Testing,MAPK Pathway,Syrup,10mg once daily,AstraZeneca,24,Low,Moderate Risk,High (>80%),Moderate,Renal,Partially Suitable
Paracetamol,Cholesterol Control,Antiviral,83.13,C17H19N3O3S,NSAID,Muscle Pain,1971,Atorvastatin Calcium,Lipitor,High Risk,Renal Excretion,Phase 3,In Vitro Studies,MAPK Pathway,Injection,500mg twice a day,Roche,6,Low,High Risk,High (>80%),Fast,Enzyme-Specific,Partially Suitable
Ranitidine,Cholesterol Control,Alzheimer's,31.57,C9H8O4,HMG-CoA Reductase Inhibitor,Muscle Pain,1971,Atorvastatin Calcium,Glucophage,Low Risk,Slow Metabolism,Phase 1,No Preclinical Data,MAPK Pathway,Injection,As prescribed,Novartis,2,Low,High Risk,High (>80%),Slow,Renal,Not Suitable
Simvastatin,Acid Reflux,Anti-Aging,80.36,C17H19N3O3S,NSAID,Acid Reflux,1971,Acetylsalicylic Acid,Aspirin,Moderate Risk,Slow Metabolism,Phase 3,In Vitro Studies,Dopaminergic Pathway,Capsule,10mg once daily,Roche,6,Low,Low Risk,Moderate (50-80%),Fast,Enzyme-Specific,Partially Suitable
Levothyroxine,Fever,Antiviral,63.61,C17H19N3O3S,Proton Pump Inhibitor,Muscle Pain,1994,Acetylsalicylic Acid,Glucophage,Moderate Risk,High Bioavailability,Completed,No Preclinical Data,Immune Response Pathway,Injection,50mg daily,Merck,6,High,High Risk,Moderate (50-80%),Slow,Liver,Not Suitable
Aspirin,Inflammation,Cancer Therapy,88.56,C4H11N5,NSAID,"Headache, Rash",1965,Ibuprofen,Glucophage,High Risk,Rapid Absorption,Phase 1,Toxicology Report,PI3K-AKT Pathway,Capsule,As prescribed,Pfizer,48,High,High Risk,Moderate (50-80%),Moderate,Renal,Partially Suitable
Metformin,Inflammation,Weight Loss,78.66,C17H19N3O3S,AMPK Activator,Muscle Pain,1965,Omeprazole,Advil,Low Risk,Slow Metabolism,Phase 2,No Preclinical Data,Dopaminergic Pathway,Tablet,250mg every 8 hours,Roche,2,High,Low Risk,High (>80%),Fast,Renal,Suitable
Ibuprofen,Pain Relief,Weight Loss,38.77,C17H19N3O3S,Proton Pump Inhibitor,"Nausea, Dizziness",1987,Omeprazole,Prilosec,Low Risk,Rapid Absorption,Phase 2,No Preclinical Data,PI3K-AKT Pathway,Capsule,As prescribed,Roche,6,High,Moderate Risk,Low (<50%),Moderate,Gut,Not Suitable
Atorvastatin,Blood Thinner,Weight Loss,61.58,C4H11N5,COX Inhibitor,Muscle Pain,1971,Metformin Hydrochloride,Lipitor,Low Risk,Liver Metabolism,Phase 2,Animal Testing,Serotonin Pathway,Injection,500mg twice a day,AstraZeneca,2,Low,Moderate Risk,Moderate (50-80%),Fast,Renal,Suitable
Omeprazole,Pain Relief,Weight Loss,93.47,C4H11N5,AMPK Activator,Gastrointestinal Issues,1971,Atorvastatin Calcium,Lipitor,High Risk,Slow Metabolism,Completed,Animal Testing,PI3K-AKT Pathway,Tablet,As prescribed,AstraZeneca,12,Moderate,Low Risk,Moderate (50-80%),Fast,Renal,Not Suitable
Losartan,Pain Relief,Antiviral,91,C33H35FN2O5,Proton Pump Inhibitor,Gastrointestinal Issues,1994,Atorvastatin Calcium,Advil,High Risk,Rapid Absorption,Completed,No Preclinical Data,Dopaminergic Pathway,Tablet,500mg twice a day,Pfizer,24,Low,Moderate Risk,High (>80%),Fast,Renal,Suitable
Paracetamol,Cholesterol Control,Parkinson's,82.25,C17H19N3O3S,COX Inhibitor,"Nausea, Dizziness",1996,Ibuprofen,Glucophage,High Risk,Liver Metabolism,Phase 1,Animal Testing,Immune Response Pathway,Injection,10mg once daily,Pfizer,48,High,High Risk,High (>80%),Moderate,Enzyme-Specific,Suitable
Ranitidine,Fever,Migraine Treatment,30.47,C4H11N5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1987,Metformin Hydrochloride,Aspirin,High Risk,Renal Excretion,Phase 3,In Vitro Studies,Immune Response Pathway,Injection,10mg once daily,Pfizer,48,High,Moderate Risk,Moderate (50-80%),Slow,Gut,Partially Suitable
Simvastatin,Pain Relief,Weight Loss,77.14,C33H35FN2O5,NSAID,Gastrointestinal Issues,1994,Metformin Hydrochloride,Lipitor,Low Risk,Rapid Absorption,Ongoing,No Preclinical Data,Serotonin Pathway,Capsule,10mg once daily,Merck,48,Low,Low Risk,Moderate (50-80%),Fast,Gut,Not Suitable
Levothyroxine,Pain Relief,Antiviral,72.53,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Acid Reflux,1994,Omeprazole,Glucophage,Low Risk,Renal Excretion,Ongoing,Animal Testing,PI3K-AKT Pathway,Tablet,500mg twice a day,Roche,24,Moderate,Moderate Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Aspirin,Acid Reflux,Weight Loss,69.38,C4H11N5,AMPK Activator,"Headache, Rash",1987,Metformin Hydrochloride,Prilosec,Moderate Risk,Renal Excretion,Phase 2,In Vitro Studies,Serotonin Pathway,Topical Gel,As prescribed,Roche,48,Low,High Risk,Low (<50%),Fast,Liver,Partially Suitable
Metformin,Thyroid Hormone Replacement,Cardiovascular Disease,84.36,C17H19N3O3S,Proton Pump Inhibitor,"Headache, Rash",1965,Atorvastatin Calcium,Glucophage,Moderate Risk,Rapid Absorption,Phase 2,In Vitro Studies,MAPK Pathway,Capsule,500mg twice a day,Pfizer,24,Moderate,Low Risk,Moderate (50-80%),Fast,Gut,Suitable
Ibuprofen,Fever,Liver Disease,92.35,C33H35FN2O5,AMPK Activator,Gastrointestinal Issues,1971,Atorvastatin Calcium,Prilosec,Low Risk,Liver Metabolism,Phase 2,Animal Testing,MAPK Pathway,Tablet,10mg once daily,Novartis,6,Low,Moderate Risk,Low (<50%),Slow,Gut,Not Suitable
Atorvastatin,Blood Thinner,Weight Loss,72.08,C13H18O2,AMPK Activator,Gastrointestinal Issues,1994,Atorvastatin Calcium,Advil,High Risk,Rapid Absorption,Phase 4,Toxicology Report,Immune Response Pathway,Syrup,50mg daily,Pfizer,6,Moderate,High Risk,Moderate (50-80%),Slow,Liver,Not Suitable
Omeprazole,Blood Thinner,Alzheimer's,32.83,C13H18O2,AMPK Activator,Gastrointestinal Issues,1996,Ibuprofen,Aspirin,Low Risk,Liver Metabolism,Phase 3,No Preclinical Data,Dopaminergic Pathway,Topical Gel,10mg once daily,Merck,24,Low,High Risk,Moderate (50-80%),Moderate,Liver,Not Suitable
Losartan,Fever,Cardiovascular Disease,91.22,C13H18O2,NSAID,"Headache, Rash",1996,Acetylsalicylic Acid,Aspirin,Moderate Risk,High Bioavailability,Completed,No Preclinical Data,MAPK Pathway,Topical Gel,10mg once daily,Merck,24,High,Low Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Partially Suitable
Paracetamol,Thyroid Hormone Replacement,Migraine Treatment,75.12,C9H8O4,COX Inhibitor,"Nausea, Dizziness",1996,Ibuprofen,Advil,Low Risk,Slow Metabolism,Phase 4,Animal Testing,Serotonin Pathway,Injection,As prescribed,Novartis,48,High,Moderate Risk,High (>80%),Moderate,Enzyme-Specific,Not Suitable
Ranitidine,Inflammation,Cardiovascular Disease,42.82,C9H8O4,Proton Pump Inhibitor,"Headache, Rash",1965,Omeprazole,Aspirin,High Risk,Liver Metabolism,Ongoing,Animal Testing,PI3K-AKT Pathway,Syrup,250mg every 8 hours,Pfizer,2,Low,Low Risk,Moderate (50-80%),Fast,Renal,Partially Suitable
Simvastatin,Inflammation,Antiviral,64.05,C17H19N3O3S,HMG-CoA Reductase Inhibitor,"Headache, Rash",1994,Omeprazole,Advil,High Risk,Renal Excretion,Phase 3,In Vitro Studies,Immune Response Pathway,Injection,10mg once daily,Novartis,2,Moderate,Low Risk,Moderate (50-80%),Slow,Enzyme-Specific,Suitable
Levothyroxine,Hypertension,Cancer Therapy,93.32,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1996,Acetylsalicylic Acid,Glucophage,Low Risk,Rapid Absorption,Completed,Animal Testing,PI3K-AKT Pathway,Syrup,500mg twice a day,Pfizer,24,High,Low Risk,Low (<50%),Slow,Liver,Not Suitable
Aspirin,Thyroid Hormone Replacement,Anti-Aging,70.43,C4H11N5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1987,Acetylsalicylic Acid,Advil,Moderate Risk,Renal Excretion,Phase 3,Toxicology Report,Serotonin Pathway,Injection,500mg twice a day,Roche,48,Low,Low Risk,Low (<50%),Moderate,Gut,Partially Suitable
Metformin,Thyroid Hormone Replacement,Parkinson's,47.65,C4H11N5,Proton Pump Inhibitor,Acid Reflux,1994,Metformin Hydrochloride,Glucophage,Moderate Risk,Rapid Absorption,Phase 3,No Preclinical Data,MAPK Pathway,Capsule,500mg twice a day,Roche,48,Moderate,Moderate Risk,Moderate (50-80%),Slow,Gut,Not Suitable
Ibuprofen,Hypertension,Parkinson's,90.87,C4H11N5,NSAID,Gastrointestinal Issues,1994,Metformin Hydrochloride,Lipitor,High Risk,High Bioavailability,Phase 2,In Vitro Studies,Serotonin Pathway,Syrup,As prescribed,Roche,48,Low,High Risk,Moderate (50-80%),Fast,Enzyme-Specific,Partially Suitable
Atorvastatin,Inflammation,Cardiovascular Disease,81.03,C4H11N5,NSAID,"Nausea, Dizziness",1994,Acetylsalicylic Acid,Prilosec,Moderate Risk,Slow Metabolism,Phase 3,No Preclinical Data,PI3K-AKT Pathway,Syrup,10mg once daily,Roche,6,Low,High Risk,Moderate (50-80%),Fast,Liver,Partially Suitable
Omeprazole,Hypertension,Alzheimer's,49.8,C13H18O2,NSAID,Muscle Pain,1971,Metformin Hydrochloride,Lipitor,Low Risk,Rapid Absorption,Completed,No Preclinical Data,Immune Response Pathway,Capsule,10mg once daily,AstraZeneca,6,Moderate,Low Risk,Moderate (50-80%),Slow,Liver,Suitable
Losartan,Hypertension,Liver Disease,86.67,C33H35FN2O5,Proton Pump Inhibitor,"Headache, Rash",1994,Atorvastatin Calcium,Lipitor,High Risk,Liver Metabolism,Completed,In Vitro Studies,Dopaminergic Pathway,Syrup,250mg every 8 hours,Novartis,48,Moderate,Low Risk,Low (<50%),Fast,Liver,Not Suitable
Paracetamol,Acid Reflux,Weight Loss,48.22,C9H8O4,AMPK Activator,"Nausea, Dizziness",1971,Atorvastatin Calcium,Lipitor,Moderate Risk,Liver Metabolism,Phase 1,Toxicology Report,Immune Response Pathway,Injection,50mg daily,Roche,6,High,Low Risk,Low (<50%),Fast,Liver,Partially Suitable
Ranitidine,Gastric Ulcer,Cardiovascular Disease,82.31,C13H18O2,Proton Pump Inhibitor,Acid Reflux,1994,Atorvastatin Calcium,Glucophage,Low Risk,High Bioavailability,Phase 4,No Preclinical Data,Immune Response Pathway,Topical Gel,As prescribed,Roche,12,Low,Moderate Risk,High (>80%),Fast,Enzyme-Specific,Suitable
Simvastatin,Hypertension,Autoimmune Disorders,44.65,C9H8O4,COX Inhibitor,"Nausea, Dizziness",1971,Acetylsalicylic Acid,Prilosec,High Risk,Slow Metabolism,Phase 1,Toxicology Report,Immune Response Pathway,Tablet,50mg daily,Merck,2,High,High Risk,Low (<50%),Slow,Renal,Suitable
Levothyroxine,Fever,Parkinson's,35.84,C13H18O2,NSAID,Muscle Pain,1965,Omeprazole,Glucophage,Moderate Risk,High Bioavailability,Phase 1,Animal Testing,Serotonin Pathway,Topical Gel,500mg twice a day,Pfizer,12,Low,Moderate Risk,High (>80%),Fast,Liver,Not Suitable
Aspirin,Inflammation,Anti-Aging,75.66,C9H8O4,Proton Pump Inhibitor,"Headache, Rash",1996,Metformin Hydrochloride,Aspirin,Moderate Risk,Rapid Absorption,Ongoing,In Vitro Studies,Immune Response Pathway,Topical Gel,250mg every 8 hours,Pfizer,48,Moderate,Low Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Not Suitable
Metformin,Fever,Parkinson's,83.96,C33H35FN2O5,NSAID,Gastrointestinal Issues,1994,Ibuprofen,Lipitor,Low Risk,Slow Metabolism,Phase 4,In Vitro Studies,Immune Response Pathway,Syrup,10mg once daily,Roche,6,High,Low Risk,Low (<50%),Fast,Gut,Suitable
Ibuprofen,Inflammation,Cardiovascular Disease,48.27,C13H18O2,Proton Pump Inhibitor,Gastrointestinal Issues,1987,Atorvastatin Calcium,Advil,High Risk,Slow Metabolism,Phase 2,In Vitro Studies,MAPK Pathway,Syrup,10mg once daily,AstraZeneca,24,High,Low Risk,High (>80%),Moderate,Enzyme-Specific,Not Suitable
Atorvastatin,Gastric Ulcer,Migraine Treatment,67.04,C4H11N5,NSAID,Gastrointestinal Issues,1965,Metformin Hydrochloride,Prilosec,High Risk,Slow Metabolism,Ongoing,In Vitro Studies,Serotonin Pathway,Topical Gel,500mg twice a day,Pfizer,6,High,Low Risk,Low (<50%),Fast,Renal,Partially Suitable
Omeprazole,Blood Thinner,Migraine Treatment,41.7,C17H19N3O3S,NSAID,"Nausea, Dizziness",1971,Atorvastatin Calcium,Prilosec,Moderate Risk,Renal Excretion,Phase 2,Animal Testing,Serotonin Pathway,Injection,500mg twice a day,AstraZeneca,48,High,High Risk,Moderate (50-80%),Slow,Gut,Suitable
Losartan,Cholesterol Control,Cancer Therapy,73.09,C13H18O2,COX Inhibitor,Acid Reflux,1971,Atorvastatin Calcium,Aspirin,Low Risk,Rapid Absorption,Ongoing,No Preclinical Data,Serotonin Pathway,Capsule,As prescribed,Merck,6,Moderate,Low Risk,High (>80%),Slow,Liver,Not Suitable
Paracetamol,Pain Relief,Weight Loss,73.29,C4H11N5,COX Inhibitor,Acid Reflux,1987,Ibuprofen,Lipitor,Low Risk,Slow Metabolism,Phase 3,Animal Testing,Serotonin Pathway,Injection,As prescribed,AstraZeneca,6,Low,High Risk,High (>80%),Moderate,Renal,Partially Suitable
Ranitidine,Inflammation,Liver Disease,50.09,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1965,Ibuprofen,Prilosec,Low Risk,High Bioavailability,Phase 2,In Vitro Studies,Immune Response Pathway,Injection,10mg once daily,AstraZeneca,24,Low,Low Risk,Low (<50%),Fast,Liver,Not Suitable
Simvastatin,Fever,Cancer Therapy,30.17,C9H8O4,NSAID,"Headache, Rash",1994,Atorvastatin Calcium,Prilosec,Moderate Risk,Renal Excretion,Phase 3,No Preclinical Data,Immune Response Pathway,Topical Gel,250mg every 8 hours,Roche,12,Moderate,Low Risk,Moderate (50-80%),Moderate,Liver,Partially Suitable
Levothyroxine,Hypertension,Parkinson's,44.23,C17H19N3O3S,NSAID,Acid Reflux,1965,Metformin Hydrochloride,Prilosec,Low Risk,Slow Metabolism,Phase 4,Animal Testing,Dopaminergic Pathway,Syrup,10mg once daily,Roche,24,Moderate,High Risk,Moderate (50-80%),Fast,Renal,Partially Suitable
Aspirin,Blood Thinner,Parkinson's,71.71,C13H18O2,Proton Pump Inhibitor,"Nausea, Dizziness",1965,Atorvastatin Calcium,Prilosec,High Risk,Rapid Absorption,Phase 2,Animal Testing,Immune Response Pathway,Topical Gel,10mg once daily,Roche,12,Low,Low Risk,Low (<50%),Moderate,Renal,Not Suitable
Metformin,Cholesterol Control,Migraine Treatment,90.09,C13H18O2,Proton Pump Inhibitor,"Headache, Rash",1987,Ibuprofen,Glucophage,High Risk,Rapid Absorption,Completed,No Preclinical Data,Dopaminergic Pathway,Capsule,As prescribed,Pfizer,24,High,Low Risk,High (>80%),Moderate,Renal,Suitable
Ibuprofen,Acid Reflux,Anti-Aging,55.45,C13H18O2,Proton Pump Inhibitor,Acid Reflux,1994,Omeprazole,Glucophage,High Risk,Liver Metabolism,Phase 2,No Preclinical Data,MAPK Pathway,Injection,250mg every 8 hours,Merck,2,High,Moderate Risk,Moderate (50-80%),Slow,Liver,Partially Suitable
Atorvastatin,Thyroid Hormone Replacement,Parkinson's,67.59,C17H19N3O3S,NSAID,"Headache, Rash",1994,Atorvastatin Calcium,Lipitor,Moderate Risk,Slow Metabolism,Phase 2,In Vitro Studies,PI3K-AKT Pathway,Injection,As prescribed,AstraZeneca,12,Moderate,High Risk,Low (<50%),Fast,Gut,Not Suitable
Omeprazole,Fever,Antiviral,40.85,C13H18O2,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1987,Omeprazole,Glucophage,Moderate Risk,Slow Metabolism,Phase 2,Animal Testing,Immune Response Pathway,Syrup,As prescribed,Merck,2,High,High Risk,Moderate (50-80%),Slow,Enzyme-Specific,Suitable
Losartan,Blood Thinner,Cardiovascular Disease,67.38,C33H35FN2O5,NSAID,Acid Reflux,1987,Ibuprofen,Aspirin,Moderate Risk,Renal Excretion,Completed,In Vitro Studies,Dopaminergic Pathway,Injection,500mg twice a day,Novartis,2,High,Low Risk,Low (<50%),Moderate,Enzyme-Specific,Suitable
Paracetamol,Inflammation,Autoimmune Disorders,87.62,C17H19N3O3S,Proton Pump Inhibitor,Gastrointestinal Issues,1994,Ibuprofen,Glucophage,High Risk,Slow Metabolism,Phase 4,In Vitro Studies,Immune Response Pathway,Capsule,As prescribed,Novartis,24,Moderate,Low Risk,Moderate (50-80%),Moderate,Liver,Partially Suitable
Ranitidine,Cholesterol Control,Liver Disease,45.52,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Acid Reflux,1987,Omeprazole,Prilosec,Moderate Risk,Renal Excretion,Ongoing,No Preclinical Data,Serotonin Pathway,Syrup,As prescribed,Roche,48,Low,High Risk,Low (<50%),Slow,Liver,Not Suitable
Simvastatin,Acid Reflux,Parkinson's,33.77,C9H8O4,COX Inhibitor,Acid Reflux,1965,Omeprazole,Glucophage,High Risk,Slow Metabolism,Phase 1,No Preclinical Data,MAPK Pathway,Injection,250mg every 8 hours,Merck,2,High,Moderate Risk,High (>80%),Moderate,Gut,Partially Suitable
Levothyroxine,Cholesterol Control,Liver Disease,31.19,C13H18O2,HMG-CoA Reductase Inhibitor,"Headache, Rash",1996,Metformin Hydrochloride,Aspirin,Moderate Risk,Renal Excretion,Phase 2,In Vitro Studies,Dopaminergic Pathway,Topical Gel,50mg daily,Pfizer,6,Moderate,Moderate Risk,High (>80%),Fast,Gut,Suitable
Aspirin,Diabetes,Cancer Therapy,34.88,C33H35FN2O5,COX Inhibitor,"Nausea, Dizziness",1965,Ibuprofen,Advil,Low Risk,High Bioavailability,Phase 2,No Preclinical Data,PI3K-AKT Pathway,Topical Gel,As prescribed,AstraZeneca,2,Moderate,High Risk,Moderate (50-80%),Slow,Enzyme-Specific,Suitable
Metformin,Inflammation,Autoimmune Disorders,34.87,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Acid Reflux,1971,Ibuprofen,Glucophage,Moderate Risk,Rapid Absorption,Phase 1,In Vitro Studies,MAPK Pathway,Capsule,As prescribed,AstraZeneca,6,Moderate,Moderate Risk,Low (<50%),Fast,Renal,Suitable
Ibuprofen,Thyroid Hormone Replacement,Liver Disease,53.17,C9H8O4,COX Inhibitor,Acid Reflux,1987,Metformin Hydrochloride,Glucophage,Low Risk,Renal Excretion,Phase 4,Toxicology Report,PI3K-AKT Pathway,Tablet,10mg once daily,Novartis,12,Low,High Risk,Moderate (50-80%),Slow,Enzyme-Specific,Suitable
Atorvastatin,Fever,Anti-Aging,82.62,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1965,Ibuprofen,Advil,High Risk,High Bioavailability,Phase 3,Toxicology Report,PI3K-AKT Pathway,Capsule,50mg daily,Merck,2,Low,Low Risk,High (>80%),Fast,Renal,Not Suitable
Omeprazole,Cholesterol Control,Alzheimer's,46.54,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Muscle Pain,1996,Metformin Hydrochloride,Lipitor,High Risk,Liver Metabolism,Ongoing,In Vitro Studies,PI3K-AKT Pathway,Injection,50mg daily,AstraZeneca,6,Moderate,Low Risk,High (>80%),Slow,Gut,Not Suitable
Losartan,Acid Reflux,Liver Disease,31.1,C4H11N5,AMPK Activator,Gastrointestinal Issues,1994,Acetylsalicylic Acid,Advil,Moderate Risk,Renal Excretion,Phase 3,No Preclinical Data,PI3K-AKT Pathway,Syrup,500mg twice a day,Roche,12,Moderate,High Risk,High (>80%),Moderate,Enzyme-Specific,Suitable
Paracetamol,Acid Reflux,Liver Disease,93.11,C4H11N5,COX Inhibitor,Acid Reflux,1965,Atorvastatin Calcium,Prilosec,High Risk,Liver Metabolism,Phase 3,In Vitro Studies,MAPK Pathway,Syrup,250mg every 8 hours,AstraZeneca,24,Moderate,Low Risk,Low (<50%),Moderate,Renal,Partially Suitable
Ranitidine,Gastric Ulcer,Anti-Aging,78.77,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Muscle Pain,1971,Ibuprofen,Advil,Moderate Risk,Renal Excretion,Phase 1,No Preclinical Data,PI3K-AKT Pathway,Injection,As prescribed,Merck,6,High,Moderate Risk,High (>80%),Moderate,Enzyme-Specific,Suitable
Simvastatin,Gastric Ulcer,Antiviral,43.17,C9H8O4,COX Inhibitor,Gastrointestinal Issues,1971,Ibuprofen,Aspirin,Low Risk,Liver Metabolism,Completed,Animal Testing,PI3K-AKT Pathway,Topical Gel,As prescribed,Pfizer,12,Moderate,High Risk,Low (<50%),Moderate,Renal,Partially Suitable
Levothyroxine,Inflammation,Cancer Therapy,89.2,C4H11N5,NSAID,"Headache, Rash",1965,Acetylsalicylic Acid,Glucophage,Low Risk,Renal Excretion,Ongoing,In Vitro Studies,Serotonin Pathway,Injection,500mg twice a day,Merck,2,Low,Low Risk,Low (<50%),Moderate,Enzyme-Specific,Not Suitable
Aspirin,Inflammation,Migraine Treatment,78.25,C17H19N3O3S,AMPK Activator,Muscle Pain,1996,Omeprazole,Prilosec,High Risk,Slow Metabolism,Ongoing,Toxicology Report,MAPK Pathway,Tablet,50mg daily,Merck,6,High,High Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Metformin,Fever,Parkinson's,83.42,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Acid Reflux,1987,Atorvastatin Calcium,Aspirin,Moderate Risk,Rapid Absorption,Phase 2,Animal Testing,Dopaminergic Pathway,Syrup,250mg every 8 hours,Merck,6,Moderate,High Risk,Low (<50%),Fast,Renal,Suitable
Ibuprofen,Blood Thinner,Cardiovascular Disease,91.17,C13H18O2,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1994,Acetylsalicylic Acid,Advil,Low Risk,High Bioavailability,Completed,No Preclinical Data,Immune Response Pathway,Topical Gel,10mg once daily,AstraZeneca,6,Moderate,Low Risk,Moderate (50-80%),Fast,Renal,Suitable
Atorvastatin,Diabetes,Antiviral,39.86,C4H11N5,AMPK Activator,"Headache, Rash",1987,Acetylsalicylic Acid,Glucophage,Moderate Risk,Liver Metabolism,Phase 1,No Preclinical Data,MAPK Pathway,Topical Gel,As prescribed,Pfizer,2,Moderate,Moderate Risk,High (>80%),Slow,Liver,Partially Suitable
Omeprazole,Cholesterol Control,Weight Loss,90.99,C33H35FN2O5,COX Inhibitor,"Headache, Rash",1996,Metformin Hydrochloride,Lipitor,Moderate Risk,High Bioavailability,Completed,Animal Testing,Dopaminergic Pathway,Injection,As prescribed,Pfizer,12,Moderate,Moderate Risk,Low (<50%),Moderate,Liver,Suitable
Losartan,Diabetes,Alzheimer's,60.7,C9H8O4,HMG-CoA Reductase Inhibitor,"Headache, Rash",1965,Ibuprofen,Glucophage,Low Risk,Renal Excretion,Completed,Toxicology Report,Serotonin Pathway,Tablet,500mg twice a day,Novartis,24,Moderate,Low Risk,Moderate (50-80%),Slow,Gut,Partially Suitable
Paracetamol,Gastric Ulcer,Cardiovascular Disease,31.11,C33H35FN2O5,Proton Pump Inhibitor,Gastrointestinal Issues,1987,Ibuprofen,Glucophage,High Risk,High Bioavailability,Phase 4,Animal Testing,Immune Response Pathway,Syrup,250mg every 8 hours,Merck,6,High,High Risk,Moderate (50-80%),Slow,Enzyme-Specific,Not Suitable
Ranitidine,Hypertension,Cardiovascular Disease,88.42,C4H11N5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1965,Acetylsalicylic Acid,Glucophage,Low Risk,Slow Metabolism,Phase 2,Animal Testing,Serotonin Pathway,Topical Gel,500mg twice a day,Merck,12,Moderate,Low Risk,Moderate (50-80%),Moderate,Gut,Suitable
Simvastatin,Inflammation,Parkinson's,75.89,C9H8O4,HMG-CoA Reductase Inhibitor,Muscle Pain,1996,Atorvastatin Calcium,Glucophage,Moderate Risk,Renal Excretion,Phase 1,Animal Testing,MAPK Pathway,Tablet,50mg daily,Novartis,24,Low,High Risk,High (>80%),Moderate,Renal,Not Suitable
Levothyroxine,Diabetes,Migraine Treatment,69.94,C33H35FN2O5,NSAID,"Nausea, Dizziness",1987,Atorvastatin Calcium,Glucophage,Moderate Risk,Liver Metabolism,Completed,Animal Testing,Immune Response Pathway,Topical Gel,10mg once daily,Novartis,6,High,Moderate Risk,Moderate (50-80%),Fast,Enzyme-Specific,Not Suitable
Aspirin,Inflammation,Parkinson's,79.21,C17H19N3O3S,AMPK Activator,Muscle Pain,1996,Atorvastatin Calcium,Prilosec,Moderate Risk,Renal Excretion,Completed,Animal Testing,Dopaminergic Pathway,Topical Gel,10mg once daily,Roche,12,Moderate,Moderate Risk,High (>80%),Slow,Renal,Partially Suitable
Metformin,Acid Reflux,Cancer Therapy,54.1,C4H11N5,COX Inhibitor,"Headache, Rash",1971,Atorvastatin Calcium,Lipitor,Moderate Risk,Rapid Absorption,Phase 4,In Vitro Studies,Serotonin Pathway,Capsule,250mg every 8 hours,Novartis,48,Moderate,Low Risk,Moderate (50-80%),Fast,Enzyme-Specific,Partially Suitable
Ibuprofen,Inflammation,Anti-Aging,38.12,C13H18O2,AMPK Activator,Acid Reflux,1996,Omeprazole,Aspirin,Low Risk,Slow Metabolism,Ongoing,Toxicology Report,PI3K-AKT Pathway,Syrup,250mg every 8 hours,Merck,12,Moderate,Low Risk,High (>80%),Moderate,Enzyme-Specific,Not Suitable
Atorvastatin,Hypertension,Migraine Treatment,64.26,C17H19N3O3S,Proton Pump Inhibitor,Muscle Pain,1965,Omeprazole,Lipitor,Low Risk,Liver Metabolism,Completed,Animal Testing,Serotonin Pathway,Capsule,As prescribed,Roche,48,Low,High Risk,Low (<50%),Moderate,Gut,Not Suitable
Omeprazole,Thyroid Hormone Replacement,Alzheimer's,39.21,C17H19N3O3S,NSAID,Muscle Pain,1994,Atorvastatin Calcium,Aspirin,Low Risk,Rapid Absorption,Ongoing,No Preclinical Data,Dopaminergic Pathway,Injection,10mg once daily,AstraZeneca,2,High,Low Risk,High (>80%),Moderate,Enzyme-Specific,Not Suitable
Losartan,Pain Relief,Cancer Therapy,58.61,C9H8O4,Proton Pump Inhibitor,Acid Reflux,1996,Atorvastatin Calcium,Prilosec,High Risk,Slow Metabolism,Ongoing,No Preclinical Data,Serotonin Pathway,Tablet,10mg once daily,Pfizer,6,Low,High Risk,Low (<50%),Slow,Liver,Suitable
Paracetamol,Hypertension,Parkinson's,64.23,C4H11N5,NSAID,Acid Reflux,1971,Acetylsalicylic Acid,Lipitor,Moderate Risk,High Bioavailability,Phase 3,In Vitro Studies,Dopaminergic Pathway,Capsule,10mg once daily,AstraZeneca,24,Low,Moderate Risk,High (>80%),Slow,Gut,Not Suitable
Ranitidine,Thyroid Hormone Replacement,Parkinson's,91.68,C17H19N3O3S,Proton Pump Inhibitor,"Headache, Rash",1965,Atorvastatin Calcium,Advil,Low Risk,High Bioavailability,Phase 2,In Vitro Studies,Serotonin Pathway,Syrup,50mg daily,Pfizer,2,Low,Low Risk,Low (<50%),Fast,Liver,Suitable
Simvastatin,Blood Thinner,Antiviral,40.95,C13H18O2,NSAID,Gastrointestinal Issues,1987,Metformin Hydrochloride,Prilosec,Moderate Risk,Slow Metabolism,Ongoing,No Preclinical Data,PI3K-AKT Pathway,Injection,10mg once daily,Merck,12,Moderate,High Risk,High (>80%),Moderate,Gut,Partially Suitable
Levothyroxine,Pain Relief,Parkinson's,41.12,C9H8O4,COX Inhibitor,"Nausea, Dizziness",1987,Acetylsalicylic Acid,Lipitor,Moderate Risk,Liver Metabolism,Ongoing,In Vitro Studies,Dopaminergic Pathway,Capsule,500mg twice a day,Roche,2,Moderate,High Risk,Moderate (50-80%),Slow,Enzyme-Specific,Not Suitable
Aspirin,Thyroid Hormone Replacement,Anti-Aging,78.67,C33H35FN2O5,NSAID,"Nausea, Dizziness",1971,Metformin Hydrochloride,Advil,Low Risk,High Bioavailability,Phase 1,In Vitro Studies,Serotonin Pathway,Tablet,10mg once daily,Novartis,12,Moderate,Low Risk,Low (<50%),Fast,Renal,Not Suitable
Metformin,Cholesterol Control,Cardiovascular Disease,35.15,C4H11N5,NSAID,Gastrointestinal Issues,1971,Acetylsalicylic Acid,Aspirin,Low Risk,High Bioavailability,Ongoing,In Vitro Studies,MAPK Pathway,Capsule,50mg daily,Pfizer,48,Low,High Risk,High (>80%),Fast,Enzyme-Specific,Partially Suitable
Ibuprofen,Pain Relief,Alzheimer's,84.59,C17H19N3O3S,HMG-CoA Reductase Inhibitor,"Headache, Rash",1996,Metformin Hydrochloride,Aspirin,Moderate Risk,Rapid Absorption,Ongoing,No Preclinical Data,Serotonin Pathway,Injection,As prescribed,Roche,12,High,Moderate Risk,High (>80%),Slow,Liver,Not Suitable
Atorvastatin,Thyroid Hormone Replacement,Antiviral,68.92,C33H35FN2O5,AMPK Activator,"Nausea, Dizziness",1965,Omeprazole,Aspirin,High Risk,Liver Metabolism,Phase 2,In Vitro Studies,Dopaminergic Pathway,Capsule,500mg twice a day,Novartis,2,High,Low Risk,Low (<50%),Moderate,Liver,Suitable
Omeprazole,Cholesterol Control,Alzheimer's,37.6,C13H18O2,Proton Pump Inhibitor,Acid Reflux,1996,Omeprazole,Lipitor,High Risk,High Bioavailability,Phase 2,No Preclinical Data,Dopaminergic Pathway,Capsule,As prescribed,Merck,6,High,Low Risk,Low (<50%),Slow,Liver,Partially Suitable
Losartan,Diabetes,Cardiovascular Disease,44.16,C17H19N3O3S,Proton Pump Inhibitor,"Headache, Rash",1994,Atorvastatin Calcium,Aspirin,Low Risk,Liver Metabolism,Phase 2,Toxicology Report,PI3K-AKT Pathway,Capsule,10mg once daily,Pfizer,48,High,Moderate Risk,Moderate (50-80%),Fast,Renal,Not Suitable
Paracetamol,Inflammation,Weight Loss,49.91,C17H19N3O3S,Proton Pump Inhibitor,"Nausea, Dizziness",1971,Ibuprofen,Glucophage,High Risk,High Bioavailability,Completed,Animal Testing,Dopaminergic Pathway,Capsule,As prescribed,Merck,48,High,Low Risk,Moderate (50-80%),Slow,Renal,Suitable
Ranitidine,Blood Thinner,Liver Disease,64.79,C33H35FN2O5,Proton Pump Inhibitor,Muscle Pain,1994,Metformin Hydrochloride,Aspirin,Low Risk,Liver Metabolism,Phase 1,Toxicology Report,Serotonin Pathway,Topical Gel,As prescribed,Pfizer,12,Low,High Risk,Low (<50%),Moderate,Renal,Not Suitable
Simvastatin,Hypertension,Parkinson's,46.21,C4H11N5,AMPK Activator,Muscle Pain,1987,Omeprazole,Glucophage,High Risk,Slow Metabolism,Ongoing,No Preclinical Data,MAPK Pathway,Syrup,10mg once daily,AstraZeneca,2,Low,High Risk,Low (<50%),Slow,Renal,Partially Suitable
Levothyroxine,Diabetes,Parkinson's,91.46,C4H11N5,Proton Pump Inhibitor,Gastrointestinal Issues,1987,Omeprazole,Lipitor,Moderate Risk,Liver Metabolism,Completed,In Vitro Studies,PI3K-AKT Pathway,Tablet,As prescribed,Pfizer,48,Moderate,High Risk,Moderate (50-80%),Slow,Renal,Partially Suitable
Aspirin,Acid Reflux,Anti-Aging,85.37,C13H18O2,Proton Pump Inhibitor,"Headache, Rash",1994,Acetylsalicylic Acid,Aspirin,Moderate Risk,Liver Metabolism,Completed,Toxicology Report,MAPK Pathway,Syrup,10mg once daily,AstraZeneca,2,Moderate,Moderate Risk,Moderate (50-80%),Slow,Enzyme-Specific,Suitable
Metformin,Gastric Ulcer,Weight Loss,74.94,C9H8O4,Proton Pump Inhibitor,"Nausea, Dizziness",1971,Atorvastatin Calcium,Lipitor,Low Risk,High Bioavailability,Phase 3,In Vitro Studies,Immune Response Pathway,Capsule,250mg every 8 hours,Roche,2,Low,Low Risk,Moderate (50-80%),Moderate,Renal,Partially Suitable
Ibuprofen,Inflammation,Autoimmune Disorders,32.25,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1987,Metformin Hydrochloride,Glucophage,High Risk,Renal Excretion,Phase 4,Toxicology Report,MAPK Pathway,Topical Gel,10mg once daily,Novartis,6,Moderate,Low Risk,Low (<50%),Slow,Gut,Suitable
Atorvastatin,Inflammation,Alzheimer's,54.1,C13H18O2,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1965,Ibuprofen,Lipitor,High Risk,Slow Metabolism,Phase 1,No Preclinical Data,Immune Response Pathway,Capsule,500mg twice a day,AstraZeneca,48,Low,High Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Not Suitable
Omeprazole,Hypertension,Weight Loss,54.02,C4H11N5,Proton Pump Inhibitor,Acid Reflux,1987,Omeprazole,Advil,Low Risk,Renal Excretion,Phase 2,Animal Testing,Serotonin Pathway,Injection,10mg once daily,Roche,24,High,Moderate Risk,High (>80%),Moderate,Renal,Not Suitable
Losartan,Cholesterol Control,Weight Loss,90.53,C4H11N5,Proton Pump Inhibitor,"Nausea, Dizziness",1965,Ibuprofen,Aspirin,Moderate Risk,Slow Metabolism,Phase 2,In Vitro Studies,Serotonin Pathway,Syrup,500mg twice a day,Roche,6,Moderate,High Risk,High (>80%),Moderate,Renal,Suitable
Paracetamol,Gastric Ulcer,Cancer Therapy,54.62,C13H18O2,AMPK Activator,Muscle Pain,1971,Omeprazole,Prilosec,High Risk,Slow Metabolism,Phase 4,No Preclinical Data,PI3K-AKT Pathway,Capsule,250mg every 8 hours,Novartis,6,Moderate,High Risk,Moderate (50-80%),Moderate,Renal,Suitable
Ranitidine,Cholesterol Control,Parkinson's,91.63,C9H8O4,HMG-CoA Reductase Inhibitor,Muscle Pain,1987,Acetylsalicylic Acid,Prilosec,Moderate Risk,Renal Excretion,Phase 1,No Preclinical Data,MAPK Pathway,Topical Gel,As prescribed,Pfizer,2,High,Moderate Risk,High (>80%),Slow,Gut,Suitable
Simvastatin,Pain Relief,Antiviral,92.93,C9H8O4,Proton Pump Inhibitor,"Nausea, Dizziness",1994,Omeprazole,Advil,Low Risk,Rapid Absorption,Completed,Animal Testing,Immune Response Pathway,Topical Gel,250mg every 8 hours,Roche,6,Low,Moderate Risk,Moderate (50-80%),Fast,Liver,Partially Suitable
Levothyroxine,Pain Relief,Anti-Aging,53.93,C13H18O2,Proton Pump Inhibitor,Muscle Pain,1996,Acetylsalicylic Acid,Lipitor,High Risk,Renal Excretion,Completed,Toxicology Report,Serotonin Pathway,Syrup,As prescribed,Merck,6,High,High Risk,Moderate (50-80%),Slow,Renal,Partially Suitable
Aspirin,Thyroid Hormone Replacement,Weight Loss,87.59,C17H19N3O3S,AMPK Activator,"Headache, Rash",1994,Omeprazole,Glucophage,Moderate Risk,Slow Metabolism,Phase 3,Toxicology Report,Immune Response Pathway,Tablet,10mg once daily,Novartis,24,High,High Risk,Low (<50%),Moderate,Gut,Not Suitable
Metformin,Hypertension,Autoimmune Disorders,68.38,C4H11N5,COX Inhibitor,"Nausea, Dizziness",1996,Ibuprofen,Advil,Moderate Risk,Rapid Absorption,Phase 4,Toxicology Report,Serotonin Pathway,Injection,250mg every 8 hours,Novartis,6,Moderate,Moderate Risk,Moderate (50-80%),Moderate,Gut,Partially Suitable
Ibuprofen,Cholesterol Control,Cardiovascular Disease,38.49,C13H18O2,NSAID,"Nausea, Dizziness",1971,Ibuprofen,Lipitor,Low Risk,Renal Excretion,Phase 1,Animal Testing,MAPK Pathway,Tablet,500mg twice a day,Merck,48,High,High Risk,High (>80%),Moderate,Enzyme-Specific,Partially Suitable
Atorvastatin,Thyroid Hormone Replacement,Autoimmune Disorders,30.13,C17H19N3O3S,AMPK Activator,"Headache, Rash",1971,Ibuprofen,Glucophage,Low Risk,Renal Excretion,Phase 2,No Preclinical Data,Serotonin Pathway,Tablet,500mg twice a day,Merck,48,Low,Low Risk,Moderate (50-80%),Moderate,Renal,Suitable
Omeprazole,Pain Relief,Autoimmune Disorders,43.21,C33H35FN2O5,AMPK Activator,Gastrointestinal Issues,1994,Atorvastatin Calcium,Advil,Low Risk,Renal Excretion,Ongoing,No Preclinical Data,Immune Response Pathway,Injection,500mg twice a day,Merck,12,Low,Moderate Risk,Low (<50%),Fast,Gut,Suitable
Losartan,Diabetes,Cardiovascular Disease,58.91,C13H18O2,COX Inhibitor,Acid Reflux,1996,Omeprazole,Glucophage,High Risk,High Bioavailability,Phase 3,Toxicology Report,Dopaminergic Pathway,Topical Gel,10mg once daily,Novartis,24,Moderate,Moderate Risk,Moderate (50-80%),Fast,Enzyme-Specific,Not Suitable
Paracetamol,Gastric Ulcer,Weight Loss,71.32,C4H11N5,AMPK Activator,Gastrointestinal Issues,1994,Acetylsalicylic Acid,Prilosec,Low Risk,Liver Metabolism,Phase 1,Animal Testing,Immune Response Pathway,Injection,10mg once daily,AstraZeneca,2,High,High Risk,High (>80%),Slow,Liver,Not Suitable
Ranitidine,Pain Relief,Autoimmune Disorders,37.88,C17H19N3O3S,Proton Pump Inhibitor,Muscle Pain,1965,Metformin Hydrochloride,Advil,Moderate Risk,Liver Metabolism,Phase 1,In Vitro Studies,Immune Response Pathway,Injection,500mg twice a day,Merck,6,High,Low Risk,Low (<50%),Fast,Enzyme-Specific,Partially Suitable
Simvastatin,Thyroid Hormone Replacement,Weight Loss,90.82,C33H35FN2O5,AMPK Activator,Gastrointestinal Issues,1965,Acetylsalicylic Acid,Aspirin,High Risk,Slow Metabolism,Phase 2,Animal Testing,Dopaminergic Pathway,Tablet,10mg once daily,AstraZeneca,6,Low,Moderate Risk,Moderate (50-80%),Fast,Gut,Partially Suitable
Levothyroxine,Pain Relief,Alzheimer's,44.76,C13H18O2,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1996,Metformin Hydrochloride,Glucophage,Moderate Risk,Renal Excretion,Phase 3,Animal Testing,Immune Response Pathway,Tablet,250mg every 8 hours,Merck,48,High,High Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Aspirin,Pain Relief,Migraine Treatment,40.59,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1971,Acetylsalicylic Acid,Advil,Moderate Risk,Slow Metabolism,Phase 2,No Preclinical Data,Dopaminergic Pathway,Injection,500mg twice a day,Pfizer,12,Low,High Risk,Low (<50%),Fast,Enzyme-Specific,Suitable
Metformin,Diabetes,Weight Loss,79.22,C17H19N3O3S,COX Inhibitor,"Nausea, Dizziness",1996,Acetylsalicylic Acid,Advil,Low Risk,Liver Metabolism,Phase 1,Animal Testing,MAPK Pathway,Topical Gel,500mg twice a day,Novartis,6,Moderate,Low Risk,Low (<50%),Fast,Gut,Suitable
Ibuprofen,Pain Relief,Weight Loss,80.73,C33H35FN2O5,AMPK Activator,"Headache, Rash",1987,Omeprazole,Prilosec,Low Risk,High Bioavailability,Ongoing,No Preclinical Data,PI3K-AKT Pathway,Injection,500mg twice a day,AstraZeneca,24,High,Moderate Risk,Low (<50%),Moderate,Renal,Partially Suitable
Atorvastatin,Acid Reflux,Anti-Aging,92.52,C33H35FN2O5,NSAID,"Nausea, Dizziness",1971,Acetylsalicylic Acid,Glucophage,High Risk,Rapid Absorption,Phase 2,No Preclinical Data,Immune Response Pathway,Syrup,As prescribed,AstraZeneca,48,Low,High Risk,Low (<50%),Fast,Renal,Not Suitable
Omeprazole,Diabetes,Autoimmune Disorders,53.49,C17H19N3O3S,Proton Pump Inhibitor,Acid Reflux,1971,Ibuprofen,Aspirin,High Risk,Rapid Absorption,Completed,No Preclinical Data,MAPK Pathway,Capsule,250mg every 8 hours,Pfizer,2,Moderate,Moderate Risk,High (>80%),Fast,Liver,Not Suitable
Losartan,Gastric Ulcer,Parkinson's,57.37,C13H18O2,NSAID,Acid Reflux,1994,Omeprazole,Glucophage,Low Risk,Renal Excretion,Phase 1,In Vitro Studies,Dopaminergic Pathway,Topical Gel,500mg twice a day,Novartis,24,High,High Risk,High (>80%),Slow,Renal,Not Suitable
Paracetamol,Blood Thinner,Parkinson's,38.27,C9H8O4,Proton Pump Inhibitor,"Headache, Rash",1994,Ibuprofen,Lipitor,High Risk,High Bioavailability,Phase 2,Toxicology Report,Dopaminergic Pathway,Injection,10mg once daily,AstraZeneca,12,Low,Moderate Risk,Moderate (50-80%),Fast,Enzyme-Specific,Not Suitable
Ranitidine,Acid Reflux,Migraine Treatment,69.51,C4H11N5,NSAID,"Headache, Rash",1965,Metformin Hydrochloride,Glucophage,Low Risk,Slow Metabolism,Phase 1,Animal Testing,Immune Response Pathway,Injection,As prescribed,AstraZeneca,2,Low,Moderate Risk,Moderate (50-80%),Fast,Liver,Partially Suitable
Simvastatin,Hypertension,Migraine Treatment,73.37,C13H18O2,AMPK Activator,Muscle Pain,1987,Omeprazole,Advil,Moderate Risk,Renal Excretion,Phase 2,Animal Testing,MAPK Pathway,Tablet,10mg once daily,Merck,48,Low,High Risk,High (>80%),Moderate,Enzyme-Specific,Suitable
Levothyroxine,Diabetes,Parkinson's,76.36,C4H11N5,Proton Pump Inhibitor,"Headache, Rash",1965,Ibuprofen,Lipitor,Low Risk,Liver Metabolism,Phase 3,In Vitro Studies,MAPK Pathway,Capsule,250mg every 8 hours,AstraZeneca,6,High,Moderate Risk,High (>80%),Slow,Renal,Suitable
Aspirin,Cholesterol Control,Liver Disease,94.3,C13H18O2,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1987,Acetylsalicylic Acid,Prilosec,High Risk,Slow Metabolism,Phase 3,In Vitro Studies,Immune Response Pathway,Injection,As prescribed,Roche,6,Low,Moderate Risk,High (>80%),Moderate,Liver,Not Suitable
Metformin,Diabetes,Liver Disease,52.48,C17H19N3O3S,AMPK Activator,Muscle Pain,1994,Omeprazole,Advil,High Risk,Slow Metabolism,Phase 1,In Vitro Studies,Serotonin Pathway,Topical Gel,500mg twice a day,AstraZeneca,12,Moderate,Low Risk,Low (<50%),Fast,Gut,Partially Suitable
Ibuprofen,Diabetes,Weight Loss,39.91,C17H19N3O3S,NSAID,"Headache, Rash",1971,Acetylsalicylic Acid,Glucophage,Moderate Risk,Renal Excretion,Phase 4,Toxicology Report,Immune Response Pathway,Injection,As prescribed,Novartis,12,Low,Moderate Risk,Low (<50%),Slow,Renal,Not Suitable
Atorvastatin,Acid Reflux,Cancer Therapy,63.7,C13H18O2,HMG-CoA Reductase Inhibitor,Acid Reflux,1987,Ibuprofen,Aspirin,High Risk,Slow Metabolism,Phase 4,Toxicology Report,Dopaminergic Pathway,Injection,500mg twice a day,Pfizer,2,High,Moderate Risk,Moderate (50-80%),Slow,Liver,Not Suitable
Omeprazole,Pain Relief,Antiviral,88.38,C13H18O2,COX Inhibitor,"Nausea, Dizziness",1994,Atorvastatin Calcium,Advil,Low Risk,Liver Metabolism,Phase 2,Animal Testing,Dopaminergic Pathway,Tablet,As prescribed,Pfizer,12,Low,High Risk,Moderate (50-80%),Slow,Enzyme-Specific,Not Suitable
Losartan,Thyroid Hormone Replacement,Weight Loss,62.44,C17H19N3O3S,COX Inhibitor,Gastrointestinal Issues,1996,Ibuprofen,Glucophage,Moderate Risk,High Bioavailability,Phase 3,Toxicology Report,PI3K-AKT Pathway,Injection,As prescribed,Merck,24,High,Moderate Risk,Moderate (50-80%),Fast,Renal,Partially Suitable
Paracetamol,Gastric Ulcer,Autoimmune Disorders,73.34,C9H8O4,COX Inhibitor,"Headache, Rash",1987,Omeprazole,Glucophage,Low Risk,Slow Metabolism,Phase 3,Animal Testing,Dopaminergic Pathway,Syrup,250mg every 8 hours,Pfizer,24,Moderate,Low Risk,High (>80%),Fast,Renal,Not Suitable
Ranitidine,Cholesterol Control,Weight Loss,66.22,C4H11N5,Proton Pump Inhibitor,"Headache, Rash",1987,Atorvastatin Calcium,Lipitor,Moderate Risk,High Bioavailability,Phase 2,Toxicology Report,Dopaminergic Pathway,Syrup,50mg daily,Merck,24,Moderate,Moderate Risk,Moderate (50-80%),Moderate,Gut,Suitable
Simvastatin,Hypertension,Anti-Aging,57.93,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1965,Acetylsalicylic Acid,Prilosec,Moderate Risk,Rapid Absorption,Phase 4,In Vitro Studies,Dopaminergic Pathway,Tablet,50mg daily,Pfizer,12,Low,High Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Partially Suitable
Levothyroxine,Cholesterol Control,Cardiovascular Disease,51.45,C13H18O2,HMG-CoA Reductase Inhibitor,Muscle Pain,1971,Metformin Hydrochloride,Glucophage,Moderate Risk,High Bioavailability,Phase 4,Toxicology Report,PI3K-AKT Pathway,Tablet,As prescribed,AstraZeneca,6,Moderate,High Risk,High (>80%),Moderate,Enzyme-Specific,Partially Suitable
Aspirin,Pain Relief,Alzheimer's,44.4,C13H18O2,AMPK Activator,Muscle Pain,1994,Ibuprofen,Prilosec,Moderate Risk,Renal Excretion,Phase 3,Toxicology Report,MAPK Pathway,Syrup,250mg every 8 hours,Novartis,2,High,High Risk,High (>80%),Moderate,Enzyme-Specific,Partially Suitable
Metformin,Blood Thinner,Migraine Treatment,85.27,C33H35FN2O5,COX Inhibitor,"Headache, Rash",1996,Atorvastatin Calcium,Glucophage,High Risk,High Bioavailability,Phase 4,Toxicology Report,PI3K-AKT Pathway,Syrup,250mg every 8 hours,Pfizer,12,Low,Low Risk,Moderate (50-80%),Slow,Renal,Not Suitable
Ibuprofen,Gastric Ulcer,Alzheimer's,42.48,C33H35FN2O5,Proton Pump Inhibitor,Muscle Pain,1971,Atorvastatin Calcium,Lipitor,Low Risk,Slow Metabolism,Ongoing,Animal Testing,MAPK Pathway,Syrup,10mg once daily,Novartis,48,Moderate,Low Risk,High (>80%),Moderate,Renal,Partially Suitable
Atorvastatin,Inflammation,Migraine Treatment,85.62,C13H18O2,AMPK Activator,Muscle Pain,1996,Omeprazole,Advil,Low Risk,Renal Excretion,Ongoing,Toxicology Report,MAPK Pathway,Injection,250mg every 8 hours,AstraZeneca,48,High,Low Risk,High (>80%),Fast,Gut,Partially Suitable
Omeprazole,Gastric Ulcer,Parkinson's,90.41,C4H11N5,Proton Pump Inhibitor,Gastrointestinal Issues,1987,Atorvastatin Calcium,Aspirin,High Risk,High Bioavailability,Ongoing,Animal Testing,Serotonin Pathway,Topical Gel,10mg once daily,Merck,12,Low,Low Risk,Moderate (50-80%),Slow,Enzyme-Specific,Not Suitable
Losartan,Gastric Ulcer,Parkinson's,48.05,C9H8O4,AMPK Activator,Muscle Pain,1971,Metformin Hydrochloride,Aspirin,High Risk,Renal Excretion,Phase 2,No Preclinical Data,Immune Response Pathway,Capsule,250mg every 8 hours,Roche,2,High,Moderate Risk,Low (<50%),Slow,Liver,Not Suitable
Paracetamol,Hypertension,Cancer Therapy,43.05,C13H18O2,NSAID,"Headache, Rash",1987,Metformin Hydrochloride,Prilosec,High Risk,Slow Metabolism,Ongoing,In Vitro Studies,MAPK Pathway,Tablet,500mg twice a day,AstraZeneca,24,Moderate,High Risk,High (>80%),Slow,Enzyme-Specific,Suitable
Ranitidine,Pain Relief,Autoimmune Disorders,42.03,C33H35FN2O5,Proton Pump Inhibitor,Muscle Pain,1994,Atorvastatin Calcium,Glucophage,Moderate Risk,High Bioavailability,Phase 3,Animal Testing,PI3K-AKT Pathway,Injection,250mg every 8 hours,Roche,48,Low,High Risk,Low (<50%),Fast,Gut,Partially Suitable
Simvastatin,Fever,Anti-Aging,80.57,C4H11N5,AMPK Activator,Gastrointestinal Issues,1971,Ibuprofen,Prilosec,Low Risk,Liver Metabolism,Completed,Toxicology Report,MAPK Pathway,Topical Gel,250mg every 8 hours,AstraZeneca,48,High,Moderate Risk,Moderate (50-80%),Moderate,Gut,Partially Suitable
Levothyroxine,Gastric Ulcer,Weight Loss,49.36,C33H35FN2O5,COX Inhibitor,Gastrointestinal Issues,1971,Acetylsalicylic Acid,Lipitor,Low Risk,Renal Excretion,Phase 1,In Vitro Studies,PI3K-AKT Pathway,Topical Gel,500mg twice a day,Merck,2,Low,High Risk,Low (<50%),Fast,Renal,Suitable
Aspirin,Cholesterol Control,Autoimmune Disorders,36.33,C4H11N5,Proton Pump Inhibitor,Gastrointestinal Issues,1987,Atorvastatin Calcium,Lipitor,Low Risk,Renal Excretion,Phase 3,Animal Testing,Immune Response Pathway,Topical Gel,As prescribed,Pfizer,12,High,High Risk,High (>80%),Moderate,Renal,Partially Suitable
Metformin,Thyroid Hormone Replacement,Alzheimer's,82.39,C17H19N3O3S,NSAID,Gastrointestinal Issues,1965,Atorvastatin Calcium,Aspirin,Moderate Risk,High Bioavailability,Completed,In Vitro Studies,Dopaminergic Pathway,Tablet,250mg every 8 hours,Pfizer,6,Moderate,Low Risk,Moderate (50-80%),Moderate,Renal,Not Suitable
Ibuprofen,Acid Reflux,Migraine Treatment,47.02,C4H11N5,Proton Pump Inhibitor,Gastrointestinal Issues,1994,Omeprazole,Aspirin,Moderate Risk,Renal Excretion,Phase 4,Animal Testing,Dopaminergic Pathway,Topical Gel,500mg twice a day,Pfizer,12,Low,Moderate Risk,Moderate (50-80%),Moderate,Liver,Suitable
Atorvastatin,Acid Reflux,Parkinson's,94.36,C33H35FN2O5,AMPK Activator,Muscle Pain,1987,Ibuprofen,Glucophage,Moderate Risk,Slow Metabolism,Phase 1,No Preclinical Data,MAPK Pathway,Tablet,As prescribed,Roche,12,Moderate,Moderate Risk,High (>80%),Slow,Liver,Suitable
Omeprazole,Acid Reflux,Autoimmune Disorders,36.31,C13H18O2,Proton Pump Inhibitor,Gastrointestinal Issues,1987,Ibuprofen,Prilosec,Low Risk,Slow Metabolism,Phase 4,Toxicology Report,Dopaminergic Pathway,Topical Gel,As prescribed,Roche,12,Moderate,Low Risk,Low (<50%),Fast,Renal,Not Suitable
Losartan,Thyroid Hormone Replacement,Weight Loss,48.07,C4H11N5,AMPK Activator,Acid Reflux,1994,Acetylsalicylic Acid,Glucophage,High Risk,Liver Metabolism,Phase 1,Animal Testing,MAPK Pathway,Injection,500mg twice a day,Merck,12,High,High Risk,High (>80%),Fast,Gut,Suitable
Paracetamol,Blood Thinner,Liver Disease,50.52,C4H11N5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1987,Acetylsalicylic Acid,Glucophage,Moderate Risk,High Bioavailability,Phase 4,Animal Testing,Immune Response Pathway,Tablet,250mg every 8 hours,Roche,12,Low,High Risk,Moderate (50-80%),Moderate,Liver,Partially Suitable
Ranitidine,Diabetes,Antiviral,78.11,C17H19N3O3S,COX Inhibitor,Muscle Pain,1994,Omeprazole,Glucophage,Low Risk,Liver Metabolism,Phase 4,Animal Testing,Serotonin Pathway,Syrup,250mg every 8 hours,Roche,2,Low,High Risk,High (>80%),Moderate,Gut,Suitable
Simvastatin,Cholesterol Control,Anti-Aging,64.71,C9H8O4,NSAID,"Nausea, Dizziness",1971,Acetylsalicylic Acid,Lipitor,High Risk,Renal Excretion,Ongoing,Toxicology Report,Serotonin Pathway,Topical Gel,10mg once daily,AstraZeneca,2,Moderate,High Risk,Low (<50%),Fast,Enzyme-Specific,Suitable
Levothyroxine,Hypertension,Antiviral,44.58,C9H8O4,Proton Pump Inhibitor,Acid Reflux,1971,Acetylsalicylic Acid,Glucophage,High Risk,Slow Metabolism,Ongoing,Toxicology Report,MAPK Pathway,Capsule,500mg twice a day,Pfizer,2,Low,Low Risk,Low (<50%),Fast,Liver,Suitable
Aspirin,Gastric Ulcer,Liver Disease,35.64,C33H35FN2O5,AMPK Activator,"Headache, Rash",1996,Ibuprofen,Lipitor,Moderate Risk,High Bioavailability,Phase 3,In Vitro Studies,PI3K-AKT Pathway,Capsule,As prescribed,Pfizer,2,Low,Moderate Risk,High (>80%),Moderate,Enzyme-Specific,Partially Suitable
Metformin,Thyroid Hormone Replacement,Migraine Treatment,59.99,C13H18O2,AMPK Activator,"Headache, Rash",1987,Metformin Hydrochloride,Aspirin,High Risk,Rapid Absorption,Phase 3,No Preclinical Data,Dopaminergic Pathway,Syrup,10mg once daily,Novartis,2,Moderate,Low Risk,Moderate (50-80%),Slow,Liver,Partially Suitable
Ibuprofen,Hypertension,Cardiovascular Disease,44.6,C33H35FN2O5,NSAID,"Nausea, Dizziness",1971,Omeprazole,Prilosec,Low Risk,High Bioavailability,Phase 3,Toxicology Report,Immune Response Pathway,Injection,500mg twice a day,AstraZeneca,6,Low,High Risk,High (>80%),Fast,Enzyme-Specific,Not Suitable
Atorvastatin,Acid Reflux,Alzheimer's,78.14,C9H8O4,HMG-CoA Reductase Inhibitor,Muscle Pain,1996,Ibuprofen,Prilosec,Low Risk,Slow Metabolism,Phase 3,No Preclinical Data,PI3K-AKT Pathway,Topical Gel,50mg daily,AstraZeneca,6,Low,Low Risk,High (>80%),Slow,Renal,Not Suitable
Omeprazole,Blood Thinner,Liver Disease,48.55,C17H19N3O3S,AMPK Activator,"Headache, Rash",1965,Ibuprofen,Advil,High Risk,Rapid Absorption,Ongoing,Toxicology Report,MAPK Pathway,Injection,250mg every 8 hours,Roche,2,Moderate,Moderate Risk,High (>80%),Moderate,Enzyme-Specific,Not Suitable
Losartan,Pain Relief,Parkinson's,80.51,C9H8O4,AMPK Activator,Gastrointestinal Issues,1987,Atorvastatin Calcium,Advil,Low Risk,Liver Metabolism,Phase 1,In Vitro Studies,Serotonin Pathway,Injection,As prescribed,Pfizer,2,Low,Moderate Risk,Moderate (50-80%),Slow,Gut,Suitable
Paracetamol,Diabetes,Alzheimer's,63.24,C17H19N3O3S,COX Inhibitor,Muscle Pain,1987,Ibuprofen,Advil,Low Risk,Renal Excretion,Phase 2,Toxicology Report,MAPK Pathway,Syrup,250mg every 8 hours,Merck,48,High,Low Risk,Moderate (50-80%),Slow,Gut,Not Suitable
Ranitidine,Blood Thinner,Autoimmune Disorders,74.55,C13H18O2,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1994,Atorvastatin Calcium,Lipitor,High Risk,Liver Metabolism,Phase 4,In Vitro Studies,PI3K-AKT Pathway,Capsule,As prescribed,AstraZeneca,48,Moderate,Low Risk,High (>80%),Moderate,Liver,Not Suitable
Simvastatin,Thyroid Hormone Replacement,Weight Loss,30.38,C13H18O2,NSAID,Gastrointestinal Issues,1987,Ibuprofen,Lipitor,Low Risk,Rapid Absorption,Phase 3,Toxicology Report,Serotonin Pathway,Injection,As prescribed,Novartis,12,Low,High Risk,Moderate (50-80%),Moderate,Liver,Partially Suitable
Levothyroxine,Fever,Cancer Therapy,48.77,C33H35FN2O5,Proton Pump Inhibitor,Gastrointestinal Issues,1994,Omeprazole,Prilosec,Moderate Risk,Renal Excretion,Ongoing,No Preclinical Data,Dopaminergic Pathway,Topical Gel,As prescribed,Roche,48,Moderate,High Risk,Moderate (50-80%),Fast,Enzyme-Specific,Suitable
Aspirin,Gastric Ulcer,Autoimmune Disorders,68.78,C17H19N3O3S,NSAID,Acid Reflux,1987,Acetylsalicylic Acid,Glucophage,High Risk,Slow Metabolism,Phase 3,Toxicology Report,Dopaminergic Pathway,Syrup,250mg every 8 hours,Pfizer,48,High,Moderate Risk,Low (<50%),Slow,Enzyme-Specific,Partially Suitable
Metformin,Pain Relief,Antiviral,33.93,C33H35FN2O5,Proton Pump Inhibitor,"Headache, Rash",1987,Omeprazole,Lipitor,Low Risk,Rapid Absorption,Phase 1,Toxicology Report,Immune Response Pathway,Tablet,10mg once daily,Merck,24,High,High Risk,Low (<50%),Moderate,Liver,Suitable
Ibuprofen,Inflammation,Cardiovascular Disease,55.5,C9H8O4,Proton Pump Inhibitor,Muscle Pain,1996,Ibuprofen,Glucophage,Moderate Risk,Liver Metabolism,Completed,No Preclinical Data,Dopaminergic Pathway,Injection,500mg twice a day,Novartis,48,High,High Risk,Low (<50%),Moderate,Gut,Partially Suitable
Atorvastatin,Inflammation,Cancer Therapy,58.44,C4H11N5,HMG-CoA Reductase Inhibitor,Acid Reflux,1996,Ibuprofen,Glucophage,Moderate Risk,Slow Metabolism,Phase 1,No Preclinical Data,PI3K-AKT Pathway,Tablet,As prescribed,Merck,12,Low,High Risk,Low (<50%),Slow,Gut,Suitable
Omeprazole,Inflammation,Migraine Treatment,53.92,C17H19N3O3S,AMPK Activator,Muscle Pain,1987,Omeprazole,Aspirin,Moderate Risk,Liver Metabolism,Completed,No Preclinical Data,Dopaminergic Pathway,Injection,As prescribed,Merck,24,High,Moderate Risk,Low (<50%),Slow,Renal,Suitable
Losartan,Acid Reflux,Antiviral,54.22,C33H35FN2O5,AMPK Activator,Muscle Pain,1971,Acetylsalicylic Acid,Glucophage,Low Risk,High Bioavailability,Phase 3,No Preclinical Data,Dopaminergic Pathway,Syrup,250mg every 8 hours,Merck,2,Low,Moderate Risk,Low (<50%),Fast,Liver,Not Suitable
Paracetamol,Thyroid Hormone Replacement,Migraine Treatment,69.07,C4H11N5,COX Inhibitor,"Nausea, Dizziness",1965,Metformin Hydrochloride,Prilosec,Moderate Risk,Slow Metabolism,Phase 1,Toxicology Report,PI3K-AKT Pathway,Tablet,500mg twice a day,AstraZeneca,2,Low,High Risk,Low (<50%),Slow,Gut,Partially Suitable
Ranitidine,Pain Relief,Weight Loss,78.96,C13H18O2,NSAID,Acid Reflux,1965,Ibuprofen,Lipitor,Moderate Risk,Liver Metabolism,Ongoing,Animal Testing,Serotonin Pathway,Capsule,As prescribed,Pfizer,48,High,High Risk,Low (<50%),Fast,Renal,Not Suitable
Simvastatin,Diabetes,Migraine Treatment,59.81,C4H11N5,AMPK Activator,"Nausea, Dizziness",1965,Ibuprofen,Lipitor,Moderate Risk,Slow Metabolism,Phase 3,Animal Testing,Immune Response Pathway,Injection,500mg twice a day,Novartis,48,Low,Moderate Risk,Low (<50%),Slow,Enzyme-Specific,Partially Suitable
Levothyroxine,Hypertension,Antiviral,45.02,C9H8O4,COX Inhibitor,Muscle Pain,1996,Metformin Hydrochloride,Prilosec,Moderate Risk,Slow Metabolism,Phase 3,No Preclinical Data,PI3K-AKT Pathway,Topical Gel,10mg once daily,Pfizer,48,Low,High Risk,Moderate (50-80%),Slow,Gut,Suitable
Aspirin,Gastric Ulcer,Cancer Therapy,48.13,C13H18O2,HMG-CoA Reductase Inhibitor,"Headache, Rash",1996,Metformin Hydrochloride,Prilosec,Low Risk,Liver Metabolism,Ongoing,Animal Testing,Dopaminergic Pathway,Capsule,50mg daily,AstraZeneca,6,Low,Moderate Risk,Moderate (50-80%),Slow,Liver,Partially Suitable
Metformin,Blood Thinner,Cancer Therapy,74.52,C9H8O4,AMPK Activator,"Nausea, Dizziness",1987,Atorvastatin Calcium,Advil,Moderate Risk,Rapid Absorption,Phase 2,Toxicology Report,Immune Response Pathway,Tablet,50mg daily,Merck,2,Moderate,High Risk,Moderate (50-80%),Moderate,Renal,Not Suitable
Ibuprofen,Diabetes,Alzheimer's,61.08,C9H8O4,Proton Pump Inhibitor,Muscle Pain,1971,Atorvastatin Calcium,Advil,Low Risk,Liver Metabolism,Completed,In Vitro Studies,Dopaminergic Pathway,Topical Gel,As prescribed,Pfizer,24,Low,High Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Not Suitable
Atorvastatin,Blood Thinner,Autoimmune Disorders,81.7,C33H35FN2O5,Proton Pump Inhibitor,Muscle Pain,1994,Ibuprofen,Aspirin,High Risk,High Bioavailability,Completed,In Vitro Studies,Serotonin Pathway,Injection,250mg every 8 hours,Roche,24,Moderate,High Risk,Moderate (50-80%),Fast,Liver,Suitable
Omeprazole,Cholesterol Control,Antiviral,91.6,C33H35FN2O5,COX Inhibitor,"Headache, Rash",1965,Atorvastatin Calcium,Glucophage,Low Risk,Rapid Absorption,Completed,Toxicology Report,MAPK Pathway,Injection,500mg twice a day,Novartis,24,High,High Risk,High (>80%),Moderate,Liver,Suitable
Losartan,Cholesterol Control,Alzheimer's,41.21,C13H18O2,COX Inhibitor,Gastrointestinal Issues,1996,Atorvastatin Calcium,Prilosec,High Risk,Liver Metabolism,Phase 4,No Preclinical Data,Dopaminergic Pathway,Topical Gel,As prescribed,Roche,24,Low,High Risk,High (>80%),Slow,Enzyme-Specific,Not Suitable
Paracetamol,Fever,Cancer Therapy,72.44,C13H18O2,AMPK Activator,Gastrointestinal Issues,1971,Acetylsalicylic Acid,Aspirin,Moderate Risk,Rapid Absorption,Completed,No Preclinical Data,Dopaminergic Pathway,Injection,500mg twice a day,Pfizer,2,Low,High Risk,Moderate (50-80%),Fast,Gut,Not Suitable
Ranitidine,Fever,Autoimmune Disorders,67.03,C13H18O2,Proton Pump Inhibitor,Muscle Pain,1987,Metformin Hydrochloride,Lipitor,Low Risk,Rapid Absorption,Phase 3,Animal Testing,Dopaminergic Pathway,Tablet,250mg every 8 hours,Novartis,2,Moderate,Moderate Risk,Low (<50%),Fast,Liver,Partially Suitable
Simvastatin,Acid Reflux,Cancer Therapy,63.17,C9H8O4,Proton Pump Inhibitor,Muscle Pain,1965,Atorvastatin Calcium,Prilosec,Moderate Risk,Rapid Absorption,Phase 1,Animal Testing,MAPK Pathway,Capsule,10mg once daily,Roche,6,Moderate,Moderate Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Levothyroxine,Gastric Ulcer,Liver Disease,47.15,C4H11N5,COX Inhibitor,Muscle Pain,1965,Atorvastatin Calcium,Prilosec,High Risk,Liver Metabolism,Ongoing,Toxicology Report,Serotonin Pathway,Injection,50mg daily,Merck,12,Moderate,Moderate Risk,Low (<50%),Slow,Gut,Not Suitable
Aspirin,Pain Relief,Weight Loss,63.28,C4H11N5,HMG-CoA Reductase Inhibitor,Muscle Pain,1987,Atorvastatin Calcium,Advil,Low Risk,Renal Excretion,Phase 4,Toxicology Report,PI3K-AKT Pathway,Capsule,10mg once daily,Roche,24,Low,Low Risk,High (>80%),Moderate,Liver,Suitable
Metformin,Pain Relief,Alzheimer's,64.16,C9H8O4,COX Inhibitor,Gastrointestinal Issues,1987,Acetylsalicylic Acid,Prilosec,Low Risk,Liver Metabolism,Completed,No Preclinical Data,MAPK Pathway,Syrup,500mg twice a day,AstraZeneca,12,High,Low Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Partially Suitable
Ibuprofen,Thyroid Hormone Replacement,Anti-Aging,60.32,C33H35FN2O5,AMPK Activator,"Nausea, Dizziness",1996,Metformin Hydrochloride,Lipitor,Moderate Risk,Renal Excretion,Ongoing,No Preclinical Data,Dopaminergic Pathway,Syrup,As prescribed,Merck,6,Moderate,High Risk,High (>80%),Slow,Liver,Not Suitable
Atorvastatin,Thyroid Hormone Replacement,Migraine Treatment,71.33,C13H18O2,Proton Pump Inhibitor,Acid Reflux,1971,Acetylsalicylic Acid,Lipitor,Low Risk,High Bioavailability,Completed,No Preclinical Data,Immune Response Pathway,Injection,50mg daily,Roche,48,High,Moderate Risk,Low (<50%),Slow,Enzyme-Specific,Suitable
Omeprazole,Acid Reflux,Alzheimer's,89.63,C17H19N3O3S,AMPK Activator,Acid Reflux,1994,Metformin Hydrochloride,Lipitor,High Risk,High Bioavailability,Phase 2,Animal Testing,PI3K-AKT Pathway,Injection,500mg twice a day,Merck,2,High,Low Risk,Low (<50%),Fast,Renal,Not Suitable
Losartan,Cholesterol Control,Autoimmune Disorders,49.43,C9H8O4,Proton Pump Inhibitor,Muscle Pain,1971,Metformin Hydrochloride,Aspirin,Low Risk,Rapid Absorption,Phase 2,Toxicology Report,Serotonin Pathway,Tablet,50mg daily,AstraZeneca,24,Moderate,Low Risk,Moderate (50-80%),Slow,Enzyme-Specific,Suitable
Paracetamol,Diabetes,Alzheimer's,32.12,C4H11N5,COX Inhibitor,Gastrointestinal Issues,1996,Omeprazole,Prilosec,Moderate Risk,High Bioavailability,Phase 3,In Vitro Studies,Serotonin Pathway,Capsule,As prescribed,AstraZeneca,2,Moderate,Low Risk,Low (<50%),Moderate,Liver,Not Suitable
Ranitidine,Gastric Ulcer,Parkinson's,59.9,C33H35FN2O5,Proton Pump Inhibitor,Gastrointestinal Issues,1971,Atorvastatin Calcium,Lipitor,Low Risk,Rapid Absorption,Phase 1,In Vitro Studies,PI3K-AKT Pathway,Syrup,As prescribed,Pfizer,12,High,Moderate Risk,High (>80%),Moderate,Renal,Partially Suitable
Simvastatin,Fever,Cancer Therapy,35.68,C33H35FN2O5,AMPK Activator,Muscle Pain,1971,Metformin Hydrochloride,Lipitor,Moderate Risk,Rapid Absorption,Phase 2,No Preclinical Data,MAPK Pathway,Tablet,10mg once daily,Novartis,12,Low,High Risk,Low (<50%),Moderate,Enzyme-Specific,Suitable
Levothyroxine,Gastric Ulcer,Liver Disease,43.6,C9H8O4,Proton Pump Inhibitor,"Headache, Rash",1994,Acetylsalicylic Acid,Glucophage,Moderate Risk,Rapid Absorption,Phase 4,In Vitro Studies,Immune Response Pathway,Tablet,500mg twice a day,Merck,6,Low,Low Risk,High (>80%),Moderate,Renal,Suitable
Aspirin,Cholesterol Control,Cancer Therapy,51.46,C9H8O4,AMPK Activator,"Nausea, Dizziness",1987,Ibuprofen,Aspirin,Low Risk,High Bioavailability,Completed,Animal Testing,Serotonin Pathway,Topical Gel,500mg twice a day,Novartis,24,High,Moderate Risk,Moderate (50-80%),Moderate,Renal,Suitable
Metformin,Inflammation,Cardiovascular Disease,94.62,C13H18O2,Proton Pump Inhibitor,"Nausea, Dizziness",1965,Acetylsalicylic Acid,Advil,High Risk,High Bioavailability,Phase 1,Toxicology Report,PI3K-AKT Pathway,Topical Gel,50mg daily,Merck,48,Moderate,Low Risk,Low (<50%),Moderate,Enzyme-Specific,Suitable
Ibuprofen,Thyroid Hormone Replacement,Cancer Therapy,86.9,C33H35FN2O5,Proton Pump Inhibitor,Muscle Pain,1971,Acetylsalicylic Acid,Lipitor,Moderate Risk,Slow Metabolism,Phase 1,In Vitro Studies,PI3K-AKT Pathway,Syrup,As prescribed,Merck,24,Low,High Risk,Moderate (50-80%),Slow,Gut,Suitable
Atorvastatin,Blood Thinner,Cancer Therapy,70.17,C9H8O4,NSAID,"Headache, Rash",1965,Ibuprofen,Prilosec,High Risk,Rapid Absorption,Phase 4,Animal Testing,Immune Response Pathway,Topical Gel,50mg daily,Pfizer,12,Moderate,High Risk,Low (<50%),Fast,Renal,Partially Suitable
Omeprazole,Hypertension,Alzheimer's,48.96,C13H18O2,Proton Pump Inhibitor,"Nausea, Dizziness",1996,Acetylsalicylic Acid,Aspirin,Moderate Risk,Liver Metabolism,Phase 4,Toxicology Report,Immune Response Pathway,Topical Gel,250mg every 8 hours,AstraZeneca,2,Low,Low Risk,Low (<50%),Moderate,Gut,Not Suitable
Losartan,Thyroid Hormone Replacement,Antiviral,49.28,C33H35FN2O5,COX Inhibitor,Muscle Pain,1987,Atorvastatin Calcium,Advil,Moderate Risk,Slow Metabolism,Phase 2,Animal Testing,PI3K-AKT Pathway,Capsule,500mg twice a day,Novartis,12,Moderate,High Risk,Moderate (50-80%),Slow,Liver,Suitable
Paracetamol,Pain Relief,Alzheimer's,52.2,C17H19N3O3S,Proton Pump Inhibitor,"Nausea, Dizziness",1965,Acetylsalicylic Acid,Lipitor,High Risk,Renal Excretion,Phase 2,Toxicology Report,MAPK Pathway,Capsule,500mg twice a day,Merck,12,Moderate,Low Risk,High (>80%),Slow,Enzyme-Specific,Partially Suitable
Ranitidine,Hypertension,Autoimmune Disorders,67.4,C33H35FN2O5,AMPK Activator,Muscle Pain,1965,Ibuprofen,Aspirin,Moderate Risk,High Bioavailability,Ongoing,Toxicology Report,Immune Response Pathway,Capsule,10mg once daily,Pfizer,48,High,Moderate Risk,Low (<50%),Slow,Gut,Not Suitable
Simvastatin,Gastric Ulcer,Weight Loss,61.63,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Muscle Pain,1996,Ibuprofen,Lipitor,High Risk,High Bioavailability,Phase 1,No Preclinical Data,Immune Response Pathway,Tablet,250mg every 8 hours,Novartis,2,Low,Low Risk,High (>80%),Moderate,Enzyme-Specific,Partially Suitable
Levothyroxine,Diabetes,Parkinson's,64.43,C13H18O2,HMG-CoA Reductase Inhibitor,"Headache, Rash",1994,Omeprazole,Advil,Low Risk,High Bioavailability,Completed,Animal Testing,PI3K-AKT Pathway,Capsule,50mg daily,Roche,48,High,High Risk,Low (<50%),Fast,Liver,Suitable
Aspirin,Cholesterol Control,Parkinson's,76.98,C33H35FN2O5,AMPK Activator,Gastrointestinal Issues,1987,Atorvastatin Calcium,Prilosec,High Risk,High Bioavailability,Phase 3,Toxicology Report,PI3K-AKT Pathway,Syrup,500mg twice a day,Pfizer,24,Moderate,Moderate Risk,Low (<50%),Slow,Gut,Suitable
Metformin,Diabetes,Anti-Aging,71.34,C17H19N3O3S,NSAID,"Nausea, Dizziness",1994,Acetylsalicylic Acid,Prilosec,Low Risk,Slow Metabolism,Ongoing,In Vitro Studies,Dopaminergic Pathway,Injection,10mg once daily,AstraZeneca,2,High,High Risk,Low (<50%),Moderate,Enzyme-Specific,Suitable
Ibuprofen,Gastric Ulcer,Cancer Therapy,49.57,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Acid Reflux,1987,Metformin Hydrochloride,Lipitor,Moderate Risk,High Bioavailability,Phase 2,No Preclinical Data,Dopaminergic Pathway,Injection,50mg daily,Novartis,48,Low,High Risk,High (>80%),Moderate,Enzyme-Specific,Partially Suitable
Atorvastatin,Thyroid Hormone Replacement,Anti-Aging,85.17,C4H11N5,AMPK Activator,Gastrointestinal Issues,1994,Acetylsalicylic Acid,Prilosec,Low Risk,Slow Metabolism,Phase 3,Animal Testing,Serotonin Pathway,Capsule,As prescribed,AstraZeneca,48,Low,Low Risk,Low (<50%),Slow,Gut,Partially Suitable
Omeprazole,Thyroid Hormone Replacement,Migraine Treatment,62.25,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1987,Atorvastatin Calcium,Lipitor,Low Risk,Renal Excretion,Phase 1,In Vitro Studies,Serotonin Pathway,Syrup,As prescribed,Pfizer,48,Low,High Risk,Moderate (50-80%),Slow,Liver,Not Suitable
Losartan,Cholesterol Control,Alzheimer's,80.05,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1987,Ibuprofen,Advil,Low Risk,Liver Metabolism,Phase 4,Toxicology Report,Immune Response Pathway,Topical Gel,As prescribed,AstraZeneca,24,Low,High Risk,Moderate (50-80%),Slow,Renal,Suitable
Paracetamol,Gastric Ulcer,Parkinson's,64.98,C9H8O4,COX Inhibitor,Gastrointestinal Issues,1994,Acetylsalicylic Acid,Advil,Low Risk,Liver Metabolism,Phase 4,Animal Testing,PI3K-AKT Pathway,Syrup,10mg once daily,Novartis,12,Moderate,Moderate Risk,High (>80%),Fast,Renal,Not Suitable
Ranitidine,Blood Thinner,Liver Disease,62.41,C13H18O2,Proton Pump Inhibitor,Muscle Pain,1965,Ibuprofen,Advil,Moderate Risk,Rapid Absorption,Phase 3,No Preclinical Data,Dopaminergic Pathway,Capsule,250mg every 8 hours,Pfizer,6,Moderate,High Risk,Moderate (50-80%),Slow,Gut,Partially Suitable
Simvastatin,Acid Reflux,Parkinson's,92.75,C17H19N3O3S,HMG-CoA Reductase Inhibitor,"Headache, Rash",1996,Acetylsalicylic Acid,Prilosec,Low Risk,High Bioavailability,Phase 3,Toxicology Report,Immune Response Pathway,Topical Gel,10mg once daily,Roche,48,High,Moderate Risk,High (>80%),Slow,Renal,Partially Suitable
Levothyroxine,Inflammation,Cancer Therapy,83.26,C9H8O4,NSAID,Muscle Pain,1971,Omeprazole,Lipitor,High Risk,Rapid Absorption,Completed,Animal Testing,MAPK Pathway,Syrup,50mg daily,Roche,24,Moderate,High Risk,High (>80%),Fast,Gut,Not Suitable
Aspirin,Hypertension,Autoimmune Disorders,36.66,C9H8O4,NSAID,Acid Reflux,1965,Acetylsalicylic Acid,Aspirin,Moderate Risk,Renal Excretion,Phase 2,No Preclinical Data,Serotonin Pathway,Injection,250mg every 8 hours,Roche,2,Low,Low Risk,High (>80%),Moderate,Liver,Suitable
Metformin,Blood Thinner,Liver Disease,49.65,C17H19N3O3S,NSAID,Muscle Pain,1996,Ibuprofen,Lipitor,Moderate Risk,Renal Excretion,Ongoing,Toxicology Report,Dopaminergic Pathway,Tablet,250mg every 8 hours,AstraZeneca,48,High,High Risk,Moderate (50-80%),Moderate,Liver,Suitable
Ibuprofen,Diabetes,Antiviral,75.23,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1994,Metformin Hydrochloride,Lipitor,Moderate Risk,Liver Metabolism,Phase 3,No Preclinical Data,PI3K-AKT Pathway,Capsule,As prescribed,Novartis,24,High,High Risk,Low (<50%),Fast,Gut,Not Suitable
Atorvastatin,Cholesterol Control,Autoimmune Disorders,74.77,C9H8O4,HMG-CoA Reductase Inhibitor,Acid Reflux,1987,Acetylsalicylic Acid,Advil,High Risk,High Bioavailability,Ongoing,Animal Testing,Dopaminergic Pathway,Topical Gel,10mg once daily,Roche,48,Moderate,Moderate Risk,Moderate (50-80%),Fast,Liver,Partially Suitable
Omeprazole,Diabetes,Antiviral,49.4,C13H18O2,NSAID,Acid Reflux,1971,Metformin Hydrochloride,Aspirin,Low Risk,Renal Excretion,Phase 1,No Preclinical Data,Serotonin Pathway,Injection,50mg daily,Novartis,24,Low,High Risk,Moderate (50-80%),Fast,Renal,Suitable
Losartan,Hypertension,Anti-Aging,57.57,C13H18O2,NSAID,Gastrointestinal Issues,1994,Atorvastatin Calcium,Prilosec,Low Risk,High Bioavailability,Phase 4,No Preclinical Data,Dopaminergic Pathway,Capsule,250mg every 8 hours,Roche,24,Moderate,Moderate Risk,Low (<50%),Fast,Enzyme-Specific,Not Suitable
Paracetamol,Pain Relief,Weight Loss,67.56,C33H35FN2O5,AMPK Activator,Acid Reflux,1994,Atorvastatin Calcium,Glucophage,Low Risk,Slow Metabolism,Phase 3,Toxicology Report,MAPK Pathway,Injection,500mg twice a day,Merck,6,Low,Moderate Risk,High (>80%),Moderate,Enzyme-Specific,Not Suitable
Ranitidine,Blood Thinner,Cardiovascular Disease,87.7,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Muscle Pain,1971,Omeprazole,Advil,Low Risk,Rapid Absorption,Phase 2,In Vitro Studies,Immune Response Pathway,Syrup,50mg daily,Merck,24,High,Low Risk,High (>80%),Fast,Enzyme-Specific,Suitable
Simvastatin,Diabetes,Parkinson's,87.54,C9H8O4,Proton Pump Inhibitor,Acid Reflux,1994,Acetylsalicylic Acid,Glucophage,Moderate Risk,Renal Excretion,Completed,Animal Testing,PI3K-AKT Pathway,Injection,10mg once daily,Roche,12,Moderate,Moderate Risk,High (>80%),Fast,Renal,Not Suitable
Levothyroxine,Thyroid Hormone Replacement,Migraine Treatment,32.27,C33H35FN2O5,COX Inhibitor,Acid Reflux,1971,Acetylsalicylic Acid,Prilosec,Moderate Risk,Liver Metabolism,Phase 3,No Preclinical Data,Dopaminergic Pathway,Capsule,250mg every 8 hours,Roche,24,Low,High Risk,High (>80%),Fast,Gut,Not Suitable
Aspirin,Diabetes,Cardiovascular Disease,81.89,C4H11N5,Proton Pump Inhibitor,"Nausea, Dizziness",1994,Atorvastatin Calcium,Prilosec,Moderate Risk,Slow Metabolism,Phase 3,No Preclinical Data,Serotonin Pathway,Capsule,50mg daily,Roche,2,Low,Moderate Risk,Low (<50%),Moderate,Liver,Not Suitable
Metformin,Pain Relief,Cancer Therapy,79.79,C9H8O4,COX Inhibitor,"Nausea, Dizziness",1965,Ibuprofen,Aspirin,High Risk,Renal Excretion,Phase 4,No Preclinical Data,PI3K-AKT Pathway,Injection,50mg daily,Novartis,24,High,High Risk,Low (<50%),Fast,Gut,Partially Suitable
Ibuprofen,Hypertension,Migraine Treatment,90.09,C4H11N5,COX Inhibitor,Muscle Pain,1965,Omeprazole,Prilosec,High Risk,High Bioavailability,Phase 2,Animal Testing,PI3K-AKT Pathway,Injection,500mg twice a day,Merck,48,Moderate,Moderate Risk,Moderate (50-80%),Fast,Renal,Partially Suitable
Atorvastatin,Diabetes,Anti-Aging,65.62,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1996,Omeprazole,Prilosec,Moderate Risk,Liver Metabolism,Ongoing,No Preclinical Data,Dopaminergic Pathway,Topical Gel,250mg every 8 hours,Novartis,6,Moderate,Moderate Risk,High (>80%),Fast,Gut,Not Suitable
Omeprazole,Inflammation,Alzheimer's,48.58,C4H11N5,NSAID,Acid Reflux,1987,Atorvastatin Calcium,Glucophage,High Risk,Renal Excretion,Phase 4,Toxicology Report,Serotonin Pathway,Topical Gel,As prescribed,Pfizer,6,Low,Low Risk,Moderate (50-80%),Fast,Gut,Partially Suitable
Losartan,Diabetes,Autoimmune Disorders,70.4,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Muscle Pain,1965,Acetylsalicylic Acid,Advil,Low Risk,Renal Excretion,Phase 1,No Preclinical Data,MAPK Pathway,Injection,As prescribed,Novartis,24,Moderate,High Risk,Low (<50%),Moderate,Gut,Partially Suitable
Paracetamol,Gastric Ulcer,Liver Disease,45.12,C4H11N5,Proton Pump Inhibitor,Muscle Pain,1971,Metformin Hydrochloride,Aspirin,High Risk,Liver Metabolism,Phase 3,Animal Testing,Dopaminergic Pathway,Injection,10mg once daily,Merck,48,High,Moderate Risk,High (>80%),Slow,Enzyme-Specific,Not Suitable
Ranitidine,Pain Relief,Autoimmune Disorders,35.31,C33H35FN2O5,NSAID,Muscle Pain,1987,Ibuprofen,Advil,Moderate Risk,High Bioavailability,Phase 2,In Vitro Studies,Dopaminergic Pathway,Topical Gel,250mg every 8 hours,Merck,12,High,Low Risk,High (>80%),Moderate,Gut,Suitable
Simvastatin,Acid Reflux,Antiviral,64.88,C13H18O2,COX Inhibitor,"Headache, Rash",1994,Metformin Hydrochloride,Aspirin,Moderate Risk,High Bioavailability,Ongoing,Toxicology Report,Dopaminergic Pathway,Capsule,As prescribed,Novartis,12,Low,Moderate Risk,Moderate (50-80%),Fast,Gut,Suitable
Levothyroxine,Fever,Alzheimer's,71.41,C17H19N3O3S,NSAID,"Headache, Rash",1994,Metformin Hydrochloride,Prilosec,High Risk,Liver Metabolism,Phase 2,No Preclinical Data,Immune Response Pathway,Capsule,As prescribed,Pfizer,12,Moderate,Low Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Aspirin,Hypertension,Autoimmune Disorders,59.48,C33H35FN2O5,AMPK Activator,Muscle Pain,1987,Acetylsalicylic Acid,Advil,High Risk,High Bioavailability,Completed,Toxicology Report,Immune Response Pathway,Topical Gel,250mg every 8 hours,Merck,6,Moderate,High Risk,Moderate (50-80%),Slow,Gut,Not Suitable
Metformin,Thyroid Hormone Replacement,Liver Disease,60.94,C33H35FN2O5,AMPK Activator,Acid Reflux,1965,Ibuprofen,Glucophage,Low Risk,High Bioavailability,Phase 4,No Preclinical Data,Serotonin Pathway,Tablet,As prescribed,AstraZeneca,24,Moderate,Moderate Risk,High (>80%),Moderate,Gut,Suitable
Ibuprofen,Cholesterol Control,Cardiovascular Disease,84.12,C17H19N3O3S,AMPK Activator,"Nausea, Dizziness",1971,Atorvastatin Calcium,Glucophage,Low Risk,High Bioavailability,Completed,Animal Testing,MAPK Pathway,Capsule,10mg once daily,Pfizer,6,Low,High Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Partially Suitable
Atorvastatin,Thyroid Hormone Replacement,Autoimmune Disorders,54.76,C9H8O4,Proton Pump Inhibitor,Acid Reflux,1994,Acetylsalicylic Acid,Prilosec,Moderate Risk,Liver Metabolism,Phase 1,No Preclinical Data,Serotonin Pathway,Capsule,50mg daily,Novartis,48,Low,High Risk,Moderate (50-80%),Slow,Enzyme-Specific,Not Suitable
Omeprazole,Pain Relief,Autoimmune Disorders,46.29,C4H11N5,NSAID,Muscle Pain,1994,Atorvastatin Calcium,Advil,High Risk,Renal Excretion,Completed,No Preclinical Data,MAPK Pathway,Syrup,As prescribed,Merck,48,High,High Risk,High (>80%),Moderate,Liver,Not Suitable
Losartan,Acid Reflux,Antiviral,58.88,C9H8O4,NSAID,"Headache, Rash",1987,Acetylsalicylic Acid,Aspirin,Moderate Risk,Renal Excretion,Phase 3,Toxicology Report,Serotonin Pathway,Injection,50mg daily,Pfizer,12,Moderate,High Risk,Low (<50%),Slow,Gut,Not Suitable
Paracetamol,Blood Thinner,Alzheimer's,63.52,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1971,Metformin Hydrochloride,Glucophage,Moderate Risk,High Bioavailability,Phase 3,Toxicology Report,MAPK Pathway,Topical Gel,500mg twice a day,Novartis,24,High,High Risk,Moderate (50-80%),Slow,Gut,Not Suitable
Ranitidine,Blood Thinner,Migraine Treatment,80.19,C17H19N3O3S,COX Inhibitor,Muscle Pain,1971,Omeprazole,Aspirin,Low Risk,Renal Excretion,Phase 2,No Preclinical Data,PI3K-AKT Pathway,Tablet,As prescribed,Roche,12,Low,Low Risk,Low (<50%),Moderate,Gut,Not Suitable
Simvastatin,Cholesterol Control,Anti-Aging,94.91,C33H35FN2O5,Proton Pump Inhibitor,Muscle Pain,1994,Atorvastatin Calcium,Lipitor,High Risk,Rapid Absorption,Phase 4,Toxicology Report,Serotonin Pathway,Capsule,250mg every 8 hours,Pfizer,2,Moderate,High Risk,Low (<50%),Moderate,Enzyme-Specific,Not Suitable
Levothyroxine,Fever,Migraine Treatment,76.97,C4H11N5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1994,Metformin Hydrochloride,Lipitor,High Risk,Rapid Absorption,Completed,No Preclinical Data,Serotonin Pathway,Tablet,500mg twice a day,Merck,24,High,High Risk,Moderate (50-80%),Moderate,Renal,Not Suitable
Aspirin,Diabetes,Liver Disease,49.7,C4H11N5,NSAID,Muscle Pain,1994,Metformin Hydrochloride,Advil,Low Risk,Liver Metabolism,Phase 3,In Vitro Studies,Serotonin Pathway,Capsule,50mg daily,Roche,2,Moderate,High Risk,Low (<50%),Slow,Enzyme-Specific,Partially Suitable
Metformin,Hypertension,Anti-Aging,38.5,C9H8O4,HMG-CoA Reductase Inhibitor,Muscle Pain,1994,Acetylsalicylic Acid,Glucophage,Low Risk,Liver Metabolism,Phase 3,In Vitro Studies,Serotonin Pathway,Topical Gel,As prescribed,Roche,24,High,Low Risk,Low (<50%),Fast,Liver,Partially Suitable
Ibuprofen,Hypertension,Anti-Aging,60.28,C17H19N3O3S,COX Inhibitor,Acid Reflux,1965,Acetylsalicylic Acid,Advil,High Risk,High Bioavailability,Phase 4,Animal Testing,Immune Response Pathway,Syrup,250mg every 8 hours,Roche,48,High,Low Risk,High (>80%),Fast,Renal,Suitable
Atorvastatin,Pain Relief,Cancer Therapy,64.71,C13H18O2,NSAID,Acid Reflux,1965,Atorvastatin Calcium,Prilosec,Low Risk,Rapid Absorption,Phase 2,In Vitro Studies,MAPK Pathway,Tablet,500mg twice a day,Roche,6,Moderate,Moderate Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Omeprazole,Fever,Alzheimer's,82.92,C33H35FN2O5,NSAID,"Nausea, Dizziness",1965,Ibuprofen,Lipitor,Low Risk,Slow Metabolism,Ongoing,No Preclinical Data,Immune Response Pathway,Injection,50mg daily,AstraZeneca,24,Low,Moderate Risk,Moderate (50-80%),Slow,Liver,Suitable
Losartan,Diabetes,Autoimmune Disorders,66.6,C17H19N3O3S,AMPK Activator,"Nausea, Dizziness",1996,Acetylsalicylic Acid,Aspirin,Moderate Risk,Slow Metabolism,Phase 1,In Vitro Studies,Dopaminergic Pathway,Capsule,As prescribed,AstraZeneca,12,Low,High Risk,Moderate (50-80%),Fast,Renal,Partially Suitable
Paracetamol,Hypertension,Autoimmune Disorders,63.29,C33H35FN2O5,COX Inhibitor,"Headache, Rash",1971,Omeprazole,Glucophage,High Risk,Liver Metabolism,Phase 4,No Preclinical Data,MAPK Pathway,Topical Gel,500mg twice a day,Novartis,48,Low,Low Risk,High (>80%),Fast,Gut,Not Suitable
Ranitidine,Thyroid Hormone Replacement,Autoimmune Disorders,67.29,C17H19N3O3S,AMPK Activator,Gastrointestinal Issues,1994,Omeprazole,Lipitor,Moderate Risk,Rapid Absorption,Phase 4,Toxicology Report,Immune Response Pathway,Topical Gel,500mg twice a day,AstraZeneca,24,High,High Risk,Low (<50%),Fast,Enzyme-Specific,Partially Suitable
Simvastatin,Inflammation,Cancer Therapy,42.9,C17H19N3O3S,NSAID,"Nausea, Dizziness",1987,Acetylsalicylic Acid,Lipitor,Moderate Risk,Liver Metabolism,Phase 2,In Vitro Studies,Dopaminergic Pathway,Injection,10mg once daily,AstraZeneca,12,Moderate,Moderate Risk,High (>80%),Moderate,Renal,Partially Suitable
Levothyroxine,Diabetes,Antiviral,64.9,C33H35FN2O5,AMPK Activator,Muscle Pain,1994,Omeprazole,Glucophage,High Risk,High Bioavailability,Phase 1,No Preclinical Data,MAPK Pathway,Syrup,10mg once daily,Merck,12,High,High Risk,Moderate (50-80%),Fast,Liver,Partially Suitable
Aspirin,Cholesterol Control,Antiviral,83.59,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1971,Atorvastatin Calcium,Lipitor,High Risk,Liver Metabolism,Completed,In Vitro Studies,PI3K-AKT Pathway,Capsule,10mg once daily,Pfizer,12,High,High Risk,High (>80%),Moderate,Gut,Suitable
Metformin,Hypertension,Weight Loss,69.81,C4H11N5,HMG-CoA Reductase Inhibitor,Muscle Pain,1965,Omeprazole,Lipitor,Low Risk,Slow Metabolism,Phase 3,In Vitro Studies,Dopaminergic Pathway,Topical Gel,250mg every 8 hours,Novartis,48,Low,High Risk,Moderate (50-80%),Fast,Gut,Suitable
Ibuprofen,Gastric Ulcer,Weight Loss,83.66,C13H18O2,AMPK Activator,Muscle Pain,1965,Ibuprofen,Aspirin,Moderate Risk,Liver Metabolism,Completed,Animal Testing,PI3K-AKT Pathway,Capsule,50mg daily,Roche,12,Low,Low Risk,High (>80%),Fast,Gut,Partially Suitable
Atorvastatin,Diabetes,Weight Loss,46.09,C4H11N5,COX Inhibitor,"Headache, Rash",1996,Ibuprofen,Glucophage,Moderate Risk,Rapid Absorption,Phase 1,Animal Testing,PI3K-AKT Pathway,Capsule,50mg daily,Novartis,12,High,High Risk,High (>80%),Slow,Renal,Not Suitable
Omeprazole,Thyroid Hormone Replacement,Cancer Therapy,84.39,C33H35FN2O5,NSAID,Acid Reflux,1971,Ibuprofen,Lipitor,Moderate Risk,Liver Metabolism,Phase 1,No Preclinical Data,PI3K-AKT Pathway,Topical Gel,50mg daily,Roche,48,Moderate,Low Risk,High (>80%),Fast,Renal,Not Suitable
Losartan,Gastric Ulcer,Migraine Treatment,85.75,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Acid Reflux,1987,Omeprazole,Prilosec,Moderate Risk,High Bioavailability,Phase 3,No Preclinical Data,Dopaminergic Pathway,Tablet,250mg every 8 hours,Pfizer,24,High,Low Risk,Moderate (50-80%),Moderate,Renal,Not Suitable
Paracetamol,Acid Reflux,Cancer Therapy,56.5,C17H19N3O3S,AMPK Activator,"Nausea, Dizziness",1996,Acetylsalicylic Acid,Lipitor,Low Risk,Renal Excretion,Ongoing,In Vitro Studies,Immune Response Pathway,Injection,250mg every 8 hours,Merck,6,High,Low Risk,Low (<50%),Slow,Renal,Not Suitable
Ranitidine,Thyroid Hormone Replacement,Antiviral,60.24,C9H8O4,COX Inhibitor,"Headache, Rash",1987,Ibuprofen,Prilosec,High Risk,Slow Metabolism,Phase 3,Animal Testing,Dopaminergic Pathway,Syrup,10mg once daily,Pfizer,12,High,High Risk,Low (<50%),Slow,Gut,Not Suitable
Simvastatin,Hypertension,Cancer Therapy,50.83,C9H8O4,NSAID,Acid Reflux,1994,Omeprazole,Glucophage,Moderate Risk,Renal Excretion,Ongoing,Toxicology Report,Immune Response Pathway,Tablet,50mg daily,Pfizer,48,Moderate,Moderate Risk,High (>80%),Moderate,Gut,Not Suitable
Levothyroxine,Fever,Parkinson's,94.57,C4H11N5,COX Inhibitor,Gastrointestinal Issues,1996,Acetylsalicylic Acid,Prilosec,High Risk,Slow Metabolism,Ongoing,No Preclinical Data,MAPK Pathway,Tablet,500mg twice a day,Roche,48,High,Moderate Risk,High (>80%),Fast,Renal,Not Suitable
Aspirin,Inflammation,Antiviral,65.19,C4H11N5,NSAID,Acid Reflux,1965,Acetylsalicylic Acid,Lipitor,Moderate Risk,Rapid Absorption,Phase 1,Animal Testing,Dopaminergic Pathway,Syrup,500mg twice a day,Merck,12,High,High Risk,Moderate (50-80%),Fast,Renal,Partially Suitable
Metformin,Diabetes,Autoimmune Disorders,35.19,C13H18O2,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1965,Acetylsalicylic Acid,Aspirin,High Risk,Liver Metabolism,Phase 1,In Vitro Studies,PI3K-AKT Pathway,Tablet,10mg once daily,Pfizer,2,Low,Low Risk,Moderate (50-80%),Slow,Gut,Not Suitable
Ibuprofen,Thyroid Hormone Replacement,Alzheimer's,92.17,C4H11N5,Proton Pump Inhibitor,"Headache, Rash",1987,Atorvastatin Calcium,Aspirin,High Risk,Renal Excretion,Phase 1,Animal Testing,Serotonin Pathway,Injection,250mg every 8 hours,Merck,48,Low,High Risk,High (>80%),Slow,Renal,Not Suitable
Atorvastatin,Fever,Migraine Treatment,52.43,C9H8O4,COX Inhibitor,"Nausea, Dizziness",1965,Omeprazole,Glucophage,Low Risk,Liver Metabolism,Phase 2,No Preclinical Data,MAPK Pathway,Capsule,10mg once daily,Merck,2,Low,High Risk,High (>80%),Moderate,Liver,Suitable
Omeprazole,Cholesterol Control,Autoimmune Disorders,34.4,C4H11N5,COX Inhibitor,Acid Reflux,1994,Ibuprofen,Glucophage,High Risk,High Bioavailability,Phase 4,In Vitro Studies,Dopaminergic Pathway,Tablet,250mg every 8 hours,Merck,12,High,High Risk,Moderate (50-80%),Moderate,Renal,Not Suitable
Losartan,Cholesterol Control,Antiviral,41.47,C9H8O4,HMG-CoA Reductase Inhibitor,Acid Reflux,1994,Ibuprofen,Advil,Moderate Risk,Rapid Absorption,Phase 1,Toxicology Report,PI3K-AKT Pathway,Injection,10mg once daily,Roche,12,High,Low Risk,Moderate (50-80%),Fast,Gut,Suitable
Paracetamol,Thyroid Hormone Replacement,Anti-Aging,35.95,C13H18O2,COX Inhibitor,Gastrointestinal Issues,1965,Atorvastatin Calcium,Prilosec,High Risk,Renal Excretion,Ongoing,No Preclinical Data,Dopaminergic Pathway,Syrup,10mg once daily,Roche,2,Moderate,High Risk,Moderate (50-80%),Moderate,Gut,Partially Suitable
Ranitidine,Cholesterol Control,Autoimmune Disorders,67.19,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1994,Omeprazole,Glucophage,Low Risk,Liver Metabolism,Ongoing,Toxicology Report,Dopaminergic Pathway,Capsule,250mg every 8 hours,Novartis,24,Low,Low Risk,Low (<50%),Fast,Gut,Not Suitable
Simvastatin,Inflammation,Cardiovascular Disease,32.8,C33H35FN2O5,Proton Pump Inhibitor,"Headache, Rash",1971,Omeprazole,Advil,High Risk,Renal Excretion,Phase 1,In Vitro Studies,Immune Response Pathway,Injection,250mg every 8 hours,Novartis,2,Low,Moderate Risk,Low (<50%),Moderate,Gut,Suitable
Levothyroxine,Acid Reflux,Autoimmune Disorders,65.76,C13H18O2,AMPK Activator,Muscle Pain,1996,Ibuprofen,Aspirin,Low Risk,Slow Metabolism,Phase 4,No Preclinical Data,Immune Response Pathway,Topical Gel,500mg twice a day,Merck,6,Moderate,Moderate Risk,High (>80%),Slow,Renal,Not Suitable
Aspirin,Inflammation,Autoimmune Disorders,72.77,C9H8O4,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1965,Metformin Hydrochloride,Lipitor,High Risk,Rapid Absorption,Completed,Animal Testing,Dopaminergic Pathway,Syrup,As prescribed,Novartis,24,High,Moderate Risk,Low (<50%),Moderate,Liver,Suitable
Metformin,Acid Reflux,Cardiovascular Disease,77.04,C13H18O2,COX Inhibitor,Gastrointestinal Issues,1994,Acetylsalicylic Acid,Glucophage,Low Risk,Rapid Absorption,Phase 2,Animal Testing,Dopaminergic Pathway,Injection,250mg every 8 hours,Merck,2,High,Moderate Risk,Low (<50%),Fast,Renal,Partially Suitable
Ibuprofen,Inflammation,Cardiovascular Disease,91.06,C17H19N3O3S,NSAID,Gastrointestinal Issues,1965,Metformin Hydrochloride,Advil,Moderate Risk,Slow Metabolism,Phase 2,No Preclinical Data,MAPK Pathway,Capsule,10mg once daily,Roche,6,High,Moderate Risk,High (>80%),Fast,Gut,Suitable
Atorvastatin,Blood Thinner,Cancer Therapy,39.84,C9H8O4,Proton Pump Inhibitor,"Nausea, Dizziness",1971,Omeprazole,Glucophage,Low Risk,Slow Metabolism,Ongoing,Toxicology Report,PI3K-AKT Pathway,Injection,500mg twice a day,Roche,6,High,High Risk,High (>80%),Slow,Gut,Partially Suitable
Omeprazole,Thyroid Hormone Replacement,Autoimmune Disorders,50.99,C33H35FN2O5,AMPK Activator,"Nausea, Dizziness",1996,Ibuprofen,Prilosec,Moderate Risk,Slow Metabolism,Completed,In Vitro Studies,PI3K-AKT Pathway,Syrup,50mg daily,Merck,6,Moderate,Moderate Risk,Low (<50%),Slow,Gut,Suitable
Losartan,Cholesterol Control,Migraine Treatment,49.44,C13H18O2,AMPK Activator,"Nausea, Dizziness",1996,Acetylsalicylic Acid,Lipitor,High Risk,High Bioavailability,Phase 4,In Vitro Studies,Serotonin Pathway,Capsule,500mg twice a day,Merck,12,Moderate,Low Risk,Low (<50%),Slow,Gut,Suitable
Paracetamol,Diabetes,Cardiovascular Disease,50.38,C17H19N3O3S,HMG-CoA Reductase Inhibitor,"Headache, Rash",1996,Atorvastatin Calcium,Lipitor,Moderate Risk,Rapid Absorption,Phase 2,No Preclinical Data,MAPK Pathway,Syrup,10mg once daily,Roche,48,Low,High Risk,Low (<50%),Fast,Liver,Not Suitable
Ranitidine,Fever,Weight Loss,50.79,C13H18O2,AMPK Activator,"Headache, Rash",1971,Atorvastatin Calcium,Advil,High Risk,Rapid Absorption,Ongoing,Animal Testing,Dopaminergic Pathway,Syrup,500mg twice a day,AstraZeneca,48,High,Low Risk,High (>80%),Slow,Renal,Not Suitable
Simvastatin,Pain Relief,Autoimmune Disorders,50.09,C9H8O4,AMPK Activator,Gastrointestinal Issues,1971,Atorvastatin Calcium,Glucophage,Low Risk,High Bioavailability,Completed,No Preclinical Data,PI3K-AKT Pathway,Injection,500mg twice a day,AstraZeneca,24,Moderate,Low Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Not Suitable
Levothyroxine,Hypertension,Liver Disease,58.73,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1994,Atorvastatin Calcium,Lipitor,Moderate Risk,High Bioavailability,Phase 3,No Preclinical Data,PI3K-AKT Pathway,Topical Gel,10mg once daily,Pfizer,6,Low,Moderate Risk,Low (<50%),Fast,Enzyme-Specific,Partially Suitable
Aspirin,Inflammation,Autoimmune Disorders,31.88,C4H11N5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1971,Metformin Hydrochloride,Lipitor,High Risk,Slow Metabolism,Phase 2,Animal Testing,Serotonin Pathway,Tablet,As prescribed,Pfizer,24,Moderate,Low Risk,Low (<50%),Slow,Enzyme-Specific,Not Suitable
Metformin,Cholesterol Control,Parkinson's,78.85,C9H8O4,AMPK Activator,Acid Reflux,1987,Ibuprofen,Prilosec,Moderate Risk,Liver Metabolism,Ongoing,In Vitro Studies,MAPK Pathway,Topical Gel,50mg daily,AstraZeneca,48,Moderate,High Risk,High (>80%),Moderate,Enzyme-Specific,Not Suitable
Ibuprofen,Thyroid Hormone Replacement,Autoimmune Disorders,85.96,C17H19N3O3S,AMPK Activator,Gastrointestinal Issues,1996,Omeprazole,Aspirin,High Risk,Rapid Absorption,Phase 3,Animal Testing,Serotonin Pathway,Capsule,As prescribed,AstraZeneca,24,Moderate,High Risk,High (>80%),Fast,Liver,Partially Suitable
Atorvastatin,Diabetes,Alzheimer's,56.4,C17H19N3O3S,Proton Pump Inhibitor,Acid Reflux,1996,Ibuprofen,Advil,Moderate Risk,Slow Metabolism,Phase 1,No Preclinical Data,Dopaminergic Pathway,Injection,500mg twice a day,Novartis,24,Moderate,High Risk,High (>80%),Fast,Renal,Not Suitable
Omeprazole,Hypertension,Cancer Therapy,40.15,C9H8O4,COX Inhibitor,"Nausea, Dizziness",1987,Atorvastatin Calcium,Glucophage,Low Risk,Renal Excretion,Completed,Toxicology Report,Dopaminergic Pathway,Topical Gel,250mg every 8 hours,AstraZeneca,12,High,High Risk,Moderate (50-80%),Fast,Renal,Suitable
Losartan,Pain Relief,Cardiovascular Disease,42.66,C17H19N3O3S,COX Inhibitor,"Headache, Rash",1994,Ibuprofen,Lipitor,High Risk,High Bioavailability,Phase 1,Animal Testing,Serotonin Pathway,Capsule,50mg daily,Pfizer,48,Moderate,Moderate Risk,Low (<50%),Fast,Liver,Not Suitable
Paracetamol,Inflammation,Migraine Treatment,88.81,C13H18O2,AMPK Activator,"Nausea, Dizziness",1987,Atorvastatin Calcium,Lipitor,High Risk,Slow Metabolism,Ongoing,No Preclinical Data,PI3K-AKT Pathway,Syrup,10mg once daily,Roche,12,Low,Moderate Risk,Low (<50%),Slow,Enzyme-Specific,Partially Suitable
Ranitidine,Cholesterol Control,Autoimmune Disorders,62.31,C4H11N5,NSAID,"Headache, Rash",1987,Atorvastatin Calcium,Glucophage,High Risk,High Bioavailability,Phase 2,No Preclinical Data,MAPK Pathway,Topical Gel,As prescribed,Roche,12,Low,High Risk,High (>80%),Moderate,Renal,Not Suitable
Simvastatin,Blood Thinner,Parkinson's,52.31,C33H35FN2O5,AMPK Activator,"Nausea, Dizziness",1987,Metformin Hydrochloride,Advil,Moderate Risk,High Bioavailability,Phase 2,Animal Testing,Serotonin Pathway,Capsule,10mg once daily,AstraZeneca,2,Low,Moderate Risk,Low (<50%),Fast,Liver,Not Suitable
Levothyroxine,Thyroid Hormone Replacement,Weight Loss,93.9,C17H19N3O3S,NSAID,Acid Reflux,1971,Metformin Hydrochloride,Lipitor,Low Risk,Liver Metabolism,Phase 3,Toxicology Report,Dopaminergic Pathway,Topical Gel,50mg daily,AstraZeneca,12,Moderate,High Risk,High (>80%),Slow,Renal,Not Suitable
Aspirin,Fever,Anti-Aging,85.12,C13H18O2,AMPK Activator,Gastrointestinal Issues,1971,Acetylsalicylic Acid,Prilosec,Moderate Risk,Renal Excretion,Phase 2,Animal Testing,Immune Response Pathway,Injection,250mg every 8 hours,Novartis,12,High,Low Risk,Low (<50%),Moderate,Gut,Suitable
Metformin,Diabetes,Liver Disease,53.52,C9H8O4,COX Inhibitor,Acid Reflux,1996,Ibuprofen,Advil,Moderate Risk,Renal Excretion,Phase 1,Animal Testing,Serotonin Pathway,Topical Gel,250mg every 8 hours,Pfizer,6,Low,High Risk,High (>80%),Fast,Enzyme-Specific,Suitable
Ibuprofen,Gastric Ulcer,Parkinson's,75.11,C13H18O2,AMPK Activator,Acid Reflux,1965,Atorvastatin Calcium,Glucophage,Low Risk,Renal Excretion,Completed,Animal Testing,Serotonin Pathway,Syrup,As prescribed,Novartis,6,Moderate,Moderate Risk,Moderate (50-80%),Moderate,Liver,Suitable
Atorvastatin,Gastric Ulcer,Migraine Treatment,46.71,C17H19N3O3S,AMPK Activator,Muscle Pain,1987,Metformin Hydrochloride,Lipitor,High Risk,High Bioavailability,Phase 1,Toxicology Report,MAPK Pathway,Topical Gel,10mg once daily,Merck,6,Moderate,Moderate Risk,Moderate (50-80%),Fast,Gut,Partially Suitable
Omeprazole,Fever,Autoimmune Disorders,76.73,C33H35FN2O5,AMPK Activator,Muscle Pain,1996,Ibuprofen,Glucophage,Low Risk,Renal Excretion,Phase 1,No Preclinical Data,Immune Response Pathway,Injection,500mg twice a day,Merck,48,High,High Risk,High (>80%),Moderate,Renal,Partially Suitable
Losartan,Diabetes,Autoimmune Disorders,57.47,C13H18O2,COX Inhibitor,"Headache, Rash",1987,Omeprazole,Advil,Low Risk,Slow Metabolism,Phase 2,No Preclinical Data,Immune Response Pathway,Topical Gel,As prescribed,Novartis,48,Moderate,High Risk,High (>80%),Fast,Renal,Suitable
Paracetamol,Hypertension,Migraine Treatment,48.85,C17H19N3O3S,AMPK Activator,"Nausea, Dizziness",1971,Atorvastatin Calcium,Aspirin,High Risk,Slow Metabolism,Phase 3,Animal Testing,MAPK Pathway,Topical Gel,10mg once daily,Novartis,2,Moderate,Moderate Risk,Low (<50%),Moderate,Renal,Suitable
Ranitidine,Blood Thinner,Liver Disease,49.19,C17H19N3O3S,Proton Pump Inhibitor,"Nausea, Dizziness",1996,Acetylsalicylic Acid,Advil,Moderate Risk,Liver Metabolism,Completed,Animal Testing,MAPK Pathway,Injection,As prescribed,Pfizer,2,High,High Risk,Low (<50%),Fast,Gut,Not Suitable
Simvastatin,Pain Relief,Antiviral,64.46,C9H8O4,Proton Pump Inhibitor,"Headache, Rash",1987,Acetylsalicylic Acid,Advil,Low Risk,Slow Metabolism,Phase 1,Toxicology Report,Immune Response Pathway,Capsule,As prescribed,AstraZeneca,48,Moderate,Moderate Risk,Moderate (50-80%),Slow,Enzyme-Specific,Not Suitable
Levothyroxine,Fever,Migraine Treatment,63.95,C9H8O4,COX Inhibitor,"Headache, Rash",1971,Acetylsalicylic Acid,Advil,High Risk,High Bioavailability,Phase 3,No Preclinical Data,Dopaminergic Pathway,Topical Gel,10mg once daily,Merck,24,Moderate,Low Risk,High (>80%),Fast,Enzyme-Specific,Not Suitable
Aspirin,Inflammation,Liver Disease,38.73,C17H19N3O3S,NSAID,Muscle Pain,1971,Omeprazole,Aspirin,Moderate Risk,High Bioavailability,Phase 3,In Vitro Studies,Dopaminergic Pathway,Tablet,500mg twice a day,Pfizer,2,Moderate,High Risk,Moderate (50-80%),Slow,Enzyme-Specific,Suitable
Metformin,Pain Relief,Autoimmune Disorders,36.87,C13H18O2,AMPK Activator,Gastrointestinal Issues,1996,Omeprazole,Advil,High Risk,Renal Excretion,Completed,In Vitro Studies,Immune Response Pathway,Injection,As prescribed,Novartis,2,Low,High Risk,High (>80%),Moderate,Renal,Not Suitable
Ibuprofen,Thyroid Hormone Replacement,Autoimmune Disorders,41.1,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1994,Acetylsalicylic Acid,Glucophage,Moderate Risk,Liver Metabolism,Ongoing,Toxicology Report,Serotonin Pathway,Tablet,As prescribed,Merck,24,Low,Low Risk,Moderate (50-80%),Fast,Enzyme-Specific,Partially Suitable
Atorvastatin,Inflammation,Antiviral,62.63,C13H18O2,NSAID,"Headache, Rash",1987,Acetylsalicylic Acid,Advil,High Risk,Slow Metabolism,Phase 2,Animal Testing,PI3K-AKT Pathway,Syrup,50mg daily,Pfizer,48,Moderate,Low Risk,Moderate (50-80%),Fast,Renal,Suitable
Omeprazole,Fever,Parkinson's,93.08,C13H18O2,AMPK Activator,Acid Reflux,1996,Metformin Hydrochloride,Prilosec,High Risk,Renal Excretion,Ongoing,Animal Testing,Serotonin Pathway,Tablet,50mg daily,Pfizer,6,High,Moderate Risk,High (>80%),Moderate,Liver,Not Suitable
Losartan,Thyroid Hormone Replacement,Cardiovascular Disease,43.96,C17H19N3O3S,NSAID,"Headache, Rash",1994,Metformin Hydrochloride,Aspirin,Moderate Risk,High Bioavailability,Phase 2,Toxicology Report,Immune Response Pathway,Injection,250mg every 8 hours,Pfizer,48,Low,Low Risk,Moderate (50-80%),Slow,Enzyme-Specific,Partially Suitable
Paracetamol,Cholesterol Control,Migraine Treatment,65.4,C33H35FN2O5,Proton Pump Inhibitor,"Headache, Rash",1987,Metformin Hydrochloride,Aspirin,High Risk,Slow Metabolism,Phase 1,No Preclinical Data,PI3K-AKT Pathway,Capsule,10mg once daily,Merck,2,High,Moderate Risk,High (>80%),Slow,Gut,Partially Suitable
Ranitidine,Inflammation,Alzheimer's,91.93,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1971,Atorvastatin Calcium,Aspirin,Moderate Risk,Slow Metabolism,Ongoing,Animal Testing,Immune Response Pathway,Capsule,250mg every 8 hours,Roche,24,Low,High Risk,High (>80%),Fast,Renal,Suitable
Simvastatin,Hypertension,Anti-Aging,67.73,C9H8O4,COX Inhibitor,Gastrointestinal Issues,1987,Acetylsalicylic Acid,Aspirin,High Risk,Renal Excretion,Ongoing,Animal Testing,Immune Response Pathway,Capsule,10mg once daily,AstraZeneca,12,Low,Moderate Risk,Moderate (50-80%),Moderate,Renal,Partially Suitable
Levothyroxine,Inflammation,Autoimmune Disorders,32.97,C4H11N5,COX Inhibitor,"Nausea, Dizziness",1987,Omeprazole,Lipitor,Low Risk,Renal Excretion,Completed,Toxicology Report,Immune Response Pathway,Topical Gel,500mg twice a day,AstraZeneca,6,Moderate,High Risk,Moderate (50-80%),Moderate,Liver,Suitable
Aspirin,Fever,Alzheimer's,69.06,C4H11N5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1996,Atorvastatin Calcium,Aspirin,Moderate Risk,High Bioavailability,Phase 2,Animal Testing,PI3K-AKT Pathway,Capsule,As prescribed,Pfizer,48,High,Low Risk,High (>80%),Fast,Renal,Suitable
Metformin,Blood Thinner,Parkinson's,57.36,C4H11N5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1971,Atorvastatin Calcium,Aspirin,Moderate Risk,High Bioavailability,Phase 3,No Preclinical Data,PI3K-AKT Pathway,Capsule,As prescribed,Novartis,2,Low,Low Risk,Low (<50%),Fast,Enzyme-Specific,Suitable
Ibuprofen,Pain Relief,Migraine Treatment,38.51,C4H11N5,AMPK Activator,Acid Reflux,1965,Omeprazole,Aspirin,High Risk,Liver Metabolism,Phase 4,In Vitro Studies,Dopaminergic Pathway,Topical Gel,500mg twice a day,Pfizer,12,High,Low Risk,Moderate (50-80%),Moderate,Renal,Not Suitable
Atorvastatin,Gastric Ulcer,Migraine Treatment,86.62,C13H18O2,Proton Pump Inhibitor,"Headache, Rash",1994,Metformin Hydrochloride,Glucophage,High Risk,Rapid Absorption,Phase 1,In Vitro Studies,Dopaminergic Pathway,Injection,500mg twice a day,AstraZeneca,12,Moderate,Low Risk,Moderate (50-80%),Fast,Enzyme-Specific,Suitable
Omeprazole,Hypertension,Antiviral,80.09,C33H35FN2O5,Proton Pump Inhibitor,"Headache, Rash",1965,Atorvastatin Calcium,Lipitor,High Risk,Liver Metabolism,Phase 2,No Preclinical Data,PI3K-AKT Pathway,Injection,As prescribed,AstraZeneca,24,High,Moderate Risk,Low (<50%),Fast,Renal,Partially Suitable
Losartan,Gastric Ulcer,Liver Disease,71.31,C33H35FN2O5,Proton Pump Inhibitor,"Nausea, Dizziness",1971,Ibuprofen,Lipitor,Moderate Risk,Slow Metabolism,Completed,Animal Testing,MAPK Pathway,Capsule,50mg daily,AstraZeneca,48,High,High Risk,Moderate (50-80%),Fast,Liver,Suitable
Paracetamol,Gastric Ulcer,Parkinson's,32.3,C13H18O2,HMG-CoA Reductase Inhibitor,Muscle Pain,1994,Metformin Hydrochloride,Advil,High Risk,Slow Metabolism,Completed,Toxicology Report,PI3K-AKT Pathway,Topical Gel,500mg twice a day,Roche,12,High,High Risk,High (>80%),Moderate,Gut,Not Suitable
Ranitidine,Diabetes,Parkinson's,57.68,C33H35FN2O5,Proton Pump Inhibitor,Gastrointestinal Issues,1965,Ibuprofen,Lipitor,Moderate Risk,Liver Metabolism,Phase 1,Toxicology Report,Serotonin Pathway,Injection,500mg twice a day,Roche,2,High,High Risk,Low (<50%),Slow,Liver,Partially Suitable
Simvastatin,Acid Reflux,Parkinson's,33.73,C9H8O4,Proton Pump Inhibitor,"Headache, Rash",1994,Metformin Hydrochloride,Lipitor,Low Risk,Slow Metabolism,Phase 2,Toxicology Report,Serotonin Pathway,Capsule,500mg twice a day,Novartis,6,Moderate,Moderate Risk,Moderate (50-80%),Slow,Liver,Suitable
Levothyroxine,Cholesterol Control,Migraine Treatment,82.31,C17H19N3O3S,AMPK Activator,Muscle Pain,1971,Metformin Hydrochloride,Advil,High Risk,Rapid Absorption,Completed,Toxicology Report,MAPK Pathway,Capsule,250mg every 8 hours,Roche,2,Low,Low Risk,Moderate (50-80%),Fast,Enzyme-Specific,Partially Suitable
Aspirin,Thyroid Hormone Replacement,Cancer Therapy,44.14,C13H18O2,AMPK Activator,Muscle Pain,1996,Atorvastatin Calcium,Glucophage,High Risk,Rapid Absorption,Phase 3,Toxicology Report,Immune Response Pathway,Tablet,250mg every 8 hours,AstraZeneca,48,Low,Moderate Risk,High (>80%),Fast,Renal,Suitable
Metformin,Thyroid Hormone Replacement,Autoimmune Disorders,88.71,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1987,Atorvastatin Calcium,Glucophage,High Risk,Slow Metabolism,Ongoing,In Vitro Studies,MAPK Pathway,Tablet,As prescribed,AstraZeneca,6,Moderate,Moderate Risk,High (>80%),Moderate,Gut,Not Suitable
Ibuprofen,Hypertension,Cancer Therapy,60.26,C13H18O2,HMG-CoA Reductase Inhibitor,Muscle Pain,1971,Atorvastatin Calcium,Advil,Moderate Risk,Renal Excretion,Ongoing,Toxicology Report,Dopaminergic Pathway,Capsule,10mg once daily,Merck,6,Low,High Risk,Moderate (50-80%),Moderate,Liver,Partially Suitable
Atorvastatin,Fever,Migraine Treatment,63.6,C17H19N3O3S,COX Inhibitor,Muscle Pain,1965,Atorvastatin Calcium,Prilosec,High Risk,Renal Excretion,Ongoing,Toxicology Report,Serotonin Pathway,Injection,As prescribed,AstraZeneca,6,High,Moderate Risk,Low (<50%),Moderate,Liver,Suitable
Omeprazole,Diabetes,Cancer Therapy,46.62,C13H18O2,Proton Pump Inhibitor,Acid Reflux,1965,Acetylsalicylic Acid,Lipitor,Moderate Risk,Liver Metabolism,Phase 1,Toxicology Report,MAPK Pathway,Topical Gel,500mg twice a day,Roche,2,Low,Low Risk,Moderate (50-80%),Moderate,Gut,Suitable
Losartan,Hypertension,Cardiovascular Disease,43.12,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1994,Ibuprofen,Glucophage,Low Risk,Rapid Absorption,Phase 1,Toxicology Report,Immune Response Pathway,Injection,10mg once daily,Pfizer,48,Low,Moderate Risk,High (>80%),Slow,Enzyme-Specific,Not Suitable
Paracetamol,Gastric Ulcer,Anti-Aging,56.58,C4H11N5,AMPK Activator,Acid Reflux,1987,Metformin Hydrochloride,Aspirin,Moderate Risk,Liver Metabolism,Phase 2,In Vitro Studies,MAPK Pathway,Tablet,As prescribed,Pfizer,24,Low,High Risk,High (>80%),Fast,Renal,Suitable
Ranitidine,Cholesterol Control,Antiviral,56.78,C33H35FN2O5,NSAID,Muscle Pain,1971,Atorvastatin Calcium,Aspirin,Moderate Risk,Renal Excretion,Completed,Animal Testing,Serotonin Pathway,Tablet,250mg every 8 hours,AstraZeneca,6,Moderate,Low Risk,Low (<50%),Moderate,Enzyme-Specific,Not Suitable
Simvastatin,Pain Relief,Weight Loss,75.7,C4H11N5,HMG-CoA Reductase Inhibitor,Acid Reflux,1965,Ibuprofen,Aspirin,High Risk,Renal Excretion,Phase 1,Animal Testing,Immune Response Pathway,Injection,As prescribed,Merck,24,High,Low Risk,High (>80%),Fast,Enzyme-Specific,Suitable
Levothyroxine,Inflammation,Parkinson's,41.01,C4H11N5,NSAID,"Nausea, Dizziness",1994,Omeprazole,Prilosec,Moderate Risk,High Bioavailability,Phase 2,No Preclinical Data,Dopaminergic Pathway,Syrup,500mg twice a day,Pfizer,48,High,High Risk,Moderate (50-80%),Slow,Renal,Partially Suitable
Aspirin,Thyroid Hormone Replacement,Alzheimer's,47.27,C4H11N5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1994,Acetylsalicylic Acid,Lipitor,High Risk,High Bioavailability,Completed,Toxicology Report,Serotonin Pathway,Injection,10mg once daily,Pfizer,6,Low,Moderate Risk,Low (<50%),Slow,Renal,Not Suitable
Metformin,Blood Thinner,Autoimmune Disorders,77.16,C4H11N5,Proton Pump Inhibitor,Gastrointestinal Issues,1971,Atorvastatin Calcium,Aspirin,High Risk,Renal Excretion,Phase 1,Toxicology Report,Serotonin Pathway,Capsule,500mg twice a day,Novartis,24,Moderate,Moderate Risk,Low (<50%),Moderate,Renal,Partially Suitable
Ibuprofen,Diabetes,Cardiovascular Disease,89.28,C9H8O4,COX Inhibitor,"Headache, Rash",1965,Omeprazole,Prilosec,Moderate Risk,Renal Excretion,Phase 3,In Vitro Studies,Dopaminergic Pathway,Injection,250mg every 8 hours,Pfizer,48,Low,Low Risk,High (>80%),Moderate,Gut,Suitable
Atorvastatin,Diabetes,Alzheimer's,61.28,C33H35FN2O5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1994,Metformin Hydrochloride,Prilosec,Low Risk,Renal Excretion,Phase 1,Toxicology Report,Dopaminergic Pathway,Capsule,10mg once daily,Merck,2,Low,Low Risk,High (>80%),Fast,Gut,Not Suitable
Omeprazole,Cholesterol Control,Liver Disease,70.23,C17H19N3O3S,COX Inhibitor,Acid Reflux,1996,Metformin Hydrochloride,Advil,Moderate Risk,Liver Metabolism,Phase 4,In Vitro Studies,PI3K-AKT Pathway,Tablet,50mg daily,Pfizer,24,Moderate,High Risk,Moderate (50-80%),Slow,Gut,Partially Suitable
Losartan,Hypertension,Autoimmune Disorders,73.67,C4H11N5,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1994,Omeprazole,Advil,Moderate Risk,Liver Metabolism,Phase 4,In Vitro Studies,Immune Response Pathway,Injection,500mg twice a day,AstraZeneca,12,High,Low Risk,Low (<50%),Slow,Gut,Partially Suitable
Paracetamol,Acid Reflux,Parkinson's,32.82,C17H19N3O3S,NSAID,"Headache, Rash",1996,Atorvastatin Calcium,Glucophage,High Risk,Renal Excretion,Ongoing,No Preclinical Data,Dopaminergic Pathway,Syrup,As prescribed,Merck,2,Low,Moderate Risk,Low (<50%),Moderate,Renal,Not Suitable
Ranitidine,Inflammation,Cardiovascular Disease,70.86,C4H11N5,COX Inhibitor,Acid Reflux,1987,Acetylsalicylic Acid,Advil,Low Risk,Rapid Absorption,Phase 1,No Preclinical Data,Serotonin Pathway,Tablet,As prescribed,AstraZeneca,12,High,Moderate Risk,Moderate (50-80%),Fast,Enzyme-Specific,Partially Suitable
Simvastatin,Inflammation,Liver Disease,42.15,C17H19N3O3S,HMG-CoA Reductase Inhibitor,"Headache, Rash",1971,Ibuprofen,Prilosec,Low Risk,High Bioavailability,Completed,No Preclinical Data,Dopaminergic Pathway,Injection,As prescribed,Merck,12,Low,High Risk,Low (<50%),Moderate,Gut,Not Suitable
Levothyroxine,Pain Relief,Migraine Treatment,52.64,C4H11N5,HMG-CoA Reductase Inhibitor,Gastrointestinal Issues,1965,Ibuprofen,Lipitor,Low Risk,Slow Metabolism,Phase 1,Animal Testing,PI3K-AKT Pathway,Syrup,10mg once daily,AstraZeneca,12,High,Moderate Risk,Moderate (50-80%),Fast,Enzyme-Specific,Not Suitable
Aspirin,Inflammation,Weight Loss,57.95,C9H8O4,AMPK Activator,"Headache, Rash",1996,Atorvastatin Calcium,Lipitor,High Risk,High Bioavailability,Phase 1,No Preclinical Data,Serotonin Pathway,Tablet,50mg daily,Pfizer,12,Low,High Risk,Moderate (50-80%),Fast,Renal,Suitable
Metformin,Acid Reflux,Weight Loss,83.05,C33H35FN2O5,AMPK Activator,"Headache, Rash",1996,Acetylsalicylic Acid,Aspirin,Low Risk,High Bioavailability,Phase 3,No Preclinical Data,Serotonin Pathway,Tablet,As prescribed,Novartis,24,Moderate,Low Risk,High (>80%),Moderate,Enzyme-Specific,Partially Suitable
Ibuprofen,Fever,Liver Disease,41.44,C17H19N3O3S,NSAID,"Nausea, Dizziness",1965,Ibuprofen,Aspirin,Low Risk,High Bioavailability,Phase 2,In Vitro Studies,Dopaminergic Pathway,Syrup,250mg every 8 hours,Novartis,12,Moderate,Low Risk,Low (<50%),Slow,Enzyme-Specific,Not Suitable
Atorvastatin,Gastric Ulcer,Parkinson's,89.5,C13H18O2,Proton Pump Inhibitor,Gastrointestinal Issues,1987,Ibuprofen,Prilosec,Moderate Risk,Rapid Absorption,Completed,No Preclinical Data,MAPK Pathway,Capsule,10mg once daily,Novartis,6,Low,High Risk,Moderate (50-80%),Slow,Enzyme-Specific,Not Suitable
Omeprazole,Diabetes,Cardiovascular Disease,34.13,C9H8O4,NSAID,Muscle Pain,1971,Omeprazole,Advil,Low Risk,Slow Metabolism,Phase 2,Toxicology Report,Dopaminergic Pathway,Syrup,10mg once daily,Merck,24,High,Moderate Risk,Moderate (50-80%),Fast,Liver,Suitable
Losartan,Inflammation,Antiviral,38.67,C33H35FN2O5,COX Inhibitor,"Nausea, Dizziness",1996,Ibuprofen,Advil,High Risk,High Bioavailability,Completed,No Preclinical Data,MAPK Pathway,Capsule,250mg every 8 hours,Pfizer,6,Low,Low Risk,Moderate (50-80%),Moderate,Liver,Suitable
Paracetamol,Fever,Antiviral,72.81,C4H11N5,AMPK Activator,"Nausea, Dizziness",1965,Metformin Hydrochloride,Glucophage,Low Risk,Slow Metabolism,Phase 2,No Preclinical Data,PI3K-AKT Pathway,Syrup,As prescribed,Pfizer,6,High,High Risk,Moderate (50-80%),Fast,Enzyme-Specific,Suitable
Ranitidine,Gastric Ulcer,Cancer Therapy,88.93,C33H35FN2O5,NSAID,Gastrointestinal Issues,1994,Atorvastatin Calcium,Prilosec,High Risk,Liver Metabolism,Phase 4,In Vitro Studies,MAPK Pathway,Injection,500mg twice a day,Pfizer,12,Low,Moderate Risk,Moderate (50-80%),Fast,Enzyme-Specific,Partially Suitable
Simvastatin,Gastric Ulcer,Cancer Therapy,55.04,C17H19N3O3S,HMG-CoA Reductase Inhibitor,Acid Reflux,1971,Atorvastatin Calcium,Glucophage,Moderate Risk,Renal Excretion,Completed,Toxicology Report,Immune Response Pathway,Tablet,500mg twice a day,AstraZeneca,2,High,Moderate Risk,Low (<50%),Moderate,Gut,Not Suitable
Levothyroxine,Cholesterol Control,Liver Disease,68.57,C13H18O2,COX Inhibitor,Acid Reflux,1994,Atorvastatin Calcium,Prilosec,Low Risk,Rapid Absorption,Ongoing,Toxicology Report,PI3K-AKT Pathway,Syrup,50mg daily,Novartis,48,High,Low Risk,Low (<50%),Slow,Gut,Suitable
Aspirin,Blood Thinner,Parkinson's,84.47,C9H8O4,HMG-CoA Reductase Inhibitor,Muscle Pain,1965,Omeprazole,Lipitor,Low Risk,Liver Metabolism,Completed,No Preclinical Data,Dopaminergic Pathway,Injection,500mg twice a day,Roche,6,Moderate,Low Risk,Low (<50%),Slow,Gut,Partially Suitable
Metformin,Thyroid Hormone Replacement,Cardiovascular Disease,36.72,C9H8O4,COX Inhibitor,Gastrointestinal Issues,1994,Atorvastatin Calcium,Lipitor,High Risk,Slow Metabolism,Ongoing,Toxicology Report,Immune Response Pathway,Capsule,As prescribed,AstraZeneca,6,High,Moderate Risk,Low (<50%),Moderate,Enzyme-Specific,Not Suitable
Ibuprofen,Blood Thinner,Anti-Aging,93.73,C33H35FN2O5,HMG-CoA Reductase Inhibitor,Acid Reflux,1965,Metformin Hydrochloride,Prilosec,High Risk,Slow Metabolism,Phase 4,In Vitro Studies,Dopaminergic Pathway,Tablet,50mg daily,Roche,6,Low,Low Risk,Low (<50%),Moderate,Liver,Partially Suitable
Atorvastatin,Cholesterol Control,Antiviral,43.47,C9H8O4,NSAID,"Headache, Rash",1994,Metformin Hydrochloride,Prilosec,Moderate Risk,Renal Excretion,Completed,Animal Testing,Immune Response Pathway,Topical Gel,50mg daily,AstraZeneca,24,Moderate,Low Risk,Low (<50%),Slow,Gut,Suitable
Omeprazole,Diabetes,Liver Disease,94.22,C17H19N3O3S,AMPK Activator,Gastrointestinal Issues,1996,Acetylsalicylic Acid,Prilosec,Moderate Risk,Slow Metabolism,Ongoing,In Vitro Studies,PI3K-AKT Pathway,Injection,10mg once daily,AstraZeneca,2,Moderate,High Risk,Low (<50%),Fast,Liver,Not Suitable
Losartan,Cholesterol Control,Alzheimer's,35.6,C17H19N3O3S,COX Inhibitor,"Headache, Rash",1996,Atorvastatin Calcium,Glucophage,Moderate Risk,Liver Metabolism,Phase 1,In Vitro Studies,MAPK Pathway,Syrup,As prescribed,Pfizer,48,High,Low Risk,High (>80%),Moderate,Liver,Not Suitable
Paracetamol,Pain Relief,Cancer Therapy,39.31,C33H35FN2O5,Proton Pump Inhibitor,Acid Reflux,1996,Omeprazole,Prilosec,High Risk,Rapid Absorption,Phase 1,No Preclinical Data,MAPK Pathway,Capsule,250mg every 8 hours,AstraZeneca,24,Moderate,Low Risk,High (>80%),Moderate,Enzyme-Specific,Suitable
Ranitidine,Inflammation,Antiviral,69.07,C33H35FN2O5,AMPK Activator,Muscle Pain,1965,Acetylsalicylic Acid,Advil,Low Risk,High Bioavailability,Completed,In Vitro Studies,Immune Response Pathway,Tablet,As prescribed,Novartis,2,Low,Moderate Risk,Moderate (50-80%),Fast,Liver,Not Suitable
Simvastatin,Hypertension,Cardiovascular Disease,39.29,C4H11N5,AMPK Activator,Gastrointestinal Issues,1996,Atorvastatin Calcium,Prilosec,Moderate Risk,High Bioavailability,Phase 2,Toxicology Report,Immune Response Pathway,Capsule,As prescribed,AstraZeneca,48,High,Low Risk,Moderate (50-80%),Slow,Renal,Not Suitable
Levothyroxine,Thyroid Hormone Replacement,Liver Disease,93.24,C33H35FN2O5,AMPK Activator,Gastrointestinal Issues,1994,Metformin Hydrochloride,Glucophage,Low Risk,Slow Metabolism,Phase 2,In Vitro Studies,Serotonin Pathway,Capsule,50mg daily,Novartis,48,Low,High Risk,Low (<50%),Fast,Enzyme-Specific,Partially Suitable
Aspirin,Gastric Ulcer,Parkinson's,54.94,C13H18O2,COX Inhibitor,"Nausea, Dizziness",1987,Atorvastatin Calcium,Lipitor,Moderate Risk,Rapid Absorption,Completed,Animal Testing,Serotonin Pathway,Capsule,As prescribed,Merck,12,Moderate,Moderate Risk,Moderate (50-80%),Moderate,Renal,Partially Suitable
Metformin,Fever,Cancer Therapy,56.05,C4H11N5,AMPK Activator,Gastrointestinal Issues,1994,Ibuprofen,Prilosec,High Risk,Liver Metabolism,Phase 2,No Preclinical Data,MAPK Pathway,Injection,500mg twice a day,Pfizer,48,Low,High Risk,Moderate (50-80%),Moderate,Enzyme-Specific,Partially Suitable
Ibuprofen,Hypertension,Antiviral,93.19,C17H19N3O3S,NSAID,Gastrointestinal Issues,1965,Ibuprofen,Lipitor,High Risk,Renal Excretion,Phase 3,In Vitro Studies,MAPK Pathway,Topical Gel,500mg twice a day,AstraZeneca,12,Low,Moderate Risk,Moderate (50-80%),Slow,Renal,Suitable
Atorvastatin,Gastric Ulcer,Liver Disease,34.81,C9H8O4,COX Inhibitor,Muscle Pain,1987,Atorvastatin Calcium,Glucophage,High Risk,Liver Metabolism,Phase 2,Toxicology Report,PI3K-AKT Pathway,Topical Gel,50mg daily,Pfizer,6,Moderate,High Risk,Moderate (50-80%),Slow,Gut,Suitable
Omeprazole,Thyroid Hormone Replacement,Cardiovascular Disease,72.41,C33H35FN2O5,Proton Pump Inhibitor,Acid Reflux,1987,Ibuprofen,Aspirin,High Risk,High Bioavailability,Ongoing,In Vitro Studies,Immune Response Pathway,Syrup,50mg daily,Roche,6,Low,Low Risk,Moderate (50-80%),Slow,Renal,Partially Suitable
Losartan,Hypertension,Antiviral,66.28,C4H11N5,COX Inhibitor,"Nausea, Dizziness",1996,Metformin Hydrochloride,Prilosec,High Risk,Slow Metabolism,Ongoing,In Vitro Studies,Dopaminergic Pathway,Tablet,500mg twice a day,Merck,48,Moderate,Moderate Risk,Moderate (50-80%),Fast,Liver,Partially Suitable
Paracetamol,Acid Reflux,Autoimmune Disorders,94.45,C4H11N5,AMPK Activator,Acid Reflux,1971,Ibuprofen,Aspirin,High Risk,Slow Metabolism,Phase 3,Animal Testing,Immune Response Pathway,Tablet,250mg every 8 hours,Novartis,6,Low,High Risk,Low (<50%),Moderate,Enzyme-Specific,Partially Suitable
Ranitidine,Hypertension,Migraine Treatment,44.73,C4H11N5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1987,Atorvastatin Calcium,Prilosec,High Risk,Renal Excretion,Phase 2,Toxicology Report,MAPK Pathway,Injection,500mg twice a day,Merck,24,High,High Risk,Moderate (50-80%),Moderate,Renal,Partially Suitable
Simvastatin,Inflammation,Liver Disease,71.73,C17H19N3O3S,NSAID,Gastrointestinal Issues,1965,Omeprazole,Glucophage,Moderate Risk,Liver Metabolism,Phase 1,No Preclinical Data,Serotonin Pathway,Syrup,500mg twice a day,Pfizer,6,High,Low Risk,Moderate (50-80%),Slow,Gut,Partially Suitable
Levothyroxine,Blood Thinner,Autoimmune Disorders,68.12,C9H8O4,AMPK Activator,"Headache, Rash",1996,Metformin Hydrochloride,Advil,Moderate Risk,Slow Metabolism,Completed,Animal Testing,Serotonin Pathway,Injection,250mg every 8 hours,Merck,24,Moderate,Moderate Risk,High (>80%),Moderate,Liver,Not Suitable
Aspirin,Acid Reflux,Liver Disease,45.52,C13H18O2,COX Inhibitor,Gastrointestinal Issues,1965,Metformin Hydrochloride,Prilosec,Low Risk,Renal Excretion,Phase 3,Toxicology Report,MAPK Pathway,Syrup,500mg twice a day,AstraZeneca,6,Low,Low Risk,Moderate (50-80%),Slow,Liver,Not Suitable
Metformin,Fever,Alzheimer's,81.15,C13H18O2,NSAID,Acid Reflux,1994,Ibuprofen,Aspirin,Moderate Risk,Slow Metabolism,Ongoing,Animal Testing,MAPK Pathway,Syrup,500mg twice a day,AstraZeneca,2,High,Low Risk,High (>80%),Fast,Renal,Partially Suitable
Ibuprofen,Fever,Weight Loss,60.21,C4H11N5,COX Inhibitor,Muscle Pain,1965,Atorvastatin Calcium,Advil,Low Risk,Renal Excretion,Ongoing,Animal Testing,Serotonin Pathway,Injection,10mg once daily,AstraZeneca,24,Low,High Risk,High (>80%),Fast,Enzyme-Specific,Not Suitable
Atorvastatin,Gastric Ulcer,Anti-Aging,79.68,C9H8O4,AMPK Activator,Acid Reflux,1965,Acetylsalicylic Acid,Lipitor,High Risk,Liver Metabolism,Ongoing,Toxicology Report,Dopaminergic Pathway,Capsule,As prescribed,Novartis,12,Low,Low Risk,High (>80%),Fast,Liver,Suitable
Omeprazole,Blood Thinner,Weight Loss,70.35,C13H18O2,HMG-CoA Reductase Inhibitor,Acid Reflux,1994,Ibuprofen,Glucophage,Moderate Risk,Liver Metabolism,Phase 2,Animal Testing,Serotonin Pathway,Injection,250mg every 8 hours,AstraZeneca,12,Moderate,High Risk,Low (<50%),Slow,Gut,Suitable
Losartan,Pain Relief,Cardiovascular Disease,49.66,C17H19N3O3S,Proton Pump Inhibitor,"Headache, Rash",1987,Ibuprofen,Prilosec,Moderate Risk,High Bioavailability,Phase 3,No Preclinical Data,PI3K-AKT Pathway,Injection,50mg daily,Pfizer,2,Moderate,Moderate Risk,Low (<50%),Fast,Renal,Suitable
Paracetamol,Acid Reflux,Anti-Aging,80.24,C17H19N3O3S,Proton Pump Inhibitor,"Nausea, Dizziness",1987,Metformin Hydrochloride,Lipitor,Moderate Risk,Rapid Absorption,Phase 2,In Vitro Studies,Immune Response Pathway,Injection,250mg every 8 hours,Roche,2,Moderate,Moderate Risk,Moderate (50-80%),Slow,Enzyme-Specific,Partially Suitable
Ranitidine,Blood Thinner,Cardiovascular Disease,93.27,C9H8O4,COX Inhibitor,"Nausea, Dizziness",1987,Acetylsalicylic Acid,Aspirin,High Risk,Slow Metabolism,Phase 1,Toxicology Report,Serotonin Pathway,Syrup,10mg once daily,AstraZeneca,48,Moderate,Low Risk,High (>80%),Slow,Liver,Suitable
Simvastatin,Pain Relief,Weight Loss,65.58,C4H11N5,Proton Pump Inhibitor,Gastrointestinal Issues,1987,Atorvastatin Calcium,Lipitor,High Risk,High Bioavailability,Completed,Toxicology Report,Serotonin Pathway,Injection,As prescribed,Roche,6,Moderate,High Risk,Low (<50%),Slow,Liver,Partially Suitable
Levothyroxine,Blood Thinner,Parkinson's,89.36,C4H11N5,HMG-CoA Reductase Inhibitor,"Headache, Rash",1971,Atorvastatin Calcium,Prilosec,Moderate Risk,Rapid Absorption,Phase 1,In Vitro Studies,Immune Response Pathway,Injection,As prescribed,Novartis,2,Low,Low Risk,Low (<50%),Moderate,Enzyme-Specific,Not Suitable
Aspirin,Blood Thinner,Cancer Therapy,87.59,C33H35FN2O5,AMPK Activator,"Nausea, Dizziness",1996,Ibuprofen,Glucophage,Low Risk,Liver Metabolism,Completed,In Vitro Studies,Dopaminergic Pathway,Capsule,50mg daily,AstraZeneca,12,Low,Low Risk,Low (<50%),Slow,Renal,Not Suitable
Metformin,Thyroid Hormone Replacement,Parkinson's,89.1,C13H18O2,AMPK Activator,"Nausea, Dizziness",1965,Omeprazole,Advil,Low Risk,Rapid Absorption,Ongoing,Animal Testing,Immune Response Pathway,Injection,10mg once daily,Roche,48,High,Low Risk,High (>80%),Fast,Liver,Suitable
Ibuprofen,Gastric Ulcer,Parkinson's,31.06,C17H19N3O3S,NSAID,"Nausea, Dizziness",1965,Omeprazole,Lipitor,Low Risk,Rapid Absorption,Phase 1,Animal Testing,MAPK Pathway,Topical Gel,As prescribed,AstraZeneca,24,Moderate,High Risk,Moderate (50-80%),Moderate,Gut,Suitable
Atorvastatin,Inflammation,Parkinson's,59.02,C9H8O4,Proton Pump Inhibitor,Gastrointestinal Issues,1996,Omeprazole,Glucophage,High Risk,Liver Metabolism,Ongoing,No Preclinical Data,Dopaminergic Pathway,Syrup,50mg daily,Novartis,6,High,Moderate Risk,High (>80%),Slow,Enzyme-Specific,Suitable
Omeprazole,Diabetes,Liver Disease,57.74,C17H19N3O3S,COX Inhibitor,"Headache, Rash",1987,Metformin Hydrochloride,Advil,Low Risk,High Bioavailability,Completed,Toxicology Report,Serotonin Pathway,Tablet,10mg once daily,AstraZeneca,24,Moderate,Low Risk,High (>80%),Moderate,Enzyme-Specific,Partially Suitable
Losartan,Blood Thinner,Alzheimer's,54.23,C9H8O4,NSAID,Gastrointestinal Issues,1996,Acetylsalicylic Acid,Prilosec,High Risk,High Bioavailability,Phase 2,Animal Testing,MAPK Pathway,Topical Gel,500mg twice a day,Merck,24,Low,Low Risk,Moderate (50-80%),Fast,Liver,Partially Suitable
Paracetamol,Cholesterol Control,Antiviral,72.65,C4H11N5,COX Inhibitor,"Nausea, Dizziness",1996,Acetylsalicylic Acid,Lipitor,Low Risk,Rapid Absorption,Phase 1,In Vitro Studies,Serotonin Pathway,Injection,500mg twice a day,Merck,2,High,Low Risk,Moderate (50-80%),Slow,Enzyme-Specific,Not Suitable
Ranitidine,Cholesterol Control,Cardiovascular Disease,91.64,C4H11N5,AMPK Activator,Muscle Pain,1996,Atorvastatin Calcium,Lipitor,Low Risk,Rapid Absorption,Phase 4,No Preclinical Data,Immune Response Pathway,Injection,50mg daily,Pfizer,2,Low,Low Risk,Low (<50%),Fast,Renal,Not Suitable
Simvastatin,Gastric Ulcer,Liver Disease,35.62,C17H19N3O3S,COX Inhibitor,Gastrointestinal Issues,1987,Metformin Hydrochloride,Glucophage,High Risk,Liver Metabolism,Completed,Toxicology Report,PI3K-AKT Pathway,Injection,500mg twice a day,AstraZeneca,24,Low,Low Risk,Low (<50%),Moderate,Enzyme-Specific,Not Suitable
Levothyroxine,Acid Reflux,Weight Loss,31.18,C13H18O2,HMG-CoA Reductase Inhibitor,"Nausea, Dizziness",1996,Metformin Hydrochloride,Advil,High Risk,Liver Metabolism,Phase 3,Animal Testing,MAPK Pathway,Topical Gel,500mg twice a day,Roche,12,Moderate,Moderate Risk,Moderate (50-80%),Fast,Gut,Partially Suitable
